Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7543817668257053,-2.921924046295677,0.0,0.0,0.0,67/87,15.95%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;SEC61B;RPL22;RPL24;SRP19
prerank,cytoplasmic translation (GO:0002181),-0.7457158195156718,-2.8921556125942516,0.0,0.0,0.0,69/91,15.86%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL22L1;RPL12;RPS20;RPL13A;ZC3H15;EIF3I;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;EIF4A1;RPL22;EIF2B3;RPL24
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7341837326362635,-2.871119667799261,0.0,0.0,0.0,63/91,13.61%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15
prerank,protein targeting to ER (GO:0045047),-0.7184948673491844,-2.8393081655859485,0.0,0.0,0.0,68/99,15.95%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;SPCS1;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;RPL22;SGTA;RPL24;SRP19
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6853731525050933,-2.737526962125632,0.0,0.0,0.0,71/110,14.64%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;PPP2R1A;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22
prerank,peptide biosynthetic process (GO:0043043),-0.6371429723267589,-2.6772731986993015,0.0,0.0,0.0,80/153,15.21%,EEF1A1;DMD;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;GGTA1;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;MRPL51;HBS1L;RPS18;CARNS1;WARS1;MRPL28;RPL12;RPS20;RPL13A;GGT5;RPS6KB2;RPL10A;RPS7;MRPL43;RPL36;RPS6;RPL3;COPS5;MRPL32;RPL15;RPL22;MRPL24;MRPS17
prerank,translation (GO:0006412),-0.5692291276004894,-2.4938089444144422,0.0,0.0,0.0,92/208,15.21%,EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;QRSL1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;MRPL52;PTCD3;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;WARS2;RPL8;EEFSEC;MRPL51;HBS1L;RPS18;CARS1;RPL22L1;LARS2;WARS1;MRPL28;RPL12;RPS20;RPL13A;ZC3H15;RPS6KB2;EEF1B2;RPL10A;RPS7;SARS2;MRPL43;RPL36;TSFM;TARS1;RPS6;RPL3;COPS5;GATC;MRPL32;RPL15;RPL22;FARS2;MRPL24;MRPS17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.565889551037083,-2.3872029116462623,0.0,0.0,0.0,78/168,14.93%,DDX5;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;CNOT7;RPL35;RPL27;PPP2R1A;RPL23A;DCPS;ERI1;RPL29;RPL34;RPL31;RPL35A;RC3H1;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;DIS3L2;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22;PAN2
prerank,cellular response to copper ion (GO:0071280),-0.8378713706540497,-2.195281671860316,0.0,0.00012768513214574446,0.001,9/16,3.96%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A
prerank,regulation of bone mineralization (GO:0030500),0.6220783611871038,2.157305010575645,0.0,0.039106426298709925,0.042,15/55,2.10%,BMP6;ENPP1;ADGRV1;WNT4;NELL1;NOTUM;BMP2;PTN;FBN2;DDR2;SLC8A1;BCOR;CYP27B1;KL;AHSG
prerank,response to copper ion (GO:0046688),-0.7590718923742612,-2.1561114645267554,0.0,0.00034474985679351004,0.003,10/20,4.92%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A;ATP5F1D
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8452868535684779,2.1386975296326054,0.0,0.025793600324681015,0.054,5/13,0.82%,LTBP1;GREM2;FBN1;BMP2;FBN2
prerank,establishment of endothelial barrier (GO:0061028),-0.6780325926809072,-2.129107118834897,0.0,0.0009402268821641184,0.009,13/29,9.53%,PECAM1;RAP1A;RAP1B;F11R;RAPGEF1;PDE4D;PPP1R16B;TJP2;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,positive regulation of synapse assembly (GO:0051965),0.6996225474707655,2.1225813628752084,0.0,0.02191069274892258,0.069,14/27,10.62%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;VSTM5
prerank,rRNA processing (GO:0006364),-0.4888162186209442,-2.0934854755928107,0.0,0.002968679322388559,0.029,87/172,25.93%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RRP15;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;PRKDC;ERI1;RPL29;RPL34;RPL31;NOP56;RPL35A;THUMPD1;RPL8;NOP2;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74;RPL24;EMG1;EXOSC8;RPLP2;HELQ;RPL7;WDR12;DDX10;RPL5;UTP4;PIH1D2;DDX49;NSA2;PWP2;MRM2;TBL3;RSL1D1;WDR55;DDX47;RPL7A;RIOK2;UTP15;DIS3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.637462254407518,-2.088744922695345,0.0,0.0030939089712238082,0.032,20/36,20.94%,CAV1;NOS3;NOSTRIN;SCARB1;GCH1;CALM1;AKT1;APOE;S100A1;LYPLA1;WASL;EGFR;NPR3;SPR;HSP90AA1;NOSIP;CYGB;NUS1;DNM2;DDAH1
prerank,activation of protein kinase A activity (GO:0034199),0.7632362313130335,2.0663055819021445,0.002380952380952381,0.053459316801959846,0.203,5/16,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5871276426872462,-2.0658715747139924,0.0,0.00517124785190265,0.057,20/58,12.89%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;ST8SIA6;KDSR;SPTSSB;SPNS2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,rRNA metabolic process (GO:0016072),-0.48654832864090103,-2.0549249910748864,0.0,0.0055159977086961616,0.065,59/160,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,positive regulation of bone mineralization (GO:0030501),0.6460465935454486,2.0430444941560677,0.0,0.06207105110390979,0.278,9/35,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,cellular response to zinc ion (GO:0071294),-0.7935604319216009,-2.0418160424387577,0.0,0.006176768267550388,0.075,9/15,3.96%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A
prerank,cAMP biosynthetic process (GO:0006171),0.8329007939877341,2.016932499775241,0.0,0.07530067191560103,0.365,4/10,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,positive regulation of ossification (GO:0045778),0.6150760564788631,2.0167709053810685,0.0,0.06454343307051516,0.365,9/39,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,response to cadmium ion (GO:0046686),-0.6562242586915321,-2.0097379590894353,0.0,0.010680485759485213,0.136,10/26,3.96%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MAPK3;MT2A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6171374662051223,1.994097512725136,0.0,0.07738080097404304,0.458,9/40,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.43606764794336306,-1.99145542166056,0.0,0.012960040912793064,0.172,135/306,25.02%,ST3GAL4;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;ING5;RPS24;RPS27A;RPL18;RPS13;RPS19;PTMA;RPL35;RPL27;MRPL52;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;RPL8;EEFSEC;RAD1;MRPL51;HBS1L;RPS18;WARS1;MRPL28;FAM111A;RPL12;RPS20;RPL13A;INHBA;XAB2;RPS6KB2;EEF1B2;RPL10A;PPP5C;E2F1;RPS7;APOE;MRPL43;RPL36;TSFM;RNPS1;RPS6;RPL3;COPS5;MRPL32;RPL15;EPC1;PTMS;RAD9B;POLR3A;RPL22;MRPL24;MRPS17;HUS1;RPA3;RAD9A;RPL24;RAD17;MED20;RPS26;RPLP2;CHEK1;TYMS;MRPS18C;RPL7;MRPS18A;MRPL35;ALAS2;RPL5;PWP1;FARSB;MRPS6;RHNO1;EIF4G1;RRAGC;MLF1;TUFM;MRPL13;RFC3;MRPL11;DHPS;POLE3;LARGE1;MCM5;RFC2;POLL;GOLPH3;EXO1;RPL7A;HOXD3
prerank,tight junction assembly (GO:0120192),-0.5744995645917712,-1.9864464934390855,0.0,0.01318516996157635,0.185,9/49,2.77%,PECAM1;OCLN;CLDN5;ESAM;LSR;ACTG1;PARD3;F11R;RAMP2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.6493126256275766,-1.984690731076177,0.0,0.01287066132029104,0.19,13/26,16.86%,ACER2;SPTLC2;NOS3;GCH1;CYP1B1;SPTLC1;AKT1;ASAH2;ABCA2;SPHK2;ACER3;SPR;NQO1
prerank,presynapse assembly (GO:0099054),0.7601873878688271,1.979481814746188,0.0,0.08764277099569033,0.547,8/16,10.34%,LRP4;PTPRD;LRRTM3;NLGN2;NLGN3;IL1RAPL1;NLGN1;PTEN
prerank,negative regulation of reproductive process (GO:2000242),0.7471155041517845,1.9793416472640502,0.0,0.07921131454547202,0.549,4/17,1.53%,IGF1;SULF1;HYAL3;GJA1
prerank,ribosome assembly (GO:0042255),-0.5788561388328105,-1.9791976297186318,0.0,0.014063605269195567,0.212,20/47,15.86%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL11;RPS28;RPS5;RPS19;RPL23A;NOP2;RPS27L;DHX37;RPL3;PPAN;MTERF3;MDN1;ERAL1;RPL24
prerank,cellular response to mechanical stimulus (GO:0071260),-0.58064883465108,-1.979003683846935,0.0,0.013424350484232133,0.212,21/46,20.22%,PIEZO2;F11R;MAPK3;PIEZO1;MAP3K1;CRADD;PDE2A;CASP8;TLR3;MAP3K2;FAS;TLR4;BAK1;TNFRSF1A;BAD;CHEK1;PTGER4;GADD45A;SOX9;CASP1;LTBR
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6586784416531325,-1.9742996770408834,0.0,0.014489486734799698,0.234,11/26,5.47%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A;SLC39A8
prerank,cellular response to glucagon stimulus (GO:0071377),0.729864248409443,1.9699648488102652,0.002304147465437788,0.08214618754429202,0.592,5/17,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,regulation of synapse assembly (GO:0051963),0.5838919449637834,1.9643386479170106,0.0,0.08230377307902248,0.617,17/46,10.83%,GPC6;SRPX2;ROBO2;GRID2;NRXN1;CLSTN2;GPC4;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;MUSK
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6381597235793626,-1.9631381195917492,0.0,0.016471382046801035,0.272,15/30,6.76%,PECAM1;ACTB;OCLN;CLDN5;ESAM;SLC12A2;JAM2;LSR;DMD;ACTG1;F11R;TJP2;JAM3;SLC1A1;MFSD2A
prerank,neurotransmitter uptake (GO:0001504),0.8007288452645636,1.960343349759039,0.0,0.07994095981520245,0.632,7/12,8.61%,SLC1A3;ATP1A2;SLC29A1;SLC22A3;SLC38A1;SNAP25;GLUL
prerank,cellular response to cadmium ion (GO:0071276),-0.6572175444613962,-1.9502457277819825,0.0039603960396039604,0.019903558398878644,0.327,10/24,3.96%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MAPK3;MT2A
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5792377899407857,-1.9439683958332141,0.0,0.021215375802677544,0.352,28/39,33.97%,RPS16;RPS14;RPSA;RPS25;RPS15;NOP14;RPS27;RPS28;RPS5;RPS24;RPS19;NOB1;RPS27L;RPS7;RPS6;ERAL1;EMG1;UTP4;PWP2;NOM1;RIOK2;NPM1;LSM6;RIOK1;LTV1;RIOK3;RRP36;RRP7A
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.6906075010870951,-1.9419971410666315,0.0,0.020855238250471596,0.358,9/22,9.03%,TMSB4X;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1;TMSB10
prerank,positive regulation of nervous system development (GO:0051962),0.5839054698267347,1.9408675095035546,0.0,0.09544820765308228,0.714,14/42,9.52%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;SERPINF1;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2
prerank,ribosomal small subunit assembly (GO:0000028),-0.7230818813854718,-1.9400258014986536,0.0,0.020890199655701977,0.369,10/16,14.99%,RPS14;RPSA;RPS15;RPS27;RPS28;RPS5;RPS19;PRKDC;RPS27L;ERAL1
prerank,negative regulation of vascular permeability (GO:0043116),-0.7880836432598763,-1.9389791076636436,0.0,0.02040760646536295,0.375,7/12,5.68%,CLDN5;PTPRJ;RAMP2;FERMT2;SLIT2;PDE2A;VEGFA
prerank,cAMP metabolic process (GO:0046058),0.7396696273933977,1.9348555782902346,0.0,0.09635157798703424,0.748,4/13,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,renal water homeostasis (GO:0003091),0.6572590740586272,1.924884398180767,0.0,0.10447448196025032,0.795,5/23,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,skeletal system development (GO:0001501),0.47084197380795934,1.917727989705665,0.0,0.1085093205309636,0.817,38/148,11.13%,IGF1;BMP6;COL13A1;FBN1;NOTUM;BMP2;TBX3;COL1A2;FGFR2;SULF1;HYAL3;BMP5;SULF2;GJA1;MATN3;TRPS1;AHSG;GLI2;CHD7;SH3PXD2B;MMP16;ANKRD11;EVC;CDH11;ANKH;COL10A1;SPEF2;PAPSS1;TGFBR1;IGF2;HES5;CNMD;SOX5;RAB33B;COL9A2;FRZB;UFD1;EXTL1
prerank,diol biosynthetic process (GO:0034312),-0.7274293252807872,-1.9159591819594546,0.0,0.028269488257067824,0.475,9/15,16.60%,ACER2;SPTLC2;GCH1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3;SPR
prerank,response to glucagon (GO:0033762),0.6904147654198409,1.91184315556987,0.004608294930875576,0.1101081648268641,0.838,5/19,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,neuron cell-cell adhesion (GO:0007158),0.7483203133469004,1.9117513917643019,0.0021929824561403508,0.10453195921054938,0.838,9/14,9.26%,NRXN1;CNTN4;NCAM2;ASTN2;NLGN2;NLGN3;NRXN3;NLGN1;CDK5R1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.561916453745776,1.9110225690493783,0.002150537634408602,0.10009581029222987,0.839,8/43,3.61%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;CCN4
prerank,gene expression (GO:0010467),-0.407899043459879,-1.9096518026114777,0.0,0.030286089569924485,0.509,144/348,23.30%,TSPAN5;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;HNRNPA2B1;RPL37A;RPL38;RPL39;DDX17;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;SRSF2;RPS19;PTMA;RPL35;SRSF5;RPL27;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;NUP93;RPL8;SRSF6;MRPL51;HBS1L;RPS18;WARS1;NDC1;HHEX;NUP54;MRPL28;RPL12;RPS20;U2AF1;HSPD1;TSPAN14;RPL13A;XAB2;RPS6KB2;RPL10A;LMF2;ZC3H11A;PPP5C;E2F1;RPS7;RBMS2;MRPL43;RPL36;RNPS1;RPS6;RPL3;COPS5;DKC1;NUP188;MRPL32;RBM6;RPL15;EPC1;SRSF4;MAGOH;NUP155;POLR3A;RANBP2;RPL22;CHTOP;HNRNPK;MRPL24;MRPS17;ALYREF;AGFG1;RPL24;TSPAN17;NUP37;DDX20;DDX39B;MED20;RPS26;RPLP2;DUSP11;SMG7;CASC3;MRPS18C;RPL7;SYNCRIP;MRPS18A;MRPL35;THOC6;RPL5;CPSF4;PWP1;FARSB;MRPS6;NUP160;EIF4G1;DDX39A;RRAGC;NCBP2;MLF1;MRPL13;MRPL11;DHPS
prerank,sphingosine biosynthetic process (GO:0046512),-0.7763024136847831,-1.9062796415558725,0.0,0.030191729882825574,0.525,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),-0.7763024136847831,-1.9062796415558725,0.0,0.030191729882825574,0.525,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5488233572540024,1.9048791629036137,0.002074688796680498,0.10258007871059777,0.857,13/57,12.65%,ADCY7;ADCY2;ADCY1;LPAR1;ADCY5;GNAI1;CHRM2;OPRK1;CHRM3;ADCY8;HTR4;HTR5A;GRM4
prerank,ribosome biogenesis (GO:0042254),-0.4380420878912353,-1.9034349477247834,0.0,0.030790894072439966,0.543,60/187,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;CUL4A;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6626142457387698,1.8956616456497013,0.0,0.11032248115409753,0.888,4/24,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.696278855965176,-1.8925862047076725,0.0018181818181818182,0.03483615219599182,0.598,9/19,12.36%,IFIH1;LIFR;MAP2K5;KLF4;ELF1;IRAK2;CBFB;DHX9;MAVS
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.5130548041945725,-1.8889501647734268,0.0,0.03549646673651696,0.614,20/67,9.77%,UTRN;FN1;CDK6;LIMS2;RREB1;VIT;DOCK1;PTK2B;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;JUP;NPNT;PPM1F;FBLN2;S100A10;EMP2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7682399945769944,-1.8867856507370164,0.001890359168241966,0.03540674204906319,0.623,7/12,14.62%,CAV1;PDE4D;CAMK2D;CALM1;GJD3;CALM3;SRI
prerank,negative regulation of growth (GO:0045926),-0.4642787540598367,-1.8820683552587762,0.0,0.03656162954941699,0.641,58/121,23.46%,APBB2;PTPRJ;SERTAD2;NOTCH1;OSGIN2;RACK1;BMPR2;SH3BP4;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;MT2A;TGFB1;TGFB2;ING5;PPP2R1A;NDUFA13;BCL6;SIPA1;RB1;WFDC1;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1;FGFR3
prerank,axonal fasciculation (GO:0007413),0.7722384424525865,1.881162237987952,0.0,0.12697831295880835,0.926,7/12,14.10%,SEMA5A;CNTN4;EPHA3;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,negative regulation of viral life cycle (GO:1903901),-0.7131893806138869,-1.8803883075961452,0.0017921146953405018,0.03671438645852252,0.654,8/15,19.75%,LY6E;MID2;PPIA;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,regulation of protein processing (GO:0070613),0.6609110041119286,1.8723641612884954,0.004395604395604396,0.13406431781658804,0.942,2/21,1.70%,CCBE1;SERPINE2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.581539631183479,-1.870822291618322,0.0019342359767891683,0.040881587184763736,0.706,18/32,12.82%,THBS1;NOTCH1;RHOJ;MAP2K5;KDR;STARD13;KLF4;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,diterpenoid metabolic process (GO:0016101),0.529323740439316,1.8676272441550683,0.00205761316872428,0.1360237993896404,0.946,8/55,4.05%,ALDH1A1;GPC6;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5766382646290104,-1.8651755071960217,0.001841620626151013,0.043135774764651386,0.733,21/37,25.91%,HSP90AB1;RPL11;RPL23;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;RPS7;SDCBP;SGTA;CSNK2A1;CSNK2A2;CCAR2;MAP1A;RPL5;TAF9;TRIM39;PARK7
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6269425761951549,1.8630578805260951,0.0,0.13770454366886156,0.952,7/25,7.40%,ERRFI1;SLC6A9;CBLB;PPARA;VPS25;CALCR;ZFYVE28
prerank,zinc ion homeostasis (GO:0055069),-0.615865541107633,-1.8628175454142524,0.003968253968253968,0.04361359299435357,0.744,11/28,5.47%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A;SLC39A8
prerank,activation of adenylate cyclase activity (GO:0007190),0.5716549125290306,1.861462868650666,0.0,0.13417602845120805,0.953,5/35,1.26%,ADCY7;ADCY2;ADCY1;LGR4;ADCY5
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6312865844713998,1.8604512232213082,0.0,0.13089955003481551,0.955,4/26,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6657700939401039,-1.8508634633698366,0.0,0.049253797369801476,0.795,7/18,4.81%,TEK;RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,endothelial cell development (GO:0001885),-0.6056042323690668,-1.850783437832403,0.0037735849056603774,0.04816051029751762,0.796,12/25,9.53%,PECAM1;RAP1A;RAP1B;RAPGEF1;PDE4D;PPP1R16B;COL18A1;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,ncRNA processing (GO:0034470),-0.429947126160337,-1.8498371989676536,0.0,0.04752440618464609,0.798,78/200,20.81%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;HNRNPA2B1;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;ADAR;RPL23;RPL17;RPL14;SARS1;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;INTS8;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;INTS1;RPL15;RPL22;FARS2;MDN1;WDR74;RPL24;EMG1;EXOSC8;TRPT1;RPLP2;SMAD2;HELQ;RPP21;RPL7;WDR12;DDX10;RPL5;UTP4
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7564332125041333,1.8485199729703992,0.0045351473922902496,0.1440023137147653,0.971,3/11,1.32%,WNT4;BMP2;BMP5
prerank,synaptic membrane adhesion (GO:0099560),0.717342981302936,1.8472890381119393,0.006741573033707865,0.14125463059526924,0.972,4/14,3.62%,GPC6;LRRC4C;GPC4;PTPRD
prerank,diol metabolic process (GO:0034311),-0.6531533974707071,-1.8396387449785956,0.005671077504725898,0.05441052087654094,0.844,11/19,20.38%,NOS3;DEGS2;GCH1;CALM1;PLPP1;AKT1;ASAH2;SPHK2;SPR;HSP90AA1;PLPP2
prerank,cell-substrate junction assembly (GO:0007044),-0.5844400629762925,-1.8394289190892077,0.0,0.05335065159740702,0.844,14/33,12.21%,FN1;ITGA6;THSD1;SORBS1;PEAK1;FERMT2;ITGB4;CD151;LAMA3;ACTN1;BCR;LAMC2;TAOK2;RCC2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.6635136002282538,-1.835106094065114,0.0018587360594795538,0.055495150558844186,0.862,10/18,16.67%,MSN;CD81;EZR;CTSC;PTTG1IP;APOE;ABCA2;VPS11;ATP5IF1;HSP90AA1
prerank,neuron projection fasciculation (GO:0106030),0.7839701150444105,1.8339918146415612,0.004545454545454545,0.15771404319232638,0.984,6/10,14.10%,SEMA5A;CNTN4;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,regulation of cell junction assembly (GO:1901888),-0.6003487270233107,-1.8328151020946257,0.0017730496453900709,0.056168429049010656,0.873,10/27,9.23%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;RAP1B;F11R;RAPGEF1;CBFB;FLOT1
prerank,positive regulation of protein processing (GO:0010954),0.6719978440981706,1.8306346547337375,0.011210762331838564,0.15749177133729125,0.985,2/19,0.75%,CCBE1;CLEC3B
prerank,cellular protein metabolic process (GO:0044267),-0.3856113897748641,-1.8282131976096498,0.0,0.058469575712179304,0.888,126/396,14.64%,FN1;ST3GAL6;ST8SIA4;IGFBP7;GPC3;EEF1A1;IGFBP6;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;MANBA;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;PLOD2;RPL37A;DAB2IP;RPL38;RPL39;IGFBP5;RPL11;APP;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;WWP2;RPS5;MSLN;ADAM10;SARS1;SPARCL1;RPL21;IGFBP3;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;SFTPA2;SFTPA1;RPL27;LTA4H;MRPL52;GATA6;RPL23A;PRKDC;MSRA;NUCB1;CSNK1G3;RPL29;IDE;RPL34;RIPK1;SPCS1;RPL31;RPL35A;RPL8;QSOX1;DENND3;MFGE8;MRPL51;HBS1L;UBE2L6;RPS18;CST3;PSENEN;SPP1;WARS1;CPE;PNPLA2;ATG3;MRPL28;RPL12;RPS20;RPL13A;UBE2G2;ABL2;RPS6KB2;RPL10A;STK38;CHRDL1;SEC11A;MMP15;RPS7;APOE;MRPL43;RPL36;ICMT;FSTL1;RNF5;RPS6;RPL3;COPS5;MRPL32;RPL15;FBXL2;LOX;FUCA2;APH1A;UBE2G1;RPL22
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7025698310547839,1.8270935164825446,0.004395604395604396,0.15927485166276634,0.988,6/16,6.49%,IGF1;IGFBP2;BMP2;BMP5;PHIP;MYORG
prerank,retinoid metabolic process (GO:0001523),0.4941299409352274,1.8179097419909527,0.0,0.17064399911195513,0.989,9/71,4.05%,ALDH1A1;GPC6;ALDH1A2;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,regulation of glucose import (GO:0046324),0.6020602139846191,1.8167552710614843,0.0022624434389140274,0.16805065501858993,0.989,7/30,5.54%,IGF1;ENPP1;PIK3R1;PID1;PRKAG2;OSBPL8;IRS2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5783469396500458,-1.8051999724944376,0.0018018018018018018,0.07694906934312659,0.941,19/30,28.04%,HSP90AB1;RPL11;N4BP1;GIPC1;USP7;SVIP;CAMLG;DDRGK1;BAG5;UBXN1;STYX;SDCBP;SGTA;CCAR2;MAP1A;TAF9;TRIM39;PARK7;USP14
prerank,chemical synaptic transmission (GO:0007268),0.40668800560629464,1.8050834819171735,0.0,0.1843456596681503,0.996,82/284,14.97%,SLC1A3;NOVA1;GRIA4;GRID2;CACNA1E;NRXN1;CDH8;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;RIMS1;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK5;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;RIMBP2;PCDHB13;KCND2;NLGN2;CHRM3;TBC1D24;NLGN3;GABRR2;SYT1;HRH1;GRID1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;PDZD11;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;PTEN;CBLN2;STAC3;BRSK1;CHRNA7;CHRFAM7A;PTPRN2;HTR4;HTR5A;STXBP3;GRM4;AMPH;APBA1;SNAPIN;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;DRD2;GABRB1;GRIA1;PCDHB16;GABRG1;FCHSD2;HCRTR1
prerank,embryonic digestive tract development (GO:0048566),0.6726978193263138,1.804556674773129,0.004555808656036446,0.1807126174447573,0.996,6/18,3.86%,SALL1;FGFR2;RARB;GLI2;PDGFRA;GLI3
prerank,amide transport (GO:0042886),-0.6019380419712529,-1.8031414821976668,0.007339449541284404,0.07728142623121184,0.945,6/26,6.03%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4887589104960469,-1.8024476569027896,0.0,0.07634366325597162,0.947,35/66,26.02%,CDK6;CCND3;KLF4;FHL1;ANXA1;PKD1;RGCC;AKT1;KANK2;RB1;FAM107A;LSM11;CDK4;E2F1;EGFR;PTPN6;CDKN1A;ANKRD17;CDKN2C;CCND1;CDK2AP2;FGF10;E2F7;RBL1;PKD2;EIF4G1;LSM10;HYAL1;AIF1;CCL2;CDKN2B;RPTOR;DCUN1D3;RDX;PLK5
prerank,bicellular tight junction assembly (GO:0070830),-0.5216174912054304,-1.8006526345865914,0.003663003663003663,0.07661107928744668,0.947,7/46,2.77%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;RAMP2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7226610770727587,-1.7989189821687968,0.0017857142857142857,0.07693145289173964,0.95,6/12,12.43%,FOXP1;MAP2K5;KLF4;TIRAP;CD74;TLR4
prerank,regulation of phospholipase activity (GO:0010517),0.7714993151919485,1.7959971931579202,0.004640371229698376,0.19235719766750656,0.998,4/10,2.26%,FGFR2;LRP1;PLA2G5;PDPK1
prerank,endoderm formation (GO:0001706),-0.5570359111281215,-1.7939656243932418,0.0,0.0810982996457114,0.958,12/35,15.46%,FN1;COL12A1;COL4A2;SOX17;LAMA3;COL6A1;MMP14;SOX7;INHBA;MMP15;ITGA7;ITGA4
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7723783036039273,-1.7925811014447184,0.0,0.08106661837232186,0.96,7/10,13.26%,NOTCH1;DPP4;FAP;TGFB1;TNFRSF1B;CST3;TNFRSF1A
prerank,ceramide metabolic process (GO:0006672),-0.5158598495408008,-1.7915518981542748,0.001941747572815534,0.08067939177374557,0.96,14/49,12.89%,SGMS1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;DEGS2;PLPP1;SPTLC1;PPP2R1A;SPTSSB;ASAH2;SGPL1;ABCA2;ACER3
prerank,sodium-independent organic anion transport (GO:0043252),-0.7571364050444043,-1.7904039248391768,0.0018315018315018315,0.08030529150054475,0.962,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.45521170740025213,-1.788713459990953,0.0,0.08072892479914695,0.963,29/92,13.75%,TEK;FOXP1;RREB1;THBS1;NRP2;DOCK1;PLCG2;FGF1;PTK2B;RAB11A;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB2;RAC1;BCAS3;VEGFA;PPM1F;EDN1;FLT4;AKT1;PFN1;RHOB;FOXC2;PRKCE;FGF2;EMC10
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4201238774852329,1.7854668528159026,0.0,0.20935698923581042,0.999,65/224,14.97%,SLC1A3;NOVA1;GRIA4;CACNA1E;NRXN1;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;PCDHB13;KCND2;NLGN2;CHRM3;NLGN3;GABRR2;SYT1;HRH1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;CHRNA7;CHRFAM7A;HTR4;HTR5A;GRM4;AMPH;APBA1;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;GABRB1;GRIA1;PCDHB16;GABRG1;HCRTR1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6265804355901292,1.7844373785604415,0.011655011655011656,0.2066608219562144,0.999,4/21,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6854587537370633,-1.7834999980199693,0.0037313432835820895,0.08381377665979925,0.971,5/14,2.59%,THBS1;NOTCH1;MAP2K5;STARD13;KLF4
prerank,regulation of epithelial cell migration (GO:0010632),-0.4998824035978323,-1.7808279293290192,0.0,0.08533485702566239,0.972,15/51,9.77%,PTPRG;BMPER;RREB1;DOCK1;PLCG2;RHOJ;RAB11A;BMPR2;PTK2;DAB2IP;TGFB2;ADIPOR1;PPM1F;PFN1;EMP2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6587831916243473,1.7806924550404015,0.00683371298405467,0.20914936659808225,0.999,3/19,2.16%,CCBE1;ROBO1;DCN
prerank,response to zinc ion (GO:0010043),-0.6091018128102825,-1.7806608332397411,0.007662835249042145,0.0841445020840456,0.972,10/25,4.64%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A;CRIP1
prerank,cellular response to ketone (GO:1901655),0.5669239571671453,1.780546051916516,0.00423728813559322,0.20438753805663135,0.999,8/35,4.24%,ADCY2;ADCY1;AR;PTGFR;ADCY5;ROCK2;GNAI1;SFRP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.7318209889823241,1.7734941111257538,0.010822510822510822,0.21339221633952155,0.999,7/11,23.90%,BLM;FBXO5;SMARCAL1;DONSON;ZRANB3;FBH1;TIMELESS
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6865370995301131,-1.7723819001406842,0.00186219739292365,0.09146644638052813,0.978,5/14,7.63%,DMD;ACTN4;WNK1;CHP1;ATP1B1
prerank,response to progesterone (GO:0032570),-0.6484555603040707,-1.7692495583200245,0.0018281535648994515,0.09368356364865692,0.981,7/18,11.52%,ABHD2;CAV1;THBS1;TGFB1;TGFB2;TGFB3;WBP2
prerank,retina homeostasis (GO:0001895),-0.603098937305908,-1.7678438985443004,0.0040650406504065045,0.09360480960211667,0.981,7/23,12.92%,ACTB;POTEF;B2M;ACTG1;HSPB1;WHRN;POC1B
prerank,endodermal cell differentiation (GO:0035987),-0.5626607194419027,-1.7637564031986148,0.001876172607879925,0.09649565643384515,0.983,10/31,15.46%,FN1;COL12A1;COL4A2;LAMA3;COL6A1;MMP14;INHBA;MMP15;ITGA7;ITGA4
prerank,negative regulation of type I interferon production (GO:0032480),-0.5331095127401452,-1.7619685784943973,0.006036217303822937,0.09710454299683867,0.984,14/40,15.59%,TAX1BP1;IFIH1;TRIM25;REL;NLRC5;RNF125;OTUD5;YY1;UBE2L6;RELB;DHX58;MAVS;ITCH;TNFAIP3
prerank,proteoglycan metabolic process (GO:0006029),0.5903672022894371,1.7608827210183957,0.00819672131147541,0.23526259650979214,0.999,6/26,1.48%,IGF1;ADAMTS12;CHST8;GAL3ST3;SULF1;SULF2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.731258370935141,-1.7608298073530102,0.0,0.09717948861788073,0.986,8/11,14.82%,ADIPOR2;CD34;KDR;VEGFA;GATA2;PRCP;MCAM;SRF
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5858190444163417,-1.7600860521514967,0.0019801980198019802,0.09662845986126667,0.987,11/28,14.53%,FOXP1;CD55;GATA6;N4BP1;CASP8;ERAP1;TIRAP;LRP8;DHX58;SAMHD1;TRIM5
prerank,intraciliary retrograde transport (GO:0035721),0.7075699228595358,1.7587695285194558,0.019438444924406047,0.23450912753973427,0.999,11/12,26.28%,DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;DYNLT2B;IFT43;WDR19;TTC21A;WDR35;TTC21B
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.47958647319651315,-1.758217592000932,0.0019880715705765406,0.09711263571648171,0.987,18/64,11.89%,UTRN;CDK6;ACER2;THBS1;ACTG1;PTK2B;LIMCH1;PEAK1;PTK2;ADAM15;MINK1;MYOC;JUP;VCL;EMP2;NF1;CIB1;DUSP3
prerank,apical junction assembly (GO:0043297),-0.5010391725573403,-1.7581280756406577,0.0,0.09590749488297233,0.987,15/53,19.08%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;CTNNA1;RAMP2;WDR1;VCL;STRN;CLDN11;CLDN10;ECT2;ARL2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5704875597089112,-1.754472978072803,0.0038240917782026767,0.09873384026524634,0.989,12/27,20.34%,MAP3K5;MAPK3;MAP3K20;UBB;UBC;RPS27A;IKBKB;MAP3K8;TAOK2;CUL1;CHUK;MAPK11
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.7131040622022911,-1.752715100854756,0.0034482758620689655,0.09913887773737694,0.99,7/12,19.75%,LY6E;MID2;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.7429483143668756,1.7515781001468513,0.011848341232227487,0.24456891303647404,0.999,5/10,10.39%,CHDH;ALDH7A1;SLC44A1;HNMT;COMT
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6417641447920016,-1.7510342605077593,0.003663003663003663,0.09977826966397055,0.991,5/18,7.38%,ESR1;DDX5;NCOR1;TGFB1;RIPK1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7273959318081793,1.7476933349451296,0.0136986301369863,0.24743799021143892,0.999,2/10,0.66%,ENPP1;PID1
prerank,peptide cross-linking (GO:0018149),-0.5813274350865647,-1.7464772888707425,0.001984126984126984,0.10402978134821707,0.992,5/25,3.46%,FN1;THBS1;TGM2;COL3A1;ANXA1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5477624237959534,-1.7459307425335835,0.003968253968253968,0.10327571467580475,0.992,21/34,21.79%,FLT1;SEMA6A;GAB1;NOTCH1;KDR;MT1G;RAMP2;VEGFC;ANXA1;DAB2IP;VEGFA;HSPB1;FLT4;VEGFD;PIK3CA;RELA;DLL4;PGF;NUS1;PRKD2;EGR3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6314348695665295,1.7458867179488766,0.006147540983606557,0.24115912561627367,0.999,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,positive regulation of glycolytic process (GO:0045821),0.6314348695665295,1.7458867179488766,0.006147540983606557,0.24115912561627367,0.999,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6059826431505995,1.7451046275054072,0.006423982869379015,0.23813317461044214,0.999,4/23,8.44%,IGF1;GSTP1;NLRP12;NLRP2B
prerank,platelet aggregation (GO:0070527),-0.5438505557391905,-1.7441270793165617,0.0019305019305019305,0.10424999943037935,0.994,10/33,9.38%,FN1;ACTB;ACTG1;CLIC1;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,positive regulation of angiogenesis (GO:0045766),-0.4290827992743654,-1.743125950828973,0.0,0.1041522774110351,0.994,38/108,18.89%,TEK;FLT1;BMPER;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;PKM;GATA2;HSPB1;JUP;TWIST1;RHOB;FOXC2;VEGFD;FGF2;S100A1;EMC10;RAPGEF3;JMJD8;XBP1;NINJ1;SP1;PGF;ANGPTL4
prerank,negative regulation of GTPase activity (GO:0034260),-0.6029325310360723,-1.7429547173873718,0.005649717514124294,0.1031089363359923,0.995,9/22,13.58%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;GMIP;RCC2;HRAS
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.745356038652223,-1.7423976115297461,0.0036968576709796672,0.1024460376916023,0.995,4/10,3.16%,PODXL;DPP4;WNK1;PIEZO1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6080356570830977,1.739507125561186,0.006134969325153374,0.2452431373058855,0.999,3/23,3.87%,IGF1;ZBTB20;PFKFB4
prerank,amyloid fibril formation (GO:1990000),-0.4957577191169866,-1.7372049163732142,0.003738317757009346,0.10720879692968911,0.996,18/51,10.13%,B2M;TSPAN5;APP;FKBP1A;UBB;ADAM10;UBC;RPS27A;TGFBI;BACE1;RIPK1;MFGE8;UBE2L6;CST3;PSENEN;USP9X;H3-3A;TSPAN14
prerank,sphingolipid metabolic process (GO:0006665),-0.4343511347261062,-1.7364981009300982,0.0,0.10659554809049131,0.997,28/108,13.77%,SGMS1;CERT1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;ESYT2;DEGS2;ELOVL7;SUMF2;HEXA;PLPP1;CSNK1G2;PRKD3;SPTLC1;PSAP;PPP2R1A;KDSR;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;ABCA2;SPHK2;ACER3;SUMF1;CERKL
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6472858163557162,1.7355956969574091,0.010964912280701754,0.24892744432448052,1.0,5/17,7.84%,IGF1;NRP1;CCN4;PDGFRB;DOCK7
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5284272129621705,-1.7337425853554498,0.001890359168241966,0.10855516324033739,0.997,24/39,29.97%,RAP1A;TIE1;NOTCH1;RAP1B;RAPGEF1;DAB2IP;MSN;HSPA8;EZR;HCFC1;BAG5;NCLN;APOE;VPS11;HSP90AA1;GFAP;RAPGEF2;TJP1;RDX;ANKRA2;PARP10;CD36;METTL18;IRGM
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5475369364110236,1.7330450773738533,0.004158004158004158,0.24967828336197614,1.0,18/35,19.40%,CDH8;PCDHB10;CDH18;DCHS1;PCDHB13;CDH11;CDH20;CDH19;CDH7;NLGN1;CDH10;CDHR3;CDH12;PCDHGB4;PCDHB16;PCDHB14;CDH9;CDH24
prerank,homotypic cell-cell adhesion (GO:0034109),-0.5222311082918529,-1.7326576477777478,0.0019342359767891683,0.10868408230443244,0.997,12/39,9.38%,FN1;ACTB;ACTG1;MEGF11;CLIC1;TJP2;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,response to lipid (GO:0033993),-0.43042785307403103,-1.7325590638901966,0.0,0.10747376349574424,0.997,38/105,20.85%,FOXP1;ACER2;LBP;NOS3;ESR1;PPARD;FOXO1;RPS6KA3;FOXO3;ANXA1;GCH1;SOCS2;TGFB1;MAPKAPK3;SMAD6;RARA;GATA6;OTUD5;TRIM16;TNFRSF11A;ABCG1;SPP1;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;ABCA2;JAK2;STRN3;TAB2;PELI1;HSD17B2;SOX9;GGT1;LGALS9;RXRB;PAQR7
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5009329902894419,-1.7318135929404832,0.005555555555555556,0.10712342293468838,0.997,23/48,14.08%,TMSB4X;THBS1;NOS3;RHOJ;KDR;ETS1;ANXA1;TGFB1;MAP3K3;HDAC7;HDAC9;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;AKT1;PIK3C2A;JCAD;FOXC2;CIB1;FGF2;STAT5A
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5456220352546327,-1.730474145645655,0.001941747572815534,0.10762986059439812,0.997,14/33,13.86%,BMPER;SEMA6A;THBS1;RHOJ;FGF1;KLF2;KLF4;PPP1R16B;EPN1;VEGFA;PKM;FGF2;S100A1;EPN2
prerank,regulation of interleukin-8 production (GO:0032677),-0.4685431139072299,-1.7298729999158233,0.0,0.10722107905667817,0.997,35/69,31.60%,TMSB4X;AFAP1L2;LBP;NOD1;MAP2K5;F3;KLF4;ANXA1;TLR3;ANXA4;RIPK1;TIRAP;MAPKBP1;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;PTPN22;BCL10;PARK7;LAMTOR5;TLR6;HYAL2;TLR1;C5AR2;NOS2;TLR5;CD14
prerank,granulocyte differentiation (GO:0030851),-0.6288187246182779,-1.7295807931760265,0.0018867924528301887,0.10641278913026343,0.997,8/18,15.87%,LEF1;CBFA2T3;LBR;RARA;TAL1;CDK4;E2F1;CDKN1A
prerank,sphingosine metabolic process (GO:0006670),-0.6342596986034148,-1.7286214468798429,0.0018181818181818182,0.10635469941080374,0.997,8/17,12.89%,ACER2;SPTLC2;PLPP1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,positive regulation of protein maturation (GO:1903319),0.7303604658771925,1.7276256640631849,0.020689655172413793,0.25542444001328385,1.0,1/11,0.01%,CCBE1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.46763480523592854,-1.7276187677805799,0.0,0.10627289063765158,0.997,42/69,31.60%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8;COX7A2L;SDHC;COA6;NDUFA2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.733056983134835,-1.7271050083969182,0.003780718336483932,0.10580978579651708,0.997,6/11,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,negative regulation of protein polymerization (GO:0032272),-0.5861664328719145,-1.7270455948897756,0.0038461538461538464,0.10475750081076551,0.997,8/27,8.85%,KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;STMN2;PFN1
prerank,positive regulation of cellular component movement (GO:0051272),-0.5765250644507247,-1.7259942134172155,0.005758157389635317,0.10497330727207298,0.997,9/24,14.21%,SPOCK2;ACTN4;ETS1;CAVIN1;RPS19;VEGFA;TWIST1;CSF1R;NTN1
prerank,aerobic electron transport chain (GO:0019646),-0.46735844617692657,-1.718688888083089,0.0019267822736030828,0.11241478837318933,0.997,38/68,28.25%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.46723817062266637,-1.7176581096667582,0.003838771593090211,0.11260643947843,0.997,24/69,20.77%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,melanocyte differentiation (GO:0030318),0.7244624013043557,1.715031034282076,0.020224719101123594,0.28028037138731093,1.0,6/11,4.30%,ENPP1;LRMDA;SLC24A5;KIT;MITF;HPS6
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.729836438401248,-1.7124615855024976,0.0018832391713747645,0.11773090347642316,0.998,6/10,15.49%,NAMPT;KDR;IL33;TLR4;JAK2;NOD2
prerank,regulation of interferon-beta production (GO:0032648),-0.5014305726186326,-1.7104481676970562,0.0,0.11897932768126186,0.999,15/46,16.67%,IFIH1;REL;TLR3;YY1;DHX9;FLOT1;RELB;TIRAP;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.560657238390203,1.709306989653942,0.008113590263691683,0.2893459520292846,1.0,7/32,5.08%,IGF1;ZBTB20;PID1;PPARA;PFKFB4;ACTN3;IL4
prerank,organic anion transport (GO:0015711),-0.45128670056113007,-1.708886195287184,0.0,0.12005339179739331,0.999,13/76,5.47%,ABCG2;SLC4A10;ABCC4;SLC26A7;SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;LRRC8C;SLC35A3;LRRC8D;CA4;SLC39A8
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6619548199373687,1.7077321174613307,0.019867549668874173,0.28851754975513316,1.0,4/13,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,tryptophan catabolic process (GO:0006569),0.7296285198708671,1.7075759207812666,0.017977528089887642,0.2839878264890908,1.0,5/11,10.06%,IL4I1;AFMID;TDO2;KMO;KYNU
prerank,positive regulation of cell projection organization (GO:0031346),0.4305857065860378,1.705790549708277,0.0,0.2834052444640731,1.0,37/115,14.64%,PLXNA2;ROBO1;CAMK1D;ROBO2;PTN;NTRK3;TENM3;MAGI2;PTK7;GRIP1;EPHA3;RIT2;PTPRD;GPC2;LYN;NPTN;IL1RAPL1;CUX1;CAMK2B;DPYSL3;CDKL3;LRRC7;DVL3;CUX2;PRKCI;FUT9;PLXNB2;NGFR;CBFA2T2;ROR1;OBSL1;DLG4;EP300;CAPRIN2;AMIGO1;MAP6;PLPPR5
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.61544081699673,1.7050409063260727,0.010822510822510822,0.2804152646050402,1.0,3/19,8.44%,IGF1;GSTP1;NLRP2B
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.465228508932457,-1.7047610388224639,0.0,0.12448541858672585,0.999,31/68,31.22%,LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;POU2F2;XBP1;ARHGEF2;LGALS9;AIF1;BCL10;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;NOS2;MBP;TYROBP
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.49252388053290364,-1.7037181699735005,0.0019342359767891683,0.12449300384210084,0.999,23/54,21.43%,CAV1;NXN;RPS3;SMAD7;RPL11;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;TNFAIP3;UFL1;HSPA1A;USP4;COPS9;RPL5;HSPA1B
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5691839295619493,-1.7035202153220173,0.001851851851851852,0.12348515906118349,0.999,11/26,17.01%,NOD1;IFIH1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6521510730883594,1.7032882453767306,0.013636363636363636,0.2804150372685311,1.0,3/16,6.04%,ADCY7;PPARA;ABCD2
prerank,stress-activated MAPK cascade (GO:0051403),-0.466516818242509,-1.7027144174450248,0.0019120458891013384,0.123303322178166,0.999,23/61,20.34%,MAP3K5;NOD1;MAP4K3;MAPK3;IRAK2;MAP3K20;UBB;MINK1;UBC;RPS27A;IKBKB;MAP3K8;MAP3K11;TRIB1;TAOK2;NOD2;TAB2;CUL1;CHUK;PTGER4;ARHGEF6;LGALS9;MAPK11
prerank,positive regulation of integrin activation (GO:0033625),-0.7162404034356714,-1.7024139869763466,0.0036036036036036037,0.12249017134072901,0.999,4/11,3.56%,RASIP1;RAP1B;PIEZO1;FERMT2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6255928948431968,-1.7009750571861229,0.007751937984496124,0.12309087654193436,0.999,6/16,4.81%,RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,positive regulation of wound healing (GO:0090303),-0.5203643644976996,-1.699506731479775,0.009615384615384616,0.12393811051081327,0.999,12/36,13.58%,ST3GAL4;OCLN;RREB1;THBS1;ACTG1;PTK2;ANXA1;FERMT2;ENPP4;FOXC2;PRKCE;HRAS
prerank,regulation of angiogenesis (GO:0045765),-0.3836493508452897,-1.6966333538600336,0.0,0.12712118947876744,0.999,63/192,18.89%,TEK;FLT1;CLDN5;BMPER;SEMA6A;THBS1;NOS3;CD34;GAB1;TIE1;RHOJ;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;PPP1R16B;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;CYP1B1;PTPRM;PIK3R6;AMOT;VEGFA;GATA6;GATA2;HSPB1;RGCC;JUP;TWIST1;WARS1;NAXE;HHEX;EMP2;ISM1;RHOB;PLXND1;EGLN1;NF1;HTATIP2;VEGFD;FGF2;EMC10;ERBB2;EPHA2;TNFAIP3;PGK1;STAT1;RAPGEF3;RNH1;XBP1;NINJ1;SP1;KRIT1;PGF;ANGPTL4
prerank,positive regulation of locomotion (GO:0040017),-0.5593940634302618,-1.696600067707749,0.012048192771084338,0.12598656846123685,0.999,9/27,14.21%,THBS1;SPOCK2;STX3;TGFB1;CAVIN1;PPM1F;TWIST1;CSF1R;NTN1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5951613393535718,-1.6953847003280136,0.00922509225092251,0.1264605156510739,0.999,5/19,4.12%,SLCO1C1;MAP2K5;KLF2;KLF4;APP
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.52454152725015,-1.6934841002879812,0.005703422053231939,0.12815791222963546,0.999,19/33,26.38%,MEF2C;THBS1;NOTCH1;MAP2K5;STARD13;KLF4;TGFB1;RGCC;JUP;CSNK2B;APOE;FGF2;DLL4;GADD45A;PDCD10;TBXA2R;ANGPT4;HDAC5;CARD10
prerank,nucleotide catabolic process (GO:0009166),-0.6338179695046517,-1.6918487171401084,0.012237762237762238,0.12938380042161193,1.0,7/16,14.01%,NT5E;GPX1;NT5C;VCP;GDA;NT5C1A;SAMHD1
prerank,regulation of dendrite development (GO:0050773),0.527285238895001,1.6897212996481075,0.016597510373443983,0.3094695231462769,1.0,12/37,10.11%,CAMK1D;HECW2;PTN;ADGRB3;BMP5;CSMD3;RAP2A;HECW1;TNIK;BCL11A;DCC;ALK
prerank,regulation of adaptive immune response (GO:0002819),0.6143577222461133,1.6887564316401533,0.022222222222222223,0.307145913543667,1.0,4/18,11.52%,ADCY7;IL4I1;TRIM27;AHR
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.6622792922704335,-1.6866946327306964,0.005504587155963303,0.13540838770517954,1.0,8/14,21.52%,TMSB4X;NFKBIA;PKD1;MDFI;CCDC22;KEAP1;PKD2;NFKBIE
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.5588171913926755,-1.6849454636046077,0.005376344086021506,0.13699270625215795,1.0,14/28,17.87%,NOTCH3;ZBTB7A;WWP2;GATA2;MMP14;AKT1;ARRDC1;TCIM;LFNG;YTHDF2;HEY1;EGFR;RITA1;DLL4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.41902429531358953,-1.6834610048086565,0.0,0.13809979770684952,1.0,42/114,23.42%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;CARD14;LIMS1;IKBKB;PSMA6;TNFRSF1B;RIPK1;TNFRSF11A;PSMB5;PSMC4;PSMC5;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;LTBR;PSMA1;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;TNFRSF9;TNFRSF12A
prerank,regulation of osteoblast proliferation (GO:0033688),0.615672212295118,1.681774133673505,0.021834061135371178,0.3202878717736096,1.0,4/17,4.24%,NELL1;BMP2;FGFR2;SFRP1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.45236424460521246,-1.681051881367254,0.005905511811023622,0.14053509966875669,1.0,20/71,12.89%,SGMS1;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;KDSR;A4GALT;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.4875579783522641,-1.6806934683398145,0.0038461538461538464,0.13992326096525198,1.0,26/49,31.60%,AFAP1L2;LBP;NOD1;F3;TLR3;RIPK1;TIRAP;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;BCL10;PARK7;LAMTOR5;HYAL2;TLR1;NOS2;TLR5;CD14
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.4873629806113718,-1.680213778674292,0.00749063670411985,0.13933153110578386,1.0,20/50,18.86%,CAV1;NXN;RPS3;SMAD7;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;LIMK1;TNFAIP3;UFL1;HSPA1A;USP4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6307968054976542,1.6786156514761403,0.02857142857142857,0.32365528069937205,1.0,4/18,8.31%,IGF1;IGFBP2;IGF2;IL18
prerank,cellular response to fatty acid (GO:0071398),0.674325715508254,1.678327196021281,0.029082774049217,0.31965910549003507,1.0,3/12,5.80%,PID1;PDK4;PDK3
prerank,positive regulation of response to stimulus (GO:0048584),-0.49695880915282054,-1.676976006750783,0.005649717514124294,0.14302773470500496,1.0,17/40,23.42%,B2M;IL15;IFIH1;TGFB2;ABI3;DHX9;YPEL3;MAVS;HOMER1;FMR1;CDKN2AIP;NSMCE4A;CGAS;RSAD2;TAF9;IER5;PRKCD
prerank,regulation of macrophage migration (GO:1905521),-0.7097602776064209,-1.6728882614956806,0.0057361376673040155,0.14787853579459395,1.0,5/10,19.16%,MTUS1;PTK2B;CD81;CX3CR1;CD200
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7182644602622659,-1.6728702514180303,0.011009174311926606,0.14548255568786236,1.0,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7182644602622659,-1.6728702514180303,0.011009174311926606,0.14548255568786236,1.0,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,lamellipodium organization (GO:0097581),-0.5359366588709112,-1.6728005264520351,0.005357142857142857,0.14439319882774249,1.0,17/29,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;CTTN;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6741068117866901,1.6713235385811596,0.015590200445434299,0.33315595373626267,1.0,5/14,10.28%,AUTS2;PRDM9;KMT2A;DNMT1;PAXIP1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6571452030007062,-1.670569734111541,0.018691588785046728,0.14642601444455533,1.0,7/13,13.89%,EPS8;PLEKHM1;EPS8L2;PFN1;FAM98A;HRAS;NDEL1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.4751591465055164,-1.6695896671161026,0.0019267822736030828,0.14674392571034686,1.0,18/56,18.78%,LBP;PLCG2;NOD1;RPS6KA3;IRAK2;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;TLR3;CTSB;TLR4;S100A1;NOD2;TAB2;IRAK4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6374229753502001,1.669102201527137,0.02643171806167401,0.33397083835950836,1.0,5/16,10.28%,AUTS2;BCOR;KMT2A;DNMT1;PAXIP1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5868671318010632,1.6672004408836787,0.02040816326530612,0.3346535746659876,1.0,4/22,4.07%,AREG;FGFR2;VDR;STXBP4
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6159603212119781,-1.6660551699140556,0.018656716417910446,0.1511883168271433,1.0,8/17,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,skeletal muscle contraction (GO:0003009),0.5961657667702709,1.6656934809802577,0.04128440366972477,0.33389043000935004,1.0,6/19,14.25%,CHRNA1;TNNC1;TNNI3;TNNI1;STAC3;TNNT3
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6885949150414807,-1.6645988520470878,0.0054446460980036296,0.1522599958074644,1.0,9/11,25.30%,CAV1;FOXO1;ATP6V0A2;FAS;ATG7;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1
prerank,apical protein localization (GO:0045176),-0.70332011398063,-1.664454988094667,0.003629764065335753,0.15133082255498453,1.0,6/10,15.89%,ACTB;ATP8B1;JAM3;MAL;CELSR1;SHROOM3
prerank,negative regulation of viral process (GO:0048525),-0.4594896099350233,-1.6630656604094152,0.001890359168241966,0.1520106345303477,1.0,18/57,18.61%,IFIH1;MID2;PPIA;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;TRIM28;TRIM14;IFIT1;FAM111A;TRIM62;MAVS;TRIM5;OAS2;STAT1;RSAD2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.622538790068137,-1.6624206213525188,0.016917293233082706,0.15172529594881556,1.0,8/16,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.4372085935455092,-1.6608341935483786,0.0019047619047619048,0.15277769735154637,1.0,27/76,16.33%,NOS3;TSPAN5;NOTCH3;NOTCH1;CCN3;ZBTB7A;TGFB2;WWP2;NEPRO;JAG2;NOTCH4;GATA2;MMP14;AKT1;ARRDC1;TSPAN14;TCIM;LFNG;YTHDF2;TM2D3;MFNG;POGLUT1;EPN2;HEY1;EGFR;NOD2;RITA1
prerank,regulation of cell growth (GO:0001558),-0.3786144775901818,-1.6605504432263698,0.0,0.15201205175433025,1.0,79/204,22.04%,PLCE1;APBB2;PTPRJ;SERTAD2;NET1;LTBP4;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;TFRC;CCN3;RPS6KA3;CAMK2D;DCUN1D5;SOX17;SLIT2;NPR1;SOCS2;ADAM15;CDKN1B;TGFB1;TGFB2;ADAM10;PPP2R1A;MFSD2A;EGLN2;PABIR1;MMP14;AKT1;NDUFA13;BCL6;SIPA1;RB1;FAM107A;WFDC1;H3-3A;WNT11;INHBA;CCDC85B;TAOK2;CRLF3;AKAP6;CIB1;KIF26A;ITCH;FXN;SPHK2;SMARCA4;NDUFS3;CISH;CDKN2AIP;LAMTOR2;SDCBP;EGFR;ERBB2;OSGIN1;SMAD4;CDKN1A;CSNK2A1;SMARCA2;OGFR;TMEM97;HSPA1A;CCAR2;DERL2;CDKN2C;SLC25A33;NME6;TSPYL2;ESR2;BRAT1;MSX1;NDRG3;HSPA1B;ADNP2;DDX49;EIF4G1
prerank,macrophage activation (GO:0042116),-0.5036297736126696,-1.658603769614805,0.009025270758122744,0.15402283075692005,1.0,11/34,17.22%,FOXP1;LBP;PLCG2;CD93;APP;DYSF;TLR4;SYK;JAK2;C1QA;IFNGR1
prerank,positive regulation of type I interferon production (GO:0032481),-0.44243892199488327,-1.6585401797847261,0.0,0.1530106205201444,1.0,36/73,34.36%,IFIH1;LRRFIP1;PRKDC;TLR3;GAPDH;DDX41;DHX9;FLOT1;HSPD1;DHX58;TRIM56;MAVS;TLR4;POLR3E;POLR3A;OAS2;STAT1;HSP90AA1;RELA;CHUK;CGAS;PTPN22;POLR3B;SETD2;CTNNB1;MRE11;POLR1C;POLR2F;PQBP1;POLR2L;CD14;RIOK3;CREBBP;TLR2;IRF3;TLR8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6764269228220025,1.6582326145283872,0.02197802197802198,0.34819602582777026,1.0,8/13,17.28%,B3GALT1;GAL3ST3;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7148822583274796,-1.6567967160470112,0.023809523809523808,0.1544990098963508,1.0,3/10,5.58%,CD55;TGFBR2;CD81
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.43035827934269694,-1.6557269741087741,0.0019230769230769232,0.15495999077784758,1.0,23/86,9.48%,PLCE1;ARHGEF28;NOTCH1;EPS8;OPHN1;STARD13;STARD8;RAPGEF1;ARHGAP17;SHOC2;DAB2IP;DENND1A;NGF;EPS8L2;TGFB2;ARHGDIA;ARHGDIB;GABARAP;SHC1;BCR;DENND3;KANK2;MAPKAP1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6271187769303249,1.6554935027343136,0.034858387799564274,0.35070975925332404,1.0,5/16,5.80%,RORA;PDK1;PDK4;PRKN;PDK3
prerank,regulation of viral entry into host cell (GO:0046596),-0.5307282704505079,-1.6541427393414068,0.0038240917782026767,0.15619433292827128,1.0,15/30,20.27%,LY6E;MID2;TRIM25;IFITM1;IFITM3;IFITM2;TRIM14;CD74;TRIM62;TRIM68;TRIM5;NECTIN2;LGALS1;SNX3;LGALS9
prerank,cristae formation (GO:0042407),-0.5420200832836084,-1.6528497494636731,0.005535055350553505,0.1572359129462574,1.0,15/27,27.78%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;CHCHD3;ATP5ME;ATP5MC3;ATP5MC1;CHCHD6;APOO;ATP5F1E;ATP5PO;MICOS13;UQCC3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.5194263832261721,-1.6525322372570508,0.003780718336483932,0.15657596013938338,1.0,11/33,16.67%,IFIH1;TLR3;DHX9;FLOT1;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,positive regulation of vasculature development (GO:1904018),-0.4144960289772449,-1.6520721017079238,0.0,0.15613885180776543,1.0,21/94,7.35%,TEK;FLT1;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;GATA2;HSPB1;JUP
prerank,regulation of transmembrane transport (GO:0034762),-0.5240052715217665,-1.6516621035477264,0.012681159420289856,0.1556671930202374,1.0,11/31,12.17%,ACTB;OCLN;SLC2A1;CTTNBP2NL;KCNJ2;NEDD4L;WWP2;KCNJ10;ACE2;KCNJ8;KCNJ15
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.42238344464695204,1.6508738838234684,0.0,0.35771381024736587,1.0,16/113,4.24%,IGF1;BMP6;TCF7L2;NRP1;BMP2;AREG;PTN;FGFR2;SEMA5A;BMP5;PRKCA;VEGFB;AKT3;TGFA;STXBP4;SFRP1
prerank,myoblast differentiation (GO:0045445),0.6397816570103249,1.6506725706219267,0.03189066059225513,0.3534083050588705,1.0,4/14,1.40%,IGF1;TCF7L2;EPAS1;NRG1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6774905922369953,-1.6499556492823448,0.014311270125223614,0.1572900989821282,1.0,4/11,14.67%,DDX5;TGFB1;RIPK1;EGFR
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.48762873810842683,-1.6494829956621044,0.007936507936507936,0.156897347413438,1.0,13/42,11.34%,VIT;NOTCH1;PTK2;FZD4;RAC1;LIMS1;MINK1;NPNT;PPM1F;FBLN2;FZD7;EMP2;NF1
prerank,regulation of ossification (GO:0030278),0.5131937119652598,1.647263452904928,0.014989293361884369,0.3570388986018104,1.0,11/36,8.07%,ENPP1;NOTUM;BMP2;PTN;DDR2;CYP27B1;AHSG;LRP4;SFRP1;ANKH;RBPJ
prerank,purine nucleotide catabolic process (GO:0006195),-0.6631885468855907,-1.6466496963272024,0.019064124783362217,0.16019695891835467,1.0,6/13,12.56%,NT5E;GPX1;NT5C;GDA;NT5C1A;HINT1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6579837182685597,-1.6454140434997424,0.009107468123861567,0.1606613585498399,1.0,4/12,5.18%,MEF2C;PRKG1;IGFBP5;DOCK4
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6574298411812498,-1.6441632297150401,0.01651376146788991,0.16158378561904035,1.0,6/13,10.73%,SEMA7A;PLCG2;TGFB1;TGFB2;TGFB3;CD74
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.6801604736428497,-1.6420741678017008,0.012589928057553957,0.16396334458927617,1.0,3/11,4.12%,MEF2C;TGFB1;TGFB2
prerank,receptor clustering (GO:0043113),0.5469673236674697,1.6410438706974975,0.020224719101123594,0.36929954420719013,1.0,9/27,13.18%,PTN;MAGI2;NRXN1;LRP4;DLG2;NLGN1;LRRC7;MUSK;DLG4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3888176977220211,-1.6404224272014358,0.0020491803278688526,0.16534016780542798,1.0,49/149,21.58%,PRKCH;CAV1;SLCO3A1;RPS6KA5;NOD1;NFKBIA;TFRC;MID2;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;UBB;PPIA;PRKCZ;UBC;RPS27A;IKBKB;PSMA6;RIPK1;TNFRSF11A;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;CIB1;TRIM62;TLR4;EDA2R;TRAF1;AIM2;TRIM68;TRIM5;FLOT2;NOD2;CX3CR1;HSPA1A;TAB2;RELA;CHUK;ARHGEF2;LGALS9;CLOCK;HSPA1B;PRKD2;BTK
prerank,clathrin coat assembly (GO:0048268),-0.63615399148516,-1.6387615989678428,0.019963702359346643,0.1665596847273522,1.0,9/15,25.63%,HIP1R;PIK3C2A;HIP1;FCHO2;SGIP1;CLTA;NSG2;EPS15;CLTB
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.5137619422698473,-1.6378393002703844,0.019157088122605363,0.1670198139545625,1.0,23/33,39.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;RHOB;IMPACT;FXN;TNFAIP3;RELA;ECT2;PRKCD;RNF112;PARK7;AQP1;ABL1;MAPK7;ANKZF1;SIGMAR1;OSER1;PLEKHA1;PPIF
prerank,negative regulation of hydrolase activity (GO:0051346),-0.47277103058573317,-1.6374516171483744,0.005747126436781609,0.16639317591464248,1.0,16/49,19.08%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;CHP1;SH3RF2;CST3;EGLN1;GMIP;RCC2;HRAS;ATP5IF1;NEIL1;ARL2
prerank,regulation of GTPase activity (GO:0043087),-0.3785987047182146,-1.6368591689767689,0.0,0.16616791891369642,1.0,59/177,20.08%,DOCK9;PKP4;CHN2;FGD5;ITGA6;RAP1A;NET1;PRKG1;RASIP1;RACK1;SIPA1L1;TGM2;SH3BP4;AGRN;F11R;CAV2;LRCH1;SGSM2;WNK1;PTK2;RAPGEF1;ARHGAP27;DAB2IP;FERMT2;PLXNA4;BCAS3;LIMS1;CHN1;CRK;FGD6;GPR137B;RGS6;CCL15;S100A10;ZC3H15;ADAP1;WNT11;PLXNA1;PLXND1;GMIP;NF1;RCC2;ARHGEF5;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;PLXNA3;ECT2;RAB3GAP2;ARL2;PIN1;FGD2;RGS10
prerank,striated muscle cell development (GO:0055002),-0.6281898260882084,-1.6347643334855417,0.01056338028169014,0.16843171108048938,1.0,5/14,8.19%,PGM5;TMOD3;LMOD1;FLII;TMOD1
prerank,presynapse organization (GO:0099172),0.7156274693426712,1.634386313042507,0.025974025974025976,0.3823655414699781,1.0,4/10,7.71%,LRRTM3;NLGN2;NLGN3;NLGN1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4433839594622986,-1.6340709802202744,0.005802707930367505,0.16836030885227649,1.0,24/73,20.77%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5032005704667065,-1.6336897666671273,0.009487666034155597,0.16788205929531702,1.0,22/38,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,lipid transport (GO:0006869),-0.4147458653031639,-1.6326064359555326,0.0,0.16845597703320486,1.0,25/97,12.95%,PITPNC1;ABCC4;CERT1;SLCO3A1;SLCO2A1;SLCO1C1;LBP;PLTP;ATP8B1;ATP8A1;SLCO2B1;SCARB1;PPARD;TNFAIP8L3;MFSD2A;PITPNA;ABCG1;SPNS2;CHKA;FABP5;PRELID2;STARD5;APOE;ABCA2;MFSD2B
prerank,gliogenesis (GO:0042063),-0.6302362801904151,-1.632395123421637,0.014519056261343012,0.16771238787069417,1.0,5/15,11.96%,CDK6;ANXA1;TGFB2;CD9;NDUFS2
prerank,regulation of viral release from host cell (GO:1902186),-0.5682196312011142,-1.632348705533649,0.012915129151291513,0.1667163758949544,1.0,8/21,18.15%,MID2;TRIM25;CHMP2B;TRIM28;TRIM62;TSG101;TRIM5;CHMP2A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.42151675363265206,-1.6321786537089855,0.006012024048096192,0.16592803380011328,1.0,24/84,8.42%,TEK;FOXP1;TMSB4X;THBS1;NOS3;NRP2;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB1;RAC1;BCAS3;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;EDN1;FLT4;AKT1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5261459685780344,-1.6319352794048736,0.009363295880149813,0.16526446260038888,1.0,10/32,17.03%,PPP1R13B;DDX5;HIPK1;DYRK2;RPS27L;HINT1;TMEM109;AEN;PHLDA3;DDIT4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5580026558100785,-1.630770599331518,0.016697588126159554,0.1660580831946379,1.0,6/22,14.98%,MAP2K5;KLF4;WNK1;CD44;FLOT1;FLOT2
prerank,regulation of actin filament polymerization (GO:0030833),-0.44298173339308555,-1.6302221760023152,0.0019723865877712033,0.1659055483680373,1.0,27/69,23.65%,ESAM;KANK3;BAIAP2L1;PTK2B;CYRIB;SLIT2;KANK4;SSH2;HIP1R;LMOD1;PFN1;DBNL;DBN1;PRKCE;WASHC5;NCKAP1;HCK;CDC42EP3;RASA1;CTTN;NCK1;HCLS1;PLEKHG2;PRKCD;CARMIL1;NCK2;ARHGAP18
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5515152306816029,-1.6298637662157984,0.007936507936507936,0.16548698136020576,1.0,12/24,14.62%,DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5088085390401769,-1.6290115008404593,0.009025270758122744,0.16580225836276494,1.0,19/36,26.64%,OPHN1;HSP90AB1;RPL11;AQP11;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;SDCBP;CCAR2;MAP1A;TAF9;ALAD;TRIM39;PARK7;F8A1
prerank,tryptophan metabolic process (GO:0006568),0.6799679259558923,1.6286236848341253,0.0368763557483731,0.3937844317558311,1.0,4/11,10.06%,IL4I1;TDO2;KMO;KYNU
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5917050733070868,-1.6283691641568665,0.021937842778793418,0.16571672914231875,1.0,8/18,16.13%,HEG1;RASIP1;CCDC125;MYOC;TNFAIP1;ABL2;MET;KCTD10
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3696183425377339,1.6283335622977917,0.0,0.3897055964122181,1.0,48/248,12.01%,BICC1;TCF7L2;IGFBP2;RNF220;LGR4;NOTUM;BMP2;LRRK1;WLS;RBMS3;DAAM2;CDK14;FGFR2;LYPD6;SEMA5A;TBL1XR1;PRICKLE1;PTK7;LRP4;DKK3;GLI3;ZEB2;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;CTNND2;FRAT1;SMURF2;TLE1;PSMA3;SOX2;ADGRA2;PSMF1;NPHP3;DVL3;GPC5;DACT3;FRZB;FUZ;SIAH2;NKD2;USP47;BTRC;RNF146;PSME3
prerank,positive regulation of immune system process (GO:0002684),-0.6167670428292774,-1.6271648004841301,0.015180265654648957,0.166802164647382,1.0,6/16,20.27%,IL15;ANXA1;TGFB2;VEGFA;RSAD2;LGALS9
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5968232869589742,1.6235539837954656,0.035864978902953586,0.39857352888807496,1.0,7/17,7.59%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1;CACNA1G;CACNB2
prerank,regulation of endothelial cell migration (GO:0010594),-0.41897960820597474,-1.6234589073904764,0.0019723865877712033,0.1716868049301013,1.0,31/85,13.75%,TEK;FOXP1;BMPER;THBS1;NRP2;RHOJ;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;PTK2;ETS1;DAB2IP;SLIT2;RAC1;BCAS3;PTPRM;VEGFA;PRCP;EDN1;FLT4;AKT1;EMP2;RHOB;FOXC2;NF1;APOE;FGF2;EMC10
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.5843317152312413,-1.623058714421369,0.015544041450777202,0.17142413018059832,1.0,8/19,18.03%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.46331593870705207,-1.6221153767842849,0.011650485436893204,0.172041738199854,1.0,22/54,15.34%,MEF2C;TMSB4X;THBS1;NOS3;KDR;ETS1;TGFB1;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;RGCC;JUP;PRCP;AKT1;CSNK2B;NF1;APOE;FGF2;STAT5A;EPHA2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5507504229627654,-1.6200449645286377,0.01845018450184502,0.17424739330522174,1.0,7/24,15.46%,PECAM1;F11R;NT5E;MSN;EZR;SYK;ITGA4
prerank,response to hydrogen peroxide (GO:0042542),-0.4752478965495309,-1.617627084121413,0.005813953488372093,0.17713287963671226,1.0,26/45,37.16%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;STK25;GPX1;RHOB;IMPACT;FXN;TNFAIP3;STK26;RELA;ECT2;PDCD10;PRKCD;PARK7;SOD1;AQP1;ABL1;HP;MAPK7;ANKZF1;FYN;OSER1
prerank,cellular response to alcohol (GO:0097306),0.4836752667319646,1.6175442323183045,0.021653543307086614,0.4109513240100313,1.0,7/42,4.24%,ADCY7;ADCY2;ADCY1;PTGFR;ADCY5;GNAI1;SFRP1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5751733345896102,1.6164977482128084,0.026200873362445413,0.4090649895708853,1.0,7/20,9.35%,IGF1;NRP1;LRP1;CCN4;SERPINE1;PDGFRB;BMPR1A
prerank,skeletal system morphogenesis (GO:0048705),0.49535657693582713,1.615276389694146,0.010869565217391304,0.40753487524261844,1.0,13/42,12.50%,FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;ANKRD11;HOXC9;SPEF2;TGFBR1;HOXB9;RAB33B;FUZ;FGFR1
prerank,heme catabolic process (GO:0042167),-0.6193263993971846,-1.613124268183979,0.02292768959435626,0.18287020342052662,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6193263993971846,-1.613124268183979,0.02292768959435626,0.18287020342052662,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5582179531525707,1.6124701577922225,0.019438444924406047,0.41051842237176656,1.0,6/24,5.18%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5504480249079725,1.6119720729609406,0.012987012987012988,0.40698092110016615,1.0,6/26,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,regulation of amyloid-beta formation (GO:1902003),0.5020631774677572,1.6098809938573237,0.017660044150110375,0.4083051466249768,1.0,8/34,11.11%,IGF1;SLC2A13;ROCK2;LRRTM3;RTN4;CASP3;TMED10;CHRNA7
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.49056255212983596,-1.609537651956204,0.0076481835564053535,0.1880669908439079,1.0,11/36,12.63%,MECOM;NCOR1;FOXO1;PPIA;TAOK3;EZR;SH3RF2;AIDA;ZMYND11;DUSP3;ITCH
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5302592963610245,-1.6083365557508156,0.013059701492537313,0.18912648810495017,1.0,17/26,25.75%,CCND3;ANXA1;RGCC;AKT1;LSM11;CDK10;EGFR;MTBP;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.593429321866214,1.607812594835598,0.030837004405286344,0.409570238748411,1.0,4/18,2.77%,BMP2;DDR2;EFEMP2;SMAD3
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5545373466905018,1.607060954011443,0.012684989429175475,0.4071663529258572,1.0,5/25,7.59%,CEMIP;PDPK1;ANK2;CALCR;CACNB2
prerank,neurotransmitter transport (GO:0006836),0.44512041084692977,1.6070413553116156,0.009765625,0.40261014787328303,1.0,21/73,13.98%,SLC1A3;ATP1A2;NRXN1;RIMS1;GABRA2;SLC29A1;SLC22A3;SLC38A1;SYT1;SNAP25;PDZD11;GLUL;GLS2;BRSK1;PTPRN2;STXBP3;GRM4;APBA1;SNAPIN;SLC1A2;PPFIA2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5800633138036767,-1.6070332865695387,0.030828516377649325,0.1904090023449307,1.0,13/18,12.82%,RHOJ;KDR;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,negative regulation of protein binding (GO:0032091),-0.4310566156753402,-1.6063583026963113,0.0038022813688212928,0.190560321031004,1.0,27/71,24.42%,CAV1;ACTB;B2M;RACK1;ADAM15;CTSZ;RALB;ATP2A3;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;STYX;MITD1;ITGA4;CDKN1A;GTF2F1;KDM1A;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16
prerank,indolalkylamine catabolic process (GO:0046218),0.6969064662377961,1.6062614519558294,0.0378619153674833,0.4003092810246193,1.0,4/10,10.06%,IL4I1;TDO2;KMO;KYNU
prerank,phospholipid transport (GO:0015914),-0.45222058166631673,-1.6062401197368112,0.007984031936127744,0.18977382098212037,1.0,16/52,14.03%,PITPNC1;ATP10A;PLTP;ATP8B1;ATP8A1;SCARB1;ATP11C;TNFAIP8L3;ATP11A;MFSD2A;PITPNA;ATP9B;ABCG1;PRELID2;APOE;PITPNM1
prerank,chordate embryonic development (GO:0043009),0.4600492963694855,1.6061196944759195,0.006521739130434782,0.39623029779158164,1.0,14/55,9.12%,ARNT2;BMP2;ALDH1A2;FGFR2;SULF1;BMP5;SULF2;CHD7;SIX4;TGFBR1;IGF2;FOXD3;HES5;GATA3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.44564047931200407,-1.605905882760832,0.006012024048096192,0.18927858524847405,1.0,23/57,20.67%,RPS16;RPL26;RPS25;RPS15;NOP14;RPL38;RPL11;RPS28;RPL14;RPS24;RPS19;RPL35A;CUL4A;PES1;DHX37;RPS7;RPS6;WDR74;EMG1;TGS1;RPL7;WDR12;RPL5
prerank,regulation of integrin activation (GO:0033623),-0.630027860191314,-1.6054420869606998,0.028735632183908046,0.18913998624749126,1.0,12/15,32.36%,RASIP1;RAP1B;PIEZO1;FERMT2;JAM3;PTGER4;SELP;SKAP1;SRC;FARP2;PLEK;FBLIM1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5282953478114917,1.6043657331326644,0.031914893617021274,0.39687053627196783,1.0,5/30,8.31%,IGF1;IGFBP2;CD274;IGF2;IL18
prerank,membrane depolarization during action potential (GO:0086010),0.5359619741688535,1.604146571431987,0.021505376344086023,0.3932741205244549,1.0,8/26,7.51%,ATP1A2;SCN7A;SLC8A1;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5785154978216168,-1.6033458888998968,0.030797101449275364,0.19154251251571647,1.0,6/19,6.72%,PRKCH;OCLN;CLDN5;F11R;IKBKB;CBFB
prerank,positive regulation of protein metabolic process (GO:0051247),-0.3960471204617963,-1.6012545833584229,0.0020161290322580645,0.19420908599367734,1.0,37/110,17.44%,WWP1;GPC3;NEDD4L;MAP2K5;NFKBIA;KLF2;FOXO1;KLF4;DAB2IP;CDKN1B;TGFB1;APP;RNF41;WWP2;EGLN2;IDE;PLK2;AKT1;NDUFA13;ATG7;VCP;PAEP;INHBA;RAB7A;OAZ2;APOE;ABCA2;ITCH;SMURF1;RAB1A;LDB1;SNF8;TNFAIP3;CSNK2A1;NR1H2;FZR1;NSF
prerank,protein localization to cell-cell junction (GO:0150105),-0.6150417955006333,-1.600433895051068,0.025408348457350273,0.1946360985667549,1.0,5/15,3.37%,ACTB;LSR;ACTG1;F11R;TJP2
prerank,regulation of wound healing (GO:0061041),-0.46855643312643597,-1.6000741306146533,0.0099601593625498,0.19415912224631596,1.0,17/42,24.19%,CAV1;OCLN;ACTG1;PTK2;ANXA1;CD109;CRK;SRSF6;PRKCE;FGF2;HRAS;TNFAIP3;PLAU;CADM4;TNFRSF12A;DMTN;CLDN1
prerank,response to cAMP (GO:0051591),-0.4794604413458789,-1.5992847782996822,0.013972055888223553,0.19454451828677372,1.0,15/37,23.47%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;NDUFS4;AKAP6;HCN2;STAT1;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,lamellipodium assembly (GO:0030032),-0.5295800316326352,-1.5990632631739228,0.018281535648994516,0.19392488360277232,1.0,16/26,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,neuronal action potential (GO:0019228),0.5633921956149569,1.598693896144617,0.045951859956236324,0.4045718244474503,1.0,6/22,7.51%,SCN7A;CHRNA1;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5866923870675633,1.5984362438214013,0.034403669724770644,0.4009788149624945,1.0,4/17,1.70%,BMP2;IL34;PTN;SERPINE2
prerank,regulation of interleukin-6 production (GO:0032675),-0.40857194333058355,-1.5983245615857253,0.0020161290322580645,0.19426439345733407,1.0,38/96,31.22%,AFAP1L2;LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;PTPN6;TNFAIP3;POU2F2;XBP1;ARHGEF2;CD200;LGALS9;PTPN22;AIF1;BCL10;TREM2;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;C5AR2;NOS2;MBP;TYROBP
prerank,hemidesmosome assembly (GO:0031581),-0.6718596054118247,-1.5979298858254896,0.029304029304029304,0.19398903289359637,1.0,5/11,9.08%,ITGA6;ITGB4;CD151;LAMA3;LAMC2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6851564675965194,1.5974924250989866,0.030042918454935622,0.3994887856737894,1.0,2/10,3.55%,AREG;TGFA
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6783220385536723,1.5962969555650754,0.04384133611691023,0.3984497933760418,1.0,3/10,8.24%,KDM1B;PCGF5;IGF2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.41862089576787775,-1.5961293917536206,0.005928853754940711,0.19631893079627602,1.0,24/72,18.03%,TAX1BP1;RACK1;LIFR;HIPK1;ELF1;IRAK2;HSP90AB1;IKBKB;CBFB;CASP8;RIPK1;CD74;SYK;TRAF1;AGPAT1;TNFRSF1A;JAK2;SIGIRR;MADD;PTPN6;TNFAIP3;STAT1;IFNGR1;CHUK
prerank,odontogenesis (GO:0042476),0.518403453426373,1.5957553360183252,0.025974025974025976,0.3960905340181101,1.0,7/35,5.19%,BMP2;COL1A2;FGFR2;BCOR;GLI2;ANKRD11;AXIN2
prerank,external encapsulating structure organization (GO:0045229),0.37176995067157903,1.5956297477739583,0.0,0.392442611130875,1.0,36/205,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6285671805748806,-1.5946417800865333,0.02631578947368421,0.19807996157872723,1.0,7/13,15.49%,NAMPT;KDR;IL33;EDN1;TLR4;JAK2;NOD2
prerank,extracellular structure organization (GO:0043062),0.3718588005822258,1.5936672701953496,0.0,0.3937018666332038,1.0,36/204,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.41592303536313385,-1.5919939021612146,0.002008032128514056,0.2018020060508049,1.0,38/76,32.29%,TMSB4X;NR3C2;NOD1;ACTN4;NFKBIA;CCN3;RPS3;APP;HDAC7;LIMS1;ADIPOR1;EZR;RASSF2;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;ADGRG3;LAPTM5;TRIP6;LGALS9;TSPAN6;PTPN22;TRAF6;PTP4A3;PDCD4;SPI1;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44;NLRP3;NLRC3
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5071735720230727,1.5917488260646608,0.031578947368421054,0.39516685415978886,1.0,5/35,1.87%,IRAG1;ADCY2;ADCY1;KSR1;PDE7B
prerank,regulation of JNK cascade (GO:0046328),-0.3982399174474172,-1.5915403338333638,0.004081632653061225,0.2016247990590794,1.0,32/101,15.49%,MECOM;IGF1R;MAP3K5;PTK2B;NCOR1;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;AIDA;FLT4;ZMYND11;FZD7;MAP3K11;TIRAP;TAOK2;ULK4;GADD45G;DUSP3;ITCH;EDA2R;COPS5;TRAF1;HRAS;SDCBP;EGFR;NOD2
prerank,toll-like receptor signaling pathway (GO:0002224),-0.4118666424077682,-1.589931571837056,0.0038240917782026767,0.2033250105316888,1.0,22/84,13.56%,SCARA3;LBP;PLCG2;RPS6KA3;IRAK2;MAP3K1;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;IKBKB;CASP8;TLR3;RIPK1;HSPD1;TIRAP;CTSB;PIK3AP1;TLR4;S100A1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7012163568651254,-1.5896961419637825,0.020257826887661142,0.2027626735058737,1.0,5/10,13.19%,ATP5PD;ATP5F1D;ATP5F1A;ATP5MC3;ATP5MC1
prerank,positive regulation of blood coagulation (GO:0030194),-0.5911250972252464,-1.589070832115708,0.026737967914438502,0.20271291579458392,1.0,5/17,2.91%,ANO6;ST3GAL4;THBS1;F3;THBD
prerank,primary alcohol metabolic process (GO:0034308),0.5345188101584097,1.5885033397992194,0.03547671840354767,0.4000292113605415,1.0,2/25,2.06%,IGF1;DHRS3
prerank,protein targeting to lysosome (GO:0006622),-0.5475016345625668,-1.5883505001573652,0.023465703971119134,0.20298027282638298,1.0,10/20,25.19%,AP3M1;HSPA8;NCOA4;RAB7A;AP4M1;GCC2;LAPTM5;ZFYVE16;GNPTAB;VPS4A
prerank,regulation of dendrite morphogenesis (GO:0048814),0.521111538844045,1.5876848042302107,0.021834061135371178,0.39828614795116585,1.0,15/32,17.47%,HECW2;ADGRB3;RAP2A;PTPRD;HECW1;IL1RAPL1;CUX1;TNIK;CDKL3;CUX2;OBSL1;SARM1;CAPRIN2;NEDD4;CUL7
prerank,regulation of vasculature development (GO:1901342),-0.5395586239470084,-1.5875983891773646,0.019762845849802372,0.20326241556632588,1.0,12/26,16.99%,BMPER;ETS1;WARS1;EMP2;PLXND1;EGLN1;NF1;HTATIP2;FGF2;ERBB2;EPHA2;RNH1
prerank,regulation of interleukin-12 production (GO:0032655),-0.46178011193721713,-1.5855649131253262,0.0057251908396946565,0.20566012079929338,1.0,13/47,20.34%,FOXP1;THBS1;PLCG2;CMKLR1;TLR3;HSPD1;TIRAP;TLR4;SYK;JAK3;LAPTM5;LGALS9;MAPK11
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4071126334322481,-1.5855382713679202,0.0018867924528301887,0.20468439990026738,1.0,31/87,15.01%,CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18;EID2;SMAD4
prerank,axon guidance (GO:0007411),0.3667494294146743,1.5854825503389587,0.0,0.40053685069938905,1.0,38/201,9.89%,LAMA1;PLXNA2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;RHOH;KIF5C;DAB1;SEMA3D;EFNA3;IRS2;NPTN;NRXN3;EPHB1;ALCAM;UNC5C;RYK;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,regulation of membrane repolarization (GO:0060306),-0.6267577618172172,-1.5849139556247396,0.027573529411764705,0.20485036490670364,1.0,7/13,14.42%,CAV1;KCNJ2;NEDD4L;KCNQ1;CACNB3;AKAP6;CASQ2
prerank,circulatory system development (GO:0072359),-0.3906041803123642,-1.584361813459769,0.00211864406779661,0.20470023006027918,1.0,40/118,16.10%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;NXN;NOTCH1;TGFBR2;MEF2A;RAMP2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;CRIP1;HDAC9;STRA6;PKD1;MICAL2;NOTCH4;CASP8;FLT4;SOX18;SMG9;FOXC2;NF1;TCF25;ACVR1;SOX4;HEY1;SRF;PIK3CA;PDLIM3;CDKN1A;ZFPM2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5481701279411815,-1.5841832575171484,0.013806706114398421,0.20395993177823304,1.0,6/21,4.89%,MTUS1;THBS1;PTK2B;MAPK3;PTK2;CMKLR1
prerank,neuromuscular junction development (GO:0007528),0.5377512538424722,1.5834713120649524,0.03153153153153153,0.40232469495679873,1.0,10/24,12.53%,PDZRN3;PPFIBP2;CHRNA1;LRP4;UNC13C;CACNB4;CACNB2;CACNB1;MUSK;DOK7
prerank,cellular response to cAMP (GO:0071320),-0.5017518060372398,-1.5833076878106724,0.01775147928994083,0.20464215637250227,1.0,13/30,23.47%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;AKAP6;HCN2;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,regulation of T cell cytokine production (GO:0002724),-0.6016480763214644,-1.5810540681317338,0.025044722719141325,0.2075709595282232,1.0,4/15,7.20%,B2M;CD55;SMAD7;TNFRSF1B
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5093220935384773,-1.5804169537934283,0.019927536231884056,0.20769637307408687,1.0,12/29,20.14%,ESR1;UFM1;CBFB;KANK2;DDRGK1;KMT2D;WBP2;VPS11;STRN3;UFL1;UBA5;SRARP
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5560053414794783,-1.5793337883477039,0.01834862385321101,0.20856808488342643,1.0,7/18,14.32%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APOE;APH1A
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5936920408008293,-1.5789692296424436,0.010948905109489052,0.20819893525486324,1.0,6/17,10.63%,TMSB4X;MAP2K5;KLF4;ANXA1;ANXA4;MAPKBP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6598384899084655,1.5787556175802884,0.04852320675105485,0.41183415539705237,1.0,3/11,5.95%,GRK3;GTF2H2;ADM
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5177359984769849,-1.5782590879810208,0.013409961685823755,0.20852946466048466,1.0,11/28,17.08%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2;RELA
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5225900839850881,-1.5782357207940683,0.025408348457350273,0.2075702048454832,1.0,18/27,31.77%,IRAK2;MAP3K1;UBB;UBC;RPS27A;HSPD1;TIRAP;TLR4;TAB2;IRAK4;BTK;TRAF6;CD36;TLR6;TLR1;TLR5;CD14;LY96
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5779756185076218,-1.5775034672321169,0.027777777777777776,0.20773641370786075,1.0,10/18,20.87%,SEL1L;UBB;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,response to prostaglandin E (GO:0034695),0.671893202371452,1.5770779117764573,0.045454545454545456,0.41283757649602504,1.0,2/10,4.24%,TGFBR3;SFRP1
prerank,positive regulation of lyase activity (GO:0051349),-0.6064340407191462,-1.576690222489594,0.018018018018018018,0.2083585350924062,1.0,10/14,33.86%,NOS3;ORAI1;NF1;FXN;CACNA1D;CACNA1C;PARK7;NOS2;NOS1;AKAP5
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5322834293720984,-1.5760064374974037,0.02819548872180451,0.20858992514577138,1.0,10/24,17.01%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,ribosomal large subunit assembly (GO:0000027),-0.5391948793296488,-1.5757655320789208,0.02717391304347826,0.20805842687613335,1.0,9/24,15.86%,RPL6;RPL10;RPL11;RPL23A;NOP2;RPL3;PPAN;MDN1;RPL24
prerank,histone H2A monoubiquitination (GO:0035518),0.5903006612561198,1.5757131500859511,0.04477611940298507,0.4129749557360218,1.0,9/17,22.65%,BCOR;DDB2;RNF2;PCGF5;PCGF6;SKP1;TRIM37;PCGF2;KDM2B
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5762394036316144,-1.5755264037173864,0.019963702359346643,0.2076285547183967,1.0,7/16,20.06%,SCARB1;GCH1;AKT1;APOE;S100A1;NPR3;NUS1
prerank,camera-type eye development (GO:0043010),0.5298847646267049,1.5747515613529808,0.023605150214592276,0.41201822359415735,1.0,4/25,1.47%,LAMA1;FBN1;FBN2;TENM3
prerank,cardiac muscle tissue development (GO:0048738),0.46299253514633615,1.5704724573410336,0.02766798418972332,0.42022389033362284,1.0,9/50,3.68%,BMP2;SGCZ;GJB6;BMP5;NRG1;GJA1;TBX18;SGCD;CSRP3
prerank,regulation of biomineral tissue development (GO:0070167),0.5315372835856569,1.5703548204728703,0.03711790393013101,0.4167304319820739,1.0,8/26,6.28%,ENPP1;NOTUM;DDR2;CYP27B1;AHSG;ROCK2;CEBPB;ANKH
prerank,pyruvate metabolic process (GO:0006090),-0.44634449383922764,-1.570304856714133,0.009861932938856016,0.2163372163367026,1.0,17/52,23.22%,BSG;ME1;GPI;DLD;HK1;PGM1;PKM;GAPDH;GLO1;LDHA;SLC16A1;ME2;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,positive regulation of JNK cascade (GO:0046330),-0.41994879693043663,-1.5696841769115166,0.004073319755600814,0.2163411755656064,1.0,22/70,15.49%,MAP3K5;PTK2B;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;SDCBP;NOD2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6056828823678388,1.5695255122168161,0.034858387799564274,0.4153943439385192,1.0,3/15,2.65%,IGF1;ROCK2;PRKCA
prerank,purine-containing compound catabolic process (GO:0072523),-0.6291728605526425,-1.5694700787777147,0.0374331550802139,0.21570431900020354,1.0,5/13,11.45%,NT5E;GPX1;NT5C;GDA;NT5C1A
prerank,ceramide biosynthetic process (GO:0046513),-0.4741054132678354,-1.568978152195154,0.02091254752851711,0.21562153122754946,1.0,10/40,8.90%,SGMS1;ST6GALNAC3;SGMS2;ST8SIA4;SPTLC2;DEGS2;SPTLC1;ST8SIA6;SPTSSB;ASAH2
prerank,negative regulation of binding (GO:0051100),-0.41502455786098924,-1.5687448402481992,0.005747126436781609,0.21505149742722104,1.0,33/81,25.91%,LEF1;CAV1;ACTB;RACK1;NFKBIA;CTSZ;SMO;RALB;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;E2F1;STYX;MITD1;SUMO3;JAK2;CDKN1A;GTF2F1;KDM1A;WAPL;MDFI;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16;BTAF1;PARK7
prerank,regulation of metal ion transport (GO:0010959),0.5905250460629188,1.5684846140377882,0.04201680672268908,0.41457524381402094,1.0,5/16,7.17%,ANK2;SLC30A10;CACNA2D1;BCL2;CAMK2B
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.40840046036266586,1.5679273551468158,0.001976284584980237,0.4125297351305307,1.0,19/102,10.65%,ADCY7;ENPP1;ADCY2;PIK3R1;ADCY1;TBC1D4;ADCY5;PDPK1;PRKACA;SLC30A10;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3;ADCY8
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4893001481440819,-1.5678846451682813,0.029354207436399216,0.21566715283773397,1.0,11/34,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6227953386500199,-1.5671635513820799,0.03527336860670194,0.21588204833327537,1.0,5/13,15.37%,CAV1;NEDD4L;PTK2B;CASQ2;CAB39
prerank,histone deubiquitination (GO:0016578),-0.5783748700903536,-1.5670277823090162,0.02443609022556391,0.21510631079661127,1.0,9/18,19.41%,TRRAP;BRCC3;USP7;UIMC1;USP3;ENY2;USP15;USP22;USP49
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5538317237536866,1.56681748890424,0.037527593818984545,0.4119379058865957,1.0,4/21,9.35%,IGF1;GJA1;DNMT1;BMPR1A
prerank,response to ethanol (GO:0045471),0.6263765264573039,1.5649716133738527,0.05506607929515418,0.4133575082065399,1.0,2/14,2.71%,ADCY7;GRIN3A
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5732226253446455,-1.5640268508954678,0.02631578947368421,0.21965564493009515,1.0,7/17,17.85%,PODXL;PIEZO1;TGFB2;FOXC2;CIB1;SYK;RET
prerank,phosphate ion homeostasis (GO:0055062),0.6586529830999854,1.563971933634332,0.04925053533190578,0.4125269279388189,1.0,2/10,8.79%,ENPP1;FGFR4
prerank,regulation of interferon-alpha production (GO:0032647),-0.5387861663167541,-1.5627825015629113,0.017271157167530225,0.22098876236960177,1.0,13/23,34.36%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK;SETD2;PTPRS;NLRC3;IRF3;TLR8
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.6456271827280426,-1.5627620677443503,0.02707581227436823,0.22006277155054768,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6026310330993262,-1.5624557653629871,0.03505535055350553,0.2197195584351676,1.0,3/14,4.91%,PTK2B;WNK1;ADAM10
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.4632478955468655,-1.5610198395144963,0.011881188118811881,0.22152582941890173,1.0,16/42,11.58%,UTRN;TEK;CDK6;PTPRJ;PTK2B;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;JUP;PPM1F;S100A10;EMP2;CIB1
prerank,positive regulation of cell motility (GO:2000147),-0.35528770435747165,-1.5598117172320267,0.0,0.22267110998948073,1.0,54/205,14.67%,LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;SEMA6A;SEMA3C;THBS1;SPOCK2;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;ACTN4;KDR;F3;PTK2;FERMT2;TGFB1;SMO;CAVIN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PDGFC;PDGFA;TWIST1;LAMC2;FAM107A;SEMA3G;DDRGK1;WNT11;HSPA5;CIB1;ACVR1;CSF1R;PIK3R3;HRAS;NTN1;SDCBP;SPAG9;EGFR
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39556351445261434,1.5598029789819223,0.0058823529411764705,0.42009440310101714,1.0,21/108,7.50%,NOTUM;BMP2;SALL1;WLS;DAAM2;TRABD2B;CDK14;FGFR2;SULF1;SULF2;LRP1;PTK7;SFRP1;RNF43;WIF1;PRKN;SENP2;TAX1BP3;CTNND2;TLE1;CXXC4
prerank,positive regulation of cell migration (GO:0030335),-0.34615174143596783,-1.5591796518111334,0.0,0.22296834988426842,1.0,52/253,9.90%,FN1;LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;RREB1;SEMA6A;SEMA3C;THBS1;GAB1;NOTCH1;ACTG1;SEMA7A;DOCK1;PLCG2;FGF1;RACK1;PTK2B;RAB11A;BMPR2;ACTN4;KDR;F3;PTK2;DAB2IP;FERMT2;TGFB1;TGFB2;SMO;SHTN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PLAA;PFN1;PDGFC;PDGFA;LAMC2;FAM107A;SEMA3G;DDRGK1
prerank,female gamete generation (GO:0007292),0.5162835053036635,1.556843052509358,0.02795698924731183,0.42457706492697356,1.0,11/29,15.76%,PTN;DMC1;PRDM9;NANOS3;DIAPH2;MCM9;FMN2;PIWIL2;MCM8;PARN;METTL3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6425425395547778,1.5566512180565504,0.057692307692307696,0.42162135885561247,1.0,7/12,17.28%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,negative regulation of JNK cascade (GO:0046329),-0.4887016916036033,-1.5556370569244091,0.018867924528301886,0.2282593798204566,1.0,9/31,12.63%,MECOM;NCOR1;TAOK3;SH3RF2;AIDA;ZMYND11;DNAJA1;DUSP3;ITCH
prerank,ethanol metabolic process (GO:0006067),0.6456244796229167,1.5546946006261306,0.05286343612334802,0.4233629941854534,1.0,1/12,0.10%,ALDH1A1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6069600935953268,1.5541470477666606,0.044585987261146494,0.4213864065734377,1.0,6/13,9.44%,GJA1;SCN3B;ANK2;KCNJ3;CACNB2;KCNJ5
prerank,neutrophil activation involved in immune response (GO:0002283),-0.3269122717422596,-1.554067579455768,0.0,0.23029091443990138,1.0,144/428,24.90%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;SYK;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,neutrophil mediated immunity (GO:0002446),-0.3265810256463732,-1.553464125760961,0.0,0.23034838132651422,1.0,145/432,24.90%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;ACE;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;IRAK4;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,membrane repolarization during action potential (GO:0086011),-0.6172889537181441,-1.5534266451460672,0.03935599284436494,0.22941401414520915,1.0,7/13,25.59%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6152345286608601,-1.5518652003414657,0.029038112522686024,0.23131143881525806,1.0,8/13,29.26%,SLC35A3;UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4506215752231225,-1.5515654526595963,0.011857707509881422,0.23085526226049383,1.0,14/47,12.21%,LIMS2;RREB1;DOCK1;ACTN4;PTK2;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1;RCC2
prerank,ketone body metabolic process (GO:1902224),0.6842965541109558,1.548016962838155,0.046875,0.4349532949583897,1.0,2/10,0.55%,ACSS3;HMGCLL1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.575940000604459,-1.547014765224492,0.03364485981308411,0.23836920536176126,1.0,8/16,29.58%,VAMP7;LYST;PLEKHM2;TUBB4B;ARL8B;KIF5B;VAMP2;CORO1A
prerank,neutrophil degranulation (GO:0043312),-0.3258582181252886,-1.5468337673083634,0.0,0.2376882978905466,1.0,143/425,24.90%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,muscle tissue morphogenesis (GO:0060415),0.5883766274100615,1.545658731783991,0.05203619909502263,0.4379946585830459,1.0,4/16,6.27%,TGFBR3;BMP2;EFEMP2;MYLK
prerank,keratan sulfate catabolic process (GO:0042340),0.6558117097577,1.5452717425997657,0.04265402843601896,0.43552910174035575,1.0,6/11,7.32%,FMOD;OMD;GNS;LUM;GALNS;OGN
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6647416985751051,-1.5445159325060558,0.03770197486535009,0.24140215462532671,1.0,10/10,33.57%,FN1;HSP90AB1;GATA6;TSKU;LAPTM4B;LILRB1;CD24;CDH3;TYROBP;FURIN
prerank,cell junction organization (GO:0034330),-0.41419402724133014,-1.5443482695371555,0.005836575875486381,0.24073348786723386,1.0,16/71,4.86%,ACTB;OCLN;LIMS2;APBB2;CXADR;ACTG1;OPHN1;AGRN;TJP2;RAB8B;FERMT2;TGFB1;APP;TGFB2;SDK1;LIMS1
prerank,activation of protein kinase activity (GO:0032147),0.39920436339922455,1.5443273505903687,0.010638297872340425,0.43493187357513197,1.0,13/106,5.08%,IGF1;ADCY7;ADCY2;ADCY1;NRK;NTRK3;ADCY5;NRG1;PDPK1;PRKACA;OSBPL8;GHR;IL4
prerank,response to chemokine (GO:1990868),-0.6078006685250625,-1.5438810170937782,0.04,0.24067849377396922,1.0,3/13,2.77%,SLC12A2;LRCH1;WNK1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5203571928029966,1.5437703566782834,0.042986425339366516,0.43304683623590695,1.0,4/26,4.89%,IGF1;FHL2;CAMTA1;ACTN3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6230565585948712,1.5435250904447138,0.053452115812917596,0.427087583270506,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6230565585948712,1.5435250904447138,0.053452115812917596,0.427087583270506,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4523040080519821,1.54341734000861,0.023305084745762712,0.42411591362646717,1.0,13/55,7.32%,CEMIP;GPC6;SPAM1;HYAL3;FMOD;DCN;GPC4;GPC2;OMD;GNS;LUM;GALNS;OGN
prerank,axonogenesis (GO:0007409),0.35263623606125705,1.5429359414537651,0.0,0.4222439684768453,1.0,43/237,9.89%,LAMA1;AUTS2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;FGFR2;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;CTNNA2;KIF5C;DAB1;SLITRK4;SEMA3D;EFNA3;IRS2;NPTN;NLGN3;NRXN3;EPHB1;UNC5C;DOCK7;NRCAM;RYK;RAB10;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,aorta development (GO:0035904),0.5977102778053128,1.542757866313974,0.07692307692307693,0.4195998516160902,1.0,5/14,6.77%,ROBO1;ROBO2;LRP1;EFEMP2;PDGFRB
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5199135080834665,-1.5399409555925834,0.03244274809160305,0.2475714047678982,1.0,5/25,3.46%,SPTBN1;PLCG2;PDE4D;RPS3;ANXA1
prerank,positive regulation of cell aging (GO:0090343),-0.6315145132119752,-1.53984783031433,0.046125461254612546,0.2467145841557412,1.0,4/11,18.58%,B2M;ABI3;YPEL3;CGAS
prerank,heart contraction (GO:0060047),0.47100654174597095,1.5396376292155916,0.03879310344827586,0.4245965690119089,1.0,8/41,4.22%,ATP1A2;SGCZ;SLC8A1;SCN3B;SGCD;TNNC1;CSRP3;TNNI3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.556208523937858,-1.5391893381860253,0.04519774011299435,0.24701871083336355,1.0,7/19,17.03%,HIPK1;DYRK2;RPS27L;TMEM109;AEN;PHLDA3;DDIT4
prerank,T-helper cell differentiation (GO:0042093),-0.5946456622436296,-1.5374643686914473,0.05054151624548736,0.24953390249304022,1.0,2/14,0.18%,LEF1;FOXP1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5464226308429276,-1.5355580142945,0.040293040293040296,0.2523334428016389,1.0,6/21,6.72%,PRKCH;FOXP1;SLC39A10;ELF1;CD81;CBFB
prerank,sodium ion transmembrane transport (GO:0035725),0.4118940784691696,1.5354527754720966,0.012096774193548387,0.4325612853678993,1.0,17/84,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;SLC9A7;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4195987156049225,1.5325687036611098,0.02,0.4370428193603657,1.0,16/74,7.95%,IGF1;TCF7L2;AR;BMP5;EYA2;GDNF;BCL2;SH3RF1;PHIP;CFLAR;IL4;SERPINE1;GSTP1;EYA1;SCG2;TGFBR1
prerank,innate immune response (GO:0045087),-0.34783482651316555,-1.5323663959282257,0.0,0.2577869389877108,1.0,56/217,18.09%,B2M;LBP;PLCG2;PTK2B;IFIH1;PTK2;MID2;GCH1;RPL39;TRIM25;ADAM15;APP;ADAR;MFHAS1;REL;NLRC5;NCF2;S100B;STYK1;IKBKB;IFITM1;IFITM3;TLR3;SRPK1;IFITM2;TRIM28;TRIM14;CLPB;RELB;IFIT1;FCER1G;PGLYRP1;DHX58;CD74;FRK;TRIM56;TTC4;TRIM62;ZDHHC1;MAVS;TLR4;NRROS;SYK;PHB2;TRIM68;TRIM5;POLR3A;CFP;NOD2;YES1;CX3CR1;ANKRD17;RELA;HCK;CHUK;SLA
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.38931907627046203,-1.5318808044659413,0.00202020202020202,0.2577109860662093,1.0,36/94,23.09%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;PSMB5;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.40370779721578254,-1.5311736818522645,0.012121212121212121,0.25808975166243175,1.0,22/76,19.95%,TMSB4X;TAX1BP1;MAP2K5;NFKBIA;KLF4;IRAK2;DAB2IP;CMKLR1;NLRC5;CYP1B1;CHP1;USP7;ANXA4;COMMD7;ITCH;AIM2;TNFAIP3;UFL1;CHUK;CDK5RAP3;CD200;CCDC22
prerank,negative regulation of cytokine production (GO:0001818),-0.35474073108608484,-1.5305070889189607,0.002061855670103093,0.25833163633221856,1.0,47/163,19.57%,FN1;LEF1;TMSB4X;THBS1;RPS6KA5;CD34;TAX1BP1;SRGN;IFIH1;MAP2K5;KLF4;ANXA1;TRIM25;RAC1;HDAC7;HDAC9;CMKLR1;SARS1;NLRC5;RNF125;RARA;EZR;N4BP1;TNFRSF21;RGCC;ANXA4;OTUD5;TRIB2;UBE2L6;DHX58;MAPKBP1;INHBA;MAVS;TLR4;ITCH;INHBB;SIGIRR;PTPN6;TNFAIP3;CD84;ATP2B1;VSIR;JAK3;PTGER4;CD200;PIN1;LAPTM5
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5498283891723227,-1.530161909705741,0.03481624758220503,0.2580889361251361,1.0,10/19,9.73%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10
prerank,ureteric bud development (GO:0001657),0.5843141294937021,1.528843326811029,0.07366071428571429,0.44383224277845923,1.0,4/17,1.11%,BMP2;ROBO2;SALL1;FGFR2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4480314291409188,1.5282611513012683,0.020833333333333332,0.44222632777050236,1.0,13/49,13.69%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TSLP
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6137386528698552,-1.527563863610841,0.04604051565377532,0.2623898943252703,1.0,6/13,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,embryonic organ morphogenesis (GO:0048562),0.47272648293410685,1.526923995683219,0.042643923240938165,0.44262131683851286,1.0,11/42,11.02%,FBN1;FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;MFAP2;RARG;HOXB9;FUZ
prerank,positive regulation of cellular senescence (GO:2000774),-0.6345173692025975,-1.5262167571392786,0.04864864864864865,0.26417141804296346,1.0,4/10,18.58%,B2M;ABI3;YPEL3;CGAS
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5693426494116631,-1.5257879800782492,0.040697674418604654,0.26409019991684135,1.0,5/15,3.06%,IGF1R;PTK2B;KDR;MAPK3;BMX
prerank,modulation by symbiont of host process (GO:0044003),-0.6553546522166229,-1.524188355133294,0.041742286751361164,0.2662174681554294,1.0,7/10,23.22%,B2M;UBB;UBC;RPS27A;PGK1;MRC1;ENO1
prerank,adenine nucleotide transport (GO:0051503),-0.5605485448085807,-1.522887006978741,0.03389830508474576,0.2678819050637466,1.0,3/17,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,positive regulation of behavior (GO:0048520),-0.650520160023681,-1.5220536726341947,0.051056338028169015,0.2686714639167339,1.0,4/10,11.50%,MEF2C;STRA6;AGRP;SGIP1
prerank,activation of protein kinase B activity (GO:0032148),0.5110885519576454,1.520892510863569,0.031055900621118012,0.4559463316617842,1.0,5/29,3.11%,IGF1;NTRK3;NRG1;PDPK1;OSBPL8
prerank,negative regulation of DNA binding (GO:0043392),-0.49693551670406944,-1.520597749055989,0.03275529865125241,0.27064428770610616,1.0,9/28,18.97%,LEF1;NFKBIA;SMO;E2F1;SUMO3;JAK2;HEY1;KDM1A;MDFI
prerank,renal system development (GO:0072001),0.43976460406495893,1.519341015403031,0.022587268993839837,0.45713510510909894,1.0,12/52,9.12%,WNT4;SALL1;GREB1L;SULF1;SULF2;GLI2;TBX18;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.40817991446566976,-1.5188985961537047,0.01002004008016032,0.27326993816531564,1.0,26/71,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,negative regulation of cell growth (GO:0030308),-0.3710941552330056,-1.5184716422410542,0.003816793893129771,0.27309335502754883,1.0,48/121,23.22%,APBB2;PTPRJ;SERTAD2;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;TGFB1;TGFB2;PPP2R1A;NDUFA13;BCL6;SIPA1;DIP2B;RB1;WFDC1;SEMA3G;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4850743047586129,-1.518201215624051,0.03571428571428571,0.27265293802407753,1.0,18/33,26.02%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;PLK3;CCL2;CDKN2B;DCUN1D3;PLK5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.47640865562722023,-1.5181768893948204,0.027079303675048357,0.2716479171722757,1.0,14/35,11.52%,NR3C2;ESR1;DDX5;DDX17;PLPP1;PPARGC1B;RBFOX2;KDM3A;SAFB;NR3C1;EGLN2;ARID1A;NCOA4;WBP2
prerank,alpha-amino acid catabolic process (GO:1901606),0.5106609188735003,1.5162511224010036,0.049783549783549784,0.4627564273303959,1.0,8/29,10.06%,ALDH4A1;IL4I1;PRODH;ACADSB;TDO2;KMO;DDO;KYNU
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4895801795832149,-1.5143183699943028,0.038817005545286505,0.2791070278269494,1.0,16/31,25.12%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;CCL2;CDKN2B;DCUN1D3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.40490689112771866,-1.5137169981167962,0.007984031936127744,0.2794221621303951,1.0,26/73,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5382801694865385,-1.5135540201139293,0.048507462686567165,0.2787293886371064,1.0,6/20,6.56%,B2M;CD55;PRKCZ;IL1R1;CD81;DENND1B
prerank,regulation of osteoclast differentiation (GO:0045670),0.47957694283604424,1.5135342986711218,0.03640256959314775,0.4671501103782812,1.0,6/33,5.13%,FBN1;OCSTAMP;GPR55;CEBPB;IL4;CAMK4
prerank,regulation of axonogenesis (GO:0050770),0.4451423962836926,1.513529521476509,0.035789473684210524,0.4639007820180843,1.0,15/51,15.34%,PLXNA2;ROBO1;ROBO2;LRRC4C;KIF13B;LRP4;MCF2;RTN4;PTEN;PLXNB2;BRSK1;NGFR;AMIGO1;MAP6;PAK1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6314243984246993,-1.5133091177842555,0.03518518518518519,0.27705705596522046,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6314243984246993,-1.5133091177842555,0.03518518518518519,0.27705705596522046,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3821298528208195,-1.5132636028855624,0.004048582995951417,0.27610977294653255,1.0,28/93,15.49%,MAP3K5;PTK2B;ARL6IP5;TPD52L1;DAB2IP;APP;TGFB2;MID1;MFHAS1;MINK1;VEGFA;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;STK25;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;EMC10;SDCBP;NOD2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5320939779903755,-1.513233063503215,0.03531598513011153,0.2751138160680548,1.0,7/21,7.58%,CAV1;DMD;RACK1;PDE4D;SMAD7;RASSF2;PPM1F
prerank,negative regulation of viral genome replication (GO:0045071),-0.45727634670182526,-1.512193603110864,0.025540275049115914,0.27618436482900155,1.0,14/40,21.38%,IFIH1;MPHOSPH8;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;MAVS;TASOR;OAS2;RSAD2;SETDB1
prerank,axon extension (GO:0048675),0.5294410121130715,1.5117270915563665,0.05893909626719057,0.46592001840964464,1.0,6/23,7.20%,AUTS2;NRP1;SEMA5A;SEMA3A;NLGN3;ALCAM
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5141946344204064,1.511099892625334,0.06382978723404255,0.4644110481595292,1.0,7/22,11.11%,SLC2A13;ROCK2;LYN;LRRTM3;EFNA3;CASP3;CHRNA7
prerank,regulation of type I interferon production (GO:0032479),-0.3946367456643865,-1.5107883878224941,0.015904572564612324,0.2779918135366433,1.0,39/84,34.35%,TAX1BP1;IFIH1;TRIM25;NLRC5;LRRFIP1;RNF125;PRKDC;GAPDH;OTUD5;DDX41;UBE2L6;DHX9;TIRAP;DHX58;TRIM56;MAVS;ITCH;POLR3E;POLR3A;NLRP4;TNFAIP3;RELA;IRF8;CGAS;PIN1;PTPN22;POLR3B;CTNNB1;MRE11;UBA7;POLR1C;POLR2F;PQBP1;POLR2L;CD14;IKBKE;CREBBP;POLA1;IRF3
prerank,embryonic eye morphogenesis (GO:0048048),0.6421348964777843,1.5105648108175034,0.07051282051282051,0.46279737109287916,1.0,4/11,7.77%,FBN1;FBN2;MFAP2;RARG
prerank,cellular component maintenance (GO:0043954),-0.6073481409411512,-1.510272994505887,0.052823315118397086,0.2780515726913561,1.0,5/12,25.89%,IGF1R;INSR;CLDN1;TREM2;MTMR2
prerank,extracellular matrix organization (GO:0030198),0.33778494924160896,1.5097516697988906,0.0,0.46184525312537794,1.0,44/276,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;FLRT2;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;DPT;MATN3;ITGA11;SCUBE1;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;SH3PXD2B;MMP16;CREB3L1;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;PLG;ITGAD;COL10A1;COL8A2;P4HA2;LOXL2;MMP11
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.552423558488072,-1.5096473170008753,0.034926470588235295,0.27846578199898336,1.0,9/17,25.43%,CCND3;CCNY;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2;SPDYA
prerank,inositol phosphate metabolic process (GO:0043647),-0.4389574306590368,-1.5093571440060152,0.029357798165137616,0.27801402981421447,1.0,15/46,16.69%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;FGF2;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5047151731594393,-1.5080268507226562,0.03544776119402985,0.2797422803908408,1.0,15/25,34.57%,HSPA8;DNAJB12;HSPA5;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13
prerank,purine ribonucleotide transport (GO:0015868),-0.5640049186618612,-1.507910813911497,0.039473684210526314,0.2789506901865936,1.0,3/16,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,gonad development (GO:0008406),0.4616229272820974,1.5076716282681937,0.041304347826086954,0.4645771483065258,1.0,9/41,9.12%,WNT4;SALL1;AR;NR2F2;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,positive regulation of catabolic process (GO:0009896),-0.4150524397111981,-1.5065883567635563,0.01160541586073501,0.28060889611834067,1.0,24/65,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;SNF8;TNFAIP3;CSNK2A1;FZR1;VSIR;NSF
prerank,membrane depolarization (GO:0051899),0.498763950429268,1.5057212824999224,0.04741379310344827,0.4670434199512927,1.0,11/32,9.64%,SCN7A;CACNA1E;SCN3B;P2RX4;SCN3A;CACNA1I;CACNG4;SCN2A;CACNA1G;CACNB4;CHRNA4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5525071390440754,1.5046099781645401,0.05555555555555555,0.46702502919057926,1.0,7/18,7.75%,GRID2;CDH8;UNC13C;GRIK5;GRIK2;GRID1;GRIK1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.42714345096234735,-1.5044359188075807,0.023166023166023165,0.284250612971371,1.0,25/54,27.42%,RPL6;RPL26;RPL10;RPL11;RPL14;RRP15;RPL23A;RPL35A;NOP2;PES1;RPL10A;RPL3;PPAN;MDN1;WDR74;RPL24;RPL7;WDR12;RPL5;NSA2;RSL1D1;RPL7A;RPF2;NPM1;TRAF7
prerank,endothelial cell proliferation (GO:0001935),-0.553979377118527,-1.503948352543591,0.050682261208576995,0.28428635373213507,1.0,4/17,2.11%,TEK;BMPER;CD34;BMPR2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5794036928387097,-1.5039152360187797,0.04363636363636364,0.28336625923325104,1.0,6/14,14.32%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APH1A
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5286357196277599,-1.5027101043961903,0.045787545787545784,0.28487009000044683,1.0,9/20,21.50%,CCND3;CCNY;HSP90AB1;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2
prerank,energy reserve metabolic process (GO:0006112),0.5444359113132057,1.5023330183841044,0.060133630289532294,0.47037366043916795,1.0,4/19,2.85%,PID1;PRKAG2;PHKA1;LEPR
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5099194717315613,1.5020253342692216,0.04357298474945534,0.4680618822924819,1.0,7/27,5.39%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1;PRKN
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5433067538511271,-1.5018860967245007,0.04189435336976321,0.2855575741454761,1.0,5/18,12.89%,LBP;PLCG2;DYSF;FCER1G;SYK
prerank,regulation of intracellular protein transport (GO:0033157),-0.48027412714262424,-1.501030363313417,0.0425531914893617,0.2863013083775607,1.0,14/32,22.97%,PTPN14;TGFB1;BCAS3;PRR5L;CEP290;PCM1;OAZ2;NDEL1;UHMK1;GCC2;RIPOR1;PDCD10;PLK3;PTPN1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.5562437069322433,-1.4999976279513392,0.05172413793103448,0.2874580343023483,1.0,8/17,13.26%,CLDN5;F11R;VEGFA;IKBKB;S1PR3;ADD1;VCL;TNFRSF1A
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3608697828503018,-1.4994056295103173,0.002053388090349076,0.2877447396279353,1.0,42/136,19.38%,TMSB4X;ESR1;TAX1BP1;ID1;ID3;MAP2K5;NFKBIA;FZD6;KLF4;IRAK2;DAB2IP;SMAD7;ZNF431;WWP2;CMKLR1;NLRC5;CYP1B1;PKD1;CHP1;BHLHE40;HEYL;USP7;ANXA4;HDAC4;TRIB1;RB1;CTNNBIP1;EGLN1;COMMD7;ITCH;HES1;AIM2;PHB2;SIGIRR;TNFAIP3;UFL1;KDM1A;CHUK;CDK5RAP3;MDFI;CD200;ADGRG3
prerank,kidney development (GO:0001822),0.4166684864016555,1.4991610750622693,0.027777777777777776,0.47307301122580675,1.0,13/65,9.12%,WNT4;ROBO2;SALL1;GREB1L;SULF1;SULF2;GDNF;GLI2;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,pancreas development (GO:0031016),0.6017077596479976,1.49710478794771,0.09360730593607305,0.47546887636627116,1.0,3/12,8.90%,TCF7L2;NKX6-1;NPHP3
prerank,regulation of defense response (GO:0031347),-0.39536425822099786,-1.495298078778761,0.017130620985010708,0.2956018333495791,1.0,28/76,20.24%,FOXP1;TMSB4X;SEMA7A;ANXA1;MGLL;IL1R1;BRD4;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;APOE;SAMHD1;BCL6B;JAK2;NOD2;UFL1;RELA;HCK;DAGLB;CASP1;GGT1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4383172780290181,1.4947037457711672,0.029350104821802937,0.47911679704032356,1.0,14/50,11.91%,RORA;FGFR2;IFT81;ZIC1;GLI3;SFRP1;EVC;IFT122;TULP3;KIF7;KCTD21;MGRN1;FUZ;BTRC
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.43989348372068476,1.4943986871321293,0.027210884353741496,0.4769949277577642,1.0,8/48,8.31%,ADCY7;ADCY2;ADCY1;ADCY5;AMPD3;SLC26A1;PAPSS1;GUCY2F
prerank,positive regulation of protein polymerization (GO:0032273),-0.4131620560150494,-1.4943898486802027,0.013282732447817837,0.2965973826231904,1.0,21/65,23.91%,OCLN;BAIAP2L1;PTK2B;RPS3;RAC1;LMOD1;SLAIN2;PFN1;DCTN1;PRKCE;MET;NCKAP1;HSP90AA1;HCK;CDC42EP3;ARL2;CTTN;NCK1;CARMIL1;NCK2;CLIP1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4987741245566816,-1.4935018615933917,0.03333333333333333,0.29757398208106944,1.0,11/25,19.69%,CXADR;JAM3;JUP;CTNNA3;ITGA7;DSG2;ITGA4;DSP;NINJ1;CD200;ITGB3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6151488381677435,1.4934056282033448,0.07432432432432433,0.4769298706428382,1.0,3/11,4.95%,IGF1;PIK3R1;GHR
prerank,regulation of trans-synaptic signaling (GO:0099177),0.48292922264102167,1.493338249451616,0.05555555555555555,0.4741693684839941,1.0,10/33,7.75%,LRRC4C;NRG3;GRID2;GRIK5;GRIK2;NLGN2;NLGN3;GRID1;NLGN1;GRIK1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6004688425989335,1.4931047331669873,0.05200945626477541,0.47192502829790695,1.0,6/13,12.72%,BMP2;BMP5;CYP27B1;DKK3;SCAP;ERLIN1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.6030473635212853,-1.4928546957993016,0.05330882352941176,0.298049019711204,1.0,7/12,12.36%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5643748827512735,-1.4926977771107102,0.046153846153846156,0.2973517219263977,1.0,4/14,7.13%,ANXA1;PRKCZ;RARA;NFKBIZ
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6327745993073778,1.4926889524622509,0.07110091743119266,0.4699843594643894,1.0,2/10,2.34%,ADGRV1;STRC
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6222381653605993,-1.492642603133745,0.05128205128205128,0.296461100990226,1.0,7/11,29.26%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6287725629922742,-1.4915096850791236,0.06735751295336788,0.29806053769992846,1.0,4/11,15.37%,CAV1;NEDD4L;CASQ2;CAB39
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6308659092415253,-1.4902103922329957,0.06306306306306306,0.29989302040387045,1.0,4/10,22.14%,HK1;PFKP;GFPT1;PFKL
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4007201620490139,-1.4900164673132785,0.013972055888223553,0.2993009223165681,1.0,25/70,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5360610476183295,1.4888685292140686,0.05922551252847381,0.47738574289556385,1.0,6/20,8.07%,TGFBR3;BMP2;TBX3;OLFM1;TGFBR1;RBPJ
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4468550804016625,1.488775741391256,0.030973451327433628,0.4747008594998642,1.0,9/47,7.28%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,positive regulation of programmed cell death (GO:0043068),-0.33031150195433545,-1.4885188730254642,0.0020491803278688526,0.30154277156680415,1.0,81/272,19.60%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FOXO3;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;HTATIP2;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;SYK;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;GADD45A;LAPTM5;ARHGEF6
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.37884322662968695,1.4873706866911522,0.016,0.4757905994583154,1.0,10/110,1.71%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3764516442353028,-1.4869950141650767,0.008032128514056224,0.30400315055554267,1.0,33/103,15.87%,ARHGAP31;RAPGEF5;PLCE1;RREB1;RASGRP3;RGL1;SHOC2;ARHGAP1;RAC1;SHTN1;RALB;CHP1;RAB18;SHC1;BCR;NUCB1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;NF1;ABR;FGF2;GNB1;HRAS;ARHGEF18;NTN1;RGL2;CDKN1A
prerank,regulation of actin filament depolymerization (GO:0030834),0.614163082241973,1.4865469537345226,0.09227467811158799,0.4752942693974758,1.0,2/12,1.18%,PLEKHH2;SEMA5A
prerank,sodium ion transport (GO:0006814),0.39522563708033676,1.486319162651872,0.022222222222222223,0.47305916841805,1.0,16/85,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6152603893569026,-1.4860068072066308,0.05945945945945946,0.3051967988992276,1.0,4/11,3.82%,SEMA6A;THBS1;KLF2;EPN1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5442012199760253,-1.485878624250952,0.07468123861566485,0.3044245705140267,1.0,7/17,12.63%,FGF1;LPCAT3;MBTPS2;ABCG1;ERLIN2;APOE;ABCA2
prerank,anterior/posterior axis specification (GO:0009948),0.5769512791317795,1.4858617419866325,0.07692307692307693,0.4715477142916859,1.0,2/15,0.85%,WLS;TBX3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5442722787372322,-1.4853538706059828,0.045454545454545456,0.30458688410330415,1.0,10/17,24.46%,PARD3;SMAD7;CALM1;CALM3;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5262898680415458,-1.485199623533601,0.05018587360594796,0.303929475199264,1.0,6/20,12.54%,RPS6KA5;MAPK3;PPARGC1A;DIP2B;TADA2B;SOX4
prerank,regulation of presynapse organization (GO:0099174),0.5382041746628597,1.4849068036253434,0.05845511482254697,0.4685639284787676,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,regulation of presynapse assembly (GO:1905606),0.5382041746628597,1.4849068036253434,0.05845511482254697,0.4685639284787676,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,epithelial tube morphogenesis (GO:0060562),-0.473132839429428,-1.4845550426217715,0.03816793893129771,0.30414598477116334,1.0,16/32,21.50%,MEF2C;PODXL;RASIP1;SOX17;SLIT2;COL4A1;PKD1;CSNK2B;RHOB;ACVR1;HES1;CSF1R;MET;FGF10;PKD2;PRKD2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.39659712481467607,1.4844578988250616,0.016359918200409,0.4669188154212204,1.0,10/85,4.44%,IGF1;BMP6;TCF7L2;TGFBR3;FGFR2;BMP5;MTSS1;TGFA;SFRP1;MCC
prerank,histone lysine methylation (GO:0034968),0.48036948684374253,1.4838307194848284,0.07006369426751592,0.4658412318221043,1.0,14/33,15.52%,PRDM5;WDR5B;PRDM9;SETMAR;MEN1;KMT2A;SMYD1;CXXC1;SMYD3;PAXIP1;EHMT2;DYDC2;EZH2;WDR82
prerank,JNK cascade (GO:0007254),-0.44769338301107503,-1.4838132800197443,0.037383177570093455,0.30473902070053127,1.0,14/40,19.60%,MAP3K5;NOD1;MAP4K3;IRAK2;UBB;MINK1;UBC;RPS27A;MAP3K11;TRIB1;NOD2;TAB2;PTGER4;ARHGEF6
prerank,regulation of hydrolase activity (GO:0051336),-0.3943245095817337,-1.4835537458666177,0.011976047904191617,0.30430453419021847,1.0,18/71,11.34%,CHN2;FGD5;CAV1;PRKG1;RASIP1;SIPA1L1;PTK2;ARHGAP27;DAB2IP;PLXNA4;CHN1;CRK;FGD6;GPR137B;ADAP1;PLXNA1;PLXND1;NF1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6009908536247183,-1.4826880559252242,0.059674502712477394,0.3051965426406001,1.0,7/12,29.26%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,nitric oxide metabolic process (GO:0046209),-0.5653178929199532,-1.4826173478898323,0.061567164179104475,0.3043513730264899,1.0,6/14,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,regulation of intracellular pH (GO:0051453),-0.4653986336227358,-1.4821035222821837,0.03877551020408163,0.30435195554170663,1.0,11/34,17.65%,SLC4A10;SLC9A2;TMEM165;CHP1;ATP5F1B;SLC4A8;SLC4A2;VPS33A;GPR89B;GPR89A;SLC9B1
prerank,positive regulation of cyclase activity (GO:0031281),-0.5759951323059178,-1.4817681737719806,0.05758157389635317,0.3041835392217944,1.0,6/14,19.15%,NOS3;MAPK3;ORAI1;NF1;CACNA1D;CACNA1C
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5073912328195982,-1.4813072302529304,0.03756708407871199,0.30422209675547174,1.0,12/25,26.64%,OPHN1;HSP90AB1;RPL11;RPL23;RPS7;SGTA;CSNK2A1;CSNK2A2;RPL5;ALAD;TRIM39;F8A1
prerank,macrophage activation involved in immune response (GO:0002281),-0.5836897702015286,-1.4805931222466815,0.046468401486988845,0.3047640968881416,1.0,5/13,15.81%,LBP;PLCG2;DYSF;SYK;CX3CR1
prerank,negative regulation of signal transduction (GO:0009968),0.33733063822694426,1.4804843765446298,0.007751937984496124,0.47204575519680797,1.0,54/249,11.44%,ENPP1;ADAMTS12;LGR4;NOTUM;BMP2;PID1;TRABD2B;SULF1;BMP5;SULF2;LRP1;AHSG;DCN;PIP4K2A;LEPROT;DKK3;BCL2;GLI3;PTPRT;CREB3L1;LYN;SFRP1;RNF43;TMEM25;WIF1;TSPAN15;TAX1BP3;NLRP12;IFT122;SMPDL3B;TLE1;CXXC4;CRY1;TULP3;MAPK8IP2;LRRC14;KIF7;ERBB3;NLRP2B;KCTD21;GPR108;CNMD;GATA3;PRKCB;DCC;MGRN1;PTEN;DACT3;FRZB;PIP4K2B;SIAH2;PTGIR;NKD2;FSTL3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.47525848733676473,-1.4792530298331423,0.033582089552238806,0.30691662817257825,1.0,11/30,17.33%,ACKR3;TPT1;RPS3;CD44;TWIST1;PTTG1IP;CD74;BCL2L1;DDX39B;CCAR2;KDM1A
prerank,organophosphate ester transport (GO:0015748),-0.4995505554056945,-1.4790796768002246,0.02529182879377432,0.3063046872794725,1.0,7/24,14.03%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PITPNA;PRELID2;PITPNM1
prerank,regulation of blood coagulation (GO:0030193),-0.4875255109616768,-1.478398022140105,0.04363636363636364,0.3067571662517001,1.0,8/27,9.15%,CAV1;ST3GAL4;THBS1;CD34;THBD;FAP;EDN1;ENPP4
prerank,cranial nerve development (GO:0021545),0.6305864410612033,1.4779127380937043,0.07415730337078652,0.4766688300061456,1.0,3/11,8.26%,SALL1;CHD7;ERBB3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6017690828601837,-1.4774151059775427,0.056338028169014086,0.3079065574611865,1.0,6/12,19.15%,CAV1;JUP;CTNNA3;DSG2;DSP;CACNA1C
prerank,sensory perception (GO:0007600),0.4422278452869097,1.4769634742501048,0.04008438818565401,0.47651548375320174,1.0,13/45,18.99%,ADGRV1;TTC8;P2RX4;OPRK1;PCDH15;TRPA1;CHRNA4;CHRNA7;PNOC;PTGES;CLRN1;SCN9A;PDYN
prerank,establishment of epithelial cell polarity (GO:0090162),-0.530086333816489,-1.4749134647679918,0.055248618784530384,0.3124116593639335,1.0,6/19,9.83%,CYTH3;PARD3;OPHN1;MSN;EZR;SIPA1L3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5308773273681442,-1.4748132576973567,0.05301645338208409,0.31159970602030823,1.0,10/18,29.30%,HIP1R;ACAA2;BAX;BAK1;CHCHD10;HSPA1A;SLC35F6;TMEM14A;MUL1;FZD9
prerank,negative regulation of biosynthetic process (GO:0009890),0.570823344810385,1.474717592374301,0.07555555555555556,0.4796968885002551,1.0,5/16,6.61%,PPARA;SLC30A10;ABCD2;GSTP1;ASXL3
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5085888929452781,1.4738124234029688,0.06651376146788991,0.4795470099073414,1.0,4/23,4.22%,TGFBR3;FGFR2;TNNC1;TNNI3
prerank,regulation of multicellular organism growth (GO:0040014),0.5599470600955921,1.4737996116726293,0.09070294784580499,0.47686485908179055,1.0,3/15,4.95%,IGF1;STAT5B;GHR
prerank,microvillus organization (GO:0032528),-0.5757694320798862,-1.473734290946608,0.06088560885608856,0.3130657032882017,1.0,5/13,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5778069766091198,1.4730121879944038,0.0706401766004415,0.47630019538861484,1.0,3/12,7.13%,MYCBP2;GLI2;EPHB1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.49104323685662143,-1.4729255661073892,0.023809523809523808,0.3138569239510958,1.0,9/26,18.61%,CAV1;LBP;MFHAS1;TLR3;FLOT1;TIRAP;SLC15A4;NINJ1;RSAD2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5331278741306864,1.4724184253632926,0.07191011235955057,0.4752884548410504,1.0,3/17,11.11%,IGF1;RTN4;CHRNA7
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.45946697168024786,-1.4719871776360227,0.04206500956022945,0.31493678821023113,1.0,19/33,25.75%,CCND3;PLCG2;ANXA1;RGCC;AKT1;DDRGK1;LSM11;PHB2;EGFR;ANKRD17;GLI1;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.3848274439345414,-1.470910960947381,0.011538461538461539,0.31621945721924627,1.0,32/86,23.91%,OCLN;BAIAP2L1;PTK2B;RPS3;APP;RAC1;WDR1;LMOD1;SLAIN2;EDN1;GPX1;STMN2;PFN1;RB1;SYNPO;DCTN1;TRPV4;APOE;PRKCE;KATNB1;LIMK1;MET;NCKAP1;HCK;CDC42EP3;ARL2;CTTN;NCK1;COLGALT1;CARMIL1;NCK2;CLIP1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.49613523398473275,1.4705979422569564,0.04583333333333333,0.47750001682336585,1.0,6/26,10.16%,IGF1;PIK3R1;OSBPL8;IRS2;C2CD5;PRKCI
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.46998460168325285,-1.4702009964714955,0.03625954198473282,0.3169285073262553,1.0,19/31,28.98%,PPP1R13B;PPP3CC;HIP1R;CASP8;BAX;BBC3;YWHAZ;E2F1;BAK1;CHCHD10;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,glycerolipid catabolic process (GO:0046503),-0.534198015049158,-1.4696602738863809,0.05291970802919708,0.31718064168305404,1.0,3/19,3.57%,GPCPD1;ABHD2;MGLL
prerank,negative regulation of peptidase activity (GO:0010466),0.4375219087295046,1.4695259685922655,0.041928721174004195,0.4779073399225441,1.0,9/47,7.28%,TIMP3;LRP1;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,regulation of cell killing (GO:0031341),-0.5510015506038627,-1.4695029277422609,0.05272727272727273,0.3166185548757177,1.0,4/16,8.56%,CD55;TGFB2;RAC1;FZD7
prerank,regulation of innate immune response (GO:0045088),-0.4073759871926154,-1.4694487803152638,0.0275049115913556,0.31579586519759134,1.0,28/57,35.07%,GBP5;HSP90AB1;N4BP1;CASP8;ERAP1;DHX9;TIRAP;LRP8;DHX58;SAMHD1;AKIRIN2;PTPN6;TNFAIP3;SLC15A4;PTPN22;PTPN1;POLR3B;XIAP;TREM2;MUL1;PARP9;RIOK3;NLRC3;LYAR;CCL5;USP18;TLR8;FCGR2B
prerank,response to nitric oxide (GO:0071731),-0.5824874690037434,-1.4689833067264135,0.04918032786885246,0.31590329498874453,1.0,4/13,10.80%,MTR;FOXO1;GUCY1B1;EGLN1
prerank,positive regulation of glucose import (GO:0046326),0.514132067969291,1.4687069649140896,0.07296137339055794,0.47763440758064635,1.0,4/21,5.54%,IGF1;PIK3R1;OSBPL8;IRS2
prerank,engulfment of apoptotic cell (GO:0043652),0.5607950637381376,1.4685082108402214,0.09014675052410902,0.4755769350186578,1.0,5/15,4.66%,XKR4;MEGF10;RHOH;XKR6;RHOBTB1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.397356305348805,-1.4678634826459689,0.02217741935483871,0.31750681512652495,1.0,34/69,31.15%,SEL1L;TRIM25;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;TMEM129;EDEM2;TMUB2;SGTB;TMUB1;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3510431627186299,-1.4678531361892482,0.0039603960396039604,0.3165510864557845,1.0,36/140,11.85%,ARHGAP31;CHN2;PLCE1;MCF2L;ARHGEF3;NET1;RHOJ;OPHN1;TGM2;RASGRF2;ARAP3;STARD13;ARHGAP23;STARD8;ARHGAP17;CYRIB;ARHGAP26;CD2AP;SLIT2;ARAP2;ARHGAP1;ARHGDIA;TRIO;RAC1;ARHGDIB;CHN1;ARHGAP25;SOS2;BCR;ITSN1;RHOT1;RHOB;PREX1;RHOT2;GMIP;ABR
prerank,maturation of LSU-rRNA (GO:0000470),-0.4862927260003631,-1.4671279185273292,0.04990757855822551,0.31730382013712694,1.0,14/26,26.10%,RRP15;RPL35;NOP2;PES1;RPL10A;URB1;RPL7;WDR12;NSA2;RSL1D1;RPL7A;FTSJ3;RPF2;ZNHIT6
prerank,regulation of cellular response to heat (GO:1900034),-0.38700305913697397,-1.4670423121639418,0.024390243902439025,0.3165408139751461,1.0,35/77,27.53%,CD34;MAPK3;CAMK2D;HSP90AB1;HSPA8;NUP93;NDC1;HSBP1;NUP54;BAG5;NUP188;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;FKBP4;HSPA1B;IER5;NUP160;DNAJB1;BAG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NUP98
prerank,negative regulation of cell death (GO:0060548),-0.38054647847383094,-1.4667341304848205,0.024193548387096774,0.3163150007189559,1.0,30/88,22.04%,MECOM;CD34;CCN3;FERMT2;PPARGC1A;PDE8A;DCPS;TNFRSF1B;DUS2;SRSF6;AKT1;KANK2;SPEF1;WNT11;INPP5A;PSMC5;IMPACT;SOX4;CCN5;FGF2;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CD200;NCK1;HSPA1B;ADNP2;EIF4G1
prerank,detection of mechanical stimulus (GO:0050982),-0.5306911861077754,-1.4667001905404202,0.05046728971962617,0.31541992216843306,1.0,5/19,7.35%,PIEZO2;PTK2;PIEZO1;PKD1;JUP
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4324779027103446,-1.4659145357377432,0.0248565965583174,0.31623312368965095,1.0,16/45,18.51%,B2M;CAMK2D;TRIM25;CD44;MT2A;MID1;TRIM62;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8
prerank,negative regulation of angiogenesis (GO:0016525),-0.38072342341972487,-1.4658753740153114,0.014028056112224449,0.3153714752407741,1.0,20/84,10.11%,TEK;CLDN5;SEMA6A;SLC12A2;THBS1;KLF2;KLF4;COL4A2;DAB2IP;NPR1;EPN1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,microvillus assembly (GO:0030033),-0.5628415509552426,-1.4657157290309712,0.06284658040665435,0.3147469274894322,1.0,5/14,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5208429504585057,1.4656596963583566,0.06277056277056277,0.4806939550724927,1.0,5/21,7.11%,PPARA;SLC30A10;PRKN;ABCD2;SIRT2
prerank,regulation of glucose metabolic process (GO:0010906),0.47702835195276416,1.4655652594145208,0.05066079295154185,0.478294022850896,1.0,6/34,5.80%,RORA;PDK1;PDK4;PRKN;IRS2;PDK3
prerank,positive regulation of immune response (GO:0050778),-0.40056105132317454,-1.4653292260262591,0.023809523809523808,0.31461616560711436,1.0,31/64,40.24%,IL15;GBP5;TGFB2;CD81;DHX9;CD74;SPHK2;AKIRIN2;NOD2;SLC15A4;XBP1;RSAD2;LGALS9;IL6ST;POLR3B;STX4;SKAP1;LILRB1;KARS1;NLRP3;RIOK3;SASH3;CCL5;TLR8;FCGR2B;CD226;GRN;MYB;IL12RB1;ITGB2;ADAM8
prerank,I-kappaB phosphorylation (GO:0007252),-0.6294606468900688,-1.4643407166663878,0.06126126126126126,0.3158452305767208,1.0,7/10,34.24%,DAB2IP;TLR3;TLR4;CHUK;PRDX4;ERC1;TLR2
prerank,heme biosynthetic process (GO:0006783),-0.512647760059278,-1.464243878224927,0.05772811918063315,0.31513567257760583,1.0,10/22,27.26%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,purine nucleotide metabolic process (GO:0006163),-0.4971278574183081,-1.4639895989978005,0.05405405405405406,0.31480655325951024,1.0,8/24,11.45%,NT5E;PRPS2;GPX1;NT5C;GDA;PRPS1;PRPS1L1;NT5C1A
prerank,mitochondrial gene expression (GO:0140053),-0.43964741770310345,-1.4635454311821587,0.044921875,0.31494655562263685,1.0,21/42,32.74%,FOXO3;QRSL1;PTCD3;MRPL51;LARS2;GATC;MRPS17;MRPL16;SLC25A33;MRPL47;MRPS18A;MRPS6;GATB;NDUFA7;MRPS24;MRPL2;MRPS14;MRPS2;IARS2;TWNK;MRPS12
prerank,synapse organization (GO:0050808),0.36944114135255673,1.4635238038006209,0.0199203187250996,0.4814295668621631,1.0,39/125,14.67%,GPC6;PDZRN3;PPFIBP2;LRRC4C;SDK2;NRXN1;PCDHB10;CHRNA1;LRP4;GPM6A;GPC4;UNC13C;PTPRD;CTNND2;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;CACNB4;CACNB2;NLGN1;CACNB1;NRCAM;RYK;ARHGAP39;SLC6A1;FARP1;PTEN;CBLN2;MUSK;RAB39B;CHRNA7;DOK7;OBSL1;MAPT;PPFIA2;DRD2;PCDHB16
prerank,substantia nigra development (GO:0021762),-0.4499049971374028,-1.4632838514151811,0.025590551181102362,0.31457574457415693,1.0,21/37,31.12%,ACTB;CALM1;COX6B1;RAD1;CKB;MAPKAP1;GNB4;HSPA5;CALM3;S100A1;NDUFS3;INA;YWHAH;FGF9;SYNGR3;CDC42;YWHAE;YWHAQ;CNP;MBP;RHOA
prerank,carbohydrate catabolic process (GO:0016052),-0.43162079495618727,-1.4630607650838534,0.03832116788321168,0.3141494933984755,1.0,18/38,29.48%,GPI;MANBA;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;NEU3;PGAM1;PGAM4;PFKL;ENO1;NEU1;NEU2;NAGA;PFKFB1;PFKFB2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5871231401107943,-1.4625936909710944,0.07387387387387387,0.3142901929756364,1.0,6/12,29.94%,LPCAT3;MFSD2A;APOC1;P4HB;SOAT2;MTTP
prerank,positive regulation of nuclear division (GO:0051785),0.5141833088044094,1.462261617838943,0.05482456140350877,0.4825183672253543,1.0,6/25,8.24%,IGF1;TGFA;PHIP;PDGFRB;SIRT2;IGF2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5320419315010467,-1.4620889345511552,0.06839186691312385,0.3144334373241609,1.0,5/17,5.35%,CAV1;ADIPOR2;PPARD;NCOR1;ADIPOR1
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4594636502390486,-1.461890886487418,0.04887218045112782,0.3139777399463856,1.0,11/33,14.42%,ANO6;KCNJ2;NEDD4L;WNK1;WWP2;KCNQ1;KCNJ10;KCNJ8;AKAP6;KCNJ15;CASQ2
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4616960442677137,-1.4614719711761284,0.041666666666666664,0.31390998865177766,1.0,12/31,20.68%,CRIM1;CDK6;NOTCH1;LRP5;HDAC7;SMAD6;TWIST1;LIMD1;GREM1;SKI;SOX9;BAMBI
prerank,pre-miRNA processing (GO:0031054),0.5728798533996621,1.460926808518396,0.07947019867549669,0.48392033426116654,1.0,9/14,23.08%,TUT4;AGO4;LIN28B;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.5435252886887838,-1.4601729930743546,0.06890130353817504,0.31582026609746555,1.0,8/16,25.17%,NCOR1;ERLIN2;ACADL;WDTC1;ACADVL;SOX9;TRIB3;APOC1
prerank,focal adhesion assembly (GO:0048041),-0.5098329438085705,-1.4593497019592852,0.05989110707803993,0.31668022352588776,1.0,11/21,20.26%,THSD1;SORBS1;PEAK1;FERMT2;ACTN1;BCR;TAOK2;RCC2;CTTN;TRIP6;PTPRK
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.494635006040883,-1.4591680328652739,0.056925996204933584,0.316146911064168,1.0,17/23,45.09%,PIK3R6;PVR;LAMP1;NECTIN2;LGALS9;RASGRP1;LILRB1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,regulation of stress fiber assembly (GO:0051492),0.39975165341541236,1.4588788620444444,0.030800821355236138,0.4870644319374519,1.0,12/74,5.18%,ARHGAP6;PIK3R1;PPM1E;NRP1;ARHGAP28;LPAR1;PHLDB2;ROCK2;ASAP3;CGNL1;SFRP1;DLC1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.633210968432957,1.4585689574175442,0.10151187904967603,0.4853722517488874,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,protein-containing complex disassembly (GO:0032984),-0.4128609150343095,-1.4582285150224772,0.03954802259887006,0.317391753364392,1.0,21/54,25.19%,CAV1;MAP1LC3B;VAMP7;RPL23;HSPA8;GABARAP;LIX1L;TECPR1;VCP;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;FZD5;RUBCNL;PPP1CA;PYM1;GABARAPL1;VPS4A
prerank,regulation of osteoblast differentiation (GO:0045667),0.3867188235432689,1.4580221700643075,0.02536997885835095,0.48438980059648423,1.0,11/82,3.69%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;FGFR2;PRKACA;CCN4;RANBP3L
prerank,cell chemotaxis (GO:0060326),0.41417799517327947,1.4575346853641538,0.02178217821782178,0.48321289120327515,1.0,14/60,9.84%,NRP1;LPAR1;SEMA5A;KIT;PDGFRA;CCR6;ACKR2;ACKR4;CCR10;PDGFRB;EPHB1;CCR9;HOXB9;CCL25
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5718978524607587,-1.4574940968005432,0.054770318021201414,0.3181572265563632,1.0,9/15,25.91%,SMAD7;RPL11;RPL23;BAG5;RPS7;LIMK1;RPL5;DTX3L;PARK7
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5768523624443378,-1.4574545899022753,0.06883365200764818,0.3173213342807122,1.0,6/13,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5550253356318133,-1.457153012336938,0.05772811918063315,0.31706480162700645,1.0,9/16,25.66%,THBS1;PPP1R16B;VEGFA;GATA2;JCAD;FGF2;DLL4;PDCD10;APLNR
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4945419971398203,1.4571133240134775,0.062360801781737196,0.48184889558147803,1.0,4/27,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5100166240209301,1.4569809126291542,0.06415929203539823,0.4797618282687283,1.0,4/22,3.80%,IGF1;ROCK2;PRKCA;P2RX4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3578456304657374,1.4568665874223052,0.011428571428571429,0.47758905396649975,1.0,41/138,12.95%,EPHA7;IL31RA;PTN;NTRK3;DDR2;FGFR2;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;EPHA6;PTPRD;PTPRT;STAP1;LYN;DDR1;AXL;SHC4;PDGFRB;EPHB1;POLR1G;ERBB3;GUCY2F;RYK;FGFR4;EPHA8;AHI1;SH2D6;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;GFRA2;FGFR1;ROR1;EPHA1;BCAR1
prerank,membrane raft organization (GO:0031579),-0.5572514447881045,-1.4563359313993067,0.058823529411764705,0.31799818462010293,1.0,7/15,14.98%,ANXA2;FLOT1;NAXE;S100A10;EMP2;NPC1;FLOT2
prerank,digestive tract development (GO:0048565),0.4711494315152352,1.4562670508864948,0.058426966292134834,0.47683811802874326,1.0,7/33,3.86%,SALL1;FGFR2;RARB;CLMP;KIT;GLI2;GLI3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.546922841227811,-1.455235246972932,0.05653710247349823,0.3195857289889232,1.0,8/15,17.07%,BMPER;FGF1;KLF4;VEGFA;PKM;FGF2;S100A1;JMJD8
prerank,embryonic hemopoiesis (GO:0035162),-0.5864817077869534,-1.455204233495407,0.056074766355140186,0.31877804982940594,1.0,5/12,8.66%,KITLG;TGFBR2;KDR;ATF4;TAL1
prerank,vesicle organization (GO:0016050),-0.42433854235241764,-1.4550593659502005,0.04411764705882353,0.3181924313845862,1.0,21/46,25.53%,CAV1;CD34;FNBP1L;SRGN;CAV2;SNX11;PI4K2A;CHMP2B;USP8;ALS2CL;WASL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;ZFYVE16;ANXA8L1;ANXA8;PHETA2;EPS15
prerank,maturation of SSU-rRNA (GO:0030490),-0.45466661995693086,-1.453948476717735,0.05871559633027523,0.3198307544686608,1.0,8/34,10.81%,RPS16;RPS14;NOP14;RPS28;RPS8;RPS19;NOB1;DHX37
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.43731565815782886,-1.4538772109105191,0.05172413793103448,0.319080841238997,1.0,10/39,14.84%,ACER2;THBS1;NOTCH1;ACTN4;FZD4;ADAM15;MYOC;FZD7;RCC2;NEXMIF
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3917793441434212,-1.4534852759643824,0.021153846153846155,0.318917759680831,1.0,31/59,34.48%,MAP3K5;NET1;PXN;MAPK3;RPS3;ANXA1;CYP1B1;RIPK1;AKT1;RHOB;IMPACT;FXN;EGFR;TNFAIP3;RELA;CHUK;ECT2;PTPRK;PKD2;PRKCD;PARK7;CAMKK2;ROMO1;AQP1;TPM1;ABL1;MAPK9;FOS;NCF1;JUN;MAPK7
prerank,positive regulation of histone methylation (GO:0031062),0.5018736173961675,1.4533735013657185,0.06889352818371608,0.4818003415486088,1.0,11/24,24.82%,AUTS2;KMT2A;DNMT1;PAXIP1;RIF1;MTF2;PAF1;DNMT3B;CTR9;SIRT1;WDR5
prerank,acylglycerol catabolic process (GO:0046464),-0.47001336485936634,-1.4526453705670472,0.05916030534351145,0.3199336450349381,1.0,5/30,13.79%,ABHD2;MGLL;PNPLA2;FABP5;FAAH
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.34300127067458075,-1.4520744033439883,0.004219409282700422,0.3204541147966415,1.0,48/151,21.69%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DMD;DEGS2;GCH1;LPCAT3;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;CDO1;MFSD2A;KDSR;SPTSSB;SPNS2;GSTA4;CHKA;CSNK2B;ELOVL5;INHBA;CEPT1;GSTM2;APOE;SGPL1;SPHK2;ACER3;GSTA3;GSTM1;TYW1;CSNK2A1;CSNK2A2;GSTO2;ELOVL1;LCAT;MGST3;PLPP2;HACD4;ALAS2;GSTK1;PCYT1A;CHAT;PRKD2;LPCAT2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5598482265298426,-1.4512273248641785,0.05419580419580419,0.3204709356691878,1.0,10/15,34.35%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.5598482265298426,-1.4512273248641785,0.05419580419580419,0.3204709356691878,1.0,10/15,34.35%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5257335239370754,-1.4511048709818095,0.07380073800738007,0.3198777101270538,1.0,6/18,15.28%,LBP;THBS1;IL33;HSPD1;TLR4;NECTIN2
prerank,neuron projection extension (GO:1990138),0.48969116718261174,1.4504018875154372,0.06794055201698514,0.4873499526222316,1.0,8/32,8.00%,AUTS2;NRP1;SEMA5A;SEMA3A;FLRT1;NLGN3;ALCAM;CDKL3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3779792283537489,-1.4501808477053812,0.03067484662576687,0.3209371072728417,1.0,37/87,25.24%,CDK6;KLF4;FHL1;PSMA6;RGCC;PSMB5;KANK2;RB1;FAM107A;PSMC4;CDK4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;CDKN1A;PSMB4;PSMD12;PSMC1;CUL1;CDKN2C;CDK2AP2;PSMA1;E2F7;PSMB1;RBL1;PSMC3;PKD2;PSMA4;PSMA2;CCL2;CDKN2B;DCUN1D3;PSMB8
prerank,regulation of small molecule metabolic process (GO:0062012),0.4946938531493171,1.4497353807902829,0.0735930735930736,0.48670397458524445,1.0,6/28,5.80%,RORA;PPARA;PDK1;PDK4;PRKN;PDK3
prerank,cellular response to dsRNA (GO:0071359),-0.5524396034882604,-1.4492969277535688,0.0718232044198895,0.3219243855058079,1.0,13/15,32.10%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS;CGAS;ZCCHC3;NPM1;MUL1;PQBP1;RIOK3
prerank,autophagosome maturation (GO:0097352),-0.45727499749252937,-1.448634873485245,0.04752851711026616,0.3224780715244937,1.0,15/32,20.97%,MAP1LC3B;CALM1;VAMP7;GABARAP;LIX1L;TECPR1;VCP;VMP1;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;RUBCNL
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.599966582728945,-1.4485774835435135,0.07550644567219153,0.3217288554272986,1.0,5/11,20.27%,THBS1;CD34;GATA6;CD200;LGALS9
prerank,inner ear morphogenesis (GO:0042472),0.503851909359968,1.4475227272510636,0.08114035087719298,0.49022474690671913,1.0,7/22,13.22%,FGFR2;ZIC1;TBX18;CHD7;TMIE;TTC39C;PAX8
prerank,response to acidic pH (GO:0010447),-0.5754215184029877,-1.44656582902784,0.07235621521335807,0.32539251242750206,1.0,6/13,26.89%,CHP1;GPR4;IMPACT;RAB11B;CTSS;RAB11FIP5
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.43605494163175607,-1.446336607614175,0.03165735567970205,0.32502979025681605,1.0,14/39,8.42%,PODXL;CDH1;NOTCH1;MAP2K5;FXYD5;KLF4;WNK1;PTK2;TGFB1;VEGFA;NOTCH4;RGCC;PPM1F;AKT1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4596189385572152,-1.4462533262190342,0.04735883424408015,0.3243295784647382,1.0,9/31,20.34%,PLCG2;TLR3;HSPD1;TIRAP;TLR4;SYK;LAPTM5;LGALS9;MAPK11
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5863043281834118,1.4461363074207603,0.09292929292929293,0.4915719388329006,1.0,2/14,5.08%,IGF1;IL4
prerank,response to cholesterol (GO:0070723),-0.5386525386607929,-1.445360081702216,0.06321839080459771,0.3253941711400222,1.0,9/17,19.13%,TGFBR2;TGFB1;SMO;GRAMD1C;GRAMD1A;ABCA2;MLC1;SMAD2;OSBPL7
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.35863763193510795,-1.4451231144814232,0.023809523809523808,0.32505915742570823,1.0,33/112,13.86%,MEF2C;CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PDE2A;LIMS1;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;NR3C1;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18
prerank,positive regulation of filopodium assembly (GO:0051491),0.49762449876521997,1.4449556650386417,0.07415254237288135,0.4922558148947909,1.0,7/24,7.71%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.36481464829850885,-1.444945013305024,0.006048387096774193,0.324596200290635,1.0,34/99,25.08%,MEF2C;ACTB;RAP1A;CDH1;RAP1B;SH3BP4;CTNNA1;RAPGEF1;CAPN2;SLIT2;IGFBP5;PDE2A;KCNQ1;DIAPH1;EZR;JUP;AKAP6;IMPACT;LAMTOR2;HCN2;RRAGD;RAPGEF3;RELA;XBP1;SOX9;RRAGA;RAPGEF2;PKD2;RRAGC;SESN2;DMTN;NSMF;GOLPH3;RPTOR
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4598080084901002,1.444761773467348,0.05274725274725275,0.4903832171596813,1.0,6/40,7.31%,SLC7A11;SLC13A3;SLC38A1;SLC36A2;SLC7A9;SLC25A10
prerank,monocarboxylic acid transport (GO:0015718),-0.4133003881808781,-1.4443534402512315,0.03614457831325301,0.3251339288381546,1.0,10/51,3.19%,ABCG2;ABCC4;SLCO3A1;SLCO2A1;SLCO1C1;ATP8B1;SLCO2B1;SLC16A6;SLC16A9;SLC5A6
prerank,carbohydrate derivative transport (GO:1901264),-0.535058831830093,-1.444144882223478,0.061371841155234655,0.32470397385482147,1.0,8/18,16.27%,LBP;PLTP;SCARB1;MFSD2A;ABCG1;SLC10A7;SLC15A2;SLC15A4
prerank,protein localization to lysosome (GO:0061462),-0.4739212379845383,-1.4440540774867316,0.05172413793103448,0.32400970540881247,1.0,13/28,26.82%,SH3BP4;AP3M1;CD81;GLMP;NCOA4;RAB7A;AP4M1;MFSD1;GCC2;LAPTM5;ZFYVE16;VPS4A;LAMTOR5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5962061473736859,-1.4424826622325313,0.07663551401869159,0.3258084278800275,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5962061473736859,-1.4424826622325313,0.07663551401869159,0.3258084278800275,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,muscle contraction (GO:0006936),-0.35158960205560624,-1.4424253748258964,0.013435700575815739,0.3250741859542896,1.0,21/126,8.19%,UTRN;ITGA1;SORBS3;EDNRA;TMOD3;SORBS1;DMD;VIM;PXN;MYL6;MYOF;CALM1;MYH11;MYOM1;DYSF;ACTA2;LMOD1;MYL12A;MYL9;GJC1;TMOD1
prerank,B cell activation (GO:0042113),-0.39107323415494244,-1.4422598309098673,0.02240325865580448,0.3245894188179599,1.0,33/68,32.98%,MEF2C;PTPRJ;PLCG2;CTPS1;TPD52;ZBTB7A;HDAC9;CASP8;HDAC4;HHEX;HSPD1;PHB2;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;BTK;LAT2;BANK1;DCAF1;NFAM1;HDAC5;PTPN2;LAX1;RASGRP1;CD86;CHRNB2;LYL1;CD40;BLNK;CR2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5466398946126924,-1.4421796012814716,0.06469500924214418,0.3239106351868076,1.0,8/16,15.28%,CAV1;TRIM25;TRIM14;TRIM62;TRIM68;FUCA2;TRIM5;NECTIN2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.48689159012653377,1.4415408931048188,0.06040268456375839,0.49662005341479837,1.0,4/28,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,endocrine system development (GO:0035270),0.5203170444984576,1.4412792600509876,0.09656652360515021,0.4948953324787824,1.0,8/21,13.60%,WNT4;SALL1;GLI2;DKK3;SOX2;TGFBR1;PAX8;NKX2-1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.4486872245526658,-1.4410714220219125,0.04844961240310078,0.32553073091872226,1.0,16/33,24.12%,ACER2;DPP4;PTK2;JAM3;TGFB2;CYP1B1;FOXC2;CIB1;SYK;NEXMIF;EPHA2;RET;PLAU;ADA;PIK3CG;SNAI2
prerank,cellular response to fluid shear stress (GO:0071498),-0.5789669840731329,-1.4405949907854267,0.07835820895522388,0.3256682831317192,1.0,4/12,2.59%,MEF2C;MAP2K5;KLF2;KLF4
prerank,regulation of ruffle assembly (GO:1900027),-0.48866308544881143,-1.4399851236357586,0.07476635514018691,0.3260961591461188,1.0,9/23,13.89%,CAV1;EPS8;PLEKHM1;EPS8L2;ABI3;PFN1;FAM98A;HRAS;NDEL1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5042215635941479,1.4396707022739734,0.08085106382978724,0.49701081676761044,1.0,3/22,1.77%,ALDH1A2;VDR;CYP27B1
prerank,negative regulation of bone mineralization (GO:0030502),0.5687286825650184,1.4392938705664469,0.08764044943820225,0.4956281097151515,1.0,3/13,2.10%,ENPP1;BCOR;AHSG
prerank,response to metal ion (GO:0010038),-0.39183722756888195,-1.4391265701742313,0.02620967741935484,0.3272340502673606,1.0,17/67,13.91%,CAV1;THBS1;TRPC3;NEDD4L;MT1A;MT1X;CALM1;ITPR3;MT2A;CRIP1;ATP5F1D;SLC25A12;CALM3;PPP5C;HOMER1;FXN;PEF1
prerank,negative regulation of cell junction assembly (GO:1901889),0.4930134605986577,1.4386702580901705,0.07246376811594203,0.4949260112790477,1.0,5/25,5.18%,ARHGAP6;ROBO2;PHLDB2;ROCK2;DLC1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4059639231267883,-1.4383020840401308,0.05162523900573614,0.3274081649470317,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4059639231267883,-1.4383020840401308,0.05162523900573614,0.3274081649470317,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5916810279574972,-1.4381883903614752,0.07014388489208633,0.3268501829196834,1.0,2/11,1.19%,MECOM;CD34
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4643982549823581,-1.4378403824461585,0.049523809523809526,0.32676599828448777,1.0,7/29,5.58%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1;CD81
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5101994697195862,1.4373480491287258,0.0611353711790393,0.4961187809347998,1.0,7/23,6.88%,TGFBR3;SMAD3;DKK3;TGFBR3L;IL4;NREP;SMURF2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5790262813661056,-1.4364987962970426,0.0712979890310786,0.3288653668193995,1.0,7/13,14.62%,CAV1;PDE4D;CAMK2D;CALM1;CALM3;CASQ2;SRI
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5521244519634767,-1.4364063044068205,0.05555555555555555,0.32823427604712013,1.0,5/15,18.25%,PLTP;SCARB1;ABCG1;APOE;LCAT
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5400640352518393,1.4363851511667283,0.09234234234234234,0.49630884057365077,1.0,4/17,2.64%,ATP1A2;SLC8A1;GJA1;PRKACA
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.49938495520195997,-1.4359629936233724,0.07797270955165692,0.32839995523048965,1.0,7/20,13.36%,LPCAT3;MBTPS2;ACADL;ACADVL;APOE;ABCA2;FMO5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5793867559879359,1.4358265608006742,0.10690423162583519,0.49545504451618844,1.0,3/13,7.11%,ENPP1;TPST1;SULT6B1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5547157324032078,-1.4357367590321608,0.0691588785046729,0.32803711075966824,1.0,7/14,21.89%,TLR3;DHX58;USP15;ANKRD17;ZDHHC5;PUM2;ZCCHC3
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5780577755880061,-1.4356320797580955,0.08075601374570447,0.3273954004740064,1.0,6/12,23.46%,PPP1R3B;AKT1;PPP1R3F;PPP1R3C;RUBCNL;PPP1R3E
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5042751857563713,1.4355494989499173,0.0855397148676171,0.4938324969056915,1.0,6/22,14.06%,SH3D19;TIMP3;SNX33;TIMP4;SNX9;NRDC
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4043459564904459,1.4346239583037954,0.04329004329004329,0.49388935959487734,1.0,8/62,5.54%,IGF1;AUTS2;ROBO1;LPAR1;GPR55;GPR174;LYN;IRS2
prerank,response to exogenous dsRNA (GO:0043330),-0.5249739445586463,-1.4343339753249837,0.06285714285714286,0.3294956964633065,1.0,9/18,13.81%,CAV1;IFIH1;RALB;TLR3;DHX9;FLOT1;IFIT1;MAVS;SLC3A2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.469468149768124,-1.4342492223492147,0.05786618444846293,0.3288302684696781,1.0,10/27,22.04%,DDX5;TGFB1;RIPK1;DHX9;WTIP;LIMD1;FMR1;EGFR;PUM2;EIF4G1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.5022261823639812,-1.4342308756995104,0.0633147113594041,0.328037614156525,1.0,7/21,9.48%,CYRIB;DAB2IP;CD2AP;SLIT2;TGFB2;ARHGAP25;MAPKAP1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3915898918385056,1.4340065964029791,0.0440251572327044,0.49319176365171546,1.0,16/66,9.92%,ROBO1;TGFBR3;FGFR2;NR2F2;SULF1;VDR;APOH;MTSS1;SFRP1;MCC;SCG2;SOX2;ATOH8;CNMD;GATA3;AIMP1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.443482347538212,-1.4335595675302006,0.05295315682281059,0.3287194226463861,1.0,20/37,26.21%,PPP1R16B;CALM1;TGFB1;MFHAS1;PPIA;HTT;PPP2R5A;PPP1R8;CALM3;PPP1R16A;PPP6R3;CDCA2;PIN1;CNEP1R1;CDH5;ARPP19;PRKCD;YWHAB;NSMF;SMPD1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3874777214495158,-1.4332732822933374,0.03420523138832998,0.3285633601671749,1.0,19/65,15.87%,LEF1;FOXP1;CBFA2T3;IL15;TGFBR2;MT1G;VEGFA;RARA;CASP8;OSTM1;TNFRSF11A;PIR;GLO1;CDK4;E2F1;CSF1R;GAB2;EPHA2;CDKN1A
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3470374688792307,-1.4329047053478814,0.007984031936127744,0.32859528748060446,1.0,40/132,19.26%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL38;HSP90AB1;RPL11;RPS28;RPS5;RPS19;SRSF5;SNRPC;RPL23A;PRKDC;SRPK1;ISY1;SRSF6;NOP2;DHX9;SNRPD3;LUC7L2;RPS27L;XAB2;RPL3;PPAN;ZRSR2;DDX23;MDN1;ERAL1;SMN1;RPL24;HSP90AA1;DDX20;DDX39B;EIF5;SCAF11;SNRPG;TGS1
prerank,regulation of interleukin-2 production (GO:0032663),-0.4222269272534228,-1.4323464376780166,0.06691449814126393,0.32914130702718386,1.0,8/43,6.47%,CD34;SPTBN1;PLCG2;PDE4D;RPS3;ANXA1;HDAC7;EZR
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6089657333873452,-1.4321139405833385,0.05605786618444846,0.3287847574402544,1.0,4/10,5.46%,PARD3;DGKH;PLPP1;PRKD3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5981184551937638,-1.4319103189093079,0.08582089552238806,0.32839567826352933,1.0,5/10,15.43%,ACAD11;ACADL;ACADVL;ETFB;ETFDH
prerank,regulation of focal adhesion assembly (GO:0051893),-0.40214267320278807,-1.431903253689841,0.037267080745341616,0.32759505829500085,1.0,20/54,12.21%,TEK;THBS1;PTPRJ;ACTG1;LIMCH1;PEAK1;KDR;PTK2;FERMT2;RAC1;BCAS3;LIMS1;VEGFA;MYOC;PPM1F;VCL;FAM107A;S100A10;DUSP3;RCC2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.42818099790580333,-1.4315075468578262,0.04961832061068702,0.3276318317259907,1.0,24/44,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;CAST;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;XIAP;YWHAE;LAMTOR5;DNAJB6;SRC;RPS6KA1;AQP1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5311964384190574,-1.4314330833431508,0.06204379562043796,0.32693068724072616,1.0,5/18,6.08%,ESR1;NCOR1;TGFB1;RPS13;PTBP3
prerank,sphingoid metabolic process (GO:0046519),-0.5755917224867466,-1.4313610625749342,0.059782608695652176,0.32629243629966376,1.0,7/12,24.77%,DEGS2;PLPP1;KDSR;ASAH2;SPHK2;PLPP2;SGPP1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34525411463103095,-1.4313259995316123,0.008064516129032258,0.3255895576272467,1.0,41/137,20.08%,DOCK9;PKP4;ITGA6;RAP1A;NET1;RACK1;TGM2;AGRN;F11R;CAV2;SGSM2;RAPGEF1;ARHGAP27;RPS3;FERMT2;CALM1;BCAS3;LIMS1;PSAP;RGS6;NDUFA13;CCL15;S100A10;ZC3H15;WNT11;NF1;CALM3;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;MAPK12;ECT2;CD200;PIN1;RGS10
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.34477134267190124,1.4312260599584266,0.016701461377870562,0.49825117491818244,1.0,28/161,11.34%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;PRICKLE1;TBX18;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;TLE1;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,positive regulation of signal transduction (GO:0009967),0.33453947206025225,1.4311180796099907,0.003683241252302026,0.49626654824233235,1.0,40/238,9.52%,CCBE1;IGF1;BMP6;ROBO1;PIK3R1;NRP1;BMP2;SALL1;WLS;NTRK3;FGFR2;SULF1;SULF2;NRXN1;CYP27B1;RIMS1;PRKCA;PTGIS;PHIP;SFRP1;EVC;AAK1;AXL;MAML3;NPTN;NLGN2;NLGN3;MYORG;LOXL3;NLGN1;CITED2;TGFBR1;RBPJ;KIF7;IGF2;STX1B;GATA3;PRKCB;MN1;CUX2
prerank,regulation of pH (GO:0006885),0.6061971151760642,1.4311157631220888,0.11617312072892938,0.49397287001724455,1.0,3/11,5.93%,ATP6V0A4;PDK4;SLC9A7
prerank,response to nutrient levels (GO:0031667),-0.5206161535045032,-1.4308489976656444,0.08538899430740038,0.3258083307564483,1.0,8/17,30.00%,KCNB1;ATF4;FAM107A;EIF4G1;CD68;MEAK7;RPTOR;RPS6KB1
prerank,myelin maintenance (GO:0043217),0.6146647490974438,1.4300368658409748,0.1047008547008547,0.49458758916014256,1.0,4/10,13.92%,EPB41L3;ABCD2;PTEN;CXCR4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.6118970777345495,-1.429974419068447,0.07561436672967864,0.3270571929937649,1.0,6/10,26.64%,PDE8A;RIPK1;GPR37L1;STK26;PARK7;TXN
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3396037403969963,1.429328485103383,0.01509433962264151,0.4941852297779,1.0,27/159,7.84%,ROBO1;GPC6;ROBO2;LRRC4C;SDK2;TENM3;GRID2;CDH8;CNTN4;PCDHB10;GPC4;CDH18;DCHS1;PTPRD;TENM2;PTPRT;PCDHB13;KIRREL3;CDH11;NPTN;CDH20;CDH19;CDH7;IL1RAPL1;ALCAM;NLGN1;TRO
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4980188022097994,-1.4279794868774331,0.07939508506616257,0.33036846236092876,1.0,13/21,35.38%,PPP1R16B;FKBP1A;MFHAS1;PPP1R8;BOD1;ARPP19;YWHAB;YWHAE;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA
prerank,response to laminar fluid shear stress (GO:0034616),-0.6095031387041439,-1.4278302599529773,0.07734806629834254,0.32987500490266275,1.0,5/10,5.65%,MAP2K5;KLF2;KLF4;SMAD7;SMAD6
prerank,oogenesis (GO:0048477),0.5536782958378144,1.427779276692128,0.10792951541850221,0.49608893433415435,1.0,6/15,19.11%,PTN;NANOS3;FMN2;PIWIL2;METTL3;MARF1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4063227580727112,1.4275255875858137,0.045454545454545456,0.49451853619550457,1.0,16/56,7.71%,NRP1;SRPX2;GRID2;NRXN1;CLSTN2;CNTNAP2;PTPRD;SFRP1;IL1RAP;COL16A1;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1
prerank,response to ketone (GO:1901654),-0.48099187344466066,-1.426797029245051,0.06093189964157706,0.3313057280738926,1.0,7/24,6.78%,ABHD2;CAV1;THBS1;SLIT2;TGFB1;TGFB2;TGFB3
prerank,platelet degranulation (GO:0002576),-0.35470145894679816,-1.42528036959124,0.02610441767068273,0.33378130202773104,1.0,28/118,9.38%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;CYRIB;VEGFC;CALM1;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;VEGFA;PSAP;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5045918870944708,-1.4251584683312202,0.09073359073359073,0.33328317677407376,1.0,5/21,5.58%,PRKCH;FOXP1;SLC39A10;RPS3;CD81
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.4888985591631585,-1.4247387001276635,0.06378986866791744,0.33343264663515604,1.0,10/24,27.26%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.38517966609193977,-1.4244466513742062,0.03180914512922465,0.3332416203880472,1.0,24/72,11.08%,HEG1;ARHGEF28;ARHGEF3;NET1;EPS8;RASIP1;OPHN1;F11R;STARD13;STARD8;COL3A1;EPS8L2;ARHGDIA;RAC1;ARHGDIB;CCDC125;GPR4;MYOC;BCR;ADGRG1;KANK2;LPAR6;TNFAIP1;ABL2
prerank,positive regulation of proteolysis (GO:0045862),0.41668575841858835,1.4243986570560276,0.05510204081632653,0.5004771689914133,1.0,14/55,17.43%,CCBE1;SH3D19;AURKAIP1;SNX33;ASPH;FGFR4;SNX9;NKD2;BTRC;NRDC;TANK;TBC1D10A;FADD;CTSH
prerank,positive regulation of cell adhesion (GO:0045785),-0.3790646368705749,-1.4239306762035424,0.025735294117647058,0.3335530648818232,1.0,20/74,15.65%,FRMD5;PTPRJ;VIT;TGM2;STX3;SMAD7;TGFB2;RAC1;LIMS1;VEGFA;ADGRG1;NPNT;PPM1F;FBLN2;FOXC2;CIB1;SYK;JAK2;ERBB2;ZFHX3
prerank,signal release from synapse (GO:0099643),0.4243490142866173,1.4233662818145958,0.06224899598393574,0.5009775328391183,1.0,12/43,12.97%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4791573655778729,-1.4231581936903728,0.07869481765834933,0.33444310070803257,1.0,10/26,19.08%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;TRPV4;KATNB1;MET;ARL2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5502612015070429,1.422483901913038,0.10044642857142858,0.5010032812956087,1.0,5/15,14.41%,IL4I1;TDO2;KMO;KYNU;GSTZ1
prerank,amino sugar metabolic process (GO:0006040),-0.6084821263655715,-1.421732486920203,0.0867992766726944,0.3368620239523156,1.0,4/10,12.62%,CSGALNACT1;SLC35A3;ST6GAL1;GFPT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.48193289123073346,1.4212085828869445,0.08277404921700224,0.5021802998696608,1.0,4/24,8.24%,IGF1;ENPP1;IRS2;IGF2
prerank,dicarboxylic acid transport (GO:0006835),0.47602802037604525,1.42118106470136,0.07851239669421488,0.5000371395989559,1.0,7/28,7.31%,SLC1A3;SLC13A3;GJA1;ABCC2;SLC26A1;SLC25A13;SLC25A10
prerank,negative regulation of RNA splicing (GO:0033119),-0.5052991832383369,-1.4209767760565268,0.05860113421550094,0.3377043736090395,1.0,9/19,20.37%,RPS13;PTBP3;SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP;RPS26;TMBIM6
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.34417628949514734,1.4208799468134359,0.015384615384615385,0.4985351432437027,1.0,22/152,8.55%,RNF220;LGR4;BMP2;LRRK1;SALL1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;SULF1;TBL1XR1;SULF2;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,oxoacid metabolic process (GO:0043436),0.4865642550397174,1.4200715641517532,0.09312638580931264,0.4985711974084285,1.0,8/27,14.00%,ENPP1;TPST1;SULT6B1;DDO;PPA2;PPA1;ABHD14B;GRHPR
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.45120005321650236,-1.4193116344147052,0.0675422138836773,0.34068000694015194,1.0,18/30,35.82%,HSPA8;DNAJB12;HSPA5;CHCHD4;CCT2;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13;UGGT1
prerank,response to iron ion (GO:0010039),0.5566374586268984,1.4192258128672226,0.10888888888888888,0.49853759767327016,1.0,2/12,3.67%,BMP6;BCL2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4915985261527281,-1.418661771426644,0.06239168110918544,0.34128329622717407,1.0,8/23,13.54%,MAP3K5;RPS3;DAB2IP;TAOK3;EDN1;TNFRSF11A;MAP3K11;ARHGEF5
prerank,regulation of apoptotic process (GO:0042981),-0.2879783519542098,-1.4184963213326245,0.0,0.3408839856649272,1.0,194/676,20.37%,LEF1;TEK;ANO6;MEF2C;PPP1R13B;IGF1R;ITGA6;MAP3K5;ACER2;THBS1;MCF2L;TPT1;ARHGEF3;NET1;TAX1BP1;RACK1;PTK2B;UNC13B;TGM2;ACTN4;RASGRF2;NFKBIA;KDR;ARL6IP5;FOXO1;EGLN3;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;FOXO3;RPS3;ANXA1;DAB2IP;CARD14;SLIT2;ZBTB7A;NGF;MAP3K20;CD44;SOCS2;TMBIM4;CRADD;CTNNBL1;REST;ARHGDIA;TRIO;UBB;PPIA;HTT;ADAM10;CYP1B1;TNFSF10;ING5;IGFBP3;CD38;UBC;RPS27A;SMAD6;VEGFA;SPTLC1;PTMA;SOS2;HIP1R;TNFAIP8;RHBDD1;UFM1;IKBKB;TMEM219;GATA6;SH3RF2;ATF4;ANP32A;ACTN1;SHC1;TGFB3;PRKDC;RASSF2;CASP8;HSPB1;TOX3;EGLN2;ANXA4;RIPK1;FLT4;PLK2;BAX;AKT1;PERP;GLO1;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;PIM3;ATG7;DDRGK1;HSPD1;HIP1;RHOB;TCIM;VCP;WNT11;LRP8;CD74;PREX1;CFL1;HSPA5;CTSB;RTKN;NF1;HTATIP2;CIB1;GADD45G;ABR;GRK5;SERPINB9;YWHAZ;BCL2L1;E2F1;AVEN;SOX4;ITCH;BAK1;FXN;FSTL1;RNPS1;SPHK2;HIGD2A;RPS6;COPS5;RPS6KA2;ARHGEF5;DHCR24;ARHGEF18;PHB2;NUAK2;APH1A;JAK2;BNIP3L;EGFR;OSGIN1;HNRNPK;TOP2A;OPN3;MADD;HYPK;PTPN6;STK26;LGALS1;OPA1;STAT1;GREM1;PHLDA3;PDCD2;HSP90AA1;DDX20;HSPA1A;RELA;BAD;XBP1;BABAM2;CCAR2;JAK3;HCK;FOXL2;ARHGEF12;CALHM2;HSPA9;ARHGEF17;CRYAB;ASNS;ARHGEF4;ARHGEF2;ECT2;ANGPTL4;RASA1;GADD45A;SRA1;SOX9;LCMT1;FAIM2;GCLC;ARHGEF6;FGD2;MCL1;CASP1;HIGD1A;DNM2;TMBIM6
prerank,metal ion homeostasis (GO:0055065),-0.4287462138021084,-1.418263307086654,0.04655493482309125,0.3406681485833605,1.0,7/40,8.00%,SLC12A7;CAV1;TMTC2;SLC12A2;FAM20A;LETM2;JPH2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5015259572434014,1.4165770852836672,0.10267857142857142,0.5036928054387773,1.0,8/21,17.48%,EPHA7;NLRP12;SOX2;NGFR;BIRC2;DELE1;PSMB9;GRIN2B
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4656014517840098,-1.4158916954750222,0.058823529411764705,0.34506080764473557,1.0,6/27,4.03%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1
prerank,nervous system development (GO:0007399),0.309472212221087,1.4158884776362757,0.00392156862745098,0.5033044093648767,1.0,92/429,13.68%,ROBO1;ADGRV1;NELL1;ARNT2;LDB2;ALDH1A2;ROBO2;RBFOX1;PTN;ATXN1;CNTFR;TBX3;LPAR1;SDK2;SEMA5A;CHST8;NRG1;NRXN1;GDNF;CNTN4;ZIC1;TEAD1;PCDHB10;LSAMP;CHD7;GPM6A;DCHS1;ARTN;ZEB2;GLRB;CHRM2;PRKN;PCDHB13;AXL;KIRREL3;GSTP1;NLGN2;CHRM3;NLGN3;RAB29;SCD5;IGF2BP2;ASIC2;APAF1;EPHB1;SCN2A;NLGN1;GRIK1;TGFBR1;ADGRA2;SCIN;NRCAM;ERBB3;HES5;ATXN3;RYK;ATN1;GMFB;TMEM223;AHI1;CYP46A1;FARP1;ERBB4;PTEN;ZIC4;ANKLE2;NFASC;APLP1;RPS6KA6;ST8SIA2;PCDHB15;NAB2;MST1R;SDHA;EDNRB;MERTK;COX7B;GFRA2;KALRN;APBA1;OBSL1;ATXN10;DLG4;PAX8;GBA2;EP300;VCAN;NAV3;YAP1;CNTN6;TENM1;POU6F2
prerank,receptor metabolic process (GO:0043112),-0.40173233846009926,-1.4156767815744202,0.043243243243243246,0.3447282762077952,1.0,16/53,13.59%,CAV1;DNM3;ACKR3;RAMP2;TFRC;TGFB1;CD81;CD9;AP2M1;FCER1G;LMTK2;KIF16B;REP15;RAB11B;SYK;SMURF1
prerank,positive regulation of protein modification process (GO:0031401),-0.3206765922871625,-1.4156034047850208,0.008583690987124463,0.3441093379338937,1.0,69/203,21.54%,TEK;PECAM1;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;PPP1R16B;CARD14;CALM1;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;CHP1;VEGFA;PDE8A;PPP2R5A;RIPK1;KRAS;SVIP;FLT4;AKT1;INSR;FLOT1;FAS;ATG7;CD74;CAMK1;CIB1;VEGFD;CALM3;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;ACE;EGFR;ERBB2;HSP90AA1;RAPGEF3;RAMP1;CDCA2;PGF;FGF9;RAB3GAP2;WDFY2;CCND1;SOX9;PIN1;ITGB3;BRAT1;FGF10;CNEP1R1;CDH5;C3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5718601578569585,1.4154940643233715,0.12751677852348994,0.502263820203068,1.0,3/13,2.89%,PLXNA2;NRP1;SEMA3A
prerank,response to molecule of bacterial origin (GO:0002237),-0.38576343890254083,-1.4154307680103344,0.03522504892367906,0.34367049976523134,1.0,23/69,22.08%,FOXP1;LBP;NOS3;CYRIB;RPS6KA3;GCH1;MAPKAPK3;SMAD6;OTUD5;TNFRSF11A;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;TNFAIP3;TAB2;PELI1;GGT1;LGALS9;FZD5;PTPN22
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4394449398890992,-1.4150244013449742,0.05273069679849341,0.34368105187617815,1.0,12/35,18.55%,HEG1;RASIP1;DAB2IP;TGFB2;CCDC125;MYOC;MAPKAP1;TNFAIP1;ABL2;MET;KCTD10;SPRY1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4693191731957131,1.4145998480814288,0.08490566037735849,0.5023906183372693,1.0,5/29,4.22%,TGFBR3;BMP2;FGFR2;TNNC1;TNNI3
prerank,defense response to virus (GO:0051607),-0.3584633952425337,-1.4144434321627517,0.0225140712945591,0.34416992873983415,1.0,29/100,18.61%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;CLPB;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;ZDHHC1;MAVS;PHB2;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,striated muscle contraction (GO:0006941),0.40794784248763294,1.414348628044059,0.06881720430107527,0.5009236455689193,1.0,9/53,8.07%,ATP1A2;SLC8A1;SCN3B;CHRNA1;TNNC1;CSRP3;TNNI3;KLHL41;TNNI1
prerank,regulation of fibroblast migration (GO:0010762),-0.5026360985847749,-1.4142161168672747,0.07393715341959335,0.3438379894228729,1.0,8/20,12.82%,THBS1;PTK2;TGFB1;RAC1;PRR5L;HAS1;PRKCE;FGF2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.508725857554669,1.4140565571266503,0.10294117647058823,0.49955810543356555,1.0,6/20,4.22%,ATP1A2;SLC8A1;ANK2;PRKACA;ATP2A2;TNNI3
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5227407285680103,1.4133217629338086,0.10989010989010989,0.4995708759658466,1.0,4/15,9.24%,HECW2;ANAPC1;CDC23;CDC16
prerank,canonical glycolysis (GO:0061621),-0.48041147431291487,-1.4132204737013327,0.06355140186915888,0.3444393430656822,1.0,10/24,23.22%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.48041147431291487,-1.4132204737013327,0.06355140186915888,0.3444393430656822,1.0,10/24,23.22%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,cellular response to metal ion (GO:0071248),-0.3432337118334218,-1.4124752677022256,0.020964360587002098,0.345313848494716,1.0,22/123,4.75%,MEF2C;ITPKB;B2M;CLIC4;SLC12A2;CDH1;PLCG2;MEF2A;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MAPK3;IQGAP1;CAMK2D;CDKN1B;MT2A;CARF
prerank,synapse assembly (GO:0007416),0.399259828795772,1.4123445660105238,0.055327868852459015,0.49996078201777483,1.0,26/67,17.64%,SDK2;GRID2;NRXN1;PCDHB10;GPM6A;GABRA2;LRRTM3;GABRB3;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;NLGN1;NRCAM;RYK;FARP1;PTEN;PLXNB2;OBSL1;DRD2;PCDHB16;PCDHB14;ACHE;FLRT3;GABRG2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3430111233243056,1.4121911283631585,0.021442495126705652,0.4982830671133764,1.0,25/152,12.26%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1;GNAI1;CHRM2;OPRK1;ADM;MC5R;IAPP;CALCR;GLP2R;ADRA1D;ADCY8;ADRA1B;PTGIR;GPR161;GNA15;CRHR1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.543648676780508,-1.4116162237165941,0.08243727598566308,0.34655153803744243,1.0,4/15,6.78%,SMAD7;TGFB1;TGFB2;TGFB3
prerank,ion homeostasis (GO:0050801),-0.45582851910497263,-1.4104109974791872,0.06048387096774194,0.3483001477499386,1.0,8/30,13.02%,SLC4A10;NEDD4L;FHL1;WNK1;CAMK2D;SLC4A8;SLC4A2;KLHL3
prerank,regulation of axon guidance (GO:1902667),0.6033613006197889,1.409798422924601,0.1388888888888889,0.5027934135396177,1.0,3/10,7.97%,NRP1;MYCBP2;ZSWIM5
prerank,histone H4 acetylation (GO:0043967),-0.40906325332557014,-1.4097233828362004,0.055441478439425054,0.3490230720283648,1.0,14/47,18.10%,LEF1;MSL2;PHF20;TRRAP;JADE2;ING5;HCFC1;TRIM16;KANSL2;EPC1;NAA60;MCRS1;BRCA2;EP400
prerank,myelination in peripheral nervous system (GO:0022011),-0.5554127670039631,-1.4097004735219534,0.07142857142857142,0.34828393637570837,1.0,8/13,29.50%,ADGRG6;PARD3;MYOC;NF1;SKI;SOD1;CNTNAP1;LGI4
prerank,smooth muscle cell differentiation (GO:0051145),-0.5777069477363395,-1.4093309823321964,0.0766488413547237,0.348388446777891,1.0,6/12,14.52%,MEF2C;MRTFB;GATA6;TMEM204;MRTFA;HEY1
prerank,cellular response to chemical stress (GO:0062197),-0.3580843537944938,-1.4092113137005537,0.032586558044806514,0.3478264880912582,1.0,46/96,33.91%,CAV1;LRRC8D;FOXO1;FOXO3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;FAS;ATG7;TRPV4;STX2;ETV5;PIK3CA;VKORC1L1;GSR;HSPA1A;CCS;CYBB;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;NUDT2;AIF1;GPX3;PARK7;STX4;SOD1;NOX1;RAD52;LRRC8E;ATP13A2;RBM11;ABL1;NCF1;SLC4A11;HTRA2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5363448803776142,-1.4090458105344574,0.08581436077057793,0.3473713107310329,1.0,5/16,17.25%,ACKR3;TPT1;RPS3;BCL2L1;CCAR2
prerank,manganese ion transport (GO:0006828),-0.5478773393714189,-1.408941595307118,0.0931098696461825,0.34682979559769406,1.0,6/14,10.93%,TRPC3;TMEM165;ATP2C1;SLC39A8;TRPC6;TRPC4
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5112397565591088,-1.4075439796361984,0.09404990403071017,0.34922460098439645,1.0,9/18,31.46%,MAPK3;MSN;EZR;VPS11;SNX3;RDX;MTMR2;SRC;SNX12
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.597135837892453,1.4075242480455992,0.10375275938189846,0.5068761010760233,1.0,6/10,21.66%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2;GABRB2
prerank,regulation of protein phosphorylation (GO:0001932),-0.31007526611369135,-1.4074081460520886,0.006355932203389831,0.34872793884975345,1.0,61/256,13.58%,FN1;TEK;PLCE1;PECAM1;OCLN;BMPER;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;DAB2IP;CARD14;SLIT2;FNIP2;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;PRR5L;CHP1;IGFBP3;VEGFA;BRD4;ATF4;PDE8A;PRKDC;HSPB1;PPP2R5A;RIPK1;KRAS;FLT4;NDUFS4;AKT1;INSR;PDGFA;WARS1;FLOT1;FAS;CD74;IMPACT;CIB1;VEGFD;MAVS;SMG8;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.40334064976133294,-1.4073604688124957,0.03137254901960784,0.34802175243813455,1.0,25/50,31.99%,NR3C2;NOD1;ACTN4;RPS3;APP;LIMS1;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;LAPTM5;TRIP6;LGALS9;TRAF6;PTP4A3;PDCD4;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.572396977141897,-1.4072702170102713,0.07879924953095685,0.3474243736197557,1.0,4/12,5.50%,FOXP1;NCOR1;ZBTB7A;HEYL
prerank,positive regulation of inflammatory response (GO:0050729),-0.36273604667240983,-1.407173270163673,0.027932960893854747,0.34689136783533703,1.0,19/86,15.55%,LBP;IL15;NFKBIA;ETS1;VAMP7;APP;PDE2A;CD81;IL33;RPS19;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;IL17RA
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5622438536201662,-1.4070873339836276,0.08778625954198473,0.34630687437590335,1.0,5/13,6.98%,ABHD2;NR3C2;ESR1;PLPP1;NR3C1
prerank,positive regulation of heart contraction (GO:0045823),0.504591810544477,1.4070592711679895,0.10514541387024609,0.5059740590572004,1.0,4/19,5.95%,ATP1A2;SCN3B;ATP2A2;ADM
prerank,negative regulation of leukocyte activation (GO:0002695),0.5407002206787463,1.40614741240383,0.09656652360515021,0.506457048912921,1.0,3/15,8.03%,IL31RA;IL4;CD300LF
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.4920758197650963,-1.4060891946136838,0.07678244972577697,0.347685477326117,1.0,10/20,24.80%,HSP90AB1;HSPD1;HSPA4;CCT2;HSP90AA1;HSPA1A;PTGES3L;PFDN6;PSMG2;MKKS
prerank,cGMP metabolic process (GO:0046068),-0.5666438673541074,-1.405397707150969,0.08712121212121213,0.3483429164120913,1.0,5/12,15.33%,NPR1;PDE2A;GUCY1B1;GUCY1A1;GUCY2C
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6071325041817,-1.4051032348141113,0.11559633027522936,0.34825086420839757,1.0,8/10,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.573883740493833,-1.4044804403462847,0.0931899641577061,0.3487770232622484,1.0,4/12,5.29%,ACTB;ACTG1;LAMA5;LAMA3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.33673043190698626,-1.4042491975656404,0.013108614232209739,0.34855504285083355,1.0,38/128,14.15%,CLDN5;DDX5;PARD3;ID1;PXN;TGFBR2;BMPR2;F11R;NLK;MAPK3;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;INHBA;HIVEP1;ACVR1;NRROS;RNF111;ZMIZ2;TMEM100;ENG;USP15;SMURF1;INHBB;ARHGEF18;EID2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3789788093048943,-1.4041771484489562,0.04990403071017274,0.34796954708603095,1.0,19/67,7.83%,FLT1;NRP2;DOCK1;WASF2;PXN;CLEC14A;PTK2B;KDR;SHB;PTK2;VEGFC;DAB2IP;MAPKAPK3;RAC1;CRK;VEGFA;NCF2;HSPB1;FLT4
prerank,myeloid cell differentiation (GO:0030099),-0.4108138106370417,-1.4041217262106498,0.05202312138728324,0.347333586489479,1.0,24/47,28.12%,RPS14;MFHAS1;ZBTB16;RPS19;SLC25A38;TAL1;TIRAP;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;UBA5;RASGRP4;SNRK;ALAS2;HCLS1;ZFPM1;CDKN2B;ACIN1;INHA;PTPN2;SPI1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.544124452793167,-1.403736883441466,0.09923664122137404,0.34734808122592314,1.0,9/16,11.48%,ESR1;DDX5;DDX17;PPARGC1B;RBFOX2;SAFB;EGLN2;ARID1A;NCOA4
prerank,regulation of interleukin-4 production (GO:0032673),-0.4957959241069556,-1.403509461074655,0.07706766917293233,0.34708590797484606,1.0,6/21,12.89%,LEF1;SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,response to amyloid-beta (GO:1904645),0.4167060541820397,1.4034666922989985,0.06625258799171843,0.5113266666336858,1.0,10/44,13.96%,IGF1;LRP1;GJA1;CACNA2D1;CALCR;CACNB1;CHRNA7;NGFR;ATP1A3;GRIN2A
prerank,endocytic recycling (GO:0032456),-0.40139266643678617,-1.4032480828060037,0.02973977695167286,0.3468926251901742,1.0,30/50,39.44%,EHD4;VPS53;DENND1A;DENND1B;EHD2;LMTK2;RAB11B;RAB7A;RAB11FIP3;SNF8;EHD1;VPS29;EHD3;SNX3;CCDC22;ANKRD50;ARL4C;MICALL2;EPS15;VPS26C;ENTR1;SNX12;CMTM6;DENND1C;SNX27;WASHC1;SNX17;ANKRD27;RAB17;EIPR1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3711093361300485,-1.4022686692135176,0.02631578947368421,0.34817732632110854,1.0,27/73,23.09%,KITLG;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PDCD2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3330494602180213,-1.4019824293183103,0.014799154334038054,0.3480899333046182,1.0,56/146,25.79%,RAB11A;DCTN2;FHL1;TUBA1A;CEP164;PPP2R1A;BRD4;PRKAR2B;CEP192;CENPJ;CEP57;PSMA6;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;CDK4;PSMC5;PCM1;TUBB4B;PSMD14;RCC2;AVEN;FBXL7;HAUS1;NDE1;RBX1;PSMD8;CETN2;CEP72;YWHAG;PSMD11;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;CUL1;CCND1;TPX2;PSMA1;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;DTL;PSMA2;PSMB8;HAUS4;YWHAE;CEP63;NEDD1
prerank,negative regulation of inflammatory response (GO:0050728),0.33604974081075645,1.4016719704599805,0.023076923076923078,0.5141873587623388,1.0,28/182,11.32%,IGF1;ADCY7;RORA;ADCY2;ADCY1;ADCY5;GPHB5;PPARA;HTR7;PRKACA;PTGIS;LYN;IL4;PTGDR;ADM;GSTP1;NLRP12;MC5R;SMPDL3B;IAPP;CALCR;HRH2;GLP2R;GATA3;TNFAIP6;ADCY8;HTR4;PTGIR
prerank,regulation of monooxygenase activity (GO:0032768),-0.4766316288520919,-1.4009765665312424,0.0718232044198895,0.34959829114971663,1.0,14/23,20.94%,CAV1;NOS3;NOSTRIN;CALM1;AKT1;LYPLA1;WASL;EGFR;SPR;HSP90AA1;NOSIP;CYGB;DNM2;DDAH1
prerank,in utero embryonic development (GO:0001701),0.474741885683444,1.4009020647491814,0.08836206896551724,0.5142283635326874,1.0,7/25,8.48%,ARNT2;BMP2;FGFR2;CHD7;TGFBR1;IGF2;FOXD3
prerank,negative regulation of metabolic process (GO:0009892),0.4059106745732074,1.399805447117277,0.05818965517241379,0.5150297664830185,1.0,12/54,9.60%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;GSTP1;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,cellular response to chemokine (GO:1990869),-0.39983904782804347,-1.3996042173788688,0.05273069679849341,0.3519508007719892,1.0,5/46,2.77%,SLC12A2;ACKR3;PTK2B;LRCH1;WNK1
prerank,neutrophil activation (GO:0042119),-0.5540878137247932,-1.3995428322144512,0.08392857142857142,0.3513321218778613,1.0,4/12,12.89%,IL15;FCER1G;PREX1;SYK
prerank,negative regulation of cell adhesion (GO:0007162),-0.37059397895855956,-1.3993448660803556,0.037422037422037424,0.3510133078555128,1.0,19/72,10.56%,PODXL;ACER2;SEMA6A;CDH1;NOTCH1;PTK2;FZD4;TGFB1;JAM3;PLXNA4;ARHGDIA;ADAM10;CYP1B1;ARHGDIB;TGFBI;FZD7;SIPA1;PLXNA1;PLXND1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.49608571373689375,1.399251475803997,0.09865470852017937,0.5143973133725135,1.0,3/19,11.11%,IGF1;RTN4;CHRNA7
prerank,bone development (GO:0060348),0.43122582136900245,1.3985469747012835,0.06157112526539278,0.5141203188654586,1.0,7/39,3.83%,NOTUM;FGFR2;SULF1;SULF2;GJA1;RANBP3L;SH3PXD2B
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.33035619908184366,1.397932778018663,0.01603206412825651,0.5135402489200441,1.0,33/186,11.34%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;TRABD2B;LRP1;PRICKLE1;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;RNF43;AXIN2;WIF1;PRKN;HECW1;TAX1BP3;TLE1;CXXC4;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5552513972898246,1.397760764839591,0.11563169164882227,0.5119256090349535,1.0,1/14,0.21%,ENPP1
prerank,cellular response to interferon-gamma (GO:0071346),-0.36409031896770183,-1.3973933724015781,0.033073929961089495,0.35466234192325036,1.0,30/88,24.96%,B2M;CAMK2D;GBP5;TRIM25;CD44;MT2A;MID1;GBP7;GAPDH;CCL15;RPL13A;TRIM62;TLR4;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8;AQP4;SYNCRIP;CASP1;LGALS9;PRKCD;AIF1;CCL2;ICAM1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.42032350001144436,-1.397343587939783,0.05471698113207547,0.35401470094210247,1.0,19/43,31.36%,LIMK2;CTNNA1;TFRC;FERMT2;TGFB1;MFHAS1;AKT1;SUMO3;CDK5RAP3;PIN1;SESN2;DTX3L;PARK7;CARD10;LAMTOR5;PLK1;ATP13A2;PARP9;CDK1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.5947252949051858,-1.3973117105760755,0.09340659340659341,0.3533107757926865,1.0,2/10,4.91%,WNK1;ADAM10
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5505023208280007,-1.3961147489333776,0.10881801125703565,0.355259325362429,1.0,5/13,14.67%,CAV1;TMEM259;RNF185;BCAP31;SGTA
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5634953554524532,-1.395441180321097,0.08858267716535433,0.3560724515926771,1.0,6/13,26.64%,RACK1;PDE8A;GPR37L1;MET;PARK7;TXN
prerank,calcium-mediated signaling (GO:0019722),0.36572987232439813,1.3953991469332472,0.03434343434343434,0.5163645810546593,1.0,17/93,8.81%,RCAN2;PTGFR;SLC8A1;PDPK1;ANK2;PRKACA;DMPK;P2RX4;ATP2A2;TNNI3;CCR6;ACKR2;ACKR4;CCR10;CHRM3;PPP1R9A;CCR9
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4352895899759002,1.3940447371463403,0.08779443254817987,0.5180068321727226,1.0,4/34,2.77%,RORA;ENPP1;RUNX1T1;SMAD3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4599946347127995,-1.3935351347135032,0.07942238267148015,0.3594127283622383,1.0,11/25,29.00%,RIN3;APP;RAC1;ANKRD13A;ABCA2;SDCBP;NEU3;ITGB3;APOC1;MTMR2;UBQLN2
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3650701315256025,-1.3928896940668258,0.043912175648702596,0.36012086951678757,1.0,30/84,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;MSN;WWP2;EZR;TNFRSF1B;EGLN2;IDE;PLK2;NDUFA13;PTTG1IP;ATG7;VCP;RAB7A;OAZ2;APOE;ITCH;SMURF1;VPS11;SNF8;TNFAIP3;CSNK2A1;HSP90AA1;FZR1;NSF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.370803188572048,-1.3927660411254867,0.03636363636363636,0.3595891956152364,1.0,36/70,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;FCER1G;PSMC4;PSMC5;PSMD14;LNPEP;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,negative regulation of cell development (GO:0010721),0.4766767265922819,1.3924426666881995,0.09955752212389381,0.5202006560104734,1.0,2/25,0.45%,IGF1;FBN1
prerank,myotube differentiation (GO:0014902),0.5304224612793258,1.392372676893081,0.11013215859030837,0.5183122527566464,1.0,5/17,7.45%,IGF1;ADGRB3;ADAMTS5;ADAM12;SIX4
prerank,regulation of cellular component organization (GO:0051128),-0.33872364413044675,-1.3918892554893112,0.006550218340611353,0.3609037806682109,1.0,52/135,25.91%,PLCE1;RAP1A;MLLT3;NET1;LTBP4;RAP1B;OPHN1;TFRC;RAPGEF1;CAMK2D;DCUN1D5;DAB2IP;SOCS2;HSPA8;HIP1R;HCFC1;EGLN2;FAM107A;WFDC1;HIP1;RAB4B;BAG5;ABL2;TAOK2;NCLN;RUFY1;RAB4A;APOE;ITCH;CISH;LAMTOR2;SETD1A;STK38L;OGFR;TMEM97;HSP90AA1;PACSIN1;TSC2;GFAP;PACSIN3;PACSIN2;RAPGEF2;MKI67;CAMSAP3;PTPN1;ANGPTL7;ZFYVE16;TJP1;RPTOR;RAB5C;ANKRA2;PARK7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4947803971924121,1.3909610206620877,0.10526315789473684,0.5200846773111895,1.0,3/20,1.32%,WNT4;BMP2;BMP5
prerank,cellular protein catabolic process (GO:0044257),-0.38853777947072626,-1.3906618055440942,0.04296875,0.3629449881242786,1.0,20/59,15.16%,FAP;CAPN2;DAB2IP;CTSZ;CTSO;CTSC;CASP8;PSMA6;IDE;RIPK1;DENND3;AP2M1;CTSF;UBE2G2;CTSB;RAB7A;RNF5;BNIP3L;UBE2G1;AP2A1
prerank,mitochondrion localization (GO:0051646),-0.49068099002531274,-1.390553772822925,0.08561020036429873,0.3624155652447817,1.0,7/19,21.47%,TRAK1;MEF2A;TRAK2;MTM1;NECTIN2;BRAT1;TLE6
prerank,cAMP-mediated signaling (GO:0019933),0.4731560825136214,1.3899525512645579,0.08167770419426049,0.5207533760174309,1.0,4/24,1.87%,ADCY2;ADCY1;KSR1;PDE7B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3622202808150004,-1.3895128740605724,0.039603960396039604,0.364065988475617,1.0,45/87,31.64%,NDUFV2;UQCC2;NDUFB2;NDUFB8;NDUFB4;COA8;NDUFS4;NDUFA13;IMMP2L;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;COA3;CHCHD4;NDUFA9;NDUFB9;NDUFS3;SURF1;NDUFS6;NDUFC1;FASTKD3;DMAC2;NDUFA3;SLC25A33;ECSIT;LYRM7;NDUFA10;NDUFB10;SDHAF4;NDUFB3;SCO1;NDUFA7;PET100;NDUFA1;NDUFAF3;BCS1L;UQCC3;SDHAF1;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3950559591691807,-1.3894554031063682,0.05609284332688588,0.36340875016084573,1.0,20/54,22.40%,RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,neurotransmitter secretion (GO:0007269),0.4140431156584806,1.3892372831349968,0.07723577235772358,0.520549046673461,1.0,12/44,12.97%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,cellular response to interferon-beta (GO:0035458),-0.5408669295902333,-1.388761927712262,0.08518518518518518,0.3641799010236715,1.0,5/14,16.32%,IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.49381887933461704,1.3884528219309913,0.10669456066945607,0.5206603502717303,1.0,4/21,3.11%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4836980670315758,-1.388305977296026,0.07360861759425494,0.3644248294835836,1.0,11/22,20.87%,SEL1L;UBB;EDEM3;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5494845806853742,1.3882805274932866,0.12307692307692308,0.5190712127354412,1.0,7/14,17.89%,SEC24D;SCAP;SEC24A;SEC31A;SEC23A;TBC1D20;MIA3
prerank,sulfur compound transport (GO:0072348),-0.45841315177373854,-1.3876018700205952,0.08007448789571694,0.3652672614651794,1.0,5/27,3.19%,ABCG2;SLC26A7;SLC6A6;LRRC8D;SLC5A6
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2856056158855342,-1.3873192854494543,0.0,0.36513620833903343,1.0,142/532,18.78%,FN1;ADIPOR2;TMSB4X;B2M;LBP;ACKR3;RPS6KA5;PTPRJ;VIM;IL15;RAP1B;NOD1;PTK2B;LIFR;ACTN4;NFKBIA;TNFRSF11B;MAOA;F3;FOXO1;MAPK3;STX3;RAPGEF1;LAMA5;CAMK2D;FOXO3;S1PR1;IRAK2;HNRNPA2B1;ANXA1;CARD14;TRIM25;CD44;SOCS2;CDKN1B;MT2A;TGFB1;MID1;MAP3K3;MSN;ADAR;UBB;ANXA2;HSPA8;PPIA;LIMS1;INPP5D;ADIPOR1;UBC;RPS27A;IL1R1;IL33;CRK;VEGFA;STX1A;IKBKB;IFITM1;IFITM3;SHC1;PITPNA;PSMA6;MAP3K8;TNFRSF1B;RIPK1;IL20RB;TNFRSF11A;PSMB5;IFITM2;AKT1;BCL6;CCL15;TWIST1;IFNAR1;CSNK2B;IFIT1;FCER1G;TALDO1;JUNB;LRP8;HNRNPDL;GRB10;TOLLIP;PSMC4;CFL1;ABL2;PSMC5;IL17RE;PSMD14;YWHAZ;TRIM62;BCL2L1;COMMD7;POU2F1;FGF2;EDA2R;SYK;TRAF1;IL18BP;CSF1R;TNFRSF1A;AIM2;TRIM68;SMARCA4;SAMHD1;STAT5A;CISH;RBX1;JAK2;TRIM5;F13A1;PSMD8;GAB2;IRF9;PIK3CA;SMAD4;CLCF1;TNFSF13;NOD2;IL17RA;PTPN6;PSMD11;NDN;CDKN1A;OAS2;STAT1;PSMB4;PSMD12;PSMC1;HSP90AA1;TAB2;RELA;IFNGR1;JAK3;HCK;CUL1;CHUK;SLA;PELI1;HSPA9;IRF8;RSAD2;IRAK4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.42117362320106844,-1.3872308892503398,0.07520325203252033,0.364598007262431,1.0,12/36,13.50%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;FZD3;NFATC1;WNT11;PPP3CB;GNB1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.40619825853611546,-1.3868820662117274,0.06015037593984962,0.36461401520875514,1.0,25/47,30.90%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;NDUFA13;CHCHD3;ATP5ME;ATP5MC3;TIMM29;ATP5MC1;OPA1;TIMM13;HSPA9;CHCHD6;TIMM10;APOO;ATP5F1E;TIMM8B;ATP5PO;TIMM10B;MICOS13;UQCC3;ROMO1;LETM1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4158126965372811,1.3867043855788506,0.07079646017699115,0.5212851608773652,1.0,11/46,9.60%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,eye morphogenesis (GO:0048592),0.5092130308891212,1.3864355593378286,0.10874200426439233,0.5198722546829317,1.0,6/19,7.77%,FBN1;FBN2;TENM3;IFT122;MFAP2;RARG
prerank,negative chemotaxis (GO:0050919),0.445110148043325,1.3857042782229922,0.08260869565217391,0.5196847794497838,1.0,6/33,7.40%,ROBO1;EPHA7;LRTM1;SEMA3A;SEMA3D;UNC5C
prerank,muscle tissue development (GO:0060537),-0.5417748117816047,-1.3854154979591062,0.08752327746741155,0.3670921167964503,1.0,6/13,13.24%,PGM5;SMO;STRA6;NF1;POGLUT1;ENG
prerank,endocardial cushion development (GO:0003197),-0.4793186046456535,-1.384078600824298,0.09482758620689655,0.3694818087193565,1.0,10/21,14.52%,NOS3;NOTCH1;BMPR2;TGFB2;TBX2;HEYL;CRELD1;ACVR1;ENG;HEY1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.42676931588545947,-1.3840546532461182,0.068762278978389,0.368780671571236,1.0,16/36,16.04%,SGMS1;RPS3;TPD52L1;DAB2IP;CRADD;NR4A2;PPIA;ING5;ASAH2;FAS;RB1;TRAF1;MADD;CX3CR1;CSNK2A1;CSNK2A2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.4621852137819294,-1.3839846914888485,0.07208872458410351,0.36820511741313694,1.0,4/25,1.79%,B2M;PLCG2;CD55;SLC7A5
prerank,positive regulation of phosphorylation (GO:0042327),0.3167973493732689,1.3834668228241906,0.02111324376199616,0.5237256846028219,1.0,55/240,13.39%,IGF1;EPHA7;NRP1;ZBTB20;BMP2;IL34;AR;NTRK3;DDR2;FGFR2;PELI2;KIT;PDGFRA;EPHA3;ROCK2;EPHA6;VEGFB;LEPR;RAP2A;LMO4;PFKFB4;LYN;FNIP1;DDR1;AXIN2;GLMN;AXL;NPTN;PDGFRB;EPHB1;TNIK;THPO;IGF2;ERBB3;RYK;FGFR4;DVL3;EPHA8;MYDGF;ERBB4;AKTIP;EPHA5;ALK;ANG;MUSK;CHRNA7;FXR2;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;P2RY1;DAXX
prerank,amide biosynthetic process (GO:0043604),-0.40427638100004637,-1.3832464335345154,0.07001795332136446,0.36908486376143446,1.0,8/47,8.90%,SGMS1;SGMS2;SPTLC2;DMD;DEGS2;SPTLC1;SPTSSB;ASAH2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3589380224865753,1.382990326734997,0.043052837573385516,0.5229966462496832,1.0,25/107,11.11%,ATP1A2;LRRC4C;NRG3;GRID2;CLSTN2;RIMS1;CHRNB4;GRIK5;GRIK2;GRM1;DLGAP1;NLGN2;NLGN3;SYT1;GRID1;CPLX2;NLGN1;GRIK1;MAPK8IP2;STX1B;MCTP2;PTEN;CNTNAP4;BAIAP3;CHRNA7
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5074167699510298,1.3829718236780357,0.09172259507829977,0.5210691774290307,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,hemopoiesis (GO:0030097),-0.35446535085224334,-1.382956148447462,0.02178217821782178,0.36898339819265574,1.0,33/87,24.03%,MECOM;KITLG;TEK;FLT1;CD34;TGFBR2;KDR;HIPK1;TGFB1;TGFB2;ZBTB16;NOTCH4;ATF4;FLT4;TAL1;TIRAP;INHBA;YTHDF2;GLRX5;CSF1R;CDK13;BMI1;L3MBTL1;RASGRP4;SNRK;ARMC6;ETV6;WNT10B;ZFPM1;PGM3;MKNK2;ASH2L;PLD4
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.565266822582774,-1.3824098701188023,0.09038461538461538,0.36941706083265385,1.0,5/12,19.53%,CSGALNACT1;SLC35A3;FUT8;GFPT1;GALT
prerank,regulation of neuroinflammatory response (GO:0150077),0.5123216237883674,1.3823378014875074,0.1028225806451613,0.5208140791547338,1.0,3/19,8.31%,IGF1;IL4;IL18
prerank,regulation of protein metabolic process (GO:0051246),-0.4062975574547337,-1.3817686788190915,0.06019417475728155,0.3700759817111106,1.0,8/44,4.23%,LTBP4;NEDD4L;MAP2K5;KLF2;KLF4;HSP90AB1;APP;FKBP1A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39491109695195253,1.3813450031397936,0.07459677419354839,0.5214273586857903,1.0,12/63,7.95%,IGF1;TCF7L2;AR;DEPTOR;SH3RF1;PHIP;CFLAR;IL4;BCL2L12;GSTP1;SCG2;TGFBR1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5168974382873365,-1.3810780388046862,0.09380863039399624,0.37087937337853033,1.0,13/16,45.09%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5094802523034767,-1.3810600780655296,0.10805500982318271,0.3701550541511332,1.0,7/16,20.94%,BMPR2;PLCB3;PRCP;ACE;GPR37L1;SPX;DDAH1
prerank,regulation of neuron differentiation (GO:0045664),0.3652383323378747,1.3808181504157895,0.04251012145748988,0.5207895250767237,1.0,16/76,10.11%,TCF4;BMP2;ZEB1;CNTN4;BRINP1;NREP;HES3;BRINP3;DTX1;NLGN1;SOX2;NRCAM;HES5;CDK5R1;KCTD11;ALK
prerank,regulation of leukocyte migration (GO:0002685),-0.5206476686920202,-1.3807750564870536,0.10276679841897234,0.3700384917004078,1.0,4/16,5.68%,ANXA1;RAC1;CD81;VEGFA
prerank,potassium ion transport (GO:0006813),0.34773377702127783,1.3806290928527314,0.02982107355864811,0.5194330632548635,1.0,34/120,20.15%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNMA1;KCNK10;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;SLC9A9;KCNH4
prerank,mesenchymal to epithelial transition (GO:0060231),0.5993652379318082,1.3805753375172998,0.12631578947368421,0.5176722074036773,1.0,3/10,13.22%,SALL1;GATA3;PAX8
prerank,regulation of kinase activity (GO:0043549),0.3627335939584974,1.3803103117439244,0.04065040650406504,0.5165838728825093,1.0,29/89,12.87%,EPHA7;LDB2;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;IRS2;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1
prerank,cellular amino acid catabolic process (GO:0009063),0.3697332675987465,1.380091016421149,0.0482897384305835,0.5152425947489995,1.0,20/87,10.98%,HMGCLL1;ASPA;ALDH4A1;IL4I1;ABAT;PRODH;ACADSB;GLDC;ALDH7A1;ALDH6A1;BCKDHB;TDO2;KMO;DDO;GLUL;GLS2;HIBADH;KYNU;HNMT;DBT
prerank,cellular response to acid chemical (GO:0071229),-0.45802784645360084,-1.3792188332683435,0.08379888268156424,0.372938090875576,1.0,18/27,35.88%,SH3BP4;KLF2;CAPN2;VEGFA;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;NSMF;RPTOR;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4384048505746578,1.3790992648720923,0.09297520661157024,0.5159025966268327,1.0,9/34,8.86%,LGR4;LYN;TICAM1;BPIFB1;SMPDL3B;CD300LF;LRRC14;NLRP2B;GPR108
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.31091698806165713,-1.3790885568370175,0.0021598272138228943,0.3724873923145578,1.0,65/234,17.33%,PRKCH;CAV1;SLCO3A1;RPS6KA5;ESR1;PLCG2;NOD1;NFKBIA;TFRC;MID2;FZD4;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;SMO;UBB;PPARGC1B;PPIA;PRKCZ;PPARGC1A;UBC;RPS27A;VEGFA;IKBKB;PSMA6;RGCC;JUP;RIPK1;EDN1;MBTPS2;TNFRSF11A;HDAC4;AKT1;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;LRP8;STK36;CIB1;TRIM62;MAVS;TLR4;EDA2R;COPS5;TRAF1;AIM2;ARHGEF5;PHB2;TRIM68;SMARCA4;TRIM5;SRF;FLOT2;NOD2;CX3CR1;TCF3;HSPA1A;TAB2;RELA;KDM1A
prerank,regulation of cell migration (GO:0030334),-0.2923245253985496,-1.3788008116707309,0.006622516556291391,0.37236684062678765,1.0,95/382,14.97%,LEF1;PECAM1;PODXL;CAV1;TMSB4X;FLT1;FRMD5;IGF1R;ITGA6;CLDN5;DACH1;SEMA6A;CLIC4;SEMA3C;CDH1;THBS1;PTPRJ;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;LIMCH1;ACTN4;KDR;F3;PTK2;CYRIB;FOXO3;ANXA1;FERMT2;SMAD7;SLIT2;IGFBP5;ADAM15;TGFB1;RNF41;PLXNA4;SMO;RAC1;ADAM10;ROBO4;PRR5L;CYP1B1;NEDD9;CD151;MINK1;AMOT;VEGFA;IFITM1;SH3RF2;MYOC;SPATA13;ABI3;PPM1F;EDN1;MMP14;AKT1;ELP6;INSR;PDGFC;PDGFA;TMSB10;LAMC2;ZMYND8;VCL;FAM107A;SEMA3G;DDRGK1;RHOB;WNT11;PLXNA1;PLXND1;CD74;HSPA5;NF1;ULK4;CIB1;DUSP3;ACVR1;RCC2;SRCIN1;FGF2;CSF1R;ENG;PIK3R3;HRAS;ACE;RNF20;SDCBP;SPAG9;EGFR;OSGIN1;LDB1
prerank,necroptotic process (GO:0070266),-0.5219620165821587,-1.3786618889643083,0.10307414104882459,0.3719144840637457,1.0,7/16,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,positive regulation of neuron projection development (GO:0010976),0.36712537721804445,1.3784871175619022,0.046610169491525424,0.5155916081443505,1.0,25/85,14.64%,CAMK1D;PTN;NTRK3;BMP5;TENM3;MAGI2;PTK7;EPHA3;RIT2;GPC2;LYN;NPTN;CAMK2B;DPYSL3;LRRC7;CUX2;ALK;PRKCI;FUT9;PLXNB2;CBFA2T2;ROR1;EP300;CAPRIN2;PLPPR5
prerank,triglyceride biosynthetic process (GO:0019432),0.5217943900432356,1.3783347756598523,0.12244897959183673,0.5140560690090242,1.0,6/18,16.49%,AGMO;MOGAT3;LPIN3;MOGAT2;DGAT2;LPIN1
prerank,amino acid transport (GO:0006865),0.4019497605668564,1.3783167185038894,0.09355509355509356,0.5122442614156973,1.0,11/49,11.87%,SLC7A11;SLC6A12;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A47;SLC1A5;SLC38A3;SLC38A9
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4960380505564469,-1.378204740802794,0.09021113243761997,0.37222160723899955,1.0,8/18,24.02%,PPP1R16B;MFHAS1;CHP1;SH3RF2;PPP1R8;PPP1R26;ARPP19;YWHAB
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.38475182961770527,-1.378086957507257,0.057494866529774126,0.3717644555718495,1.0,23/63,22.40%,RPL26;CRADD;CDKN1B;CNOT7;PRKDC;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;CCND1;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,positive regulation of growth (GO:0045927),-0.37632163485310594,-1.3769529594244845,0.043137254901960784,0.373561586342301,1.0,28/64,25.08%,RPS6KA3;TGFB2;ADAM10;MFSD2A;PPM1F;PABIR1;MMP14;AKT1;INSR;H3-3A;AKAP6;CIB1;FXN;CDKN2AIP;SDCBP;EGFR;ERBB2;CSNK2A1;DERL2;SLC25A33;ZPR1;BRAT1;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;RPTOR
prerank,atrial septum morphogenesis (GO:0060413),-0.5832631004027854,-1.376901697125816,0.11690647482014388,0.37292274183705404,1.0,4/10,12.54%,BMPR2;TGFB2;ACVR1;SOX4
prerank,negative regulation of chemotaxis (GO:0050922),0.43865457842216027,1.3767870117993315,0.09484536082474226,0.5142892996013274,1.0,6/31,4.77%,ROBO1;ROBO2;ANGPT2;SEMA5A;SEMA3A;SEMA3D
prerank,glycolipid metabolic process (GO:0006664),-0.39495244138027674,-1.3767341296956743,0.07020872865275142,0.3726177080404765,1.0,25/47,32.56%,ST3GAL6;ST3GAL4;ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;ST8SIA6;ABCA2;SUMF1;ESYT3;NEU3;PIGW;SCCPDH;GLTP;SMPD1;NEU1;NEU2;NAGA;B4GALNT1;ARSA;SMPD2;FUCA1;ST3GAL2;HEXB
prerank,protein catabolic process (GO:0030163),-0.3804831102173384,-1.3766788942220116,0.043222003929273084,0.37200379223169006,1.0,30/59,33.91%,MANBA;TPP1;DAB2IP;RNF41;HSPA8;FBXO17;IDE;RIPK1;DENND3;CTSD;UBE2G2;VCP;APOE;RNF5;UBE2G1;UCHL3;HSP90AA1;OGA;USE1;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;PMAIP1;CAPN3;PRPF19;PSMA8;TRIM24;HTRA2
prerank,positive regulation of macrophage activation (GO:0043032),-0.5036647321995125,-1.3765562724266938,0.09851301115241635,0.3714992598734289,1.0,5/17,12.43%,LBP;THBS1;IL33;HSPD1;TLR4
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4612244468940018,-1.3765020208302834,0.08752327746741155,0.370894523140064,1.0,10/25,23.22%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5164848528147229,1.3762611104580669,0.11231101511879049,0.513820413501684,1.0,3/16,2.65%,IGF1;ROCK2;PRKCA
prerank,plasma membrane repair (GO:0001778),-0.532075839242455,-1.3750500118392037,0.09836065573770492,0.37342461312680847,1.0,8/13,31.52%,AHNAK2;MYOF;DYSF;ARL8B;MYH9;SMPD1;SYT7;RAB3A
prerank,artery development (GO:0060840),0.48108703457247204,1.374693541606011,0.1108695652173913,0.516069543929386,1.0,4/23,2.13%,ROBO1;NRP1;ROBO2;EFEMP2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.508342667255657,1.3746033922818537,0.10323886639676114,0.5144613956769277,1.0,3/19,5.08%,CAMK1D;DAPK2;IL4
prerank,cellular response to lipid (GO:0071396),0.3260985417370736,1.3743505196545436,0.017374517374517374,0.5133164193646772,1.0,42/191,15.39%,RORA;ADCY2;ADCY1;ATP1A2;PID1;AR;ADCY5;PTK7;EPHA3;ROCK2;GNAI1;PDK4;STAP1;LYN;SFRP1;TICAM1;ZNF35;BRINP1;AXL;SERPINE1;PDK3;BRINP3;GSTP1;PPBP;CD274;ABCB4;NUGGC;PABPN1;TNIP3;PDE4B;ADCY8;AHR;FZD10;ATP1A3;BRINP2;ATM;CD180;WNT6;CXCL1;WNT5B;KAT5;NCOA3
prerank,cellular response to ionizing radiation (GO:0071479),-0.40213941408714377,-1.3742519152824832,0.07034220532319392,0.37453769218889676,1.0,24/47,29.46%,NET1;RPL26;MAP3K20;EEF1D;RAD1;RHOB;HRAS;TMEM109;RAD9B;HUS1;RAD9A;CDKN1A;KDM1A;CRYAB;ECT2;GADD45A;NIPBL;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;TSPYL5;SWI5
prerank,lipid oxidation (GO:0034440),-0.5600370416778064,-1.3739223705391215,0.10619469026548672,0.37462592002172557,1.0,3/12,5.35%,ADIPOR2;PPARGC1A;ADIPOR1
prerank,ceramide transport (GO:0035627),-0.5609627401165805,-1.3737517974708193,0.10909090909090909,0.3742856811258586,1.0,7/12,24.77%,CERT1;PLTP;PSAP;ABCA2;GLTP;ABCA13;SGPP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3893614276281804,1.3736309613976283,0.059063136456211814,0.513298864640544,1.0,12/57,12.14%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5213454044826374,-1.3735036658078457,0.1102803738317757,0.374101945057495,1.0,6/15,14.96%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCNJ8;KCND3
prerank,negative regulation of macrophage activation (GO:0043031),0.5285847240917405,1.3711505324074482,0.11776447105788423,0.5179757398534347,1.0,2/16,5.08%,IL31RA;IL4
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5766973040280207,1.370393747785676,0.1159090909090909,0.5179918270605979,1.0,5/11,15.34%,NRP1;SIRT2;MST1R;BCAR1;PAK1
prerank,negative regulation of response to stimulus (GO:0048585),-0.3847411284887843,-1.3702622210172024,0.06854838709677419,0.38080719044837813,1.0,15/60,11.98%,CDK6;CD34;MAP2K5;KLF4;COL3A1;SLIT2;KLF7;LPCAT3;MAP3K3;IGFBP3;AQP11;TWIST1;PIM3;KIF26A;ACVR1
prerank,sensory perception of smell (GO:0007608),0.5752905366679649,1.3700828222628167,0.15124153498871332,0.5169648066891116,1.0,4/11,14.14%,OMP;SLC24A4;UBR3;DRD2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3767590205992303,-1.3695865368934341,0.04938271604938271,0.3815724568323126,1.0,12/62,11.27%,MEF2C;CDK6;THBS1;TNRC6C;PTK2B;KMT2C;RBBP5;ZBTB16;CBFB;MYL9;H3-3A;KMT2D
prerank,epithelial to mesenchymal transition (GO:0001837),0.4047524164475227,1.3691485110892412,0.07111111111111111,0.517635372039303,1.0,11/47,8.07%,TGFBR3;WNT4;BMP2;TBX3;ROCK2;OLFM1;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5394924227345874,-1.3681188853607462,0.12159709618874773,0.3841479240854377,1.0,7/13,22.97%,RACK1;DDRGK1;HSPA5;UFL1;NCK1;BFAR;PTPN1
prerank,cellular response to amyloid-beta (GO:1904646),0.42852385276486077,1.3679559904222987,0.08768267223382047,0.5189238322031388,1.0,4/35,3.32%,IGF1;LRP1;GJA1;CACNA2D1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4547492119118353,-1.3674134760572112,0.09591474245115453,0.38504877209247956,1.0,12/26,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RNF111;RBX1;CETN2;GTF2H4;ERCC4
prerank,sister chromatid segregation (GO:0000819),-0.439809569332521,-1.367327098483315,0.08775137111517367,0.3845363954990402,1.0,15/31,32.81%,SMC4;ZW10;RB1;TOP2A;KIF18A;KNSTRN;KIF18B;NSL1;NDC80;CDCA8;SGO1;TOP2B;TUBG2;PLK1;ESPL1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5283846199048953,-1.3672291386146587,0.11775700934579439,0.3839971051584553,1.0,6/14,9.62%,MEF2C;PRKG1;SLIT2;IGFBP5;IGFBP3;TRIB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5387134284783245,1.366683051751755,0.13228699551569506,0.5206410828715118,1.0,3/15,3.98%,BMP2;GLI2;ANKRD11
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3795363612170836,-1.365455067466242,0.04474708171206226,0.3871403346803208,1.0,19/59,19.19%,NFKBIA;IRAK2;DAB2IP;UBB;REL;UBC;RPS27A;IKBKB;TLR3;RIPK1;FAIM;AKT1;RELB;TLR4;TNFRSF1A;TAB2;RELA;CHUK;NKIRAS2
prerank,response to interferon-beta (GO:0035456),-0.4714054133143819,-1.3649666423634563,0.11071428571428571,0.38748156833016995,1.0,7/22,16.32%,IFITM1;IFITM3;IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,negative regulation of blood pressure (GO:0045776),-0.5334845082055062,-1.3644596059327205,0.11195445920303605,0.3879341962268561,1.0,8/13,33.71%,NOS3;BMPR2;PRCP;GPR37L1;SCPEP1;APLN;NOS2;NOS1
prerank,T cell homeostasis (GO:0043029),-0.5746204928418532,-1.3642542487714777,0.1103448275862069,0.38773220138298625,1.0,5/10,17.47%,AKT1;FAS;ZC3H8;PPP2R3C;JAK3
prerank,dendritic cell differentiation (GO:0097028),0.4859384116432822,1.3641741608027003,0.09719222462203024,0.5251488042806443,1.0,5/22,5.75%,PRTN3;LYN;IL4;CAMK4;AXL
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3003294454410853,-1.363977309221747,0.010775862068965518,0.38760142743518106,1.0,65/260,15.75%,FGD5;ANO6;ABLIM1;ABCC4;DNM3;RAP1A;EXOC4;PARVB;NOTCH1;EXOC6;FNBP1L;RAP1B;RAB11A;OPHN1;CDC14A;FXYD5;EHD4;S1PR1;RAB8B;CD2AP;IFT20;CEP164;RAC1;SHTN1;ABLIM3;PKD1;MINK1;FGD6;EZR;SPATA13;EHD2;CENPJ;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;VCL;EMP2;RAB8A;CEP290;SPEF1;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ABLIM2;EMP1;ARL6;RFX2;NTN1;RAB11FIP3;RAB1A;SDCBP;CCDC28B;KIF24;STK26;DNAH5
prerank,positive regulation of phospholipase activity (GO:0010518),0.4829335408010845,1.3638649434041705,0.12636165577342048,0.5240716017302194,1.0,6/22,2.26%,NTRK3;FGFR2;KIT;PLA2G5;PDGFRA;PDPK1
prerank,collagen fibril organization (GO:0030199),0.3607709811992947,1.3636795901530343,0.04338842975206612,0.5228009881158789,1.0,21/88,11.05%,COL4A6;COL4A5;COL13A1;DDR2;COL1A2;COL22A1;DPT;COL4A4;COL16A1;LUM;COL4A3;COL10A1;COL8A2;P4HA2;LOXL2;LOXL3;TGFBR1;COL20A1;COL26A1;COL9A2;COL6A3
prerank,regulation of myotube differentiation (GO:0010830),-0.46471628162024087,-1.363407644941358,0.11602209944751381,0.3882379967913249,1.0,7/24,8.40%,NOTCH1;CCN3;PIEZO1;HDAC9;ATP11A;HDAC4;MMP14
prerank,mesonephric tubule development (GO:0072164),0.5384849198923845,1.3633123039465351,0.15296803652968036,0.5219651405465962,1.0,3/15,1.11%,ROBO2;SALL1;FGFR2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.48500837157563714,-1.363003128336992,0.09770114942528736,0.3884532610313031,1.0,5/20,4.12%,ANO6;ENTPD1;NT5E;HSP90AB1;APP
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5554251226391135,1.3625529306477822,0.1393258426966292,0.5221038451933637,1.0,3/11,6.04%,PPARA;SLC30A10;ABCD2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.47323614760779464,-1.3622950998960077,0.09803921568627451,0.38935720493062076,1.0,10/20,29.73%,GATM;PLOD2;GCLM;CNDP2;GCLC;GGT1;GGCT;MTHFS;SLC27A1;MGST2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.45763427349933616,-1.3621486997762267,0.08103130755064457,0.38898183144903226,1.0,5/24,2.97%,MEF2C;CDON;CTNNA1;MEF2A;BOC
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5257368562424044,-1.3619608707743023,0.11882998171846434,0.3886820222888854,1.0,11/15,39.87%,SCARB1;MFSD2A;NR1H2;CNEP1R1;C3;SIK1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5075751987370731,1.3618534403310008,0.1346153846153846,0.5220598579862417,1.0,5/18,10.65%,CAMK1D;ADCY1;LPAR5;EPHA5;ADCY8
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3485040933330397,-1.3606465455265042,0.036,0.3909624433420997,1.0,33/86,23.09%,KLF2;EGLN3;UBB;UBC;RPS27A;VEGFA;ATF4;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;IMPACT;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;CHEK1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;DNAJB1;ATF3;PSMA4;PSMA2
prerank,regulation of protein binding (GO:0043393),-0.33594808387494135,-1.3601406223978105,0.03225806451612903,0.3914464095448225,1.0,27/114,11.06%,CAV1;ACTB;CLDN5;B2M;RACK1;RPL11;APP;FKBP1A;CTSZ;RALB;PKD1;CRK;HIP1R;IDE;NMD3;NES;HDAC4;BAX;AKT1;DISC1;PRMT8;ADD1;FLOT1;IFIT1;CTNNBIP1;CAMK1;GAS8
prerank,organelle fusion (GO:0048284),-0.4793830863892919,-1.3590803893205938,0.11433756805807622,0.39312108041116045,1.0,15/22,41.33%,EEA1;MIEF1;BAX;CHCHD3;MIEF2;VPS11;OPA1;FIS1;STX4;MFF;THG1L;MIGA1;CYP26C1;GDAP1;MFN1
prerank,amino acid import across plasma membrane (GO:0089718),0.47544406889638735,1.3589703505484036,0.11206896551724138,0.5276311034158333,1.0,5/24,1.76%,SLC1A3;SLC6A9;SLC7A2;SLC6A13;SLC22A4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5643662612494054,-1.3575370581730475,0.12302284710017575,0.39595808724829995,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,bicarbonate transport (GO:0015701),-0.45615899791284453,-1.3571142169943369,0.08695652173913043,0.39620528498071683,1.0,7/25,12.98%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC4A2;CYB5R1
prerank,insulin receptor signaling pathway (GO:0008286),-0.36574161943199807,-1.3567113273845839,0.05084745762711865,0.3964213706641371,1.0,22/69,16.30%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;ATP6V0B;ATP6V0A2;SHC1;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;GRB10;FOXC2;PIK3R3;PIK3CA;ATP6V1G1;BCAR3;PIK3R2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.39635951670454245,-1.356638488344161,0.06534653465346535,0.39582749631282316,1.0,18/47,16.62%,IGF1R;ARL6IP5;FOXO1;MAPK3;DAB2IP;TGFB2;MID1;PPIA;TAOK3;STK25;FAS;TAOK2;ULK4;COPS5;EGFR;NOD2;GREM1;IGBP1
prerank,regulation of receptor binding (GO:1900120),0.5751556723401606,1.3564989896182176,0.15402298850574714,0.5326597056879889,1.0,2/10,3.83%,GREM2;ATP2A2
prerank,positive regulation of apoptotic process (GO:0043065),-0.2972304914925676,-1.356149835666963,0.010080645161290322,0.3962346500488599,1.0,81/293,18.66%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FAP;FOXO3;RPS3;TPD52L1;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TGFB2;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;BACE1;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2
prerank,positive regulation of telomerase activity (GO:0051973),-0.4251987178625718,-1.3560611205851756,0.09796672828096119,0.3956733555407703,1.0,10/33,16.67%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1
prerank,embryonic skeletal system development (GO:0048706),0.4295952830567541,1.3557363906029576,0.11324786324786325,0.5328756560537767,1.0,8/35,11.02%,SULF1;SULF2;HOXC4;PDGFRA;HOXB3;HOXC9;HOXB9;FUZ
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5452461848813347,1.355510444790299,0.1297539149888143,0.5316585751728402,1.0,6/12,23.13%,MCM3;GINS2;MCM2;CDC7;MCMDC2;MCM7
prerank,homeostasis of number of cells (GO:0048872),-0.552595592672636,-1.3555092776181965,0.10091743119266056,0.3962119583215692,1.0,6/12,15.81%,NOS3;NOTCH1;CCN3;LPCAT3;OCIAD1;CX3CR1
prerank,cellular response to BMP stimulus (GO:0071773),0.3728364535941439,1.3553654690251395,0.06223175965665236,0.5302123324589333,1.0,7/66,4.24%,BMP6;TGFBR3;ADAMTS12;BMP2;BMP5;SMAD3;SFRP1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.42594606940440527,-1.3548331113576724,0.08875739644970414,0.39699419847450423,1.0,18/35,30.76%,CDK6;FOXO3;ETS1;PRKDC;TAL1;INHBA;LDB1;STAT1;HSPA1A;FAM210B;HSPA9;MAPK11;HSPA1B;ZFPM1;SPI1;HMGB2;ANKRD54;ABCB10
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5181131511227446,-1.354759416233795,0.11466165413533834,0.3964346188738333,1.0,6/14,22.08%,CD55;TGFBR2;CD81;SYK;LGALS9;PTPN22
prerank,mammary gland development (GO:0030879),0.4884981779556667,1.3546921152537392,0.1159090909090909,0.5302478549430002,1.0,4/21,2.15%,WNT4;TBX3;NRG1;GLI2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.42730921866257415,1.3545918217294342,0.08914728682170543,0.5287216570639695,1.0,14/34,18.84%,GRID2;MPP2;GABRA2;NLGN3;MAPK8IP2;GABRA5;CHRNA4;GRIN2A;DRD2;GABRG1;GABRG3;GRIN2B;GABRG2;RAB3GAP1
prerank,modified amino acid transport (GO:0072337),0.5153334462837619,1.3543734237360785,0.11713665943600868,0.5276119508274452,1.0,5/15,11.56%,SLC16A12;SLC6A13;SLC7A9;CTNS;SLC46A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4790852802485205,1.3541081409269984,0.10191082802547771,0.5265674515331857,1.0,10/23,13.71%,ENPP1;GLI3;IFT122;TULP3;KIF7;KCTD21;MGRN1;GPR161;BTRC;SUFU
prerank,polyol metabolic process (GO:0019751),-0.39630659770932875,-1.3540489243783924,0.07522935779816514,0.3973029290991627,1.0,14/46,16.69%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5291676035262279,-1.353864534853812,0.11785714285714285,0.3970103665081787,1.0,3/14,7.21%,ANO6;THBS1;RGCC
prerank,regulation of sensory perception of pain (GO:0051930),-0.5654395359729607,-1.353568901432931,0.125,0.39697119118972257,1.0,6/11,25.04%,CCN3;MGLL;ZFHX2;TMEM100;SPX;ATPSCKMT
prerank,regulation of organelle organization (GO:0033043),-0.3539655310736405,-1.3528714324710251,0.03937007874015748,0.3978400649428164,1.0,35/80,28.21%,CLIC4;F11R;MAPK3;PTK2;CAPN2;MSN;PDE2A;DIAPH1;EZR;CPLANE2;RHOT1;SPEF1;MIEF2;RHOT2;SURF4;MAVS;ARHGEF5;VPS11;MTM1;TBC1D25;ARMH3;EHD3;TMEM33;FIS1;PDCD10;STX5;CAMSAP3;GOLPH3;TJP1;PLXNB1;RDX;CAPN6;CENPV;MFF;MUL1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5632774222688384,-1.3524042825386524,0.14,0.39823467066700813,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,positive regulation of cell differentiation (GO:0045597),0.31074529678281204,1.351297172004093,0.02053388090349076,0.5322961014091868,1.0,36/237,9.72%,IGF1;BMP6;TCF4;WNT4;NELL1;BMP2;AR;PTN;FBN2;DDR2;RIN2;ZEB1;GJA1;GDNF;PLA2G5;SMAD3;CCN4;RANBP3L;CTNNA2;SFRP1;SP7;OLFM1;CEBPB;AXIN2;BRINP1;BRINP3;MEDAG;LOXL2;RRAS;TGFBR1;NRCAM;IL18;SMYD1;BMPR1A;SOX5;KCTD11
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5416916243742866,-1.3507384130504592,0.12028725314183124,0.4010800856879359,1.0,8/13,24.02%,NFKBIA;PKD1;DBN1;MDFI;KEAP1;PKD2;NFKBIE;YWHAB
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.548007344104045,1.350730576810422,0.1588785046728972,0.5318753151840288,1.0,3/12,4.13%,IL34;OCSTAMP;LYN
prerank,regulation of chemokine production (GO:0032642),-0.4154999467932674,-1.3505289282101838,0.0873015873015873,0.4007706561724652,1.0,12/36,25.39%,FOXP1;APP;IL33;TLR3;CD74;TLR4;CSF1R;SIGIRR;LGALS9;AIF1;SNAI2;TREM2
prerank,ureteric bud morphogenesis (GO:0060675),0.5306867876835805,1.3499082987267097,0.13004484304932734,0.5321829463499151,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,positive regulation of catalytic activity (GO:0043085),-0.4086721851523019,-1.3498987172370027,0.08163265306122448,0.4013825313186937,1.0,11/37,15.49%,CAV1;MAPK3;BCAS3;PSENEN;PHACTR4;ABL2;CIB1;FXN;APH1A;CHTOP;NOD2
prerank,positive regulation of innate immune response (GO:0045089),-0.4362829607965409,-1.3497968833634677,0.10820895522388059,0.40087446243354347,1.0,9/30,16.27%,LBP;GBP5;NLRC5;RPS19;DHX9;TRIM62;MAVS;AKIRIN2;SLC15A4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5688886250266794,-1.34965938650478,0.12797074954296161,0.40044150639793097,1.0,4/10,5.14%,ACER2;WNK1;JAM3;CYP1B1
prerank,positive regulation of synaptic transmission (GO:0050806),0.3713185735603422,1.3494300264279617,0.055666003976143144,0.5317326506738717,1.0,20/72,13.96%,ADCY1;NRXN1;CLSTN2;RIMS1;MPP2;GRIK2;NPTN;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;STX1B;SLC24A2;ADCY8;BAIAP3;CHRNA7;ZDHHC2;DLG4;GRIN2A
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4022604410344186,-1.3493329230706343,0.08840864440078586,0.4005387411949859,1.0,13/44,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ACVR1;HES1;ENG;SRF
prerank,mitochondrion morphogenesis (GO:0070584),0.5595833958271299,1.3485171830664702,0.12526997840172785,0.53245070284605,1.0,3/11,10.46%,PID1;NUBPL;PNPT1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4400616673991785,-1.347569973432347,0.08846153846153847,0.4038891607211372,1.0,9/27,11.12%,AHNAK;DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;CACNB3
prerank,actin cytoskeleton reorganization (GO:0031532),0.3771626101824893,1.3468580410248794,0.0824524312896406,0.5348119867906813,1.0,11/63,7.53%,AUTS2;NRP1;NRK;PTK7;ANTXR1;KIT;EFS;RAP2A;THSD7B;THSD7A;TNIK
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.46943225996900684,-1.3467392969568261,0.10609037328094302,0.4049873997060717,1.0,12/21,31.14%,VEGFA;FZD3;NES;DISC1;CX3CR1;KDM1A;DLL4;TOX;LRP2;CTNNB1;FZD9;SMARCD3
prerank,cellular response to oxygen levels (GO:0071453),-0.5733179346457913,-1.3465945670478316,0.11131059245960502,0.4046270260138126,1.0,7/10,30.68%,ATP6V0A2;NDUFS2;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1;CPEB4
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.33492082827744113,-1.3461434471135778,0.04142011834319527,0.40493795453551057,1.0,28/112,17.36%,FOXP1;LBP;THBS1;PTPRJ;CD34;PLCG2;IFIH1;APP;IL33;RARA;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;PTPN6;TNFAIP3;CX3CR1;OAS2;IFNGR1;VSIR
prerank,regulation of protein autophosphorylation (GO:0031952),0.42670778574851154,1.3461225581339784,0.1062124248496994,0.5348422449618714,1.0,6/36,7.92%,EPHA7;ENPP1;ERRFI1;RAP2A;NLRP12;PDGFD
prerank,mitochondrial fission (GO:0000266),-0.5159710729719333,-1.3448044202772707,0.11029411764705882,0.40725828578293516,1.0,10/16,28.21%,DNM3;MIEF1;MTFR1;OPA1;DNM1;DNM2;FIS1;MTFR2;MFF;MUL1
prerank,neuromuscular synaptic transmission (GO:0007274),0.49206071299022963,1.344614754525617,0.1277056277056277,0.5369980656149069,1.0,7/18,14.80%,CHRNA1;CHRNB4;RIMBP2;TBC1D24;STAC3;CHRNB1;FCHSD2
prerank,regulation of JUN kinase activity (GO:0043506),-0.42785265243123505,-1.344538022200567,0.09107806691449814,0.40715826162492513,1.0,9/33,8.98%,MAP3K5;RPS3;DAB2IP;TAOK3;AIDA;EDN1;TNFRSF11A;MAP3K11;DNAJA1
prerank,defense response to symbiont (GO:0140546),-0.3453233914977033,-1.344504406128253,0.04896421845574388,0.40652630779272053,1.0,26/92,18.61%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;MAVS;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,regulation of lymphocyte migration (GO:2000401),-0.5726536245089644,-1.3443111038020326,0.125,0.40623230735930127,1.0,5/10,14.29%,JAM2;STK10;MSN;AKT1;WASL
prerank,heart development (GO:0007507),-0.31762499431060737,-1.3438981014864082,0.03375527426160337,0.40645124141963057,1.0,30/150,5.82%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;GPC3;NOTCH1;TGFBR2;BMPR2;MEF2A;RAMP2;PTK2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;FKBP1A;TBX2;CRIP1;HDAC9;NDUFV2;STRA6;PKD1;VEGFA;MICAL2
prerank,positive regulation of response to wounding (GO:1903036),-0.4421216314884965,-1.3434444734088573,0.10251450676982592,0.4067576331192808,1.0,5/24,3.46%,OCLN;ACTG1;SCARF1;PTK2;ANXA1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.33467728128153235,-1.342828732431125,0.04609218436873747,0.40753816701593826,1.0,22/107,8.87%,ATP13A5;CAV1;SLC39A10;TPT1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;MT2A;TMEM165;ATP2C1;SLC39A8;ATP2A3;ATP1B1;EDN1;STIM2;CCL15;SLC10A7
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.345773139420587,1.3424764429980967,0.04208416833667335,0.5406997848374684,1.0,18/116,11.32%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R;ADCY8;HTR4;PTGIR
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3289023586949123,1.3420634844807198,0.03571428571428571,0.5399721684181594,1.0,31/150,9.81%,TCF7L2;PIK3R1;AREG;FGFR2;SEMA5A;NRG1;KL;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4
prerank,regulation of neuron projection development (GO:0010975),0.3224938919943484,1.3405243825344444,0.0437375745526839,0.5422903101138079,1.0,39/163,14.64%,CAMK1D;PTN;LPAR1;NTRK3;LRRC4C;CSMD3;TENM3;MAGI2;PTK7;KIF13B;EPHA3;SEMA3A;RIT2;CTNNA2;GPC2;LYN;NPTN;RAB29;IL1RAPL1;CAMK2B;DPYSL3;STX1B;LRRC7;CDK5R1;DCC;PRKCI;FUT9;PTEN;PLXNB2;BRSK1;FBXO7;KIF1A;CBFA2T2;ROR1;FRMD7;EP300;PPFIA2;PDLIM5;PLPPR5
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.44220826447368655,-1.3402171619404826,0.0918918918918919,0.4133563051632363,1.0,12/29,24.43%,RPS16;RPS14;NOP14;RPS21;RPS8;RPS19;DHX37;UTP4;PWP2;TBL3;ABT1;TSR1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5823067465626618,1.3398895640674513,0.19419642857142858,0.5422618221535236,1.0,2/10,2.64%,ABCA1;PRKACA
prerank,positive regulation of developmental growth (GO:0048639),-0.38668374043575837,-1.3396356362423358,0.08743169398907104,0.4141060165566047,1.0,14/49,15.29%,SEMA7A;NEDD4L;AGRN;ITSN2;NGF;SHTN1;INSR;PLAA;DBNL;DBN1;SYT2;SMURF1;NTN1;LIMK1
prerank,positive regulation of neuron migration (GO:2001224),-0.5628484623888549,-1.3394363634217799,0.13211009174311927,0.4138628304485683,1.0,8/11,24.49%,SEMA6A;DAB2IP;SHTN1;PLAA;ARHGEF2;NIPBL;RAPGEF2;NSMF
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.49097654923231315,-1.3377121518567092,0.13966480446927373,0.41729783698211015,1.0,14/17,47.78%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,negative regulation of immune effector process (GO:0002698),-0.535072279188673,-1.3375074176428514,0.12410071942446044,0.41707220454876104,1.0,3/13,7.75%,CD55;RPS19;RC3H1
prerank,bile acid and bile salt transport (GO:0015721),-0.45143781389902976,-1.3374079516964263,0.11231884057971014,0.41656970350329736,1.0,4/24,1.27%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.40196338367219886,1.3371658586122577,0.09053497942386832,0.5477461872532645,1.0,8/43,12.94%,ENPP1;PID1;AHSG;PIP4K2A;IGF2;PRKCB;PIP4K2B;GKAP1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.43737916694627377,-1.3366275909482017,0.10707803992740472,0.41768953893623084,1.0,15/29,30.24%,DCUN1D5;SMAD7;DCUN1D1;BAG5;FEM1A;LIMK1;BMI1;PIN1;TRIB3;DTX3L;DCUN1D3;PARK7;MAGEC2;RPS2;PLK1
prerank,cGMP-mediated signaling (GO:0019934),0.534183128501096,1.3357985038504359,0.14853556485355648,0.5496148595112588,1.0,1/13,0.05%,IRAG1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3582958137113102,-1.3357160045286909,0.05930470347648262,0.4190356753792094,1.0,34/67,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4094291188753031,-1.3355942423072582,0.0855614973262032,0.4186210819559136,1.0,20/40,28.58%,PTK2B;PTK2;RPL11;RPL23;FOXF2;RPS7;SMURF1;SGTA;CSNK2A1;CSNK2A2;UFL1;CDK5RAP3;LAPTM5;CCDC22;RPL5;UBE3A;RAD23A;TRIM39;RAD23B;XPO1
prerank,positive regulation of cell communication (GO:0010647),0.44576600144179807,1.3355021152447701,0.12043010752688173,0.5486606149454281,1.0,10/28,19.21%,WLS;CLSTN2;RIMS1;GRIK2;SYT1;GATA3;DLG4;HCRT;RIMS2;LGI1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.48716038535320333,1.3354026293036836,0.1447084233261339,0.5471890690099631,1.0,3/18,0.98%,IL34;PTN;DAAM2
prerank,protein phosphorylation (GO:0006468),-0.2795378267301135,-1.3353148627771054,0.0022026431718061676,0.41855611189093206,1.0,121/479,16.04%,PRKCH;TEK;ERG;FLT1;IGF1R;CDK6;MAP3K5;RPS6KA5;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;KDR;HIPK1;NLK;MAPK3;WNK1;PTK2;STK10;BMX;NEK7;RPS6KA3;CAMK2D;DAB2IP;SMAD7;MAP3K1;RICTOR;MAP3K20;FNIP2;TGFB1;MAPKAPK3;APP;TGFB2;FAM20A;MAP3K3;CSNK1G2;ADAM10;PRKCZ;PKD1;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;ABI3;BCR;TLR3;CSNK1G3;SRPK1;RIPK1;TRIB2;FLT4;STK25;PLK2;DYRK2;AKT1;INSR;GTF2H3;MAP3K11;CDC42BPB;VRK3;TRIB1;CSNK2B;STK32B;PIM3;LMTK2;WNT11;CAMK1;CDK4;ABL2;TAOK2;ULK3;RPS6KB2;FRK;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;TLR4;SYK;CSF1R;FASTK;USP15;RPS6KA2;CDKL4;ABI1;TBCK;NUAK1;CAD;NUAK2;MAST4;JAK2;EGFR;UHMK1;ERBB2;PRKAG1;COQ8A;LMTK3;LIMK1;CAB39;NEK3;PTPN6;STK38L;STK26;CDK13;CSNK2A1;CSNK2A2
prerank,negative regulation of innate immune response (GO:0045824),-0.4212724144035939,-1.3352257886908194,0.10831721470019343,0.4180051832985319,1.0,21/34,40.04%,NLRC5;RPS19;CNOT7;DHX58;YTHDF2;USP15;SAMHD1;TNFAIP3;TTLL12;FAM3A;PTPN2;MUL1;A2M;YTHDF3;NLRC3;LYAR;USP18;GRN;SUSD4;OAS3;CACTIN
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4486399233355133,-1.3352106144069331,0.11397058823529412,0.4173298295530047,1.0,11/25,22.33%,STMN2;SPEF1;TRPV4;CIB1;KATNB1;MAP1B;ARHGEF2;TPX2;MAP1A;APC2;CAMSAP3
prerank,organelle fission (GO:0048285),-0.45630528760280814,-1.3350646980238603,0.1233644859813084,0.41694712355127755,1.0,15/24,28.21%,DNM3;MIEF1;MTFR1;WASHC5;ACOT8;OPA1;DNM1;DNM2;FIS1;MTFR2;PEX11G;PEX11A;SEC16B;MFF;MUL1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4910391574463802,-1.3347077588400111,0.12099644128113879,0.417019419526902,1.0,9/18,14.52%,NOS3;NOTCH1;TGFBR2;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4632789946312612,-1.3343188887899202,0.10831721470019343,0.41721515944659965,1.0,8/22,11.93%,CALM1;HTT;ATP1B1;JPH2;AKAP6;GSTM2;VMP1;CALM3
prerank,positive regulation of cation channel activity (GO:2001259),-0.40151498172004785,-1.3342939834317635,0.08946322067594434,0.41655979807916454,1.0,14/40,25.04%,TMSB4X;SHANK3;CALM1;HTT;JPH2;AKAP6;GSTM2;CALM3;PKD2;KCNIP2;CTSS;CCL2;CASQ1;ATPSCKMT
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5178058661790714,-1.3337023152679481,0.13595706618962433,0.41723083014566803,1.0,7/15,15.81%,TMSB4X;THBS1;NOTCH1;FGF1;HSPB1;FGF2;MET
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5010267197637691,1.333653438371682,0.1393939393939394,0.5501191469793177,1.0,2/17,1.65%,CAMK1D;DAPK2
prerank,glycolytic process (GO:0006096),-0.42853140502203796,-1.3331117935234893,0.12037037037037036,0.4178161851066723,1.0,11/28,23.22%,GPI;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4823976998728098,-1.3330513240920658,0.1254681647940075,0.41722063559774114,1.0,4/18,6.15%,CTNNA1;MFHAS1;CHP1;UFM1
prerank,mitochondrion organization (GO:0007005),-0.3141118203966252,-1.3330455543387918,0.037578288100208766,0.4165064836128546,1.0,51/165,20.81%,DNM3;CXADR;NOS3;VPS13D;TRAK1;CAV2;MEF2A;ATP5F1D;PPARGC1A;MIEF1;TMEM70;CHCHD2;ATP5F1B;HCFC1;TRAK2;BAX;CHCHD3;RHOT1;IMMP2L;ESRRA;HSPD1;MIEF2;GABPA;RHOT2;TIMM17A;BCL2L1;AGTPBP1;MTFR1;HIGD2A;TOMM22;CHCHD4;PHB2;BCAP31;BNIP3L;MTM1;CHCHD10;NIPSNAP2;ADCK1;OPA1;TIMM13;DNM1;HSD17B10;SLC25A33;RAB32;BIK;PTCD2;HIGD1A;DNM2;TOMM5;HIGD1B;TIMM50
prerank,cardiac muscle contraction (GO:0060048),0.42392099615253803,1.3318247981727638,0.11479028697571744,0.5530673142198866,1.0,6/34,4.22%,ATP1A2;SLC8A1;SCN3B;TNNC1;CSRP3;TNNI3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4749436038658277,-1.330343413321165,0.14028776978417265,0.4221211233367728,1.0,11/17,34.05%,COX4I1;COX7C;COX6B1;COX15;COX6C;NDUFA4;COX10;COX8A;COX4I2;COX7A2L;COX5B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5683667401875042,1.3292898496822014,0.17713004484304934,0.5581044585175402,1.0,3/10,5.49%,HECW2;ATP1A2;HECW1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.38973258261282906,-1.329251798030719,0.0888030888030888,0.4240304971027826,1.0,18/48,20.46%,HIPK1;FNIP2;CRIP1;PRKDC;TNFRSF1B;BAX;DYRK2;RPS27L;BCL2L1;E2F1;BAK1;TMEM109;AEN;EPHA2;PHLDA3;DDIT4;MCL1;SFN
prerank,basement membrane organization (GO:0071711),0.5259815003388695,1.3291592934642094,0.16363636363636364,0.5567071363204019,1.0,3/14,2.52%,FLRT2;NID2;NID1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4514091894824403,-1.3282010597463105,0.11194029850746269,0.42588020265878634,1.0,10/24,24.95%,MTR;TXN2;CDO1;MSRA;SMS;CTH;ADI1;GCLC;AHCY;MTRR
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4787798339346668,1.3280250537756562,0.148068669527897,0.5580490381640489,1.0,6/20,10.58%,GRK3;CRY1;GPRASP1;BICD1;MGRN1;APLP1
prerank,positive regulation of defense response (GO:0031349),-0.34420476948543116,-1.3278351666096688,0.03406813627254509,0.42595170767825835,1.0,21/89,18.87%,MEF2C;IL15;NFKBIA;ETS1;GBP5;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;AKIRIN2;IL17RA;SLC15A4;NINJ1;PTGER4
prerank,negative regulation of programmed cell death (GO:0043069),-0.28563126350356666,-1.3272856646438285,0.019867549668874173,0.42661127898912027,1.0,114/355,22.70%,MECOM;LEF1;TEK;IGF1R;THBS1;TPT1;TAX1BP1;PTK2B;NFKBIA;KDR;FOXO1;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;ARHGDIA;UBB;ADAM10;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;DCPS;PRKDC;HSPB1;ANXA4;RIPK1;FLT4;PLK2;AKT1;GLO1;KANK2;DNAJA1;FAS;PIM3;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;HSPA5;PSMC5;HTATIP2;CIB1;RAB7A;GRK5;SERPINB9;YWHAZ;BCL2L1;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;HNRNPK;OPN3;GPX4;HYPK;MET;OPA1;GREM1;HSPA1A;RELA;XBP1;BABAM2;HCK;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;LAPTM5;MCL1;HIGD1A;TMBIM6;THOC6;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,iron ion transmembrane transport (GO:0034755),-0.5614882088569937,-1.3264078023154604,0.13114754098360656,0.4280046958614124,1.0,6/10,35.33%,SLC39A8;SLC40A1;SLC25A28;ABCB6;SLC11A2;ABCB7
prerank,anterior/posterior pattern specification (GO:0009952),0.38252985186795124,1.3262476626623503,0.08888888888888889,0.5610698724548295,1.0,11/53,9.94%,BMP2;WLS;HOXC4;HOXB3;HOXC5;HES3;HOXC9;TGFBR1;HES5;HOXB9;HOXC6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.33778539358941956,-1.3260497565945908,0.04780114722753346,0.4281660324605202,1.0,34/104,19.47%,CRIM1;CAV1;BMPER;NOTCH1;TGFBR2;BMPR2;CCN3;SMAD9;SMAD7;ZBTB7A;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;ASPN;IL17RD;HTRA3;HTRA4;SKIL;ACVR1;SMURF1;EID2;SMAD4;GREM1;HSPA1A;SMAD2;SPRY1;SKI;BMPR1B;PIN1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5654835419341958,1.3259411069066207,0.15575620767494355,0.5601525138103134,1.0,6/11,16.51%,PARP16;PARP11;PARP12;TIPARP;PARP4;PARP3
prerank,sphingolipid catabolic process (GO:0030149),-0.503574459542417,-1.325592130006074,0.13051470588235295,0.42855119153598226,1.0,5/15,12.89%,ACER2;ASAH2;SMPDL3A;SGPL1;ACER3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5385685439608472,1.325256861147412,0.1776765375854214,0.5603816637330931,1.0,4/13,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,regulation of T cell chemotaxis (GO:0010819),-0.5486406315059382,-1.324975968340193,0.13848920863309352,0.4293129064124198,1.0,2/11,4.91%,WNK1;ADAM10
prerank,negative regulation of cyclase activity (GO:0031280),0.5274373901020768,1.3242607061995104,0.18202764976958524,0.5612709822253908,1.0,4/14,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3342794828973234,-1.3241385386350433,0.05533596837944664,0.43059509891182185,1.0,33/101,17.09%,THBS1;VIM;RPL26;NFKBIA;KLF4;EEF2;NIBAN1;RPS4X;TGFB1;MSN;EZR;PRKDC;CASP8;AKT1;PERP;PTTG1IP;ATG7;RPS27L;EIF3D;INHBA;LARP4B;CIRBP;UPF3A;SOX4;BAK1;FMR1;VPS11;ERBB2;NR1H2;HSP90AA1;IST1;PCIF1;BAD
prerank,response to unfolded protein (GO:0006986),-0.3808899993032483,-1.323932388802118,0.10039370078740158,0.430356914419921,1.0,21/48,22.97%,DAB2IP;HSP90AB1;HSPA8;RHBDD1;HSPB1;BAX;DNAJA1;HSPD1;HSPA5;BAK1;ERP44;HSPA4;HSPB8;HSP90AA1;HSPA1A;HSPA9;HSPE1;TMBIM6;HSPA1B;DNAJB1;PTPN1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5403640929064658,-1.323531354523505,0.14100185528756956,0.4305439302053273,1.0,11/11,46.01%,CYC1;UQCRQ;UQCRB;UQCR11;UQCRH;UQCC3;UQCRFS1;UQCRC1;UQCRC2;CYCS;UQCR10
prerank,positive regulation of neutrophil migration (GO:1902624),0.4895069751492219,1.3235173416832717,0.14489795918367346,0.5615257658409142,1.0,2/18,1.65%,CAMK1D;DAPK2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5056839294192936,1.3234498224318494,0.16481069042316257,0.5600364973721284,1.0,6/16,9.81%,IGF1;TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.44406934830785266,-1.3228732958409497,0.12156862745098039,0.4314132383026126,1.0,11/26,19.97%,EEF1A1;IQGAP1;DAB2IP;PDE8A;DUSP3;PTPN12;EGFR;ERBB2;ZPR1;SOX9;KNSTRN
prerank,endothelial cell migration (GO:0043542),-0.40134764339981044,-1.3228091226795355,0.08620689655172414,0.4308079190848559,1.0,16/37,16.32%,NOS3;ID1;DPP4;PXN;STARD13;CCN3;FAP;CYP1B1;VEGFA;GIPC1;SOX18;EMP2;PLXND1;FSTL1;PIK3CA;STAT1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.541799032598102,1.3222454808126871,0.17687074829931973,0.5615768543025639,1.0,10/12,28.14%,PARP16;PARP11;PARP12;TIPARP;PARP3;PARP1;TNKS;PARP8;TNKS2;PARP6
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.47378081940252903,-1.3218756798830635,0.13134851138353765,0.43234678489186545,1.0,10/19,15.01%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL;SMAD6;ACVR1;SOX4;HEY1;SMAD4
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5515365798892305,-1.321445481056811,0.152014652014652,0.4327159299683097,1.0,9/11,39.87%,SCARB1;MFSD2A;NR1H2;CNEP1R1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,positive regulation of biosynthetic process (GO:0009891),0.399136177081193,1.3205400000091914,0.11594202898550725,0.5645683933457517,1.0,6/40,3.98%,WNT4;ZBTB20;PPARA;SLC5A3;LARP6;CREB3L1
prerank,positive regulation of GTPase activity (GO:0043547),-0.30806483959276043,-1.3202376381010585,0.02145922746781116,0.4348806136682548,1.0,49/188,15.69%,DOCK9;PKP4;ITGA6;ARHGAP42;RAP1A;NET1;RACK1;SIPA1L1;TGM2;AGRN;F11R;CAV2;SGSM2;RALGAPA2;RAPGEF1;TBC1D8;ARHGAP27;ARHGEF15;GRTP1;FERMT2;BCAS3;LIMS1;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;CCL15;S100A10;SIPA1L3;ZC3H15;WNT11;GMIP;NF1;ABR;TBC1D9B;ARHGEF5;TBCK;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;EPHA2;BCAR3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.336701317676428,-1.3192125421647807,0.04329896907216495,0.4366160053330605,1.0,48/96,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,regulation of protein modification process (GO:0031399),-0.38103255353738436,-1.3190827022454896,0.10980392156862745,0.43621199380082826,1.0,20/50,24.65%,FN1;PTK2;PPP1R16B;FNIP2;HSPB1;NDUFS4;WARS1;ATG7;HPF1;ABCA2;CCAR2;PPP1R16A;PIN1;ROPN1L;CDH5;CADM4;SESN2;PPIB;SPRED3;CCDC88A
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3821230256496977,-1.3185629179864322,0.0933852140077821,0.4359730359543531,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3821230256496977,-1.3185629179864322,0.0933852140077821,0.4359730359543531,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4567987189978102,-1.318173349345077,0.1200750469043152,0.4353912912719848,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4567987189978102,-1.318173349345077,0.1200750469043152,0.4353912912719848,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,negative regulation of apoptotic process (GO:0043066),-0.2779204977961168,-1.317925984778479,0.009111617312072893,0.4353003536147784,1.0,138/444,22.70%,PRKCH;LEF1;TEK;MEF2C;CAV1;IGF1R;THBS1;TPT1;NOTCH1;TAX1BP1;PTK2B;MAP2K5;NFKBIA;KDR;FOXO1;KLF4;MAPK3;TFRC;PTK2;TBX1;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;SIX1;ARHGDIA;UBB;NR4A2;ADAM10;PPARGC1A;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;TGFB3;PRKDC;HSPB1;TOX3;ANXA4;RIPK1;FOXQ1;FLT4;GPX1;PLK2;FZD3;AKT1;GLO1;ASAH2;DNAJA1;FAS;PIM3;RB1;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;MAEA;HSPA5;SFPQ;HTATIP2;BEX3;CIB1;GRK5;SERPINB9;YWHAZ;BCL2L1;APOE;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;PIK3CA;HNRNPK;OPN3;CLCF1;HYPK;CX3CR1;CSNK2A1;CSNK2A2;OPA1;GREM1;IGBP1;HSPA1A;RELA;XBP1;BABAM2;HCK;AGAP2;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;PTRH2;MCL1;HIGD1A;TMBIM6;SFN;THOC6;HCLS1;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4182997315707875,1.3171739297011344,0.1271186440677966,0.571990379838962,1.0,7/33,10.34%,IGF1;PIK3R1;MYO16;SIRT2;ERBB3;GATA3;PTEN
prerank,calcium ion transport (GO:0006816),0.334122741916671,1.3170890867697158,0.07003891050583658,0.5704151142614651,1.0,23/113,9.64%,NALCN;SLC24A3;SLC8A1;CACNA1E;CYP27B1;ITPR1;SLC24A5;ANK2;GRIN3A;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;ORAI2;CACNA1I;TRPM5;TRPA1;CACNA1G;CACNB2;SLC24A4;SLC24A2;CHRNA4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5431928931163829,-1.3169330950227243,0.1391304347826087,0.43701690317494585,1.0,5/11,24.57%,ITM2A;BACE2;ABCA2;NECAB3;NECAB2
prerank,regulation of NMDA receptor activity (GO:2000310),0.4235834881202356,1.3163605984212896,0.13090128755364808,0.5707674842562888,1.0,13/32,14.40%,SLC6A9;GRIA4;DLG2;DAPK1;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,regulation of viral genome replication (GO:0045069),-0.3696908851461366,-1.3162779434242182,0.08349514563106795,0.4379818801194474,1.0,15/56,16.17%,IFIH1;ADAR;PPIA;CNOT7;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;STAU1;MAVS;NR5A2;OAS2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4599383911656882,-1.3159721348439208,0.13200723327305605,0.43800053488902213,1.0,6/20,18.22%,CDK6;PTK2B;ZBTB16;CIB1;LDB1;HSPA9
prerank,inorganic cation transmembrane transport (GO:0098662),0.2979820807010609,1.3159046941258778,0.03207547169811321,0.5702534103558148,1.0,40/268,10.31%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ATP6V0A4;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SLC24A5;SCN3B;SLC30A10;ABCB8;TRPM3;P2RX4;ATP2A2;TRPM1;CCDC51;SCN3A;SLC39A6;SLC36A2;KCND2;SLC9A7;TRPM5;KCNJ16;TRPA1;ASIC2;SCN2A;CACNA1G;KCND1;SLC24A4;SLC24A2;SLC41A1;SLC6A11;SLC6A1;DMAC2L;ATP6V1H;KCNJ14
prerank,positive regulation of protein secretion (GO:0050714),0.3603481900835113,1.3158575780870607,0.10559006211180125,0.5686676630721725,1.0,4/69,0.72%,IGF1;BMP6;TCF7L2;WLS
prerank,filopodium assembly (GO:0046847),-0.49128867275387433,-1.3154075056323036,0.11754068716094032,0.43861918561699087,1.0,6/16,10.18%,FGD5;DNM3;FGD6;EZR;SPATA13;SPEF1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32636876709925705,1.3153421952345028,0.06134969325153374,0.568246816839888,1.0,18/129,8.55%,RNF220;LGR4;LRRK1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;TBL1XR1;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4355622412670463,-1.315135203210363,0.1218568665377176,0.43853688887333575,1.0,8/26,15.84%,FOXP1;NCOR1;ZBTB7A;HEYL;KANK2;SMARCA4;VPS11;STRN3
prerank,regulation of cellular component size (GO:0032535),-0.4249003377200321,-1.3151057951998284,0.115234375,0.43788498040811896,1.0,15/30,32.66%,EPS8;RIN3;MSN;RAC1;EZR;AP2M1;PPP1CA;PEX11G;PEX11A;RPTOR;RDX;LAMTOR5;ATP13A2;RAB3B;VAV3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3385578898794122,1.3148353072237167,0.0642570281124498,0.5678678478810905,1.0,15/117,8.39%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R
prerank,positive regulation of kinase activity (GO:0033674),0.33589709583196864,1.3144700778677285,0.07543520309477757,0.5671548578766143,1.0,31/107,13.80%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PRKAG2;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;SNX9;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;DAXX;MAPT
prerank,response to muramyl dipeptide (GO:0032495),-0.5440909077380344,-1.314064176993079,0.12825278810408922,0.4397832718380435,1.0,5/12,22.08%,VIM;NOD1;NOD2;ARHGEF2;PTPN22
prerank,cardiac conduction system development (GO:0003161),0.4659598645152062,1.3140520506444913,0.15879828326180256,0.5666393915728904,1.0,6/24,12.22%,GJB6;GJA1;TBX18;CACNA1G;BMPR1A;MAML1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5759173811726394,-1.3139204772080784,0.16074766355140188,0.439416405289207,1.0,3/10,10.73%,CD81;FCER1G;CD74
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3308372417480922,-1.3135088569917315,0.06326530612244897,0.4397020526931037,1.0,31/108,14.41%,MAP3K5;ACER2;NOD1;RACK1;ARL6IP5;F3;EGLN3;RPS3;NGF;CRADD;REST;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;PPM1F;BAX;NDUFA13;CTSD;SOX7;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3;SYK;BCAP31;JAK2
prerank,negative regulation of cellular process (GO:0048523),-0.2704680091281297,-1.3125346959817266,0.004464285714285714,0.4413751134040748,1.0,116/521,15.01%,ZBTB7C;PODXL;PTPN14;PPP1R13B;CDK6;ITGA1;APBB2;JAM2;CTTNBP2NL;IGFBP7;NOS3;PTPRJ;CD34;SERTAD2;IGFBP6;NOTCH1;CBFA2T3;OSGIN2;RACK1;PTK2B;BMPR2;SH3BP4;KLF4;FHL1;CCN3;TBX1;ETS1;SOX17;DAB2IP;FERMT2;SLIT2;NPR1;NGF;ADAM15;CDKN1B;TGFB1;LPCAT3;REST;APP;TGFB2;RNF41;COL18A1;PLXNA4;ARHGDIA;TES;PLPP1;ADAM10;CYP1B1;ING5;ARHGDIB;CTBP1;IGFBP3;TGFBI;DYSF;SMAD6;CNOT7;AQP11;PPP2R1A;WNT9A;NOTCH4;IFITM1;ACTN1;PDE8A;TGFB3;TNFRSF21;CD9;TNFRSF1B;RGCC;DUS2;ADGRG1;SRSF6;NDUFA13;BCL6;SIPA1;KANK2;SOX7;WARS1;CSNK2B;RB1;WFDC1;SPEF1;RHOB;WNT11;MYBL1;PLXNA1;PLXND1;DIS3L2;INHBA;CCDC85B;GAS8;CRLF3;FRK;IMPACT;CIB1;FTH1;TMEM115;CDK10;SOX4;CCN5;FGF2;SPHK2;RPS6KA2;ABI1;HRAS;TMEM109;P3H2;SMARCA4;NDUFS3;CDKN2AIP;JAK2;BNIP3L;RAD18;SMYD2;STRN;OSGIN1;SMAD4
prerank,intestinal absorption (GO:0050892),-0.5220570407456262,-1.3121687623279914,0.14821763602251406,0.4415969567154705,1.0,3/13,5.13%,F11R;TJP2;KCNQ1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4896898927255523,1.312104758372837,0.15090090090090091,0.5703286872282936,1.0,5/19,7.87%,ENPP1;TPST1;SLC26A1;SULT6B1;PAPSS1
prerank,regulation of developmental growth (GO:0048638),0.42392224855051125,1.311981070625252,0.1328976034858388,0.5689773364207225,1.0,7/29,10.83%,IGF1;STAT5B;OLFM1;GHR;SIX4;NRCAM;MUSK
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.43934140632954966,-1.311868849837257,0.12199630314232902,0.4416299678198267,1.0,8/24,15.22%,PTK2B;UBB;PKD1;CTSC;GPX1;PSMD14;APOE;ATP5IF1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4008378005028827,-1.3099163856057743,0.1227364185110664,0.4455956981283668,1.0,14/35,17.48%,TEK;ESAM;BAIAP2L1;PTK2B;F11R;ARHGDIA;BCAS3;ARHGDIB;ABI3;ABL2;CSF1R;HRAS;RAPGEF3;HCK
prerank,positive regulation of cell killing (GO:0031343),-0.5133640800638934,-1.3097831104584796,0.1492007104795737,0.445239706003935,1.0,5/13,30.84%,RAC1;FZD7;SYK;NOX1;NOS2
prerank,synaptic vesicle cycle (GO:0099504),0.4294834197646028,1.3095296118893267,0.1308016877637131,0.5736668459307994,1.0,9/30,16.13%,RIMS1;SYNDIG1;CPLX2;SNAP25;OTOF;NLGN1;BRSK1;SNAPIN;PLD2
prerank,translational elongation (GO:0006414),-0.33436635091256955,-1.3090415915316993,0.07539682539682539,0.4462138173343183,1.0,39/101,25.95%,EEF1A1;RACK1;EEF2;MRPL52;PTCD3;EEF1D;EEFSEC;MRPL51;MRPL38;MRPL28;EEF1B2;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;LTN1;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.36669840760099426,-1.3088303903783058,0.1015625,0.44602452218586225,1.0,17/57,17.57%,MAP3K5;NOD1;ARL6IP5;REST;TNFSF10;CASP8;PPM1F;PERP;NDUFA13;CTSD;SOX7;BAK1;SYK;AIM2;BCAP31;BAD;FOXL2
prerank,negative regulation of viral transcription (GO:0032897),-0.5255989792872311,-1.3070909148422578,0.14312267657992564,0.44942744192859413,1.0,4/13,12.16%,MID2;IFITM3;TRIM14;TRIM62
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.42196420565115067,-1.306695992066809,0.12596899224806202,0.4497519199180181,1.0,19/29,42.79%,HSP90AB1;NLRC5;CNOT7;YTHDF2;MAVS;SAMHD1;PTPN6;TTLL12;PTPN1;PTPN2;MUL1;YTHDF3;USP18;IFNAR2;CDC37;OAS3;CACTIN;STAT2;ZBP1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.48712869366325645,-1.3064447759279363,0.1619718309859155,0.44963705414296284,1.0,4/16,24.19%,CLDN5;CLDN11;CLDN10;CLDN1
prerank,DNA replication initiation (GO:0006270),0.40635963711975315,1.3062704782978318,0.1154639175257732,0.5804745262865596,1.0,14/37,23.13%,MCM3;ORC4;RPA2;MCM2;MCM8;ORC1;POLE4;RPA1;ORC3;ORC5;CDC7;PRIM1;PRIM2;MCM7
prerank,cellular response to growth factor stimulus (GO:0071363),-0.30855649967594534,-1.3059884935111055,0.05052631578947368,0.4500061250708502,1.0,33/151,8.42%,MEF2C;FLT1;SEMA6A;RAP1A;EEF1A1;NOTCH1;TGFBR2;RACK1;BMPR2;MAP2K5;KDR;KLF4;MT1G;IQGAP1;RAMP2;RAPGEF1;TBX1;SMAD9;ANXA1;DAB2IP;SMAD7;CD44;TGFB1;PDE2A;LIMS1;VEGFA;SHC1;PDE8A;NR3C1;HSPB1;FLT4;STMN2;AKT1
prerank,Rap protein signal transduction (GO:0032486),-0.5588461441219542,-1.3057830995074384,0.17005545286506468,0.44977556929015694,1.0,4/10,8.12%,RAP1A;RAP1B;RAPGEF1;PLK2
prerank,regulation of protein kinase B signaling (GO:0051896),0.3081453076979212,1.3055119240735675,0.05156537753222836,0.5808371502005798,1.0,36/193,10.34%,TCF7L2;PIK3R1;AREG;NTRK3;FGFR2;SEMA5A;NRG1;MAGI2;KL;PPARA;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;RRAS;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4;PTEN
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5207136279236708,1.3052104961810915,0.1724137931034483,0.5799496005875463,1.0,1/13,0.08%,IGF1
prerank,negative regulation of receptor binding (GO:1900121),-0.5554792983437751,-1.305036083348189,0.14210526315789473,0.450869031213203,1.0,3/10,6.17%,B2M;ADAM15;ATP2A3
prerank,vasculogenesis (GO:0001570),-0.4147614669771832,-1.3049597946304936,0.12934362934362933,0.45031943608295366,1.0,9/32,5.68%,CAV1;NOTCH1;TGFBR2;RASIP1;KDR;RAMP2;SOX17;TGFB1;VEGFA
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3179976291690838,1.304626633596145,0.04208416833667335,0.5797937130526373,1.0,27/150,8.95%,ENPP1;PPM1E;ERRFI1;PID1;PTPN13;LDLRAD4;NTRK3;FBLN1;PRKAG2;PDPK1;DEPTOR;LYN;SFRP1;GPD1L;PMEPA1;PRKN;CEP85;GSTP1;NLRP12;PLPP3;SIRT2;IBTK;MEN1;CEP43;TRIM27;NLRP2B;PPP1R15B
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2750855701253503,-1.304499845227329,0.004273504273504274,0.45075815404092195,1.0,108/420,18.68%,ARHGAP31;TEK;CHN2;VWF;SGMS1;PPP1R13B;TMSB4X;MCF2L;ARHGEF3;NET1;PLCG2;RHOJ;FGF1;PIP5K1B;OPHN1;RASGRF2;NFKBIA;ARAP3;HIPK1;STARD13;ARHGAP23;MAPK3;STARD8;ARHGAP17;ARHGAP26;PPP1R16B;DAB2IP;RICTOR;PHF20;TMBIM4;ARAP2;RPL11;RNF41;ARHGAP1;ARHGDIA;TRIO;PDE2A;RAC1;CMKLR1;ING5;ARHGDIB;MINK1;CHN1;MOB3B;CRK;VEGFA;ARHGAP25;SOS2;TAOK3;EZR;PRKAR2B;MYOC;USP7;RASSF2;BCR;HSPB1;RAD1;DYRK2;AKT1;NOP2;ITSN1;PIP4P1;RHOT1;MAPKAP1;CSNK2B;MTA2;RHOB;PREX1;RHOT2;MBD3;TAOK2;GMIP;AKAP6;ULK4;ABR;SPHK2;TRAF1;ARHGEF5;TBCK;FBXL2;NUAK1;ARHGEF18;SLC15A2;RAD9B;SMYD2;EGFR;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;UFL1;SLC15A4;PIK3R2;RBBP4;RAD17;DDIT4;PRKAR2A;RELA;ARHGEF12;ARHGEF17;L3MBTL1;CHD4;ARHGEF4;ARHGEF2;ECT2;CHEK1
prerank,renal absorption (GO:0070293),-0.5573591188678532,-1.3043350122122948,0.1563573883161512,0.45045125733039,1.0,6/10,35.98%,KCNQ1;KLHL3;SLC15A2;HAS2;HYAL2;WNK4
prerank,regulation of secretion (GO:0051046),0.5256237514240935,1.3042671407187811,0.17002237136465326,0.5791748765525983,1.0,4/13,8.26%,NRG1;OPRK1;SCIN;ERBB3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.49398063949195226,-1.304098069276576,0.15129151291512916,0.45042215309877487,1.0,13/16,34.99%,DDX5;DDX17;SRSF6;DHX9;SFPQ;CDK13;RBM17;SRSF9;PQBP1;SRSF1;RSRC1;HNRNPM;PUF60
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.33606013395907447,-1.3040937382455902,0.05625,0.4497112781194877,1.0,18/91,7.01%,ABCG2;SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;ATOX1;TFRC;MT2A;APP;SLC39A8;SLC40A1;ATP6V0A2;FTL
prerank,positive regulation of histone acetylation (GO:0035066),-0.44541985675092977,-1.303889518763896,0.15254237288135594,0.4494419828681185,1.0,7/23,15.01%,RPS6KA5;MAPK3;PPARGC1A;TADA2B;WBP2;SPHK2;SMAD4
prerank,regulation of stem cell proliferation (GO:0072091),0.4923309777849493,1.303884951190005,0.16702819956616052,0.5785095202500066,1.0,2/17,1.53%,FBLN1;GJA1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4039734910245658,1.3035854976053767,0.12691466083150985,0.5777172150140422,1.0,11/40,12.50%,ARHGAP6;LPAR1;NTRK3;KIT;PDGFRA;GPR55;PDGFRB;ANG;GNA15;ITK;FGFR1
prerank,phospholipid biosynthetic process (GO:0008654),-0.39924304704289487,-1.3034639517192586,0.10849909584086799,0.44972455687866325,1.0,13/36,27.46%,SGMS1;SGMS2;SPHK2;FAR1;MBOAT1;PCYT2;AGPAT5;NUS1;CPNE3;FDPS;DHDDS;IDI1;PIP5K1A
prerank,organic acid transport (GO:0015849),0.33994237805774397,1.3032116348102527,0.07188160676532769,0.5771475119428142,1.0,21/94,11.56%,SLC7A11;SLC13A3;SLC6A12;SLC43A1;SLC7A2;SLC6A13;NCOA2;SFXN5;ABCC2;ACSL1;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A10;NCOA1;SLC10A1;SLC25A47;SLC1A5;SLC38A3;SLC46A1
prerank,regulation of response to external stimulus (GO:0032101),-0.3207674645662903,-1.302898947958246,0.03556485355648536,0.45043152286789645,1.0,31/121,18.30%,FOXP1;CAV1;TMSB4X;SEMA7A;CD55;CYRIB;ANXA1;MGLL;CALM1;IL1R1;BRD4;GATA6;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;SAMHD1;BCL6B;JAK2;TRIM5;NOD2;UFL1;RELA;HCK;DAGLB
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.43697152999947003,-1.3027838516641497,0.13092979127134724,0.4499834857741747,1.0,13/28,21.44%,PTK2;DAB2IP;CTSC;DDRGK1;PSMC5;FMR1;SMURF1;ATP5IF1;CDK5RAP3;OSBPL7;LAPTM5;CCDC22;PSMC3
prerank,regulation of protein localization to membrane (GO:1905475),0.43227923139822005,1.3021503304014592,0.13983050847457626,0.5782593317657341,1.0,8/28,10.06%,GPC6;AR;SLC5A3;GPC4;GPC2;PRKN;STX7;GPC5
prerank,phospholipid translocation (GO:0045332),-0.42518599396622536,-1.3021376304378056,0.1294559099437148,0.45092956543451285,1.0,8/28,8.51%,ANO6;ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;MFSD2A;ATP9B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5080025212236648,1.3017630525639021,0.16744186046511628,0.5776795352986815,1.0,2/15,5.39%,IGF1;PRKN
prerank,gastrulation (GO:0007369),-0.4980216138618081,-1.301583218273446,0.15254237288135594,0.4514385899052822,1.0,5/15,24.80%,GPC3;LRP5;TASOR;SMAD2;MKKS
prerank,sprouting angiogenesis (GO:0002040),0.38288949249595755,1.3014643628847067,0.10557768924302789,0.5768491682599042,1.0,6/51,2.72%,CCBE1;ROBO1;NRP1;SEMA5A;RECK;VEGFB
prerank,heart process (GO:0003015),0.5119904492363202,1.3014469709847238,0.1782608695652174,0.5752804924027243,1.0,3/14,4.22%,SGCZ;SGCD;TNNI3
prerank,regulation of defense response to virus by host (GO:0050691),-0.4209548592334155,-1.3012728825603976,0.10408921933085502,0.4514604580066374,1.0,17/30,31.99%,DHX9;ZDHHC1;MAVS;AIM2;TNFAIP3;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;IFNLR1;MUL1;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,ceramide catabolic process (GO:0046514),-0.5106820092438371,-1.3009224165064635,0.1574074074074074,0.45158101423956976,1.0,8/14,26.89%,ACER2;HEXA;ASAH2;ACER3;NEU3;NEU1;NEU2;NAGA
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4786041861179309,-1.3002247951996149,0.15145985401459855,0.4525509677599716,1.0,7/18,26.19%,JAM2;SLC39A8;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3534294533029282,-1.2998962948403876,0.07414829659318638,0.45263007028825597,1.0,20/70,14.41%,HIPK1;DAB2IP;NGF;CRADD;TGFB1;TGFB2;RNF41;GABARAP;CASP8;TLR3;TNFRSF1B;RIPK1;BAX;FAS;INHBA;CIB1;BCL2L1;BAK1;TNFRSF1A;JAK2
prerank,regulation of cellular pH (GO:0030641),-0.4233801962755752,-1.2995784541818522,0.12,0.4527232243320269,1.0,12/29,28.71%,SLC4A10;SLC9A2;CHP1;ATP5F1B;SLC4A8;SLC4A2;SLC9B1;ATP6AP1;SLC9A5;SLC9A4;SLC4A3;SLC26A6
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.33310354200207276,-1.2993730033109498,0.07878787878787878,0.4524966779783223,1.0,27/95,16.82%,RAB11A;DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;CEP162;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;CC2D2A;HAUS1;NDE1;CETN2;CEP72;KIF24;YWHAG;HSP90AA1;CEP41;TMEM67
prerank,limb development (GO:0060173),0.4320456892932057,1.299150725820382,0.15367965367965367,0.5798207830869148,1.0,6/28,6.38%,SALL1;CHD7;LRP4;GLI3;ZNRF3;IFT122
prerank,programmed necrotic cell death (GO:0097300),-0.47239499790052764,-1.298278767864027,0.15439856373429084,0.4545299701064077,1.0,7/18,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,cell junction assembly (GO:0034329),-0.32610128177362485,-1.2980547759149574,0.06172839506172839,0.45433690621511685,1.0,15/100,4.86%,FN1;PKP4;ACTB;SHANK3;DNM3;ITGA6;CLDN5;LIMS2;CDH1;SPOCK2;ACTG1;OPHN1;FERMT2;SDK1;LIMS1
prerank,acylglycerol metabolic process (GO:0006639),-0.4002128325182641,-1.298037151456261,0.09883720930232558,0.45368264127059793,1.0,8/37,12.33%,ABHD2;CAV1;DGKH;SEL1L;MGLL;PNPLA2;PLAAT3;APOE
prerank,regulation of Rac protein signal transduction (GO:0035020),0.49038749249454533,1.2971111166905276,0.14042553191489363,0.5837622914721721,1.0,2/16,6.54%,AUTS2;ARHGAP24
prerank,positive regulation of chemokine production (GO:0032722),-0.3793885706592235,-1.2962698142267453,0.09266409266409266,0.4572103103354876,1.0,11/44,15.55%,APP;IL33;TLR3;TWIST1;TIRAP;CD74;MAVS;TLR4;SYK;CSF1R;IL17RA
prerank,muscle cell development (GO:0055001),0.42255910360152504,1.2960843404023803,0.1300639658848614,0.5848323520724282,1.0,6/30,3.63%,IGF1;SGCZ;SLC8A1;EFEMP2;ANK2;MEGF10
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5582747738897325,-1.2957242801106812,0.1761467889908257,0.4578143527138633,1.0,1/10,0.35%,CAV1
prerank,TOR signaling (GO:0031929),-0.4279665360850722,-1.2955165890225295,0.13255360623781676,0.45766339065931055,1.0,14/26,30.71%,RICTOR;PRR5L;AKT1;MAPKAP1;RPS6KB2;RPS6;EIF4EBP1;MEAK7;SMG1;CCDC88A;RPTOR;CARD11;RPS6KB1;RHEBL1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5301580715003671,-1.2954518405103044,0.1702127659574468,0.4571210108322262,1.0,4/12,17.16%,NOTCH1;CCN3;HDAC4;XBP1
prerank,regulation of filopodium assembly (GO:0051489),0.4004972196037355,1.2953164761707368,0.13016528925619836,0.5853031220409712,1.0,7/38,7.71%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,regulation of cell cycle (GO:0051726),-0.28496787924625866,-1.2950910642865212,0.0205761316872428,0.4572588668065823,1.0,81/271,21.50%,MECOM;PPP1R13B;CDK6;APBB2;AFAP1L2;THBS1;TTC28;NOTCH1;RACK1;JUND;CDC14A;IQGAP1;FAP;NEK7;DAB2IP;MAP3K20;HSP90AB1;CDKN1B;RPRD1B;TGFB1;TGFB2;RPL23;RPS15A;ADAM10;PKD1;CTBP1;RARA;GATA6;HCFC1;RGCC;RASSF1;PLAGL1;SIPA1;ASAH2;PIM3;RB1;JUNB;PHACTR4;RHOB;PES1;INHBA;MAEA;CDK4;CRLF3;GADD45G;GRK5;CDK10;CDC14B;RPS6KA2;HRAS;DHCR24;RNF20;SDCBP;GAS2L1;UHMK1;MADD;CDKN1A;CSNK2A1;CSNK2A2;LIN54;RBBP4;ANKRD17;FBXL3;TSC2;CDKN2C;L3MBTL1;MAPK12;CHEK1;CDK5RAP3;GADD45A;TTLL12;CCND1;SRA1;SOX9;TSPYL2;PTPRK;WDR12;FGF10;ZBTB49;TBRG4;PKD2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.49490725801038715,-1.2949901086969742,0.13670411985018727,0.45674692487005814,1.0,8/15,30.79%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4635724628465536,-1.2948887791003885,0.16883116883116883,0.4563191338429694,1.0,12/19,35.15%,CHP1;CENPJ;DKC1;CCT2;CCT3;CCT8;CCT7;TREM2;PTP4A3;WRAP53;CCT4;CCT6A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35016228906674796,1.2942609982623423,0.100990099009901,0.5864970105367454,1.0,13/77,7.95%,IGF1;TCF7L2;AR;BCL2;SH3RF1;PHIP;CFLAR;IL4;PRKN;GSTP1;SCG2;MAPK8IP2;TGFBR1
prerank,gland development (GO:0048732),0.3659937376295664,1.2940083990615172,0.10330578512396695,0.5854439684094899,1.0,11/59,7.95%,TGFBR3;WNT4;SALL1;TBX3;FGFR2;NRG1;GLI2;DKK3;SOX2;CITED2;TGFBR1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.38720576472387136,-1.2939903221119,0.11287128712871287,0.4577330694031205,1.0,24/43,32.38%,BRCC3;TAOK3;FOXN3;UIMC1;PABIR1;BABAM1;TAOK2;CDC14B;HUS1;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;INTS3;CDK1;CDC6;TICRR
prerank,hyaluronan catabolic process (GO:0030214),0.4817454233350805,1.2937896745810071,0.15560640732265446,0.5844174305608665,1.0,3/18,1.32%,CEMIP;SPAM1;HYAL3
prerank,adipose tissue development (GO:0060612),-0.5390754832267396,-1.2937561281206598,0.1583629893238434,0.45767820800384357,1.0,4/11,6.33%,SPTLC2;NAMPT;LRP5;PGRMC2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5215092957806002,-1.2935706861448313,0.1332116788321168,0.4574276131336314,1.0,5/12,25.75%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,regulation of chromatin binding (GO:0035561),-0.5531562076310806,-1.293518263549496,0.1545138888888889,0.45687215064428693,1.0,6/10,36.33%,HMBOX1;WAPL;DTX3L;BTAF1;PARP9;MED25
prerank,protein localization to cell periphery (GO:1990778),-0.30825766599877213,-1.292858561094434,0.06134969325153374,0.45787559002449324,1.0,48/133,21.37%,CAV1;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;AP4M1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3504533094762441,-1.2928223312109641,0.10038610038610038,0.45727412065784034,1.0,29/72,25.39%,SHANK3;KANK3;CYRIB;SLIT2;HSPA8;PFDN5;KANK4;SSH2;HIP1R;STMN2;PFN1;SPEF1;CIB1;APOE;KATNB1;PIK3CA;SMAD4;CRYAB;ARHGEF2;TPX2;SHANK1;CDH5;APC2;PFDN6;CAMSAP3;PRKCD;PFDN4;STMN1;TREM2
prerank,negative regulation of viral release from host cell (GO:1902187),-0.5151794261643466,-1.29217984788594,0.17481203007518797,0.4580513843633025,1.0,3/13,14.53%,MID2;TRIM28;TRIM5
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4878045156735167,-1.291949781833338,0.15355805243445692,0.4579375187389483,1.0,8/16,28.35%,SCARB1;MFSD2A;PNPLA2;NR1H2;DAGLB;CNEP1R1;SREBF1;SLC27A1
prerank,B cell differentiation (GO:0030183),-0.37882981658213283,-1.290729266422946,0.13291139240506328,0.4601985934020838,1.0,23/46,33.98%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;IRF2BP2;HDAC4;HHEX;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;DCAF1;NFAM1;HDAC5;PTPN2;SYVN1;LYL1;BLNK;CR2;MS4A1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.442714645397155,1.2907148809327946,0.15932914046121593,0.5910752618968425,1.0,4/24,2.62%,ERRFI1;VDR;CYP27B1;ROCK2
prerank,potassium ion transmembrane transport (GO:0071805),0.3175728213621458,1.290461459169797,0.06349206349206349,0.5901303280238921,1.0,32/135,17.84%,SLC1A3;KCNK2;KCNT2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNK10;ATP1A3;SLC12A3;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5
prerank,T cell proliferation (GO:0042098),-0.5139056624107308,-1.289877241659908,0.17196261682242991,0.4615892522854109,1.0,11/13,37.82%,CTPS1;MSN;PPP3CB;PIK3CG;RASGRP1;LILRB1;DOCK8;CADM1;LMBR1L;SLC11A1;CRTAM
prerank,entry into host (GO:0044409),-0.5131776043979304,-1.2888059505600844,0.18026565464895636,0.4635079741289507,1.0,8/13,35.14%,CDH1;PPIA;MET;CBLL1;CTNNB1;SRC;CBL;ITGAV
prerank,glutamate receptor signaling pathway (GO:0007215),0.395891846084217,1.2887846666713272,0.1468682505399568,0.5929519011271545,1.0,14/37,18.62%,GRIA4;GRID2;GRIN3A;TRPM1;GRIK2;GRM1;GRIK1;CDK5R1;GRIA3;GRM4;GRIN2A;CLN3;GRIN2B;HOMER2
prerank,vascular transport (GO:0010232),0.3478222545151114,1.288248626952867,0.09302325581395349,0.5928163213701542,1.0,16/81,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,positive regulation of cellular component organization (GO:0051130),-0.3219794671610502,-1.2881878315554647,0.07184466019417475,0.4643666689674504,1.0,32/107,12.89%,SHANK3;IGF1R;ATP10A;GPC3;NEDD4L;RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;TGFB2;CD151;VEGFA;TGFB3;PLEKHM2;GPX1;BAX;INSR;TAL1;WARS1;ADD1;FLOT1;RB1;DCTN1;TIRAP;VCP;CAMK1;SURF4;APOE;BAK1;SYK
prerank,protein localization to mitochondrion (GO:0070585),-0.520357399122095,-1.2880244948580906,0.1705989110707804,0.4640960203614422,1.0,3/11,8.98%,HK1;AKT1;DNAJA1
prerank,response to interleukin-6 (GO:0070741),0.5466031366818082,1.28793028635482,0.19189765458422176,0.5920806802489008,1.0,4/10,6.59%,PID1;PTGIS;PTPRT;FOXA2
prerank,response to steroid hormone (GO:0048545),-0.41738501833638797,-1.2879159096844286,0.14634146341463414,0.46365931213993816,1.0,10/31,12.63%,ABHD2;CAV1;THBS1;ATP1A1;TGFB1;TGFB2;TGFB3;NR3C1;WBP2;ABCA2
prerank,glutathione biosynthetic process (GO:0006750),-0.5318230666121503,-1.2877861370306767,0.16030534351145037,0.4633012076478244,1.0,6/11,29.73%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4400314938882471,-1.287075793253039,0.14721723518850988,0.46440378470211124,1.0,10/24,24.12%,ACKR3;TPT1;CD44;CD74;BCL2L1;CCAR2;KDM1A;TAF9;TRIAP1;SNAI2
prerank,phosphorylation (GO:0016310),-0.27367879911338755,-1.2867699021093224,0.010845986984815618,0.46442070127092344,1.0,105/385,18.83%,PRKCH;ERG;CDK6;MAP3K5;RPS6KA5;DGKH;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;BMX;NEK7;CAMK2D;HK1;MAP3K1;MAP3K20;FNIP2;TGFB1;APP;TGFB2;FAM20A;CSNK1G2;ADAM10;PRKCZ;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;BCR;SRPK1;TRIB2;STK25;PLK2;DYRK2;AKT1;INSR;MAP3K11;CDC42BPB;TRIB1;PIM3;LMTK2;WNT11;TOLLIP;CAMK1;CDK4;TAOK2;FRK;LIMD1;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;PNKP;SPHK2;SYK;FASTK;CDKL4;TBCK;NUAK1;CERKL;NUAK2;JAK2;ERBB2;PIK3CA;PRKAG1;COQ8A;LMTK3;LIMK1;NEK3;STK38L;STK26;CDK13;CSNK2A1;PGK1;MAP3K9;JAK3;HCK;DGKZ;RET;CHUK;POMK;MAP3K6;TXK;CHEK1;NADK;FAM20B
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4857284299097336,1.2859231302773997,0.16052060737527116,0.5958122706134854,1.0,2/17,2.65%,BMP6;PRKCA
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3029138633723686,1.2859158270546165,0.06640625,0.5942201520379307,1.0,33/199,10.70%,ALDH1A1;ROBO1;LGR4;BMP2;PLCL1;LDLRAD4;NOVA1;BMP5;GJA1;ADAMTS5;TBX18;ROCK2;LRP4;WWC1;SFRP1;MCC;ACTN3;IL4;ADM;NLRP12;PLCL2;NPTN;FOXA2;LOXL2;ACOT11;DOCK7;RBPJ;SFMBT1;GATA3;HOXC10;BBS2;PTEN;RPS6KA6
prerank,glucose import (GO:0046323),-0.5119408986485374,-1.2849492182650604,0.17890772128060264,0.46815012671452433,1.0,6/13,28.35%,SLC2A1;RAB4B;SLC2A3;SLC2A4;SLC2A10;SLC27A1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.410927577427057,1.2847150589258758,0.15234375,0.5959491044850385,1.0,8/33,9.12%,TCF7L2;SEMA5A;PPARA;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,RNA export from nucleus (GO:0006405),-0.325353638274876,-1.2836565646699247,0.0625,0.4706390491756711,1.0,49/100,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;HNRNPA1;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.37015133293844893,-1.2833881635437132,0.10546139359698682,0.470581849528795,1.0,26/50,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;PLAUR;XIAP;YWHAE;PARK7;LAMTOR5;DNAJB6;SRC;RPS6KA1;PAK2;AQP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3845445842125521,-1.283118286356343,0.11281070745697896,0.4704652329673528,1.0,13/38,16.67%,CAV1;CD34;KLF2;KLF4;HSP90AB1;RAC1;EDN1;AKT1;INSR;TLR4;JAK2;CX3CR1;HSP90AA1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4960674655531428,-1.2830940500226582,0.14177693761814744,0.469825376830193,1.0,4/14,10.20%,LIMS2;LIMS1;EMP2;PHACTR4
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.29694514626838747,-1.282552342292358,0.062111801242236024,0.4704452132462891,1.0,57/175,24.36%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;RPS3;DAB2IP;CARD14;LIMS1;IKBKB;TNFRSF21;PSMA6;TNFRSF1B;RIPK1;NPNT;YBX3;TNFRSF11A;PSMB5;AKT1;CCL15;DHX9;PSMC4;PSMC5;CIB1;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;ARHGEF2;HAS2;LTBR;PSMA1;ADAMTS7;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;HYAL1;TNFRSF9;TNFRSF12A;TRAF6;CCL2
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.37331066218216535,-1.2823290310164164,0.11450381679389313,0.47033778889268363,1.0,13/47,17.01%,NFKBIA;KLF4;RPL10;FOXO3;TGFB1;APP;EDN1;AKT1;INHBA;APOE;RBM4B;NR1H2;PCIF1
prerank,pulmonary valve development (GO:0003177),-0.4650698744301043,-1.2818624816985087,0.1680960548885077,0.4707367202670775,1.0,12/18,14.52%,NOS3;NOTCH1;BMPR2;SLIT2;TGFB2;STRA6;HEYL;SMAD6;TNFRSF1B;NFATC1;TNFRSF1A;HEY1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4702048767102108,1.2816227191167706,0.18502202643171806,0.6028225224998705,1.0,3/18,4.13%,CAMK1D;PTN;LYN
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4181455237900533,1.28150147820285,0.14883720930232558,0.601555430118133,1.0,8/31,9.35%,TGFBR3;FGFR2;NRG1;TNNC1;TNNI3;TGFBR1;RBPJ;BMPR1A
prerank,regulation of protein kinase C signaling (GO:0090036),0.5103616195642384,1.2804896875049676,0.19491525423728814,0.6027667489521193,1.0,3/14,4.33%,ADGRV1;DGKD;GPD1L
prerank,cGMP biosynthetic process (GO:0006182),-0.5434327660488237,-1.2804347582156534,0.1773308957952468,0.47349702880310207,1.0,4/10,15.33%,NPR1;GUCY1B1;GUCY1A1;GUCY2C
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.32484100076350725,-1.2804161425795983,0.07644628099173553,0.4728354815123284,1.0,27/98,17.44%,SLCO1C1;THBS1;TGFBR2;NFKBIA;PPARD;KLF4;TGFB1;RNF41;ANXA2;VEGFA;ACLY;CHCHD2;RIPK1;AKT1;INSR;IFNAR1;ACE2;INHBA;APOE;AGPAT1;FMR1;RAB1A;CDKN1A;NR1H2;GREM1;CBR1;NSF
prerank,Ras protein signal transduction (GO:0007265),-0.3082904609926695,-1.2802883550179942,0.06889352818371608,0.47242356842156996,1.0,43/137,16.94%,PLCE1;RREB1;RAP1A;RASGRP3;ARHGEF3;EPS8;RAP1B;RAPGEF1;SHOC2;EPS8L2;ARHGAP1;ARHGDIA;RAC1;SHTN1;RALB;ARHGDIB;SHC1;ADGRG1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;GDI1;PHACTR4;RHOB;CFL1;RTKN;NF1;DBNL;FGF2;GNB1;HRAS;NTN1;CELSR1;LIMK1;RGL2;CDKN1A;NCKAP1;RAPGEF3
prerank,regulation of plasminogen activation (GO:0010755),0.5247312200238032,1.2798707529489788,0.18693693693693694,0.6027746816603178,1.0,3/12,5.80%,CLEC3B;SERPINE2;SERPINE1
prerank,regulation of cell division (GO:0051302),-0.3439958905147838,-1.2795906235246657,0.09497206703910614,0.47338916890187804,1.0,35/72,31.40%,MLLT3;FGF1;RACK1;RAB11A;CALM1;ZFYVE26;PLK2;TAL1;PRDM15;CIB1;CALM3;BCL2L1;RAB11FIP3;CETN2;KLHL9;KLHL21;PIN1;CDK2AP2;PRPF40A;SFN;KIF18B;TLE6;KIF13A;PLK3;PLK5;MYO19;SETD2;CSPP1;ENTR1;HTR2B;PLK1;MYC;DLL1;AURKA;PIK3R4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.48245700339497777,1.2794878539793686,0.17197452229299362,0.6021679632616046,1.0,2/17,0.36%,ROBO1;NRP1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3951400002747975,1.2789506579182686,0.1446280991735537,0.6019893495131198,1.0,11/37,12.32%,IFT81;DYNLL1;DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;IFT74;KIF3C;KIF3A;IFT43
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5122841040965576,-1.2785345760648148,0.16044776119402984,0.47531462468264674,1.0,9/13,34.78%,SVIP;UBE2G2;BCAP31;DERL2;ERLEC1;EDEM2;BRSK2;EDEM1;OS9
prerank,reticulophagy (GO:0061709),-0.5243689641000119,-1.2781592192386266,0.18,0.475588718502428,1.0,5/12,19.01%,UFM1;DDRGK1;UFL1;UFC1;UBA5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.43357670875458465,1.2781336278063118,0.15555555555555556,0.6025377973338337,1.0,8/27,14.14%,LPAR1;GPR55;GPR174;GRM1;LPAR4;C3AR1;GNA15;DRD2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.41297592922976906,1.2777182598698449,0.15705765407554673,0.6020641901353283,1.0,6/35,6.78%,ACSS3;HMGCLL1;PAM;ALOX12;GGT7;SCD5
prerank,blood vessel morphogenesis (GO:0048514),0.3725523549199598,1.2775054777936656,0.12883435582822086,0.6010925339771054,1.0,10/54,8.07%,CCBE1;LAMA1;TGFBR3;NRP1;TNNI3;TGFBR3L;GLMN;ADM;TGFBR1;RBPJ
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.48514261544827697,-1.2773390764036274,0.1821561338289963,0.4769106692418443,1.0,4/14,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5309455326957315,-1.2754340127907726,0.1841620626151013,0.4810607050715456,1.0,7/11,25.59%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,embryonic organ development (GO:0048568),0.35988239783634246,1.2752192099428823,0.11475409836065574,0.6056438078273721,1.0,15/61,9.35%,COL13A1;SALL1;FGFR2;GDNF;RARB;TEAD1;KIT;GLI2;GLI3;PBX4;IFT122;KMT2A;RBPJ;GATA3;BMPR1A
prerank,transport across blood-brain barrier (GO:0150104),0.34242039543541947,1.2752102988742138,0.1124031007751938,0.6040760301591475,1.0,16/83,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.5459475570539607,-1.2748814980981455,0.17996289424860853,0.4818196605631118,1.0,3/10,14.68%,MAP2K5;KLF4;SIGIRR
prerank,regulated exocytosis (GO:0045055),-0.2987404979729235,-1.2745561815083328,0.06860706860706861,0.48187256954833163,1.0,38/173,12.98%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;ARHGAP17;CYRIB;VEGFC;CALM1;VAMP7;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;RAB11FIP1;VEGFA;PSAP;STX1A;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL;RAB11B;VEGFD;PPP3CB;SYT2;CDC37L1;CYB5R1
prerank,heart looping (GO:0001947),-0.38650395433769535,-1.2745316051017952,0.1245136186770428,0.48121417450339715,1.0,11/40,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.34650643350081156,-1.2740705168684356,0.11067193675889328,0.4816835686049949,1.0,23/72,22.81%,ACER2;RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3;SESN2
prerank,striated muscle tissue development (GO:0014706),-0.40063114174087683,-1.2739847717007053,0.1346153846153846,0.4811701650099362,1.0,8/29,4.68%,MEF2C;CAV1;PGM5;MYL6;BMPR2;SIX1;TBX2;NDUFV2
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3623791738750583,-1.2738272596047715,0.12048192771084337,0.4808622076608736,1.0,10/49,11.58%,MEF2C;THBS1;TNRC6C;KMT2C;RBBP5;CBFB;MYL9;H3-3A;KMT2D;CIB1
prerank,regulation of MAPK cascade (GO:0043408),0.30864475515016504,1.2736343926648976,0.06349206349206349,0.6069076023026089,1.0,26/157,9.39%,IGF1;EPHA7;TGFBR3;NRK;BMP2;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;ROCK2;RIT2;WWC1;LYN;GSTP1;IAPP;EPHB1;RRAS;TNIK;THPO;SOX2;IGF2;RYK;EPHA8;MYDGF
prerank,glycoprotein biosynthetic process (GO:0009101),0.3447339587588337,1.2735310603899372,0.13387423935091278,0.6056032343055149,1.0,12/79,5.53%,IGF1;B3GALT1;CHST8;GAL3ST3;GAL3ST2;B3GALNT1;ST6GALNAC1;ST3GAL5;B3GNT7;ST8SIA1;ALG5;FUT4
prerank,regulation of lamellipodium organization (GO:1902743),-0.5037084455823071,-1.2734701455444528,0.18165467625899281,0.4810767334016257,1.0,9/14,38.26%,CD44;RAC1;EPHA2;DMTN;CARMIL1;CDC42;CAPZB;TWF2;VIL1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5483843150275658,-1.2727585921793312,0.2007168458781362,0.4821091126851516,1.0,4/10,22.08%,LBP;TIRAP;NINJ1;PTPN22
prerank,positive regulation of transport (GO:0051050),-0.32890478367978543,-1.2726164138286347,0.079002079002079,0.4818060869782442,1.0,23/85,15.09%,ACTB;GPC3;IL15;NEDD4L;ANXA1;RAB27A;ANXA2;CHP1;CD151;HIP1R;GATA2;BAX;PLAA;FLOT1;FCER1G;APOE;BAK1;FMR1;CAPN10;TUB;MLC1;LMAN2;CHCHD10
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.42719443466769186,-1.2722846090885458,0.15101289134438306,0.4819424934919546,1.0,4/24,7.84%,DACH1;BMPR2;RPS3;ERCC1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3265803015847836,-1.2720759138930393,0.06862745098039216,0.4818068581227657,1.0,34/100,21.45%,CBFA2T3;RACK1;RNF144B;SMAD7;HSP90AB1;RPL11;GABARAP;SH3RF2;N4BP1;GIPC1;USP7;TRIB2;PABIR1;CAMLG;FOXF2;TRIB1;DDRGK1;VCP;USP5;BAG5;UBXN1;RBX1;SDCBP;HECTD1;UFL1;HSPA1A;CCAR2;RNF19A;ELOB;MAP1A;KEAP1;TRIB3;HSPA1B;TAF9
prerank,regulation of cell development (GO:0060284),-0.39122028426308975,-1.2718928853743459,0.1411530815109344,0.48158283405045155,1.0,11/36,15.81%,FOXO1;HDAC9;BHLHE40;HEYL;RPS19;AKT1;PRUNE1;YTHDF2;HES1;HEY1;CX3CR1
prerank,response to ionizing radiation (GO:0010212),-0.34099500403208055,-1.2717322904061907,0.09856262833675565,0.4812970667394958,1.0,35/70,32.43%,NET1;ANXA1;BRCC3;EEF1D;UIMC1;RAD1;BABAM1;RHOB;MTA1;RAD9B;AEN;HUS1;RAD9A;CDKN1A;BABAM2;ECT2;GADD45A;BRAT1;IKBIP;CLOCK;RHNO1;COP1;MRNIP;DCUN1D3;SMPD1;FANCD2;RAD51AP1;LIG4;TNKS1BP1;RNF8;SWI5;MYC;INTS3;TICRR;FIGNL1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.4903438397024208,-1.2715199104184212,0.17765567765567766,0.48111375283561436,1.0,10/14,34.08%,RPL35;PES1;URB1;RPL7;WDR12;FTSJ3;RPF2;ZNHIT6;DDX18;ZNHIT3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.4331708812682979,-1.2714903064740062,0.16468253968253968,0.4804807892533101,1.0,13/25,30.76%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B;HMGB2;ANKRD54;ABCB10
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4393241237261303,-1.271233508857903,0.15846994535519127,0.48041848820449806,1.0,12/22,30.15%,DDX5;RPS15;RPL23;UBB;RPS20;RPS7;CDK5RAP3;MSX1;SPRED3;PMAIP1;RPL37;SPRED1
prerank,mRNA export from nucleus (GO:0006406),-0.3209529430771476,-1.2711744946802448,0.07547169811320754,0.47989441239790537,1.0,50/102,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;ENY2;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;DDX19A;NUP88;NUP214
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.33953278298881867,-1.2711660843874106,0.1016597510373444,0.4792414214941045,1.0,17/75,10.11%,TEK;CLDN5;SEMA6A;THBS1;KLF4;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,regulation of inflammatory response (GO:0050727),-0.29065118790525635,-1.270937461779039,0.04449152542372881,0.47915346951850396,1.0,49/190,20.24%,TEK;FOXP1;TMSB4X;SEMA7A;IL15;NFKBIA;PPARD;KLF4;CCN3;ETS1;ANXA1;MGLL;LPCAT3;APP;MFHAS1;PDE2A;IL1R1;IL33;GPR4;BRD4;TLR3;PSMA6;NFKBIZ;TNFRSF1B;RIPK1;BCL6;DHX9;RB1;ACE2;PIK3AP1;APOE;TLR4;TNFRSF1A;FEM1A;BCL6B;JAK2;NOD2;IL17RA;TNFAIP3;UFL1;RELA;HCK;NINJ1;DAGLB;PTGER4;CD200;METRNL;CASP1;GGT1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5410301165397308,1.270879378407296,0.20776255707762556,0.61128275944193,1.0,6/11,17.38%,LEPROT;SNX33;TAX1BP3;ACTN2;LEPROTL1;GOPC
prerank,positive regulation of axonogenesis (GO:0050772),0.3880120383667245,1.2707597446194683,0.14498933901918976,0.6100407997024452,1.0,3/43,0.57%,PLXNA2;ROBO1;ROBO2
prerank,selective autophagy (GO:0061912),-0.35730353967006123,-1.2707452991716026,0.11278195488721804,0.4789211046901488,1.0,17/56,19.74%,VIM;MAP1LC3B;UBB;DYNC1LI2;UBC;RPS27A;UFM1;DDRGK1;RAB7A;KLHL3;PHB2;DYNC1LI1;UFL1;AMBRA1;UFC1;UBA5;DYNLL2
prerank,histone H2A ubiquitination (GO:0033522),0.47621256829014275,1.270667052409384,0.17745302713987474,0.6087362966145948,1.0,3/17,5.22%,BCOR;DDB2;RNF2
prerank,regulation of cell differentiation (GO:0045595),-0.30125587664452014,-1.270663983526781,0.05622489959839357,0.47842969768575805,1.0,39/148,16.55%,SLC6A6;CDK6;SMOC1;SPOCK2;DDX5;LTBP4;KLF4;PTK2;TBX1;RPS6KA3;SMAD7;NGF;HSP90AB1;DDX17;SIX1;TGFB1;REST;PPP2R1A;UQCC2;NOTCH4;ATF4;CBFB;PHLDB1;BCL6;MCRIP1;EMP2;CAMK1;NF1;OCIAD1;ZFHX2;BCL6B;HEY1;SRF;FLOT2;YWHAG;ZFHX3;GREM1;YWHAH;PDCD2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5240890590414744,-1.2706454267148435,0.18773234200743494,0.47780514825583276,1.0,8/11,37.52%,JAK2;STAT1;IL6ST;IL12RB2;STAT4;IL27RA;CANX;IL12A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.40384877320713064,-1.2706285978891174,0.14747474747474748,0.47716131704900416,1.0,20/32,34.13%,BRCC3;TAOK3;FOXN3;UIMC1;BABAM1;TAOK2;CDC14B;CDKN1A;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;CDK1;TICRR;CLSPN
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44507599959143707,1.2703133319692304,0.17913832199546487,0.6080641863654485,1.0,2/21,1.99%,SAMD4A;TUT4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4868479866054507,1.2702925420798328,0.20588235294117646,0.6065656334416922,1.0,4/15,14.06%,SH3D19;SNX33;SNX9;NRDC
prerank,regulation of membrane depolarization (GO:0003254),-0.46120291633379096,-1.2701256634056566,0.15539305301645337,0.47777675301193406,1.0,4/18,3.59%,NEDD4L;FHL1;CAMK2D;SMAD7
prerank,retinoic acid metabolic process (GO:0042573),0.48906475502991004,1.2700981429152427,0.1902654867256637,0.6055282426002069,1.0,1/14,0.56%,ALDH1A2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3594072174866415,-1.2698829452807623,0.10337972166998012,0.47769159932332195,1.0,25/56,25.75%,CCND3;RAB11A;ANXA1;BRD4;RGCC;ANAPC11;AKT1;RB1;LSM11;CDK4;RCC2;PHB2;EGFR;ANAPC7;CDC27;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;DTL;HYAL1;AIF1;RPTOR;RDX
prerank,mitochondrial fusion (GO:0008053),-0.4660576167007982,-1.269601295420384,0.17028985507246377,0.4777178941262103,1.0,12/18,41.33%,MIEF1;BAX;CHCHD3;MIEF2;OPA1;FIS1;MFF;THG1L;MIGA1;STOML2;GDAP1;MFN1
prerank,blood vessel diameter maintenance (GO:0097746),-0.3945119313239502,-1.2688262843349873,0.14760147601476015,0.4789270804690682,1.0,9/34,19.55%,EDNRA;NOS3;KLF2;NPR1;EDN1;ACE2;ACE;GCLM;GCLC
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3453292326461034,1.2683520918837985,0.1203883495145631,0.6087588361822855,1.0,14/69,11.07%,IGF1;PIK3R1;PLCL1;PDGFRA;MYO16;IRS2;PLCL2;PDGFRB;SIRT2;PLCH1;ERBB3;GATA3;PTEN;PLCD4
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.39284091619664246,-1.2682130579143744,0.15551181102362205,0.47977929487579424,1.0,13/34,16.64%,TEK;FLT1;PTK2B;PTK2;DAB2IP;TNFAIP8L3;TGFB1;PIK3IP1;FGF2;PIK3R3;NOD2;PIK3R2;AMBRA1
prerank,type I interferon signaling pathway (GO:0060337),-0.3811722626551904,-1.2678375920417122,0.13382899628252787,0.47928404079744885,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,cellular response to type I interferon (GO:0071357),-0.3811722626551904,-1.2678375920417122,0.13382899628252787,0.47928404079744885,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5037237721519032,-1.2673878036109882,0.17049808429118773,0.4796808534368567,1.0,3/13,5.34%,RREB1;SIX1;SOX13
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5151218815751086,1.2673525533604817,0.20140515222482436,0.6082806786245709,1.0,2/12,4.89%,FHL2;ACTN3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5151218815751086,1.2673525533604817,0.20140515222482436,0.6082806786245709,1.0,2/12,4.89%,FHL2;ACTN3
prerank,regulation of RNA metabolic process (GO:0051252),-0.34942449556426386,-1.2671553656656558,0.12149532710280374,0.47957629939680224,1.0,15/59,13.27%,AHNAK;NOVA2;AHNAK2;MBNL1;HNRNPLL;RBM20;PTBP3;ZNF326;TNFRSF1B;RC3H1;FUS;PCBP4;YTHDF2;CLK1;FASTK
prerank,outflow tract septum morphogenesis (GO:0003148),0.44096330478932,1.266996318025799,0.15904139433551198,0.6077364338175889,1.0,4/24,1.11%,ROBO1;NRP1;ROBO2;FGFR2
prerank,osteoclast differentiation (GO:0030316),-0.4486276390133751,-1.26691614955207,0.17343173431734318,0.4795055531318251,1.0,8/22,15.34%,FOXP1;ANXA2;OSTM1;TNFRSF11A;GLO1;CSF1R;GAB2;EPHA2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.48242528161637777,1.2652486274916153,0.18895966029723993,0.6109032832752352,1.0,5/14,11.02%,SULF1;SULF2;CREB3L1;GATA3;FUZ
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5364834567771664,1.2648314359762216,0.22429906542056074,0.6104710099220481,1.0,3/10,6.09%,ENPP1;ERRFI1;NLRP12
prerank,axonal transport of mitochondrion (GO:0019896),-0.5319884891964393,-1.2640806082920262,0.18650088809946713,0.485719555517314,1.0,4/11,16.25%,TRAK1;NEFL;TRAK2;OPA1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3874831614819137,1.2634712733538433,0.14853556485355648,0.6125685917446911,1.0,10/46,11.32%,IGF1;TCF7L2;CCN4;PDGFRB;OGN;IL18;HES5;ANG;IL6R;PTGIR
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4909810778304519,1.2634315359904467,0.18526785714285715,0.6111345819025523,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,regulation of protein transport (GO:0051223),-0.41676784704665487,-1.2631308772320815,0.13721804511278196,0.4873642458443507,1.0,14/27,31.46%,HSPA8;WWP2;CHP1;PPM1F;DNAJA1;NDEL1;SNX3;PTPN1;RHBDF2;NDFIP2;P3H1;ATP13A2;NDFIP1;SNX12
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.48822915657799615,1.2626268227441428,0.20668058455114824,0.6117670013787814,1.0,4/16,2.64%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,activation of phospholipase C activity (GO:0007202),0.40953631838968596,1.262552671803276,0.17584745762711865,0.6104673090991809,1.0,3/29,2.42%,ARHGAP6;LPAR1;GPR55
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.27302307693664035,-1.262455401801511,0.020134228187919462,0.4882732434635902,1.0,84/348,15.87%,TEK;PECAM1;CAV1;SLCO3A1;RAP1A;RPS6KA5;PTPRJ;CCND3;PLCG2;IL15;FGF1;RACK1;PTK2B;LIMCH1;BMPR2;LIMK2;KDR;MAPK3;IQGAP1;TFRC;PTK2;NIBAN1;TBX1;VEGFC;CSPG4;CARD14;NGF;CD44;HSP90AB1;CALM1;FNIP2;TGFB1;APP;TGFB2;FAM20A;RAC1;PPIA;RALB;CD81;VEGFA;PDE8A;TGFB3;RASSF2;RIPK1;KRAS;FLT4;AKT1;INSR;PDGFC;PDGFA;FLOT1;FAS;CSNK2B;DDRGK1;LRP8;CD74;CAMK1;INHBA;TAOK2;CIB1;VEGFD;MTCP1;CALM3;ACVR1;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;INHBB;JAK2;SDCBP;EGFR;LCP2;MMD;ERBB2;PRKAG1;SMAD4;CAB39;BCAR3;CX3CR1;CDKN1A
prerank,positive regulation of sodium ion transport (GO:0010765),0.4981233967165537,1.2619918819158162,0.20232558139534884,0.6105012376202645,1.0,2/12,4.33%,SCN3B;GPD1L
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.40256676250611084,-1.2614331693798615,0.155893536121673,0.49016858437109295,1.0,15/33,28.16%,PTPRJ;RPS3;CD81;EZR;RC3H1;DUSP3;NECTIN2;RELA;DGKZ;LAPTM5;PRKD2;PTPN22;BCL10;PTPN2;CARD11
prerank,endothelial cell differentiation (GO:0045446),-0.5038895666190379,-1.2605802767149148,0.20535714285714285,0.4916323164692995,1.0,5/12,12.73%,TIE1;BMPR2;KDR;SOX18;FSTL1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3381748675321159,-1.2602394149374085,0.12248995983935743,0.49176556822199685,1.0,17/71,11.24%,FAP;CAPN2;RNF41;CTSZ;UBB;UBC;RPS27A;CTSO;RHBDD1;CTSC;CASP8;PSMA6;IDE;USP9X;CTSF;VCP;CTSB
prerank,negative regulation of neuron projection development (GO:0010977),0.363877019569136,1.260118053961786,0.13184584178498987,0.6139130020161991,1.0,14/56,12.60%,LPAR1;LRP4;SEMA3A;MCF2;RTN4;RAB29;DPYSL3;BCL11A;NLGN1;STX1B;DCC;PTEN;NGFR;CBFA2T2
prerank,anion transmembrane transport (GO:0098656),0.3576690188843976,1.2597925997563095,0.1111111111111111,0.6132551629112292,1.0,11/67,7.31%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;SLC7A2;SLC6A13;SLC13A4;MFSD12;SLC25A13;SLC25A42;SLC25A10
prerank,monocyte chemotaxis (GO:0002548),-0.40086661505429105,-1.2595720586173114,0.155893536121673,0.4927868046994367,1.0,5/32,8.73%,FLT1;ANXA1;RPS19;TNFRSF11A;CCL15
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4987057732412097,-1.2592781365493022,0.18772563176895307,0.492930732740292,1.0,4/13,15.01%,NOTCH1;TGFBR2;CPE;SMAD4
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3670971591850228,-1.2592135214779705,0.12896825396825398,0.49242480573851605,1.0,13/48,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;PRKDC;S100A10;CAPRIN1;CIB1
prerank,mesenchymal cell differentiation (GO:0048762),0.3684746227293547,1.2586087607750132,0.15164835164835164,0.6148758264543266,1.0,11/51,8.07%,TGFBR3;WNT4;BMP2;FGFR2;ROCK2;RANBP3L;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,extracellular transport (GO:0006858),-0.506021241556139,-1.258563567424998,0.15827338129496402,0.49325676085828696,1.0,8/13,27.29%,WWP2;ARRDC1;TSG101;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.49377491570895865,-1.2580961668711212,0.20599250936329588,0.4937185808227385,1.0,7/14,33.13%,HTT;PRKAR2B;PRKAR2A;RAPGEF2;PKIG;PKIB;ADRB2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4341348560223924,1.258032261363578,0.16842105263157894,0.6149355784847698,1.0,6/24,9.56%,ADAMTS12;TRPS1;LOXL2;TGFBR1;SCIN;SOX5
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.43613945456746434,-1.257974855333493,0.1676190476190476,0.49332197403952194,1.0,3/22,4.03%,IL15;SLC7A5;TGFB1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3937927707186344,1.2579094064971563,0.17697228144989338,0.6137336040934495,1.0,4/37,6.04%,ADCY7;PPARA;TICAM1;ABCD2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.4291523318046847,-1.2578011701439906,0.15471698113207547,0.49303148915023476,1.0,7/23,4.89%,THBS1;MAPK3;PTK2;STK10;SLIT2;MSN;CMKLR1
prerank,natural killer cell mediated immunity (GO:0002228),-0.47704855902391213,-1.2563946373793087,0.1813186813186813,0.49587460441706654,1.0,4/15,19.40%,LYST;PLEKHM2;TUBB4B;ARL8B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5284400651703098,-1.256238899420835,0.1918819188191882,0.4955767465221102,1.0,3/11,6.53%,RACK1;REST;ATF4
prerank,negative regulation of lyase activity (GO:0051350),0.4819198481070681,1.2562004541864167,0.22075055187637968,0.6167244509221821,1.0,4/16,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,hyaluronan metabolic process (GO:0030212),0.4371172647730445,1.2560025507207344,0.17073170731707318,0.6157202456517201,1.0,3/23,1.32%,CEMIP;SPAM1;HYAL3
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.386552361981903,-1.2557655701326536,0.12692307692307692,0.4960744338800744,1.0,12/36,12.82%,MEF2C;THBS1;NOTCH1;DAB2IP;SLIT2;TGFB1;PTPRM;RGCC;JUP;CSNK2B;APOE;FGF2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.46711424870280416,-1.2557535139876321,0.18214936247723132,0.49543251921237574,1.0,7/17,15.49%,ARL6IP5;TGFB2;MID1;TAOK3;STK25;TAOK2;NOD2
prerank,cell part morphogenesis (GO:0032990),0.49321840455572685,1.2557514295576975,0.20378151260504201,0.6148963463865311,1.0,3/13,10.46%,PID1;NUBPL;PNPT1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3105143471487137,-1.255447593528808,0.07976653696498054,0.49551485514247673,1.0,30/113,14.34%,ESR1;RASIP1;RAP1B;RACK1;UNC13B;TFRC;PIEZO1;RPS3;GBP5;DAB2IP;FERMT2;FNIP2;TGFB1;VEGFA;ERCC1;CUL4A;BAX;TAL1;GTF2H3;WARS1;CHD1L;TIRAP;VCP;PSMC4;PSMC5;TLR4;BAK1;SYK;SLF1;RBX1
prerank,regulation of fat cell differentiation (GO:0045598),0.3377363409554637,1.255077368640405,0.13836477987421383,0.615193337438614,1.0,11/74,9.31%,RORA;ENPP1;BMP2;RUNX1T1;SMAD3;SFRP1;CEBPB;MEDAG;SIRT2;GATA3;FTO
prerank,phosphatidylserine metabolic process (GO:0006658),0.408006526377967,1.2550451406820433,0.1535181236673774,0.6137923061998503,1.0,4/32,3.11%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,regulation of muscle cell differentiation (GO:0051147),-0.39483921250713605,-1.2550443084310907,0.17009345794392525,0.4957835716826686,1.0,12/31,20.34%,MEF2C;CDON;CTNNA1;MEF2A;BOC;HDAC9;CAMK1;SPAG9;SRF;TCF3;MAPK12;MAPK11
prerank,ERBB2 signaling pathway (GO:0038128),0.41597828535473985,1.2549772941749362,0.17551020408163265,0.6124487040439623,1.0,7/31,9.81%,PIK3R1;NRG1;PRKCA;NRG4;NRG2;ERBB3;ERBB4
prerank,positive regulation of peptidase activity (GO:0010952),-0.4427017707629668,-1.2547306421438538,0.1706422018348624,0.49589937508822146,1.0,7/20,18.46%,NDUFA13;PSENEN;DDRGK1;VCP;APH1A;VSIR;MAPK12
prerank,actin filament network formation (GO:0051639),-0.5255215024541752,-1.2546983406136016,0.21142857142857144,0.49531699172993965,1.0,3/11,6.61%,COBL;PLS3;ACTN1
prerank,early endosome to late endosome transport (GO:0045022),-0.447075331713757,-1.2545905517452036,0.18299445471349354,0.4949158321515458,1.0,6/20,15.29%,EEA1;EMP2;LMTK2;KIF16B;RAB7A;SNF8
prerank,regulation of extracellular matrix organization (GO:1903053),0.4789963819871202,1.254140212768844,0.18203309692671396,0.613236183228133,1.0,6/15,8.79%,DDR2;LRP1;EFEMP2;DDR1;AEBP1;FGFR4
prerank,response to calcium ion (GO:0051592),-0.3178902032663757,-1.2540406315007966,0.1127348643006263,0.4955860390901914,1.0,21/102,14.42%,MEF2C;CAV1;ITPKB;CLIC4;THBS1;PLCG2;TRPC3;MEF2A;IQGAP1;CAMK2D;CALM1;ITPR3;CARF;CPNE8;ADD1;SLC25A12;CALM3;HOMER1;SYT2;PEF1;CASQ2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5014098474453235,-1.2537021749806334,0.1856060606060606,0.49575863479140925,1.0,7/12,34.16%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2;BDH2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5159974099746664,1.2535962629122204,0.20726495726495728,0.6131978705946134,1.0,2/12,1.22%,PIK3R1;BCL2L11
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4519114235462481,1.2533954095129947,0.19078947368421054,0.6122874956923052,1.0,5/18,11.11%,SLC2A13;ROCK2;LRRTM3;CASP3;CHRNA7
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4464323952895429,-1.253102161816055,0.19516728624535315,0.49658787425805573,1.0,6/19,16.48%,CSGALNACT1;EXTL3;NDST1;NDST3;HS3ST3B1;XYLT2
prerank,regulation of programmed cell death (GO:0043067),-0.29609157943679276,-1.2530711017644387,0.07039337474120083,0.49599768829159224,1.0,39/161,16.67%,MECOM;PPP1R13B;ACER2;TPT1;TGM2;ACTN4;RPS3;ZBTB7A;CRADD;IGFBP3;TMEM219;ANP32A;ACTN1;DCPS;TOX3;RIPK1;BAX;AKT1;PERP;BCL6;KANK2;FAS;HIP1;VCP;LRP8;CTSB;RTKN;PSMC5;HTATIP2;ACER3;JAK2;BNIP3L;OSGIN1;MADD;PTPN6;STK26;LGALS1;STAT1;HSP90AA1
prerank,alpha-amino acid metabolic process (GO:1901605),0.3737371664459466,1.2529104630231525,0.15876288659793814,0.6120812334800285,1.0,19/45,23.74%,ASPA;ALDH18A1;SLC25A13;KMO;GLUL;GLS2;FOLH1;MTHFD1;ASS1;DDAH2;ASPG;NOX4;GPT2;GOT1;GOT2;MMUT;KYAT1;CBS;MTHFR
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4928126810202153,1.2529032422763469,0.21247113163972287,0.6106238852297489,1.0,3/13,8.24%,IGF1;IRS2;IGF2
prerank,cellular response to nutrient levels (GO:0031669),-0.340788528042085,-1.2527354789710994,0.12401574803149606,0.4961936537688796,1.0,28/62,25.22%,BMPR2;FOXO1;KCNB1;MAP1LC3B;HSPA8;RALB;MFSD2A;FAM107A;ATG7;MAP1LC3A;INHBB;GAS2L1;STK26;RRAGD;XBP1;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;EIF4G1;CD68;RRAGC;NUPR2;CDKN2B;RPTOR;SREBF1
prerank,negative regulation of catalytic activity (GO:0043086),-0.4234118910513548,-1.25269132831724,0.15934065934065933,0.4956531987439812,1.0,7/24,17.61%,NOTCH1;NES;IFIT1;ATP5IF1;APBA3;CCAR2;NOSIP
prerank,regulation of isotype switching (GO:0045191),0.4924516190651363,1.2521119077831995,0.21108742004264391,0.6112486673986834,1.0,7/14,16.51%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B;PARP3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.372284954046212,1.251918239172847,0.16041666666666668,0.6103237996257482,1.0,3/45,1.32%,BMP6;BMP2;BMP5
prerank,protein localization to plasma membrane (GO:0072659),-0.30137203789800343,-1.2517646187581786,0.08298755186721991,0.49722994142951094,1.0,46/129,21.37%,BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;GORASP2;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,vascular process in circulatory system (GO:0003018),-0.5024246015383008,-1.251755294881099,0.19962686567164178,0.49591800194436514,1.0,7/13,22.67%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,regulation of tube diameter (GO:0035296),-0.5024246015383008,-1.251755294881099,0.19962686567164178,0.49591800194436514,1.0,7/13,22.67%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,regulation of protein catabolic process (GO:0042176),-0.32184245262990263,-1.2516428593379616,0.10474308300395258,0.49552749030523546,1.0,29/99,19.75%,WWP1;GPC3;EEF1A1;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;EGFR;SNF8;TNFAIP3;CSNK2A1;FZR1;NSF;AGAP2;GFAP;PIN1;SNX3
prerank,inositol lipid-mediated signaling (GO:0048017),0.3646568562690096,1.2516057189750005,0.15950920245398773,0.6096912879886973,1.0,8/50,7.69%,IGF1;PIK3R1;PLCL1;PDGFRA;IRS2;PLCL2;PDGFRB;PLCH1
prerank,myotube cell development (GO:0014904),0.5394693891174908,1.2514845295642973,0.2,0.6086021788436716,1.0,2/10,6.49%,IGF1;MYORG
prerank,glycogen biosynthetic process (GO:0005978),-0.513733090430945,-1.2513526863305502,0.20545454545454545,0.4949598993929706,1.0,5/12,27.19%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,glucan biosynthetic process (GO:0009250),-0.513733090430945,-1.2513526863305502,0.20545454545454545,0.4949598993929706,1.0,5/12,27.19%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5144076728979098,-1.2512273993186929,0.2017857142857143,0.4945980837309099,1.0,8/12,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.45033205726076486,-1.2511869846962582,0.17333333333333334,0.494030496943952,1.0,2/18,0.48%,OCLN;SLC2A1
prerank,calcium ion import across plasma membrane (GO:0098703),0.4892347124366443,1.2510121242752892,0.1902834008097166,0.6084076099571012,1.0,3/14,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5363867131966492,-1.2509046474964514,0.2088724584103512,0.49408984759896296,1.0,3/10,8.42%,CTTNBP2NL;THBS1;AKT1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.43669767891850547,-1.2508290504724626,0.1726078799249531,0.49360932772006216,1.0,4/22,10.02%,B2M;CD55;CYRIB;HSPD1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5212366282636746,-1.250110331453849,0.20925925925925926,0.4947062031545097,1.0,7/11,19.37%,TGFBR2;LRP5;TBX1;PDGFA;CTNNBIP1;STAT1;SOX9
prerank,protein modification process (GO:0036211),-0.33432369310296906,-1.2500047393149938,0.12277227722772277,0.494344077547936,1.0,23/76,19.45%,ST3GAL6;ST8SIA4;MANBA;PLOD2;WWP2;PRKDC;MSRA;CSNK1G3;UBE2L6;CPE;ATG3;ABL2;STK38;MMP15;ICMT;FBXL2;LOX;YES1;PHEX;MCRS1;FBXW2;UBL5;LCMT1
prerank,male gonad development (GO:0008584),0.3969567908178758,1.2491156094855087,0.16806722689075632,0.6119187617769244,1.0,7/34,9.12%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,cellular response to drug (GO:0035690),-0.4202509674008806,-1.2489944146330987,0.18984962406015038,0.4961423092369325,1.0,7/25,8.70%,MEF2C;ACER2;TFRC;REST;KCNQ1;PPM1F;RBM22
prerank,regulation of interleukin-13 production (GO:0032656),-0.4921682814496816,-1.2489135709067958,0.19488188976377951,0.4956993205556833,1.0,5/13,12.85%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,ventricular septum development (GO:0003281),0.39115353997560104,1.248612232293634,0.1615720524017467,0.6117880851203339,1.0,4/37,0.61%,ROBO1;TGFBR3;ROBO2;SALL1
prerank,regulation of ATP metabolic process (GO:1903578),-0.35450256123550267,-1.2483183576885708,0.136986301369863,0.49643979378265446,1.0,23/54,27.53%,ZBTB7A;UQCC2;NUP93;NDC1;NUP54;SPHK2;NUP188;NUP155;RANBP2;PRKAG1;ATP5IF1;NUP37;JMJD8;SLC25A33;FIS1;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,regulation of cellular component movement (GO:0051270),0.3633769156168303,1.2480186300903338,0.1629327902240326,0.6119641570641206,1.0,12/49,9.81%,TGFBR3;MYCBP2;NRG1;ROCK2;LYN;NRG4;NRG2;TGFBR1;ZSWIM5;MEMO1;ERBB3;ERBB4
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4052090027647698,1.2474966216675598,0.16494845360824742,0.6118496506922663,1.0,8/31,11.02%,FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;TGFBR1;HOXB9;FUZ
prerank,ameboidal-type cell migration (GO:0001667),-0.35525280371543716,-1.2474697100354848,0.1442125237191651,0.4979123509807384,1.0,14/51,12.52%,SEMA6A;SEMA3C;GPC3;SEMA7A;CCN3;TBX1;PDLIM1;AMOT;AKT1;SEMA3G;PHACTR4;FAT2;PKN3;SGPL1
prerank,mitotic recombination (GO:0006312),0.4833239683835436,1.2472932785896411,0.21581196581196582,0.6109270683595336,1.0,6/15,18.37%,DMC1;GEN1;TEP1;SMC6;SMC5;NSMCE2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5284077880293588,1.2469106055176666,0.22595078299776286,0.6105505176801128,1.0,4/10,23.19%,IL4I1;KYNU;PCBD1;KYAT1
prerank,regulation of neurogenesis (GO:0050767),-0.3537881446601019,-1.2465512535428038,0.12348178137651822,0.49955831536306117,1.0,13/55,15.81%,B2M;NOTCH1;TGM2;REST;BHLHE40;HEYL;FAIM;PRUNE1;YTHDF2;PCM1;HES1;HEY1;CX3CR1
prerank,mRNA transport (GO:0051028),-0.3156348940602558,-1.2462262111962847,0.11434511434511435,0.49980328020097936,1.0,49/101,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4840844766539848,-1.246221474888274,0.19499105545617174,0.49916063576412784,1.0,4/14,8.26%,RFK;PAICS;ADSS2;IMPDH1
prerank,UV protection (GO:0009650),-0.5272022571268983,-1.24615151641957,0.19320214669051877,0.49866480696430354,1.0,2/10,8.01%,SCARA3;GPX1
prerank,vitamin D metabolic process (GO:0042359),0.5097588685659178,1.246074387367824,0.2324561403508772,0.6113266017259207,1.0,2/13,1.77%,VDR;CYP27B1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3121568968514366,-1.2460407351420144,0.09145129224652088,0.49829280558336514,1.0,31/108,19.57%,CAV1;NXN;RPS3;SMAD7;HSP90AB1;FKBP1A;IVNS1ABP;UBB;CHP1;SH3RF2;N4BP1;DCUN1D1;FBXO4;AKT1;DNAJA1;CAMLG;FOXF2;FAM107A;PTTG1IP;BAG5;UBXN1;SOX4;SPRTN;PRMT3;TNFAIP3;UFL1;HSP90AA1;HSPA1A;CDK5RAP3;USP4;LAPTM5
prerank,cation transport (GO:0006812),-0.29101420956434587,-1.2457943630829424,0.07723577235772358,0.49820831577529645,1.0,19/167,5.23%,SLC47A1;PIEZO2;ANO6;SLC6A6;SLC12A2;KCNK5;ANO1;KCNJ2;NEDD4L;SLC9B2;SLC7A1;TRPM7;ABCC9;TRPM6;PIEZO1;SLC5A6;SLC38A5;SLC1A1;CHP1
prerank,regulation of cardiac conduction (GO:1903779),0.3596426932151163,1.2456241947479882,0.1487603305785124,0.6112204676983458,1.0,10/54,6.07%,ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;ATP2A2;FXYD1;ASPH
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5244647213522834,-1.2455937729168103,0.18932874354561102,0.4980450492766735,1.0,7/10,31.46%,WWP2;PPM1F;DNAJA1;SNX3;NDFIP2;NDFIP1;SNX12
prerank,positive regulation of cellular process (GO:0048522),-0.25717499784695136,-1.2454119206359644,0.013513513513513514,0.4978524346034534,1.0,122/565,15.78%,FN1;KITLG;LEF1;CAV1;SLC6A6;FLT1;FRMD5;IGF1R;CLDN5;ACER2;LBP;THBS1;PTPRJ;NOTCH1;PARD3;IL15;DPP4;NAMPT;TRPC3;FGF1;TGFBR2;LRP5;PTK2B;TGM2;LIFR;ACTN4;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;RPS6KA3;VEGFC;ETS1;HSP90AB1;CDKN1B;RPRD1B;TGFB1;CNBP;TGFB2;RAB27A;TBX2;RPL23;RAC1;RPS15A;DNAJA2;ADAM10;CD81;RPS19;VEGFA;CNOT7;S100B;AQP11;ACLY;RARA;SHC1;GATA2;MFSD2A;TGFB3;HCFC1;TNFRSF1B;ADGRG1;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;PABIR1;MMP14;AKT1;INSR;FZD7;TAL1;NOP2;PDGFC;PDGFA;LAMC2;FLOT1;EMP2;FCER1G;DDRGK1;H3-3A;CDK4;KMT2D;S100A13;AKAP6;CIB1;VEGFD;FAM98A;GRK5;TLR4;SOX4;FXN;FGF2;HES1;RPS6;ACER3;AGPAT1;FMR1;CSF1R;CAPN10;HRAS;TUB;CDKN2AIP;MLC1;SDCBP;RAD18;EGFR;CHTOP;LMAN2;SRF;ERBB2;GAB2;CLCF1;TNFSF13;PTPN6;ZFHX3;NSMCE4A;CDK13
prerank,regulation of interleukin-10 production (GO:0032653),-0.3684037652086347,-1.2449518297202804,0.16377649325626203,0.4982534842754879,1.0,11/44,17.47%,CD34;PLCG2;PRKCZ;TNFRSF21;TRIB2;HSPD1;TLR4;SYK;NOD2;VSIR;JAK3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.35434561451709523,-1.2444067365681557,0.1157495256166983,0.4990053741122806,1.0,13/55,12.16%,CAV1;RACK1;RPS3;TPD52L1;DAB2IP;CRADD;TNFSF10;ING5;RIPK1;BAX;FAS;BBC3;BCL2L1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5001892963618835,1.2443615248202082,0.1926605504587156,0.613210436406055,1.0,3/12,8.24%,IGF1;IRS2;IGF2
prerank,embryonic heart tube development (GO:0035050),-0.4773439635533828,-1.24414481437577,0.19823008849557522,0.4989902013253849,1.0,5/14,12.83%,SOX17;TBX2;SOX18;ACVR1;HES1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4790547666831356,-1.2440438662877398,0.17823639774859287,0.4985796715449682,1.0,7/14,18.61%,PRKCZ;CD81;RARA;DENND1B;CD74;NOD2;RSAD2
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3175309091430007,-1.243620858157697,0.12062256809338522,0.4989022927597509,1.0,24/87,14.95%,ESAM;EPS8;PTK2B;F11R;IQGAP1;ARHGAP17;RICTOR;ARHGDIA;RAC1;ARHGDIB;CRK;HIP1R;EZR;ABI3;PDGFA;FAM107A;RHOB;ABL2;TAOK2;CDK10;CSF1R;ARHGEF5;CELSR1;PIK3CA
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.437742096483867,-1.2431338121550364,0.2037037037037037,0.49937031527313575,1.0,6/21,12.56%,PDE4D;NT5E;PDE2A;NT5C1A;NUDT4;HINT1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3162627417405742,-1.2429181670303688,0.09195402298850575,0.4992573899592724,1.0,34/93,27.00%,CAV1;DMD;RACK1;TFRC;PDE4D;SMAD7;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;RASSF2;PPM1F;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;DDIT4;NCK1;HCLS1;PRKD2;PDCD10;EIF4G1;DMTN;NCK2;RPTOR;PARK7;TXN;TNKS1BP1
prerank,protein mannosylation (GO:0035268),0.4375901382616286,1.2427027841006184,0.1935483870967742,0.6162664673337304,1.0,9/22,19.50%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;DPY19L1;B4GAT1;DPM1;DPY19L4
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3950699909146786,1.2426902049260458,0.18951612903225806,0.6148726673574889,1.0,7/34,9.24%,IGF1;TGFA;PHIP;PDGFRB;CDC23;IGF2;CDC16
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5272571406063197,-1.241972782523272,0.23302752293577983,0.5009672139105453,1.0,4/10,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,leukocyte tethering or rolling (GO:0050901),-0.4635435335421051,-1.2417941184634516,0.2007233273056058,0.5007510062470376,1.0,11/17,43.59%,JAM2;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7;ADD2;ROCK1;TNF;GCNT1;SELE
prerank,negative regulation of MAPK cascade (GO:0043409),-0.3202378086330911,-1.2412169362784018,0.10891089108910891,0.5015684254971019,1.0,31/87,27.92%,CAV1;SEMA6A;PTPRJ;FOXO1;DAB2IP;PPIA;PEBP1;EZR;PRDM15;UCHL1;NF1;STK38;DUSP3;APOE;TLR4;SMAD4;PIK3R2;IGBP1;SPRY1;CDK5RAP3;PIN1;PTPN1;DUSP4;PRKCD;SPRED3;PPEF2;SMPD1;SPRY4;DUSP6;PTPN2;DUSP1
prerank,amino acid transmembrane transport (GO:0003333),0.3750242617336685,1.2412028981932715,0.1799163179916318,0.6172766166950464,1.0,8/45,7.15%,SLC7A11;SLC6A13;SLC22A4;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC25A13
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5256303861824031,-1.2410827849057473,0.2124756335282651,0.5012507347386745,1.0,7/10,31.14%,VEGFA;FZD3;DISC1;CX3CR1;KDM1A;CTNNB1;SMARCD3
prerank,regulation of immune response (GO:0050776),-0.2899065515785075,-1.2408226530350628,0.09036144578313253,0.5012460641075946,1.0,26/135,15.46%,FOXP1;CXADR;B2M;CD34;IL15;CLEC2D;COL3A1;TGFB2;FKBP1A;CD81;IFITM1;DENND1B;N4BP1;CASP8;ERAP1;PVR;BCL6;TIRAP;LRP8;DHX58;ICAM2;SYK;SAMHD1;JAML;NECTIN2;ITGA4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.33214853117051124,-1.2406934174296582,0.12981744421906694,0.5009354490277198,1.0,26/80,17.57%,MAP3K5;THBS1;NOD1;MAP2K5;ARL6IP5;KLF4;RPS6KA3;NGF;CD44;REST;TNFSF10;VEGFA;PPM1F;GPX1;AKT1;NDUFA13;CTSD;SOX7;BEX3;SYK;DHCR24;BCAP31;CSNK2A1;IGBP1;BAD;FOXL2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4096981389939935,-1.240367765062816,0.1830188679245283,0.5011110227582918,1.0,8/29,8.85%,SHANK3;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5161152301810705,1.2401163532427308,0.24347826086956523,0.6188029272481765,1.0,3/11,5.13%,STAP1;TICAM1;CAMK4
prerank,negative regulation of cell differentiation (GO:0045596),0.2916019257403265,1.2400771109466142,0.078,0.6174855937126306,1.0,27/181,9.12%,RORA;ENPP1;ADGRV1;ADAMTS12;RUNX1T1;LDLRAD4;TBX3;BMP5;ABCA1;CNTN4;PPARA;SMAD3;RANBP3L;SFRP1;HOXB8;HES3;DTX1;FOXA2;SIRT2;MEN1;SOX2;TGFBR1;ABCA5;IGF2;HES5;NPHP3;GATA3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.47783664185249125,-1.2399430864778127,0.19889502762430938,0.5015387624396767,1.0,12/15,42.56%,NLRC5;CNOT7;YTHDF2;SAMHD1;TTLL12;PTPN2;MUL1;YTHDF3;USP18;OAS3;CACTIN;STAT2
prerank,positive regulation of neuron differentiation (GO:0045666),0.37653168410612964,1.2398977889321934,0.16289592760180996,0.6164605592839142,1.0,10/40,14.30%,TCF4;BMP2;ZEB1;BRINP1;BRINP3;NRCAM;KCTD11;FGFR1;BRINP2;GPRC5B
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.42136034799618216,1.2397704671732837,0.20689655172413793,0.6153335916239581,1.0,5/26,8.86%,LGR4;SMPDL3B;LRRC14;NLRP2B;GPR108
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32858194154023507,-1.239705317739222,0.12629399585921325,0.5014929166836254,1.0,17/75,11.10%,MEF2C;ACTB;PARD3;OPHN1;MEF2A;KLF7;APP;SHTN1;MINK1;S100B;MFSD2A;BTBD3;RB1;S100A6;RAB8A;LMTK2;TAOK2
prerank,positive regulation of cell growth (GO:0030307),-0.314854586707575,-1.2393282720547714,0.10311284046692606,0.501763244254054,1.0,40/96,25.08%,SEMA7A;NEDD4L;RPS6KA3;ITSN2;NGF;TGFB2;SHTN1;ADAM10;MFSD2A;EDN1;PABIR1;MMP14;AKT1;PLAA;H3-3A;AKAP6;CIB1;DBNL;DBN1;SYT2;FXN;SMURF1;CDKN2AIP;NTN1;SDCBP;EGFR;ERBB2;LIMK1;CSNK2A1;DERL2;SLC25A33;BRAT1;UNC13A;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;ZFYVE27;RPTOR
prerank,T cell differentiation in thymus (GO:0033077),0.48469985505350144,1.2389839613595324,0.2261640798226164,0.615948060308948,1.0,6/14,22.28%,GLI3;CCR6;FADD;RABL3;SHH;ZFP36L2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.4056542371894648,-1.2384163358265556,0.16822429906542055,0.5033333362777788,1.0,3/30,1.42%,PPP1R13B;ACER2;DDX5
prerank,lymphocyte proliferation (GO:0046651),-0.4351074139836807,-1.23840863111299,0.19760479041916168,0.5027144445685422,1.0,5/22,12.38%,MEF2C;CTPS1;MSN;HSPD1;PPP3CB
prerank,regulation of cell population proliferation (GO:0042127),-0.24937468263078835,-1.2380238378286201,0.016055045871559634,0.5030271858274463,1.0,155/691,16.42%,FN1;KITLG;LEF1;ZBTB7C;PTPN14;FLT1;IGF1R;CDK6;CLDN5;ITGA1;ACER2;IGFBP7;THBS1;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;BMPR2;LIFR;SH3BP4;JUND;KDR;KLF4;EGLN3;STX3;TFRC;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;ETS1;DAB2IP;NGF;SIX1;CDKN1B;RPRD1B;TGFB1;CNBP;REST;APP;TGFB2;RNF41;COL18A1;TBX2;RPL23;RPS15A;DNAJA2;TES;PLPP1;LIMS1;ADAM10;CYP1B1;ING5;CTBP1;IGFBP3;CD81;SMAD6;VEGFA;CNOT7;S100B;AQP11;JAG2;RBFOX2;WNT9A;RARA;IFITM1;SHC1;TGFB3;PRKDC;RGCC;ADGRG1;JUP;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;AKT1;INSR;BCL6;NOP2;KANK2;SOX7;PDGFC;PDGFA;WARS1;LAMC2;HHEX;CSNK2B;EMP2;DDRGK1;ACE2;JUNB;DIS3L2;INHBA;CDK4;GAS8;KMT2D;S100A13;FRK;CIB1;VEGFD;FTH1;TMEM115;FAM98A;GRK5;CDK10;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;ENG;RPS6KA2;ABI1;HRAS;NUAK1;P3H2;STAT5A;EID2;BCL6B;JAK2;SDCBP;SMYD2;EGFR;CHTOP;ERBB2;STRN;GAB2;OSGIN1;CLCF1;TNFSF13;PTPN6;CDK13;CDKN1A;CSNK2A1;NPR3;SMARCA2;UFL1;STAT1;GREM1;RBBP4
prerank,cardiocyte differentiation (GO:0035051),0.5292961915506097,1.2380132001230058,0.2234513274336283,0.6171529691323138,1.0,2/10,1.40%,BMP2;NRG1
prerank,negative regulation of protein transport (GO:0051224),-0.4116491698543222,-1.2371308265412337,0.17624521072796934,0.504518736412431,1.0,12/25,31.77%,WWP2;PPM1F;DPH3;APOE;RSAD2;SNX3;CSK;RHBDF2;NDFIP2;NDFIP1;SNX12;HMGCR
prerank,response to interferon-alpha (GO:0035455),-0.4591818309660212,-1.2369560839390221,0.19858156028368795,0.5042784387213347,1.0,5/16,9.14%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3119202755936728,1.2366692744447962,0.10916179337231968,0.6193603181775273,1.0,23/121,14.30%,IGF1;BMP6;IL31RA;NRP1;IL34;KIT;TNK2;LYN;GHR;IL4;IGF2;ERBB3;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TEC;DOK7;DLG4;TSLP;GPRC5B
prerank,regulation of monocyte differentiation (GO:0045655),-0.482543302446111,-1.2365023448522454,0.18857142857142858,0.5047961833932343,1.0,4/14,10.73%,FOXP1;CDK6;CTNNBIP1;CD74
prerank,receptor internalization (GO:0031623),-0.36580786631253315,-1.2356233067779092,0.16356877323420074,0.5063073200438925,1.0,9/44,9.89%,CAV1;DNM3;ACKR3;RAMP2;TFRC;CD81;CD9;AP2M1;FCER1G
prerank,aminoglycan biosynthetic process (GO:0006023),0.36916710657343177,1.2352893338123696,0.16633266533066132,0.6215312422322248,1.0,18/49,18.10%,GPC6;B3GALT1;B3GALNT1;GPC4;GPC2;B3GNT7;PXYLP1;GPC5;B3GALT2;HS2ST1;HS6ST2;B3GALT5;HS3ST6;HS3ST5;HSPG2;B4GAT1;B3GNT6;B4GALT7
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3267527368017278,-1.235137742456564,0.11450381679389313,0.5069221503652092,1.0,25/76,21.43%,CBFA2T3;RACK1;PTK2;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;SMURF1;RBX1;HECTD1;HSPA1A;CDK5RAP3;RNF19A;ELOB;LAPTM5;CCDC22;KEAP1;TRIB3;HSPA1B
prerank,V(D)J recombination (GO:0033151),-0.5114411361764942,-1.234809078875013,0.21568627450980393,0.5071149428570499,1.0,5/11,28.59%,PRKDC;TCF3;DCAF1;LIG4;HMGB2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5066387652748275,-1.2346149467633596,0.2092130518234165,0.5069203620198439,1.0,3/11,3.59%,RIN3;CCN3;SLIT2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3082694771665651,-1.2337140482781854,0.098,0.5084528898341716,1.0,46/98,32.81%,RAB11A;DCTN2;SMC4;ZW10;CHMP2B;KIF23;CSNK2B;RB1;DIS3L2;POGZ;CSNK2A1;CSNK2A2;SMC2;KIF18A;CHMP2A;BOD1;RAD21;KNSTRN;NCAPH;KIF18B;NIPBL;NSL1;NDC80;KIF22;NCAPG;REC8;SPDL1;CDCA8;CEP55;VPS4A;KMT5A;SEH1L;SGO1;EML3;NCAPH2;CHMP7;NAA50;TUBG2;TTN;PLK1;CDK1;NCAPD2;PSRC1;CHMP4B;CHMP4A;ESPL1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5096424003597934,-1.2332943701296626,0.2111111111111111,0.5089070274719413,1.0,8/12,32.17%,SEC63;HSPA5;SEC61B;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,cellular modified amino acid catabolic process (GO:0042219),0.47211894319969994,1.2332766178864027,0.21784232365145229,0.6255597530794117,1.0,3/15,6.00%,ALDH4A1;PRODH;GGT7
prerank,protein O-linked mannosylation (GO:0035269),0.4515842360353033,1.232709667222155,0.211864406779661,0.6256990643386212,1.0,7/18,17.56%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;B4GAT1;DPM1
prerank,regulation of acute inflammatory response (GO:0002673),0.4484808263230589,1.2325554024389263,0.21120689655172414,0.6246758741811369,1.0,5/18,16.60%,IL4;GSTP1;OSMR;PTGES;KLKB1
prerank,actin filament depolymerization (GO:0030042),0.5186375221446949,1.2325047812374101,0.22972972972972974,0.6234067322546246,1.0,1/11,0.13%,MICAL3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4285345757960345,-1.232229108660105,0.18164435946462715,0.5108516560421271,1.0,3/21,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4712580108262612,1.2321392482275684,0.21929824561403508,0.6229417526120995,1.0,3/16,3.98%,WNT4;LARP6;CREB3L1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4776905635064301,-1.232028721646327,0.1969111969111969,0.5107006170410494,1.0,11/14,26.68%,DAB2IP;BAX;DDRGK1;HSPA5;BAK1;COPS5;UFL1;TMEM33;BFAR;PTPN1;FICD
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4315486221898021,-1.2316664932535772,0.19288389513108614,0.5109101401764252,1.0,7/21,14.97%,ACTG1;LIMCH1;PEAK1;PTK2;VCL;DUSP3;LDB1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4926548521051054,1.2314747257438967,0.21380846325167038,0.6233127664518067,1.0,5/13,14.72%,PDPK1;AKT3;IGF2;FGFR1;SIRT6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.370444252781188,-1.2311995387321792,0.16435643564356436,0.5114217803128736,1.0,10/43,6.98%,DDX5;PPARD;KLF4;FOXO3;ETS1;TGFB1;REST;TGFB2;GATA2;NR3C1
prerank,regulation of translation (GO:0006417),-0.2905189557605255,-1.2310712113828335,0.072,0.5110952271076358,1.0,52/173,23.02%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;RPS6KA3;RPL10;FOXO3;RPS3;IGFBP5;APP;EIF4G3;EIF5B;CNOT7;PRKDC;HSPB1;GAPDH;NCL;DHX9;RPL13A;CAPRIN1;RPS27L;EIF3D;LARP4B;IMPACT;CIRBP;UPF3A;SOX4;TSFM;FMR1;RBM4B;ERBB2;PCIF1;LSM14A;GIGYF2;EIF5;ZCCHC4;TYMS;PAIP2B;SYNCRIP;EIF1;RPL5;YTHDF1;LTN1;PAIP1;EIF4G1;EIF4A2;NCBP2;PYM1;MRPL13
prerank,negative regulation of ossification (GO:0030279),0.4267136778569597,1.230677130715874,0.20594965675057209,0.6240888635009783,1.0,5/23,4.24%,ENPP1;BCOR;AHSG;LRP4;SFRP1
prerank,embryonic digit morphogenesis (GO:0042733),0.4566168659374933,1.23058429987351,0.221505376344086,0.6229861444322087,1.0,3/18,3.86%,SALL1;TBX3;GLI3
prerank,cortical cytoskeleton organization (GO:0030865),0.3774525951047083,1.2301107140704817,0.19126819126819128,0.6229089763284202,1.0,12/41,15.55%,EPB41L3;ROCK2;RHOH;RHOBTB1;FMNL3;FHOD3;NLGN1;RHOBTB3;RHOF;LLGL1;RND1;RHOQ
prerank,regulation of stem cell population maintenance (GO:2000036),0.4554370902425586,1.2300642619127877,0.22746781115879827,0.621638497661179,1.0,5/18,15.39%,PTN;TAF6L;LOXL2;TAF5L;NCOA3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3821248360372069,1.2295678838384287,0.18376068376068377,0.6215738566394602,1.0,8/37,10.34%,IGF1;GJA1;EFEMP2;TAFA5;DNMT1;BMPR1A;SOD2;PTEN
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.44132975200746616,-1.2294305825796312,0.20833333333333334,0.5144846933501364,1.0,9/19,23.08%,PLCE1;PPP3CC;EDN1;NFATC1;INPP5A;PPP3CB;ADGRB2;NFATC3;NMUR2
prerank,cellular response to interleukin-4 (GO:0071353),-0.5215853193932445,-1.2289940883701878,0.22867513611615245,0.5148492085777666,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,cardiac ventricle development (GO:0003231),-0.4244999730164235,-1.228546813033439,0.22282608695652173,0.5153165175030046,1.0,10/20,17.87%,NOTCH1;PDE2A;STRA6;HEYL;HES1;ENG;HEY1;HECTD1;TMEM65;DLL4
prerank,negative regulation of immune response (GO:0050777),0.2999168922965714,1.22831210265921,0.08761904761904762,0.6235887116877324,1.0,21/154,11.32%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;SIRT2;TRIM27;HRH2;GLP2R;RNF26;ADCY8;HTR4;PTGIR
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.451191870740026,1.2272007624781094,0.22058823529411764,0.6251126872491224,1.0,10/18,13.18%,NRXN1;RIMS1;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,positive regulation of T cell proliferation (GO:0042102),0.3544800625325832,1.227034909017669,0.1653061224489796,0.62416306810489,1.0,6/55,8.31%,IGF1;IGFBP2;IL4;CD274;IGF2;IL18
prerank,actin filament organization (GO:0007015),-0.2884748418377577,-1.2267107913816935,0.07468879668049792,0.5192457771075749,1.0,53/151,26.40%,NEBL;SHROOM4;MYO1D;BAIAP2L1;TMOD3;COBL;EPS8;VILL;ARHGAP17;PLS3;CD2AP;MPRIP;RAC1;NEDD9;ARHGAP25;HIP1R;ACTN1;LMOD1;FLII;TMOD1;EMP2;HIP1;RHOB;TRPV4;DBN1;ABI1;WASL;GAS2L1;SHROOM1;SHROOM3;TPM3;MYO1F;MARCKSL1;ARHGEF2;CAPG;TPM2;TPM4;RND2;TLE6;GAS2;AVIL;DMTN;CARMIL1;RFLNB;CORO7;AIF1;CDC42;MCU;ELMO3;INPPL1;MYO7A;TMOD2;MYO19
prerank,response to glucose (GO:0009749),0.3695393439828396,1.2266050699607736,0.1700404858299595,0.6239456591273591,1.0,6/46,5.80%,TCF7L2;ZBTB20;PRKACA;NKX6-1;IRS2;PDK3
prerank,response to organophosphorus (GO:0046683),-0.46195005700389447,-1.226377924992793,0.20555555555555555,0.5193706895183281,1.0,7/16,23.07%,TRPC3;ABCC9;TRIM16;NDUFS4;STAT1;TYMS;RFC3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.35327950160405686,-1.2262230174642677,0.16895874263261296,0.5191782829004761,1.0,25/52,28.98%,PPP1R13B;ABLIM3;PPP3CC;CASP8;SAE1;BBC3;YWHAZ;E2F1;VPS11;YWHAG;CSNK2A2;YWHAH;BAD;UBL5;SFN;FZD5;NPEPPS;MICALL2;YWHAB;YWHAE;UBE2J2;ATG13;NMT1;PMAIP1;YWHAQ
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3969357182358128,1.22593311921077,0.17516629711751663,0.6244192400474536,1.0,9/29,13.60%,LDLRAD4;BMP5;SFRP1;FOXA2;GATA3;PTEN;FUZ;ZNF750;NKX2-1
prerank,positive regulation of hormone secretion (GO:0046887),-0.4635144549571792,-1.2259322814483955,0.21080139372822299,0.5192209887065617,1.0,14/17,51.99%,VAMP7;EDN1;SPP1;RASL10B;EDN3;C1QTNF3;HFE;VAMP8;TFR2;CYP19A1;HCAR2;NMB;SOX11;GRP
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.339841770384665,-1.22585183716933,0.1553784860557769,0.5188259464410275,1.0,20/57,19.30%,BRCC3;TAOK3;FOXN3;PRKDC;UIMC1;BABAM1;RPS27L;TAOK2;CDC14B;RAD9B;HUS1;EME2;RAD9A;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;CCND1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.43162842797239703,-1.2257214418041804,0.20917431192660552,0.5185037846174391,1.0,8/22,22.43%,ESR1;MED24;PSMC4;PSMC5;SRF;MED14;PSMC3;MED13
prerank,postsynaptic membrane organization (GO:0001941),0.4656177823999823,1.2256894431525114,0.22431865828092243,0.6237335108235935,1.0,8/17,13.18%,NRXN1;LRP4;NLGN2;NLGN3;NLGN1;MUSK;CHRNB1;DLG4
prerank,sympathetic nervous system development (GO:0048485),0.4749865309011667,1.2256779403817817,0.22,0.6224072437612781,1.0,3/15,2.89%,NRP1;GDNF;SEMA3A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.28467967898788304,-1.225199627672805,0.07926829268292683,0.5191147016430805,1.0,66/185,26.49%,CDC14A;DCTN2;TUBA1A;CEP164;ZW10;UBB;PKD1;UBC;RPS27A;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;ANAPC15;PSMA6;RGCC;ANAPC11;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;PSMC5;PCM1;TUBB4B;PSMD14;E2F1;CDC14B;HAUS1;NDE1;PSMD8;CETN2;CEP72;YWHAG;PTPN6;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;FZR1;CUL1;TPX2;PSMA1;ANAPC2;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;PSMA2;ANLN;PSMB8;HAUS4;RIOK2;YWHAE;CEP63;NEDD1;PLK5;XPC
prerank,estrogen metabolic process (GO:0008210),-0.47464359332609674,-1.2251365011416848,0.2247787610619469,0.5186480985109805,1.0,4/15,18.41%,SULT1A1;CYP1B1;HSD17B10;HSD17B2
prerank,cellular response to starvation (GO:0009267),-0.28977645168017235,-1.2250364947185737,0.07956989247311828,0.5182922144119253,1.0,51/147,25.88%,MAP3K5;BMPR2;FOXO1;MAPK3;FOXO3;DAPL1;MAP1LC3B;ATP6V0B;HSPA8;RALB;GABARAP;ATF4;MFSD2A;FAS;ATP6V0C;ATG7;HSPA5;XPR1;IMPACT;MAP1LC3A;NUAK1;INHBB;NUAK2;LAMTOR2;GAS2L1;PRKAG1;ATP6V1G1;STK26;CDKN1A;RRAGD;XBP1;HNRNPA1;ASNS;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;RRAGC;SESN2;BRSK2;NUPR2;SIK1;CASTOR2;RPTOR;GABARAPL1;SREBF1;ATP6V0D1;SEH1L;SEC13
prerank,inhibitory synapse assembly (GO:1904862),0.5063402049482285,1.2246853616124864,0.2080536912751678,0.623638970991809,1.0,2/11,5.56%,GABRA2;GABRB3
prerank,skin development (GO:0043588),-0.33208873368642505,-1.2242101448149523,0.15384615384615385,0.5196911160330625,1.0,18/65,16.29%,ITGA6;CLIC4;LSR;COL5A2;COL3A1;ANXA1;ITGB4;PKD1;GATA6;BCR;PDGFA;COL5A3;DHCR24;HRNR;OPN3;EPHA2;MET;DSP
prerank,neuron migration (GO:0001764),0.36140092741318214,1.2241001138223038,0.17256637168141592,0.6237986679319346,1.0,11/48,13.81%,AUTS2;NRP1;SEMA3A;GPM6A;SH3RF1;ASTN2;NRCAM;CDK5R1;LRP12;FGFR1;TUBGCP2
prerank,regulation of necroptotic process (GO:0060544),-0.42682137738948694,-1.224003736462231,0.18882466281310212,0.5195884853863748,1.0,10/23,18.57%,CASP8;RIPK1;YBX3;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1;ARHGEF2
prerank,cellular response to inorganic substance (GO:0071241),-0.4227445176792934,-1.2237115371040974,0.19288389513108614,0.5196428728572221,1.0,3/21,4.92%,MTR;FOXO1;GUCY1B1
prerank,supramolecular fiber organization (GO:0097435),-0.26389437456760473,-1.2228044259404858,0.0465587044534413,0.521427867344403,1.0,72/334,12.53%,SHROOM4;COL25A1;PGM5;ITGA6;MYO1D;TLL1;B2M;TSPAN5;COL12A1;TMOD3;COL5A2;VIM;COL6A2;ARHGAP17;COL3A1;TNXB;PLOD2;COL4A2;CD2AP;ITGB4;HSP90AB1;MYH11;MPRIP;APP;TGFB2;COL18A1;FKBP1A;UBB;COL4A1;RAC1;ADAM10;CYP1B1;CHP1;CD151;LAMA3;UBC;RPS27A;TGFBI;COL6A1;ARHGAP25;BACE1;HIP1R;ACTN1;LMOD1;CENPJ;FLII;NEFL;COLGALT2;SLAIN2;RIPK1;MFGE8;STMN2;TMOD1;UBE2L6;CST3;PSENEN;LAMC2;USP9X;EMP2;H3-3A;TSPAN14;HIP1;DCTN1;COL5A3;RHOB;TRPV4;NF1;CIB1;PCM1;DBN1;PLOD3;KATNB1
prerank,renal filtration (GO:0097205),0.5153817542358476,1.2226209489668693,0.23725055432372505,0.6263331629182807,1.0,5/10,15.03%,SULF1;SULF2;JCHAIN;TBC1D8B;MYO1E
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3804806859099519,1.2222847004146726,0.19057377049180327,0.6259112829571379,1.0,10/41,15.67%,IL34;AREG;TGFA;STAP1;ERBB3;DOK7;DLG4;BTC;GPRC5B;FCGR1A
prerank,positive regulation of signaling (GO:0023056),0.3801965673736756,1.2219830976754933,0.19381443298969073,0.625272449250026,1.0,12/37,19.21%,WLS;CLSTN2;RIMS1;GRIK2;RAB29;SYT1;GATA3;DLG4;HCRT;VAMP3;RIMS2;LGI1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3670314645402547,-1.2215902847728572,0.16015625,0.5238187131508486,1.0,11/43,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4232007654562619,-1.2215131231474505,0.2078853046594982,0.5233838359883609,1.0,14/23,27.65%,UBB;UBC;RPS27A;CUL4A;COPS6;COPS5;RBX1;CETN2;COPS7A;COPS4;COPS7B;XPC;GPS1;RAD23B
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5135013899198366,1.2213858636334414,0.24557522123893805,0.625473782913139,1.0,4/10,12.63%,STAT5B;LYN;GHR;PRLR
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3886960753019675,1.2210867459284036,0.1908713692946058,0.6249261202296401,1.0,6/34,4.22%,SLC8A1;ANK2;PRKACA;P2RX4;ATP2A2;TNNI3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4504816416410146,-1.2208209804697872,0.20471014492753623,0.5245128790910035,1.0,5/17,12.89%,SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4642780423718876,-1.2205549784441168,0.20074349442379183,0.5244858485167158,1.0,9/16,28.86%,RB1;POGZ;BOD1;RAD21;NIPBL;REC8;SGO1;DSCC1;NAA50
prerank,regulation of astrocyte differentiation (GO:0048710),0.491470123265636,1.2204187735132623,0.23373493975903614,0.625353608534858,1.0,3/12,8.54%,BMP2;SERPINE2;HES5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.31400398073139046,-1.2199549658450388,0.13195876288659794,0.5253773825280187,1.0,34/88,27.47%,FBXO17;PSMA6;CUL4A;PSMB5;FBXO4;PSMC4;PSMC5;FBXL14;PSMD14;FBXW5;FBXL7;FBXL2;RBX1;PSMD8;PSMD11;CCNF;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;CUL1;DMAC2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;FBXL18;FBXO6;PSMB8;FBXO38;FBXL8;FBXO2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.40799722057546045,-1.2185343368374308,0.20857699805068225,0.5283041736623735,1.0,8/25,28.44%,BRD4;ZMYND11;NELFE;LDB1;CDK13;EAPP;ELL;RNF8
prerank,intermediate filament organization (GO:0045109),-0.4540969902777575,-1.2183722135650512,0.23290203327171904,0.5281201847241859,1.0,6/17,22.78%,VIM;NEFL;MTM1;DSP;GFAP;KLHL24
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.322263837473264,1.2183596310911153,0.15221579961464354,0.6294061616586192,1.0,7/86,4.95%,IGF1;BMP6;EPHA7;NRP1;TNK2;SFRP1;GHR
prerank,heart morphogenesis (GO:0003007),0.35540009241754755,1.2183346306634717,0.1522198731501057,0.6281191412719798,1.0,7/50,5.18%,TGFBR3;FLRT2;BMP2;TBX3;CHD7;OLFM1;DLC1
prerank,membrane assembly (GO:0071709),0.38405274922436383,1.2181811037649042,0.19603960396039605,0.6271633369267755,1.0,11/34,11.05%,NRXN1;LRP4;PTPRD;UBXN2B;NLGN2;NLGN3;UBXN2A;IL1RAPL1;NLGN1;PTEN;TLCD2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3892880657755672,1.2178289368057575,0.17916666666666667,0.6267009294146196,1.0,4/36,6.45%,NRP1;AREG;TGFA;NLGN3
prerank,response to UV (GO:0009411),-0.3117387126117035,-1.2176454861794834,0.14450867052023122,0.5293364066236738,1.0,28/95,23.42%,SCARA3;RPL26;MAP4K3;USP1;RHBDD1;ATF4;N4BP1;GPX1;YY1;AKT1;CIRBP;SPRTN;BAK1;FMR1;EGFR;RELA;CCAR2;KDM1A;POLK;ERCC4;CCND1;COPS9;PTPRK;UBE2B;RHNO1;TRIAP1;DTL;PRKCD
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5130865005505368,-1.2176401392455192,0.21503496503496503,0.5287173967004937,1.0,7/11,29.30%,CASP8;RIPK1;YBX3;PELI1;ARHGEF2;SLC25A4;FZD9
prerank,peptidyl-proline modification (GO:0018208),-0.4088444848792228,-1.217444592727549,0.19288389513108614,0.5285570550808095,1.0,11/25,25.21%,FKBP5;FKBP1A;PPIA;PPIC;P3H2;PPIG;PIN1;NTMT1;FKBP4;PPIB;PPID
prerank,regulation of cytokinesis (GO:0032465),-0.3258834597911348,-1.217325548526849,0.14587332053742802,0.5282205158752998,1.0,39/78,32.08%,PKP4;RAB11A;CDC14A;CALM1;GIPC1;ZFYVE26;PLK2;KIF23;CALM3;BCL2L1;PRKCE;CDC14B;RAB11FIP3;CETN2;KLHL9;ECT2;KLHL21;PIN1;PRPF40A;E2F7;KIF13A;PLK3;CDC42;CIT;VPS4A;PLK5;MYO19;SETD2;RACGAP1;CENPV;CSPP1;ENTR1;PLK1;AURKA;RHOA;PIK3R4;CDC6;E2F8;OPN1MW
prerank,chloride transmembrane transport (GO:1902476),0.35973030180178317,1.217086423390502,0.18309859154929578,0.6272629175731903,1.0,16/48,14.69%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;GABRB3;ANO3;GABRR2;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5046973887553149,-1.217039439295477,0.22467771639042358,0.5282802401886674,1.0,5/11,24.97%,F11R;TJP2;RAB1A;RAPGEF2;TJP1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5128690431840685,-1.2170228429290972,0.234375,0.5277012428727327,1.0,2/11,2.58%,NOTCH1;FOXO1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.39446383745800295,-1.21701005384229,0.19324577861163228,0.5271016371065621,1.0,7/30,15.49%,CD34;PLCG2;PRKCZ;HSPD1;TLR4;SYK;NOD2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.41442596586859126,-1.2167896139734242,0.20155038759689922,0.5270073398266637,1.0,10/25,19.15%,CAV1;CXADR;CAMK2D;CALM1;JUP;CTNNA3;CALM3;DSG2;DSP;CACNA1C
prerank,positive regulation of transferase activity (GO:0051347),0.2959745530570461,1.2164543886983532,0.1189083820662768,0.6276290290829478,1.0,37/142,13.38%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;MAPKAPK5;AXL;PDGFRB;EPHB1;IGF2;ERBB3;RYK;FGFR4;EPHA8;RFC5;PABPN1;ERBB4;EPHA5;TOPORS;ALK;MUSK;HNRNPD;CHRNA7;MST1R;DCUN1D4;MERTK;FGFR1;NBN;ROR1;EPHA1;SERINC1;PARN
prerank,positive regulation of neurogenesis (GO:0050769),0.3389701224617727,1.2163501891207842,0.16205533596837945,0.6265945554305727,1.0,17/68,14.57%,PLXNA2;ROBO1;ROBO2;PTPRD;SERPINF1;NPTN;IL1RAPL1;CUX1;CDKL3;CUX2;PLXNB2;NGFR;OBSL1;CAPRIN2;AMIGO1;DRD2;MAP6
prerank,endothelial tube morphogenesis (GO:0061154),-0.5066965390201633,-1.2157218223461859,0.2490842490842491,0.5289647623722665,1.0,7/10,31.12%,STARD13;CSNK2B;RHOB;PRKD2;CTNNB1;ACVRL1;RHOA
prerank,response to lipopolysaccharide (GO:0032496),-0.29070394104703595,-1.2156463734649074,0.1079429735234216,0.5285370053205929,1.0,56/138,34.11%,FOXP1;MEF2C;LBP;NOS3;VIM;SCARB1;RPS6KA3;DAB2IP;GCH1;MAPKAPK3;SMAD6;TNFRSF1B;OTUD5;TNFRSF11A;PLAA;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;NOD2;TNFAIP3;CX3CR1;TAB2;RELA;XBP1;PELI1;CASP1;GGT1;LGALS9;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SELP;SHPK;NOCT;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;NOS2;RHOA;CD14;LY96;NLRP3;TNIP2;SRR;NOS1;CXCL5;SLC11A1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4525819066747747,1.2153368848790238,0.24078091106290672,0.6278521414991133,1.0,2/17,0.68%,ATP1A2;AR
prerank,negative regulation of synaptic transmission (GO:0050805),0.42126508116706907,1.2147843274919494,0.22469635627530365,0.6280888511699246,1.0,12/23,25.67%,TMEM25;SLC24A2;PTEN;DRD2;SYT11;ACHE;PRRT1;GRIK3;STXBP1;SHANK2;DRD3;SLC24A1
prerank,nucleoside catabolic process (GO:0009164),-0.5068537456946638,-1.214588720856986,0.25276752767527677,0.5306042309798938,1.0,4/11,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3734001155663986,1.2144559955043677,0.19148936170212766,0.6276268311369786,1.0,8/39,10.13%,STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3216808028961169,-1.2140126113997054,0.1512770137524558,0.5314408543524752,1.0,25/70,23.09%,LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.33520363474411025,1.2140077100966533,0.19827586206896552,0.6274295890019315,1.0,7/65,2.77%,LTBP1;FBN1;LDLRAD4;FBN2;PPARA;PDPK1;SMAD3
prerank,BMP signaling pathway (GO:0030509),0.3391835339384702,1.2137571023929368,0.1789709172259508,0.6267902201869452,1.0,5/62,2.77%,BMP6;TGFBR3;BMP2;BMP5;SMAD3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.38516956434810445,-1.2135770952293394,0.20708955223880596,0.5319356539389712,1.0,9/31,12.32%,SHANK3;SIPA1L1;ABI3;CAPRIN1;LRP8;CFL1;DBNL;DBN1;SRCIN1
prerank,response to fatty acid (GO:0070542),0.45484378107460965,1.213545366310812,0.21748400852878466,0.6259784378796023,1.0,4/17,5.80%,PID1;PDK4;GLDC;PDK3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4407625331920857,1.213495391981201,0.23390557939914164,0.6248206038813916,1.0,3/19,3.98%,WNT4;LARP6;CREB3L1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.5095576914929341,-1.2134447359379235,0.226691042047532,0.5316468105932752,1.0,5/11,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,cellular glucose homeostasis (GO:0001678),-0.36192143553862255,-1.2133005416797904,0.17,0.5313695442809985,1.0,9/41,5.37%,IGF1R;RACK1;UNC13B;LRRC8D;FOXO1;HK1;KCNB1;PPARGC1A;FOXK1
prerank,ERAD pathway (GO:0036503),-0.3225519751040885,-1.2132607593080706,0.15051546391752577,0.5308399816627012,1.0,36/83,31.15%,SEL1L;TRIM25;RHBDD1;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;ERLEC1;TMEM129;TMUB2;SGTB;TMUB1;BRSK2;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3315135190406594,-1.2131653450209896,0.166,0.5304407144501027,1.0,25/65,25.24%,FHL1;PSMA6;PSMB5;PABIR1;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;CHEK1;CDK5RAP3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;VPS4A;PSMB8
prerank,positive regulation of immune effector process (GO:0002699),-0.39632550089441665,-1.2130715066863778,0.20676691729323307,0.530065454745938,1.0,8/27,20.27%,LBP;PTPRJ;CD81;RPS19;DHX58;ANKRD17;XBP1;LGALS9
prerank,calcium ion import into cytosol (GO:1902656),0.46457219091230373,1.2130264260798356,0.22244488977955912,0.6246687981187723,1.0,3/15,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4311123700603749,-1.212979878119159,0.21481481481481482,0.5296626219632743,1.0,3/20,7.21%,ANO6;THBS1;RGCC
prerank,cardiac cell development (GO:0055006),-0.5042934903158826,-1.2126744382688321,0.2331511839708561,0.5298048662991839,1.0,4/11,5.68%,CXADR;NOTCH1;MYH11;VEGFA
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.4301120878079023,-1.212357848512261,0.2263056092843327,0.5299035132154112,1.0,7/20,17.08%,TGFB1;ADAM10;RHBDD1;MBTPS2;PSENEN;APH1A;RELA
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5175605092734495,-1.2114042196286496,0.22140221402214022,0.5316979949611839,1.0,4/10,19.16%,LRCH1;AKT1;WASL;CD200
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4185370110841914,1.2113894433914933,0.22172949002217296,0.6275960396905205,1.0,4/21,2.62%,ENPP1;BCOR;AHSG;ROCK2
prerank,mitochondrion distribution (GO:0048311),-0.49065264079563065,-1.211363400086903,0.24577861163227016,0.5311858855700473,1.0,4/12,15.08%,TRAK1;MEF2A;TRAK2;MTM1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.43215034906020955,-1.2100304009293315,0.1996370235934664,0.5338584232177453,1.0,6/19,19.08%,HK1;AKT1;ARL2BP;HSPA5;CHCHD10;ARL2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4346039963425258,-1.209659116291491,0.23351158645276293,0.5341510144564957,1.0,5/19,12.43%,LBP;TIRAP;PIK3AP1;PRKCE;TLR4
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4012160792364923,-1.2092635532322478,0.20881226053639848,0.5345316288367866,1.0,10/28,23.91%,OCLN;RPS3;RAC1;SLAIN2;DCTN1;MET;HSPA1A;ARL2;HSPA1B;CLIP1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.27442728868276667,-1.2092076152097169,0.08050847457627118,0.5340172596763738,1.0,69/204,25.79%,CDK6;CCND3;EPS8;CCNY;DCTN2;TPD52L1;TUBA1A;CDKN1B;CEP164;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;CUL4A;PLK2;NES;CEP70;DCTN3;CCNG2;RB1;PPP1CB;CEP290;CNTRL;DCTN1;INHBA;E2F3;CDK4;CRLF3;PPP1R12B;PCM1;TUBB4B;ACVR1;E2F1;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CCNF;CDKN1A;ANAPC7;CDC27;HSP90AA1;CEP41;FBXL3;CUL1;CHMP2A;CDKN2C;CCND1;LCMT1;RCC1;DNM2;PPP2R2D;TUBA4A;EIF4EBP1;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;EIF4E;SPDYA;HAUS4;YWHAE;CEP63;NEDD1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.40691788095817877,-1.2085769641365915,0.21772639691714837,0.5349321679137883,1.0,11/24,11.89%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10;DUSP3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3785451971639856,-1.2084465530072885,0.1776937618147448,0.5340278291971956,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,tRNA export from nucleus (GO:0006409),-0.3785451971639856,-1.2084465530072885,0.1776937618147448,0.5340278291971956,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.31927044986936026,-1.208322658401974,0.1378640776699029,0.5336941581524338,1.0,27/78,24.41%,CAV1;CBFA2T3;RACK1;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;BCAP31;RBX1;SGTA;HECTD1;FZR1;HSPA1A;RNF19A;ELOB;KEAP1;TRIB3;HSPA1B;PLK3;RAD23A;COP1
prerank,carboxylic acid transport (GO:0046942),0.349551661498519,1.2077739606690991,0.17786561264822134,0.6359332736940599,1.0,13/55,11.29%,SLC13A3;SLC6A12;SLC6A9;SLC16A12;SLC6A13;SLC17A1;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC1A5;SLC38A3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4088671125386031,-1.2077511474748253,0.21468926553672316,0.534495746809187,1.0,9/25,17.25%,ZNF326;ZMYND11;HMGN1;TSFM;LDB1;ALYREF;CCNK;DDX39B;CCAR2
prerank,response to thyroid hormone (GO:0097066),-0.47628739958195176,-1.2077090552920644,0.23369565217391305,0.5339823332921751,1.0,5/13,25.75%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,L-amino acid transport (GO:0015807),0.39661763183875,1.2077083307361671,0.22127659574468084,0.6347987748147069,1.0,10/28,15.98%,SLC1A3;SLC7A2;SLC36A2;SLC7A9;SLC25A13;SLC38A3;CTNS;SLC1A2;SLC7A3;SLC25A18
prerank,mesenchyme morphogenesis (GO:0072132),-0.4576753418046307,-1.207591228437053,0.2110912343470483,0.5336445485096173,1.0,10/17,19.37%,NOS3;NOTCH1;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1;SMAD2;SOX9
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3780314150000791,-1.2075790129116286,0.17938931297709923,0.5330468551581474,1.0,14/35,18.39%,MEF2C;CAV1;FLT1;THBS1;CAV2;PTPRM;ATP5F1A;RGCC;NF1;APOE;ATP5IF1;STAT1;DLL4;KRIT1
prerank,response to growth factor (GO:0070848),-0.365485724608167,-1.207175016743084,0.188,0.5334389595310138,1.0,12/41,15.34%,TGFBR2;RACK1;BMPR2;MAP2K5;KLF4;GATA6;SHC1;AKT1;CIB1;ACVR1;ERBB2;EPHA2
prerank,response to histamine (GO:0034776),0.5307762292163122,1.206744352635323,0.2543859649122807,0.6359973195681751,1.0,7/10,25.54%,GABRB3;HRH1;DRD2;GABRB1;GABRG2;GABRB2;DRD3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.38561391938620376,-1.2066749159639754,0.2047244094488189,0.5340610531743127,1.0,19/30,39.33%,CAV1;PRKCZ;PPP2R1A;SRCIN1;PTPN6;CADM4;PRKCD;DMTN;PTPN2;PARP14;MVP;HYAL2;NF2;SH3BP5;NTF3;PPP2CA;INPP5F;SFRP2;SOCS3
prerank,inorganic anion transport (GO:0015698),-0.3440420300346454,-1.2063265909786876,0.1710794297352342,0.5342761237020222,1.0,7/53,2.99%,SLC4A10;ANO6;SLC26A7;CLIC4;ANO1;CLIC1;CLIC5
prerank,regulation of smooth muscle contraction (GO:0006940),-0.42478666462333203,-1.2058917151015378,0.2034548944337812,0.5346760480608932,1.0,2/20,0.35%,PLCE1;CAV1
prerank,cell-cell junction assembly (GO:0007043),0.3361095038427013,1.2056004552304873,0.17338709677419356,0.6377086252094796,1.0,14/63,6.72%,EPB41L3;TLN2;GJB6;GJA1;CDH8;PRKCA;CDH18;DCHS1;ARVCF;CTNND2;CDH11;CDH20;CDH19;CDH7
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.3021370460088141,-1.2055667432374872,0.1350806451612903,0.5348965279039128,1.0,28/104,19.30%,ACTB;CCND3;LRP5;DAB2IP;CALM1;CDKN1B;HTT;RALB;TRIB2;AKT1;CCNG2;TRIB1;RB1;CAMK1;CIB1;MTCP1;CALM3;CSF1R;TSG101;SNF8;CAB39;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,erythrocyte development (GO:0048821),-0.517410312420774,-1.205395214525376,0.24302788844621515,0.5346845729152189,1.0,5/10,32.94%,ZBTB7A;ALAS2;DMTN;ABCB10;LYAR
prerank,acylglycerol homeostasis (GO:0055090),0.43139074139932093,1.2053508040559102,0.24735729386892177,0.6370361141002311,1.0,3/20,11.14%,RORA;IL18;PLA2G12B
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.40054099778089836,-1.2053493446837464,0.2210144927536232,0.5341947187807528,1.0,4/27,3.29%,UTRN;NEDD4L;FXYD5;CAMK2D
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.25431690469246904,-1.2053218634386147,0.033185840707964605,0.5336493205661589,1.0,89/417,14.15%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;HMBOX1;ID3;PPARD;NCOR1;FOXO1;KLF4;DAB2IP;ZBTB7A;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;TWIST1;TRIM28;HHEX;SOX18;RB1;ZC3H8;FOXP2;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;CIART;MTERF3;PHF12;EPC1;MLX;PHB2;SMARCA4;EID2
prerank,membrane organization (GO:0061024),-0.2727138336490325,-1.20513642958903,0.08333333333333333,0.5335027069857017,1.0,63/227,22.02%,CERT1;ACTB;DNM3;SPTBN1;ACTG1;FNBP1L;TFRC;MYOF;FZD4;EPN1;VAMP7;LPCAT3;ATP2C1;UBB;IGF2R;HSPA8;CHP1;UBC;RPS27A;NAPA;DYSF;HIP1R;REPS2;CHMP2B;A4GALT;NUP93;ARPC5;AP2M1;ITSN1;PIK3C2A;HIP1;FCHO2;SGIP1;TOR1AIP1;SYT2;ACTR3;TMEM43;MITD1;EPN2;NPC1;NUP155;WASL;EGFR;AP2A1;AGFG1;SLC2A8;OPA1;SYNJ1;RABEP1;REEP4;VTI1B;DNM1;CHMP2A;TOR1AIP2;CTTN;SNX3;PACSIN2;DNM2;TMEM33;TIMM50;LPCAT2;CLTA;GLTP
prerank,calcium ion import (GO:0070509),0.3964159639857699,1.204036123802804,0.22474226804123712,0.639216428126718,1.0,7/28,7.59%,SLC8A1;CACNA1E;ATP2A2;CACNA1I;MICU3;CACNA1G;CACNB2
prerank,regulation of exit from mitosis (GO:0007096),-0.36892380516280576,-1.2039466095891642,0.1944990176817289,0.535882227818092,1.0,12/38,16.23%,CDC14A;ZW10;UBB;UBC;RPS27A;ANAPC15;RGCC;ANAPC11;CDC14B;PHB2;ANAPC7;CDC27
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4850344903839233,-1.2038128529979193,0.25045045045045045,0.5355915575193072,1.0,3/12,3.87%,PTPRJ;F3;IFT20
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.3119626638030887,-1.2037368239469,0.14450867052023122,0.5351703674963972,1.0,26/88,15.29%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;VEGFA;RGCC;ERCC1;BAX;TAL1;PFN1;WARS1;FLOT1;SYNPO;TIRAP;VCP;RAB7A;BAK1;SLX4;SYK;SLF1;SDCBP;TSG101;LIMK1;SNF8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3262063257817738,-1.203667965795343,0.1640625,0.534717379554802,1.0,18/63,23.81%,MEF2C;IL15;SLC7A1;TFRC;ANXA1;CD38;CD81;TIRAP;CD74;CLCF1;JAK3;CD320;NCK1;FGF10;IL6ST;TNFSF13B;NCK2;AIF1
prerank,cellular response to heat (GO:0034605),-0.37158406375756803,-1.202961624057714,0.20683111954459202,0.5358137874877386,1.0,9/35,10.66%,THBS1;ANO1;FGF1;HSP90AB1;CLPB;HSBP1;TCIM;VCP;TRPV4
prerank,mesoderm development (GO:0007498),-0.44446814919045724,-1.2027507464998473,0.22545454545454546,0.5357232359401494,1.0,13/18,31.82%,TIE1;TBX1;BMX;MESD;VEGFA;FOXC2;JAK2;HCK;BTK;MEST;GDF11;TCF15;TBX6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.38246063226095584,1.2025470167251109,0.21181262729124237,0.6420348055010693,1.0,5/35,4.77%,PLXNA2;NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3004631365955909,-1.2021431965519245,0.1310483870967742,0.5365940110044106,1.0,27/110,12.89%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;HSPA8;RALB;PRKCZ;NAPA;VEGFA;HCFC1;AIDA;SVIP;KIF9;BAX;TAL1;WARS1;RB1;TIRAP;VCP;HSPA5;NCLN;IMPACT;APOE;BAK1;SYK
prerank,aorta morphogenesis (GO:0035909),0.4519282877681671,1.2019490054539863,0.2546583850931677,0.6422862366375368,1.0,7/17,11.83%,LRP1;EFEMP2;MYLK;PDGFRB;RBPJ;BMPR1A;ADAMTS9
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.33783473204344344,-1.2013549322052188,0.18181818181818182,0.5380002173057525,1.0,18/54,22.12%,TAX1BP1;RACK1;HIPK1;IKBKB;CASP8;RIPK1;SYK;TRAF1;TNFRSF1A;MADD;TNFAIP3;HSPA1A;CHUK;TRAIP;LAPTM5;CASP1;HSPA1B;CCDC3
prerank,cell-cell junction organization (GO:0045216),-0.31211690144889676,-1.2011453570643145,0.1565040650406504,0.5378866482590654,1.0,19/79,10.88%,PKP4;OCLN;CLDN5;LIMS2;CXADR;CDH1;CTNNA1;TJP2;TGFB1;TGFB2;SDK1;LIMS1;CDH4;TGFB3;JUP;GJC1;PVR;TRPV4;CDH6
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.33094427932686526,-1.200940862342997,0.17704280155642024,0.5377798436167271,1.0,32/60,37.80%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;RGCC;FBXO4;PNKP;FGF2;DKC1;CCT2;GREM1;HSP90AA1;CCT3;HNRNPA1;CCT8;PRKD2;RFC3;RFC2;CCT7;DSCC1;CTNNB1;CHTF18;MYC;PKIB;WRAP53;CCT4;MAP2K7;CCT6A;MAPK15;NVL;GRHL2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.39154916914924465,-1.2009330713395303,0.1927927927927928,0.5371948946888888,1.0,15/29,34.63%,CAV1;THBS1;TNFSF10;RIPK1;INHBA;PPP2R1B;RET;LTBR;TNFRSF12A;BCL10;PMAIP1;PAK2;HYAL2;HTRA2;TNFSF12
prerank,regulation of epidermal cell differentiation (GO:0045604),0.43385887702453096,1.2007588808566805,0.2224824355971897,0.6440417797303711,1.0,2/21,2.62%,ERRFI1;ROCK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4202805347764778,-1.2004308663964194,0.2202486678507993,0.5379279394489801,1.0,9/22,17.82%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;GTF2H4
prerank,apoptotic process (GO:0006915),-0.277729944966801,-1.2003443521019137,0.102880658436214,0.5375374008645173,1.0,56/203,20.16%,SEMA6A;TGFBR2;PTK2B;NFKBIA;PPARD;FOXO1;EGLN3;FAP;TBX1;ADAM15;RFK;APP;PPIA;MAGI3;ZBTB16;DPF2;PPP2R1A;CASP7;TNFRSF21;CASP8;RIPK1;GAPDH;DDX41;BAX;AKT1;PLAGL1;MAL;FAS;HSPD1;HIP1;RHOB;TNFAIP1;PAEP;TAOK2;PRUNE2;CIB1;BBC3;BCL2L1;PRKCE;BAK1;DHCR24;JAK2;MRPS30;PIK3CA;NCKAP1;DDIT4;BAD;TSC2;TRAIP;CHEK1;MAGEH1;GADD45A;ARHGEF6;BIK;BRAT1;CASP1
prerank,regulation of cell motility (GO:2000145),-0.2904296740017323,-1.2000275527491269,0.136,0.5377462939109803,1.0,34/121,14.97%,TMSB4X;FRMD5;CDK6;SPOCK2;FGF1;CYRIB;TGFB1;PLXNA4;RAC1;CAVIN1;ROBO4;MINK1;AMOT;DIAPH1;CRK;CCDC125;SPATA13;ABI3;AKT1;TWIST1;TMSB10;RHOB;PLXNA1;PLXND1;ABL2;RCC2;SRCIN1;FGF2;CSF1R;NTN1;EGFR;ERBB2;OSGIN1;LDB1
prerank,tRNA aminoacylation (GO:0043039),-0.3644623445776116,-1.199915636007793,0.2,0.5373969567618504,1.0,17/37,30.43%,SARS1;QRSL1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;GATC;FARS2;FARSB;IARS1;GATB;GARS1;KARS1;NARS1;IARS2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45875423847638763,1.1998587385077064,0.24053452115812918,0.6450324095066094,1.0,7/15,16.39%,NLGN2;NLGN1;CNTNAP4;BAIAP3;DRD2;ADRA1A;CLN3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4484163163545866,1.1995186988938003,0.2635135135135135,0.64468168250448,1.0,11/17,23.41%,VIRMA;ZC3H3;CPEB3;CPSF7;CCNT1;CDK9;CPEB1;HSF1;CPSF6;NUDT21;CTR9
prerank,negative regulation of secretion by cell (GO:1903531),-0.3564237852565449,-1.1993553277454125,0.1893939393939394,0.5382014496635241,1.0,7/38,13.26%,STXBP6;NOTCH1;ANXA1;TNFRSF1B;DPH3;APOE;TNFRSF1A
prerank,membrane protein proteolysis (GO:0033619),-0.3626941298576581,-1.1989048513504958,0.18446601941747573,0.5386800440266353,1.0,12/37,17.85%,BACE2;TGFB1;ADAM10;BACE1;RHBDD1;ADAM19;ERAP1;MBTPS2;PSENEN;APH1A;RELA;RET
prerank,protein localization to synapse (GO:0035418),0.4924246740851391,1.1987693997999582,0.23974082073434125,0.6454148801477221,1.0,5/12,17.07%,NRXN1;NLGN2;NLGN1;DLG4;ZDHHC15
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3256754057840168,-1.1986417283502484,0.18046709129511676,0.5387461342336112,1.0,25/67,26.20%,PODXL;CAV1;ATP8B1;TBC1D8;PPP1R16B;IFT20;RAC1;TBC1D1;TBC1D22A;ATG3;FMR1;TBC1D9B;EPHA2;TBC1D2;RABEP2;DCDC2;TBC1D15;DMTN;FSCN1;CDC42;ODAD3;MYO10;TBC1D17;RDX;CDKL5
prerank,negative regulation of interferon-beta production (GO:0032688),-0.5102606043777995,-1.1982869601635764,0.23392857142857143,0.5389988801771747,1.0,6/10,32.29%,REL;YY1;RELB;LILRB1;PTPRS;NLRC3
prerank,sulfur compound catabolic process (GO:0044273),0.3732760284068508,1.198165260792632,0.18813905930470348,0.6457056102090867,1.0,8/38,7.32%,FMOD;DCN;OMD;GNS;LUM;GGT7;GALNS;OGN
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.45213582278259534,1.1977100655329829,0.25313807531380755,0.6456134645556573,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5005398336980106,-1.197427477226208,0.23684210526315788,0.5405134699503324,1.0,2/11,3.73%,RREB1;CD44
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.3595009102931251,-1.1973823535279433,0.20119521912350596,0.5400168441001667,1.0,7/39,7.21%,TEK;ANO6;THBS1;KDR;RAMP2;GATA2;RGCC
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.46707577625020036,1.1968015786487034,0.24528301886792453,0.6467564001090197,1.0,4/15,6.19%,TNK2;DGKD;AAK1;SNAP91
prerank,lipid translocation (GO:0034204),-0.4178244235978312,-1.1965234211643474,0.2174721189591078,0.5415281959098832,1.0,6/21,8.51%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;ATP9B
prerank,histone H4-K5 acetylation (GO:0043981),-0.4546317291235656,-1.1965078646094602,0.24436090225563908,0.5403540843481244,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),-0.4546317291235656,-1.1965078646094602,0.24436090225563908,0.5403540843481244,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4911852250960558,1.1964507714134636,0.25663716814159293,0.6463823883808,1.0,2/11,0.54%,TGFBR3;BMP2
prerank,development of primary male sexual characteristics (GO:0046546),0.38000610313907024,1.1963362361120005,0.21413276231263384,0.6453791775689735,1.0,7/34,9.12%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5042370221580569,1.1963065583948964,0.2413793103448276,0.6428908194534972,1.0,10/10,49.61%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5042370221580569,1.1963065583948964,0.2413793103448276,0.6428908194534972,1.0,10/10,49.61%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.260055208581764,1.196253264724073,0.08759124087591241,0.6417632367065266,1.0,71/390,12.95%,COL4A6;IGF1;EPHA7;PIK3R1;IL31RA;NRP1;FLRT2;ATP6V0A4;NTRK3;DDR2;ANGPT2;FGFR2;SULF1;NRG1;SULF2;KL;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;ROCK2;EPHA6;VEGFB;FLRT1;PDK4;PTPRT;STAP1;PHIP;LYN;DDR1;EFNA3;GHR;IRS2;AXL;SHC4;CASP3;PDGFRB;SIRT2;EPHB1;POLR1G;PDGFD;IGF2;ERBB3;RYK;POLR2G;FGFR4;CDK5R1;SH2D2A;EPHA8;AHI1;SH2D6;ERBB4;ESRP1;EPHA5;ATP6V1H;ALK;BRK1;MUSK;MST1R;NGFR;MERTK;GFRA2;ANKS1B;FGFR1;PRLR;KALRN;ROR1;EPHA1;BCAR1
prerank,positive regulation of gene expression (GO:0010628),-0.25016876249526726,-1.195909062783263,0.05215419501133787,0.541238079739486,1.0,87/442,13.26%,FN1;LEF1;MEF2C;ACTB;OCLN;CLDN5;THBS1;NOS3;CD34;TNRC6C;NOTCH1;DDX5;ACTG1;PLCG2;VIM;IL15;RPL26;FGF1;F3;KLF4;MAPK3;EEF2;RAMP2;TFRC;NIBAN1;RPS4X;RPS3;ETS1;NGF;RPL11;HNRNPLL;TGFB1;RBM20;APP;RAB27A;MSN;RPL23;SMO;PDE2A;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;EZR;ATF4;ADAM19;GATA2;PRKDC;LURAP1;TLR3;HCFC1;RGCC;RIPK1;KRAS;GAPDH;PPM1F;AKT1;RBM22;TWIST1;WARS1;FLOT1;DDRGK1;WNT11;RPS27L;GABPA;EIF3D;CD74;INHBA;LARP4B;S100A13;WBP2;CIRBP;FAM98A;SERPINB9;UPF3A;E2F1;RPS7;TLR4;SOX4;FGF2;SPHK2;AGPAT1;FMR1;PIK3R3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.31612981037508847,-1.1953033380369091,0.15851272015655576,0.5420804820911909,1.0,29/74,25.24%,NOTCH1;EGLN3;UBB;UBC;RPS27A;VEGFA;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;HIF1AN;PSMB8
prerank,histone H4-K16 acetylation (GO:0043984),-0.4305177089671607,-1.194974585650955,0.23863636363636365,0.5422979089927986,1.0,5/19,8.18%,MSL2;PHF20;JADE2;HCFC1;KANSL2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.3190189023393354,-1.1948627280661188,0.17038539553752535,0.5419868235124103,1.0,27/72,26.38%,CARD14;REL;TLR3;PSMA6;PSMB5;AKT1;RELB;TIRAP;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;TRAF6;PSMB8;CARD10
prerank,cellular response to interleukin-1 (GO:0071347),-0.2830583428613207,-1.1942634836218908,0.10245901639344263,0.5428128537879279,1.0,46/143,24.36%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;DAB2IP;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;RC3H1;PSMB5;CCL15;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;SOX9;HAS2;MAPK11;PSMA1;ADAMTS7;PSMB1;PSMC3;PSMA4;PSMA2;HYAL1;TRAF6;CCL2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.43506892722290613,1.1940948001859268,0.2288329519450801,0.6461524704991375,1.0,3/18,5.08%,FBN1;GPR55;IL4
prerank,granulocyte chemotaxis (GO:0071621),-0.3350338768489048,-1.1940692469973926,0.19157088122605365,0.5427156854127113,1.0,10/55,14.21%,BSG;CXADR;ANXA1;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,positive regulation of T cell activation (GO:0050870),-0.32140343676662597,-1.1940547104279395,0.1905697445972495,0.5421420314354578,1.0,17/62,24.36%,IL15;SLC7A1;TFRC;CYRIB;ANXA1;CD81;HSPD1;FLOT2;NOD2;XBP1;JAK3;LGALS9;NCK1;IL6ST;NCK2;AIF1;CCL2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3715910149067736,-1.1939794098834022,0.22099447513812154,0.5417486865638921,1.0,14/37,21.54%,CAV1;RACK1;RPS3;UBB;BAX;SFPQ;BBC3;BCL2L1;RPS7;BCAP31;BAD;MSX1;NCK1;FIS1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.47457987749858954,1.1938465715334887,0.2708803611738149,0.6455089446696808,1.0,4/14,4.95%,PIK3R1;STAT5B;LYN;GHR
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.33732231351826947,1.1937925549964818,0.1934826883910387,0.6443483412486664,1.0,4/56,1.32%,BMP6;BMP2;LDLRAD4;BMP5
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3645846719838565,-1.193697307176697,0.21691176470588236,0.5418369318418764,1.0,13/39,18.07%,UTRN;NEDD4L;FXYD5;FHL1;WWP2;RIPK1;TRPC6;HOMER1;SPHK2;PHB2;CACNA1D;YWHAH;SCN2B
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.28528272495598833,-1.1930802178013986,0.11563169164882227,0.5428638272364251,1.0,33/151,14.67%,TEK;BMPER;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;SHC1;PDE8A;NPNT;FLT4;TNFRSF11A;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;APOE;FGF2;CSF1R;HRAS;PHB2;EGFR
prerank,neutrophil migration (GO:1990266),-0.3295130106518281,-1.1929866642696383,0.18304431599229287,0.5424861742515175,1.0,10/58,14.21%,PECAM1;BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4819949430696966,-1.192791226524045,0.2332730560578662,0.5424001203089766,1.0,3/12,2.73%,PODXL;PROM1;IQGAP1
prerank,iron ion transport (GO:0006826),0.35305541271445695,1.1923564786505,0.2079207920792079,0.6468963408272642,1.0,4/47,1.49%,CP;STEAP3;ATP6V0A4;HEPH
prerank,actin polymerization or depolymerization (GO:0008154),0.35467160307712864,1.19180491666109,0.20901639344262296,0.647185476472686,1.0,3/50,0.25%,MICAL3;SVIL;ARHGAP6
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3021665969365255,-1.1910372783873866,0.13253012048192772,0.5461229205805558,1.0,30/101,15.49%,FLT1;CCND3;FGF1;CCNY;TPD52L1;DAB2IP;FERMT2;CALM1;TGFB1;RALB;PKD1;PIK3R6;VEGFA;RGCC;EDN1;AKT1;PDGFC;PDGFA;TCIM;CAMK1;CIB1;MTCP1;CALM3;FGF2;CSF1R;HRAS;EGFR;ERBB2;CAB39;NOD2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3894326217499298,-1.1909297111408108,0.2462406015037594,0.5457908682331941,1.0,12/29,20.30%,NAPA;RAB6B;GOSR1;COPG1;COPB2;COG8;COG3;GOLGA5;COG5;VTI1B;NSF;COG2
prerank,vesicle transport along actin filament (GO:0030050),-0.4255723096717368,-1.1906701723571655,0.2426470588235294,0.5458325190620726,1.0,3/19,2.18%,MYO1D;FNBP1L;ACTN4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4025680027379588,-1.190614304964527,0.23345588235294118,0.5453718691119882,1.0,5/25,8.00%,CAV1;TMTC2;TRPM7;FAM20A;JPH2
prerank,ventricular septum morphogenesis (GO:0060412),0.40036867417754024,1.190310038656918,0.2251655629139073,0.6499516494260612,1.0,3/27,0.57%,ROBO1;TGFBR3;ROBO2
prerank,cellular component assembly (GO:0022607),-0.26549924156930216,-1.190096381600341,0.09955752212389381,0.5460073297207556,1.0,53/253,16.42%,ACTB;OCLN;SLC2A1;LIMS2;BAIAP2L1;PARVB;SPTBN1;ACTG1;PARD3;RHOJ;EPS8;PTK2B;OPHN1;PLS3;FERMT2;CD2AP;TGFB1;ZW10;RAC1;LIMS1;GORASP2;RP1;NEDD9;PPARGC1A;PPP2R1A;TAPBP;REPS2;EZR;STK25;QSOX1;PDGFA;ADD1;FAS;FAM107A;CEP290;SPEF1;CD74;GAS8;TEAD2;YTHDF2;HAS1;VMP1;YWHAZ;HES1;TRAF1;CDAN1;WASL;MDN1;CHCHD10;SHROOM1;SKAP2;NCKAP1;RBBP4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.43087089035044956,1.1900507547570363,0.23505154639175257,0.6493167721455468,1.0,10/20,23.08%,HENMT1;AGO4;SNIP1;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;DICER1
prerank,negative regulation of nuclear division (GO:0051784),0.49444858846786477,1.1898154370786396,0.25813953488372093,0.6487120604856947,1.0,4/11,16.62%,AURKAIP1;TOM1L2;TOM1L1;FBXO5
prerank,regulation of protein kinase A signaling (GO:0010738),0.4244197404457696,1.1890920353456673,0.22510822510822512,0.6493691641216175,1.0,3/20,6.91%,ADGRV1;IAPP;CALCR
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4708891436308443,-1.189043548055072,0.29285714285714287,0.5479437896924725,1.0,5/13,13.01%,IFIH1;DHX9;CD74;MAVS;AGPAT1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.409764700147181,1.1885468600911646,0.2398286937901499,0.649535504120292,1.0,4/23,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4323204165302679,1.1884110444224771,0.2539325842696629,0.6486360413014973,1.0,3/20,13.44%,WNT4;CRY1;EP300
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5122520298593591,1.1882337195294599,0.2823779193205945,0.6478531659376036,1.0,4/10,18.79%,KIT;LYN;BTLA;FGR
prerank,regulation of mitochondrial fusion (GO:0010635),0.49639472484587754,1.1878965747039718,0.27294117647058824,0.6475151508363706,1.0,3/11,5.39%,PID1;OMA1;PRKN
prerank,leukotriene metabolic process (GO:0006691),0.4331785245349997,1.1878699189505917,0.2336065573770492,0.6463302978718549,1.0,4/19,7.34%,PLA2G5;ALOX12;PLA2G4A;DPEP2
prerank,purine-containing compound salvage (GO:0043101),0.4714030693804294,1.1878122661519719,0.2554585152838428,0.6452399711560617,1.0,2/12,6.90%,AMPD3;GMPR
prerank,lysosome localization (GO:0032418),-0.35554055502409454,-1.1874882893003094,0.22285714285714286,0.5512760974232817,1.0,20/37,31.97%,PLEKHM1;PLEKHM2;BORCS5;PIP4P1;S100A13;FAM98A;NDEL1;SPAG9;VPS33A;ARL8B;TFEB;MILR1;BORCS6;PIK3CG;MYH9;KXD1;KIF5B;VPS33B;RAB3A;LAMTOR1
prerank,heterochromatin organization (GO:0070828),-0.4627453880316653,-1.1874721249122853,0.2694394213381555,0.5507150256900587,1.0,2/14,4.27%,MECOM;PRDM16
prerank,mesenchyme development (GO:0060485),0.4573419389606098,1.1874439076945236,0.25279642058165547,0.6450211677190323,1.0,3/15,7.95%,BMP2;FGFR2;TGFBR1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5107346110211347,1.1873535134319013,0.2832618025751073,0.6440479589755417,1.0,2/10,7.15%,SLC1A3;SLC25A13
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.47588872246012226,-1.186927039810424,0.2672566371681416,0.5514658266623652,1.0,2/12,9.23%,CD44;FLOT1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5059164364962014,-1.1867576082767373,0.2586520947176685,0.5512646494999365,1.0,5/11,16.40%,EGLN3;EGLN2;EGLN1;P3H2;CRTAP
prerank,positive regulation of protein binding (GO:0032092),-0.3329798124903886,-1.1854402491733367,0.20695970695970695,0.5539767961503336,1.0,13/56,9.23%,CAV1;CLDN5;B2M;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;IDE;NMD3;ADD1;FLOT1
prerank,regulation of lipid kinase activity (GO:0043550),0.4785276047272979,1.1849263117619144,0.27157894736842103,0.6490194305707243,1.0,1/11,0.26%,PIK3R1
prerank,regulation of dephosphorylation (GO:0035303),-0.4465797815315774,-1.184911557465684,0.23204419889502761,0.5546829301028291,1.0,8/15,30.98%,PPP1R16B;IGBP1;PPP1R16A;SMG7;CDK5RAP3;MTMR2;SRC;SMG6
prerank,protein localization to vacuole (GO:0072665),-0.46866303892033023,-1.18488634774476,0.25464684014869887,0.5541511192313525,1.0,4/13,14.70%,SH3BP4;CD81;GLMP;MFSD1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4696582256812266,1.1848579992984662,0.2679738562091503,0.6479753444066464,1.0,3/13,9.35%,BMP6;TGFBR1;BMPR1A
prerank,acute inflammatory response (GO:0002526),-0.4044016165696336,-1.1845057693783203,0.2261029411764706,0.554510659873528,1.0,3/23,2.55%,ANO6;LBP;F3
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.42951525786841255,-1.184402358027166,0.27052238805970147,0.5541281852233723,1.0,12/18,35.86%,MANBA;FBXO17;SAMHD1;OGA;FBXO6;NEU2;NAGA;FBXO2;STT3B;FUCA1;AOAH;NEU4
prerank,regulation of microtubule-based process (GO:0032886),0.36748231744650794,1.1843562903249578,0.22950819672131148,0.6479518493700368,1.0,9/36,14.57%,PHLDB2;EPHA3;ATF5;KLHL42;MEMO1;BICD1;MAP10;MAPT;MAP6
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.37046730581464005,1.1842018686254219,0.23841059602649006,0.6471440289290858,1.0,9/43,11.19%,IGF1;GJA1;CCN4;PDGFRB;IL18;DNMT1;HES5;BMPR1A;IL6R
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4066636201649905,-1.1840975261672586,0.2523020257826888,0.5542981373163026,1.0,8/22,25.56%,BRD4;HMGN1;ALYREF;CDK13;CCNK;DDX39B;EAPP;ELL
prerank,ERBB signaling pathway (GO:0038127),0.34131813182580395,1.183968453886167,0.21052631578947367,0.6464930173421339,1.0,10/64,4.45%,PIK3R1;AREG;NRG1;PDPK1;PRKCA;SLC30A10;DGKD;TGFA;NRG4;NRG2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3539669616709592,-1.1839092348504934,0.21560574948665298,0.5541475442893319,1.0,17/44,27.92%,PTPRJ;DAB2IP;AIDA;DNAJA1;UCHL1;NF1;STK38;APOE;SPRY1;CDK5RAP3;PTPN22;PTPN1;PRKCD;SMPD1;SPRY4;PDCD4;DUSP1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.42807016982529233,-1.1837512763868792,0.25,0.5539501690302795,1.0,8/20,13.09%,SHANK3;CAPRIN1;LRP8;CAMK1;DBNL;DBN1;APOE;FMR1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4193505283487581,1.1835867336265309,0.24152542372881355,0.646303216770302,1.0,4/20,6.24%,SULF1;SULF2;CREB3L1;NPTN
prerank,protein secretion (GO:0009306),0.34019692239732224,1.1835546811163937,0.19624217118997914,0.6451605137708118,1.0,13/56,16.10%,WLS;STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2;CYB5R4;COPG2;PORCN;SVBP
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4074113732705783,-1.183192204152418,0.22030651340996169,0.5548020809618144,1.0,9/22,16.40%,CALM1;VEGFA;RASSF2;PDGFC;PDGFA;TAOK2;CALM3;ACE;GREM1
prerank,regulation of fatty acid oxidation (GO:0046320),0.45758226474139496,1.1830097601231926,0.2678185745140389,0.6453742230797616,1.0,3/16,3.91%,PPARA;PRKAG2;PDK4
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3068974532504317,-1.1830021452665282,0.15264187866927592,0.554672460658906,1.0,27/85,21.44%,CBFA2T3;RACK1;RNF144B;DAB2IP;TMEM259;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;RNF185;VCP;USP5;PSMC5;FMR1;RBX1;HECTD1;HSPA1A;RNF19A;OSBPL7;ELOB;KEAP1;TRIB3;HSPA1B;PSMC3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4750395374133945,-1.1824129203087246,0.28342245989304815,0.5555798400048558,1.0,2/12,4.03%,PTPN14;TGFB1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.35862662630051073,-1.1822797825776805,0.21839080459770116,0.555333635233384,1.0,8/39,5.31%,PTPRG;PODXL;CDH1;DPP4;PTK2;SMAD7;TGFB1;MINK1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.45199981817125945,1.1821486602843343,0.25118483412322273,0.6463546881043823,1.0,3/15,7.03%,MOXD1;SAT1;TPH2
prerank,regulation of mitotic nuclear division (GO:0007088),0.35028338894801125,1.1819539408935298,0.2111801242236025,0.6456657801055087,1.0,12/55,13.29%,IGF1;AURKAIP1;TGFA;PHIP;CUL9;PDGFRB;IGF2;BORA;TOM1L2;TOM1L1;OBSL1;BTC
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4455952053246276,-1.181666132318354,0.25364963503649635,0.5557062232545735,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4455952053246276,-1.181666132318354,0.25364963503649635,0.5557062232545735,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,anion transport (GO:0006820),-0.3733425810578557,-1.1815541026328782,0.2184557438794727,0.5553917732202143,1.0,5/33,2.31%,ABCG2;SLC26A7;SLCO2B1;LRRC8C;LRRC8D
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4014085484354791,-1.18149267239572,0.24266144814090018,0.5549489450577171,1.0,13/22,39.24%,CHP1;UFM1;GDI1;RANGAP1;RAB23;DMTN;PARK7;BARD1;INSIG1;SIAH3;APOD;CABP1;INPP5K
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.49188265091382266,-1.1807122151400902,0.27355072463768115,0.5563548143003898,1.0,2/11,3.46%,MEF2C;ANXA1
prerank,negative regulation of cell motility (GO:2000146),0.3034393504082686,1.1806012206988528,0.15368852459016394,0.647878328451729,1.0,28/108,14.26%,ROBO1;LDLRAD4;PODN;FBLN1;SULF1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;SPOCK3;DLC1;SRGAP3;SRGAP2;SERPINE1;DPYSL3;CITED2;GATA3;PTEN;FUZ;AFDN;NGFR;EPHA1;NAV3;NKX2-1;DRD2;ARPIN
prerank,positive regulation of translation (GO:0045727),-0.30287409976975216,-1.180487194510031,0.16634429400386846,0.5562700215087825,1.0,29/94,17.01%,THBS1;VIM;RPL26;EEF2;NIBAN1;RPS4X;RPS9;CNBP;UQCC2;PKM;PRKDC;YBX3;DHX9;RPS27L;EIF3D;LARP4B;RPS6KB2;YTHDF2;CIRBP;UPF3A;SOX4;FMR1;COA3;TRMT10C;UHMK1;ERBB2;RPUSD4;FASTKD3;PCIF1
prerank,amyloid-beta metabolic process (GO:0050435),-0.44237117544439974,-1.1803428298560723,0.225,0.5560371695238666,1.0,6/16,14.32%,BACE2;BACE1;IDE;PSENEN;ACE;APH1A
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.40716641736267845,-1.1802766717822133,0.21121495327102804,0.5556261358992598,1.0,3/21,2.33%,CAV1;PLTP;NFKBIA
prerank,positive regulation of T cell migration (GO:2000406),-0.41141269470950426,-1.1802216474076823,0.2757352941176471,0.5552098642281665,1.0,3/20,4.91%,WNK1;APP;ADAM10
prerank,cellular protein modification process (GO:0006464),-0.23344045433802663,-1.1801508009881003,0.009950248756218905,0.5547798226836094,1.0,217/983,17.51%,FN1;PTPRB;PRKCH;ST3GAL6;PTPRG;ERG;ST3GAL4;PTPN14;CDK6;MAP3K5;ST8SIA4;CTTNBP2NL;IGFBP7;THBS1;GPC3;RPS6KA5;PTPRJ;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;RAB11A;BMPR2;TGM2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;EGLN3;WNK1;LMO7;MANBA;STK10;BMX;COL3A1;NEK7;CAMK2D;PLOD2;ANXA1;MAP3K1;MAP3K20;SOCS2;IGFBP5;FNIP2;TGFB1;APP;TGFB2;RBBP5;FAM20A;SUMF2;KLHL5;WWP2;CSNK1G2;MSLN;ADAM10;SPARCL1;PRKCZ;CTDSP1;CTBP1;PTPRM;IGFBP3;MINK1;SSH2;DCAF6;ZBTB16;PPP3CC;RHBDD1;TAOK3;NRBP1;PTP4A2;PPP2R1A;KLHL2;IKBKB;RARA;ST8SIA6;PRKDC;FBXO17;BCR;MSRA;MGAT1;NUCB1;PSMA6;CSNK1G3;SRPK1;PPP2R5A;DCUN1D1;PPM1F;WSB2;TRIB2;STK25;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;PLK2;UBE2L6;DYRK2;AKT1;INSR;CST3;MAP3K11;SPP1;CDC42BPB;CPE;PNPLA2;ATG3;TRIB1;PIM3;ART3;PPP1CB;ATG7;RAB8A;LMTK2;ASB8;COPS6;WNT11;UBE2F;DAD1;PSMC4;CAMK1;WDTC1;CDK4;ABL2;TAOK2;PSMC5;FRK;STK36;FBXL14;VRK1;RAB11B;PPP2R1B;STK38;CHRDL1;GRK5;ACVR1;MMP15;PKN3;PPP5C;PSMD14;YWHAZ;FBXW5;FBXW10;APOE;PRKCE;CDK10;PPP3CB;ICMT;FSTL1;PPP2R2A;SYK;COPS5;KLHL3;FBXL7;CDC14B;FASTK;SUMF1;PIGT;ST6GALNAC2;CDKL4;TBCK;SERP2;FBXL2;NUAK1;NPC1;LOX;NUAK2;FUCA2;CISH;FEM1A;PTPN12;RBX1;RAB1A;JAK2;F13A1;COG3;PSMD8;ERBB2;PRKAG1;COQ8A;WSB1;MTM1;LMTK3;PARP2;GLRX;LIMK1;NEK3;PTPN6;PSMD11;YES1;CCNF;STK38L;STK26;CDK13;UCHL3;CSNK2A1;LGALS1;UFL1;DSP;PSMB4;PSMD12;PSMC1;PHEX;FBXL3;FBXL16;F5;PPP2R5E;GAN;CTH;RCE1;MAP3K9;JAK3;HCK;CUL1;MCRS1
prerank,tRNA transport (GO:0051031),-0.364149174361039,-1.180042928212196,0.19348659003831417,0.5544543875182248,1.0,17/35,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,response to interleukin-4 (GO:0070670),-0.5005817631792161,-1.1796254362244658,0.25226860254083483,0.5548730056357786,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,neuron projection morphogenesis (GO:0048812),0.2929014497430727,1.1795359028473902,0.16498993963782696,0.6495163884814927,1.0,28/137,10.84%,NRK;EPB41L3;FGFR2;CNTN4;CNTNAP2;LRP4;GPM6A;FLRT1;DOCK10;CTNNA2;SLITRK4;MYO16;SRGAP2;CTNND2;EPHB1;ALCAM;GAS7;TNIK;NLGN1;MAPK8IP2;DOCK7;NRCAM;RYK;RAB10;DCC;FARP1;PTEN;BRSK1
prerank,fluid transport (GO:0042044),-0.4815117082051604,-1.1792476948731176,0.26124567474048443,0.5552335220084883,1.0,9/12,51.87%,AQP11;AQP4;SLC26A6;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5013580545923697,-1.1792314844849594,0.28385899814471244,0.5546848868720328,1.0,3/10,3.71%,RAP1A;RAPGEF1;NGF
prerank,extracellular matrix assembly (GO:0085029),-0.4063439410806984,-1.1789275874969485,0.2365988909426987,0.5548273972596808,1.0,7/23,11.70%,RAMP2;TNXB;MYH11;TGFB1;NTN4;QSOX1;HAS1
prerank,potassium ion homeostasis (GO:0055075),-0.4017969733687553,-1.1788484115120696,0.2465277777777778,0.5544575178345886,1.0,5/23,7.63%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2802852667463252,-1.1776193015936416,0.14919354838709678,0.5568328409532222,1.0,49/158,21.16%,NOD1;TFRC;MID2;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;RIPK1;EEF1D;GAPDH;PLK2;TRIM14;TIRAP;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;TNFRSF1A;TRIM68;TRIM5;NOD2;TMEM101;LGALS1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5019521556126468,1.1774395375630058,0.2831858407079646,0.6535195710175413,1.0,1/10,0.47%,ATP1A2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.45745465968387955,1.1773488695370946,0.2791762013729977,0.6524905202345911,1.0,5/15,17.95%,TCF7L2;XPO4;EMD;BAG3;TP53
prerank,acidic amino acid transport (GO:0015800),0.44017939266770856,1.1771033085673008,0.27973568281938327,0.651966102581161,1.0,3/17,1.59%,SLC1A3;GJA1;SLC6A13
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4049704489969376,-1.1769087555344135,0.23473282442748092,0.5579922348457768,1.0,6/21,8.83%,BACE2;ADAM10;BACE1;ADAM19;ERAP1;PSENEN
prerank,response to insulin (GO:0032868),0.3171946607026384,1.176838552868493,0.1932938856015779,0.6513908623159995,1.0,12/80,10.59%,ENPP1;PIK3R1;TBC1D4;PDPK1;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.31733781798419725,-1.176173995880785,0.16153846153846155,0.5592483790959507,1.0,13/70,6.61%,FN1;TEK;MEF2C;PARVB;PXN;OPHN1;PEAK1;LAMA5;FERMT2;RAC1;NTN4;ATF4;ACTN1
prerank,transition metal ion homeostasis (GO:0055076),0.3966194719147701,1.175964355501117,0.23326133909287258,0.6524214393892463,1.0,4/28,5.39%,CP;HEPH;NEO1;PRKN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4543092372597537,1.175892146949556,0.27637130801687765,0.6501950861902983,1.0,3/16,5.18%,ARHGAP6;PHLDB2;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4543092372597537,1.175892146949556,0.27637130801687765,0.6501950861902983,1.0,3/16,5.18%,ARHGAP6;PHLDB2;DLC1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4899599852555848,-1.175837218786092,0.2730560578661845,0.5595412221799805,1.0,5/11,19.76%,DHX9;WTIP;LIMD1;FMR1;PUM2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.447830132329536,1.1756979430846577,0.25165562913907286,0.6494810071718604,1.0,3/17,3.98%,WNT4;LARP6;CREB3L1
prerank,regulation of gene expression (GO:0010468),-0.23361157553735928,-1.174587181658347,0.014218009478672985,0.5620484920194923,1.0,174/903,14.99%,BNC2;FN1;LEF1;FOXP1;MEF2C;PRDM6;OCLN;CDK6;CLDN5;AHNAK;APBB2;RREB1;CDH1;NOS3;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;ACTG1;PLCG2;NOVA2;RPL6;SLC7A5;FGF1;AHNAK2;MBNL1;RACK1;HMG20B;KDR;JMJD1C;F3;KLF4;NLK;MAPK3;RAMP2;TFRC;RPS3;ETS1;SOX17;NGF;VSX1;RPL11;SIX1;HNRNPLL;TGFB1;RBM20;CNBP;REST;APP;TGFB2;RAB27A;TRRAP;AFF4;MSN;RPL23;SMO;PDE2A;NFYA;ZNF431;CRIP1;REL;WWP2;ASCC2;PPARGC1B;LIMS1;ADAM10;PFDN5;FOXD1;RLIM;PRDM2;PPARGC1A;BHLHE40;MYOM1;SOX13;SLC39A8;IL33;VEGFA;CNOT7;ACTA2;PTBP3;PPP2R1A;TAPBP;PRDM4;EZR;ATF4;ADAM19;FOXN3;ZNF326;GATA2;CASP8;NR3C1;TLR3;HCFC1;NFKBIZ;RGCC;KRAS;UBAP2;PPM1F;ATP1B1;YBX3;RC3H1;GPX1;NR2C2;YY1;HDAC4;ATXN1L;AKT1;SPIN1;INSR;FZD7;BCL6;FUS;SOX7;PCBP4;TWIST1;WARS1;TRIM14;SOX18;RB1;ESRRA;TDRD7;DDRGK1;ACE2;PRRX2;WNT11;MYBL1;HNRNPDL;GABPA;WTIP;CD74;INHBA;MTA1;CDK4;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;YTHDF2;FAM98A;SERPINB9;E2F1;RPS7;ZNF423;APOE;CLK1;TLR4;SOX4;HINT1;TOB2;FGF2;TSKU;ENG;PIK3R3;FASTK;PHF12;BTN3A3;HRAS;POGZ;HCFC2;MLX;TRIM68;RNF20;CAVIN4;BCL6B;NR5A2;HEY1;TRIM5;HNRNPK;LDB1;FLOT2;PRKAG1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.46474478888950815,-1.1741843231280626,0.2752808988764045,0.5625295109954516,1.0,6/13,26.94%,ELOVL7;ELOVL5;TECRL;ELOVL1;HACD4;HACD2
prerank,mitochondrial protein processing (GO:0034982),0.487299571380968,1.173649602576746,0.27872340425531916,0.6536588325318915,1.0,5/11,20.83%,OMA1;IMMP1L;YME1L1;PMPCA;AFG3L2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.4052400699348216,-1.1735647831504847,0.24305555555555555,0.5635347169950882,1.0,7/21,26.41%,GPI;HK1;PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.44409992035727697,-1.1735641890131243,0.26714801444043323,0.5629458316015742,1.0,3/16,5.28%,MEF2C;BOC;IGFBP3
prerank,miRNA metabolic process (GO:0010586),0.4167883911068865,1.1735305729964027,0.24288840262582057,0.6527675257980545,1.0,7/20,16.05%,TUT4;LIN28B;KHSRP;XPO5;PARN;BCDIN3D;DROSHA
prerank,muscle organ development (GO:0007517),0.34538351186533967,1.1733543593424998,0.2033195020746888,0.6520020878364787,1.0,7/54,4.40%,IGF1;LAMA2;VAMP5;ITGA11;SGCD;SGCE;EVC
prerank,amino acid import (GO:0043090),-0.4191090478045183,-1.1733288968061413,0.24293785310734464,0.5629303571671601,1.0,7/21,5.92%,SLC47A1;SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC1A1;SLC25A38
prerank,neuron projection regeneration (GO:0031102),0.501955418071376,1.1732759243071387,0.2606837606837607,0.6510039199593205,1.0,2/10,5.48%,PTN;NREP
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.31591067770406395,-1.1732687117253187,0.19477911646586346,0.562494634856685,1.0,20/73,11.91%,ACER2;NOD1;RACK1;F3;EGLN3;NGF;CRADD;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;BAX;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3
prerank,sensory perception of chemical stimulus (GO:0007606),0.4636177458183215,1.172915761312982,0.27191011235955054,0.6508032992012636,1.0,4/15,14.14%,OMP;SLC24A4;UBR3;DRD2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.35028138576466095,-1.172660554365618,0.21626617375231053,0.5634908819705001,1.0,10/41,12.17%,SLC12A7;SLC12A2;KCNJ2;ABCC9;ATP1A1;KCNJ10;ATP1B1;KCNJ8;KCNK9;KCNJ15
prerank,chloride transport (GO:0006821),-0.3123073833124247,-1.172633044327185,0.18217821782178217,0.5629799912031856,1.0,10/74,4.60%,SLC4A10;ANO6;SLC12A7;SLC26A7;CLIC4;SLC12A2;ANO1;CLIC1;CLIC5;SLC1A1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3560538202644387,1.1719362706456184,0.24549549549549549,0.6520282636252092,1.0,8/37,7.71%,TENM3;GRID2;DCHS1;PTPRD;TENM2;IL1RAPL1;ALCAM;NLGN1
prerank,regulation of hemopoiesis (GO:1903706),0.5089699477599228,1.1719181818613995,0.26697892271662765,0.650874283784184,1.0,2/10,9.15%,PTN;PRKCB
prerank,ruffle organization (GO:0031529),-0.436597796101735,-1.1717025088022661,0.2608695652173913,0.5647637089778045,1.0,11/16,39.24%,RAC1;CSF1R;CARMIL1;AIF1;PIP5K1A;PLEK;TPM1;LIMA1;CYFIP1;PLEKHA1;INPP5K
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3697587965761905,-1.1715988992563393,0.22857142857142856,0.5644426895722254,1.0,10/35,19.52%,HMBOX1;MAPK3;NEK7;HNRNPA2B1;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4348674296456497,1.171524510137384,0.26153846153846155,0.6506871446163394,1.0,3/18,5.04%,LTBP1;SMAD3;LRRC32
prerank,histone monoubiquitination (GO:0010390),0.406531352726427,1.1715079438912428,0.26195426195426197,0.6495352648187036,1.0,12/24,27.46%,BCOR;DDB2;RNF2;SKP1;TRIM37;WAC;PAF1;KDM2B;CTR9;RNF168;RYBP;LEO1
prerank,regulation of spindle organization (GO:0090224),0.44007021256018886,1.170732961906485,0.27107061503416857,0.6504162668147834,1.0,7/18,19.01%,GNAI1;MAP9;BORA;FSD1;PARP3;NUMA1;NUP62
prerank,ERK1 and ERK2 cascade (GO:0070371),0.41941444098866204,1.1703543769639144,0.26371308016877637,0.6502793002175757,1.0,1/21,0.08%,IGF1
prerank,proteoglycan biosynthetic process (GO:0030166),0.381815303343647,1.1701200382548609,0.23695652173913043,0.6496966572665183,1.0,4/31,4.91%,IGF1;CHST8;GAL3ST3;PXYLP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.392833984121179,1.1698382454383829,0.2653927813163482,0.6492861429218688,1.0,4/26,3.41%,GDNF;VDR;CYP27B1;POR
prerank,positive regulation of cytokine production (GO:0001819),-0.25314204407744906,-1.1697589478541985,0.09876543209876543,0.5685350401688594,1.0,114/292,32.07%,FOXP1;AFAP1L2;LBP;CD34;SPTBN1;PLCG2;IL15;SLC7A5;NOD1;IFIH1;F3;PDE4D;CYRIB;RPS3;ANXA1;GBP5;TGFB1;APP;PRKCZ;CYP1B1;IL1R1;LRRFIP1;IL33;RARA;ATF4;PRKDC;LURAP1;TLR3;RGCC;RIPK1;GAPDH;DDX41;FLT4;DHX9;TWIST1;FLOT1;FCER1G;HSPD1;TIRAP;DHX58;PAEP;CD74;S100A13;MAVS;TLR4;SPHK2;SYK;AGPAT1;POLR3E;CSF1R;RAB1A;POLR3A;NOD2;IL17RA;POU2F2;HSPA1A;RELA;XBP1;ARHGEF2;CGAS;TXK;PTGER4;CD200;LAPTM5;LGALS9;MAPK11;FZD5;IL6ST;HSPA1B;PRKD2;C3;PTPN22;POLR3B;PIK3CG;ZFPM1;AIF1;HILPDA;IL12RB2;TRAF6;BCL10;NFAM1;TMEM106A;PARK7;LAMTOR5;SOD1;CTNNB1;RASGRP1;CARD11;LILRB1;CD86;C1QTNF4;MRE11;NOX1;TLR6;POLR1C;POLR2F;EGR1;HTR2B;LY9;HYAL2;TLR1;SCRIB;NOS2;PLCB1;MBP;TLR5;PQBP1;TYROBP;POLR2L;CD14;CADM1;SLAMF6;KAT2A;NLRP3
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3445539265074387,-1.1692424649016129,0.22878228782287824,0.5691964527258885,1.0,12/44,23.64%,BAIAP2L1;PTK2B;LMOD1;PFN1;PRKCE;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;CARMIL1;NCK2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3347324196752349,1.1690538672826734,0.20496894409937888,0.650063610185806,1.0,8/51,7.53%,NRK;EPB41L3;CNTNAP2;GPM6A;MYO16;SRGAP2;GAS7;TNIK
prerank,integrin-mediated signaling pathway (GO:0007229),-0.31056650281520176,-1.1689778136482214,0.17729083665338646,0.5692699891519473,1.0,13/73,5.29%,FN1;SEMA7A;DOCK1;PTK2B;PTK2;COL3A1;LAMA5;FERMT2;ITGB4;ADAM15;ADAM10;NEDD9;LAMA3
prerank,aggrephagy (GO:0035973),-0.38274228784523373,-1.1682586777049833,0.2536764705882353,0.5704996844349695,1.0,5/27,5.40%,VIM;UBB;DYNC1LI2;UBC;RPS27A
prerank,xenobiotic transport (GO:0042908),-0.4373813555829703,-1.1678828274436794,0.2702702702702703,0.570859605864395,1.0,3/17,1.79%,ABCG2;SLC47A1;SLC7A5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.39823031277035736,1.1676100838059038,0.2511111111111111,0.6526792836821377,1.0,3/25,9.12%,IGF1;NSD1;GATA3
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.3486355602986072,-1.1672650068009744,0.20833333333333334,0.5718331768046947,1.0,18/41,27.53%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.394077278343062,1.1668630961771729,0.2505050505050505,0.653414928624128,1.0,11/26,13.18%,NRXN1;RIMS1;TMEM25;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.35156022260902753,1.1666010932135764,0.2398190045248869,0.6529424282340736,1.0,4/46,2.77%,TCF7L2;PIK3R1;ZIC1;SMAD3
prerank,meiosis I (GO:0007127),0.40876156220662097,1.1656792648876115,0.26170212765957446,0.6541819497307453,1.0,4/23,7.97%,BCL2L11;MEIKIN;HSF2BP;ZSCAN21
prerank,muscle cell differentiation (GO:0042692),-0.3735513691448964,-1.1652933663452516,0.24029574861367836,0.5761833798037759,1.0,6/32,2.95%,MEF2C;NEBL;MRTFB;SYNE1;DMD;TBX1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.33833065900146586,-1.1651651092454578,0.23493975903614459,0.575897105117932,1.0,23/49,31.18%,MANBA;DAB2IP;MTREX;FBXO17;IDE;RIPK1;DENND3;PPP1R8;UBE2G2;RNF5;UBE2G1;OGA;DNASE1L2;RNASEH2C;DFFB;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;XRN2;ISG20;SIDT2
prerank,regulation of viral life cycle (GO:1903900),-0.4029099156892014,-1.1644257663811945,0.2581818181818182,0.5772202533542087,1.0,8/21,15.28%,TRIM25;PPIA;TRIM14;TRIM62;TRIM68;TSG101;TRIM5;NECTIN2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.418286837712403,-1.1642648363487398,0.2706766917293233,0.5769725555582397,1.0,7/18,21.89%,SEC14L1;RNF125;DHX58;USP15;ANKRD17;PUM2;ZCCHC3
prerank,regulation of aerobic respiration (GO:1903715),-0.44075679605747076,-1.1639015959632075,0.28835489833641403,0.5772893100954946,1.0,4/15,10.41%,CBFA2T3;UQCC2;IDE;VCP
prerank,ganglion development (GO:0061548),0.49421089998959306,1.1638858047230605,0.3133047210300429,0.6577107601516214,1.0,3/11,7.40%,NRP1;SEMA3A;UNC5C
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.43415541453420703,-1.1638617367748487,0.26716141001855287,0.576814106918553,1.0,7/17,27.16%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22;PTPN2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.47327731865981876,-1.1636854859924992,0.26229508196721313,0.5766808538802815,1.0,2/12,5.01%,SORBS1;PRKCZ
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4123405500295715,1.163610628890005,0.259958071278826,0.6572910663382711,1.0,2/24,0.26%,AUTS2;PIK3R1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.445239908191262,-1.1634037400642414,0.25996204933586337,0.5768095304831422,1.0,3/15,12.49%,ENTPD1;ENTPD7;ENTPD6
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2957822943378979,-1.1631877688185155,0.16913319238900634,0.5767742814164126,1.0,41/107,23.34%,MAP3K5;THBS1;RASGRF2;NIBAN1;SEL1L;DAB2IP;TMEM259;GORASP2;RHBDD1;UFM1;ATP2A3;ATF4;MBTPS2;DNAJB12;BAX;FLOT1;DDRGK1;RNF185;VCP;HSPA5;BBC3;BAK1;RNF5;ERP44;BCAP31;UFL1;PIK3R2;UFC1;CDK5RAP3;UBA5;ERLEC1;CREB3L2;NCK1;TMEM33;PDIA4;TRIB3;SELENOK;THBS4;ERO1A;ATF3;BRSK2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3764579125034597,-1.1630068630237265,0.26824817518248173,0.5766661789150834,1.0,7/29,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2649376334893758,-1.1620850560234601,0.1317365269461078,0.5783866232394922,1.0,26/182,6.75%,FOXP1;MEF2C;OCLN;CLDN5;CD34;TNRC6C;ESR1;NOTCH1;SLC7A5;RACK1;RIN3;KDR;KLF4;HSP90AB1;TGFB1;REST;APP;TGFB2;SMO;REL;WWP2;ADAM10;VEGFA;CNOT7;ANKRD13A;GATA2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3467081365899184,-1.1618911694288288,0.22789783889980353,0.5782735732045692,1.0,18/41,27.53%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,negative regulation of calcium ion transport (GO:0051926),0.4501222223216112,1.1618522210300022,0.27956989247311825,0.6605614826407226,1.0,2/15,7.91%,ATP1A2;TRIM27
prerank,B cell proliferation (GO:0042100),-0.4277368542699981,-1.1614704043604624,0.2658959537572254,0.5787728607725957,1.0,3/17,10.02%,MEF2C;CTPS1;HSPD1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4463676735792165,1.1612064475544894,0.29473684210526313,0.6610516901027479,1.0,2/15,2.06%,ADGRV1;KIT
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3249781466606098,-1.1610540018549425,0.208984375,0.5792301306120168,1.0,16/59,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,mononuclear cell differentiation (GO:1903131),0.4023427499159123,1.1610090751340623,0.2787878787878788,0.6604021814636644,1.0,4/24,5.75%,IL31RA;LYN;IL4;AXL
prerank,pinocytosis (GO:0006907),0.5018564515346856,1.160626257228504,0.2923076923076923,0.6602329631494964,1.0,2/10,2.92%,AHSG;SNX33
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.430317659530397,-1.1605577707159673,0.2744360902255639,0.5798982808390005,1.0,11/17,29.30%,BAX;BBC3;BCL2L1;BAK1;BAD;SFN;TIMM50;GGCT;FIS1;MFF;FZD9
prerank,response to hexose (GO:0009746),0.39815999964639137,1.160435522080798,0.2689075630252101,0.6595459683135577,1.0,2/25,5.54%,TCF7L2;IRS2
prerank,regulation of dopamine secretion (GO:0014059),0.39753313724445816,1.1600446873127421,0.23858921161825727,0.6593641601293271,1.0,9/25,18.07%,GDNF;PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3469332634950372,1.1599490559599561,0.2222222222222222,0.658469806138055,1.0,10/46,7.83%,ATP1A2;NRXN1;GRM1;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;GRIK1;MAPK8IP2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.46253644707972175,-1.15985736255106,0.296229802513465,0.5810104758448997,1.0,7/13,31.00%,CD81;BCAP31;TMEM30A;EDEM2;SEC16B;TMEM30B;EDEM1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3351781213960023,-1.1594999954320977,0.24308300395256918,0.5812982426116857,1.0,25/48,35.32%,ZBTB7A;PRDM16;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;RUBCNL;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;NOS2;RAE1;NUP88;NUP214;GCGR
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4382114092110645,-1.1591113841526224,0.27416173570019725,0.5816250917306576,1.0,3/16,5.34%,RREB1;SIX1;SOX13
prerank,import into cell (GO:0098657),0.361030833229739,1.159054682659337,0.25630252100840334,0.659654335700141,1.0,9/41,8.61%,SLC1A3;ATP1A2;SLC6A13;SLC22A4;SLC5A3;SLC29A1;SLC38A1;SNAP25;GLUL
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.38340200506501343,1.1573786034724571,0.2665289256198347,0.6627049899848539,1.0,14/29,23.08%,TUT4;SMAD3;AGO4;LIN28B;SNIP1;METTL3;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;PUS10;DICER1
prerank,ncRNA export from nucleus (GO:0097064),-0.35254344618935657,-1.1573174628676022,0.23047619047619047,0.5855199866644718,1.0,16/36,27.53%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NCBP2;NUP43;SEH1L;SEC13;NUP107;NUP42;NPM1;NUP98
prerank,positive regulation of myelination (GO:0031643),-0.4875629717777795,-1.15729403264122,0.2833333333333333,0.5849872983718474,1.0,2/11,7.20%,PARD3;TNFRSF1B
prerank,organic hydroxy compound transport (GO:0015850),-0.35497790397016676,-1.1570853725071324,0.24440298507462688,0.5849314059780224,1.0,5/36,5.09%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1;STRA6
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24015152991411742,-1.1566259332340119,0.0684326710816777,0.5854914588472133,1.0,121/497,18.44%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;RACK1;HMBOX1;BMPR2;ID3;PPARD;NCOR1;FOXO1;KLF4;RPS3;DAB2IP;ZBTB7A;IGFBP5;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;GAPDH;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;NCL;TWIST1;TRIM28;HHEX;SOX18;DBI;RB1;ZC3H8;FOXP2;RPL13A;CAPRIN1;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;FMR1;CIART;MTERF3;PHF12;CDAN1;EPC1;MLX;PHB2;SMARCA4;EID2;HEY1;LDB1;SMAD4;CDKN1A;ZFPM2;SMARCA2;NR1H2;RAD17;PCIF1;RELA;LSM14A;GIGYF2;CCAR2;KDM1A;FOXL2;WAPL;SCML2;SMAD2;CRYAB;ZNF568;L3MBTL1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.36044032000487713,-1.1564782984577817,0.2490842490842491,0.5853051634343068,1.0,10/33,18.09%,PLCG2;CDKN1B;PKD1;DDRGK1;TCIM;E2F1;PHB2;PTPN6;CDKN1A;GLI1
prerank,regulation of endopeptidase activity (GO:0052548),0.3358865639403592,1.1563681817118314,0.24586776859504134,0.6641640421350291,1.0,9/59,7.68%,TIMP3;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4;PSMA3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5008510139852671,-1.156354028645864,0.28371278458844135,0.5850114009530046,1.0,4/10,10.66%,UBB;UBC;RPS27A;DIS3L2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.284150212064454,-1.1563227637611253,0.18421052631578946,0.5845062373752493,1.0,35/119,17.68%,ITPKB;EFR3B;PLCG2;PIP5K1B;BMX;SOCS2;PI4K2A;INPP5D;PIK3R6;PIGL;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIK3C2A;PIGF;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;PIK3R3;PITPNM1;IP6K1;CISH;PIGC;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,macrophage migration (GO:1905517),0.4539350189299314,1.1561447164593464,0.30158730158730157,0.663576470066901,1.0,4/13,19.87%,P2RX4;EDNRB;CKLF;TAFA4
prerank,regulation of cellular senescence (GO:2000772),-0.38927465036293596,-1.1558851648578259,0.25996204933586337,0.5849903973149437,1.0,6/28,9.25%,CDK6;B2M;MAP3K3;ABI3;TWIST1;YPEL3
prerank,cellular response to unfolded protein (GO:0034620),-0.3796894168244485,-1.1558533452668536,0.2608695652173913,0.5844747102652574,1.0,13/26,22.97%,DAB2IP;HSPA8;RHBDD1;BAX;HSPD1;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,organelle transport along microtubule (GO:0072384),-0.37294134945169244,-1.1552397329924724,0.24716981132075472,0.5854199050621934,1.0,11/31,14.39%,TRAK1;UBB;HTT;TRAK2;BORCS5;RHOT1;COPG1;RHOT2;NDE1;NDEL1;RAB1A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.42051564522457063,-1.1549952871731066,0.2819047619047619,0.5854586373269867,1.0,11/17,34.48%,PPIA;HSPB1;AKT1;BAG5;SFPQ;TREM2;SOD1;P4HB;VNN1;HTRA2;MAPK7
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.31519527341311354,-1.1547044196979144,0.21875,0.5856183174206147,1.0,21/66,15.49%,FLT1;MAP3K5;FGF1;RPS3;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;TAOK3;EDN1;TNFRSF11A;MAP3K11;PDGFC;PDGFA;FGF2;ARHGEF5;HRAS;EGFR;ERBB2;NOD2
prerank,establishment of protein localization to membrane (GO:0090150),-0.3112453333730107,-1.154686809932122,0.225531914893617,0.5850695240006013,1.0,17/66,14.67%,PARD3;RAB11A;GORASP2;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;RAB11B;ZDHHC1;ICMT;ARL6;NPC1;ZDHHC20;SDCBP;EGFR
prerank,telomere maintenance (GO:0000723),0.33977137026647813,1.1545938696318616,0.23870967741935484,0.6664035278109726,1.0,21/50,21.96%,STN1;BLM;RPA2;TEP1;NBN;ATM;RIF1;RPA1;SMC6;PARP3;PARP1;SP100;SMC5;POLD4;NSMCE2;POLD1;RTEL1;PCNA;POLD3;POLD2;DCLRE1B
prerank,T cell mediated immunity (GO:0002456),-0.45371579859698397,-1.1544990119905827,0.27695167286245354,0.5849600998548299,1.0,3/13,13.51%,CD55;EMP2;BTN3A3
prerank,response to estradiol (GO:0032355),-0.3617530635145562,-1.1543420622452136,0.24293785310734464,0.5847842429183701,1.0,11/31,20.24%,ESR1;ANXA1;SOCS2;TGFB1;NRIP1;GGT5;LCOR;EGFR;STRN3;FAM210B;GGT1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.396378187588572,1.1542564778654616,0.2835820895522388,0.6661248470270729,1.0,4/24,4.77%,NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,negative regulation of cell migration (GO:0030336),0.2870557975919775,1.1541819407726126,0.20606060606060606,0.6651600423617922,1.0,19/137,5.80%,ROBO1;LDLRAD4;PODN;SULF1;PHLDB2;LRP1;GJA1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;MCC;IL4;DLC1;SRGAP3;SRGAP2;SERPINE1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3720302833155039,-1.1540294138361613,0.25504587155963304,0.5849944714499238,1.0,13/30,24.03%,FLT1;MLLT3;KDR;TGFB1;FLT4;INHBA;CSF1R;ACE;UFL1;HOXB4;ARMC6;MLF1;PLD4
prerank,positive regulation of DNA binding (GO:0043388),0.3741263718803579,1.1537610515396872,0.26247288503253796,0.6650537979030264,1.0,5/31,9.12%,IGF1;PRKN;SIRT2;PINX1;GATA3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.41324545685837866,1.1530192535681276,0.2876404494382023,0.6658709796183151,1.0,6/19,9.81%,TGFBR3;FGFR2;TGFBR1;RBPJ;BMPR1A;ERBB4
prerank,regulation of fibrinolysis (GO:0051917),-0.45822852179792933,-1.1529845622025354,0.28324697754749567,0.586991107632061,1.0,3/13,2.94%,THBS1;THBD;FAP
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4795790976771428,1.1529182531552322,0.3274725274725275,0.6649332617047766,1.0,3/12,6.04%,PPARA;IRS2;ABCD2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24851272496060464,-1.152760776340949,0.09345794392523364,0.5869970683958224,1.0,67/348,13.26%,FN1;LEF1;MEF2C;OCLN;CLDN5;NOS3;CD34;TNRC6C;NOTCH1;ACTG1;PLCG2;FGF1;MAP2K5;F3;KLF2;KLF4;MAPK3;RAMP2;TFRC;RPS3;ETS1;NGF;RPL11;TGFB1;APP;RAB27A;MSN;RPL23;SMO;PDE2A;ANXA2;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;MPHOSPH8;EZR;ATF4;ADAM19;GATA2;TLR3;HCFC1;RGCC;KRAS;PPM1F;AKT1;INSR;TWIST1;WARS1;TRIM28;DDRGK1;WNT11;GABPA;CD74;INHBA;FAM98A;SERPINB9;E2F1;RPS7;TLR4;ITCH;FGF2;FMR1;PIK3R3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3359474430403267,-1.1524731665404824,0.24124513618677043,0.5871106085423208,1.0,20/46,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.32705106560269476,1.1524097792109318,0.2556701030927835,0.6650827588573794,1.0,16/57,14.40%,GRIA4;DLG2;SHISA9;DLGAP1;DAPK1;NLGN2;CACNG4;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3226305056844877,-1.1523815627974523,0.2198443579766537,0.5868031335266701,1.0,19/53,25.24%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;BCKDK;PSMB8
prerank,regulation of vasculogenesis (GO:2001212),-0.43762704737062746,-1.1520504095890645,0.29981378026070765,0.5870365835185499,1.0,6/14,14.52%,RAP1A;CD34;KDR;EMP2;TMEM100;HEY1
prerank,sterol transport (GO:0015918),-0.40499317872822704,-1.1520021411310513,0.255859375,0.5865586159970984,1.0,9/19,36.08%,CAV1;NPC1;LCAT;MSR1;CD36;OSBPL2;OSBPL5;ARV1;LDLR
prerank,regulation of neuron death (GO:1901214),-0.3008810333250865,-1.1519929640171813,0.2222222222222222,0.585990393158085,1.0,12/82,8.42%,MEF2C;MAP3K5;CD34;EGLN3;REST;CTSZ;UBB;PPARGC1A;CHP1;TNFRSF1B;EGLN2;AKT1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2507268602710571,-1.1519584294339784,0.11020408163265306,0.5854813813412055,1.0,75/327,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;ACTN4;JMJD1C;NLK;SOX17;VSX1;SIX1;CNBP;REST;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.27292278826254174,-1.151829795628221,0.13813229571984437,0.5852259664725051,1.0,37/153,16.04%,PRKCH;RPS6KA5;TGFBR2;HIPK1;NLK;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;RIPK1;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;CAB39;STK38L;CSNK2A1;CSNK2A2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.29133225201788243,1.1515189514600779,0.2,0.6662319260195938,1.0,14/132,6.12%,IGF1;SH3D19;ZBTB20;PPARA;DCN;TRIM38;SNX33;PIM2;PFKFB4;TICAM1;IRS2;DAPK1;ABCD2;LIN28B
prerank,metanephric mesenchyme development (GO:0072075),0.500411363094694,1.1510082314085657,0.3036876355748373,0.666471915753058,1.0,2/10,7.45%,WNT4;SIX4
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.31295815449827524,-1.1509927394891404,0.23416506717850288,0.586813587432303,1.0,34/66,31.36%,CDH1;LIMK2;TFRC;FERMT2;TGFB1;JUP;NMD3;AKT1;RBM22;TRIM28;MAVS;DKC1;CCT2;PIK3R2;CCT3;MCRS1;ECT2;CDK5RAP3;ZPR1;CCT8;MEPCE;HCLS1;SESN2;PRKCD;DTX3L;CCT7;PARK7;CARD10;LAMTOR5;HDAC3;PLK1;HYAL2;PARP9;CDK1
prerank,positive chemotaxis (GO:0050918),0.4378592650168476,1.1509239511040545,0.2875536480686695,0.665555372544126,1.0,3/17,7.30%,NRP1;SEMA5A;SCG2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3104250515238371,-1.150877428903531,0.203125,0.5864971773221133,1.0,22/67,17.48%,TEK;FLT1;IGF1R;IL15;PTK2B;KDR;MAPK3;PTK2;BMX;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,eye development (GO:0001654),0.3309390772880587,1.1507288090134926,0.24554455445544554,0.6649364852129149,1.0,5/54,3.95%,LAMA1;FBN1;FBN2;SH3PXD2B;PBX4
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.37702199584451723,1.1505590753719448,0.27645788336933047,0.6642355167991708,1.0,6/30,6.88%,TGFBR3;SMAD3;DKK3;TGFBR3L;NREP;SMURF2
prerank,mitotic nuclear division (GO:0140014),-0.3065102755153042,-1.1502507668948874,0.21810699588477367,0.587407698575069,1.0,29/71,32.81%,EPS8;RAB11A;SMC4;ZW10;CEP192;NDE1;NDEL1;LSM14A;KIF18A;CHMP2A;MISP;TPX2;KNSTRN;PPP2R2D;KIF18B;NSL1;NDC80;SPICE1;CDCA8;SGO1;KIFC2;CHMP7;TUBG2;KIF11;PLK1;BCCIP;RHOA;CHMP4B;ESPL1
prerank,positive regulation of DNA replication (GO:0045740),0.43644480459775076,1.1500749583258822,0.2889908256880734,0.6643860975367281,1.0,4/16,7.90%,GLI2;STN1;ATAD5;BRPF3
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3625910062066632,-1.149976701006215,0.24862888482632542,0.58749364813577,1.0,19/33,36.47%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;CASTOR2;NSMF;RPTOR;LAMTOR5;SESN1;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5;FYN
prerank,organelle assembly (GO:0070925),-0.24041277930724195,-1.149176855355707,0.08768267223382047,0.5889810714336599,1.0,94/385,19.96%,ABLIM1;ABCC4;PGM5;EXOC4;CD34;TMOD3;NOTCH1;EXOC6;FNBP1L;RAB11A;RPS23;CDC14A;NCOR1;EHD4;NEK7;RPS3;RAB8B;MAP1LC3B;IFT20;CEP164;GORASP2;ABLIM3;ATXN2L;PKD1;CHMP2B;GABARAP;EHD2;LMOD1;CENPJ;CEP162;FLII;CDS2;RC3H1;CDS1;TMOD1;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;ATG3;SYNPO;ATG7;RAB8A;CEP290;DHX37;EXOC1;FHDC1;LIMD1;STK36;YTHDF2;RAB7A;DBNL;CIRBP;PCM1;VMP1;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;VPS36;MAP1LC3A;POGZ;ARL6;RFX2;RAB11FIP3;RAB1A;TSG101;GOLGA8B;CCDC28B;KIF24;SNF8;DNAH5;HPS1;EMC6;AMBRA1;CEP41;TMEM67;IST1;LSM14A;MAPRE2;CHMP2A;E2F4;EHD1;SPAG16;RAB32;TMEM231;EHD3;DYNLL2;WIPI2;RCC1
prerank,negative regulation of DNA recombination (GO:0045910),0.34757108069993026,1.1487232374772596,0.23217922606924643,0.6666795853425824,1.0,14/43,21.74%,SHLD2;UBQLN4;POLR2G;RADX;BLM;SMCHD1;DAXX;RIF1;PARP3;POLR2D;RTEL1;POLR2K;ZRANB3;FBH1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.41884966692745795,1.148507329632078,0.30603448275862066,0.6661638157618596,1.0,1/20,0.08%,IGF1
prerank,myelin assembly (GO:0032288),0.4935462947143306,1.1484783329172372,0.29347826086956524,0.6651140019316054,1.0,1/10,0.51%,EPB41L3
prerank,protein localization to membrane (GO:0072657),-0.2626170041141163,-1.1481915094501904,0.14444444444444443,0.5908716205340762,1.0,57/187,19.65%,CAV1;SHANK3;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;AGRN;F11R;RAMP2;EHD4;KCNB1;RAB8B;FERMT2;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;NDC1;CPE;FLOT1;NUP54;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;RAB11B;SLMAP;TNFRSF1A;SMURF1;NPC1;NUP155;AP4M1;TMEM88;FLOT2;EPHA2;ITGA4;TSPAN17;PACSIN1;NRXN2;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;RAB32;FYB2;EHD3
prerank,actin crosslink formation (GO:0051764),-0.4740618597619265,-1.1481679923051733,0.30654205607476637,0.5903595531958402,1.0,5/12,23.81%,BAIAP2L1;EPS8;GAS2L1;GAS2;AIF1
prerank,hepaticobiliary system development (GO:0061008),0.4208065173984955,1.1481632836410052,0.29555555555555557,0.6647979266478187,1.0,5/20,11.24%,TGFBR3;WNT4;CITED2;PRKCSH;ARID5B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.35679747903296927,-1.1476635591322648,0.2409867172675522,0.5910213638589512,1.0,11/34,28.61%,SLC7A5;GPI;SPHK2;PHB2;CLCF1;NOD2;XBP1;LAPTM5;PTPN22;STX4;CD86
prerank,neutrophil chemotaxis (GO:0030593),-0.3243732453822726,-1.1472189844436902,0.23017408123791103,0.5915217366219558,1.0,9/53,14.21%,BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,cell-matrix adhesion (GO:0007160),-0.29743568836831474,-1.147186215712045,0.2396039603960396,0.5910206776970831,1.0,23/95,12.81%,FN1;ITGA1;THSD1;CD34;SORBS1;PEAK1;COL3A1;FERMT2;ITGB4;CD44;ADAM15;RAC1;MSLN;PKD1;BCAM;ACTN1;BCR;NPNT;VCL;EMP2;TAOK2;RCC2;ITGA7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.446020921004758,-1.14627209387896,0.29213483146067415,0.5927063796512438,1.0,5/14,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;NUDT18
prerank,defense response to protozoan (GO:0042832),-0.46999531027567215,-1.1461873222223782,0.28,0.5923333270085649,1.0,9/12,45.74%,LYST;GBP7;GBP4;CD40;SLC11A1;BATF;PF4;MYD88;IRF4
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.39634781541253183,-1.1458433651902982,0.29608938547486036,0.592656344724116,1.0,7/22,17.53%,LBP;DAB2IP;MFHAS1;FLOT1;TIRAP;TNFAIP3;NINJ1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.32889805837586805,1.145830796304619,0.2549407114624506,0.6696405145686437,1.0,6/52,3.15%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3;GNAI1
prerank,cellular response to oxidative stress (GO:0034599),-0.27919102919294314,-1.145754593204052,0.18711018711018712,0.5922829473295065,1.0,53/118,33.91%,PXN;FOXO1;MAPK3;FOXO3;RPS3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;AKT1;STX2;ETV5;EGFR;VKORC1L1;GSR;HSPA1A;CCS;CHUK;CYBB;PTPRK;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;PRKCD;NUDT2;AIF1;GPX3;PARK7;STX4;CAMKK2;SOD1;RAD52;ROMO1;ATP13A2;RBM11;TPM1;ABL1;MAPK9;ANKRD2;FOS;NCF1;SLC4A11;JUN;HTRA2
prerank,atrioventricular valve development (GO:0003171),-0.45243996325954366,-1.1454679732135589,0.2857142857142857,0.592417032776222,1.0,5/14,5.50%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL
prerank,negative regulation of phosphorylation (GO:0042326),0.3053377552633485,1.1453915544378055,0.2112676056338028,0.6695886080130247,1.0,17/85,10.45%,PID1;PTPN13;NTRK3;FBLN1;PPARA;STAP1;LYN;ACTN3;DYNLL1;PRKN;IRS2;PLPP3;IBTK;MEN1;PPP1R15B;PTEN;ANKLE2
prerank,nuclear membrane reassembly (GO:0031468),-0.3290926854855468,-1.1452497386466365,0.2504970178926441,0.5924086111304073,1.0,29/54,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3464753906497084,1.1450724293025998,0.23922413793103448,0.6692426321237769,1.0,7/46,5.19%,PIK3R1;NRP1;ATRNL1;LAMC3;ANTXR1;RADIL;SRGAP2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4273178299243712,-1.1450699164408815,0.27850467289719627,0.5922983810328538,1.0,4/17,13.51%,CD55;TLR4;IL18BP;BTN3A3
prerank,positive regulation of lipid storage (GO:0010884),-0.40003314491426994,-1.1449717352661708,0.28785046728971964,0.591978206593476,1.0,6/21,24.15%,SCARB1;PLIN3;EHD1;MSR1;C3;HILPDA
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3684613870338856,-1.1448970603364763,0.2523364485981308,0.5915927644609099,1.0,4/27,4.05%,CAV1;PLTP;NFKBIA;LPCAT3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.23424145482640324,1.1442939524087248,0.08703374777975133,0.6701993112261262,1.0,100/834,9.64%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;WWC1;TFCP2;ZEB2;PHIP;SP7;TFDP1;PHOX2A;CEBPB;IL4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;GABPB1;GABPB2;FOXA2;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;KMT2A;NFIX;RARG;SOX2;CITED2;ZSCAN21;RBPJ;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;AHI1;HOXC10;HDAC8
prerank,organelle organization (GO:0006996),-0.24390500242874835,-1.1432990546927992,0.11659192825112108,0.5949512285899029,1.0,98/388,20.30%,PLCE1;FGD5;CAV1;CXADR;SYNE1;SEMA6A;NOS3;ATP8B1;VPS13D;FNBP1L;ARAP3;CAV2;SNX11;PI4K2A;ZW10;BCAS3;PPIA;HTT;GORASP2;BRWD3;NEDD9;PPARGC1A;DIAPH1;RAB18;FAM174B;FGD6;MICAL2;TTC17;PDZD8;CHMP2B;CHCHD2;ATP5F1B;HCFC1;PLEKHM2;MREG;ATL3;TRIP11;SPTSSB;KIF9;SIPA1;ATL2;CDC42BPB;RHOT1;ESRRA;SIPA1L3;PLAAT3;TRAPPC11;MIEF2;GABPA;WTIP;RHOT2;BAG5;CFL1;SURF4;LIMD1;YTHDF2;RAB7A;VMP1;AGTPBP1;MTFR1;APOE;FAF2;PHB2;WASL;MAST4;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;CHCHD10;NIPSNAP2;NECTIN2;TNFAIP3;ADCK1;OPA1;HPS3;PACSIN1;HSD17B10;RANBP10;CHMP2A;SLC25A33;TMED1;PLEKHF1;TOR1AIP2;RAB32;PRPF40A;PACSIN3;IQCG;TMED5;PACSIN2;FGD2;PTCD2;STRIP2;ATP8B2;COG2
prerank,relaxation of cardiac muscle (GO:0055119),0.4489053705274348,1.1429578072800672,0.30357142857142855,0.6724759082418643,1.0,3/13,3.80%,ATP1A2;SLC8A1;P2RX4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3781279108907534,-1.1429275235024128,0.2874015748031496,0.595301524458882,1.0,9/27,19.15%,CAV1;PDE4D;CAMK2D;JUP;CTNNA3;DSG2;SRI;DSP;CACNA1C
prerank,regulation of vacuole organization (GO:0044088),-0.4030118138899992,-1.1425224138178713,0.28442028985507245,0.5957001369175818,1.0,7/20,23.22%,IFT20;ANXA2;TBC1D12;MTM1;LAPTM4B;ADPRH;ENO1
prerank,positive regulation of cell cycle (GO:0045787),-0.3091641754445709,-1.1424471025858436,0.23018867924528302,0.5953059095391979,1.0,26/62,26.08%,CCND3;CCNY;CDKN1B;APP;TGFB2;RPS15A;PKD1;RARA;HCFC1;RGCC;AKT1;TAL1;CDK4;DUSP3;EGFR;ANKRD17;USP22;ASNS;CHEK1;CCND1;PKD2;EIF4EBP1;RAD23A;EIF4E;SPDYA;TTL
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4744163327827746,-1.1424306980944718,0.2932330827067669,0.5947757450365119,1.0,4/11,29.89%,AKAP6;KCNIP2;TREM2;RNF207
prerank,response to amino acid starvation (GO:1990928),-0.30200126574436786,-1.1423094042961657,0.22540983606557377,0.594490872215617,1.0,23/72,27.35%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.37978283991566497,-1.1421621199883707,0.2704761904761905,0.5942841957063956,1.0,10/25,21.50%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.46818753756970555,-1.1417943950019442,0.31560283687943264,0.5946253508756104,1.0,4/12,12.83%,NOTCH1;REST;YTHDF2;HES1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.37229446943927125,-1.1410502786076904,0.27151051625239003,0.595977734933739,1.0,7/27,15.87%,DACH1;HMBOX1;BMPR2;RGCC;PDGFA;FGF2;CDKN1A
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.43377932776648476,1.141031668761279,0.2924731182795699,0.6762618633621239,1.0,2/18,1.22%,PIK3R1;BCL2L11
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.38495448172985297,-1.1409634618938114,0.28790786948176583,0.5956065315436622,1.0,7/26,11.07%,ADIPOR2;ADIPOR1;ERLIN2;ELOVL5;ACADL;WDTC1;ACADVL
prerank,cellular response to amino acid starvation (GO:0034198),-0.3028630819296766,-1.1409173215731874,0.23819301848049282,0.5951443297046117,1.0,23/71,27.35%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2693010276623356,-1.1408503864809534,0.1801980198019802,0.5947315877272402,1.0,60/160,26.07%,STXBP6;DMD;PXN;POMP;RPL38;HSP90AB1;TGFB1;FKBP1A;HIP1R;NUP93;AP2M1;DNAJB12;DHX9;NDC1;PIK3C2A;IMMP2L;CSNK2B;HSPD1;HIP1;FCHO2;SGIP1;TTC12;HIGD2A;CHCHD4;HSPA4;POGZ;ARL6;CCT2;EID2;CASQ2;SMAD4;GPX4;PSMD11;SRP19;HSP90AA1;HSPA1A;PTGES3L;CHMP2A;SMAD2;ARL2;HIGD1A;NCK1;HIGD1B;CLTA;PFDN6;CENPF;NSG2;NCK2;ANLN;PSMG2;CENPA;CASQ1;SMAD1;MKKS;EIF4B;TBCE;EPS15;CLTB;EIF4H;NUP107
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3401265194681789,-1.1405947958226432,0.2593283582089552,0.5948159189448256,1.0,10/39,14.39%,MYO1D;FNBP1L;TRAK1;ACTN4;HTT;TRAK2;NDE1;NDEL1;WASL;RAB1A
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.39909881035382466,-1.1405262164973957,0.2827324478178368,0.5944031815010352,1.0,11/21,24.83%,TGM2;MCUB;PDZD8;MCUR1;BCAP31;RAP1GDS1;MICU2;FIS1;SMDT1;MCU;SLC8B1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.46180342146835585,-1.1403279931750674,0.285451197053407,0.5942972387655939,1.0,1/13,0.49%,TMSB4X
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2818851962961533,-1.1401805248942964,0.19047619047619047,0.5940914278600505,1.0,40/109,25.24%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4538795598050477,-1.139716615009441,0.3076923076923077,0.5946770235301435,1.0,2/13,5.01%,SORBS1;PRKCZ
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.38270781258319475,-1.1396477522219624,0.28875968992248063,0.5942725810646969,1.0,4/23,5.35%,TMSB4X;CCN3;HDAC7;ADIPOR1
prerank,actomyosin structure organization (GO:0031032),-0.3011105405435207,-1.1390093406597979,0.20857699805068225,0.5952834375201882,1.0,16/75,11.22%,FRMD5;PGM5;TMOD3;SORBS1;F11R;PDLIM1;EPB41L4A;WDR1;LMOD1;FLII;FAM171A1;TMOD1;CDC42BPB;EPB41L5;TNFAIP1;FHDC1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.47360170111740635,-1.1385444226613126,0.30783582089552236,0.5959023732165698,1.0,2/11,6.77%,MAPK3;USP7
prerank,regulation of glycolytic process (GO:0006110),0.31648509551913234,1.1382059753867884,0.23715415019762845,0.682506076143335,1.0,6/68,4.89%,IGF1;ZBTB20;PPARA;PRKAG2;PFKFB4;ACTN3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4655885000008037,1.1381470236393127,0.29931972789115646,0.6815214785939139,1.0,7/12,23.37%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,Notch signaling involved in heart development (GO:0061314),-0.48109905629510125,-1.137900552792918,0.30892857142857144,0.5969031853842527,1.0,5/11,24.12%,NOTCH1;HEYL;HEY1;DLL4;SNAI2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42675578723437646,1.1376794960242849,0.2607758620689655,0.6815882579555116,1.0,7/16,16.51%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,dendrite morphogenesis (GO:0048813),0.35448148028562737,1.1373676896999112,0.27607361963190186,0.6812360053817252,1.0,12/35,14.57%,PTN;LRP4;DOCK10;CTNNA2;CTNND2;EPHB1;MAPK8IP2;FARP1;PTEN;CHRNA7;DLG4;MAP6
prerank,tRNA metabolic process (GO:0006399),-0.4180136120433899,-1.1369019688651953,0.29390018484288355,0.5988227380914838,1.0,10/17,39.35%,SARS1;FARS2;TRPT1;RPP21;ADAT1;KARS1;AARS1;THG1L;YARS2;RPP30
prerank,relaxation of muscle (GO:0090075),0.44071249332599993,1.1368791231596882,0.3274336283185841,0.6814002731041331,1.0,3/13,3.80%,ATP1A2;SLC8A1;P2RX4
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.420883026887255,1.1359945521860366,0.30168776371308015,0.6825222393870554,1.0,2/19,0.65%,CAMK1D;IL34
prerank,regulation of microtubule polymerization (GO:0031113),-0.34417767986853165,-1.1356857995561969,0.2776735459662289,0.6012553292988384,1.0,13/40,25.21%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;PRUNE1;MET;ARL2;CDH5;CAMSAP3;CLIP1;STMN1
prerank,actin filament bundle assembly (GO:0051017),-0.3598855114833121,-1.1356260662416116,0.3003731343283582,0.6008360308857478,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,regulation of heart contraction (GO:0008016),0.30108812605826674,1.1355799645734137,0.24603174603174602,0.6824526179404881,1.0,12/90,6.07%,CELF2;ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;P2RX4;ATP2A2;FXYD1;ASPH
prerank,carbohydrate transport (GO:0008643),-0.47669341174527213,-1.1355192616372993,0.30052724077328646,0.6005232862840322,1.0,8/11,43.32%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.30779238857073177,1.1352130666618514,0.22505307855626328,0.6822837133145354,1.0,14/74,10.34%,BMP2;LDLRAD4;BMP5;PHLDB2;EPHA3;SMAD3;SFRP1;OLFM1;AXIN2;FOXA2;LOXL2;TGFBR1;GATA3;PTEN
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.466639095481613,1.1351598445118452,0.3230769230769231,0.681298495667377,1.0,2/12,2.16%,ADAMTS12;DCN
prerank,T cell activation involved in immune response (GO:0002286),-0.46915369486381153,-1.1347522322463048,0.29523809523809524,0.6018657160242769,1.0,10/12,50.20%,FCER1G;CD74;ICAM1;LILRB1;SLC11A1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,histone H3-K36 demethylation (GO:0070544),0.49446498885889245,1.1344018900218487,0.32537960954446854,0.6821431967087812,1.0,6/10,26.08%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,genitalia development (GO:0048806),0.45762087874085866,1.1339436857966618,0.314410480349345,0.6821764336896428,1.0,2/12,2.66%,TBX3;CHD7
prerank,skeletal muscle organ development (GO:0060538),-0.37936463718872343,-1.1338045888049664,0.29277566539923955,0.6036768049505927,1.0,5/26,5.09%,MEF2C;CAV1;MYL6;SIX1;STRA6
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.27974496967206886,1.1336090318161738,0.2198852772466539,0.6819377025262959,1.0,31/140,14.14%,LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;GPR55;CACNA2D1;P2RX4;TRPM1;GPR174;CCR6;GRM1;ACKR2;ACKR4;CCR10;PTGDR;NPTN;IAPP;CALCR;LPAR4;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;GNA15;DLG4;P2RY1;CXCR4;DRD2
prerank,regulation of histone modification (GO:0031056),0.4500324380056698,1.1335093206423306,0.326133909287257,0.6810472759586645,1.0,6/13,18.12%,AKAP8L;IGF2;SETD5;CDK9;AKAP8;UBE2N
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24728637751999474,-1.133102230561949,0.139186295503212,0.6048267134394573,1.0,56/308,13.01%,PRKCH;LEF1;CAV1;ADIPOR2;IGF1R;RREB1;LBP;IL15;TGFBR2;BMPR2;GATM;TFRC;FERMT2;NPR1;VAMP7;SIX1;TGFB1;REST;TGFB2;PRDM16;SMO;PPARGC1B;CMKLR1;FOXD1;PPARGC1A;ADIPOR1;ZBTB16;IL33;RPS19;VEGFA;UCP2;KDM3A;TGFB3;LURAP1;RGCC;GAPDH;TRIM16;NR2C2;PDGFC;TWIST1;FLOT1;DECR1;FABP5;GRB10;ACADL;INHBA;CFL1;EBF2;S100A13;GADD45G;ACVR1;APOE;FGF2;TSKU;SYK;AGPAT1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.28914527338660356,-1.1330020284596507,0.2248062015503876,0.6045026899779484,1.0,23/88,14.08%,TEK;CAV1;THBS1;NRP2;TIE1;BMPR2;KDR;CAV2;F3;VEGFC;PPP1R16B;PTPRM;VEGFA;ATP5F1A;RGCC;FLT4;AKT1;NF1;VEGFD;APOE;FGF2;EMC10;STAT5A
prerank,cardiac muscle cell action potential (GO:0086001),0.36828711169930434,1.1329093713794167,0.27741935483870966,0.6814174354025768,1.0,5/30,3.32%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.44532040473895373,1.1328218971266835,0.2980132450331126,0.6805225898045985,1.0,5/16,14.45%,SHLD2;UBQLN4;RADX;SMCHD1;RIF1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.23894181984228702,-1.132646887303799,0.13815789473684212,0.6048542372592866,1.0,100/423,16.40%,FN1;PRKCH;KITLG;LEF1;FOXP1;MEF2C;FLT1;IGF1R;CDK6;CLDN5;ACER2;THBS1;NOTCH1;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;LIFR;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;RPRD1B;TGFB1;CNBP;TGFB2;MAP3K3;TBX2;RPL23;RPS15A;DNAJA2;ADAM10;CD81;VEGFA;CNOT7;S100B;AQP11;RARA;SHC1;TGFB3;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;NDUFS4;NES;HDAC4;AKT1;INSR;NOP2;DHX9;PDGFC;PDGFA;LAMC2;EMP2;S100A6;DDRGK1;CD74;CDK4;KMT2D;S100A13;CIB1;VEGFD;FAM98A;GRK5;E2F1;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;HRAS;SAAL1;SDCBP;EGFR;CHTOP;ERBB2;GAB2;CLCF1;TNFSF13;NOD2;PTPN6;CDK13;CDKN1A;BMI1;CSNK2A1;ZFPM2;UFL1;STAT1;GREM1
prerank,mitotic DNA replication (GO:1902969),0.46755927977748385,1.1320609722578667,0.3062645011600928,0.6813657103642125,1.0,2/10,10.37%,MCM3;MCM2
prerank,regulation of macrophage activation (GO:0043030),-0.3559005104913656,-1.1319715517834146,0.2957486136783734,0.6059824346002225,1.0,8/30,12.43%,LBP;THBS1;MFHAS1;IL33;GPR137B;HSPD1;CD74;TLR4
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26897115894947404,-1.1319079711411557,0.1857451403887689,0.6055672578769998,1.0,24/141,7.35%,MEF2C;ACTB;RAP1A;CDH1;ESR1;RAP1B;TGM2;ARL6IP5;CTNNA1;RAPGEF1;ATP1A1;IGFBP5;TGFB1;MSN;PDE2A;SLC1A1;KCNQ1;CYP1B1;DIAPH1;NRIP1;CASP7;EZR;NR3C1;JUP
prerank,cellular copper ion homeostasis (GO:0006878),-0.4439790405295668,-1.1318425695748722,0.3041144901610018,0.6051550271856274,1.0,3/14,4.12%,ATOX1;MT2A;APP
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2935732378327294,-1.1314614523964641,0.24497991967871485,0.6055295023089421,1.0,27/82,19.46%,ACTB;ARHGEF28;ACTG1;SIPA1L1;ARPC1B;PTK2;RAC1;CHN1;CRK;ARPC5;AP2M1;ANKS1A;PSENEN;ITSN1;ACTR3;HRAS;WASL;APH1A;SDCBP;AP2A1;EPHA2;YES1;DNM1;EPHB6;EFNB3;RASA1;EFNB1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33995470143910245,-1.1313899750650611,0.2781954887218045,0.6051180819718467,1.0,7/41,9.23%,PODXL;PIEZO1;SMAD7;CD44;ADAM19;DENND6A;FLOT1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.31145258726604974,-1.1313558943299897,0.2535211267605634,0.6046308231758153,1.0,29/62,34.81%,TGFB1;NUP93;DHX9;NDC1;NUP54;H3-3A;WTIP;LIMD1;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3875556152218453,1.1313309403850125,0.30721649484536084,0.6821965386120704,1.0,10/25,17.28%,B3GALT1;B3GALNT1;B3GNT7;NDST4;FUT9;B3GALT2;HS2ST1;B3GALT5;B4GAT1;B3GNT6
prerank,pigment granule transport (GO:0051904),-0.4154528766645343,-1.1312726638498924,0.30111524163568776,0.6036935097738501,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,melanosome transport (GO:0032402),-0.4154528766645343,-1.1312726638498924,0.30111524163568776,0.6036935097738501,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,water transport (GO:0006833),-0.46387092723962586,-1.1309131641448213,0.30404217926186294,0.6040234842679826,1.0,9/12,53.64%,AQP11;AQP4;AQP1;AQP9;AQP6;CFTR;PDPN;AQP7;SLC5A1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.45484951172508464,-1.130901617594349,0.2956989247311828,0.6034820980864081,1.0,5/13,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,protein stabilization (GO:0050821),-0.26339117026591635,-1.1308998555975487,0.17586912065439672,0.6029234660610436,1.0,57/168,23.42%,NLK;SEL1L;SOX17;SMAD7;HSP90AB1;RPL11;RPL23;PPARGC1A;CHP1;HIP1R;USP7;RASSF2;HCFC1;GAPDH;ATP1B1;COA8;GLMP;PFN1;CAMLG;IFT46;FLOT1;USP9X;LAMP1;HSPD1;HIP1;BAG5;NCLN;RPS7;SOX4;CDC37L1;PHB2;CCT2;COG3;MFSD1;TMEM88;FLOT2;HYPK;CDKN1A;CRTAP;HSP90AA1;CCT3;HSPA1A;CRYAB;TBL1X;PIN1;CCT8;MSX1;UBE2B;RPL5;ATP1B2;HSPA1B;TAF9;PDCD10;BAG1;WNT10B;PPIB;PRKCD
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.41053337402912105,1.130532621967757,0.29723502304147464,0.6832313050793035,1.0,9/19,17.47%,PTPRD;IL1RAPL1;CUX1;CAMK2B;CDKL3;CUX2;OBSL1;CAPRIN2;CUL7
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.291564109019914,-1.1304436733081327,0.23892100192678228,0.6034957297045831,1.0,20/90,12.89%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;KDM3A;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK
prerank,establishment of protein localization to organelle (GO:0072594),-0.3006232518888874,-1.1302930302993184,0.24857685009487665,0.6033486968237514,1.0,23/72,26.54%,RAB11A;HK1;NUP93;AKT1;LAMP1;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;TNPO3;RPAIN;TSPAN17;TSC2;NXT2;CD68;TNPO2;NEURL1B;FAM53A;SEC13;NUP107;IPO13
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33170876792264004,-1.1302625757676235,0.26305220883534136,0.6028506551411185,1.0,12/45,10.94%,PLCE1;RPS6KA5;GAB1;PTK2B;IQGAP1;PTK2;TGFB1;REPS2;SHC1;AKT1;PIK3C2A;KIF16B
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2857930416765527,1.1297650994615849,0.20881226053639848,0.6840767394007993,1.0,14/118,5.49%,SH3D19;HECW2;PID1;ADGRB3;LRRC4C;FGFR2;PHLDB2;GDNF;KIF13B;RAP2A;PHIP;SFRP1;ZMYM6;HECW1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.440330176779562,-1.129371913700473,0.313953488372093,0.6044870952693355,1.0,5/14,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2943604047442769,-1.1291042926438197,0.2345679012345679,0.6045939705616515,1.0,30/83,26.10%,DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;HAUS1;NDE1;CETN2;CEP72;YWHAG;HSP90AA1;CEP41;TPX2;TUBA4A;CENPF;HAUS4;YWHAE;CEP63;NEDD1;NEK10
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.44417896326930034,1.1289767881897326,0.3092105263157895,0.6850386715630346,1.0,4/16,7.92%,NRP1;PDGFRA;PDGFRB;PDGFD
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3167513339603433,1.1286657592429106,0.27044025157232704,0.6847811918980499,1.0,8/65,7.16%,RORA;EPAS1;PTGIS;MDM2;SFRP1;KCND2;SIRT2;SCN2A
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4527302730106213,-1.1286274119481996,0.30111524163568776,0.6051972664185079,1.0,5/13,33.42%,ABL2;NOD2;ECSIT;ABL1;HP
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.42240643875017125,-1.1284537461141824,0.3182674199623352,0.605078145436285,1.0,4/16,12.33%,NOS3;GUCY1B1;GUCY1A1;APOE
prerank,stabilization of membrane potential (GO:0030322),0.4216711891859801,1.128321386916674,0.3115468409586057,0.6845893833974355,1.0,1/16,0.14%,KCNK2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.42088552136034096,-1.1279105848421176,0.30514705882352944,0.6058994723399037,1.0,3/16,6.13%,CAV1;ADIPOR1;PPP2R1A
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4134205563719741,-1.1275600082173955,0.31078610603290674,0.6061984777232438,1.0,3/17,6.91%,CAV1;KLF7;APOLD1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4541597701831016,-1.1269540012357544,0.3242258652094718,0.6071162022838179,1.0,7/13,31.35%,CD81;GCC2;TMEM30A;BRSK2;SEC16B;TMEM30B;INSIG1
prerank,protein acylation (GO:0043543),-0.3398733318901086,-1.126170915711268,0.2702169625246548,0.6085297402833159,1.0,18/38,32.61%,FOXO1;ING5;ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;CLOCK;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;NAT9;NAA80;KAT2A;CREBBP
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.4533967802753484,-1.1261238158138713,0.3408239700374532,0.6080735359197741,1.0,6/13,31.81%,SMUG1;UPP2;NT5C;NEIL1;TDG;DCTPP1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.47547362652144104,-1.1260639363660527,0.3239929947460595,0.6076712288029478,1.0,4/11,7.38%,SCARA3;CASP8;TLR3;RIPK1
prerank,positive regulation of chemotaxis (GO:0050921),0.3461605855479208,1.1259347825840225,0.27800829875518673,0.6898206919058965,1.0,5/43,3.80%,NRP1;PTN;NTRK3;SEMA5A;P2RX4
prerank,linoleic acid metabolic process (GO:0043651),0.4180009155216159,1.1257341358397008,0.2974137931034483,0.689251100105225,1.0,3/17,6.08%,ALOX12;ACSL1;GSTP1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4619729987494709,-1.1254285711809826,0.3408239700374532,0.6087676084386409,1.0,2/12,4.12%,MBNL1;TGFB2
prerank,chromatin remodeling at centromere (GO:0031055),-0.35849074110152823,-1.1253078494349082,0.2984790874524715,0.608550752588952,1.0,17/31,34.41%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.34826098800791533,-1.125135324022487,0.2958801498127341,0.6084263563803032,1.0,10/36,14.41%,CAV1;NOTCH1;NLK;CYP1B1;ADIPOR1;CENPJ;CRLF3;OCIAD1;HES1;JAK2
prerank,positive regulation of secretion by cell (GO:1903532),0.3083294517542903,1.1249639105810352,0.24842105263157896,0.6901323820260423,1.0,5/70,4.15%,IGF1;BMP6;BMP2;P2RX4;CADPS
prerank,regulation of striated muscle contraction (GO:0006942),0.3815084721411559,1.124728816808069,0.29411764705882354,0.6896406199608769,1.0,5/27,8.07%,ATP1A2;ANK2;PRKACA;P2RX4;TNNI1
prerank,visual system development (GO:0150063),-0.34621524772217055,-1.1246716423123657,0.2685370741482966,0.6090316505700375,1.0,12/37,21.54%,SMOC1;HIPK1;TGFB2;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1;ADAMTS18;C1QA;BMPR1B;C3
prerank,electron transport chain (GO:0022900),-0.4341813420392897,-1.1242613915256525,0.3339285714285714,0.609517535567141,1.0,7/15,20.23%,PDIA5;ENOX2;PPARGC1A;ETFB;ETFDH;CYB561;SDHB
prerank,T cell migration (GO:0072678),-0.45636643871342797,-1.1240612226440434,0.3430127041742287,0.6094685722063142,1.0,3/13,4.35%,SLC12A2;S1PR1;MSN
prerank,artery morphogenesis (GO:0048844),-0.3569549855637031,-1.1237983285293507,0.3078393881453155,0.6096010350026282,1.0,11/30,13.24%,NOTCH1;BMPR2;TBX1;SMAD7;TGFB2;TBX2;STRA6;VEGFA;NF1;HES1;ENG
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.38467873193659713,-1.1231649520572482,0.3032015065913371,0.6106064527442645,1.0,8/26,15.09%,REST;PPIA;ATF4;PDE8A;HSPB1;AKT1;BAG5;GPR37L1
prerank,glial cell development (GO:0021782),-0.37407722256829057,-1.1227818459021992,0.2933579335793358,0.6109933519672013,1.0,6/25,15.54%,CDK6;APP;NF1;SOX4;NRROS;EIF2B3
prerank,sensory perception of sound (GO:0007605),0.2943926472637182,1.1226958943383163,0.25051334702258726,0.6938185058505828,1.0,9/88,6.54%,ADGRV1;CEMIP;ATP6V0A4;KIT;OTOS;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,nuclear migration (GO:0007097),0.44843088043213497,1.1224514228332898,0.30217391304347824,0.6933504905448976,1.0,3/13,7.84%,CLMN;SYNE2;DOCK7
prerank,regulation of transferase activity (GO:0051338),-0.41034598426289304,-1.122409162196492,0.32251908396946566,0.6113543099394616,1.0,9/17,17.07%,HMBOX1;NLRC5;SPTSSB;EMP2;PPP1R3F;BAG5;FEM1A;LDB1;JMJD8
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4616266987346749,1.1220468419862157,0.3219178082191781,0.6933193690752191,1.0,5/13,13.21%,HYAL3;CACNA1I;SYT1;CACNA1G;SCAMP5
prerank,positive regulation of macrophage differentiation (GO:0045651),0.46430413725909137,1.121626782357035,0.31648351648351647,0.6933230161714816,1.0,2/11,2.65%,IL34;PRKCA
prerank,organic substance transport (GO:0071702),-0.27347317442515007,-1.1215095237680262,0.22417153996101363,0.6130118842991583,1.0,21/121,12.95%,ABCG2;SLC47A1;SLCO2A1;PLTP;ATP8A1;SLCO2B1;ARL6IP5;RAMP2;CUBN;CHMP2B;MFSD2A;ABCG1;SPNS2;NDC1;CHKA;ARRDC1;CEP290;RUFY1;RAB7A;ABCA2;MFSD2B
prerank,liver development (GO:0001889),0.37018683027494953,1.1212309784278496,0.31497797356828194,0.6932587561845686,1.0,7/32,11.24%,TGFBR3;WNT4;CEBPB;CITED2;NPHP3;PRKCSH;ARID5B
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.4386224502940972,-1.120878499649743,0.3246753246753247,0.6140902738308629,1.0,7/14,27.92%,PPM1F;PPP5C;PPP2R2A;NCK1;PPP2R2D;PPP1CA;DUSP1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3433584458612981,1.1207435470790843,0.30465116279069765,0.693370150086249,1.0,18/40,23.90%,GEN1;SETMAR;BLM;MCM9;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;POLD1;RTEL1;DONSON;PCNA;ZRANB3;FBH1;RFWD3;TIMELESS
prerank,RNA destabilization (GO:0050779),0.4207607542573837,1.1206479475913735,0.3125,0.6925336849019734,1.0,7/18,15.76%,ROCK2;LIN28B;FTO;RIDA;METTL16;RBM24;METTL3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4496538607558967,1.1205823421269234,0.32882882882882886,0.6915899150132843,1.0,1/12,0.69%,AKR1B1
prerank,actin filament bundle organization (GO:0061572),-0.35745075077201444,-1.1202853376044881,0.2984790874524715,0.6150870087919003,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4052162529024865,-1.1199324703461049,0.3172043010752688,0.6153915887951633,1.0,4/17,6.78%,MEF2C;PRKG1;CDKN1B;TGFB3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3745538524503756,1.1197151669810392,0.29912663755458513,0.6927749122129002,1.0,6/28,13.17%,ADCY1;PTN;CYP46A1;ADCY8;CHRNA7;ZDHHC2
prerank,negative regulation of receptor internalization (GO:0002091),-0.456775390985455,-1.119552502463035,0.3246753246753247,0.6157992273528301,1.0,6/12,29.00%,RIN3;ANKRD13A;SDCBP;NECAB2;MTMR2;UBQLN2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.40429402372274126,-1.1195220199348237,0.3029126213592233,0.6153183696667835,1.0,8/20,18.19%,CASP8;RIPK1;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1
prerank,regulation of cell communication (GO:0010646),-0.3487788012119099,-1.119450968658309,0.3044315992292871,0.614937632438334,1.0,16/35,23.07%,CXADR;IGFBP7;CAMK2D;ANXA1;MGLL;SOCS2;CRK;NCLN;GRK5;CASQ2;SRI;YWHAG;TSPYL2;VEPH1;PTPN1;GJA5
prerank,negative regulation of insulin secretion (GO:0046676),-0.4126025683534982,-1.1192145965616531,0.33269961977186313,0.6149855233770731,1.0,6/17,13.84%,CCN3;KCNB1;KLF7;REST;PIM3;INHBB
prerank,regulation of interleukin-17 production (GO:0032660),-0.36172492332327094,-1.1187856900157158,0.29354207436399216,0.615500502038983,1.0,6/31,17.36%,IL15;SLC7A5;TGFB1;TLR4;NOD2;VSIR
prerank,catecholamine metabolic process (GO:0006584),0.43622457573260315,1.1186391591301066,0.3254310344827586,0.6945174521832082,1.0,3/14,14.14%,PRKN;COMT;DRD2
prerank,autonomic nervous system development (GO:0048483),0.42370654962099846,1.1186253242509598,0.3165938864628821,0.6934576679488841,1.0,6/17,11.98%,NRP1;GDNF;SEMA3A;PHOX2A;GATA3;EDNRB
prerank,protein ADP-ribosylation (GO:0006471),0.37469988555065553,1.1185020896455091,0.3171247357293869,0.692686926073328,1.0,14/28,24.81%,PARP16;SIRT2;PARP11;PARP12;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8
prerank,response to UV-A (GO:0070141),-0.4316666854137282,-1.118393081183251,0.33634719710669075,0.6158905661643092,1.0,8/14,35.91%,AKT1;EGFR;OPN3;CCND1;PPID;MMP3;MMP1;CERS1
prerank,cellular respiration (GO:0045333),-0.33221174428852474,-1.118280381017495,0.2980769230769231,0.6156189449105921,1.0,15/41,22.14%,ATP5F1D;PPARGC1A;NDUFS4;COX15;MTFR1;SURF1;ETFB;ETFDH;UQCRB;COX10;UQCRH;LYRM7;SDHB;SDHAF4;MTFR2
prerank,regulation of cellular respiration (GO:0043457),-0.4098239459227913,-1.1175355870376045,0.32833020637898686,0.6169119292598002,1.0,5/17,10.41%,CBFA2T3;PRDM16;IDE;IFNAR1;VCP
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.28699239435080465,-1.1174835767604134,0.2437137330754352,0.6164705139649929,1.0,27/95,15.01%,CAV1;THBS1;LTBP4;TGFBR2;SMAD7;ZBTB7A;HSP90AB1;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;GIPC1;ASPN;IL17RD;HTRA3;HTRA4;SKIL;RNF111;ENG;SMURF1;EID2;SDCBP;SMAD4
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3486335875965336,1.117400970643407,0.29740518962075846,0.694476553775722,1.0,2/38,2.65%,BMP6;PRKCA
prerank,centromere complex assembly (GO:0034508),-0.34613366193240475,-1.1167568205141958,0.3125,0.61779568811789,1.0,19/36,34.41%,POGZ;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPF;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2728953204877016,-1.116704338986448,0.22535211267605634,0.6173656806749003,1.0,56/125,33.64%,DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;PLK2;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;MAD1L1;KIF18A;RANGAP1;DYNLL2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;SETD2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;TACC3;ESPL1;ITGB3BP;CDC20;BUB1
prerank,photoreceptor cell development (GO:0042461),-0.4337500814536622,-1.116648866296156,0.3225806451612903,0.6169374849371183,1.0,7/14,25.80%,RP1;VEGFA;MFSD2A;CEP290;CDHR1;ARL3;MYO7A
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2907012962604121,-1.1162890303376467,0.2445759368836292,0.6172316542672874,1.0,33/88,24.28%,PTPRB;CAV1;LRP5;DAB2IP;CDKN1B;ADAR;PPIA;CHP1;DBNDD2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;DUSP3;SRCIN1;YWHAG;CDKN1A;UBASH3B;TSC2;CDK5RAP3;GADD45A;DTNBP1;SFN;TRIB3;PTPRO;PTPRQ;PTPN1;CDKN1C;DBNDD1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.35489465426396405,-1.1160267380530862,0.31477927063339733,0.6173380761456783,1.0,9/31,17.16%,BRCC3;USP7;OTUD5;USP8;UIMC1;BABAM1;PSMD14;TNFAIP3;BABAM2
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4514578814501705,-1.1156805853860299,0.3234750462107209,0.6175993200426303,1.0,5/13,16.25%,UBB;NEFL;RHOT1;RHOT2;OPA1
prerank,regulation of platelet aggregation (GO:0090330),0.41483247055586425,1.1154256779897287,0.2995689655172414,0.6985388350471654,1.0,4/17,4.13%,SERPINE2;ALOX12;PRKCA;LYN
prerank,positive regulation of MAPK cascade (GO:0043410),0.25585364560086993,1.1153560773350983,0.23046875,0.697634011199663,1.0,35/245,10.08%,IGF1;ROBO1;NRP1;BMP2;IL34;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;PLA2G5;PDGFRA;GPR55;ROCK2;PRKCA;SLC30A10;RIT2;WWC1;MAP3K12;IAPP;PDGFRB;CALCR;THPO;SOX2;PDGFD;IGF2;RYK;KLHDC10;FGFR4;EPHA8;MYDGF;ERBB4;CCL25;ADRA1D
prerank,cellular response to interleukin-12 (GO:0071349),-0.321811131821025,-1.1153462214264285,0.27788649706457924,0.6179272066300685,1.0,20/48,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,nucleic acid-templated transcription (GO:0097659),-0.33577114086396476,-1.115245354278065,0.2901353965183752,0.6176221536778095,1.0,20/42,32.33%,MEF2A;NR4A2;PTMA;XAB2;PPP5C;E2F1;RNPS1;EPC1;POLR3A;MED20;PWP1;RRAGC;MLF1;HOXD3;TAF1B;POLR2F;POLR2L;POLR2I;POLR2C;TERT
prerank,cellular response to cytokine stimulus (GO:0071345),-0.23382204108895097,-1.115223929691515,0.1348314606741573,0.6171115194412832,1.0,113/416,20.73%,FN1;LEF1;ST3GAL6;PTPN14;SLC12A2;LBP;PTPRJ;VIM;LIFR;LRCH1;MAOA;F3;FOXO1;MT1X;WNK1;STX3;RAPGEF1;LAMA5;FOXO3;RPS3;S1PR1;IRAK2;ANXA1;GBP5;DAB2IP;SOCS2;CDKN1B;MT2A;TGFB1;UBB;PDE2A;HSPA8;INPP5D;UBC;RPS27A;IL1R1;CRK;VEGFA;GBP7;STX1A;IKBKB;SHC1;TNFRSF21;TNFRSF1B;RIPK1;GAPDH;NPNT;YBX3;RC3H1;IL20RB;IFITM2;AKT1;NDUFA13;BCL6;CCL15;DHX9;ASAH2;TWIST1;IFNAR1;IFIT1;JUNB;RPL13A;UBE2G2;LRP8;GRB10;ABL2;AKAP6;CIB1;YWHAZ;BCL2L1;TLR4;POU2F1;FGF2;SYK;IL18BP;CSF1R;TNFRSF1A;AIM2;STAT5A;PTPN12;JAK2;F13A1;SIGIRR;GAB2;PIK3CA;CLCF1;PTPN6;NDN;CDKN1A;STAT1;HSP90AA1;RELA;XBP1;IFNGR1;JAK3;HCK;CHUK;SLA;IRF8;AQP4;ARHGEF2;IRAK4;IL3RA;CCND1;SOX9;SYNCRIP;MCL1;CASP1;HAS2;LGALS9;MAPK11;CSF2RB;IL10RB
prerank,mesoderm formation (GO:0001707),-0.4038075951421489,-1.1150694773281458,0.3079777365491651,0.6169271914630864,1.0,4/17,19.69%,BMPR2;ITGB4;SMAD2;ITGB3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.27696182541031134,1.1141483465165143,0.2383838383838384,0.699642905134721,1.0,13/117,8.24%,IGF1;ALDH1A2;PPARA;ALDH4A1;ALOX12;ABAT;PCCA;ACADSB;BAAT;CPT1C;MSMO1;ACOT11;PDZD11
prerank,heart trabecula morphogenesis (GO:0061384),-0.3993718052466173,-1.11404916641363,0.3286467486818981,0.6189859708695412,1.0,6/18,4.23%,TEK;ADGRG6;NOTCH1;S1PR1;TGFB2;FKBP1A
prerank,toxin transport (GO:1901998),0.4732628111567625,1.1132110150083574,0.3235294117647059,0.7009989209827434,1.0,3/10,6.61%,ANTXR1;SLC22A3;RAB29
prerank,regulation of RNA splicing (GO:0043484),-0.3036082922354521,-1.1128457725158623,0.2438563327032136,0.6214748312894813,1.0,20/69,20.37%,AHNAK;AHNAK2;MBNL1;HNRNPLL;RBM20;QKI;RPS13;PTBP3;ZNF326;SRPK1;FUS;RBM22;JMJD6;CLK1;FASTK;HNRNPK;HSPA1A;RPS26;ZPR1;TMBIM6
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3045648436308372,1.1128059945005933,0.24660194174757283,0.7009343724190367,1.0,13/72,9.39%,IGF1;PIK3R1;NTRK3;KIT;DCN;PDGFRA;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF
prerank,B cell receptor signaling pathway (GO:0050853),-0.3527253651161761,-1.112502799026069,0.297029702970297,0.621848844310069,1.0,5/32,8.37%,MEF2C;PLCG2;BMX;CD38;BAX
prerank,lymphocyte differentiation (GO:0030098),-0.30038930893220367,-1.111857348701804,0.2803347280334728,0.6228491006481819,1.0,25/68,25.76%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;JAG2;HDAC4;HHEX;RELB;LFNG;SOX4;CLCF1;ITGA4;TCF3;KLF6;GPR89B;GPR89A;JAK3;DLL4;ADGRG3;PTPN22;DCAF1;TOX;NFAM1;HDAC5
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.34326435248681547,1.1118254309401845,0.2948717948717949,0.7024182408777436,1.0,3/40,5.39%,IGF1;BCL2L11;PRKN
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.32018205774358494,-1.1117239572427773,0.2964426877470356,0.6226143458904713,1.0,9/47,8.42%,RREB1;LRP5;PPARD;SIX1;CMKLR1;SOX13;ZBTB16;CDS1;AKT1
prerank,protein autoubiquitination (GO:0051865),0.31613733784490894,1.1115784036162761,0.280561122244489,0.702001954643012,1.0,7/61,7.72%,RNF220;SH3RF3;SH3RF1;DDB2;MDM2;PRKN;RNF181
prerank,striated muscle cell differentiation (GO:0051146),0.42188612596431296,1.1115233910996902,0.32158590308370044,0.7010547657669152,1.0,2/16,1.40%,BMP2;NRG1
prerank,carnitine shuttle (GO:0006853),0.45769429164848974,1.111454724296035,0.34942528735632183,0.7001390403074328,1.0,4/11,16.74%,PRKAG2;CPT2;ACACA;PRKAB2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.43974847797763805,1.1113298985018372,0.34156378600823045,0.6993775628897141,1.0,6/13,21.85%,ADHFE1;PHYH;D2HGDH;GPT2;GOT1;GOT2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3655917056874649,-1.1113016437758565,0.32007575757575757,0.6230539412772192,1.0,13/26,29.22%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2;TMEM106A;CD36;TLR6
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3568854807150396,-1.111046566318023,0.32051282051282054,0.6231356219793338,1.0,7/30,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4725647862249178,-1.1108871436726786,0.33455210237659966,0.622973828558263,1.0,6/10,19.37%,TGFBR2;LRP5;TBX1;PDGFA;STAT1;SOX9
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2233260234560098,-1.1107857758050197,0.09438202247191012,0.6226591006113658,1.0,155/807,14.63%,KLF12;MECOM;LEF1;FOXP1;ELK3;MEF2C;CAV1;PRDM6;DACH1;WWP1;RREB1;ATP8B1;RPS6KA5;ESR1;NOTCH1;DDX5;RPS14;CBFA2T3;ID1;ZHX3;NEDD4L;HMBOX1;ID3;MAP2K5;PPARD;NCOR1;MEF2A;KLF2;FOXO1;KLF4;RPL10;FOXO3;DAB2IP;SMAD7;ZBTB7A;IRF2BPL;CDKN1B;KLF7;FNIP2;TGFB1;CNBP;REST;KDM5C;PRDM16;TBX2;RPL23;UBB;PDE2A;ZNF431;HDAC9;HSPA8;WWP2;NR4A2;LIMS1;PFDN5;SARS1;KCTD1;FOXD1;RLIM;PRDM2;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;UBC;RPS27A;HEYL;ZBTB16;LRRFIP1;DPF2;IL33;VEGFA;CNOT7;MPHOSPH8;DPF3;NRIP1;RBFOX2;RARA;NOTCH4;EZR;GATA6;ATF4;SHC1;FOXN3;CBFB;KLF8;NR3C1;MXD4;HCFC1;CBX5;PPM1F;CIC;EDN1;UIMC1;IRF2BP2;MOSPD1;HDGF;NR2C2;YY1;HDAC4;ZMYND11;NDUFA13;BCL6;KANK2;SOX7;TWIST1;MAF1;TRIM28;USP9X;HHEX;HSBP1;SOX18;RB1;MXD1;ZC3H8;FOXP2;MTA2;WNT11;SKIL;FOXC2;ZBTB18;CCDC85B;MTA1;SP3;SFPQ;FRK;LIMD1;TCF25;PHC1;IMPACT;HIVEP1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;MIER2;HES1;CIART;MTERF3;LCOR;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;EID2;BCL6B;SDCBP;HEY1;SMYD2;ETV5
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.34586274404301337,-1.1103065146421582,0.32504780114722753,0.6233787730247409,1.0,7/33,9.62%,MEF2C;PRKG1;IGFBP5;CDKN1B;IGFBP3;TGFB3;TRIB1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.22967050244011464,-1.1101489905198902,0.13043478260869565,0.6232539025957136,1.0,118/509,17.11%,FN1;KITLG;TEK;VWF;CAV1;FLT1;IGF1R;NR3C2;THBS1;PTPRJ;GAB1;ESR1;PLCG2;FGF1;NOD1;RACK1;TGM2;ACTN4;KDR;CAV2;F3;IQGAP1;RPS15;TFRC;PTK2;MID2;TBX1;RPS3;DAB2IP;FERMT2;RICTOR;TRIM25;TNFAIP8L3;HSP90AB1;TGFB1;APP;TGFB2;ATP2C1;FKBP1A;MAP3K3;RPL23;MFHAS1;RAC1;REL;LIMS1;TNFSF10;VEGFA;S100B;IKBKB;BRD4;MYOC;SHC1;LURAP1;CASP8;TLR3;RIPK1;EEF1D;GAPDH;FLT4;PLK2;BAX;INSR;PDGFC;PDGFA;TRIM14;RPS20;HIP1;JCAD;TIRAP;TCIM;WNT11;DHX58;CD74;S100A13;PIK3AP1;BBC3;PPP5C;TRIM62;BCL2L1;MAVS;TLR4;MIB2;FGF2;EDA2R;SPHK2;ENG;TNFRSF1A;USP15;HRAS;PHB2;TRIM68;BCAP31;LAMTOR2;JAK2;TRIM5;EGFR;ERBB2;STRN;GAB2;PIK3CA;GPR37L1;NOD2;PTPN6;BCAR3;TMEM101;CX3CR1;MET;LGALS1;PIK3R2;RRAGD;HSP90AA1;ANKRD17;MIER1;TAB2;JMJD8;RELA;BAD;GPR89A
prerank,protein localization to cell junction (GO:1902414),-0.3860387520043709,-1.1100396519107054,0.31721470019342357,0.6229682888005043,1.0,4/22,4.07%,HEG1;TJP2;FERMT2;JAM3
prerank,negative regulation of complement activation (GO:0045916),-0.4716954192965561,-1.1098192927051274,0.3425925925925926,0.622936628600272,1.0,1/10,1.66%,CD55
prerank,protein targeting (GO:0006605),-0.27524420721015674,-1.1097973695555146,0.24334600760456274,0.6224372222702319,1.0,26/118,14.47%,RASSF9;PARD3;TRAK1;RPL11;AQP11;GABARAP;GIPC1;TRAK2;SPCS1;HACL1;ATG3;NACA;SEC63;ZDHHC9;TAOK2;TIMM17A;AKAP6;ZDHHC1;KATNB1;ICMT;TOMM22;ARL6;BCAP31;ZDHHC20;AP4M1;SDCBP
prerank,negative regulation of histone methylation (GO:0031061),0.48105163025030895,1.1096165327090082,0.35214446952595935,0.702712816138636,1.0,5/10,24.82%,BCOR;DNMT1;MTF2;DNMT3B;WDR5
prerank,positive regulation of macrophage migration (GO:1905523),-0.393346907647439,-1.109509690664398,0.31467181467181465,0.6225981233403007,1.0,4/19,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,protein deubiquitination (GO:0016579),-0.2472245525428112,-1.1094884871486144,0.16952789699570817,0.6221049742089061,1.0,65/242,21.44%,ACTB;ESR1;IFIH1;NFKBIA;MINDY2;SMAD7;MINDY1;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;ENY2;BABAM1;RHOT1;USP9X;OTUB1;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;PSMB1;PSMC3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3144653440295493,-1.1089571959853601,0.27431906614785995,0.6229018308364503,1.0,18/50,25.24%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4753069199195494,1.1089431280801803,0.33029612756264237,0.7034280524254043,1.0,4/10,25.80%,PRKN;AOC3;HDAC6;SNCA
prerank,regulation of lymphocyte differentiation (GO:0045619),0.410324758954592,1.1089156361070518,0.32967032967032966,0.7024087068143161,1.0,2/18,3.59%,IL4I1;TBX21
prerank,response to estrogen (GO:0043627),-0.3480764205453713,-1.1088674786380754,0.3121495327102804,0.622572436861357,1.0,11/31,12.06%,CAV1;ESR1;TRIM25;RBBP5;BCAS3;RARA;PELP1;KMT2D;NCOA4;WBP2;SERPINB9
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2794120471990362,1.1088520655247254,0.2613861386138614,0.7014722451164758,1.0,24/122,11.57%,IGF1;PRR16;AR;SAMD4A;SLC6A9;GLI2;LARP6;STN1;IL4;IRS2;NLRP12;PDGFRB;ATAD5;BRPF3;IGF2;CPEB3;FGFR4;EIF3C;PLD1;PLXNB2;HNRNPD;PIWIL2;FXR2;HSPH1
prerank,myeloid cell development (GO:0061515),-0.39857254036935463,-1.1081081198150269,0.33205374280230326,0.623915229817104,1.0,3/18,4.62%,FOXP1;APP;ANXA2
prerank,regulation of organelle assembly (GO:1902115),-0.2925678220421918,-1.1077287407340541,0.2777777777777778,0.6243604015902346,1.0,30/73,29.03%,TBC1D8;IFT20;MSN;ATXN2L;TBC1D1;TBC1D12;EZR;CENPJ;TBC1D22A;PLK2;KIF9;ATG3;TBC1D9B;TSG101;VPS11;HCK;TBC1D2;RABEP2;ADPRH;DCDC2;TBC1D15;SPICE1;ODAD3;TBC1D17;RDX;CDKL5;NPM1;TBC1D5;UBQLN2;STAM
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3212366245356667,-1.1076050699125652,0.28063241106719367,0.6241407602323854,1.0,5/47,1.44%,STXBP6;EXOC4;SPTBN1;EXOC6;EXOC6B
prerank,positive regulation of vasculogenesis (GO:2001214),-0.46166127167950843,-1.107500218200348,0.34593572778827975,0.6238881810876015,1.0,3/10,2.36%,RAP1A;CD34;KDR
prerank,positive regulation of stem cell differentiation (GO:2000738),0.4245444657660889,1.1074841652164187,0.3420479302832244,0.703857892014044,1.0,5/16,14.51%,PTN;SP7;SOX5;LTBP3;RBM24
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.44708754093274083,-1.1073921871218286,0.3467889908256881,0.6236431079319439,1.0,2/12,4.12%,JAM2;APP
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4145287418342187,-1.106789854850293,0.3351063829787234,0.6245657756478074,1.0,9/17,31.36%,ZW10;RB1;KNL1;MTBP;BOD1;SPDL1;CENPA;BUB3;CDK1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3551837321830701,-1.1067480878164648,0.32136105860113423,0.6241221282699383,1.0,4/30,4.40%,CHST11;CSGALNACT1;CSPG4;HEXA
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.391054266300363,-1.1065115306698274,0.3054003724394786,0.6241693138421133,1.0,9/20,25.21%,FKBP5;FKBP1A;PPIA;PPIC;PPIG;PIN1;FKBP4;PPIB;PPID
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3402033613146001,-1.1064086891975569,0.3208955223880597,0.62387156645359,1.0,13/38,19.49%,THBS1;NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;MADD;TNFAIP3;ARHGEF2;FAIM2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3514831109450196,-1.1063937368534882,0.29354207436399216,0.6233623867476125,1.0,11/33,17.08%,KLF4;FOXO3;ETS1;TGFB1;TGFB2;GATA2;NR3C1;FGF2;SMARCA4;SRF;RELA
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3704266642188802,-1.1058150569617387,0.3272058823529412,0.6242290813113021,1.0,13/24,31.99%,ZDHHC1;MAVS;AIM2;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.23879027338049247,-1.1058101093202832,0.1857451403887689,0.6236903953739763,1.0,81/366,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;JMJD1C;NLK;RPL10;FOXO3;SOX17;VSX1;SIX1;CNBP;REST;APP;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;PDGFA;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;RBM4B;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;ANKRD17;PCIF1;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,epithelial cell migration (GO:0010631),-0.33785341453124573,-1.1056626162431862,0.29080675422138835,0.6235163342828534,1.0,14/37,16.32%,NOS3;DPP4;PXN;STARD13;FAP;CYP1B1;GIPC1;KANK2;FAT2;PLXND1;PKN3;FSTL1;PIK3CA;STAT1
prerank,regulation of synapse organization (GO:0050807),0.3657322432234473,1.1054202789126595,0.3059360730593607,0.7082528546431636,1.0,10/26,17.94%,CTNNA2;SLITRK4;ARHGAP22;IL1RAPL1;CAMK2B;SETD5;PDLIM5;NEDD4;CLN3;ABHD17C
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.23271761344288897,1.1050781128083584,0.1478743068391867,0.7080388091904659,1.0,77/572,9.64%,BMP6;TCF7L2;FHL2;LDB2;BMP2;SALL1;AR;ATXN1;TBX3;GLIS3;MXI1;FGFR2;NR2F2;BCOR;ZEB1;TBL1XR1;VDR;RARB;TRPS1;PPARA;ZHX2;GLI2;MITF;PRDM5;SMAD3;TFEC;KDM1B;NKX6-1;TBX21;MDM2;GLI3;WWC1;TENM2;ZEB2;UXT;FNIP1;AEBP1;FOSB;ZMYM5;CEBPB;IL4;RNF2;JAZF1;PRKN;SUMO1;LIN37;HDAC10;ZHX1;LOXL2;SMURF2;SIRT2;CUX1;MEN1;MBD2;NFIX;CRY1;BCL11A;RARG;SOX2;TRIM27;CITED2;RBPJ;NSD1;IGF2;FOXD3;HES5;MIER3;CPEB3;ATN1;BRMS1;BRMS1L;GLIS1;GATA3;CTCF;KCNIP3;CUX2;HDAC8
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3599688470168508,1.1046815698291554,0.33122362869198313,0.7079685699938721,1.0,4/32,6.91%,CEMIP;PDPK1;P2RX4;CALCR
prerank,response to cytokine (GO:0034097),-0.26493462680080565,-1.1041918577925516,0.2332657200811359,0.6266709541165072,1.0,47/141,21.45%,LEF1;PTPN14;MAP4K3;LIFR;COL3A1;IRAK2;ANXA1;GCH1;MAPKAPK3;APP;ADAR;REL;ADAM10;IL1R1;IFITM1;IFITM3;CASP8;RIPK1;TNFRSF11A;HDAC4;IFITM2;ASAH2;RELB;CD74;GGT5;AKAP6;TRIM56;BCL2L1;IL18BP;CSF1R;PTPN12;JAK2;SIGIRR;SRF;TIMP2;PTPN6;STAT1;IGBP1;RELA;JAK3;MCL1;CASP1;GGT1;LGALS9;HCLS1;IL6ST;TAF9
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.30576619218044526,-1.104171353063178,0.301498127340824,0.6261695549504612,1.0,24/62,25.91%,ACKR3;TPT1;PPIA;HSPB1;YBX3;AKT1;NDUFA13;DNAJA1;PTTG1IP;BAG5;BCL2L1;NDUFS3;OPA1;HSPA1A;XBP1;CCAR2;ARHGEF2;MCL1;TMBIM6;ENO1;SNAI2;HYOU1;PLAUR;PARK7
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3862538526510565,-1.103820268128673,0.3345388788426763,0.6265224085878973,1.0,8/21,22.33%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;APC2;CAMSAP3
prerank,fatty acid oxidation (GO:0019395),-0.3087034354974746,-1.1034632354971747,0.29277566539923955,0.6268177399142424,1.0,15/57,18.04%,ADIPOR2;PPARD;ACAD11;PPARGC1A;ADIPOR1;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;ECI1;MECR;HSD17B10
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.43107968940667124,-1.102973350807281,0.34686346863468637,0.6274587049255168,1.0,2/14,4.89%,THBS1;CMKLR1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3367454870366612,1.1029046268850224,0.3159041394335512,0.7114985732941175,1.0,7/40,7.95%,TCF7L2;BMP2;SMAD3;OLFM1;AXIN2;LOXL2;TGFBR1
prerank,cellular response to estrogen stimulus (GO:0071391),0.4216678864632247,1.102608520425292,0.3235294117647059,0.7111620402713329,1.0,3/14,4.24%,AR;OCSTAMP;SFRP1
prerank,positive regulation of coagulation (GO:0050820),-0.4733155936781186,-1.1024340321848811,0.3447653429602888,0.6277126125920262,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,positive regulation of hemostasis (GO:1900048),-0.4733155936781186,-1.1024340321848811,0.3447653429602888,0.6277126125920262,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,aortic valve development (GO:0003176),0.35082308628665554,1.102124702613305,0.29464285714285715,0.7112756407181162,1.0,4/34,2.62%,ROBO1;BMP2;ROBO2;ROCK2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4148389263816652,1.102003661748787,0.35091743119266056,0.7105276255900249,1.0,3/17,4.33%,SCN3B;ANK2;GPD1L
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2909165386032737,-1.1019653610247102,0.2874493927125506,0.6283521329266578,1.0,14/75,12.33%,HEG1;PTPRJ;LRP5;RASIP1;DAB2IP;CDKN1B;PRKAR2B;AKT1;HHEX;RB1;UCHL1;NF1;STK38;APOE
prerank,negative regulation of anoikis (GO:2000811),-0.4283432647219822,-1.101936038408348,0.34581105169340465,0.6278761737293796,1.0,3/14,2.88%,CAV1;NOTCH1;PTK2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4823462560772743,1.1019138053291802,0.3553530751708428,0.7096613957150362,1.0,6/10,22.71%,CRY1;RPA2;THOC1;ETAA1;WDR76;RFWD3
prerank,lipoprotein transport (GO:0042953),0.47525590373013543,1.1019036777938058,0.3251121076233184,0.7086078366410268,1.0,5/10,18.81%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,regulation of protein kinase activity (GO:0045859),-0.277530429709603,-1.1018622698429308,0.278118609406953,0.627516251866894,1.0,42/106,27.63%,PLCE1;RAP1A;PTK2B;IQGAP1;PTK2;PPIA;CHP1;DBNDD2;RASSF2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;SMG8;LCP2;MMD;PRKAG1;YWHAG;CDKN1A;TAB2;UBASH3B;AGAP2;TSC2;ECT2;DTNBP1;TSPYL2;SFN;RAPGEF2;TRIB3;DBNDD1;MRNIP;SPDYA;PARK7;MMD2;CAMKK2;SOD1;RTRAF;ADCYAP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.45116613446696585,1.1017904906796447,0.30023640661938533,0.7078457895552819,1.0,2/11,4.13%,PRKCA;LYN
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.2500837134428415,-1.101787928430204,0.23870967741935484,0.6271420660587134,1.0,45/190,17.08%,CAV1;TMSB4X;THBS1;PTPRJ;ESR1;RACK1;SH3BP4;CCN3;PDE4D;CYRIB;DAB2IP;CD2AP;SLIT2;PDE2A;HDAC7;ADIPOR1;PEBP1;ARHGAP25;PIK3IP1;CASP8;RIPK1;ZMYND11;AKT1;NDUFA13;TWIST1;CARD19;PRDM15;TNFAIP8L1;MAPKBP1;WTIP;EPM2A;NF1;LIMD1;CIB1;DUSP3;BCL2L1;NDUFS3;EPHA2;PHLPP2;TNFAIP3;PIK3R2;STAT1;PHLDA3;DDIT4;RELA
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3207046986835945,-1.1013556754939322,0.30118110236220474,0.6276965842408795,1.0,23/47,31.22%,THBS1;PLCG2;TGFBR2;TGFB1;RNF41;RAB27A;RIPK1;ACE2;TLR4;SYK;CDKN1A;CBR1;GADD45A;PRKCD;DCXR;GRIN1;SOD1;CD36;TLR6;XDH;ROMO1;DHRS4;TYROBP
prerank,defense response to tumor cell (GO:0002357),0.4787495195128551,1.1009366728566248,0.34285714285714286,0.7090380306393579,1.0,3/10,5.99%,RBMS3;DLEC1;DAPK1
prerank,regulation of cell cycle process (GO:0010564),-0.2779795863704248,-1.100510961550771,0.28180039138943247,0.629321050366392,1.0,42/104,31.40%,RAB11A;CAV2;CALM1;RPRD1B;ZFYVE26;PLK2;YTHDF2;CALM3;BCL2L1;RAB11FIP3;CETN2;CDK13;CSNK2A1;CSNK2A2;MAD1L1;L3MBTL1;KLHL9;ECT2;CHEK1;KLHL21;SOX9;PIN1;PRPF40A;RCC1;KNSTRN;MKI67;KIF13A;PLK3;CDC42;CDKN2B;DCUN1D3;PLK5;TTL;MYO19;SETD2;RACGAP1;CTNNB1;ENTR1;KIF11;PLK1;AURKA;PIK3R4
prerank,negative regulation of cell population proliferation (GO:0008285),-0.23344023276276338,-1.100267160779093,0.17634854771784234,0.629414455743801,1.0,76/351,16.42%,ZBTB7C;PTPN14;CDK6;ITGA1;B2M;IGFBP7;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;PTK2B;BMPR2;SH3BP4;KLF4;CCN3;FAP;ETS1;DAB2IP;NGF;IGFBP5;CDKN1B;TGFB1;REST;APP;TGFB2;RNF41;COL18A1;TES;PLPP1;CYP1B1;ING5;CTBP1;IGFBP3;SMAD6;CNOT7;AQP11;WNT9A;IFITM1;GATA6;GATA2;TGFB3;RGCC;ADGRG1;KANK2;SOX7;WARS1;TRIB1;CSNK2B;DIS3L2;CTNNBIP1;INHBA;E2F3;GAS8;NF1;FRK;CIB1;FTH1;TMEM115;E2F1;CDK10;SOX4;HES1;RPS6KA2;ABI1;HRAS;P3H2;JAK2;SMYD2;STRN;PTPN6;TNFAIP3;CDKN1A;SMARCA2;GREM1;RBBP4
prerank,establishment of melanosome localization (GO:0032401),-0.39937504059088463,-1.1002267204588185,0.33707865168539325,0.6289766312981331,1.0,6/19,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,morphogenesis of an epithelium (GO:0002009),-0.37187564550900204,-1.0998867328896318,0.33657587548638135,0.6292826147830359,1.0,5/25,9.38%,ACTB;ACTG1;LAMA5;LAMA3;VCL
prerank,negative regulation of ATP metabolic process (GO:1903579),0.4013838330907798,1.0994901507836132,0.3199152542372881,0.711653753474183,1.0,3/17,4.89%,PID1;PPARA;ACTN3
prerank,protein deacylation (GO:0035601),0.37782689428807303,1.0992533973642218,0.33974358974358976,0.7111335009235904,1.0,7/23,17.94%,NOTUM;HDAC10;SIRT2;ABHD10;SIRT6;HDAC1;ABHD17C
prerank,adherens junction organization (GO:0034332),-0.3180621186740646,-1.0992236455973725,0.30518234165067176,0.6303117313004092,1.0,12/48,10.88%,ACTB;CDH1;CTNNA1;RAMP2;FERMT2;SMAD7;JAM3;CDH4;JUP;PVR;VCL;CDH6
prerank,Wnt signaling pathway (GO:0016055),-0.28125873012869174,-1.0984998919224445,0.2857142857142857,0.631517621077208,1.0,19/92,10.46%,LEF1;NXN;PLCG2;LRP5;FZD6;FZD4;FERMT2;UBB;NR4A2;CSNK1G2;UBC;RPS27A;WNT9A;CSNK1G3;FZD3;FZD7;CPE;DIXDC1;WNT11
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4802051031013166,-1.0981974658718514,0.35929203539823007,0.6317506631044137,1.0,3/10,11.37%,ESR1;PSMC4;PSMC5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4673268529805822,-1.0978371086839118,0.3395176252319109,0.6320581443315622,1.0,1/10,0.23%,ANO6
prerank,aminoglycan metabolic process (GO:0006022),0.4658244086644341,1.0977232227555582,0.3709677419354839,0.7141994292415355,1.0,4/10,21.64%,GAL3ST3;B4GALT7;B3GAT1;B3GALT6
prerank,protein localization to condensed chromosome (GO:1903083),-0.45230103474454836,-1.0976640133485571,0.34587813620071683,0.6319715489849272,1.0,6/12,31.36%,ZW10;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3213143497148251,1.097545830810144,0.32298136645962733,0.7135689781837385,1.0,3/51,0.54%,GREM2;FBN1;BMP2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.31383020323477334,-1.0974663473684332,0.3047034764826176,0.6319391686349608,1.0,12/50,19.30%,ACTB;CCND3;HSP90AB1;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,RNA metabolic process (GO:0016070),0.27655038726178216,1.0974567938419697,0.26587301587301587,0.7127537156955687,1.0,46/127,25.34%,CELF2;ATXN1;NOVA1;RBMS1;ADARB2;HNRNPUL1;AGO4;DHX8;MPHOSPH10;RBM5;POLR2G;PCBP3;FTO;BICD1;PABPN1;PNPT1;RNASE4;HNRNPD;NOL9;THOC1;PARN;METTL3;DROSHA;RNASEL;POLR2D;RNASEH1;PAPOLA;AGO3;HNRNPF;AGO1;POLR2K;AGO2;RNASE3;DDX24;TENT2;MRPL44;RNASEH2B;ATXN2;DICER1;SETX;POLR2B;RBM39;WTAP;FASTKD1;CLP1;RNGTT
prerank,histone H3 acetylation (GO:0043966),-0.32897246787312945,-1.0973213210460446,0.33079847908745247,0.6317693365706323,1.0,15/40,28.47%,LEF1;JADE2;ING5;TRIM16;NAA60;LDB1;BRCA2;TADA3;BRPF1;TAF9;POLE3;KAT6B;SPI1;TAF10;TAF5
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2600862366467599,1.0971894394148989,0.2339622641509434,0.7124013487297733,1.0,22/170,9.43%,IGF1;NELL1;NOVA1;SLC8A1;C1D;GDNF;TRIM38;AFF2;PRDM5;ROCK2;AFF1;ZNF462;ZNF513;PRDM9;IGF2BP2;SOX2;TRIM27;STX1B;PCBP3;FUBP1;NPAT;CTCF
prerank,protein localization to cell surface (GO:0034394),-0.37026098079702807,-1.096927442162152,0.32196969696969696,0.632220992005845,1.0,11/26,21.91%,MESD;JAM3;RIC3;VCL;EMP2;WNT11;SMURF1;USP4;PTPRK;FGF10;PTPRU
prerank,cilium assembly (GO:0060271),-0.23660367414837807,-1.096738690023925,0.19750519750519752,0.6321737739469957,1.0,71/297,19.74%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;DCTN2;EHD4;RAB8B;TUBA1A;IFT20;CEP164;RP1;ABLIM3;PKD1;PPP2R1A;PRKAR2B;CEP192;EHD2;CENPJ;CEP57;CEP162;TRIP11;CEP70;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;DCTN3;RAB8A;CEP290;CNTRL;DCTN1;EXOC1;GAS8;FHDC1;STK36;PCM1;TUBB4B;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;ARL6;NDE1;RFX2;RAB11FIP3;RAB1A;CETN2;CEP72;CCDC28B;KIF24;YWHAG;DNAH5;HSP90AA1;CEP41;TMEM67;E2F4;EHD1;RPGRIP1;SPAG16;TMEM231;EHD3;IFT27;DYNLL2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.40029259416660673,1.0966314284743715,0.3277661795407098,0.712775898771656,1.0,4/21,2.64%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,brain development (GO:0007420),0.27309239914201316,1.0964267172486448,0.24703557312252963,0.7122536539624617,1.0,25/136,14.10%,EPHA7;ARNT2;ROBO2;ATXN1;CNTN4;ZIC1;AFF2;CNTNAP2;PBX4;CTNNA2;SPEF2;HES5;CDK5R1;BBS2;PTEN;EML1;EEF1AKMT4-ECE2;PLXNB2;CTNS;PHF8;NKX2-1;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,respiratory system development (GO:0060541),0.34769360942103233,1.0950731184081148,0.3108695652173913,0.7146551181323996,1.0,8/32,13.60%,FGFR2;GLI2;CHD7;SPEF2;LOXL3;NPHP3;SMCHD1;NKX2-1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.46780104814806706,-1.0950378594214556,0.36363636363636365,0.6358219943384461,1.0,3/10,13.09%,CALM1;CALM3;FMR1
prerank,actin filament-based transport (GO:0099515),-0.3868056788344121,-1.0947317387775422,0.32075471698113206,0.6360213953699372,1.0,3/21,2.18%,MYO1D;FNBP1L;ACTN4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4416915706699756,-1.0946660088754638,0.361003861003861,0.6356385387974254,1.0,10/12,52.61%,SLC11A1;IL12RB1;ZBTB1;CARD9;IL23A;IL23R;IL12B;CCR2;CLEC6A;IL1B
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.44027616577691564,-1.0944925719131722,0.3469387755102041,0.6355729403528743,1.0,6/12,20.02%,MAOA;AMD1;OAZ2;DDC;SMS;SRM
prerank,chromatin remodeling (GO:0006338),-0.2813796499601586,-1.0944890151423212,0.2697768762677485,0.635044662573706,1.0,38/100,32.39%,ACTB;ESR1;ZBTB7A;KDM5C;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;MBD3;GATAD1;SATB2;HCFC2;SMARCA4;GATAD2B;SMARCA2;RBBP4;KDM6A;CHD4;SOX9;SMARCC1;POLE3;EZH1;HDAC5;RUVBL1;NPM1;CHRAC1;SMARCD2;SMARCA5;MYC;MYSM1;SMARCD3;NPM3;KAT2A;HNRNPC
prerank,regulation of autophagosome maturation (GO:1901096),0.43311015290420013,1.0941329837369045,0.34120171673819744,0.7160419862735258,1.0,4/13,16.39%,PHF23;UBQLN4;CLEC16A;CLN3
prerank,fatty acid beta-oxidation (GO:0006635),-0.31154396114732097,-1.094125057030307,0.327683615819209,0.6354264692121919,1.0,15/51,18.04%,PPARD;ACAD11;ACAA2;ACOX3;ECHS1;DECR1;ACADL;ACADVL;CROT;ETFB;ETFDH;ECI1;ACOT8;MECR;HSD17B10
prerank,negative regulation of wound healing (GO:0061045),-0.35991582665797994,-1.0939092496304843,0.33807829181494664,0.6353885090358509,1.0,8/28,12.82%,SLC12A2;CD34;THBD;CD109;CRK;EDN1;APOE;FGF2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3153996347383831,-1.093680575243391,0.29902912621359223,0.6354353398585124,1.0,24/48,38.45%,SLC7A5;PDE4D;CYRIB;IL1R1;TLR3;HSPD1;TLR4;TXK;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;IL12RB1
prerank,ear morphogenesis (GO:0042471),0.39514157207525835,1.093661463889472,0.3283582089552239,0.7162201024579986,1.0,3/20,2.66%,FGFR2;ZIC1;CHD7
prerank,response to amino acid (GO:0043200),-0.355175770433419,-1.0931023359998953,0.33459357277882795,0.6362916648453246,1.0,19/31,35.88%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;TMBIM6;RRAGA;RRAGC;SESN2;MEAK7;NSMF;RPTOR;GRIN1;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,response to organic cyclic compound (GO:0014070),-0.31724502661888343,-1.0930772230010404,0.3115079365079365,0.6358223747730707,1.0,12/52,12.63%,ESR1;ARL6IP5;ANXA1;SOCS2;IGFBP5;TGFB1;SLC1A1;CYP1B1;TLR3;SPP1;GGT5;ABCA2
prerank,defense response to bacterium (GO:0042742),-0.272499022119255,-1.092767842873585,0.2710843373493976,0.6360299724843377,1.0,21/105,16.68%,LBP;NOD1;RPL30;RPL39;STAB1;LYST;RPS19;GBP7;SHC1;TLR3;FCER1G;PGLYRP1;TIRAP;MAVS;TLR4;SYK;RAB1A;CFP;NOD2;OAS2;ANKRD17
prerank,epithelial structure maintenance (GO:0010669),-0.4637941682997014,-1.0925710683293428,0.3364140480591497,0.6359722513061583,1.0,5/11,36.09%,CXADR;NOD2;MUC13;PIWIL4;MUC6
prerank,regulation of lipid biosynthetic process (GO:0046890),0.35050998712374615,1.0925474287510282,0.31359649122807015,0.7180655110434742,1.0,5/32,6.61%,ZBTB20;PPARA;PRKAG2;PDK4;ASXL3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.35852851675067104,1.0925024503500538,0.32075471698113206,0.7171121111772996,1.0,5/30,7.25%,ROBO1;LPAR1;GPR55;GPR174;LPAR4
prerank,regulation of cytokine production (GO:0001817),-0.26849652769953863,-1.0920245540102609,0.28051391862955033,0.6368407488226197,1.0,25/126,14.94%,FOXP1;AFAP1L2;RPS6KA5;IL15;SRGN;IFIH1;ANXA1;HDAC9;IL33;N4BP1;LURAP1;CASP8;TNFRSF1B;RGCC;GAPDH;BCL6;FLOT1;ACE2;S100A13;TRIM56;PLD3;AGPAT1;BTN3A3;BCL6B;NLRP4
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.43447579290154037,1.0919802320296792,0.3371824480369515,0.7175017287843384,1.0,4/12,18.38%,BLM;NUGGC;NBN;WRNIP1
prerank,protein kinase B signaling (GO:0043491),0.37706951104354913,1.0917480016438794,0.3182844243792325,0.7170494971469653,1.0,1/23,0.08%,IGF1
prerank,metal ion export (GO:0070839),0.35200417203904877,1.0916739271826084,0.3093812375249501,0.7161708692873152,1.0,2/31,0.47%,KCNT2;ATP1A2
prerank,apoptotic cell clearance (GO:0043277),0.3594992228259753,1.0915398315495919,0.3252032520325203,0.7154646976107204,1.0,7/30,8.10%,LRP1;XKR4;MEGF10;RHOH;XKR6;RHOBTB1;TXNDC5
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.31641998920848624,-1.091536633941793,0.2803921568627451,0.6375333720480951,1.0,14/48,14.62%,DMD;PTK2B;PDE4D;CAMK2D;CALM1;FKBP1A;DIAPH1;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,icosanoid secretion (GO:0032309),-0.4412180872847502,-1.0914053797101693,0.3690248565965583,0.6373196299547353,1.0,2/12,3.46%,ABCC4;ANXA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3894363914189052,1.091321057087053,0.3355855855855856,0.7139530630930011,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.3894363914189052,1.091321057087053,0.3355855855855856,0.7139530630930011,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3291674682455356,1.0911398057945336,0.3418803418803419,0.7133696914538804,1.0,5/43,7.91%,IGF1;IL4;GSTP1;CD274;TRIM27
prerank,acylglycerol biosynthetic process (GO:0046463),0.38368021606069524,1.090888267706743,0.3370288248337029,0.7129801416502719,1.0,8/23,16.49%,AGMO;PLA2G4A;MOGAT3;LPIN3;ANG;MOGAT2;DGAT2;LPIN1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3510560418673825,-1.0905753981685586,0.3295668549905838,0.6389151204019476,1.0,9/32,19.52%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3270383739691977,1.0903293267921972,0.3117408906882591,0.7133859114572392,1.0,8/44,9.73%,CYP7B1;PRKAG2;ALOX12;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2556220911231992,-1.0902618197886889,0.25667351129363447,0.6391248683783446,1.0,48/163,23.09%,MEF2C;PTPRJ;PLCG2;WNK1;PDE4D;BMX;INPP5D;CD38;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;SYK;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;SPG21;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;BTK;LAT2;PTPN22;CSK;PSMA4;PSMA2
prerank,glucose transmembrane transport (GO:1904659),-0.3984077050448953,-1.0900608210278409,0.35,0.6390880139394246,1.0,9/18,28.76%,SLC2A1;PPARD;RAB4B;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,positive regulation of developmental process (GO:0051094),0.2614108146604748,1.0900330126481315,0.2821011673151751,0.7131036217281728,1.0,25/164,10.28%,BMP2;AR;PTN;BMP5;PHLDB2;GJA1;NRXN1;GDNF;GRIP1;DCN;SHLD2;CEBPB;PRKN;RTN4;FOXA2;SMURF2;CAMK2B;NLGN1;KMT5C;CPEB3;DVL3;BMPR1A;SOX5;ALK;PAXIP1
prerank,lipid droplet organization (GO:0034389),-0.3766101723835932,-1.0897657551725892,0.3544061302681992,0.6393059484029865,1.0,5/22,12.75%,PPIA;RAB18;CDS2;CDS1;FAF2
prerank,inorganic anion transmembrane transport (GO:0098661),0.3111727627008386,1.0897126494561482,0.30181086519114686,0.7128891613091265,1.0,20/63,15.95%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;SLC20A2;GABRB3;ANO3;GABRR2;SLC25A10;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1;SLC25A30;GABRG3
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.43381563715558696,-1.0895559767972984,0.36589698046181174,0.6392979258554528,1.0,3/13,7.75%,PRR5L;CNOT7;RC3H1
prerank,cellular glucan metabolic process (GO:0006073),0.44399152471614967,1.089312658643462,0.32175925925925924,0.7128991547198162,1.0,2/11,2.55%,PRKAG2;PHKA1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3859996377893333,1.0893026010289601,0.3676148796498906,0.7118863635265577,1.0,4/23,8.22%,ATP1A2;ANK2;CACNA2D1;CACNB1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.22722868794877327,-1.0891979086040422,0.19238900634249473,0.6396241671074047,1.0,111/476,18.21%,MECOM;LEF1;MEF2C;MAP3K5;AFAP1L2;RREB1;CDH1;MLLT3;ESR1;NOTCH1;FLI1;LRP5;PPARD;KLF2;FOXO1;KLF4;ELF1;TBX1;FZD4;FOXO3;ETS1;SOX17;SIX1;TGFB1;CNBP;REST;PRDM16;NFYA;PPARGC1A;ING5;FOXK1;CD38;ZBTB16;ACTA2;IKBKB;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;KDM3A;TGFB3;HCFC1;TRIM16;MED24;HDAC4;AKT1;SPIN1;FZD7;ENY2;TAL1;SPP1;MAP3K2;TRIM28;NFATC1;HHEX;SOX18;FOXF2;ARID1A;JMJD6;CEP290;ZIC3;WNT11;MYBL1;CD74;FOXC2;INHBA;SP3;ILF2;CRLF3;PSMC5;WBP2;TEAD2;ACVR1;TRIM56;E2F1;ZNF423;APOE;PPP3CB;SOX4;FGF2;HES1;RNF111;EPC1;SMARCA4;RNF20;NR5A2;HEY1;EGFR;SMAD4;ZFHX3;RAI1;SMARCA2;NR1H2;STAT1;YWHAH;TCF3;KLF6;ETS2;ZBTB48;RELA;MED14;USP22;BRCA2;FOXL2;SP1;RET;CHUK;GLI1;SMAD2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3535083804640795,1.0889008908839646,0.33406113537117904,0.7118529121863674,1.0,5/31,7.73%,IL4I1;LYN;CEBPB;GLMN;CD274
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.44202998038660307,-1.088681165985083,0.3685185185185185,0.6403666030641036,1.0,2/12,8.53%,IGF1R;INSR
prerank,cellular response to ATP (GO:0071318),0.4230579077148827,1.0886547025789137,0.3558951965065502,0.7114344164305242,1.0,5/14,24.01%,P2RX4;HSP90B1;P2RY1;TAF1;RYR3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3861216848049449,-1.0885694216251163,0.3580952380952381,0.6401288414872186,1.0,8/22,30.29%,SLC7A5;TNFRSF1B;SPHK2;NOD2;LAPTM5;BTK;LILRB1;TRPM4
prerank,positive regulation of B cell proliferation (GO:0030890),-0.34715679304436764,-1.0885586475043436,0.33771106941838647,0.639620520259638,1.0,8/29,17.77%,MEF2C;TFRC;CD38;CD81;TIRAP;CD74;CLCF1;CD320
prerank,cell cycle G1/S phase transition (GO:0044843),-0.29980890760988543,-1.0885171935248628,0.3081395348837209,0.6391744908270207,1.0,21/61,25.43%,CDK6;CDKN1B;CUL4A;PLK2;MAP3K11;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;RCC1;EIF4EBP1;PLK3;EIF4E;SPDYA
prerank,regulation of phosphate metabolic process (GO:0019220),0.41328961062574243,1.0884488242077124,0.3590308370044053,0.7109348995716608,1.0,3/16,7.11%,SRPX2;IL4;SIRT2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.24955909553643993,-1.0883729668365727,0.2435344827586207,0.6390169771837678,1.0,61/208,21.16%,ESR1;PLCG2;NOD1;TFRC;MID2;DAB2IP;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;HSPB1;RIPK1;EEF1D;GAPDH;PLK2;ZMYND11;CARD19;TRIM14;TIRAP;MAPKBP1;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;SPHK2;TRAF1;TNFRSF1A;TRIM68;TRIM5;NOD2;TNFAIP3;TMEM101;LGALS1;UFL1;STAT1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2893894266925913,-1.0880765195714,0.3147410358565737,0.6392258492883078,1.0,14/75,12.17%,SLC12A7;SLC9A2;SLC12A2;SLC39A10;KCNJ2;ABCC9;ATP1A1;SLC39A8;KCNJ10;ATP1B1;TRPV4;KCNJ8;KCNK9;KCNJ15
prerank,oligosaccharide biosynthetic process (GO:0009312),0.389880040356556,1.0876260457544076,0.32751091703056767,0.7120586691625984,1.0,7/20,12.72%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,mitochondrial translation (GO:0032543),-0.273786606846086,-1.0875348161844618,0.2729007633587786,0.6400530077379198,1.0,42/104,30.43%,QRSL1;MRPL52;PTCD3;MRPL51;MRPL38;LARS2;MRPL28;MRPL43;TSFM;GATC;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;GATB;NDUFA7;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2;IARS2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.33934926773552615,-1.0874808571739119,0.3449612403100775,0.639648291053182,1.0,6/33,5.35%,PTPRG;THBS1;DAB2IP;SLIT2;PTPRM;ADIPOR1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.44225821025382184,-1.0874220734355013,0.37593984962406013,0.6392643247206445,1.0,4/12,22.82%,ACLY;ACO1;IDH3A;ACO2
prerank,membrane lipid metabolic process (GO:0006643),-0.37970678991839946,-1.0873936307053846,0.35036496350364965,0.6387940689528935,1.0,6/22,13.77%,ST3GAL6;CYP1B1;SPTLC1;B4GALT4;SPHK2;CERKL
prerank,receptor signaling pathway via STAT (GO:0097696),0.366010951552912,1.0873278964716182,0.3494736842105263,0.7118105168235148,1.0,4/25,7.58%,IL31RA;STAT5B;GHR;THPO
prerank,regulation of cell adhesion (GO:0030155),-0.26308372334048813,-1.0872566988788697,0.2605932203389831,0.6386032957755198,1.0,24/129,11.53%,PKP4;PODXL;FRMD5;PTPRJ;PTK2B;TGM2;STX3;PTK2;PLXNA4;ARHGDIA;ADAM10;ARHGDIB;MINK1;TGFBI;VEGFA;PPP2R1A;GPR4;ADGRG1;SIPA1;PPP1CB;PLXNA1;PLXND1;ABL2;YTHDF2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.36303093121032054,-1.087113793213222,0.33865248226950356,0.638431912531873,1.0,11/25,26.61%,CENPJ;STMN2;TRPV4;KATNB1;KIF24;KIF18A;PIN1;KIF18B;NCKAP5L;STMN1;MAP7D3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4487536761281812,-1.0865464880481133,0.3517857142857143,0.6388269115209583,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,cellular response to interleukin-2 (GO:0071352),-0.4487536761281812,-1.0865464880481133,0.3517857142857143,0.6388269115209583,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,regulation of cytoplasmic translation (GO:2000765),-0.422233674602184,-1.0861375895335148,0.38,0.6393806567294977,1.0,5/14,13.09%,CNBP;PKM;YBX3;DHX9;FMR1
prerank,positive regulation of TOR signaling (GO:0032008),-0.3239095662692789,-1.086036463833113,0.3127413127413127,0.6390780271979236,1.0,18/40,32.31%,RICTOR;GPR137B;PIP4P1;LAMTOR2;PIK3CA;RRAGD;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SIK3;SEC13;LAMTOR5;HDAC3;LAMTOR1;LAMTOR3
prerank,blood vessel endothelial cell migration (GO:0043534),0.38897321591324063,1.0856541637328465,0.37782340862423,0.7151345228340894,1.0,2/22,0.36%,ROBO1;NRP1
prerank,positive regulation of binding (GO:0051099),-0.2857968548790397,-1.0852184894481411,0.31417624521072796,0.6405927201285115,1.0,18/84,9.23%,CAV1;CLDN5;B2M;HMBOX1;NGF;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;RARA;IDE;NMD3;DPH3;DHX9;ADD1;FLOT1
prerank,regulation of ERAD pathway (GO:1904292),-0.45880773092338795,-1.0850350117481053,0.3486238532110092,0.6405410585868891,1.0,4/11,11.64%,TMEM259;AQP11;RNF185;UBXN1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3468201545186802,1.084705452385516,0.3431578947368421,0.7165539603902377,1.0,9/34,13.80%,ROCK2;LEPROT;SNX33;UBXN2B;TAX1BP3;LZTFL1;ACTN2;LEPROTL1;MAPT
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3527660699106361,-1.0846932427423055,0.3443579766536965,0.6403640957727981,1.0,16/29,34.41%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3527660699106361,-1.0846932427423055,0.3443579766536965,0.6403640957727981,1.0,16/29,34.41%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,regulation of gene silencing by RNA (GO:0060966),-0.31284162357184175,-1.08446145272363,0.317907444668008,0.639871813077247,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.31284162357184175,-1.08446145272363,0.317907444668008,0.639871813077247,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.30144503410418355,-1.0843181491703513,0.32765151515151514,0.6396924316450103,1.0,24/57,28.77%,KDR;HTT;TNFSF10;PPARGC1A;MIEF1;HIP1R;BAX;MIEF2;BBC3;BAK1;CHCHD10;ADCK1;BAD;BIK;FIS1;MCU;PLAUR;TREM2;PARK7;CAMKK2;HRK;MFF;MUL1;PMAIP1
prerank,nitrogen compound transport (GO:0071705),0.2695174058635718,1.0836726110782626,0.3025210084033613,0.718227441559537,1.0,14/141,6.25%,SLC7A11;SLC6A12;SLC43A1;TXNIP;SLC7A2;SLC6A13;SLC22A4;SLC35F3;LRP1B;ABCC2;SLC22A3;SLC38A1;SLC36A2;SLC7A9
prerank,positive regulation of organelle organization (GO:0010638),-0.339422166947509,-1.0836204578469706,0.34949494949494947,0.6408626946231195,1.0,12/32,26.70%,SORBS3;ANXA1;ANXA2;PPARGC1A;ATL3;SURF4;SHCBP1L;SYNJ1;RAB3GAP2;DOC2B;TREM2;LIG4
prerank,nucleoside salvage (GO:0043174),-0.46353187215229463,-1.083421559224778,0.3713768115942029,0.6408148822777647,1.0,9/10,51.45%,UPP2;TK2;UPP1;DCK;UCK2;TK1;UCKL1;UCK1;HPRT1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.39276440098264204,1.0828304857679796,0.3564154786150713,0.7194237248874111,1.0,5/18,7.71%,NRXN1;NLGN2;NLGN3;CACNG4;NLGN1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3085265485379193,-1.082626594632117,0.31196581196581197,0.6423471340488801,1.0,20/55,23.09%,FHL1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.290554074358812,-1.0823552250941253,0.29469548133595286,0.6425110616576643,1.0,27/73,29.97%,CAV1;TFRC;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;HCLS1;PRKD2;PDCD10;EIF4G1;RPTOR;PARK7;TXN;TNKS1BP1;SH2D3C;TERF2IP;IRGM
prerank,neural crest cell migration (GO:0001755),0.34475300591558655,1.082322263397845,0.34698275862068967,0.7196899355201064,1.0,6/36,4.77%,NRP1;SEMA5A;GDNF;SEMA3A;RADIL;SEMA3D
prerank,steroid metabolic process (GO:0008202),0.29623093327580924,1.0822969417715604,0.3134020618556701,0.7187347997034724,1.0,7/72,5.87%,CYP7B1;VDR;CYP27B1;CYP27A1;BAAT;CYP2A6;MSMO1
prerank,cellular iron ion homeostasis (GO:0006879),0.31219287544194896,1.082248656488275,0.3225152129817444,0.7178397051344072,1.0,3/55,1.49%,BMP6;CP;HEPH
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4386036906661609,-1.0822024727260213,0.37258347978910367,0.6423613117920352,1.0,7/12,37.33%,MAD1L1;BOD1;NDC80;RMDN1;SEH1L;NUF2;KIF2C
prerank,regulation of cell death (GO:0010941),-0.274487695115243,-1.082202469418787,0.2892057026476578,0.6418356478707651,1.0,30/94,22.04%,ACER2;CCN3;FERMT2;CDKN1B;CTSZ;UBB;CHP1;PDE8A;TNFRSF1B;DUS2;SRSF6;SPEF1;WNT11;IMPACT;SOX4;CCN5;FGF2;ACER3;DHCR24;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CRYAB;NCK1;HSPA1B;ADNP2;SNCG;EIF4G1
prerank,regulation of cellular response to stress (GO:0080135),-0.26539862372196,-1.0821949537277467,0.296969696969697,0.6413324550453223,1.0,44/115,27.53%,MAPK3;CAMK2D;HSP90AB1;HSPA8;ATF4;CHCHD2;NUP93;MBTPS2;NDC1;HSBP1;NUP54;BAG5;NUP188;NUAK1;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;AMFR;MCL1;FKBP4;HSPA1B;NUP160;EIF4G1;DNAJB1;BAG1;ATF3;RSL1D1;SMG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NPM1;NUP98
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3264125353074744,1.0820704850421008,0.3369330453563715,0.7172606847287891,1.0,6/43,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,mesonephros development (GO:0001823),-0.44879647887190666,-1.081839893347619,0.3752310536044362,0.6416572212055287,1.0,2/11,5.53%,FGF1;ZBTB16
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2715705743928332,-1.0817845572767957,0.2948207171314741,0.6412713193350169,1.0,30/104,21.87%,ST3GAL6;ST3GAL4;CHST11;CSGALNACT1;SLC26A2;CSPG4;TPK1;MAT2A;GGTA1;CDO1;SLC10A7;GSTA4;B4GALT4;GGT5;GSTM2;GSTA3;SLC35B3;SLC35D2;GSTM1;GSTO2;CTH;GCLM;MGST3;CNDP2;GCLC;GGT1;B3GNT3;GSTK1;GGCT;CHPF
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34519862618572245,-1.0816707557102603,0.3473053892215569,0.6410566409964757,1.0,13/31,22.97%,DAB2IP;HSPA8;RHBDD1;DNAJB12;BAX;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,mitotic spindle organization (GO:0007052),-0.25467823315920723,-1.0811959993217046,0.2703252032520325,0.6417105090427505,1.0,60/153,31.12%,RAB11A;DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;CEP192;PLK2;KIF23;VCP;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;LSM14A;MAD1L1;KIF18A;MISP;RANGAP1;DYNLL2;TPX2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;SPICE1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;KIFC2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;RHOA
prerank,skeletal muscle tissue development (GO:0007519),-0.34178738796750396,-1.081159036108093,0.34063745019920316,0.641280587987131,1.0,5/32,3.90%,MEF2C;CAV1;MYL6;CAV2;SIX1
prerank,B cell mediated immunity (GO:0019724),-0.4608918229722123,-1.0810364536670407,0.37957610789980734,0.6410748415135753,1.0,8/10,52.32%,FCER1G;CD74;TLR8;FCGR2B;CARD9;SLA2;MSH2;CD19
prerank,regulation of mRNA catabolic process (GO:0061013),-0.26701269981287884,-1.0810163805802175,0.2842741935483871,0.6405956851208968,1.0,42/121,25.93%,VIM;UBB;HSPA8;PRR5L;UBC;RPS27A;CNOT7;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;PCBP4;PSMC4;PSMC5;YTHDF2;PSMD14;YWHAZ;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;EXOSC8;PUM2;SERBP1;PSMA1;YTHDF1;PSMB1;PSMC3;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB;PSMB8;PABPC1;DIS3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.46524922118469886,-1.080773975793505,0.37640449438202245,0.6406531491225728,1.0,7/10,40.10%,SVIP;UBE2G2;DERL2;ERLEC1;INSIG1;OS9;UBAC2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36820678935496065,-1.080680546966465,0.3670886075949367,0.6403607330520122,1.0,11/24,29.30%,DAB2IP;HHEX;GRB10;EPN2;TMEM204;ITGB3;CADM4;PRKD2;PTPN1;PDCD6;ITGA5
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.42476142076340223,1.080571749030588,0.3638392857142857,0.7201888890322641,1.0,4/15,8.79%,DDR2;LRP1;DDR1;FGFR4
prerank,negative regulation of protein modification process (GO:0031400),-0.2828571382154014,-1.080187292369478,0.2879684418145957,0.6409886834542755,1.0,19/79,12.51%,OCLN;DMD;NIBAN1;PPP1R16B;DAB2IP;SLIT2;TGFB1;MFHAS1;PPIA;PRR5L;CHP1;IGFBP3;PRKDC;WARS1;DBI;PPP1R8;IMPACT;CIB1;PNKP
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.43270456554885806,-1.0800337255657524,0.36731107205623903,0.6408445386332369,1.0,5/12,20.93%,DMD;WNK1;ATP1B1;GLRX;ATP1B2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44116740564815804,-1.0795303183311282,0.35778175313059035,0.641562269262356,1.0,6/12,22.03%,RPL26;CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,oligosaccharide metabolic process (GO:0009311),0.32004771050869285,1.0795035185483113,0.3232931726907631,0.7219676276685265,1.0,15/46,14.74%,B3GALT1;ST6GALNAC5;GAL3ST3;AMY1B;AMY1C;AMY1A;ST8SIA1;FUT4;ST6GALNAC6;FUT9;ST8SIA2;B3GALT2;B3GALT5;GLA;ST8SIA5
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.24569136795948499,-1.0793192206185356,0.2805907172995781,0.6415406201054138,1.0,47/214,15.56%,FN1;TEK;BMPER;SEMA6A;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;DAB2IP;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;EZR;SHC1;PDE8A;NPNT;FLT4;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;DUSP3;YWHAZ;APOE;TLR4;FGF2;SYK;STYX;CSF1R;ARHGEF5;HRAS;PHB2;EGFR;ERBB2;SMAD4;EPHA2;NOD2;PTPN6
prerank,positive regulation of viral genome replication (GO:0045070),-0.35020339433639935,-1.0792934552961992,0.34285714285714286,0.6410879525058468,1.0,8/29,15.00%,ADAR;PPIA;CNOT7;SRPK1;IFIT1;STAU1;NR5A2;TOP2A
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3855526451826254,-1.079254232834594,0.361003861003861,0.6406657200058413,1.0,4/21,3.86%,MEF2C;ITGA1;HSP90AB1;CALM1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3804963591519855,1.0790475037180816,0.3544857768052516,0.7221911353527168,1.0,2/23,2.08%,CEMIP;PRKAG2
prerank,regulation of sodium ion transport (GO:0002028),0.340248009211544,1.0789494443215308,0.3378684807256236,0.7214302415229882,1.0,15/34,24.30%,SCN3B;NKAIN2;P2RX4;GPD1L;NKAIN3;DRD2;WNK3;NEDD4;FGF12;PER1;ATP2B4;DLG1;SCN5A;RANGRF;CNKSR3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3359691480151407,-1.0788128317244785,0.3483992467043315,0.6412551385238745,1.0,10/35,18.62%,ITGA1;HSP90AB1;CALM1;FKBP1A;HTT;CSNK2B;CALM3;NUAK1;BOD1;PPP6R3
prerank,regulation of protein secretion (GO:0050708),-0.26194310383315866,-1.0787429363251135,0.2839506172839506,0.6408955442606964,1.0,19/119,8.64%,ITPR2;SLC2A1;RAP1A;SLC12A2;DPP4;UNC13B;KCNB1;CD2AP;ITPR3;TGFB1;TGFB2;PPIA;MYOM1;STX1A;UQCC2;EZR;TGFB3;DPH3;ABCG1
prerank,postreplication repair (GO:0006301),-0.31224546919127305,-1.0781035730334119,0.332703213610586,0.6420246117660519,1.0,16/45,25.71%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RAD18;RPA3;POLK;UBE2B;DTL;RFC3;RFC2;NSMCE1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3438411998133694,1.0776057306548779,0.3304535637149028,0.7238624244561092,1.0,4/33,6.76%,IGF1;OMA1;PRKN;IAPP
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4247049072042931,-1.0775606822832646,0.3777372262773723,0.6428659574618196,1.0,6/13,20.61%,PPARD;REST;SRF;RELA;SOX9;NFATC3
prerank,regulation of cilium movement (GO:0003352),0.4629029837462516,1.077473831412187,0.3851203501094092,0.7232112341768493,1.0,3/10,11.51%,CFAP43;CCDC65;DNAH11
prerank,cardiac muscle cell development (GO:0055013),0.3919885241385758,1.0773175420652017,0.3741648106904232,0.7226445063007029,1.0,9/20,14.83%,SLC8A1;PDGFRA;CSRP3;FHOD3;PDGFRB;ALPK3;OBSL1;PDLIM5;MYLK3
prerank,MAPK cascade (GO:0000165),-0.23571200206939136,-1.0773079332333872,0.24458874458874458,0.6429811334200074,1.0,86/295,21.44%,KITLG;TEK;MEF2C;SHANK3;MAP3K5;RASAL2;RASGRP3;SPTBN1;FGF1;RASGRF2;KDR;MEF2A;MAPK3;PTK2;RGL1;SHOC2;DAB2IP;MAP3K20;CALM1;TGFB1;MAP3K3;UBB;MINK1;UBC;RPS27A;PEBP1;TAOK3;IKBKB;SHC1;PSMA6;NEFL;MAP3K8;KRAS;PSMB5;SPTAN1;PDGFA;IL17RD;PPP1CB;PSMC4;ZDHHC9;TAOK2;NF1;PSMC5;PPP5C;PSMD14;BCL2L1;ICMT;FGF2;HRAS;LYPLA1;LAMTOR2;RBX1;JAK2;EGFR;PSMD8;ERBB2;PIK3CA;RGL2;PSMD11;MET;PIK3R2;PSMB4;PSMD12;PSMC1;RCE1;JAK3;CUL1;RGL3;RET;CHUK;MAPK12;FGF9;PTGER4;RASA1;ARL2;IL3RA;SOX9;RASGRP4;LGALS9;MAPK11;CSF2RB;PSMA1;FGF10;RAPGEF2;PSMB1;PSMC3
prerank,regulation of lamellipodium assembly (GO:0010591),0.347445489590195,1.077170059900031,0.35403726708074534,0.7219851004158909,1.0,2/34,0.26%,AUTS2;PIK3R1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4564742294306339,1.0770047071883966,0.36342592592592593,0.7213758118271582,1.0,3/11,8.22%,CACNA2D1;CACNB2;CACNB1
prerank,Golgi organization (GO:0007030),-0.2662896160172471,-1.076956777740081,0.3182711198428291,0.6433510839090099,1.0,52/112,31.50%,SYNE1;ATP8B1;PI4K2A;ZW10;BCAS3;HTT;GORASP2;FAM174B;PLEKHM2;ATL3;TRIP11;STK25;ATL2;TRAPPC11;BAG5;FHDC1;SURF4;VRK1;VMP1;YWHAZ;RAB1A;COG3;GOLGA5;GOLGA8B;LMAN2;GCC2;VTI1B;TMED1;TMED5;ATP8B2;COG2;PDCD10;STX5;PLK3;LMAN2L;RAB43;CDC42;GOLPH3;GOLPH3L;PLK5;TMED3;GOLGB1;SEC16B;DNAJC28;STX16;ATP8B4;SPTBN5;DYM;VAMP4;TRAPPC12;CDK1;HACE1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.36789231963312985,1.0769550375661137,0.3487903225806452,0.7204850177807187,1.0,9/25,18.84%,GRID2;MPP2;NLGN3;MAPK8IP2;CHRNA4;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3580817429247682,-1.0769446913311962,0.3761467889908257,0.6428684879773597,1.0,6/28,8.37%,DAB2IP;NGF;CRADD;GABARAP;CASP8;BAX
prerank,response to purine-containing compound (GO:0014074),-0.392376179309024,-1.076806529079822,0.38,0.6426993210425315,1.0,3/17,8.10%,TRPC3;ABCC9;NDUFS4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4508693449671072,-1.076214137068116,0.3879310344827586,0.6436187696678047,1.0,3/11,8.34%,TPK1;CTPS2;SLC19A3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.391739140175732,1.0761653727994327,0.3598233995584989,0.721480294881829,1.0,5/19,15.91%,AR;NAB2;ICE1;TENM1;ICE2
prerank,Fc receptor signaling pathway (GO:0038093),-0.2647020900130439,-1.0761305154895884,0.29637526652452023,0.6432807651043987,1.0,40/110,25.24%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,cell projection organization (GO:0030030),-0.3429082799827481,-1.0758173600698107,0.34392523364485983,0.6435266255315054,1.0,10/30,25.34%,PARVB;RHOJ;RAC1;PDGFA;NCKAP1;CAPG;PACSIN2;ATP1B2;CDC42;KIF17
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3808556999406162,-1.0752695018501672,0.3799212598425197,0.6443301276834588,1.0,10/22,28.29%,NOP14;RPS21;ERI1;PES1;URB1;EXOSC8;WDR12;ABT1;FTSJ3;EXOSC9
prerank,protein polymerization (GO:0051258),-0.3070008580020782,-1.075227297689447,0.3339805825242718,0.6439161214109894,1.0,22/56,24.73%,COBL;RAC1;DIAPH1;TTC17;CENPJ;FAM107A;WASHC3;TRPV4;PREX1;ARL6;WASL;JAK2;CASQ2;WASHC5;GPX4;CHMP2A;PIN1;MSRB2;MICALL2;CORO7;AIF1;CASQ1
prerank,glucose homeostasis (GO:0042593),-0.2755267635719303,-1.0750596453384544,0.3115079365079365,0.6437992466814054,1.0,11/83,5.37%,ADIPOR2;IGF1R;LRRC8D;FOXO1;HK1;KCNB1;BACE2;KLF7;PPARGC1A;ADIPOR1;FOXK1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4350840534364683,-1.074832414489788,0.3759124087591241,0.6438100398287357,1.0,2/13,1.71%,DDX5;RPL26
prerank,protein neddylation (GO:0045116),-0.43363431644435774,-1.0748294032971215,0.3788706739526412,0.643300300295186,1.0,4/13,14.34%,DCUN1D5;DCUN1D1;UBE2F;RBX1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3503035442634622,-1.0746722128154353,0.3532710280373832,0.6431521471820791,1.0,11/30,19.49%,NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;TNFAIP3;ARHGEF2;FAIM2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.45719833635159934,1.074539710727692,0.3638392857142857,0.724633758798861,1.0,5/10,23.08%,HENMT1;DROSHA;AGO2;MRPL44;DICER1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2878908857338254,1.0742589294122074,0.32577319587628867,0.7243518442614891,1.0,12/86,9.35%,BMP6;BMP2;SULF1;BMP5;ZEB2;UBE2O;MEN1;CITED2;TGFBR1;RBPJ;HES5;BMPR1A
prerank,icosanoid biosynthetic process (GO:0046456),0.4591316873336445,1.0741309045849723,0.3678646934460888,0.7236839111029614,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.43058766428489115,-1.0740688515685335,0.375,0.6441222881689443,1.0,4/13,16.28%,LPCAT3;AQP11;MBTPS2;NR1H2
prerank,positive regulation of cell cycle process (GO:0090068),0.28044392619233177,1.0739998736124836,0.32238193018480493,0.7229840093178403,1.0,17/91,15.12%,IGF1;SVIL;TGFA;PHIP;UBXN2B;PDGFRB;GEN1;SIRT2;IGF2;MAP10;CDC25B;AURKC;BTC;DRD2;SPAST;RANBP1;USP19
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3302655494685349,-1.0739519279407093,0.3320964749536178,0.6438868665835764,1.0,17/36,31.42%,MAP3K20;RAD1;E2F1;RAD9B;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;DNA2;ATRIP;PRPF19;CDC5L;CDC6
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.32284199683289994,-1.0735022510680114,0.35969868173258,0.6445342473686742,1.0,15/39,24.23%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4;RFC3;RFC2;FAN1
prerank,ion transport (GO:0006811),0.2784398921083005,1.0733935048465686,0.31020408163265306,0.7235236574313137,1.0,24/111,13.14%,SLC1A3;SLC24A3;SLC8A1;SLC24A5;SLC17A1;CNGB3;VDAC2;TRPM3;CHRNB4;GLRB;SLC20A2;SLC26A1;SLC36A2;SLC9A7;TRPA1;SLC25A10;SLC24A4;SLC24A2;CHRNA4;CHRNA7;CTNS;SLC12A3;CHRNB1;SLC1A2
prerank,thyroid hormone generation (GO:0006590),0.4593082657177471,1.072330948943036,0.38074398249452956,0.7252999819518448,1.0,2/10,5.83%,DIO2;CPQ
prerank,regulation of cellular localization (GO:0060341),0.3219491401508937,1.072286698827327,0.3297644539614561,0.724386932311703,1.0,14/46,17.73%,ADCY5;WWC1;STXBP4;LYN;PRKN;FOXA2;DVL3;EPHA5;BRSK1;PARD6G;CDK16;TRIM46;NUMA1;PARP1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3530398625445258,-1.0717999436217907,0.3726937269372694,0.648300417092213,1.0,13/27,30.15%,DDX5;CD44;TWIST1;PTTG1IP;CD74;SMYD2;KDM1A;MSX1;SPRED3;SNAI2;KMT5A;PMAIP1;SPRED1
prerank,neutral amino acid transport (GO:0015804),0.35243053460460283,1.0715442854646982,0.3516949152542373,0.7253703043572395,1.0,9/28,13.28%,SLC6A9;SLC43A1;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;CTNS;SLC38A6
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3275465922970037,-1.0715354083363087,0.36162361623616235,0.648462624152036,1.0,6/39,3.29%,UTRN;DMD;NEDD4L;FXYD5;WNK1;CAMK2D
prerank,peptidyl-serine modification (GO:0018209),-0.25210582525014813,-1.0713909317362222,0.2694610778443114,0.6483019690031866,1.0,39/166,16.57%,PRKCH;RPS6KA5;TGFBR2;HIPK1;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;HPF1;POGLUT1;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;PARP2;CAB39;STK38L;CSNK2A1;CSNK2A2;POGLUT3
prerank,regulation of cartilage development (GO:0061035),0.39902861658780536,1.071216512644042,0.3882113821138211,0.725243080168738,1.0,4/18,9.56%,BMP2;TRPS1;SCIN;SOX5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.28204571658446415,1.0709124105039374,0.3408163265306122,0.7250051153578898,1.0,11/84,11.37%,IGF1;SAMD4A;DAPK1;RTN4;IGF2BP2;NANOS3;CPEB3;DDX6;RIDA;CHRNA7;FXR2
prerank,cellular response to pH (GO:0071467),-0.39250698678636176,-1.070764597524872,0.3580705009276438,0.6493389959852742,1.0,5/17,26.89%,CHP1;IMPACT;RAB11B;HYAL1;RAB11FIP5
prerank,COPII-coated vesicle budding (GO:0090114),0.29797685797484263,1.0702472356972537,0.3514644351464435,0.7256021744382913,1.0,17/68,17.89%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SCAP;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20;GOSR2;MIA3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.44525619381864934,-1.0702472059755777,0.351985559566787,0.6501214368592124,1.0,4/11,7.87%,MAP3K5;ARL6IP5;CYP1B1;STK25
prerank,carnitine metabolic process (GO:0009437),0.4431368795203652,1.0701784328277828,0.3827433628318584,0.7247619709144744,1.0,3/12,6.83%,BBOX1;CPT1C;CPT2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.45825035130384806,1.0696848538650907,0.3733031674208145,0.7250511675218348,1.0,7/10,25.80%,KLF15;NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,pulmonary valve morphogenesis (GO:0003184),-0.39842047619362836,-1.0692672190254209,0.37300177619893427,0.6521018091587473,1.0,8/17,9.30%,NOS3;NOTCH1;SLIT2;TGFB2;STRA6;HEYL;SMAD6;NFATC1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3195986986044842,-1.069247573915813,0.33941605839416056,0.6516271930870954,1.0,12/41,14.52%,MEF2C;NOTCH1;TGFBR2;SMAD7;TGFB1;TGFB2;FKBP1A;HEYL;CPE;SOX4;ENG;HEY1
prerank,neuron projection development (GO:0031175),0.253427337230616,1.069214493285252,0.2976190476190476,0.725178447641661,1.0,33/168,13.80%,ADGRV1;NRK;EPB41L3;GDNF;CNTN4;CNTNAP2;GPM6A;DOCK10;GPRIN2;LYN;GPRIN1;MYO16;SRGAP2;CTNND2;TBC1D24;EPHB1;GAS7;TNIK;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;PTEN;LRP12;RASGRF1;SNAPIN;ATXN10;DLG4;CDK16;MAPT
prerank,melanosome localization (GO:0032400),-0.37581860519118926,-1.0689052918581066,0.36617100371747213,0.6519357764525129,1.0,7/21,16.80%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6;VPS33A
prerank,positive regulation of lamellipodium organization (GO:1902745),0.349818697257966,1.0688192457600314,0.372,0.7251847056887047,1.0,2/32,0.26%,AUTS2;PIK3R1
prerank,neural crest cell development (GO:0014032),0.31997143336099904,1.068771347362819,0.33755274261603374,0.7243038072930393,1.0,6/44,4.77%,SEMA5A;NRG1;GDNF;SEMA3A;RADIL;SEMA3D
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4464838634814316,-1.0685945920100208,0.39473684210526316,0.652201243813488,1.0,2/11,2.05%,MLLT3;RSPO3
prerank,spinal cord development (GO:0021510),-0.44178381835649394,-1.0684652614865773,0.390990990990991,0.6519986506946471,1.0,7/12,21.50%,VIT;PKD1;SOX12;NF1;SOX4;ZPR1;PKD2
prerank,positive regulation of autophagy (GO:0010508),-0.278625172886181,-1.0682117429738294,0.3472222222222222,0.652098836688074,1.0,24/81,22.81%,SH3BP4;KDR;FOXO1;MID2;FOXO3;HTT;SVIP;PLK2;SCOC;TRIM14;PIK3C2A;EPM2A;PHB2;TRIM68;BNIP3L;TRIM5;UFL1;BAD;TSC2;PLEKHF1;TMEM59;TFEB;PLK3;SESN2
prerank,vasodilation (GO:0042311),-0.4180385155645647,-1.068165394303388,0.36450381679389315,0.6517057187876728,1.0,2/13,2.57%,NOS3;KLF2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2748623546166782,-1.0681226155809216,0.3221343873517787,0.6513023697633761,1.0,20/94,12.65%,PPP1R13B;MAP3K5;DDX5;ARL6IP5;DAB2IP;FNIP2;CRIP1;CYP1B1;ATP2A3;ATF4;PRKDC;TNFRSF1B;PPM1F;CUL4A;BAX;BBC3;BCL2L1;E2F1;HINT1;BAK1
prerank,endoderm development (GO:0007492),-0.4305097552321501,-1.067169775510557,0.38353765323992994,0.6531528156873437,1.0,8/13,38.74%,SOX17;SOX7;KIF16B;DUSP4;DUSP1;TBX20;DUSP5;DUSP2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4507624063742076,1.0659236262247487,0.37668161434977576,0.7307269897366643,1.0,2/10,6.13%,BMP6;PLG
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.40685909843192464,1.0655803312977958,0.35135135135135137,0.730558492827382,1.0,8/15,25.72%,TRPM1;GRM1;GRM4;HOMER2;GRIK3;DAGLA;GRM5;GRM8
prerank,positive regulation of protein transport (GO:0051222),-0.2902993705194579,-1.0654125211012515,0.32633587786259544,0.6568382981153102,1.0,19/67,13.54%,RACK1;UNC13B;CD2AP;TGFB1;TGFB2;ATP2C1;BCAS3;PPIA;PRR5L;CHP1;MYOM1;EZR;TGFB3;ABCG1;CEP290;EXOC1;PCM1;OAZ2;ARHGEF5
prerank,mitotic metaphase plate congression (GO:0007080),-0.30046167757876713,-1.0652681731811555,0.33659491193737767,0.6567006704349384,1.0,22/51,32.17%,RAB11A;DCTN2;ZW10;CHMP2B;MAD1L1;KIF18A;CHMP2A;BOD1;NDC80;RMDN1;KIF22;SPDL1;CDCA8;CEP55;VPS4A;SEH1L;EML3;CHMP7;NUF2;PSRC1;CHMP4B;CHMP4A
prerank,cellular response to UV (GO:0034644),-0.28212278350195075,-1.0651704076914381,0.3326959847036329,0.6564172469370703,1.0,31/76,30.92%,RPL26;CRIP1;RHBDD1;ATF4;N4BP1;ERCC1;YY1;IMPACT;BAK1;FMR1;OPN3;CDKN1A;KDM1A;POLK;CHEK1;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;HYAL1;PRKCD;CARD16;PPID;SMPD1;XPC;NPM1;MMP3;MYC;HYAL2;AQP1
prerank,lysine metabolic process (GO:0006553),-0.4351856722009723,-1.0648036995175174,0.40036563071297987,0.6563259763882836,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,lysine catabolic process (GO:0006554),-0.4351856722009723,-1.0648036995175174,0.40036563071297987,0.6563259763882836,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.35161581362040445,1.0646563713834523,0.35294117647058826,0.7320214171548818,1.0,7/29,14.51%,GDNF;TENT5A;AXIN2;DHX34;TENT5B;NBAS;RBM24
prerank,membrane fusion (GO:0061025),-0.332622600016204,-1.0642801190550715,0.35714285714285715,0.6570892706077158,1.0,11/33,20.36%,DNM3;MYOF;CHP1;NAPA;DYSF;OPA1;RABEP1;VTI1B;NSF;DNM1;DNM2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3334778341079315,1.0641867439502382,0.3490364025695932,0.7322111353728478,1.0,5/39,2.15%,NRP1;BMP2;SALL1;GDNF;GLI2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2050582279466866,-1.0641432012578496,0.14676616915422885,0.6569232331133107,1.0,337/1645,18.51%,BNC2;KLF12;MECOM;LEF1;FOXP1;ELK3;ERG;ZBTB7C;MEF2C;DACH1;MAP3K5;APBB2;AFAP1L2;WWP1;RREB1;TBX15;NR3C2;CDH1;ATP8B1;MLLT3;RPS6KA5;ESR1;KLF3;NOTCH1;DDX5;CBFA2T3;ID1;RPL6;ZHX3;FLI1;DACH2;CDK17;LRP5;TEAD4;HMBOX1;TRAK1;ID3;JUND;PPARD;JMJD1C;NCOR1;MEF2A;KLF2;FOXO1;KLF4;NLK;ELF1;ZBTB46;TBX1;SMAD9;FZD4;ZSCAN29;RPS6KA3;CAMK2D;FOXO3;ETS1;SOX17;DAB2IP;BRD3;SMAD7;ZBTB7A;PHF20;IRF2BPL;VSX1;DDX17;SIX1;CDKN1B;KLF7;TGFB1;LHX6;CNBP;REST;KDM5C;PRDM16;TRRAP;TBX2;ARID3B;NFYA;ZNF431;REL;HDAC9;HSPA8;WWP2;NR4A2;CARF;ASCC2;PPARGC1B;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTDSP1;TFCP2L1;BRWD3;PRDM2;PPARGC1A;ING5;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;SLC39A8;HEYL;ZBTB16;LRRFIP1;DPF2;BRD9;CRK;SMAD6;VEGFA;CNOT7;ACTA2;MPHOSPH8;DPF3;AEBP2;USF2;PPP2R1A;IKBKB;RBFOX2;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;FOXN3;KDM3A;ZNF326;CBFB;GATA2;TGFB3;KLF8;SAFB;NR3C1;MXD4;HCFC1;ZNF276;TOX3;CBX5;ANXA4;FOXQ1;CC2D1B;PPM1F;CIC;UIMC1;IRF2BP2;HDGF;TRIM16;MED24;NR2C2;YY1;HDAC4;ATXN1L;ZMYND11;AKT1;PLAGL1;SPIN1;INSR;FZD7;NDUFA13;ENY2;BCL6;FUS;TAL1;NOP2;SOX7;MKX;DHX9;SPP1;TWIST1;MED27;MAP3K2;TRIM28;NFATC1;BAZ1A;HHEX;PRDM15;RELB;SOX18;FOXF2;RB1;SP110;ESRRA;MXD1;ARID1A;JMJD6;ZC3H8;HSPD1;CEP290;JUNB;ZIC3;FOXP2;ZFP14;PRRX2;TCIM;WNT11;MYBL1;GABPA;WTIP;CD74;MED6;FOXC2;ZBTB18;INHBA;TADA2B;E2F3;CCDC85B;EBF2;SP3;ILF2;CRLF3;SOX12;KMT2D;SFPQ;PSMC5;LIMD1;HTATIP2;PHC1;WBP2;TEAD2;HIVEP1;ZNF83;OLIG1;IFRD1;ACVR1;TRIM56;CIPC;TOX2;MED29;ZFHX2;E2F1;ZNF423;APOE;PPP3CB;COMMD7;SOX4;HINT1;ZNF471;ABCA2;TSFM;POU2F1;FGF2;HES1;RNF111;SATB2;ZMIZ2;PLAGL2;GRHL1;ZNF367;TOX4;ENG;CIART;MTERF3;LCOR;ZNF569;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;STAT5A;MRGBP;EID2;RFX2;RNF20;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;ERBB2;PURG;IRF9;HNRNPK;LDB1;SMAD4;ETV4;SNF8;ZFHX3;SOX6;RFX5;CDKN1A;RAI1;DRAP1;ZFPM2;CELSR2;SMARCA2;POU2F2;LIN54;NR1H2;STAT1;SAP30L;ZNF76;YWHAH;TCF3;GMEB2;CCNK;KLF6;ZNF319;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;RELA;ZNF22;CCAR2;KDM1A;MED14;USP22;BRCA2;FOXL2;NR6A1;SP1;MED20;SCML2;DRGX;RET;ARID4B;CHUK;FOXP4;GLI1;E2F4;SMAD2;MED8;CRYAB;ZNF568;L3MBTL1;CHD4;PHF5A;IRF8
prerank,pentose-phosphate shunt (GO:0006098),-0.44691625931019985,-1.0640450832373853,0.37725631768953066,0.6566569030109258,1.0,5/11,26.41%,PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,endoplasmic reticulum organization (GO:0007029),-0.2851278327131657,-1.0635621471883128,0.33539094650205764,0.6572871768767903,1.0,25/72,27.69%,CAV2;LPCAT3;APP;SHTN1;RAB18;STX1A;ATL3;SPTSSB;ATL2;SEC61B;DOP1B;SGTA;LMAN2;REEP4;RTN3;TOR1AIP2;TMEM33;TLE6;STX5;LMAN2L;RNF112;UBE2J2;SEC16B;TRAM1;SEC61A1
prerank,mitochondrial translational elongation (GO:0070125),-0.27775062058443345,-1.0634689587583954,0.32142857142857145,0.6570084289817306,1.0,36/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,aortic valve morphogenesis (GO:0003180),-0.34802088718110624,-1.0632070622320797,0.38632162661737524,0.6571376531146732,1.0,10/30,9.65%,NOS3;TIE1;NOTCH1;SLIT2;TGFB1;HEYL;SMAD6;TWIST1;NFATC1;RB1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.45286188150749496,-1.062860820740776,0.4010507880910683,0.6574662585653345,1.0,4/11,14.12%,ITPKB;IPMK;FGF2;IP6K1
prerank,negative regulation of cellular component movement (GO:0051271),0.4129236301736666,1.0626936750604734,0.3902439024390244,0.7350412428715373,1.0,4/15,9.12%,TGFBR3;FBLN1;SPOCK3;GATA3
prerank,proton transmembrane transport (GO:1902600),0.33155371266961875,1.0625980033853875,0.35232067510548526,0.7342861267487895,1.0,7/36,12.33%,ATP1A2;ATP6V0A4;SLC36A2;DMAC2L;ATP6V1H;SLC46A1;ATP1A3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.31122812185590654,-1.0624359798213405,0.35526315789473684,0.657989308388267,1.0,9/44,13.50%,ANO6;KCNJ2;WNK1;KCNQ1;KCNJ10;ATP1B1;AKAP6;KCNJ15;GNB1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.26407887686759784,-1.0622480866715707,0.31983805668016196,0.6579691311687749,1.0,20/108,11.10%,CLIC4;SORBS3;F11R;MAPK3;IQGAP1;PTK2;ARHGAP17;CAPN2;RICTOR;RAC1;DIAPH1;CRK;HIP1R;EZR;PHLDB1;PDGFA;FAM107A;SPEF1;RHOB;TAOK2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.21335475308121932,1.0621688791286754,0.21391304347826087,0.7343799022813167,1.0,119/1082,9.64%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;WNT4;IL31RA;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;ZIC1;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;CREB5;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;PIM2;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;TFCP2;ZEB2;PBX4;PHIP;SFRP1;SP7;TFDP1;PHOX2A;CEBPB;MAP3K12;IL4;CAMK4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;ZNF318;GABPB1;GABPB2;FOXA2;TRIP4;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;TP53INP2;SIX4;KMT2A;NFIX;RARG;SOX2;CITED2;TGFBR1;ZSCAN21;RBPJ;NSD1;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;CXXC1;ATOH8;BLM;CREB3L4;CREB3;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;AHI1;HOXC10;HDAC8
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3593683149830319,1.0621086312582613,0.34279918864097364,0.7335437489862712,1.0,3/27,2.19%,IGF1;DDR2;PDGFRA
prerank,sterol metabolic process (GO:0016125),0.297343672261914,1.0619572320912307,0.35,0.7329297895897614,1.0,10/60,9.73%,CYP7B1;ABCA1;PRKAG2;CYP27A1;IL4;MSMO1;ABCA5;INSIG2;SCAP;CYP46A1
prerank,cellular response to calcium ion (GO:0071277),-0.2902300794435057,-1.061914331498064,0.3558282208588957,0.6582391787868627,1.0,9/67,6.89%,MEF2C;ITPKB;CLIC4;PLCG2;MEF2A;IQGAP1;CAMK2D;CARF;CPNE8
prerank,response to reactive oxygen species (GO:0000302),-0.30020653403468467,-1.0616530376806401,0.341948310139165,0.658399957483885,1.0,26/54,33.74%,PXN;MAPK3;RPS3;STK25;COA8;GPX1;AKT1;APOE;EGFR;STK26;CHUK;PTPRK;PKD2;PDCD10;PLK3;HYAL1;CAMKK2;SOD1;ROMO1;HYAL2;TPM1;MAPK9;HP;FOS;NCF1;JUN
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.38270435340151676,1.061507223380127,0.3783783783783784,0.733108798905542,1.0,5/20,9.75%,BCL2;IL4;CASP3;ERBB3;DCC
prerank,zinc ion transmembrane transport (GO:0071577),-0.36927005577349886,-1.0613823754255418,0.3673469387755102,0.6585631612710346,1.0,6/22,14.06%,SLC39A10;SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,regulation of interleukin-1 production (GO:0032652),-0.4056231803049112,-1.0613293137289832,0.3963302752293578,0.6581835986885213,1.0,2/15,3.46%,FOXP1;ANXA1
prerank,neuromuscular process (GO:0050905),0.41149558019225474,1.061239050278563,0.36942675159235666,0.7328441638531226,1.0,3/16,2.31%,MYCBP2;NRXN1;CHRNA1
prerank,protein complex oligomerization (GO:0051259),-0.2787185634860923,-1.0611608689725767,0.3430232558139535,0.6580841269724749,1.0,29/85,26.10%,LRRC8C;LRRC8D;EHD4;MAT2A;AQP11;ATL3;FUS;ATL2;KCNC3;PRMT8;JMJD6;HOMER1;OPA1;NINJ1;CHMP2A;POLQ;EHD1;TRMT61B;ECT2;EHD3;PKD2;UPB1;LRRC8A;CLDN1;BCL10;ALAD;MCU;RNF112;ZNHIT6
prerank,positive regulation of macroautophagy (GO:0016239),-0.3084321655552843,-1.0608442903406443,0.3678861788617886,0.6583112364753988,1.0,12/48,18.96%,SPTLC2;VPS13D;KDR;HTT;RALB;SPTLC1;SCOC;EPM2A;HSPB8;BNIP3L;TSC2;RAB3GAP2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4227092276399054,1.0608375245996893,0.3744394618834081,0.7328387812998322,1.0,5/13,9.81%,TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4117088071322625,-1.0607973010876954,0.3962962962962963,0.6579229730301328,1.0,10/15,35.37%,SEL1L;VCP;FAF2;SEC61B;DERL2;TMEM129;DERL1;SYVN1;OS9;AUP1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2750892833699072,-1.0606165672177479,0.3333333333333333,0.6578514635959064,1.0,38/84,34.73%,UBB;UBC;RPS27A;ANAPC15;PSMA6;ANAPC11;PSMB5;RB1;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;BUB3;PSMC6;PLK1;AURKA;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;CUL3;PSMD2;UBE2C
prerank,aminoglycan catabolic process (GO:0006026),0.3557308875488419,1.060612956040949,0.3610503282275711,0.7324207698453908,1.0,4/28,4.99%,GPC6;GPC4;GPC2;GNS
prerank,Golgi to lysosome transport (GO:0090160),-0.45516372423325285,-1.0599940151710938,0.3958333333333333,0.6588467037975265,1.0,5/11,19.65%,LAMP1;CCDC91;AP4M1;LAPTM5;EHD3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.27923550856505136,1.0598760149860584,0.3410041841004184,0.7334664540359771,1.0,9/85,6.54%,ADGRV1;CEMIP;ATP6V0A4;OTOS;P2RX4;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.25380002532184476,-1.0597944119494103,0.32677165354330706,0.6588189270774721,1.0,55/148,28.92%,PPP1R13B;HIPK1;RPS15;RICTOR;PHF20;RPL11;RPL23;ING5;USP7;RAD1;DYRK2;AKT1;NOP2;PIP4P1;MAPKAP1;CSNK2B;RPS20;MTA2;MBD3;NUAK1;RAD9B;SMYD2;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;RBBP4;RAD17;L3MBTL1;CHD4;CHEK1;CDK5RAP3;PIN1;TPX2;MAPK11;RPL5;BRPF1;TAF9;RHNO1;PLK3;RFC3;RFC2;EXO1;KMT5A;RPF2;DNA2;BARD1;ATRIP;TAF4;TAF10;TAF5;RPL37;MRE11
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3772694656118526,-1.059734444947065,0.3754646840148699,0.6584483039720488,1.0,3/20,1.47%,SEMA6A;SEMA3C;SEMA7A
prerank,regulation of neuron migration (GO:2001222),-0.35017900008026104,-1.0595681855243786,0.3669201520912547,0.6583305727080464,1.0,11/26,20.91%,SEMA6A;COL3A1;DAB2IP;SHTN1;ADGRG1;PLAA;ULK4;NEXMIF;ARHGEF2;NIPBL;RAPGEF2
prerank,action potential (GO:0001508),0.32535987344391026,1.0594120405036689,0.34773218142548595,0.7336513993657288,1.0,10/44,11.72%,SCN7A;SCN3B;CHRNA1;SCN3A;CACNA1I;KCND2;SCN2A;CACNA1G;CHRNA4;GNA15
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3536649467029153,-1.0590411044904358,0.3848987108655617,0.6591525257824408,1.0,7/26,15.37%,NEDD4L;FHL1;WWP2;ATP1B1;CASQ2;CACNA1D;CAB39
prerank,sodium ion export across plasma membrane (GO:0036376),0.4154057128026031,1.0590214781855496,0.36343115124153497,0.7336516937415082,1.0,3/13,14.05%,ATP1A2;ATP1A3;ATP1B3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.45421578807658375,-1.0586121087076545,0.40974729241877256,0.6597274695439294,1.0,2/10,3.51%,SEMA6A;DAB2IP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.38448787002503193,1.0583481698643413,0.3870967741935484,0.7344974953076847,1.0,8/19,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,receptor-mediated endocytosis (GO:0006898),-0.2577804159617953,-1.0578950589044347,0.3241650294695481,0.6609807829534253,1.0,23/132,12.89%,CAV1;DNM3;ACKR3;FNBP1L;SCARB1;SCARF1;CAV2;RAMP2;TFRC;ARHGAP27;CUBN;STAB1;IGF2R;CD81;HIP1R;CD9;AP2M1;INSR;FCER1G;FCHO2;SGIP1;APOE;SYK
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3530758903298365,-1.0565123516641646,0.37404580152671757,0.6639612161310031,1.0,3/24,3.59%,ANO6;CCN3;SLIT2
prerank,nucleotide-excision repair (GO:0006289),-0.2667313634434565,-1.0563872244630774,0.3485148514851485,0.6637620950891817,1.0,48/101,34.21%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;CHD1L;COPS6;XAB2;HMGN1;PNKP;SLX4;COPS5;RNF111;RBX1;XRCC1;CETN2;HUS1;RPA3;BRCA2;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;RAD23A;COPS4;RFC2;COPS7B;FAN1;POLL;XPC;GPS1;LIG4;RAD23B;POLR2F;AQR;POLB;PRPF19;POLR2L;POLR2I;POLR2C;POLE;SLC30A9;POLA1
prerank,exit from mitosis (GO:0010458),-0.4207738909207719,-1.0563507932899903,0.3894927536231884,0.6633288636453103,1.0,7/12,36.63%,EPS8;CHMP2A;PPP2R2D;CHMP7;CHMP4B;UBE2C;SIRT7
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2071677961623304,1.0562296971397758,0.19669421487603306,0.7389122349947446,1.0,193/1667,9.67%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;FHL2;ZBTB20;LDB2;BMP2;MAF;SALL1;PID1;AR;CDK8;ATXN1;TBX3;GLIS3;EPAS1;HLF;MXI1;FGFR2;NFIA;NR2F2;BCOR;BMP5;ZEB1;TBL1XR1;HIVEP2;GDNF;VDR;RBAK;RARB;TRPS1;NCOA2;ZIC1;TEAD1;PRRX1;PPARA;KIT;HOXC4;ZHX2;GLI2;DCN;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;IL4I1;SMAD3;CREB5;TFEC;KDM1B;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TGFA;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;MDM2;GLI3;WWC1;VRTN;TENM2;TFCP2;ZEB2;PBX4;CREB3L1;UXT;PHIP;FNIP1;SP7;TFDP1;KDM7A;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CAMTA1;ZMYM5;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;IL4;GTF2H2;RNF2;SOX21;JAZF1;PRKN;ZNF292;ZNF513;HES3;SUMO1;ZKSCAN7;MNAT1;MLLT10;HNF4G;LIN37;MED12L;SERPINE1;MAML3;AGO4;HOXC9;BCL2L12;TAF6L;ATF5;HDAC10;BBX;GABPB1;GABPB2;ZNF394;BAZ1B;FOXA2;ASXL3;ZHX1;ZNF296;LOXL2;DMRTA2;SMURF2;SP5;PCGF5;SIRT2;CUX1;LHX4;MEN1;MBD2;DMTF1;SIX4;KMT2A;NFIX;KTI12;CRY1;BCL11A;HTATSF1;TNRC6A;RFX7;RARG;SOX2;TRIM27;CITED2;ZSCAN21;RBPJ;NSD1;IGF2;PPM1D;SAFB2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;MIER3;ZBTB45;CPEB3;ATN1;ATOH8;CREB3L4;CREB3;BRMS1;BRMS1L;GLIS1;GATA3;PRKCB;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;KCNIP3;CUX2;SOX5;AHI1;HOXC10;BRWD1;VGLL3;HDAC8;PCGF6
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22900019609020025,-1.0558640855850305,0.27906976744186046,0.6640410594113951,1.0,89/314,23.28%,WWP1;NEDD4L;SEL1L;TRIM25;UBB;ZNRF1;WWP2;UBC;RPS27A;FBXO17;ANAPC15;PSMA6;ANAPC11;CUL4A;DNAJB12;PSMB5;FBXO4;NHLRC3;KCTD5;MAN1B1;PLAA;RB1;ERLIN2;RNF185;UCHL1;UBE2G2;VCP;TNFAIP1;PSMC4;MTA1;MAEA;HSPA5;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;UBXN8;ITCH;FAF2;RNF5;FBXL7;SMURF1;FBXL2;SEC61B;FEM1A;RBX1;UBE2G1;SGTA;PSMD8;PSMD11;CCNF;RNF121;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;TMEM67;FBXL3;FZR1;FBXL16;CUL1;DMAC2;DERL2;PELI1;ZSWIM8;TBL1X;AMFR;KCTD2;TMEM129;UBE2B;PSMA1;ZFAND2B;TMUB2;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;LTN1;SGTB;PSMA4;PCNP;FBXL19;PSMA2;FBXL18;TMUB1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4003883292033405,1.0556941250145233,0.39014373716632444,0.7392801040682052,1.0,3/17,4.01%,NRP1;NTRK3;STAP1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.29779666123320264,-1.055382444276678,0.3514018691588785,0.6647319265297875,1.0,12/54,15.37%,CAV1;KCNJ2;NEDD4L;FHL1;WWP2;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1;CACNA1D;CAB39
prerank,phospholipid catabolic process (GO:0009395),-0.35899838423229,-1.0553696888518203,0.38533834586466165,0.6642576232052683,1.0,8/24,28.84%,GPCPD1;SMPDL3A;ENPP6;GDE1;PLA2G4F;ENPP2;SMPD1;PLA2G4B
prerank,negative regulation of cellular component organization (GO:0051129),0.2876072951718468,1.055198207820284,0.35173824130879344,0.7395889094872198,1.0,5/74,3.69%,BMP6;AR;EPHA3;SNX33;DNAJB8
prerank,snRNA metabolic process (GO:0016073),-0.3875655611363592,-1.054820092121434,0.38394415357766143,0.6651168318959134,1.0,9/17,31.56%,MTREX;INTS8;INTS1;RBM7;MEPCE;INTS12;INTS2;INTS3;ZCCHC8
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.38470669779627503,-1.0545034687870012,0.3752310536044362,0.6654155079051429,1.0,3/17,3.86%,ITGA1;HSP90AB1;CALM1
prerank,calcium ion transmembrane transport (GO:0070588),0.2806496016485617,1.0541815051648609,0.3326732673267327,0.7412040780319173,1.0,16/86,9.82%,NALCN;SLC24A3;SLC8A1;SLC24A5;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;TRPM5;TRPA1;MICU3;CACNA1G;SLC24A4;SLC24A2;PARL
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4083370852640483,1.0541241388311116,0.38266384778012685,0.740356638450936,1.0,2/15,3.11%,PPARA;OSBPL8
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.36442365212802524,-1.053863829031969,0.39807692307692305,0.6664672651392582,1.0,8/24,22.56%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A
prerank,positive regulation of metabolic process (GO:0009893),-0.2672541343771429,-1.053859860646841,0.34765625,0.665970294807696,1.0,23/103,13.01%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;ACLY;KDM3A;INSR;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK;AGPAT1
prerank,regulation of postsynapse organization (GO:0099175),-0.3426533646343196,-1.0537033607952844,0.38691588785046727,0.6658682320415708,1.0,6/28,12.62%,SHANK3;SIPA1L1;ABI3;CFL1;SRCIN1;HOMER1
prerank,cellular sodium ion homeostasis (GO:0006883),0.40018420294364687,1.0535277986318536,0.37122969837587005,0.7409052624571917,1.0,2/15,1.17%,ATP1A2;SLC8A1
prerank,chromatin organization (GO:0006325),-0.2552914266446755,-1.053500556953229,0.3333333333333333,0.6658582230267096,1.0,48/132,31.95%,MECOM;ESR1;ZBTB7A;KDM5C;PRDM16;SAFB;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;HMGN1;GATAD1;SATB2;CDAN1;HCFC2;SMARCA4;HMGN2;SMARCA2;RBBP4;PWWP3A;KDM6A;L3MBTL1;SOX9;SETDB1;SMARCC1;EZH1;PHF19;HDAC5;FAM50A;SETD2;CHD1;RUVBL1;NPM1;CHRAC1;SPI1;SMARCD2;HMGB2;SMARCA5;HDAC3;MYC;MYSM1;SMARCD3;NPM3;KAT2A
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35208503725897355,1.0528409237796785,0.39414414414414417,0.741670154647919,1.0,3/28,2.77%,PIK3R1;ZIC1;SMAD3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29376224528433026,1.0528124977459827,0.36041666666666666,0.7407622474663972,1.0,7/68,7.30%,ENPP1;AMPD3;TPST1;ACSM5;BAAT;SULT6B1;ACOT11
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.35928681557039144,-1.052793690782066,0.40350877192982454,0.6671075894537348,1.0,12/26,31.48%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A;SLC8B1;HTR2B;LETM1;HTR2C
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.30095147177509296,1.0527543035469349,0.35699797160243407,0.7399110464685085,1.0,9/59,7.84%,ROBO1;ROBO2;SDK2;TENM3;CNTN4;PTPRT;KIRREL3;NPTN;TRO
prerank,response to interferon-gamma (GO:0034341),-0.28594569371866807,-1.052361824109196,0.3499005964214712,0.6677276022254143,1.0,17/67,20.27%,GBP5;GCH1;GBP7;IFITM1;IFITM3;GAPDH;IFITM2;CCL15;RPL13A;CD74;TLR4;STAT1;IRF8;AQP4;SYNCRIP;CASP1;LGALS9
prerank,protein sumoylation (GO:0016925),-0.30093774582881516,-1.0519752698876588,0.3516260162601626,0.6681659148248058,1.0,25/49,34.81%,IFIH1;STX1A;NUP93;NDC1;TRIM28;NUP54;SAE1;NUP188;SUMO3;NUP155;RANBP2;NUP37;UBA2;RANGAP1;NUP160;NUP43;SEH1L;NUP107;NUP42;NUP98;TRPM4;UBE2I;RAE1;NUP88;NUP214
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.39967628950490997,-1.051839272590485,0.40808823529411764,0.6680302875520813,1.0,7/16,26.82%,GPR137B;PIP4P1;RRAGD;RRAGA;SEH1L;SIK3;LAMTOR5
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3903356568846007,-1.051755991288718,0.3977272727272727,0.6677065353610369,1.0,5/17,10.56%,NOTCH3;NOTCH1;HEYL;NOTCH4;PLXND1
prerank,copper ion homeostasis (GO:0055070),-0.3919148701125881,-1.0517163818528212,0.3961605584642234,0.6672987637492334,1.0,3/17,4.12%,ATOX1;MT2A;APP
prerank,RNA interference (GO:0016246),0.39847304093628927,1.0516604988529636,0.3933333333333333,0.7417485738530061,1.0,9/17,25.23%,HENMT1;AGO4;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1;CLP1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.36368581542826606,1.0515342494496653,0.39149888143176736,0.7410629661718403,1.0,2/23,1.40%,IGF1;NRG1
prerank,vesicle coating (GO:0006901),0.29869124265399544,1.0515260611558295,0.3755274261603376,0.7381420508685405,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,COPII vesicle coating (GO:0048208),0.29869124265399544,1.0515260611558295,0.3755274261603376,0.7381420508685405,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29869124265399544,1.0515260611558295,0.3755274261603376,0.7381420508685405,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,lymphocyte mediated immunity (GO:0002449),-0.4211751519634128,-1.0513959761153122,0.4198895027624309,0.6675288748600055,1.0,2/12,13.51%,CD55;BTN3A3
prerank,regulation of insulin secretion (GO:0050796),0.27255641033569294,1.0507101729920667,0.3481781376518219,0.739266326363628,1.0,15/101,7.62%,TCF7L2;ADCY5;RAPGEF4;CACNA1E;ITPR1;PRKCA;STXBP4;SFRP1;FAM3D;PRKN;IRS2;NLGN2;FOXA2;SNAP25;TM7SF3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.28265357340534114,-1.0501407688016235,0.3576923076923077,0.6700848074454163,1.0,21/73,21.17%,CRIM1;BMPER;NOTCH1;BMPR2;SMAD9;SMAD7;FOXD1;SMAD6;HTRA3;SKIL;ZNF423;FSTL1;ENG;SMURF1;SMAD4;GREM1;SMAD2;SKI;BMPR1B;BAMBI;CDH5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.25469382965503223,-1.0499152768081177,0.356,0.6701325254645809,1.0,44/129,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,positive regulation of endocytosis (GO:0045807),-0.3111061263377919,-1.0498813523778898,0.37037037037037035,0.6697189413805232,1.0,9/45,12.33%,ANO6;B2M;GPC3;NEDD4L;CD151;FLOT1;HIP1;SGIP1;APOE
prerank,sulfate transport (GO:0008272),-0.4073708416976236,-1.049761819308374,0.4107806691449814,0.6694908554584683,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.35405842972730694,-1.049180344587699,0.3949416342412451,0.6703428963873848,1.0,4/25,6.52%,TGFB2;FKBP1A;CHP1;SH3RF2
prerank,cellular response to hormone stimulus (GO:0032870),0.2909220750202913,1.0491143632840012,0.35185185185185186,0.742424954447102,1.0,8/69,4.95%,ATP1A2;ROBO2;AR;OCSTAMP;NCOA2;STAT5B;SFRP1;GHR
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3710707160051372,-1.0491009296633966,0.3985637342908438,0.6700323530210256,1.0,8/20,22.16%,TGM2;CAMK2D;BAX;BAK1;BCAP31;RAP1GDS1;FIS1;SELENOK
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.2529990443402925,1.0490207937897331,0.3592233009708738,0.7416912555769649,1.0,29/142,15.36%,ATP1A2;LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;PRKACA;SMAD3;CCR6;ACKR2;ACKR4;CCR10;PTGDR;NPTN;IAPP;CALCR;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;DLG4;P2RY1;CXCR4;DRD2;HCRTR1;TRPC1;ADRA1A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3571738040389497,-1.0490065062133322,0.4037735849056604,0.6697733709899355,1.0,10/24,20.37%,RACK1;LPCAT3;AQP11;UBXN1;BCL2L1;OPA1;NR1H2;HSPA1A;XBP1;TMBIM6
prerank,cardiac muscle cell contraction (GO:0086003),-0.36867942684759425,-1.048988401848029,0.38421052631578945,0.6693183477232192,1.0,8/19,19.15%,KCNJ2;ATP1A1;CAMK2D;SCN1A;CACNA1D;PIK3CA;SCN2B;CACNA1C
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40250717820096255,-1.0488942551791471,0.4072727272727273,0.6690343521358317,1.0,6/15,15.81%,TMSB4X;KDR;VEGFA;HSPB1;FGF2;MET
prerank,copper ion transport (GO:0006825),0.4463929902000663,1.0486549828907166,0.40765765765765766,0.7416524989112196,1.0,2/11,6.74%,STEAP3;SLC31A2
prerank,cellular response to sterol (GO:0036315),0.43214737432036443,1.0485929906728129,0.41935483870967744,0.7408452077147221,1.0,3/13,9.54%,RORA;INSIG2;GRAMD1B
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28576449546754573,1.047801135303409,0.3393939393939394,0.7418395381162798,1.0,7/78,2.58%,PIK3R1;PID1;AR;LRP1;DPP10;PDPK1;EPHA3
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2791242944836584,-1.0476059876700612,0.3687258687258687,0.6715917297977912,1.0,8/67,6.37%,ITPR2;SLC2A1;RAP1A;DPP4;KCNB1;ITPR3;STX1A;UQCC2
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.22785021949334638,-1.047178632991255,0.3158995815899582,0.6721491172381036,1.0,106/336,27.25%,FOXP1;ACER2;FOXO1;MAPK3;PAXX;DCUN1D5;RPS3;FNIP2;RBBP5;TRRAP;CRIP1;MTREX;TAOK3;SUSD6;CBX1;PRKDC;TNFRSF1B;CBX5;ERCC1;RAD1;CUL4A;YY1;USP3;BAX;DYRK2;BCL6;GTF2H3;TRIM28;OTUB1;CHD1L;FAM111A;HERC2;VCP;TAOK2;CIB1;HPF1;BCL2L1;E2F1;PNKP;SPRTN;BAK1;SLX4;FMR1;SAMHD1;RAD9B;CDKN2AIP;SLF1;RAD18;TOP2A;PARP2;HUS1;EPHA2;NSMCE4A;RAD9A;RPAIN;CDKN1A;UFL1;CCNK;RAD17;PWWP3A;BABAM2;WDR48;GTF2H4;POLQ;POLK;TRAIP;MAPK12;CGAS;ZBTB40;CHEK1;ERCC4;GADD45A;CCND1;BRAT1;MCL1;UBE2B;SFN;UBA1;CHCHD6;NIPBL;TAF9;PLK3;CCDC13;DTL;EID3;RFC3;POLE3;NUPR2;DTX3L;ASH2L;RFC2;FAN1;EXO1;MRNIP;FBXO6;ALKBH7;XIAP;SPDYA;CEP63;PARK7;PLK5;XPC;RAD51AP1;KIN;SLF2;NPM1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.32106524367758005,-1.0471504633034823,0.3803921568627451,0.6717290490468981,1.0,17/35,30.10%,DAB2IP;MFHAS1;MINK1;VEGFA;EZR;ULK4;GADD45G;EMC10;GADD45A;LGALS9;PTPN22;TREM2;DUSP1;SPI1;RASGRP1;XDH;PJA2
prerank,protein autophosphorylation (GO:0046777),0.2522376819418534,1.0471136835364785,0.326,0.7425335556030471,1.0,35/157,13.15%,DDR2;FGFR2;DAPK2;STK17B;KIT;PDGFRA;PDPK1;PIM2;LYN;DDR1;AAK1;MAPKAPK5;MAP3K12;CAMK4;DAPK1;PDGFRB;EPHB1;CAMK2B;TNIK;MAK;FGFR4;STK33;EPHA8;ERBB4;ALK;MEX3B;MAP3K10;MUSK;EEF2K;ITK;FGFR1;TEC;EPHA1;ULK2;ATM
prerank,signal transduction in response to DNA damage (GO:0042770),-0.30392733125194094,-1.047038271244201,0.36988847583643125,0.6715044434927271,1.0,23/49,35.65%,ACER2;MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;GADD45A;E2F7;CLOCK;RHNO1;TRIAP1;SESN2;FBXO6;CEP63;ATRIP;PRPF19;CDC5L;ABL1;CLSPN;MAD2L2;BATF
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.41241906465523465,-1.0470327329922213,0.41467889908256883,0.6710157113950702,1.0,6/13,25.98%,DAB2IP;HHEX;EPN2;CADM4;PTPN1;PDCD6
prerank,cell differentiation in spinal cord (GO:0021515),-0.44708022377563644,-1.0469663808059502,0.40966010733452596,0.6706938456185612,1.0,3/10,15.70%,SOX13;SOX4;SOX6
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3626285129088365,1.0465683098878131,0.3836477987421384,0.7429883384185191,1.0,3/21,9.35%,BMP6;TGFBR1;BMPR1A
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4058238249215427,-1.0465037569378963,0.41030534351145037,0.6712979877396961,1.0,4/15,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,negative regulation of mRNA processing (GO:0050686),-0.4057924764549596,-1.046474016551458,0.412109375,0.6708689534377902,1.0,5/15,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4442369487979875,-1.046461335898023,0.4103448275862069,0.6703907460638542,1.0,4/10,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,lung epithelium development (GO:0060428),0.44864350496157274,1.0463966717793924,0.40311804008908686,0.74247066154078,1.0,1/10,0.46%,ERRFI1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4237650915196106,-1.0462102214313393,0.41760299625468167,0.6704711006300231,1.0,6/12,25.17%,ERLIN2;ACADL;WDTC1;ACADVL;TRIB3;APOC1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.39403836055956526,-1.0461748751104634,0.3866432337434095,0.6700565077332329,1.0,7/15,28.92%,RAD9B;HUS1;EME2;RAD9A;RAD17;FANCD2;MRE11
prerank,androgen receptor signaling pathway (GO:0030521),-0.43122924545026603,-1.0461019166717895,0.4,0.6697522224114058,1.0,5/11,9.87%,DDX5;DDX17;PLPP1;KDM3A;ARID1A
prerank,cognition (GO:0050890),-0.3101828991403966,-1.0460615233199502,0.382,0.6693422082990935,1.0,9/42,11.34%,ST3GAL4;SHROOM4;APP;DGCR2;STRA6;CHMP2B;MFSD2A;FAM107A;NF1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.36776857914811334,-1.045927991023485,0.4074074074074074,0.6691895060892521,1.0,5/20,7.63%,SLC12A2;KCNJ2;NEDD4L;ATP1A1;ATP1B1
prerank,stem cell differentiation (GO:0048863),0.32692605772625444,1.0458032933560186,0.4392712550607287,0.7429851678801952,1.0,6/39,5.29%,FGFR2;KIT;GPM6A;SFRP1;SP7;SOX21
prerank,negative regulation of neuron death (GO:1901215),-0.2668416100562583,-1.045426301323806,0.3866396761133603,0.6698877903100539,1.0,13/93,8.42%,MEF2C;CD34;PTK2B;NGF;SIX1;REST;PPARGC1A;ATF4;TGFB3;TOX3;TNFRSF1B;FOXQ1;AKT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3216451663274414,1.0451750555691974,0.3839835728952772,0.7437098711607831,1.0,13/40,21.65%,NELL1;TIMP3;SIRT2;TIMP4;FMN2;PRKCG;SF3B3;CYP51A1;SNRNP70;IRAK3;AZIN2;RGP1;TIMP1
prerank,cell projection assembly (GO:0030031),-0.3601334243750191,-1.0450122363261167,0.39543726235741444,0.6704081756686782,1.0,4/22,8.93%,PARVB;RHOJ;RAC1;PDGFA
prerank,response to sterol (GO:0036314),0.4299055166056255,1.0449425163700783,0.4142538975501114,0.743354703644729,1.0,1/11,0.19%,RORA
prerank,myoblast fusion (GO:0007520),0.42832306858561214,1.0446509532276589,0.40217391304347827,0.7431108229955367,1.0,3/12,5.50%,ADGRB3;ADAMTS5;ADAM12
prerank,cilium organization (GO:0044782),-0.23480498425682533,-1.0446321907998721,0.33880903490759756,0.6707963081566699,1.0,44/210,16.82%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;EHD4;RAB8B;IFT20;CEP164;ABLIM3;PKD1;TTC17;EHD2;CENPJ;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;RAB8A;CEP290;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ARL6;RFX2;RAB11FIP3;RAB1A;CCDC28B;KIF24;DNAH5;CEP41;TMEM67
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.35620056410365536,1.0443456542037608,0.39828693790149894,0.7429497003783895,1.0,5/27,7.15%,SLC1A3;SLC6A9;SLC7A2;SLC38A1;SLC25A13
prerank,nucleotide biosynthetic process (GO:0009165),-0.38188880017395155,-1.0442958670627145,0.40574506283662476,0.6710942856967376,1.0,5/18,13.47%,ME1;PRPS2;PRPS1;PRPS1L1;RRM1
prerank,cardiolipin metabolic process (GO:0032048),0.4104606836419561,1.0435788525129188,0.40350877192982454,0.7439814951270866,1.0,2/13,2.58%,PLA2G5;PLA2G4A
prerank,glycoprotein metabolic process (GO:0009100),-0.2967294453137389,-1.043510855423017,0.3835051546391753,0.6724642625773645,1.0,9/53,9.28%,ST3GAL4;ST6GALNAC3;ST8SIA4;MANBA;GANC;ST8SIA6;FBXO17;MAN1B1;FUT8
prerank,cellular response to glucose starvation (GO:0042149),-0.3159315051830045,-1.0431040005003402,0.3821292775665399,0.6729598983670972,1.0,18/41,33.29%,FOXO3;ATF4;HSPA5;IMPACT;NUAK1;NUAK2;PRKAG1;XBP1;HNRNPA1;ASNS;SESN2;BRSK2;SIK1;SESN1;PMAIP1;CPEB4;PIK3R4;ATG14
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4142369398333307,-1.0429423873433183,0.41740674955595025,0.6728368038420005,1.0,4/13,7.63%,SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,digestive tract morphogenesis (GO:0048546),0.4163463433918194,1.0428338849735037,0.4053452115812918,0.7448931380410093,1.0,2/14,2.19%,FGFR2;PDGFRA
prerank,triglyceride homeostasis (GO:0070328),0.35205631739620624,1.042542785099024,0.39705882352941174,0.7446614458881702,1.0,5/26,17.53%,RORA;IL18;PLA2G12B;DGAT2;MLXIPL
prerank,positive regulation of dendrite development (GO:1900006),0.4398638101342034,1.0423837947994745,0.4316702819956616,0.7441207518190172,1.0,2/10,1.32%,PTN;BMP5
prerank,vasoconstriction (GO:0042310),-0.44172040538974733,-1.0421741926906467,0.42702702702702705,0.6742169090545527,1.0,4/11,9.34%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,erythrocyte differentiation (GO:0030218),-0.30632558120919307,-1.041645096555696,0.3931947069943289,0.6749897904969756,1.0,21/44,27.16%,RPS14;MFHAS1;RPS19;VEGFA;SLC25A38;TAL1;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;CDK5RAP3;UBA5;ALAS2;HCLS1;ZFPM1;DMTN;ACIN1;INHA;PTPN2
prerank,protein modification by small protein removal (GO:0070646),-0.2302187204995943,-1.0414626868256414,0.34408602150537637,0.6749053879174391,1.0,100/252,32.48%,ACTB;ESR1;IFIH1;NFKBIA;SMAD7;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;BABAM1;RHOT1;USP9X;OTUB1;COPS6;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USPL1;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;COPS7A;PSMB1;PSMC3;PSMA4;PSMA2;INO80D;RAD23A;COPS4;COPS7B;TRAF6;SENP5;TFPT;SMAD1;PSMB8;GPS1;RUVBL1;RAD23B;BARD1;USP14;TAF10;STAM2;JOSD2;FOXO4;STAM;POLB;USP35;PSMC6;MYC;MYSM1;FOXK2;RHOA;CDK1;PSMD6;KAT2A;NLRP3;PSMA8;USP12;TNIP2
prerank,negative regulation of developmental process (GO:0051093),-0.2820427765469323,-1.041017264177288,0.3699421965317919,0.6754924471258678,1.0,13/69,8.73%,CDK6;NOS3;NOTCH1;TFRC;TBX1;ARHGEF15;KLF7;TGFB1;TBX2;VAT1;NOTCH4;RC3H1;CST3
prerank,catecholamine biosynthetic process (GO:0042423),-0.42804512239178016,-1.0407347184782914,0.41100917431192663,0.6756783398695199,1.0,3/11,12.38%,GCH1;TGFB2;DDC
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4146966111837017,-1.0405578825078585,0.42911153119092627,0.6756283624169214,1.0,5/13,6.44%,TGFBR2;KDR;COL4A1;VEGFA;NOTCH4
prerank,vitamin transport (GO:0051180),-0.3417221622587785,-1.040528515290467,0.3802559414990859,0.6751880639190999,1.0,7/29,17.77%,ABCG2;SLC5A6;CUBN;SLC52A3;SLC2A8;SLC52A2;CD320
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.27856208393133913,-1.0401877910813904,0.3757455268389662,0.6755007030790795,1.0,24/72,24.21%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;COPS6;XAB2;HMGN1;COPS5;RBX1;XRCC1;RPA3;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;COPS4;RFC2;COPS7B
prerank,Rho protein signal transduction (GO:0007266),-0.2910426744556517,-1.03999409107204,0.3920792079207921,0.6754653418107093,1.0,16/53,15.29%,ARHGEF3;RHOJ;EPS8;EPS8L2;ARHGAP1;ARHGDIA;SHTN1;ARHGDIB;ADGRG1;PHACTR4;RHOB;CFL1;RTKN;NTN1;CELSR1;LIMK1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3532500780073038,1.0398078194472722,0.39439655172413796,0.7498094936922475,1.0,2/24,2.58%,PLA2G5;PLA2G4A
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.34202451139151724,-1.0397555109578702,0.4070631970260223,0.6755466391134141,1.0,3/27,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,regulation of macrophage differentiation (GO:0045649),0.39689184478641537,1.0396941488027203,0.4,0.7491166633704289,1.0,2/15,2.65%,IL34;PRKCA
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3552303156226395,-1.0395171873769478,0.40524193548387094,0.67561768469762,1.0,6/23,13.50%,TGM2;MAPK3;KCNQ1;ATF4;GABPA;GNB1
prerank,epithelium development (GO:0060429),0.2673305303430378,1.0394636231033862,0.38085539714867617,0.7487415175911327,1.0,7/107,2.41%,WNT4;ERRFI1;BMP2;ALDH1A2;SALL1;FGFR2;DLX3
prerank,post-translational protein modification (GO:0043687),-0.22263254688014275,-1.0393924296063568,0.33182844243792325,0.6754667238215046,1.0,101/332,25.24%,FN1;IGFBP7;GPC3;RAB11A;LMO7;SOCS2;IGFBP5;APP;RBBP5;SUMF2;KLHL5;MSLN;ADAM10;SPARCL1;IGFBP3;DCAF6;ZBTB16;RHBDD1;PTP4A2;KLHL2;FBXO17;NUCB1;PSMA6;DCUN1D1;WSB2;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;CST3;SPP1;PNPLA2;RAB8A;ASB8;COPS6;UBE2F;PSMC4;WDTC1;PSMC5;FBXL14;RAB11B;CHRDL1;PSMD14;FBXW5;FBXW10;APOE;ICMT;FSTL1;COPS5;KLHL3;FBXL7;SUMF1;FUCA2;CISH;FEM1A;RBX1;RAB1A;PSMD8;WSB1;PSMD11;CCNF;UCHL3;LGALS1;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;F5;GAN;CUL1;FBXW2;KLHL9;KLHL21;ELOB;PRSS23;CCDC22;KEAP1;KCTD7;PSMA1;COPS7A;VWA1;PSMB1;PSMC3;C3;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18;COPS4;COPS7B;COP1;FBXO6;EVA1A;TULP4;KCTD6;DCUN1D3;PSMB8
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.26766855754264335,1.039151000468287,0.3981651376146789,0.7485288269361148,1.0,17/100,10.90%,IGF1;PIK3R1;PTPN13;NTRK3;KIT;DCN;PDGFRA;PIP4K2A;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF;PTEN;PIP4K2B
prerank,cytoplasmic translational initiation (GO:0002183),-0.3925324515278727,-1.0388792498303472,0.424860853432282,0.6762332939327137,1.0,9/17,25.68%,EIF3D;EIF3I;EIF4A1;EIF2B3;EIF5;EIF4G1;EIF4A2;EIF4B;EIF4H
prerank,regulation of establishment of protein localization (GO:0070201),-0.40418142690450787,-1.0388602386312713,0.40613718411552346,0.6757762765945726,1.0,4/14,10.06%,CENPJ;CTSD;DNAJA1;CEP290
prerank,steroid biosynthetic process (GO:0006694),0.2991486169372096,1.038750996026,0.37553648068669526,0.7486253638811814,1.0,10/56,12.63%,CYP7B1;PRKAG2;HSD11B2;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1;OSBP;PRLR
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3023313035527676,1.038652041190187,0.3917748917748918,0.7479418715819166,1.0,7/52,8.29%,CELF2;RBFOX1;NOVA1;SRSF12;KHDRBS1;CELF4;RBM5
prerank,regulation of signal transduction (GO:0009966),0.24479828374860985,1.0384832772291155,0.3687258687258687,0.7474124770633706,1.0,22/190,8.26%,RORA;IGFBP2;GRK3;FGFR2;SEMA5A;GPHB5;SULF1;GDNF;IFT81;ZIC1;DHRS3;KCTD8;RGS20;TSPAN15;SENP2;NLRP12;DTX1;YJEFN3;FRMPD1;TULP3;MAPK8IP2;ERBB3
prerank,RNA splicing (GO:0008380),-0.26453855445435664,-1.03821657881553,0.3787575150300601,0.6768563598646149,1.0,27/95,19.99%,MBNL1;IVNS1ABP;PPARGC1A;PRPF8;SRSF2;PPP2R1A;SNRNP48;SRPK1;DHX15;FUS;SNRPD3;U2AF1;SFPQ;RNPS1;ZRSR2;SRSF4;MAGOH;DDX23;SF3A3;DDX39B;CCAR2;SCAF11;PPIG;SNRPG;PDCD7;LSM1;SYNCRIP
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.31869441388613917,-1.0380852209339582,0.3968871595330739,0.6766595060120095,1.0,18/38,34.41%,H3-3A;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;ASF1B;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,membrane lipid catabolic process (GO:0046466),-0.4423794456324309,-1.0380289582050706,0.4252252252252252,0.6763091015339916,1.0,8/10,36.20%,CYP1B1;SGPL1;ENPP2;NAGA;MGST2;SMPD2;FUCA1;PDXDC1
prerank,dopamine metabolic process (GO:0042417),-0.37179810687800235,-1.0378392381139445,0.43186180422264875,0.6762977429501614,1.0,3/18,4.12%,MAOA;GCH1;TGFB2
prerank,regulation of protein sumoylation (GO:0033233),-0.3834823142372227,-1.0374900425414673,0.42193308550185876,0.6766414756849919,1.0,9/17,32.73%,HDAC4;SAE1;UBA2;PARK7;CTNNB1;MUL1;CAPN3;EGR1;RASD2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.33603349089679146,-1.0370509774231398,0.4027237354085603,0.6771969249018852,1.0,15/32,26.21%,ITGA1;PPP1R16B;HSP90AB1;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3403105457369113,1.0366801569546331,0.4243119266055046,0.7510947028296571,1.0,6/30,7.51%,GJA1;SCN3B;ANK2;CACNA2D1;GPD1L;CACNA1G
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.24394833848153225,-1.036636971311149,0.36764705882352944,0.6776886991642694,1.0,46/166,18.29%,THBS1;SORBS1;VIM;RPL26;SCARB1;KLF2;KLF4;EEF2;NIBAN1;RPS4X;HSP90AB1;PPARGC1A;CHP1;GIPC1;MFSD2A;PRKDC;RGCC;EDN1;NMD3;DYRK2;AKT1;INSR;DHX9;ELOVL5;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;TLR4;SOX4;FGF2;FMR1;PAOX;EGFR;ERBB2;LDB1;OPN3;STAR;BCAR3;NR1H2;HSP90AA1;PCIF1;SP1;GLI1;ZCCHC4
prerank,cellular response to peptide (GO:1901653),0.29748728492044874,1.0363923865685272,0.4051383399209486,0.7508548615093461,1.0,5/56,3.85%,IGF1;LRP1;GJA1;CACNA2D1;MDM2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.40412817995716843,-1.0361588126550392,0.4175824175824176,0.6783472734917684,1.0,2/13,6.72%,TGFBR2;CBFB
prerank,positive regulation of intracellular transport (GO:0032388),-0.313603917324346,-1.0360361067197785,0.38847583643122674,0.6781285760429643,1.0,12/38,22.40%,BCAS3;PRR5L;EHD2;CEP290;PCM1;OAZ2;CAPN10;MLC1;EHD1;RIPOR1;PDCD10;PLK3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.36998124998946325,-1.0359976879179142,0.404296875,0.6777195055983335,1.0,6/18,19.51%,RAP1A;RAP1B;SLC4A8;FMR1;RIMS4;DTNBP1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36928699230388656,1.0359067698573365,0.40765765765765766,0.7511844836492015,1.0,2/20,9.73%,AKR1B1;CYP46A1
prerank,lipoprotein catabolic process (GO:0042159),0.4208638599350858,1.0350977265585042,0.4014084507042254,0.7523771157620156,1.0,1/11,0.50%,NOTUM
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3696586609681133,-1.0348552964172262,0.39697542533081287,0.6794820911736524,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,glutathione derivative metabolic process (GO:1901685),-0.3696586609681133,-1.0348552964172262,0.39697542533081287,0.6794820911736524,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.42417499696574573,-1.0343683714634124,0.4424778761061947,0.6801953898073279,1.0,3/12,7.75%,ELF1;CBFB;RC3H1
prerank,female gonad development (GO:0008585),0.38156278715693676,1.034306562006562,0.39601769911504425,0.7533867529127435,1.0,5/19,11.49%,NR2F2;KIT;CEBPB;ANG;EIF2B5
prerank,protein polyglutamylation (GO:0018095),0.4290086839176599,1.0341847541132638,0.42070484581497797,0.7527519231696902,1.0,2/11,5.52%,TTLL11;TTLL9
prerank,negative regulation of cilium assembly (GO:1902018),-0.42136523876308485,-1.0339167599184467,0.4290657439446367,0.6807925697680045,1.0,3/12,12.35%,LIMK2;MAP4;CDK10
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3299925028705816,-1.03383106140056,0.4066797642436149,0.6804938839946404,1.0,13/32,21.54%,BAX;ATG3;HSPD1;BBC3;BCL2L1;BAK1;BAD;CCAR2;BIK;SFN;TIMM50;GGCT;FIS1
prerank,cellular response to lectin (GO:1990858),-0.26083936692234716,-1.0337253050839785,0.40208333333333335,0.6797621735817156,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.26083936692234716,-1.0337253050839785,0.40208333333333335,0.6797621735817156,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,cellular response to leucine starvation (GO:1990253),-0.4452002796593588,-1.032986129388815,0.425569176882662,0.6811004895072534,1.0,7/10,45.47%,IMPACT;RRAGD;SESN2;SESN1;GCN1;SESN3;LARS1
prerank,positive regulation of B cell activation (GO:0050871),-0.2959610595022234,-1.0329517817393885,0.394990366088632,0.6806977486966522,1.0,13/50,17.77%,MEF2C;TFRC;CD38;CD81;MMP14;PPP2R3C;TIRAP;CD74;SYK;CLCF1;NOD2;XBP1;CD320
prerank,positive regulation of heart rate (GO:0010460),0.37917223185460575,1.0329291933442108,0.4073226544622426,0.7550150468053284,1.0,5/17,10.71%,SCN3B;ATP2A2;ADM;ADRA1D;ADRA1B
prerank,regulation of B cell proliferation (GO:0030888),-0.3014035886532599,-1.0323067846813532,0.3934740882917466,0.6817851882511133,1.0,8/44,10.73%,MEF2C;TFRC;CD38;CD81;TNFRSF21;RC3H1;TIRAP;CD74
prerank,endomembrane system organization (GO:0010256),-0.23967550480823546,-1.0314479583066514,0.3752620545073375,0.6833647426095684,1.0,45/178,20.30%,SYNE1;ATP8B1;SPTBN1;SRGN;CAV2;MYOF;PI4K2A;ZW10;BCAS3;HTT;GORASP2;DYSF;FAM174B;CHMP2B;PLEKHM2;A4GALT;NUP93;USP8;ATL3;TRIP11;SPTSSB;ATL2;TRAPPC11;BAG5;SURF4;VMP1;ALS2CL;NUP155;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;WASHC5;LAPTM4B;REEP4;DNM1;TMED1;PLEKHF1;TOR1AIP2;TMED5;ATP8B2;COG2
prerank,cation transmembrane transport (GO:0098655),0.31262556050684276,1.0311128441080755,0.4270833333333333,0.7587720248911193,1.0,8/44,7.08%,ATP1A2;SLC6A9;SLC7A2;TRPM3;TRPM1;MFSD12;TRPM5;ASIC2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3159494593579753,-1.0309804757204808,0.42613636363636365,0.683954530705262,1.0,12/37,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.27494083390358615,-1.030663102018918,0.40229885057471265,0.6837058627276518,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.27494083390358615,-1.030663102018918,0.40229885057471265,0.6837058627276518,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,determination of bilateral symmetry (GO:0009855),-0.35508030502788707,-1.0304051539629737,0.4200743494423792,0.6838424073217118,1.0,9/25,24.80%,NOTCH1;TBX1;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,positive regulation of protein import (GO:1904591),0.33635034731215996,1.0301187048075489,0.41834451901565994,0.7602982297745389,1.0,3/30,2.77%,PIK3R1;ZIC1;SMAD3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.37106344571885674,1.0300531128057255,0.42669584245076586,0.7595021916899568,1.0,8/19,23.42%,AMPD3;GMPR;APRT;POLD1;POLD3;POLD2;AMPD2;DGUOK
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4208738250229297,1.0300191121979545,0.4230769230769231,0.758631472175656,1.0,2/12,6.08%,AR;GSTP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.31108791866261815,1.0298202564163053,0.39065817409766457,0.7581763513733841,1.0,5/44,4.24%,PPM1E;NRP1;LPAR1;ROCK2;SFRP1
prerank,defense response to fungus (GO:0050832),-0.377847576025289,-1.0297395301086303,0.43470149253731344,0.6849592670318403,1.0,5/17,24.55%,PLCG2;GAPDH;CX3CR1;FAM3A;BCL10
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4435006611946454,1.0297241922081084,0.4040632054176072,0.7574729710688969,1.0,1/10,0.35%,NELL1
prerank,regulation of cation channel activity (GO:2001257),0.2716178038599171,1.029265448421373,0.3979591836734694,0.7577373774423789,1.0,23/89,15.09%,FGF14;GRIA4;ANK2;PRKACA;DLG2;SHISA9;DAPK1;NLGN2;CACNG4;CAMK2B;CACNB4;CACNB2;NLGN1;MAPK8IP2;CACNB1;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1;JPH1;KCNS1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4022656062403186,-1.0289628426538973,0.44964028776978415,0.6863256686557939,1.0,5/13,17.33%,CD44;TWIST1;PTTG1IP;CD74;KDM1A
prerank,cellular response to hexose stimulus (GO:0071331),-0.35569511922479313,-1.0288754087873855,0.4227005870841487,0.6860208441029975,1.0,4/23,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38081903469039324,-1.0288084041692958,0.44505494505494503,0.6856941833420129,1.0,4/18,7.38%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.38396715847383467,-1.0287006135178607,0.42964352720450283,0.6854529009447452,1.0,13/16,47.78%,TNFRSF21;TRIB2;VSIR;JAK3;LILRB1;DLL1;TYROBP;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,sensory perception of pain (GO:0019233),0.36862919137965616,1.028677793491297,0.4313304721030043,0.7582572157693541,1.0,6/21,17.40%,P2RX4;OPRK1;TRPA1;CHRNA4;PTGES;SCN9A
prerank,regulation of neuron apoptotic process (GO:0043523),-0.25815537024056723,-1.0285869781312549,0.3907815631262525,0.6852300875230756,1.0,16/96,8.37%,MEF2C;PTK2B;EGLN3;FOXO3;KCNB1;NGF;SIX1;TGFB2;PPARGC1A;BACE1;ATF4;TGFB3;TOX3;EGLN2;FOXQ1;BAX
prerank,epithelial cell-cell adhesion (GO:0090136),-0.42653283267254205,-1.0284460560780508,0.42987249544626593,0.6850874422584308,1.0,6/11,22.33%,CCN3;JUP;VCL;DSP;THBS4;CAMSAP3
prerank,transepithelial transport (GO:0070633),-0.40044291533913334,-1.02842250934656,0.4321880650994575,0.6846562701205439,1.0,4/15,4.60%,ABCG2;CXADR;SLC12A2;SLC1A1
prerank,positive regulation of reproductive process (GO:2000243),0.33170572554333877,1.0280242928308647,0.42127659574468085,0.7590513601840552,1.0,5/31,7.11%,HYAL3;PRDM9;CFAP69;SMURF2;SIRT2
prerank,generation of neurons (GO:0048699),0.2435109491794207,1.0279388691217972,0.3817829457364341,0.758338939709831,1.0,32/190,14.23%,AUTS2;WNT4;NRP1;SEMA3A;GPM6A;ARTN;PTPRD;SH3RF1;ASTN2;HES3;CASP3;IL1RAPL1;LHX4;SIX4;DOCK7;NRCAM;HES5;RYK;ATOH8;CDK5R1;FUT9;EML1;PLXNB2;BRSK1;LRP12;FZD10;FGFR1;YAP1;MAPT;TUBGCP2;TAFA1;WNT6
prerank,regulation of mitotic cell cycle (GO:0007346),-0.24075668553683754,-1.0277419794514764,0.375,0.6858401371386541,1.0,53/171,24.00%,AFAP1L2;TTC28;CAV2;IQGAP1;NEK7;CDKN1B;TGFB1;APP;ANAPC15;PSMA6;ANAPC11;PSMB5;TAL1;ASAH2;PIM3;RB1;PSMC4;MAEA;PSMC5;DUSP3;PSMD14;CDK10;RNF20;SDCBP;PSMD8;PSMD11;CDK13;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;USP22;CUL1;L3MBTL1;ASNS;CDK5RAP3;TTLL12;SRA1;PIN1;RCC1;PSMA1;MKI67;ANAPC2;PSMB1;PSMC3;EIF4EBP1;PSMA4;PSMA2;BTG3;SIK1;CDKN1C
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3942917888398187,1.0276716647085509,0.42437923250564336,0.7580469317431738,1.0,4/15,8.90%,DAAM2;ZNRF3;SFRP1;NPHP3
prerank,negative regulation of double-strand break repair (GO:2000780),0.3434533049320773,1.027662702145895,0.4066390041493776,0.7571149740464332,1.0,7/30,14.45%,SHLD2;UBQLN4;TRIP12;RADX;OTUB2;SMCHD1;RIF1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25422021338085576,-1.027569691631806,0.39300411522633744,0.6857663609562684,1.0,31/109,17.68%,PLCG2;PIP5K1B;BMX;PLCB3;PI4K2A;INPP5D;PIK3R6;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIP4P1;PIK3C2A;PLAAT3;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;CSF1R;PIK3R3;PITPNM1;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,regulation of fibroblast proliferation (GO:0048145),-0.29802353541339327,-1.0274718557002862,0.41141732283464566,0.6855309860689329,1.0,13/45,12.22%,FN1;CDK6;DAB2IP;NDUFS4;DHX9;PDGFC;PDGFA;S100A6;CD74;CDK4;NF1;FTH1;E2F1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.32045787342566623,-1.0270745139264585,0.4151291512915129,0.6859931572277713,1.0,14/34,27.92%,PTPRB;PTPRJ;DUSP3;PTPN12;PTPN6;UBASH3B;PTPRO;PTPRQ;PTPN22;PTPN1;DUSP4;DUSP6;PTPN2;DUSP1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.27397707310674524,-1.026904518524347,0.4003831417624521,0.6859243477398178,1.0,29/79,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2899068090184376,-1.0265433664441534,0.4153846153846154,0.6863479021141253,1.0,7/51,5.68%,ANO6;THBS1;MAPK3;PTK2;VEGFC;CMKLR1;VEGFA
prerank,spermatid development (GO:0007286),-0.3253032226092664,-1.0261963981841926,0.40816326530612246,0.6866865482076296,1.0,11/32,28.44%,JAM2;CEP57;CIB1;TDRD5;RFX2;NECTIN2;IQCG;SYCP3;MKKS;CDYL;RNF8
prerank,negative regulation of chemokine production (GO:0032682),-0.39355853758219433,-1.026025032911778,0.4402390438247012,0.6866378399241008,1.0,2/14,2.59%,MAP2K5;KLF4
prerank,negative regulation of cell activation (GO:0050866),-0.40170544132697455,-1.0255043785349165,0.43609022556390975,0.6874784561288638,1.0,4/14,12.33%,NOS3;THBD;PDGFA;APOE
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.268613526484852,-1.0254575507490278,0.3977055449330784,0.6871099052928297,1.0,25/80,18.29%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;PRKDC;ABCG1;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;SOX4;ABCA2;SPHK2;FMR1;TNFRSF1A;ERBB2;PCIF1;RELA;IFNGR1;SP1;ZCCHC4
prerank,negative regulation of response to wounding (GO:1903035),-0.3669799750814081,-1.025050478466054,0.4233576642335766,0.6875964070859727,1.0,10/19,37.68%,CD109;CRK;FGF2;RTN4RL1;RTN4R;CERS2;ALOX5;PTPRS;KLK8;INPP5F
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.41581665048319344,-1.0250239066611484,0.45869947275922673,0.6871630484824225,1.0,3/12,8.26%,PAICS;ADSS2;IMPDH1
prerank,alanine transport (GO:0032328),-0.4472847815747635,-1.024369970028944,0.4625,0.688266601215085,1.0,1/10,0.38%,SLC6A6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.25863267334040074,-1.0242996134232172,0.4270833333333333,0.6879457737647616,1.0,48/105,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3332141948916298,-1.0240171498655122,0.4160714285714286,0.6881234812738996,1.0,14/28,31.04%,MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;ATRIP;PRPF19;CDC5L
prerank,regulation of translational initiation (GO:0006446),-0.2868387916438605,-1.0239991864662383,0.41366223908918404,0.687688536585182,1.0,33/63,33.69%,EIF4G3;EIF5B;ATF4;HSPB1;RPS6KB2;IMPACT;YTHDF2;FMR1;UHMK1;EIF5;PAIP2B;EIF1;NCK1;YTHDF1;PAIP1;EIF4G1;EIF4A2;EIF4EBP1;NCBP2;ATF3;NCK2;EIF4B;EIF4H;PAIP2;NPM1;BOLL;RPS6KB1;GLE1;YTHDF3;MIF4GD;MTIF2;CTIF;CCL5
prerank,regulation of acrosome reaction (GO:0060046),-0.4408450559870681,-1.0233838523380383,0.4561717352415027,0.6887016363607795,1.0,7/10,54.41%,CACNA1H;PLCB1;GLRA1;SERPINA10;FAM170B;PRSS37;PLA2G10
prerank,neurogenesis (GO:0022008),-0.3063136690303965,-1.0232585808387549,0.42777777777777776,0.6885267799511223,1.0,7/43,7.22%,CDK6;TRAK1;ANXA1;SIX1;TGFB2;TRAK2;BTBD3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3868998315356044,1.023162472591268,0.4124168514412417,0.7677062978356671,1.0,3/16,5.08%,PID1;PPARA;IL4
prerank,protein depolymerization (GO:0051261),0.34444229045302494,1.0230970012417664,0.40825688073394495,0.7668994913363579,1.0,2/27,3.06%,MICAL3;NCKAP5
prerank,N-glycan processing (GO:0006491),-0.37008670421726764,-1.0230037995898256,0.44036697247706424,0.6887181831913228,1.0,5/18,9.28%,ST8SIA4;GANC;ST8SIA6;MAN1B1;FUT8
prerank,lipoprotein localization (GO:0044872),0.4266497865210035,1.022995649863318,0.4083885209713024,0.7661889865938679,1.0,5/11,18.81%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,glycerophospholipid metabolic process (GO:0006650),-0.27690364503450837,-1.0229010403161076,0.4243027888446215,0.6884835489891319,1.0,27/75,32.52%,GPCPD1;DGKH;PLCB3;PIGL;PIGF;CSF1R;FAR1;PLA1A;PIGC;ENPP6;SYNJ1;PIGW;LCAT;GDE1;CPNE3;PLA2G4F;ACP6;PIP5K1A;PLA2G4B;PLEK;PLA2G7;PLCB1;PIGM;CPNE7;SERINC5;ABHD6;PLCB2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3836145911535234,-1.02264774054048,0.4425925925925926,0.6885961026553681,1.0,7/17,19.84%,SEL1L;RHBDD1;VCP;FAF2;SEC61B;DERL2;TMEM129
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.27437897879666123,1.0224887413873518,0.4171656686626746,0.7665855118802977,1.0,6/80,3.90%,AUTS2;PIK3R1;NRP1;DOCK11;GPM6A;TENM2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.26744307832149594,1.0223400220819747,0.3976143141153082,0.7660001613392027,1.0,24/95,16.23%,CEMIP;GPC6;FMOD;UST;DCN;GPC4;GPC2;B3GNT7;PXYLP1;OMD;LUM;OGN;GPC5;DSE;CHST1;HS2ST1;HS6ST2;VCAN;CHSY3;HS3ST6;HS3ST5;HSPG2;CHSY1;ST3GAL1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.41255535693154205,-1.0218154220152218,0.4542056074766355,0.6901257216661871,1.0,2/11,5.35%,CAV1;ADIPOR1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2698853881195348,-1.021532991970615,0.4158607350096712,0.690263666321323,1.0,23/76,24.27%,TEK;SORBS3;BAIAP2L1;PTK2B;BCAS3;WDR1;LMOD1;EDN1;NES;PFN1;SYNPO;PRKCE;HRAS;LIMK1;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;HCLS1;CARMIL1;NCK2;CDC42
prerank,protein-DNA complex disassembly (GO:0032986),-0.376893210518705,-1.0212464616403525,0.4492481203007519,0.6904863305827698,1.0,9/16,37.58%,RPL23;ARID1A;SMARCA4;SMARCC1;SMARCD2;MYC;SMARCD3;NFE2;HMGA1
prerank,protein localization to centrosome (GO:0071539),-0.3783923545554101,-1.0208110956997185,0.43161634103019536,0.6911006265413285,1.0,4/17,11.72%,DCTN2;CEP192;NUDCD3;PCM1
prerank,negative regulation of axonogenesis (GO:0050771),0.3423773048101622,1.0205678320312195,0.4088050314465409,0.7695558749554565,1.0,9/27,15.69%,LRP4;MCF2;RTN4;CDKL3;DCC;PTEN;NGFR;ULK2;TRIM46
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4058889285793958,1.0203900325081736,0.4150537634408602,0.7690703675974112,1.0,3/13,8.61%,ASPA;DDO;GLUL
prerank,RNA transport (GO:0050658),-0.2720492447181523,-1.0199700686135975,0.4407766990291262,0.6926080345024529,1.0,22/71,22.45%,TGFBR2;HNRNPA2B1;SRSF2;SRSF5;SRSF6;FLOT1;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;DDX39B;HNRNPA1;CASC3;THOC6;DDX39A;NCBP2
prerank,carbohydrate biosynthetic process (GO:0016051),0.3618310208032974,1.019953971488002,0.4403470715835141,0.7692409937136034,1.0,7/21,12.72%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,protein dephosphorylation (GO:0006470),-0.24374973144044068,-1.0199254020555109,0.39478957915831664,0.6922475442573897,1.0,46/135,27.16%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;RPRD1B;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;PPP2R5E;UBASH3B;UBLCP1;DUSP11;PTPRK;NCK1;PPP2R2D;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;PPEF2;MTMR2;PPP2R5B;PDP1;RPRD1A;DUSP6;PTPN2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4012346375732203,-1.0198273634112087,0.43447037701974867,0.6920222341766109,1.0,6/13,32.48%,IRAK2;PIK3AP1;IRAK4;TRAF6;PIK3R4;TNIP2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4415095659577818,-1.0197907363957934,0.45072992700729925,0.6916336491194868,1.0,5/10,30.78%,ST6GAL1;AMDHD2;RENBP;GNPDA1;GNE
prerank,cellular response to nitrogen compound (GO:1901699),0.3706861069245344,1.019587536551426,0.4104803493449782,0.7692219551191237,1.0,7/20,23.90%,ROCK2;BLM;DAXX;EPG5;ATP2B4;HSF1;TIMELESS
prerank,negative regulation of gene expression (GO:0010629),-0.2216848175935409,-1.0195556168485562,0.3991507430997877,0.691698188497196,1.0,73/302,20.37%,FOXP1;MEF2C;OCLN;CLDN5;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;SRGN;SLC7A5;RACK1;KDR;NCOR1;KLF4;RPS3;IGFBP5;TGFB1;REST;APP;TGFB2;SMO;REL;HDAC9;WWP2;ADAM10;RPS13;VEGFA;CNOT7;MPHOSPH8;AEBP2;PTBP3;N4BP1;GATA2;RGCC;GAPDH;YY1;NCL;RB1;DDRGK1;H3-3A;RPL13A;CAPRIN1;DIS3L2;YTHDF2;APOE;FGF2;FMR1;ENG;HRAS;EPC1;FLOT2;BMI1;TASOR;ATP2B1;RBBP4;RNH1;HSPA1A;PCIF1;LSM14A;GIGYF2;CNPY2;DLL4;RPS26;PTGER4;MSR1;LSM2;TYMS;PAIP2B;PTRH2;SYNCRIP;LGALS9;TMBIM6
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4164196454685527,-1.01934864002523,0.4318936877076412,0.6916990631636228,1.0,7/11,30.55%,NDUFA13;TIMM29;TIMM13;TIMM10;TIMM8B;TIMM10B;ROMO1
prerank,response to glucocorticoid (GO:0051384),-0.3405606194451746,-1.0189608726708044,0.44612476370510395,0.692137407849401,1.0,5/26,9.68%,ANXA1;SLIT2;REST;NR3C1;FAM107A
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.2941462230121885,-1.0181737616474649,0.4186046511627907,0.6936206396141462,1.0,14/51,10.46%,SORBS3;PXN;LIMCH1;ARHGEF15;FERMT2;RAC1;MYOC;TGFB3;RGCC;PPM1F;PFN1;SYNPO;S100A10;WNT11
prerank,positive regulation by host of viral transcription (GO:0043923),-0.38407825919201855,-1.0179611206308488,0.4392523364485981,0.6936346239355637,1.0,1/15,0.14%,LEF1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3761946173353411,1.0177976501360009,0.4486607142857143,0.7728146839135102,1.0,6/21,16.02%,BCL2L11;CREB3L1;PRKN;CREB3;TXNDC12;DDIT3
prerank,regulation of anoikis (GO:2000209),-0.3668302599539575,-1.0172847055554322,0.43830570902394106,0.6947728777140921,1.0,3/19,2.88%,CAV1;NOTCH1;PTK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.30986801706152356,1.0169758972328478,0.44325481798715205,0.7739783187040317,1.0,4/41,7.91%,IGF1;IL4;GSTP1;TRIM27
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.27861957845018925,-1.0167300342220695,0.428,0.6956120267028147,1.0,27/65,30.02%,ITGA1;AFAP1L2;PTPRJ;DAB2IP;EPN1;MVB12B;HIP1R;AKT1;HIP1;DUSP3;SHKBP1;PTPN12;TSG101;EGFR;BCAR3;NEU3;SPRY1;RHBDF2;CDC42;CCDC88A;PLAUR;EPS15;PTPN2;STAM2;STAM;MVP;ARAP1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.40746321132532487,1.0167158733995403,0.43907563025210083,0.773668651340456,1.0,3/13,8.31%,TICAM1;AXL;IL18
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3230320871476807,-1.016635171561771,0.42778793418647165,0.6953649488307944,1.0,11/32,25.21%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;FKBP4;CDH5;APC2;CAMSAP3;STMN1
prerank,negative regulation of heart contraction (GO:0045822),0.4232431013784468,1.0162917803669573,0.4353448275862069,0.773816197210279,1.0,1/11,0.47%,ATP1A2
prerank,regulation of telomerase activity (GO:0051972),-0.3006606805373366,-1.0160261508230517,0.43737574552683894,0.6963530684637653,1.0,24/45,37.80%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1;ERCC4;CTNNB1;SRC;MYC;PKIB;SMG6;PIF1;WRAP53;CCT4;MAP2K7;CERS1;MAPK15;NVL;GRHL2
prerank,phosphate ion transport (GO:0006817),0.38558050870926963,1.0154993326114894,0.4391304347826087,0.7748128091824199,1.0,3/16,7.31%,SLC17A1;SLC20A2;SLC25A10
prerank,sarcomere organization (GO:0045214),0.3404585850109498,1.0154339019334555,0.4407894736842105,0.7740428218550031,1.0,8/27,14.83%,CSRP3;FHOD3;SIX4;CSRP2;ACTN2;SYNPO2L;TNNT3;MYLK3
prerank,SNARE complex assembly (GO:0035493),-0.43534363614637017,-1.0154226738036685,0.45027124773960214,0.6973726223408143,1.0,1/10,1.02%,STXBP6
prerank,cellular response to organic substance (GO:0071310),0.2564166126418268,1.0153045831610625,0.4220532319391635,0.7734276724174898,1.0,19/116,9.35%,ROBO2;PID1;PTPN13;CLEC3B;NCOA2;NFAT5;SMAD3;STAT5B;SFRP1;GHR;NLRP12;IL1RAPL1;DPYSL3;TGFBR1;IL18;IL1RL2;NCOA1;PTPN4;BMPR1A
prerank,negative regulation of myoblast differentiation (GO:0045662),0.40455239233996204,1.0152869112754035,0.4245689655172414,0.7725288704026565,1.0,2/13,1.64%,TBX3;PRICKLE1
prerank,DNA strand elongation (GO:0022616),0.36458903435311457,1.01507107601046,0.4198645598194131,0.7721388206035583,1.0,8/18,23.13%,MCM3;GINS2;NBN;POLD3;MCMDC2;POLD2;DCLRE1B;MCM7
prerank,macromolecule catabolic process (GO:0009057),-0.33820786335605424,-1.0148834636739763,0.43902439024390244,0.6981924320823703,1.0,6/26,16.02%,TPP1;TGFB1;IDE;KIF16B;SMURF1;UCHL3
prerank,negative regulation of platelet activation (GO:0010544),-0.3813969739627044,-1.0148173090046946,0.42990654205607476,0.6978523457224066,1.0,7/16,16.44%,NOS3;PRKG1;THBD;CD9;PDGFA;APOE;ADAMTS18
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2803780853387997,-1.014800779065232,0.4207436399217221,0.6974097143550064,1.0,26/58,34.21%,PAXX;ZBTB7A;BRCC3;PRKDC;UIMC1;ERCC1;BABAM1;HERC2;PSMD14;DCLRE1C;CYREN;BABAM2;POLQ;ERCC4;POLL;LIG4;BARD1;RNF8;HMGB2;MRE11;POLB;PRPF19;NSD2;RAD50;ATP23;POLA1
prerank,regulation of cholesterol esterification (GO:0010872),-0.4279221710199872,-1.014500538959139,0.4340659340659341,0.6976556014028296,1.0,6/10,35.25%,ABCG1;APOE;ABCA2;APOC1;LAMTOR1;STARD4
prerank,ether lipid biosynthetic process (GO:0008611),0.43837686257913655,1.014448224894631,0.45454545454545453,0.7727544840585723,1.0,2/10,2.58%,CHPT1;PLA2G4A
prerank,regulation of steroid metabolic process (GO:0019218),0.3526036642042653,1.0142924143750247,0.4264069264069264,0.7722200087763027,1.0,1/23,0.19%,RORA
prerank,lung development (GO:0030324),0.32113637354226887,1.0142622420041605,0.4093816631130064,0.7713645548513177,1.0,5/33,8.90%,ERRFI1;FGFR2;GLI2;LOXL3;NPHP3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.22373506764349604,-1.0142408475668525,0.4117647058823529,0.6977679683065091,1.0,108/264,34.99%,DDX5;NOVA2;HNRNPA2B1;DDX17;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;DCPS;SRPK1;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;SMN1;CDK13;EFTUD2;SF3A3;DDX20;DDX39B;PCBP1;GTF2F1;HNRNPA1;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;TGS1;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;CLNS1A;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;SNUPN;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,positive regulation of protein depolymerization (GO:1901881),-0.41753760588242333,-1.0141079309729777,0.41697416974169743,0.6976076309310265,1.0,5/11,12.53%,WDR1;STMN2;NES;TRPV4;KATNB1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3258947748588049,1.0140190875071589,0.4350515463917526,0.7710264065031561,1.0,3/33,2.65%,IL34;OCSTAMP;PRKCA
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3591030440459678,1.013995214694339,0.4298245614035088,0.7701492067938926,1.0,2/22,2.05%,ZBTB20;PPARA
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.42783597961312764,-1.0138100329020798,0.4660377358490566,0.6978751680658775,1.0,3/10,7.75%,SMAD7;NFKBIZ;RC3H1
prerank,replicative senescence (GO:0090399),0.4073986167842079,1.0136401953485954,0.43231441048034935,0.7700890217199245,1.0,4/12,17.95%,PLA2R1;SERPINE1;ATM;TP53
prerank,regulation of mRNA metabolic process (GO:1903311),-0.4285573608282058,-1.0135889442786026,0.46897810218978103,0.6978876717832426,1.0,3/11,8.77%,SAFB;SRPK1;DHX9
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.34745440661922306,-1.013540569033227,0.46122448979591835,0.6975263809563785,1.0,7/23,10.73%,DPP4;SLIT2;JAM3;RAC1;TIRAP;MOSPD2;CD74
prerank,connective tissue development (GO:0061448),-0.3176946384436176,-1.0135221058907922,0.43289224952741023,0.6970861177662522,1.0,9/35,9.90%,SPTLC2;NAMPT;LRP5;CD44;PKD1;ZBTB16;PGRMC2;TRIP11;DDRGK1
prerank,secretion (GO:0046903),0.40286775914244666,1.013495047180339,0.43612334801762115,0.7694934438679383,1.0,6/14,18.68%,SLC22A4;RIMS1;PRKCI;FBLN5;GUCA1B;SLC22A2
prerank,regulation of T cell differentiation (GO:0045580),0.3330072169868444,1.012701887349822,0.43013100436681223,0.7705291622415303,1.0,7/33,15.76%,TBX21;RHOH;IL4;CAMK4;GATA3;CLPTM1;METTL3
prerank,protein localization to kinetochore (GO:0034501),-0.398589414394222,-1.0124658728645322,0.4543828264758497,0.6990821871462702,1.0,7/14,31.36%,ZW10;RCC2;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.32665012238368746,-1.0118526502306604,0.4411764705882353,0.7001255327228587,1.0,12/31,21.05%,CNOT7;DCPS;HBS1L;DIS3L2;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41126301634541806,1.0116515625561406,0.4489795918367347,0.7721921996955172,1.0,5/12,17.89%,PPARA;FUT4;FUT9;ASS1;MIA3
prerank,cardiac muscle cell differentiation (GO:0055007),0.3716457688669885,1.0116385093405993,0.42637362637362636,0.7712937667915309,1.0,3/21,1.40%,BMP2;SLC8A1;NRG1
prerank,negative regulation of cation channel activity (GO:2001258),-0.3364404239311868,-1.011476703886918,0.4329268292682927,0.7005369433017551,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,Notch signaling pathway (GO:0007219),-0.28129780946378347,-1.0114585580807043,0.42996108949416345,0.7000894781536291,1.0,17/59,16.32%,SORBS2;NOTCH3;NOTCH1;ADAM10;HEYL;JAG2;NOTCH4;DTX3;PSENEN;PLXND1;ZNF423;ITCH;HES1;APH1A;HEY1;DTX2;STAT1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3302341415497481,-1.0113675288698984,0.4376130198915009,0.6998073620735065,1.0,11/29,21.05%,CNOT7;DCPS;HBS1L;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2628710327450908,-1.0113143655339525,0.43452380952380953,0.6994544052737711,1.0,20/84,14.96%,DDX5;NOVA2;MBNL1;ZBTB7A;DDX17;REST;QKI;RBFOX2;SRPK1;SRSF6;NCL;PCBP4;JMJD6;CIRBP;RNPS1;FMR1;SRSF4;SFSWAP;MAGOH;HNRNPK
prerank,regulation of protein localization to centrosome (GO:1904779),0.43363699298044406,1.0109879843425558,0.43859649122807015,0.7720335015738078,1.0,4/10,20.12%,UBXN2B;BICD1;NUP62;APC
prerank,cell cycle G2/M phase transition (GO:0044839),-0.24501536465725413,-1.0107633355191037,0.42771084337349397,0.7003246534583961,1.0,44/130,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CENPJ;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,canonical Wnt signaling pathway (GO:0060070),0.2765077364708223,1.0104558438603997,0.42570281124497994,0.7724215911920809,1.0,16/68,15.78%,TCF7L2;WNT4;SFRP1;FRAT1;PLPP3;RARG;RYK;GATA3;DVL3;PTEN;FRZB;FZD10;WNT6;WNT5B;TCF7L1;PORCN
prerank,positive regulation of vascular permeability (GO:0043117),-0.40075372236554924,-1.0101009345105185,0.42857142857142855,0.7014774395835943,1.0,6/12,10.66%,OCLN;TJP2;TGFB1;PDE2A;VEGFA;TRPV4
prerank,regulation of receptor internalization (GO:0002090),-0.31288829609284785,-1.0100933407151766,0.4269230769230769,0.701012700213547,1.0,8/35,16.40%,RIN3;VEGFA;ANKRD13A;INSR;FLOT1;FMR1;SDCBP;GREM1
prerank,regulation of response to oxidative stress (GO:1902882),0.4251213200192875,1.0094521894658002,0.4330357142857143,0.7740433071309161,1.0,3/11,14.30%,PRKN;GGT7;STOX1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3007151069734878,-1.0094492773619943,0.44901960784313727,0.7020852932949626,1.0,18/45,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,dermatan sulfate metabolic process (GO:0030205),0.3984832666121889,1.0092951253301696,0.4227467811158798,0.7734729889545757,1.0,7/13,23.37%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,regulation of DNA binding (GO:0051101),-0.30040136641560267,-1.0087588643361494,0.41392649903288203,0.703300749949804,1.0,15/44,19.97%,LEF1;NFKBIA;ZBTB7A;NGF;TGFB1;SMO;CSNK2B;E2F1;HES1;SUMO3;JAK2;KDM1A;MDFI;SKI;EDF1
prerank,RNA polyadenylation (GO:0043631),0.3401825984668144,1.0086156739655603,0.4381338742393509,0.7733371124188071,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.3401825984668144,1.0086156739655603,0.4381338742393509,0.7733371124188071,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,nuclear transport (GO:0051169),-0.3752143626827798,-1.0086023404492688,0.4548736462093863,0.7031959144592212,1.0,11/16,39.92%,ANP32A;NXT2;PSIP1;NPM1;NUP98;XPO1;BANF1;RBM15B;RSRC1;HMGA1;NXT1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.309339778722883,1.0083836873732983,0.44988864142538976,0.7729919016212142,1.0,14/44,16.36%,ROCK2;NANOS3;TNRC6A;CPEB3;POLR2G;FTO;RIDA;PNPT1;KHSRP;TNRC6B;METTL16;RBM24;METTL3;TOB1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3367138910895344,-1.0081297383125385,0.45179584120982985,0.7038418432245641,1.0,4/27,3.87%,VPS13D;VPS13A;GBP5;IFT20
prerank,regulation of mitochondrial translation (GO:0070129),-0.35261269220542957,-1.007843184460164,0.45787545787545786,0.7040122657777935,1.0,6/21,16.81%,UQCC2;TSFM;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,peptidyl-threonine modification (GO:0018210),-0.2728023892826853,-1.0078341703295155,0.4594594594594595,0.7035524193626825,1.0,16/66,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,mammary gland epithelium development (GO:0061180),0.4005210920081872,1.0074114365468203,0.441588785046729,0.7745932833419188,1.0,1/14,0.32%,WNT4
prerank,central nervous system development (GO:0007417),0.23356461603036416,1.0072362242293365,0.4251968503937008,0.7741489819110615,1.0,45/250,14.10%,EPHA7;ARNT2;ROBO2;ATXN1;TBX3;CHST8;CNTN4;ZIC1;AFF2;CNTNAP2;CHD7;PBX4;PRKN;GSTP1;ASIC2;LOXL3;GRIK1;ADGRA2;SCIN;NRCAM;HES5;ATN1;CDK5R1;AHI1;PTEN;ZIC4;ANKLE2;EML1;EEF1AKMT4-ECE2;RPS6KA6;PLXNB2;CTNS;EIF2B5;PHF8;COX7B;PAX8;GBA2;VCAN;NKX2-1;CNTN6;POU6F2;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,axon development (GO:0061564),0.2732644233150679,1.0071714259190283,0.45401174168297453,0.7733890052236464,1.0,18/78,14.14%,FGFR2;SEMA5A;CNTN4;CTNNA2;SLITRK4;NREP;RTN4;DOCK7;NRCAM;RYK;RAB10;CDK5R1;DCC;BRSK1;LLGL1;MAPT;AMIGO1;DRD2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4037442481227038,1.0065251091236118,0.4503311258278146,0.7741432105136143,1.0,2/13,4.38%,PHF23;SCFD1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.42790111301721345,-1.0064311483495134,0.4927007299270073,0.7064966832707931,1.0,3/10,6.47%,OPHN1;MSN;EZR
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3692987010668208,1.0058773333731386,0.4498977505112474,0.7749213740555204,1.0,3/19,6.04%,PPARA;IRS2;ABCD2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4189963019086022,-1.0057757408897965,0.4794520547945205,0.7076020266416184,1.0,7/11,50.06%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,regulation of dendrite extension (GO:1903859),-0.37054634392426716,-1.0055233282419773,0.4582560296846011,0.7077380171448462,1.0,5/18,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,T cell receptor signaling pathway (GO:0050852),-0.24118133628241176,-1.0055011078671994,0.4376278118609407,0.7073019843490878,1.0,41/138,23.09%,PTPRJ;PLCG2;WNK1;PDE4D;INPP5D;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;PTPN22;CSK;PSMA4;PSMA2
prerank,endosome organization (GO:0007032),-0.30183712946039404,-1.0054512661366948,0.45607476635514016,0.7069488536784787,1.0,16/41,25.16%,PI4K2A;RAB27A;EEA1;CHMP2B;USP8;CLCN3;ALS2CL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;SNX3;ANXA8L1;ANXA8;PHETA2
prerank,glycine transport (GO:0015816),0.437883878449814,1.0049045638285123,0.4539170506912442,0.7764505898665177,1.0,2/10,5.51%,SLC6A9;SLC36A2
prerank,telomere organization (GO:0032200),0.30666203668539477,1.0044818787070866,0.4336283185840708,0.7765591162956335,1.0,18/43,21.96%,STN1;BLM;RPA2;NBN;ATM;RIF1;RPA1;PARP3;PARP1;SP100;POLD4;POLD1;RTEL1;PCNA;POLD3;DOT1L;POLD2;DCLRE1B
prerank,aerobic respiration (GO:0009060),-0.3513656523498817,-1.004379318110342,0.45315487571701724,0.7090480723152228,1.0,7/20,22.14%,ATP5F1D;MTFR1;SURF1;UQCRB;UQCRH;SDHB;MTFR2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3160048295966202,-1.0042827846876128,0.444022770398482,0.7088085236861771,1.0,6/30,12.63%,CAV1;PLTP;NFKBIA;NAXE;APOE;ABCA2
prerank,response to ATP (GO:0033198),-0.36565679364634773,-1.0042083462427642,0.4613935969868173,0.708523929079104,1.0,2/18,2.17%,TRPC3;ABCC9
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2809855634411418,-1.0039261731407378,0.4416826003824092,0.7086931341856465,1.0,18/56,17.48%,TEK;FLT1;PTK2B;KDR;PTK2;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,regulation of peptidase activity (GO:0052547),-0.3589063921112614,-1.0037991231426457,0.4537037037037037,0.7085011882455031,1.0,3/19,8.73%,CAV1;NDUFA13;CST3
prerank,rRNA 3'-end processing (GO:0031125),-0.4332667867549247,-1.003396653804682,0.46567717996289426,0.7090152410329534,1.0,3/10,17.09%,RPS21;ERI1;EXOSC8
prerank,protein maturation (GO:0051604),-0.2510235926031531,-1.0033816797363768,0.4534653465346535,0.7085721275925213,1.0,18/95,17.24%,TSPAN5;NNAT;SRGN;F3;ADAM10;BACE1;ADAM19;MMP14;PSENEN;CPE;HSPD1;TSPAN14;LMF2;NAA60;APH1A;TSPAN17;PHEX;CCS
prerank,regulation of MAP kinase activity (GO:0043405),-0.25738248996958984,-1.0032558170451022,0.41929133858267714,0.7084118393809978,1.0,40/92,28.62%,FLT1;PTPRJ;FGF1;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;EDN1;TRIB2;PDGFC;PDGFA;TRIB1;UCHL1;NF1;STK38;APOE;FGF2;HRAS;TSG101;EGFR;ERBB2;SNF8;NOD2;SPRY1;CDK5RAP3;TRIB3;PDCD10;PTPN1;PIK3CG;PRKCD;PIK3R5;PPEF2;FGF18;NEK10;SMPD1;SPRY4;DUSP1;RASGRP1;CD24
prerank,calcium ion homeostasis (GO:0055074),0.26352479073056334,1.0030429436214334,0.42947368421052634,0.779427072482879,1.0,14/95,8.94%,SLC24A3;SLC8A1;CYP27B1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2
prerank,extracellular matrix disassembly (GO:0022617),-0.2909740739761686,-1.002942384583564,0.4552238805970149,0.7087059813150961,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.37093724043967496,-1.002896300325237,0.46946564885496184,0.7083348277142754,1.0,4/18,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.26386408775107134,-1.0025851269116863,0.41735537190082644,0.7086208430850054,1.0,31/80,27.61%,KLC1;ZW10;KDELR1;HTT;NAPA;TAPBP;ARF5;RAB6B;ATP9B;ERGIC1;KIF23;COPG1;SURF4;KIF26A;TMEM115;COPB2;RAB1A;COG3;LMAN2;NSF;KIF18A;KIF1C;USE1;KIF22;COPZ2;GOLPH3;GOLPH3L;TMED3;ARF3;RACGAP1;DNAJC28
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3945641777927075,-1.002567333304261,0.4834558823529412,0.7081802730351953,1.0,5/14,16.81%,UQCC2;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,regulation of phospholipase C activity (GO:1900274),0.3904182171122314,1.0024986022326674,0.4634146341463415,0.7798837611087612,1.0,6/15,12.50%,NTRK3;KIT;PDGFRA;PDGFRB;BICD1;FGFR1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.34223247187933353,1.0023799626597507,0.43595505617977526,0.7792837956310794,1.0,3/25,5.41%,NRP1;AR;GLMN
prerank,positive regulation of axon extension (GO:0045773),0.35911987711914967,1.0023022006391797,0.47186147186147187,0.778551490803724,1.0,2/22,1.18%,NRP1;SEMA5A
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3218619246479473,1.0022512304437512,0.45610278372591007,0.7777472387956146,1.0,9/32,16.18%,RIMS1;CHRNB4;CPLX2;STX1B;MCTP2;BAIAP3;SNAPIN;SYT11;HCRT
prerank,phospholipid homeostasis (GO:0055091),0.4146232356773203,1.0022162212378463,0.48660714285714285,0.776913485433812,1.0,2/11,11.05%,ABCA1;TLCD2
prerank,regulation of cholesterol transport (GO:0032374),0.3569532921126021,1.0021948024333804,0.46593406593406594,0.7760591552986125,1.0,4/20,8.12%,LRP1;YJEFN3;ABCB4;ABCA5
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3957312131387178,-1.0020776961480988,0.48677248677248675,0.7088879109649071,1.0,1/13,0.35%,CAV1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.38406664641747823,-1.0018346731540388,0.455743879472693,0.708999045014172,1.0,9/14,20.06%,GAB1;KDR;VEGFC;VEGFA;FLT4;VEGFD;PIK3CA;PGF;NUS1
prerank,positive regulation of lipid localization (GO:1905954),0.4243343084096469,1.0017091804503369,0.4394904458598726,0.7763286367171307,1.0,1/11,1.51%,LRP1
prerank,histone H4 deacetylation (GO:0070933),-0.42007578233462717,-1.0010915203856008,0.4893238434163701,0.710259971112364,1.0,3/10,8.31%,REST;HDAC9;HDAC4
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.43128559942779815,-1.0010744781814047,0.4791288566243194,0.7098218104085323,1.0,3/10,16.67%,HSP90AB1;RB1;HSP90AA1
prerank,negative regulation of nervous system development (GO:0051961),-0.3716175236136886,-1.0006874640757908,0.45080500894454384,0.7102955146811254,1.0,3/17,4.11%,B2M;NOTCH1;REST
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.28853583845830794,-1.000309996631987,0.4359925788497217,0.7107391544498513,1.0,24/53,30.21%,OPHN1;DAB2IP;HSP90AB1;UBB;PKD1;GPX1;FOXF2;DDRGK1;PSMC5;PSMD14;APOE;FMR1;UFL1;OSBPL7;PSMC3;RAD23A;ALAD;TREM2;F8A1;RAD23B;USP14;XPO1;PSMC6;ECSCR
prerank,cholesterol biosynthetic process (GO:0006695),-0.3171442812702048,-0.9999476231309409,0.4618181818181818,0.711179101326796,1.0,14/31,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.30272502756408187,-0.9993105938568296,0.4612476370510397,0.7122139190462821,1.0,12/38,19.15%,CAV1;KCNJ2;CAMK2D;KCNQ1;JUP;CTNNA3;CACNA1D;DSG2;KCND3;DSP;SCN2B;CACNA1C
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4176833220887217,-0.9981185510472934,0.48731884057971014,0.7145108867886906,1.0,7/11,30.81%,MFHAS1;TIRAP;TNFAIP3;TREM2;TLR6;PJA2;TLR1
prerank,regulation of coagulation (GO:0050818),-0.428532545557372,-0.9978992617790979,0.47697974217311234,0.714570534826016,1.0,1/11,0.35%,CAV1
prerank,response to peptide hormone (GO:0043434),0.3030155097404041,0.9977204979765796,0.4509394572025052,0.7854205563101676,1.0,4/43,3.15%,TGFBR3;ROCK2;STAT5B;GNAI1
prerank,cellular component disassembly (GO:0022411),-0.29080737698642833,-0.9974461850682504,0.4550561797752809,0.7152027564136398,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3938528376615327,-0.9974085493665501,0.4576271186440678,0.714804507326159,1.0,10/14,37.19%,RPS3;CD81;NECTIN2;RELA;PRKD2;BCL10;CARD11;IKBKG;CD226;TESPA1
prerank,protein glycosylation (GO:0006486),-0.24119341076996745,-0.9972220276657735,0.47244094488188976,0.7147482281381012,1.0,44/125,27.54%,ST3GAL6;ST3GAL4;EOGT;ST8SIA4;TRAK1;PLOD2;TMEM165;SLC39A8;AQP11;ST8SIA6;MGAT1;C1GALT1C1;GALNT10;FUT8;KRTCAP2;DAD1;POGLUT1;PLOD3;GFPT1;ST6GALNAC2;SERP2;NPC1;COG3;TMEM258;POMK;OGA;ALG9;NUS1;B3GNT3;B3GNT8;ALG12;MGAT5;ALG1;PGM3;LARGE1;MPI;GCNT4;POMGNT2;RPN2;ALG2;GALNT6;GALNT9;ALG3;STT3B
prerank,histone H3-K4 methylation (GO:0051568),0.3414525924889682,0.9968234602162749,0.45010183299389,0.7868034451304248,1.0,9/26,15.52%,WDR5B;PRDM9;SETMAR;MEN1;KMT2A;CXXC1;PAXIP1;DYDC2;WDR82
prerank,translesion synthesis (GO:0019985),-0.29582094566789174,-0.9966567278024422,0.4605009633911368,0.7156447848311125,1.0,14/42,24.17%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;REV3L;USP43;RPA3;POLK;DTL;RFC3;RFC2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3397952800871651,-0.9965943346550685,0.4676524953789279,0.7152978402897396,1.0,9/24,20.01%,B2M;TAPBP;ERAP1;IDE;FCER1G;ACE;BCAP31;TAP2;SEC24B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.36220361768363346,-0.9965730546801413,0.48226950354609927,0.7148659803816126,1.0,9/17,35.12%,ALG9;NUS1;ALG12;ALG1;DHDDS;ALG2;ALG3;MPDU1;ALG6
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3890342943014105,0.996356654186874,0.47045951859956237,0.7870857198194516,1.0,3/14,6.04%,PPARA;IRS2;ABCD2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.335262075705768,-0.9962698724625775,0.4506283662477558,0.715114205176608,1.0,6/24,11.03%,NOTCH1;KLF2;VEGFA;ATF4;MBTPS2;HSPA5
prerank,chromosome condensation (GO:0030261),-0.3044237484230396,-0.9958309697772285,0.48,0.7156716662849071,1.0,19/36,31.91%,SMC4;CSNK2B;RB1;TOP2A;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;DFFB;ACIN1;KMT5A;BANF2;NCAPH2;TTN;PLK1;CDK1;BANF1;NCAPD2
prerank,regulation of transport (GO:0051049),0.31693373050990764,0.995689709806537,0.4621676891615542,0.7878710461945532,1.0,5/36,5.39%,NRP1;LEPR;WWC1;SCFD1;PRKN
prerank,positive regulation of dendrite extension (GO:1903861),-0.3772057181313261,-0.995657705825095,0.4832089552238806,0.7155897010794294,1.0,5/17,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3828439649179846,-0.9955483140111483,0.48256880733944957,0.7153751311874764,1.0,6/15,27.76%,VCP;GSTO2;HNRNPA1;ATF3;MKNK2;GSTO1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.38408785972165627,-0.9950098480184041,0.4963898916967509,0.7162172525221115,1.0,5/14,14.03%,NT5E;UPP2;NT5C;NT5C1A;CAD
prerank,mitochondrial translational termination (GO:0070126),-0.2585782337658747,-0.9949428927991416,0.4115384615384615,0.7158723115209307,1.0,34/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3949942887017224,-0.9949014917277988,0.46408839779005523,0.7154956749181852,1.0,6/13,27.90%,CHP1;UFM1;RANGAP1;RAB23;PARK7;BARD1
prerank,macroautophagy (GO:0016236),-0.24528390802855565,-0.9948879162837749,0.4573170731707317,0.715048386396398,1.0,36/118,21.48%,PLEKHM1;MAP1LC3B;VAMP7;CHMP2B;GABARAP;LIX1L;MTMR14;TECPR1;PLAA;ATG3;CSNK2B;ATG7;VCP;ULK3;KLHL3;TOMM22;MTERF3;VPS36;MAP1LC3A;PGAM5;TSG101;PRKAG1;SNF8;CSNK2A1;CSNK2A2;VPS16;AMBRA1;VPS33A;VTI1B;CHMP2A;ARL8B;DYNLL2;WIPI2;TOMM5;RUBCNL;VPS41
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.31357178251098183,-0.9947752405145288,0.4749536178107607,0.7148188342517287,1.0,2/29,1.00%,ANO6;JAM2
prerank,negative regulation of DNA replication (GO:0008156),-0.3849717837141674,-0.9940242996597936,0.4748322147651007,0.7161681627263461,1.0,4/13,19.58%,CDAN1;RAD17;WAPL;TSPYL2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.36670198887107164,-0.9939974016844858,0.4703770197486535,0.7157465166377844,1.0,4/16,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.42164511907064983,-0.9929498442748007,0.4981060606060606,0.7178023185855329,1.0,6/10,44.29%,CX3CR1;LGALS9;LILRB1;FCGR2B;CEACAM1;KLRD1
prerank,regulation of endocytic recycling (GO:2001135),-0.4173728142863117,-0.9929144216789502,0.5054347826086957,0.7174091246877555,1.0,4/11,18.42%,ARHGAP1;EHD2;RAB11B;EHD1
prerank,multivesicular body organization (GO:0036257),-0.31426594532762625,-0.9927511002494758,0.491395793499044,0.7173174606524274,1.0,15/31,32.17%,RAB11A;RAB27A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,actin filament polymerization (GO:0030041),-0.32693057116035773,-0.9927320000284935,0.502835538752363,0.7168900782861413,1.0,14/29,23.81%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;PREX1;WASL;JAK2;WASHC5;MSRB2;MICALL2;CORO7;AIF1
prerank,regulation of myoblast differentiation (GO:0045661),-0.31380986287070495,-0.9925763382278326,0.470479704797048,0.7168026845855278,1.0,5/32,5.28%,MEF2C;NOTCH1;BOC;TGFB1;IGFBP3
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3952763584878792,0.9925549012355874,0.4634146341463415,0.7946550388351415,1.0,4/13,8.69%,ALDH4A1;PRODH;GLUL;GLS2
prerank,cellular metal ion homeostasis (GO:0006875),0.25695316022029285,0.9922171784810255,0.45188284518828453,0.7945577831098517,1.0,15/102,9.00%,ATP1A2;SLC24A3;SLC8A1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2;SLC41A1
prerank,outer dynein arm assembly (GO:0036158),-0.38514926019901635,-0.9919551441525056,0.4890909090909091,0.7178166591374122,1.0,8/15,34.95%,ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;DNAH17;DNAAF4;CCDC63
prerank,sodium ion homeostasis (GO:0055078),0.3544663204751506,0.9919466417564716,0.4533029612756264,0.7943092957138548,1.0,2/21,1.17%,ATP1A2;SLC8A1
prerank,positive regulation of protein kinase activity (GO:0045860),-0.23802247741995194,-0.9919294425579919,0.46624472573839665,0.7173996749914137,1.0,37/148,19.84%,RAP1A;TGFBR2;PTK2B;IQGAP1;PTK2;DAB2IP;HSP90AB1;CALM1;TGFB2;RALB;NEDD9;MINK1;VEGFA;TAOK3;RASSF2;INSR;EMP2;LRP8;CAMK1;TAOK2;CIB1;MTCP1;CALM3;SRCIN1;CSF1R;ACE;LCP2;MMD;PRKAG1;CAB39;CDKN1A;HSP90AA1;TAB2;AGAP2;ECT2;ITGB3;TPX2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31848727488376055,-0.9914109246066184,0.48616600790513836,0.7181810180422669,1.0,8/30,13.98%,FOXP1;DDX5;NCOR1;ZBTB7A;HEYL;H3-3A;TRIM68;SMARCA4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3973030292504546,0.9913229106258252,0.4864864864864865,0.7948973181944811,1.0,1/13,0.21%,ENPP1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3735565330752825,0.9910321061850904,0.47956989247311826,0.7946780729270155,1.0,2/17,3.32%,ANK2;CACNA2D1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3747765034127975,0.9910030880099802,0.46916299559471364,0.7938198187845303,1.0,4/17,13.61%,GJA1;THPO;LTBP3;N4BP2L2
prerank,import into nucleus (GO:0051170),-0.26593045511498437,-0.9906121758144534,0.4532803180914513,0.7196057424726604,1.0,24/73,26.54%,NUP93;AKT1;SNRPD3;PTTG1IP;E2F3;HTATIP2;SYK;NUP188;PHB2;NUP155;TNPO3;SMN1;RPAIN;DDX20;HNRNPA1;TSC2;SNRPG;NXT2;TNPO2;SNRPB;FAM53A;SEC13;NUP107;IPO13
prerank,regulation of phosphorylation (GO:0042325),0.24693166658036608,0.9904448211110428,0.4708171206225681,0.7943087567071153,1.0,18/120,10.73%,NRP1;SRPX2;LDB2;AR;PRKAG2;STAP1;PHIP;LYN;FNIP1;IL4;DYNLL1;GLMN;SIRT2;NUP205;ANKLE2;ANG;NUP35;PLXNB2
prerank,second-messenger-mediated signaling (GO:0019932),0.2697268261939234,0.9902685492580144,0.47770700636942676,0.7938631565837018,1.0,13/82,10.24%,RCAN2;PDPK1;DGKD;P2RX4;CCR6;ACKR2;ACKR4;CCR10;CHRM3;HRH1;PPP1R9A;CCR9;MCTP2
prerank,cellular response to gamma radiation (GO:0071480),-0.37219317878130714,-0.989103890295442,0.4854014598540146,0.722812638142922,1.0,6/17,18.35%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.317231885792077,0.9889078835335724,0.474468085106383,0.7962772601260579,1.0,7/31,10.16%,PARD3B;DLG2;RAP2A;ANK1;PDZD11;LRRC7;PRKCI
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.32261879771170426,-0.988618101907579,0.4838709677419355,0.7234577260862189,1.0,11/28,26.04%,STMN2;PRUNE1;GAS2L1;MAP1B;MAPRE2;ARL2;MAP1A;FKBP4;CAMSAP3;STMN1;SKA3
prerank,positive regulation of RNA splicing (GO:0033120),0.3261821098380149,0.9885663419890699,0.45905172413793105,0.796229104526841,1.0,4/29,7.62%,PIK3R1;DAZAP1;TRA2A;CELF4
prerank,ncRNA metabolic process (GO:0034660),0.3078136741204578,0.9885068709241678,0.4815668202764977,0.7954528948609216,1.0,11/37,20.54%,TUT4;HENMT1;KHSRP;PIWIL2;XPO5;PARN;MAPT;BCDIN3D;DROSHA;NIFK;AGO2
prerank,positive regulation of phagocytosis (GO:0050766),0.29884995724858243,0.9882189602283639,0.44861660079051385,0.7952578394077366,1.0,5/47,4.01%,CAMK1D;PLA2G5;AHSG;C4B;STAP1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2550546294847379,0.988021743639679,0.4670781893004115,0.794825230676938,1.0,10/98,5.39%,CEMIP;PIK3R1;LRP1;DPP10;PDPK1;EPHA3;SLC5A3;BCL2;TFDP1;PRKN
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.32293525378210325,-0.9879563687586816,0.45960502692998206,0.7245625390573439,1.0,10/29,17.82%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;RPA3;GTF2H4
prerank,leukotriene biosynthetic process (GO:0019370),0.3873292586199909,0.9878783261287457,0.4432314410480349,0.7942939259192159,1.0,3/14,6.00%,PLA2G5;PLA2G4A;GGT7
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.32078313124442004,0.9878684822952439,0.44536082474226807,0.7934057457902308,1.0,2/32,2.26%,CEMIP;PDPK1
prerank,regulation of histone acetylation (GO:0035065),-0.3142363126734383,-0.9877913047985414,0.5084427767354597,0.7244826640312118,1.0,6/33,10.90%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;CAMK1;TADA2B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3830330610907884,-0.9877246282041768,0.47368421052631576,0.7241691269889866,1.0,4/14,13.71%,NOS3;EDN1;ACE2;ACE
prerank,fatty acid elongation (GO:0030497),-0.3940791692323109,-0.9877151609127415,0.4756335282651072,0.7237153808433883,1.0,5/13,26.94%,ELOVL7;ELOVL5;ELOVL1;HACD4;HACD2
prerank,negative regulation of T cell differentiation (GO:0045581),0.4219132919504509,0.9873834543626,0.48504273504273504,0.7937122147814856,1.0,2/10,11.79%,GLI3;LAG3
prerank,regulation of cation transmembrane transport (GO:1904062),0.3217558237540853,0.9869787184303994,0.47096774193548385,0.7938450738051015,1.0,12/29,23.03%,KCNIP4;DPP10;KCNIP3;DPP6;WNK3;FGF12;ATP2B4;DLG1;PDZK1;KCNAB2;SCN5A;RANGRF
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.340811035800665,0.9869557383597577,0.4645308924485126,0.7929976773983789,1.0,1/22,0.29%,PPM1E
prerank,hexose transmembrane transport (GO:0008645),-0.34818386897438425,-0.9865874928794052,0.47454545454545455,0.7258869541152521,1.0,8/21,28.76%,SLC2A1;PPARD;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,regulation of potassium ion transport (GO:0043266),0.3235943978977939,0.9864090782469681,0.44763860369609854,0.7934913203085607,1.0,7/31,14.14%,KCNIP4;DPP10;ANK2;KCNIP3;ACTN2;DPP6;DRD2
prerank,negative regulation of autophagy (GO:0010507),-0.28041257307398243,-0.9859399300210112,0.48502994011976047,0.7269412393174918,1.0,19/54,25.39%,RASIP1;DAPL1;EIF4G3;FOXK1;QSOX1;AKT1;ATG7;PIK3CA;MET;TAB2;MCL1;RRAGA;EIF4G1;PTPN22;WDR6;SMG1;RUBCN;EIF4E;TREM2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.23902173848811747,-0.9859085722721248,0.50293542074364,0.7265454210043782,1.0,22/133,11.62%,ATP13A5;CAV1;TPT1;TRPC3;CAV2;MCUB;CAMK2D;TMEM165;ATP2C1;SLC35G1;ATP2A3;PDZD8;ATP1B1;EDN1;BAX;STIM2;CCL15;SLC10A7;TRPC6;TRPV4;TRPC4;ATP2B3
prerank,protein localization to phagophore assembly site (GO:0034497),0.41738489451703975,0.9857864738852089,0.48306997742663654,0.794238018708012,1.0,4/11,21.67%,WDR45B;WIPI1;ATG9A;WDR45
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4266515151111877,-0.9855901627496474,0.48295454545454547,0.7268461066475383,1.0,3/10,10.60%,SEC14L1;RNF125;DHX58
prerank,negative regulation of glycolytic process (GO:0045820),-0.4179347529841737,-0.985293204212338,0.47947761194029853,0.726620944344511,1.0,3/10,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4179347529841737,-0.985293204212338,0.47947761194029853,0.726620944344511,1.0,3/10,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,regulation of protein localization (GO:0032880),-0.2759779643300329,-0.9849159295757576,0.47610294117647056,0.727121171982489,1.0,19/58,19.69%,RACK1;TRIM25;HSP90AB1;FKBP1A;PLEKHM2;PPM1F;USP8;CTSD;TRIM14;CEP290;CAMK1;TRIM68;TRIM5;MMD;UFL1;HSP90AA1;KDM1A;TMEM231;ITGB3
prerank,midbody abscission (GO:0061952),-0.3648444637410251,-0.9847202325844859,0.46111111111111114,0.7271318979985246,1.0,8/17,32.17%,CHMP2B;MITD1;CHMP2A;CEP55;VPS4A;CHMP7;CHMP4B;CHMP4A
prerank,cellular response to radiation (GO:0071478),-0.3002583754627983,-0.9845478509341051,0.48823529411764705,0.727100521490928,1.0,21/40,32.43%,NET1;EEF1D;RAD1;RHOB;RAD9B;OPN3;HUS1;RAD9A;CDKN1A;ECT2;GADD45A;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;SWI5;RRH;OPN1MW3;OPN1MW;FIGNL1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.42152918360551805,-0.9844832722670884,0.5074906367041199,0.7267740080164135,1.0,2/10,4.12%,SHANK3;APP
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.36497387338312004,-0.9842784466938725,0.47191011235955055,0.7267834385742773,1.0,6/15,30.56%,RACK1;SPHK2;TNFRSF1A;PRKCD;ORMDL1;SMPD2
prerank,pharyngeal system development (GO:0060037),0.3674274336677836,0.9841266519355959,0.46444444444444444,0.7975248092131629,1.0,5/15,9.35%,BMP5;SIX4;TGFBR1;GATA3;BMPR1A
prerank,wound healing (GO:0042060),0.2761490558377203,0.9841177800003542,0.45759368836291914,0.796632439546075,1.0,6/62,4.25%,IGF1;NRG1;PDGFRA;SMAD3;PPL;CFLAR
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.21202046831224255,-0.9839918422228582,0.5172413793103449,0.7270471435949747,1.0,39/291,11.49%,MEF2C;ACTB;RAP1A;LBP;ESR1;MTR;VIM;PXN;RAP1B;PTK2B;TGM2;SH3BP4;FOXO1;MAPK3;RAPGEF1;TBX1;FZD4;CAPN2;RPS3;DAB2IP;SLIT2;IGFBP5;PDE2A;GUCY1B1;KCNQ1;NRIP1;WNT9A;EZR;TNFRSF1B;AKT1;FZD7;NDUFA13;PLAA;TIRAP;VCP;WNT11;ABL2;AKAP6;IMPACT
prerank,phagosome-lysosome fusion (GO:0090385),0.409657863770935,0.9839319004102461,0.45633187772925765,0.7962193249598226,1.0,4/10,19.23%,PLA2G5;RAB20;CLN3;RAB7B
prerank,positive regulation of response to external stimulus (GO:0032103),-0.24069443818985192,-0.9839162880759161,0.5120481927710844,0.7267482901994783,1.0,28/128,17.53%,THBS1;IL15;NFKBIA;SCARF1;STX3;THBD;ETS1;GBP5;TGFB1;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;PPM1F;DHX9;DHX58;TLR4;TNFRSF1A;USP15;FEM1A;AKIRIN2;IL17RA;SLC15A4;ANKRD17;NINJ1
prerank,positive regulation of exocytosis (GO:0045921),-0.3062647757226664,-0.9837145046688035,0.4925925925925926,0.7267667086454876,1.0,14/35,33.07%,RAB27A;RAB7A;SDCBP;TSG101;SNF8;CHMP2A;RAB2B;RAB3D;ATP6AP1;VPS4A;STAM;ATP13A2;RAB3A;RAB15
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.41979090613229364,0.9835488399330238,0.4572072072072072,0.7962364445587208,1.0,2/10,5.49%,HECW2;HECW1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.27679423768715344,-0.9829556759334749,0.469811320754717,0.728110200262956,1.0,22/52,31.67%,EXTL3;PDIA5;TPP1;SHC1;HDGF;ADD1;DCTN1;HSPA5;ACADVL;GFPT1;XBP1;KLHDC3;TSPYL2;YIF1A;HYOU1;ATP6V0D1;PPP2R5B;PLA2G4B;ERN1;EDEM1;SYVN1;SRPRA
prerank,potassium ion export across plasma membrane (GO:0097623),0.39054460009632624,0.9828079045025626,0.474120082815735,0.7972190458602884,1.0,1/13,0.43%,KCNT2
prerank,RNA processing (GO:0006396),0.23710588652000048,0.9825598496622965,0.4766536964980545,0.7969749743722242,1.0,23/176,11.06%,CELF2;ATXN1;NOVA1;RBMS1;TUT4;AURKAIP1;PRKACA;SNRPN;ADARB2;AKAP8L;SNRPA1;RNPC3;HNRNPUL1;LIN28B;DHX8;MPHOSPH10;RBM5;SLU7;BICD1;PABPN1;HNRNPD;KHSRP;PIWIL2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3095776378066064,-0.9821207695019047,0.481335952848723,0.7296083069522546,1.0,10/33,21.43%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B
prerank,protein deneddylation (GO:0000338),-0.42001576454559486,-0.981921065412302,0.4990892531876138,0.7296300623476683,1.0,6/10,26.57%,COPS6;COPS5;COPS7A;COPS4;COPS7B;GPS1
prerank,regulation of dendritic spine development (GO:0060998),-0.35090193005677983,-0.981624952464697,0.48811700182815354,0.7298400793613626,1.0,5/19,13.09%,MEF2C;SHANK3;CAMK1;APOE;FMR1
prerank,cytoskeleton organization (GO:0007010),0.2556608501862099,0.9815313762719544,0.48118811881188117,0.7986703922437158,1.0,19/114,10.67%,MICAL3;SH3D19;EPB41L3;RHOH;PHIP;FGD4;RHOBTB1;ZMYM6;ANK1;FMNL3;TNIK;FGD1;AJUBA;RHOBTB3;BRWD1;CAMSAP1;PRKCI;CECR2;MICAL1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4147409073164934,0.9813601175239278,0.4988558352402746,0.7982290078972959,1.0,2/10,5.75%,LYN;AXL
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.40217553265006933,-0.9813599938784849,0.4937833037300178,0.7300027815576727,1.0,4/12,12.26%,PROM1;VEGFA;CEP290;AGTPBP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.31635573753671886,-0.9811578077951751,0.48411214953271026,0.7300085679720688,1.0,11/28,23.34%,MAP3K5;DAB2IP;ATP2A3;ATF4;BAX;BBC3;BAK1;TRIB3;SELENOK;ERO1A;BRSK2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34184406126949546,-0.9809750929520852,0.47769516728624534,0.7299606544912932,1.0,11/23,31.08%,HSP90AB1;NLRC5;JAK2;NR1H2;STAT1;IFNGR1;TXK;PTPN2;PARP14;IRGM;PARP9
prerank,protein-containing complex assembly (GO:0065003),-0.2182127904547735,-0.980969911887603,0.5104602510460251,0.7294984475122714,1.0,62/259,20.01%,FN1;LEF1;ANO6;OCLN;SLC2A1;DMD;PARD3;PTK2B;TLE4;FERMT2;CD2AP;RBBP5;TRRAP;ZW10;CTSZ;ADAM10;PPARGC1A;NAPA;PYGO2;PPP2R1A;TAPBP;REPS2;TLE3;CTSC;CASP8;RIPK1;AP2M1;DNAJB12;DHX9;FAS;CSNK2B;CD74;KMT2D;TEAD2;DBNL;HES1;TRAF1;FBXL7;TNFRSF1A;AIM2;PEF1;SMARCA4;WASL;RBX1;RAB1A;MCFD2;MDN1;CHCHD10;SKAP2;TRAPPC5;OPA1;BAD;F5;NSF;CUL1;WIPF1;PPP6R3;CAPG;ELOB;SOX9;SHANK1;SEC24B
prerank,positive regulation of transmembrane transport (GO:0034764),-0.37944975211337173,-0.9807323067823949,0.49725776965265084,0.7295887075197941,1.0,1/13,0.23%,ANO6
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.37809515180370534,-0.9807034142361458,0.5,0.7291742297058346,1.0,8/14,31.12%,OPHN1;MSN;EZR;CAMSAP3;FSCN1;CDC42;SCRIB;RHOA
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.37460615724748897,-0.9803644809402241,0.489247311827957,0.7295353247882445,1.0,4/15,15.55%,GBP5;TLR4;NOD2;IL17RA
prerank,regulation of establishment of planar polarity (GO:0090175),-0.24845285117081195,-0.9799445707828933,0.46893787575150303,0.7299873805764243,1.0,45/88,35.76%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;SPEF1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2;CDC42;PSMB8;VANGL2;AP2A2;PSMC6;WNT7A;RHOA;PARD6A;PSMD6;PSMA8;AP2B1;PKHD1;ROR2;PSMD2;PSMB2;CELSR3
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23670665598615961,-0.9798485066516435,0.4942084942084942,0.7297242443893656,1.0,49/144,23.42%,PPP1R13B;CDH1;KCNB1;TGFB1;BCAS3;PRR5L;ABLIM3;CHP1;MIEF1;CD81;PPP3CC;CASP8;JUP;RBM22;TRIM28;CEP290;MIEF2;CAMK1;CIB1;PCM1;SAE1;BBC3;YWHAZ;OAZ2;E2F1;MAVS;HRAS;VPS11;ERBB2;YWHAG;CSNK2A2;PIK3R2;YWHAH;RAPGEF3;BAD;TMEM30A;ECT2;UBL5;ZPR1;SFN;FZD5;RIPOR1;HCLS1;FIS1;PDCD10;NPEPPS;PLK3;MICALL2;PRKCD
prerank,mitotic cytokinetic process (GO:1902410),-0.3463959346614747,-0.9798396958580228,0.47102803738317756,0.7292736322504195,1.0,10/20,32.17%,CHMP2B;MITD1;CHMP2A;CNTROB;CEP55;VPS4A;CHMP7;RHOA;CHMP4B;CHMP4A
prerank,mitotic cytokinesis (GO:0000281),-0.2838642937249005,-0.9793789194232863,0.47549909255898365,0.7298889361038101,1.0,24/47,33.49%,SPTBN1;USP8;KIF23;RHOB;RTKN;MITD1;SNX18;ECT2;RASA1;ANLN;CNTROB;CENPA;EFHC2;CIT;CEP55;STMN1;ARL3;RACGAP1;TRIM36;PLK1;CHMP4B;ESPL1;UNC119;STAMBP
prerank,iron ion homeostasis (GO:0055072),0.28248870859269376,0.9789891313082455,0.4790794979079498,0.8033246406018745,1.0,3/58,1.49%,BMP6;CP;HEPH
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.32345874137409836,-0.9789080550792585,0.5192307692307693,0.7305004804265786,1.0,8/27,24.36%,CYRIB;ETS1;CD44;HSPD1;RELA;HAS2;TRAF6;CCL2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22493198395942815,-0.9788413285873112,0.5082644628099173,0.7301873095161316,1.0,42/198,16.69%,PTPRB;PLCE1;ITPKB;PLCG2;LIMK2;GPI;MAPK3;PLCB3;HK1;TNFAIP8L3;CALM1;TGFB1;PLPP1;INPP5D;IPMK;PFKP;NT5C;AKT1;PLAA;PIP4P1;PLAAT3;TOLLIP;INPP5A;LIMD1;ISYNA1;DUSP3;PPP3CB;NUDT4;PNKP;GFPT1;SPHK2;AGPAT1;CERKL;IP6K1;PIK3CA;COQ8A;GPX4;PGK1;MINPP1;SYNJ1;DUSP23;IMPA2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.3929847638079665,-0.9784117605096002,0.5072202166064982,0.7307216079757837,1.0,3/11,7.75%,ANXA1;SMAD7;RC3H1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3398686792222615,0.9782359000965384,0.4968421052631579,0.8043595523232221,1.0,2/23,2.58%,PLA2G5;PLA2G4A
prerank,negative regulation of kinase activity (GO:0033673),0.27630516095823965,0.9779357696122887,0.4782608695652174,0.8041783640793468,1.0,9/62,7.91%,PPM1E;PRKAG2;PDPK1;DEPTOR;CEP85;IRS2;GSTP1;CEP43;TRIM27
prerank,dephosphorylation (GO:0016311),-0.23309611896147114,-0.9777962325825545,0.4898785425101215,0.7316917979066363,1.0,51/147,28.27%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;PLPP1;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;NT5C;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PNKP;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;DUSP23;PPP2R5E;UBLCP1;DUSP11;PTPRK;PLPP2;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;ACP6;PPEF2;SGPP1;MTMR2;THNSL2;PPP2R5B;PDP1;DUSP6;PLPP6;DUSP1;PPP4R1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3666590381584153,-0.9776696674317057,0.5036630036630036,0.731524883817769,1.0,2/16,8.53%,IGF1R;INSR
prerank,protein localization to nucleus (GO:0034504),-0.2462224588801184,-0.9768730524876037,0.5,0.7329551928564134,1.0,30/102,26.54%,ZBTB7A;RPL11;SIX1;NUP93;AKT1;HHEX;PTTG1IP;ARL2BP;E2F3;TOR1AIP1;SYK;NUP188;PHB2;NUP155;TNPO3;CHCHD10;RPAIN;TSC2;TOR1AIP2;ARL2;MSX1;CNEP1R1;NXT2;TNPO2;YWHAE;FAM53A;SEC13;RPF2;NUP107;IPO13
prerank,response to retinoic acid (GO:0032526),-0.27033576116299807,-0.9765166124517165,0.48902195608782434,0.7332906262020895,1.0,12/59,11.08%,ACER2;PTK2B;TBX1;FZD4;WNT9A;RARA;GATA6;TRIM16;FZD7;NDUFA13;WNT11;ABL2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4098514320272063,-0.9764418347301845,0.47036328871892924,0.7329990120452499,1.0,3/10,6.57%,RACK1;KDR;MYOC
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3676905388007912,-0.9760603662600751,0.48623853211009177,0.7334018450080866,1.0,6/15,25.01%,RAB18;ATL2;REEP4;RTN3;TMEM33;ZFYVE27
prerank,tRNA processing (GO:0008033),-0.2697536447778116,-0.9759769578977034,0.5118110236220472,0.7331400183156986,1.0,24/61,29.51%,SARS1;THUMPD1;TRMT9B;QTRT2;URM1;TRMT10C;FARS2;TRDMT1;TRPT1;QTRT1;TSEN54;RPP21;CPSF4;TRMT6;AARS2;ANKRD16;RTCB;METTL1;ADAT1;ADAT2;RTRAF;CTU2;TSEN2;KARS1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.37729066998422894,-0.9759504622805791,0.4834307992202729,0.732732671589914,1.0,2/15,6.27%,HMGCS2;ACLY
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4055586769786742,-0.9758091660133882,0.47305389221556887,0.7325790903110061,1.0,6/10,30.00%,SLC2A1;SPX;SLC27A2;SLC27A1;CD36;RPS6KB1
prerank,cellular response to purine-containing compound (GO:0071415),0.4227721063722492,0.9757583199353032,0.48081264108352145,0.8086649624547385,1.0,1/10,1.17%,SLC8A1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3593371562014952,-0.975468171754058,0.5140845070422535,0.7329053832433587,1.0,2/17,0.97%,SLC9A2;SLC12A2
prerank,monocyte differentiation (GO:0030224),0.42694849418068753,0.9753921212501919,0.4837310195227766,0.8086697532930522,1.0,1/10,0.34%,IL31RA
prerank,activation of GTPase activity (GO:0090630),-0.25111900476318083,-0.9751209911750954,0.516260162601626,0.7332327291165393,1.0,32/89,22.60%,ARHGAP42;SIPA1L1;SGSM2;RALGAPA2;TBC1D8;ARHGEF15;GRTP1;BCAS3;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;SIPA1;SIPA1L3;GMIP;ABR;TBC1D9B;ARHGEF5;TBCK;EPHA2;TBC1D25;TBC1D2;ECT2;RANGAP1;APC2;ADPRH;RAP1GAP;TBC1D15;ARHGAP45
prerank,epithelial cell differentiation (GO:0030855),-0.2523899203633548,-0.9747454071642273,0.5105973025048169,0.7335985987213614,1.0,28/88,23.58%,KDR;TBX1;TPP1;ANXA1;SIX1;VEGFA;GATA6;ANXA4;AKT1;FZD7;TDRD7;TOLLIP;ACADVL;CTSB;CPT1A;FSTL1;TAGLN2;PGK1;CBR1;TAGLN;GLI1;E2F4;EDF1;GSTK1;E2F7;CNN3;CASP6;ANXA7
prerank,cellular response to interleukin-15 (GO:0071350),-0.3830180574158051,-0.9745754382660414,0.5035335689045937,0.7330880421176239,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3830180574158051,-0.9745754382660414,0.5035335689045937,0.7330880421176239,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,protein import into nucleus (GO:0006606),-0.2615358939949125,-0.9738177630689683,0.48349514563106794,0.7344051974862693,1.0,22/66,26.54%,RPL23;NUP93;KPNA1;AKT1;NUP54;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;RANBP2;TNPO3;RPAIN;TSC2;KPNA4;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.41114378331306833,0.9736957914024346,0.5152173913043478,0.8119971178642689,1.0,1/11,2.09%,PLA2G5
prerank,protein polyubiquitination (GO:0000209),-0.21236057418980328,-0.973226414994474,0.5472527472527473,0.7353659556952435,1.0,84/297,23.16%,WWP1;NEDD4L;LMO7;RNF144B;HERC6;RNF41;UBB;ZNRF1;WWP2;RLIM;UBC;RPS27A;RNF125;UBE2Q2;CBFB;FBXO17;PSMA6;RNF114;ANAPC11;RC3H1;PSMB5;FBXO4;NHLRC3;UBE2L6;TRIM14;UBE2G2;PSMC4;PSMC5;FBXL14;TRIM56;PSMD14;TRIM62;FBXW5;UBE2Q1;FBXW10;MIB2;ITCH;RNF5;TRAF1;KLHL3;FBXL7;LNPEP;SMURF1;TRIM68;RNF20;RBX1;UBE2G1;TRIM5;PSMD8;WSB1;PSMD11;TNFAIP3;CCNF;ANAPC7;HECTD1;CDC27;PSMB4;PSMD12;PSMC1;FBXL3;FZR1;FBXL16;CUL1;ZNRF2;FBXW2;PELI1;RNF19A;AMFR;TMEM129;UBE2B;PSMA1;UBE3A;BLMH;ANAPC2;PSMB1;PSMC3;BFAR;NPEPPS;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.28105392278682906,0.973076228973055,0.4824016563146998,0.8126392693605433,1.0,10/59,14.22%,ALDH1A2;CYP7B1;CYP27A1;ACSM5;BAAT;CYP46A1;NDUFAB1;OSBP;MCAT;ACACA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3460534331509382,0.9729968982240169,0.48643006263048016,0.8119159740910882,1.0,7/21,17.43%,SULF1;SULF2;HS6ST3;HS2ST1;HS6ST2;HS3ST5;HPSE
prerank,RNA stabilization (GO:0043489),0.3118943919127023,0.9729033184648375,0.5021739130434782,0.8112232514264182,1.0,7/33,14.51%,GDNF;TENT5A;AXIN2;PHAX;TENT5B;PARN;RBM24
prerank,positive regulation of organelle assembly (GO:1902117),0.29382099157417757,0.9727672162614499,0.5020576131687243,0.8106533450805469,1.0,13/44,24.31%,ASAP1;PIP4K2A;STX18;PIP4K2B;FUZ;LRSAM1;NUMA1;RAB3GAP1;NUP62;BBS4;G3BP1;PDCD6IP;CNOT2
prerank,organelle disassembly (GO:1903008),-0.3131418510251816,-0.9726128274257869,0.49162011173184356,0.7363364755208025,1.0,19/33,37.46%,KLC1;UFM1;KIF9;DDRGK1;VCP;VRK1;UFL1;UFC1;UBA5;STX5;PLK3;PLK5;KIF5B;CDK1;MTIF2;MCTS1;DYRK3;ULK1;PELO
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2623657291146311,-0.9721241461279103,0.5167652859960552,0.7370415239871307,1.0,18/64,19.79%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;HACL1;ASAH2;ELOVL5;ACADL;GSTM2;CPT1A;ACSL5;FAAH;GPX4;ACOT8;ELOVL1;DAGLB;ACOT2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2635889965514021,0.9719952901173706,0.49803149606299213,0.8117646580959745,1.0,7/75,3.08%,NRP1;BMP2;SEMA5A;PDPK1;PRKCA;VEGFB;AKT3
prerank,positive regulation of cellular protein localization (GO:1903829),-0.26499622963301683,-0.9719851485116217,0.5074349442379182,0.7368942239230377,1.0,30/69,31.48%,LIMK2;STX3;TFRC;FERMT2;HSP90AB1;TGFB1;RIC3;GPR137B;AKT1;DDRGK1;GAS8;CDK5RAP3;MAP1A;NDC80;SESN2;MEAK7;DTX3L;NECAB2;CCDC88A;PARK7;CARD10;STX4;LAMTOR5;ENTR1;PLK1;PARP9;TRAPPC12;TYROBP;CDK1;PARD6A
prerank,glutamate metabolic process (GO:0006536),0.3532933947665004,0.9719250456524011,0.4945054945054945,0.8110372010007164,1.0,5/19,11.17%,ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,cardiac myofibril assembly (GO:0055003),0.3718560748654765,0.9715731760453324,0.48466257668711654,0.8109918854724999,1.0,6/15,14.83%,PDGFRA;CSRP3;FHOD3;PDGFRB;OBSL1;MYLK3
prerank,chondrocyte differentiation (GO:0002062),0.31442221430474043,0.9714966250759053,0.4969818913480885,0.8102892017319012,1.0,3/32,1.48%,BMP2;SULF1;SULF2
prerank,cholesterol transport (GO:0030301),-0.281640944367329,-0.9714172459737365,0.5304182509505704,0.737759576385869,1.0,18/45,33.05%,CAV1;SCARB1;ABCG1;STARD5;APOE;TSKU;NPC1;STAR;LCAT;MSR1;SERAC1;APOC1;VPS4A;CD36;SOAT2;OSBPL2;OSBPL5;LIMA1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3332447800934198,-0.9713487005737709,0.5030549898167006,0.7374593207045881,1.0,5/22,14.62%,AHNAK;DMD;CACNB3;FMR1;SRI
prerank,non-motile cilium assembly (GO:1905515),0.31809668276349407,0.9710293332266082,0.4789356984478936,0.8104952714530013,1.0,15/30,26.70%,TMEM17;TTC8;IFT122;C2CD3;FUZ;PIBF1;ARL13B;IFT88;IFT57;BBS4;TMEM107;TMEM80;CSNK1D;CEP250;CEP89
prerank,regulation of execution phase of apoptosis (GO:1900117),0.39972005375732245,0.9709186306485805,0.48,0.8098641977939772,1.0,3/11,7.11%,PTGIS;DLC1;SIRT2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3472955636677,-0.9706027422038552,0.5147058823529411,0.7387598101302538,1.0,8/20,31.62%,SYNE1;ARL2BP;CHCHD10;ARL2;RANGAP1;PARK7;BARD1;TAF3
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39417229070471843,-0.9701854286511742,0.5066413662239089,0.7392524077349412,1.0,7/12,32.72%,ABCC9;KCNJ8;CACNA1H;PKD2;ABCC8;TRPM4;P2RX3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.28245183383344796,-0.9696554756970314,0.5226824457593688,0.7400644842494625,1.0,19/51,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;S100A13;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.40885166067048684,-0.9695635576759323,0.5083798882681564,0.7398130804487997,1.0,5/11,16.40%,MEF2C;TGFB1;FZD7;SOX6;GREM1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3907674268826822,0.9694467892621392,0.46788990825688076,0.8126793513758058,1.0,3/12,8.12%,ABCA1;PPARA;ABCA5
prerank,protein hydroxylation (GO:0018126),-0.3723252060504188,-0.969380655064776,0.5192660550458715,0.7397571641933439,1.0,7/15,29.08%,EGLN3;PLOD2;PLOD3;P3H2;HIF1AN;VPS33B;P3H1
prerank,error-prone translesion synthesis (GO:0042276),-0.33812202845614586,-0.9692576638932413,0.49544626593806923,0.7395637681549441,1.0,8/21,24.17%,UBB;UBC;RPS27A;REV3L;RPA3;POLK;RFC3;RFC2
prerank,negative regulation of cell division (GO:0051782),0.41242571868481637,0.9690488206892716,0.4646924829157175,0.8127840812848113,1.0,2/11,8.95%,TXNIP;BLM
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.29048393663758354,-0.9689247069008816,0.497131931166348,0.7398651947752838,1.0,13/42,24.17%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RPA3;POLK;DTL;RFC3;RFC2
prerank,secondary palate development (GO:0062009),0.3770459883913979,0.9689124790022825,0.4801670146137787,0.8122209057737064,1.0,3/14,5.04%,TGFBR3;CHD7;LRRC32
prerank,positive regulation of telomere maintenance (GO:0032206),-0.3059941137922872,-0.9686416066068511,0.49816176470588236,0.7400928271904615,1.0,6/31,12.82%,MAPK3;NEK7;HNRNPA2B1;ERCC1;PNKP;SLX4
prerank,positive regulation of T cell differentiation (GO:0045582),0.30310096642859785,0.9684941728761169,0.4959349593495935,0.8123757241233398,1.0,5/36,5.08%,GLI2;IL4I1;RHOH;GLI3;IL4
prerank,negative regulation of protein secretion (GO:0050709),-0.2918469565590607,-0.9677989624811427,0.498989898989899,0.7415710341398771,1.0,10/38,19.16%,CCN3;KCNB1;REST;RAB11FIP1;DPH3;APOE;INHBB;RAB11FIP3;RSAD2;CD200
prerank,spindle assembly (GO:0051225),-0.2618714421529005,-0.9675568310777162,0.52,0.7417123661454881,1.0,22/67,31.12%,RAB11A;NCOR1;NEK7;RPS3;CEP192;HAUS1;GOLGA8B;LSM14A;MAPRE2;MISP;TPX2;RCC1;SPICE1;HAUS4;CEP63;KIFC2;SAC3D1;TUBGCP6;KIF11;HDAC3;BCCIP;RHOA
prerank,cellular response to insulin stimulus (GO:0032869),-0.23358466459100924,-0.9672130962834612,0.5386178861788617,0.7420653609435658,1.0,22/124,10.84%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;RAB8B;ATP6V0B;HDAC9;ATP6V0A2;PKM;SHC1;PRKDC;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;RAB8A;GRB10;FOXC2
prerank,T cell activation (GO:0042110),-0.2561342791570262,-0.9671534646349259,0.5245901639344263,0.741742911128492,1.0,22/69,23.64%,CXADR;DPP4;CTPS1;CD44;FKBP1A;MSN;JAG2;CASP8;HSPD1;CD74;LFNG;PPP3CB;SOX4;JAML;GPR89B;GPR89A;DLL4;NCK1;PTPN22;ADA;PIK3CG;NCK2
prerank,positive regulation of histone modification (GO:0031058),-0.3009329672331338,-0.966947717611385,0.5219047619047619,0.7417360553815021,1.0,8/33,17.33%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;TADA2B;FMR1;CHTOP;KDM1A
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.29073799229088665,-0.9668174872556534,0.5348837209302325,0.7415916269410809,1.0,13/45,19.20%,DDX5;HNRNPLL;TGFB1;RBM20;RIPK1;NMD3;RBM22;ZC3H18;HRAS;EGFR;HSPA1A;RELA;ZPR1
prerank,epidermal cell differentiation (GO:0009913),-0.2934399177154721,-0.9667894285985406,0.5277777777777778,0.7411839695107172,1.0,13/41,27.73%,CLIC4;ANXA1;GATA6;BCR;OPN3;EPHA2;DSP;GLI1;EVPL;SCEL;CERS3;PIP5K1A;CTNNB1
prerank,plasma membrane tubulation (GO:0097320),-0.38905342564243167,-0.9665613606686243,0.49353049907578556,0.7412584769620038,1.0,6/13,19.94%,FNBP1L;CAVIN2;EHD2;PACSIN1;PACSIN3;PACSIN2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3156707095826022,0.9665590222466697,0.49166666666666664,0.8163550570376885,1.0,4/32,5.80%,ARHGAP6;PHLDB2;DLC1;SERPINE1
prerank,intracellular protein transport (GO:0006886),-0.2119787299121195,-0.9664644297213464,0.5660377358490566,0.7410293373602002,1.0,99/304,27.41%,RASSF9;TRAK1;SGSM2;STX3;TBC1D8;GRTP1;RPL11;TGFB1;AP3B1;PKD1;CHP1;SYNRG;NAPA;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;GABARAP;GIPC1;TRAK2;TBC1D22A;NUP93;ARF5;AKT1;RAB6B;PTTG1IP;HERC2;CD74;E2F3;STX2;SURF4;AKAP6;RAB24;RAB7A;COPB2;KATNB1;ARL4A;SYK;NUP188;TBC1D9B;VPS36;TBCK;SMURF1;ARL6;PHB2;NUP155;RAB1A;AP4M1;TNPO3;AP2A1;SNF8;RPAIN;YWHAH;VPS33A;NSF;TBC1D25;CCHCR1;TSC2;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;ARL4C;RAB23;ADPRH;STX5;NXT2;CAMSAP3;KIF13A;TBC1D15;CACNG3;TNPO2;COPZ2;RAB43;STXBP2;TBC1D30;TBC1D17;FAM53A;SEC13;RAB5C;PDCD6;RTN2;NUP107;TMED3;NUP42;BCS1L;IPO13;STX4;ARF3;NPM1;TBC1D5
prerank,myofibril assembly (GO:0030239),0.2969458810774025,0.9664300166807818,0.49464668094218417,0.8158072880881153,1.0,13/42,14.83%,PDGFRA;CSRP3;CFLAR;KLHL41;FHOD3;PDGFRB;SIX4;CSRP2;ACTN2;OBSL1;SYNPO2L;TNNT3;MYLK3
prerank,positive regulation of bone resorption (GO:0045780),-0.4083539617249058,-0.9656405045367531,0.5223880597014925,0.7424689797675189,1.0,4/11,12.89%,PLEKHM1;TNFRSF11A;SPP1;SYK
prerank,cortical actin cytoskeleton organization (GO:0030866),0.33992249195233043,0.9655905800432705,0.5052192066805845,0.8170535480926678,1.0,5/20,15.55%,ROCK2;FMNL3;FHOD3;LLGL1;RHOQ
prerank,tyrosine metabolic process (GO:0006570),0.40261192763197273,0.9655288016639936,0.49122807017543857,0.8163078474611905,1.0,2/11,14.41%,IL4I1;GSTZ1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3892188931418828,0.9651119640246681,0.5111111111111111,0.8165178525514051,1.0,5/14,15.91%,SHLD2;KMT5C;PAXIP1;RIF1;KMT5B
prerank,DNA double-strand break processing (GO:0000729),0.3525408119348128,0.9648792610861973,0.4696969696969697,0.8161702503759881,1.0,7/18,18.12%,RNF138;SETMAR;BLM;NBN;ATM;KAT5;UBE2N
prerank,membrane repolarization (GO:0086009),-0.3689724936808551,-0.9648286824000615,0.5137111517367459,0.7438981515221451,1.0,7/15,21.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;ATP1B2;KCNIP2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3485891680886414,0.9644005627519212,0.4956140350877193,0.8164403577698855,1.0,3/19,6.59%,BMP6;PLG;FOXA2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.30923657174879926,-0.9642152303493301,0.5202205882352942,0.7448277733620605,1.0,7/29,12.33%,SORBS1;SCARB1;CHP1;MFSD2A;AKT1;ELOVL5;APOE
prerank,protein modification by small protein conjugation (GO:0032446),-0.20834985154844712,-0.9637055377910093,0.5969827586206896,0.7455687863858524,1.0,92/361,20.48%,WWP1;NEDD4L;RACK1;IFIH1;LMO7;MSL2;DCUN1D5;RNF41;UBB;WWP2;RLIM;UBC;RPS27A;UFM1;KLHL2;STX1A;UBE2Q2;USP7;PRKDC;RNF38;DCUN1D1;NUP93;ANAPC11;TRIM47;CUL4A;FBXO4;DTX3;NDC1;TRIM28;TRIM14;USP9X;NUP54;ATG3;ARRDC1;HERC2;ATG7;DDRGK1;UBE2G2;VCP;UBE2F;TNFAIP1;USP5;SAE1;TRIM62;FBXW5;MIB2;ITCH;RNF111;NUP188;KLHL3;FBXL7;URM1;SMURF1;FBXL2;TRIM68;SUMO3;RNF20;NUP155;RBX1;UBE2G1;RAD18;TRIM5;RANBP2;VPS11;DTX2;CCNF;TSPAN17;ANAPC7;UCHL3;KCTD10;CDC27;UFL1;NUP37;FBXL3;UFC1;UBA2;GAN;CUL1;TRAIP;KLHL9;CDK5RAP3;ZSWIM8;KLHL21;UBA5;AMFR;RANGAP1;ELOB;TMEM129;CCDC22;KEAP1;UBE2B;UBA1
prerank,diacylglycerol metabolic process (GO:0046339),-0.33080860436848164,-0.9635282896408328,0.5132075471698113,0.7455523658517607,1.0,2/23,1.69%,PLCE1;DGKH
prerank,respiratory chain complex IV assembly (GO:0008535),-0.34257657199676866,-0.9633004187741177,0.5215759849906192,0.7456274095702441,1.0,12/21,32.70%,COA8;COX15;TIMM21;COA3;SURF1;FASTKD3;COX10;SCO1;PET100;BCS1L;COA6;SCO2
prerank,macrophage differentiation (GO:0030225),0.38391266147815895,0.9631708539668123,0.5185995623632386,0.8185476998321342,1.0,1/13,0.34%,IL31RA
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3555388446878186,-0.9623491558840793,0.5371747211895911,0.747303420529668,1.0,2/16,3.35%,ST3GAL4;ETS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3724170918516718,-0.962296856218987,0.5205992509363296,0.7469659334581635,1.0,4/15,16.28%,PPARD;PPARGC1A;ELOVL5;NR1H2
prerank,ganglioside metabolic process (GO:0001573),-0.343136678219652,-0.9622854054061974,0.5073529411764706,0.7465196294469266,1.0,4/20,6.49%,ST6GALNAC3;ST8SIA4;HEXA;ST8SIA6
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.33461314852498597,-0.96216212770743,0.51171875,0.7463353186237718,1.0,12/23,35.37%,SEL1L;VCP;SURF4;FAF2;SEC61B;DERL2;TMEM129;SEC13;DERL1;SYVN1;OS9;AUP1
prerank,cartilage development (GO:0051216),0.28687462950766823,0.9618476866354648,0.5063291139240507,0.8209262437671988,1.0,4/49,1.48%,BMP2;SULF1;HYAL3;SULF2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31440308467881883,0.961596011114298,0.528344671201814,0.8206574427579988,1.0,3/30,5.54%,IGF1;LYN;IRS2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.38759883227143777,-0.9615539656102056,0.5260223048327137,0.7473578266550078,1.0,5/12,16.40%,CCN3;SLIT2;AKT1;WASL;GREM1
prerank,regulation of water loss via skin (GO:0033561),-0.3716845321761165,-0.9607858051238096,0.492831541218638,0.7482455479908483,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,establishment of skin barrier (GO:0061436),-0.3716845321761165,-0.9607858051238096,0.492831541218638,0.7482455479908483,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3945221384047021,-0.9607126079025006,0.5473098330241187,0.7479660510004613,1.0,4/12,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,neuromuscular process controlling balance (GO:0050885),0.39435923112738813,0.9606639598204607,0.49889135254988914,0.8220633585441565,1.0,4/12,16.39%,NRXN1;PCDH15;CLRN1;CLN3
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.29269352604484977,-0.960521983022387,0.5223048327137546,0.7479253274275335,1.0,7/37,14.47%,RIN3;NCOR1;ANKRD13A;EDN1;APOE;ABCA2;SDCBP
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.27928614426240717,-0.9603446057100409,0.5330812854442344,0.7478717747485896,1.0,5/42,11.58%,ACKR3;PTK2B;WNK1;CCL15;CIB1
prerank,regulation of neutrophil migration (GO:1902622),-0.4124197749084365,-0.9600893227240661,0.5311871227364185,0.7479834768892404,1.0,2/10,4.56%,JAM3;RAC1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3743227284060388,-0.9600007065050944,0.5113636363636364,0.7477477174799616,1.0,6/15,22.19%,PDSS2;COQ6;NDUFA9;COQ8A;COQ7;UBIAD1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3338400700986084,-0.9596685455905523,0.5363636363636364,0.7476039829292058,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3338400700986084,-0.9596685455905523,0.5363636363636364,0.7476039829292058,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,B cell homeostasis (GO:0001782),0.4131153738915017,0.9595842395233446,0.4945770065075922,0.8238148585099433,1.0,3/10,4.13%,DOCK11;DOCK10;LYN
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3445583553249211,0.9593607223255756,0.4808510638297872,0.8234510285638038,1.0,4/19,10.16%,PARD3B;DLG2;LRRC7;PRKCI
prerank,thymus development (GO:0048538),-0.36844152250407824,-0.959258718255742,0.5182481751824818,0.7480451299877453,1.0,5/13,27.08%,TBX1;SIX1;HES1;FGF10;SOD1
prerank,neural tube closure (GO:0001843),0.30275713207202376,0.9589606077250904,0.5032967032967033,0.8235512531895142,1.0,9/34,12.31%,PRICKLE1;LMO4;DLC1;IFT122;DVL3;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,arachidonic acid metabolic process (GO:0019369),-0.2899977395603572,-0.958367248180066,0.5239852398523985,0.7496598467855402,1.0,10/35,18.30%,PTGDS;MGLL;EPHX1;CYP1B1;GPX1;PTGS1;FAAH;GPX4;CBR1;DAGLB
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3733693116138282,0.9582183615876024,0.5096359743040685,0.8244996433753182,1.0,2/14,7.95%,ADAMTS12;TGFBR1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.37403887021803484,-0.958191612126197,0.5045045045045045,0.7495940521291415,1.0,7/14,33.91%,CARD14;TLR3;TIRAP;TRAF6;CARD10;TLR6;TNFSF15
prerank,chemical homeostasis (GO:0048878),-0.2652975704992673,-0.9580000627847931,0.5158102766798419,0.7495639389465832,1.0,14/61,19.62%,SLC4A10;NEDD4L;WNK1;AQP11;USF2;SLC4A8;ACOX3;PNPLA2;SLC4A2;KLHL3;TLCD3A;ADCK1;AQP4;ABHD8
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.4061324681276974,-0.9577654470890223,0.5368620037807184,0.7496299233875062,1.0,3/11,26.34%,GPX1;GPX3;PRDX4
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2542336163134533,-0.957667895537832,0.5108055009823183,0.7493843566156815,1.0,32/80,30.24%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;FAM107A;PTTG1IP;MTA1;SPRTN;PEF1;RBX1;BMI1;KDM1A;CDK5RAP3;PIN1;LAPTM5;UBE3A;TRIB3;TRAF6;BCL10;DCUN1D3;XIAP;PDCD6;TSPYL5;NDFIP2;MAGEC2;DERL1;RPS2;HDAC3;PLK1
prerank,regulation of lipid metabolic process (GO:0019216),0.2552371520685969,0.9572545083935822,0.5111561866125761,0.8259381286059174,1.0,6/88,2.08%,RORA;TBL1XR1;CHD9;NCOA2;PPARA;PRKAG2
prerank,monoacylglycerol metabolic process (GO:0046462),0.3857684641072551,0.9572268226335091,0.5195652173913043,0.8251190670327413,1.0,4/13,14.53%,PLA2G4A;MOGAT3;MOGAT2;DGAT2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.37703275735754205,0.9562400783116943,0.5196304849884527,0.8267165445438722,1.0,1/14,1.34%,OCSTAMP
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.288747909879925,-0.9561625477005412,0.5290697674418605,0.7523762314801329,1.0,13/39,15.49%,NOS3;TSPAN5;NOTCH1;CCN3;TGFB2;NEPRO;JAG2;NOTCH4;TSPAN14;TM2D3;POGLUT1;EPN2;NOD2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38355135463646095,0.955816406631803,0.5195402298850574,0.826816293129827,1.0,4/13,13.17%,ADCY1;ADCY8;CHRNA7;ZDHHC2
prerank,negative regulation of cartilage development (GO:0061037),0.37527447486905413,0.9557922285692025,0.4957627118644068,0.8259799928756364,1.0,2/13,7.95%,ADAMTS12;TGFBR1
prerank,mRNA metabolic process (GO:0016071),-0.24647330624719532,-0.9555692914225387,0.5333333333333333,0.7532954828222147,1.0,37/90,33.10%,DDX5;HNRNPA2B1;PPARGC1A;PRPF8;SRSF2;SRSF5;DHX15;SNRPD3;U2AF1;LSM11;DIS3L2;SFPQ;YTHDF2;SRSF4;SF3A3;RNH1;HSPA1A;SCAF11;SNRPG;LSM2;LSM3;TBRG4;HSPA1B;NCBP2;LSM10;SNRPB;SF3A1;SF3A2;KIN;HNRNPR;ERN1;SRSF9;LSM6;SRSF1;ZC3H12D;PCF11;DCP2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.34871606343886036,-0.9555416134057697,0.5194085027726433,0.7529061469972821,1.0,8/18,18.77%,DAB2IP;MSN;EZR;PTTG1IP;VPS11;HSP90AA1;ATRAID;CDK5RAP3
prerank,fibrinolysis (GO:0042730),0.3773046632196102,0.9551409406174537,0.49311926605504586,0.8266617678446617,1.0,2/13,6.13%,SERPINE1;PLG
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.323624202390533,-0.955023466649075,0.5503597122302158,0.7536153839703152,1.0,8/24,14.41%,NOTCH1;PTK2B;CYP1B1;CENPJ;CRLF3;OCIAD1;HES1;JAK2
prerank,response to alcohol (GO:0097305),0.3232705433324807,0.9546549418663608,0.5136268343815513,0.8270386023948386,1.0,2/27,2.71%,TGFBR3;GRIN3A
prerank,regulation of melanin biosynthetic process (GO:0048021),0.40247358266518896,0.9544608206584002,0.5257510729613734,0.8266185511549734,1.0,3/10,11.46%,ZEB2;MFSD12;CTNS
prerank,negative regulation of T cell proliferation (GO:0042130),0.3181509699384446,0.9542481140819473,0.5233050847457628,0.8262632037679588,1.0,4/28,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,establishment of vesicle localization (GO:0051650),-0.33898716768427795,-0.9540572607159249,0.5194085027726433,0.7553594841935878,1.0,3/18,4.21%,RAB11A;LIMK2;RAB27A
prerank,regulation of protein polymerization (GO:0032271),-0.2956142682672594,-0.9538470749709401,0.5235404896421846,0.755386186423784,1.0,13/35,23.65%,ESAM;PFN1;PRUNE1;DBNL;DBN1;HSP90AA1;RASA1;ARL2;CTTN;HCLS1;PLEKHG2;CAMSAP3;ARHGAP18
prerank,synaptic vesicle endocytosis (GO:0048488),0.31012845730864946,0.9528286738743614,0.4863157894736842,0.828929859033652,1.0,7/33,7.71%,DNAJC6;STON1;SNAP91;NLGN2;NLGN3;SYT1;NLGN1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2534444424365311,-0.9518175932673831,0.542,0.7597411693137471,1.0,21/79,19.31%,CRIM1;BMPER;THBS1;NOTCH1;BMPR2;SMAD9;DAB2IP;SMAD7;SLIT2;SMAD6;HHEX;HTRA3;SKIL;FGF2;SMURF1;EPN2;SMAD4;GREM1;SPRY1;SKI;BMPR1B
prerank,plasma membrane organization (GO:0007009),-0.2633263710876479,-0.951579632095929,0.5525812619502868,0.759842270574149,1.0,9/61,7.53%,ANO6;SPTBN1;FNBP1L;AHNAK2;CAVIN2;MYOF;DYSF;EHD2;A4GALT
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.40557988716019855,-0.9515451849532566,0.517921146953405,0.7589818633839457,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.40557988716019855,-0.9515451849532566,0.517921146953405,0.7589818633839457,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,peptidyl-arginine modification (GO:0018195),-0.3651672462079507,-0.9512144983064376,0.5289719626168224,0.759281011685009,1.0,3/15,10.12%,PRMT8;ART3;KRTCAP2
prerank,hippo signaling (GO:0035329),0.32069157976594165,0.9510799918430625,0.509719222462203,0.8324174391767397,1.0,4/26,6.63%,TEAD1;DCHS1;WWC1;CASP3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.29322503305398573,-0.9501778314117346,0.5484496124031008,0.7611863663437328,1.0,5/36,5.70%,THBS1;DOCK1;VAMP7;RAC1;ARHGAP25
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2772510558102987,0.9501264599797581,0.5112016293279023,0.8338742552966906,1.0,5/52,2.58%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3
prerank,folic acid metabolic process (GO:0046655),0.3542428707068912,0.9498899809338621,0.5280172413793104,0.8335859981446471,1.0,8/18,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3682793962692902,0.9495030543340478,0.5358744394618834,0.8336594223783697,1.0,3/15,5.95%,PPARA;IRS2;ADM
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.3254978546587164,-0.9490363318717479,0.52046783625731,0.763406830932397,1.0,8/22,25.24%,PSMA6;PSMB5;PSMB4;PSMA1;PSMB1;PSMA4;PSMA2;PSMB8
prerank,motor neuron axon guidance (GO:0008045),-0.3604672821435214,-0.948983381748712,0.5205223880597015,0.7630484647327651,1.0,5/15,14.21%,SLIT2;RAC1;CHN1;LAMC2;NTN1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.35639661632659325,-0.9489446851254846,0.5162523900573613,0.7626637640249823,1.0,1/15,0.12%,PRKCH
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3249207325854216,-0.9489056262330419,0.5394495412844037,0.761843701192538,1.0,6/23,15.01%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3249207325854216,-0.9489056262330419,0.5394495412844037,0.761843701192538,1.0,6/23,15.01%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,protein localization to chromatin (GO:0071168),-0.3451861783157949,-0.9488551272640042,0.5333333333333333,0.7614843557577661,1.0,8/18,30.24%,ESR1;TASOR;WAPL;RAD21;NIPBL;MRNIP;CHMP7;PLK1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.40487205439705054,-0.9487435963145532,0.5257548845470693,0.761284997733296,1.0,4/10,24.95%,TXN2;CTH;BLMH;MTRR
prerank,cellular response to virus (GO:0098586),-0.30951378635885374,-0.9487428929915948,0.5463137996219282,0.7608203670294184,1.0,16/30,37.52%,IFIH1;BAX;FMR1;POU2F2;HSP90AA1;CHUK;LGALS9;MAPK11;VWCE;IRGM;RIOK3;CCL5;IRF3;EIF5A;POU2AF1;IL12A
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.28323335717842424,-0.9487045600215407,0.5310734463276836,0.7604363314428217,1.0,9/42,18.45%,ACTB;ARID1A;MTA2;MBD3;SMARCA4;GATAD2B;SMARCA2;RBBP4;CHD4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3459986450724644,0.9480215030885651,0.5135746606334841,0.8364895296212341,1.0,7/18,23.13%,MCM3;GINS2;PCNA;POLD3;MCMDC2;POLD2;MCM7
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2756670695346799,-0.9479562393831887,0.5476673427991886,0.7617049542487784,1.0,13/49,21.54%,SGMS1;CAV1;RACK1;BAX;NDUFA13;BBC3;BCL2L1;NDUFS3;BCAP31;BAD;PTPMT1;MCL1;FIS1
prerank,synaptic vesicle localization (GO:0097479),0.37317439995514157,0.947243189106697,0.510250569476082,0.8375968505945528,1.0,5/13,16.28%,KIF5C;SYNDIG1;NLGN1;SNAPIN;TMEM230
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.29750222823138817,0.9471413674766882,0.5526838966202783,0.8369352497144424,1.0,5/38,6.94%,RORA;RHOH;GSTP1;NLRP12;TLE1
prerank,negative regulation of cell projection organization (GO:0031345),0.27910862216336135,0.947106851281093,0.5337552742616034,0.836122892015255,1.0,11/48,17.48%,LPAR1;SEMA3A;RAB29;DPYSL3;STX1B;DCC;PTEN;CBFA2T2;DENND5A;PTPN9;GRIN2B
prerank,gene silencing by miRNA (GO:0035195),-0.2997431968115235,-0.9468744565733974,0.5260115606936416,0.7637110291095995,1.0,6/32,11.40%,TNRC6C;ADAR;CNOT7;NOTCH4;WTIP;LIMD1
prerank,anterograde axonal transport (GO:0008089),-0.293364084777973,-0.9462969847816385,0.5368620037807184,0.7645830091256278,1.0,7/37,9.75%,TRAK1;AP3M1;AP3B1;NEFL;TRAK2;HSPB1;KIF1B
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.20996913038279585,-0.9462436182704147,0.6127744510978044,0.7642550400398075,1.0,98/241,34.99%,DDX5;NOVA2;HNRNPA2B1;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2773491480840273,0.9454859330247294,0.5110663983903421,0.8392725158305352,1.0,9/53,12.42%,HTR7;CHRM2;MC5R;CHRM3;HRH1;HRH2;HTR4;PTGIR;HTR5A
prerank,steroid hormone biosynthetic process (GO:0120178),0.31026470615742896,0.945422218459387,0.5422993492407809,0.8385304372979991,1.0,1/29,0.69%,AKR1B1
prerank,nuclear export (GO:0051168),-0.25028067030818407,-0.9452759048435995,0.5691382765531062,0.7659745539271346,1.0,24/80,22.45%,TGFB1;PKD1;CHP1;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;NUP188;SMURF1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;RITA1;DDX39B;HNRNPA1;CCHCR1;CASC3;THOC6;DDX39A;NCBP2
prerank,vasculature development (GO:0001944),0.3552263755776663,0.9439873631320223,0.5157894736842106,0.8411465330724172,1.0,3/16,6.77%,ERRFI1;PDGFRA;PDGFRB
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.38294462129220624,0.9438661862589058,0.5197215777262181,0.8405688546908621,1.0,2/13,3.42%,BCL2L11;VDAC2
prerank,cellular response to glucose stimulus (GO:0071333),-0.30679753935268045,-0.9437833515614222,0.5390625,0.7689810271931149,1.0,4/30,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3824278010548279,0.9427573157446071,0.5235042735042735,0.8424283693138774,1.0,3/12,6.74%,RIMS1;UNC13C;SYT1
prerank,histone modification (GO:0016570),0.23953909343090318,0.9424461789611717,0.5596868884540117,0.8422767508717371,1.0,23/109,15.46%,EYA2;TBL1XR1;PRDM5;MAP3K12;TAF6L;HDAC10;BAZ1B;EYA1;SIRT2;ATXN7;NSD1;KAT8;MIER3;BRMS1;BRMS1L;EHMT2;NEK11;AURKC;NSD3;EP300;EZH2;KAT5;PADI1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3273508019313425,0.9422792132399004,0.5418502202643172,0.8417730248278527,1.0,7/23,16.00%,GJA1;GDNF;SIX4;PAX8;SIRT6;WNT5B;LIF
prerank,phosphatidic acid metabolic process (GO:0046473),0.28056240809975214,0.9420456208637915,0.5353535353535354,0.8414274245963212,1.0,12/48,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G6;PLA2G12A
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3969782340528915,-0.9420046249246431,0.5513307984790875,0.7725975703907763,1.0,5/10,15.15%,CALM1;CACNB3;CALM3;SRI;NIPSNAP2
prerank,cytosolic transport (GO:0016482),-0.23492847099934228,-0.941433266775491,0.5758754863813229,0.7734782638093468,1.0,40/108,29.97%,MYO1D;VPS13A;VPS53;EEA1;RAB6B;TMEM87B;HEATR5A;GOSR1;LAMP1;EMP2;LMTK2;DCTN1;KIF16B;RAB7A;CCDC91;DOP1B;AP4M1;SPAG9;AP2A1;SNF8;GCC2;VTI1B;TBC1D23;VPS29;LAPTM5;EHD3;STX5;VPS54;CORO7;PHETA2;TBC1D17;EPS15;SNX2;TBC1D5;PREPL;ERC1;STX16;HEATR5B;RAB6A;AP1G1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24810700462694588,-0.9412184592057327,0.578838174273859,0.7735096265433178,1.0,17/78,19.30%,ACTB;CCND3;CCNY;CDKN1B;PKD1;RGCC;AKT1;HHEX;CCNG2;EGFR;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.2675690541061156,-0.9405081264646941,0.566147859922179,0.7746461602052804,1.0,26/54,35.79%,NEDD4L;ZNRF1;UBE2Q2;UBE2G2;ITCH;RNF5;KLHL3;RBX1;UBE2G1;TNFAIP3;PELI1;AMFR;UBE2B;UBE3A;BFAR;DTX3L;RNF187;FBXO38;RNF8;SYVN1;HACE1;UBE2T;CUL3;UBE2R2;UBE2C;RNF152
prerank,GTP metabolic process (GO:0046039),-0.3548177362195308,-0.9405049585824595,0.5357142857142857,0.7741844756385733,1.0,4/15,21.30%,IMPDH1;ENTPD7;OPA1;RAB23
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2867959584727336,-0.9403100327485948,0.5458015267175572,0.7741721460718962,1.0,10/37,23.54%,ENTPD1;MTREX;PPP1R8;ENTPD7;ENTPD6;DNASE1L2;ENTPD2;RNASEH2C;NUDT18;DFFB
prerank,positive regulation of cartilage development (GO:0061036),0.3618464723937679,0.940309191379378,0.5303370786516854,0.8449299139161697,1.0,3/17,9.56%,BMP2;LOXL2;SOX5
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3292493990087331,0.9402819784370345,0.5041322314049587,0.8440956806849247,1.0,4/24,8.45%,PID1;LEPR;SLC25A13;NDUFS1
prerank,pore complex assembly (GO:0046931),-0.33438612478612045,-0.9401977846300409,0.5459662288930581,0.7739571603222156,1.0,4/19,9.18%,ANO6;ADAM10;NUP93;NDC1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.38088349623105167,0.939941236009029,0.5374449339207048,0.8440037898779353,1.0,3/12,10.34%,MYCBP2;EPHB1;PTEN
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3085516709022681,0.9394828788282539,0.5545851528384279,0.8442723266815039,1.0,7/30,13.61%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2650850025925957,0.9392088506319511,0.5528942115768463,0.8440049050843688,1.0,9/59,11.38%,TCF7L2;CDK8;MITF;CEBPB;AGO4;TNRC6A;PPM1D;PTEN;TNRC6B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.29085046079116295,0.9390415882155305,0.569593147751606,0.843511841257901,1.0,5/39,9.92%,TCF7L2;IRS2;NLGN2;TM7SF3;AIMP1
prerank,neuron development (GO:0048666),0.23169181147773113,0.9389425931649625,0.58,0.8428682944807054,1.0,30/141,13.80%,TENM3;GDNF;CNTN4;GLI2;CNTNAP2;GPM6A;GPRIN2;TENM2;PBX4;LYN;GPRIN1;TBC1D24;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;EPHA5;ALK;ATP8A2;LRP12;RASGRF1;SNAPIN;ATXN10;GBA2;TENM1;CDK16;MAPT
prerank,excitatory postsynaptic potential (GO:0060079),0.33911931460289346,0.9388451208801464,0.5308151093439364,0.8422016032745928,1.0,7/19,18.84%,GRID2;MPP2;MAPK8IP2;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,DNA methylation or demethylation (GO:0044728),0.3434092863333837,0.9387964733519476,0.5192307692307693,0.8405598532506863,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,DNA alkylation (GO:0006305),0.3434092863333837,0.9387964733519476,0.5192307692307693,0.8405598532506863,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,smoothened signaling pathway (GO:0007224),0.2966914832020885,0.9385330528631797,0.511482254697286,0.8403145762907186,1.0,11/32,19.76%,TMEM17;GLI2;GLI3;GPC2;HES5;MAP3K10;EVC2;ARL13B;SHH;DISP3;DISP2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3375934451824381,0.9384163288876044,0.5258620689655172,0.8397369923504265,1.0,5/18,11.56%,PRDM9;SETMAR;KMT2A;SETD7;EHMT2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.28148729591772237,-0.9379797212853352,0.5717017208413002,0.7785848027678958,1.0,5/40,10.31%,LBP;RPL39;GBP7;PGLYRP1;TIRAP
prerank,regulation of cell size (GO:0008361),0.33315239598212726,0.9379755029923214,0.5317796610169492,0.8399395772080454,1.0,4/23,10.34%,PRR16;DEPTOR;RARG;PTEN
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.39969910508767764,-0.9378256119047563,0.5443786982248521,0.7784696625052806,1.0,3/10,6.42%,ACTN4;TBX1;RARA
prerank,cell junction maintenance (GO:0034331),0.3660603845664657,0.9377791729504854,0.5439330543933054,0.8395479129240951,1.0,3/14,10.73%,PRTN3;NLGN2;CBLN2
prerank,regulation of stem cell differentiation (GO:2000736),-0.24081095802796787,-0.9377680407688549,0.58,0.7781099510278363,1.0,24/89,17.06%,NOTCH1;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;OCIAD1;PSMD14;ITCH;HES1;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;HOXB4
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.403962939226441,-0.9371658966068522,0.546617915904936,0.7790089211657477,1.0,6/10,40.15%,MFSD2A;PHB2;MTMR2;GNB3;ABCA3;MTMR3
prerank,regulation of AMPA receptor activity (GO:2000311),-0.31677515127045486,-0.9371102189712117,0.5123809523809524,0.7786777873185491,1.0,3/25,5.31%,MEF2C;SHANK3;MINK1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.37030417880633265,-0.9369105030043827,0.552212389380531,0.7786759813949179,1.0,4/13,20.18%,CYRIB;PVR;NECTIN2;MR1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.2990045823851564,-0.9367183334651182,0.5467625899280576,0.7786887416160198,1.0,13/30,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,autophagy of nucleus (GO:0044804),0.36150455064767106,0.9363030531538018,0.5217391304347826,0.8421482832116247,1.0,7/16,21.67%,WDR45B;ATG12;WIPI1;ULK2;ATG9A;ATG5;WDR45
prerank,negative regulation of secretion (GO:0051048),0.4009795205182575,0.935993019598537,0.5211864406779662,0.8420240961183011,1.0,2/10,8.26%,NRG1;ERBB3
prerank,negative regulation of histone modification (GO:0031057),-0.36104944362454783,-0.9359306568978273,0.5677655677655677,0.7799747182239272,1.0,4/14,19.23%,CTBP1;TWIST1;SPHK2;AASS
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.39461045160067054,0.9357720796558961,0.5319587628865979,0.8416696201107782,1.0,2/10,2.55%,SERPINE2;ALOX12
prerank,glutathione metabolic process (GO:0006749),-0.28290181328184727,-0.9356936763807551,0.5654761904761905,0.7800317048133439,1.0,16/38,27.08%,GPX1;GSTA4;GGT5;GSTM2;GSTA3;GSTM1;GSR;GCLM;CNDP2;GCLC;GGT1;GSTK1;GGCT;GSTM5;PARK7;SOD1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26320614853104973,-0.9356425112977362,0.5671641791044776,0.7796698001270304,1.0,21/53,30.31%,DDX5;RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;FMR1;EGFR;NSMCE4A;BABAM2;CCAR2;MSX1;FGF10;PRKCD;SPRED3;NSMCE1;RNF8;PMAIP1;SPRED1;MYC
prerank,DNA methylation (GO:0006306),0.32777480378076657,0.9347705557503435,0.5600907029478458,0.843167867697863,1.0,7/23,22.69%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP;ZFP57
prerank,protein targeting to membrane (GO:0006612),-0.24439909401215915,-0.9344740387501422,0.5956607495069034,0.7819429036636374,1.0,34/83,32.23%,PARD3;RAB8B;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;ZDHHC1;ICMT;ARL6;ZDHHC20;SDCBP;SGTA;SRP19;SSR2;ZDHHC23;FIS1;SGTB;ZDHHC12;ZDHHC3;ZDHHC18;TRAM1;SEC61A1;PEX14;GOLGA7B;NACAD;ZDHHC24;ABCD3;SRPRA;VPS37C;CHMP4B;CHMP4A;CHM
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.31186969568344625,-0.934370994005945,0.5452865064695009,0.7817247946115528,1.0,8/27,25.80%,CTPS1;CTPS2;RRM1;GLRX;GSR;TYMS;NME1;AK9
prerank,positive regulation of ion transport (GO:0043270),0.27822029394129116,0.9343014013189295,0.5639412997903563,0.8434633584275695,1.0,7/48,7.59%,GDNF;SCN3B;ANK2;P2RX4;GPD1L;MYLK;CACNB2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.34062900323761136,-0.9341285689863864,0.5612788632326821,0.7817971762495551,1.0,6/18,17.16%,NOTCH1;CCN3;HDAC4;FZD7;SOX6;XBP1
prerank,glycine metabolic process (GO:0006544),0.3800912334194918,0.9340689375562267,0.5552995391705069,0.8431931661425845,1.0,3/12,9.74%,GLDC;BAAT;RIDA
prerank,aspartate family amino acid metabolic process (GO:0009066),0.34323893021080054,0.9340373864006111,0.551063829787234,0.8424004812235786,1.0,9/18,23.74%,ASPA;SLC25A13;FOLH1;MTHFD1;ASS1;ASPG;GOT1;GOT2;MTHFR
prerank,regulation of blood circulation (GO:1903522),0.3036402437215697,0.9339731327521561,0.5234042553191489,0.8416801420071164,1.0,3/34,5.75%,CELF2;DMPK;FXYD1
prerank,peptide metabolic process (GO:0006518),-0.24843894642922962,-0.9333950651734032,0.6062378167641326,0.7830283055452435,1.0,18/75,15.05%,DMD;TPP1;BACE2;BACE1;LTA4H;ERAP1;IDE;SPCS1;GPX1;GSTA4;CPE;CARNMT1;GSTM2;SEC11A;GSTA3;LNPEP;ACE;GSTM1
prerank,fat cell differentiation (GO:0045444),0.2695776505989985,0.9332638096687159,0.5692007797270955,0.8424910288378078,1.0,5/57,6.14%,TCF7L2;PID1;OSBPL8;SENP2;ATF5
prerank,vacuolar acidification (GO:0007035),0.3357900223167712,0.9325310962103308,0.5230125523012552,0.8433768182753443,1.0,5/21,17.06%,ATP6V0A4;ATP6V1H;DMXL1;CLN3;DMXL2
prerank,regulation of mast cell activation (GO:0033003),0.39012715093822786,0.9323401257807044,0.5361050328227571,0.8429989472149545,1.0,4/10,16.35%,LYN;CD300LF;TSLP;CRLF2
prerank,T cell differentiation (GO:0030217),0.2919644428347424,0.9322248075194967,0.5555555555555556,0.8424106231543278,1.0,5/40,3.86%,KIT;CHD7;LEPR;RHOH;GLI3
prerank,branched-chain amino acid catabolic process (GO:0009083),0.34208831765571407,0.9317123524604567,0.5252100840336135,0.8419008523769027,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.34208831765571407,0.9317123524604567,0.5252100840336135,0.8419008523769027,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.31222700105640055,-0.9315007811234456,0.5708661417322834,0.7869082852363463,1.0,7/25,17.50%,AFAP1L2;HIP1R;AKT1;HIP1;SHKBP1;BCAR3;NEU3
prerank,translational termination (GO:0006415),-0.23856858121276703,-0.9314987998025026,0.6107899807321773,0.7864373308828904,1.0,34/95,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.33174807983574683,-0.9312111642361107,0.5413533834586466,0.7866432055278877,1.0,11/18,39.03%,ESR1;NRIP1;LCOR;EGFR;FAM210B;SSTR2;POU4F1;RAMP3;GPER1;CRHBP;SSTR1
prerank,regulation of autophagy (GO:0010506),-0.2102863616418628,-0.9310338417543366,0.6570155902004454,0.7865629196705742,1.0,62/216,25.39%,ACER2;EXOC4;EEF1A1;RASIP1;SH3BP4;FOXO1;MID2;FOXO3;DAPL1;ATP6V0B;EIF4G3;FOXK1;PSAP;ATP6V0A2;GPR137B;HSPB1;GAPDH;SVIP;PLK2;AKT1;TRIM14;PIK3C2A;ATP6V0C;RAB8A;UCHL1;EXOC1;ABL2;FBXL2;TRIM68;LAMTOR2;TRIM5;PRKAG1;ATP6V1G1;MET;CSNK2A2;UFL1;PIK3R2;RRAGD;TAB2;BAD;VPS29;GFAP;PLEKHF1;OSBPL7;TMEM59;MCL1;KEAP1;FZD5;RRAGA;TFEB;TRIB3;EIF4G1;PTPN22;RRAGC;TPCN2;WDR6;RUBCN;EIF4E;RPTOR;SREBF1;ATP6V0D1;TREM2
prerank,positive regulation of embryonic development (GO:0040019),0.34146937263946414,0.9310103977098125,0.5538793103448276,0.8426645616758046,1.0,2/19,6.59%,WNT4;FOXA2
prerank,cellular protein localization (GO:0034613),-0.20345175319270467,-0.93029843683709,0.6928104575163399,0.7877654721490319,1.0,81/285,22.57%,OCLN;ESAM;DMD;ID1;SGSM2;STX3;TBC1D8;GRTP1;MESD;FERMT2;JAM3;AP3B1;RIC3;SYNRG;NAPA;AMOT;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;TBC1D22A;ARF5;RAB6B;ITSN1;CPLANE2;CPE;HHEX;VCL;HERC2;EMP2;WNT11;CD74;STX2;GAS8;RAB24;COPB2;ARL4A;TBC1D9B;TBCK;SMURF1;ARL6;LAMTOR2;RAB1A;CEP68;AP4M1;CELSR1;COG3;EGFR;AP2A1;RRAGD;YWHAH;PACSIN1;VPS33A;NSF;TBC1D25;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;USP4;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;WIPI2;PTPRK;FGF10;RRAGA;NIPBL;ARL4C;RAB23;ADPRH;PTPRU;STX5;KIF13A;RRAGC;TBC1D15
prerank,DNA duplex unwinding (GO:0032508),-0.26622394059955506,-0.930270380860097,0.5677655677655677,0.7873543111625113,1.0,12/50,17.82%,ANXA1;UBB;UBC;RPS27A;CUL4A;GTF2H3;DHX9;CHD1L;RBX1;CETN2;ASCC3;GTF2H4
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.33278015808282246,-0.9301212504080182,0.5454545454545454,0.7872139129733411,1.0,7/19,29.11%,GPX1;ACOX1;GPX3;PARK7;PRDX4;SOD1;NOX1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.36337871343918393,-0.9298223919523511,0.5348399246704332,0.7873960265898917,1.0,4/15,14.84%,MVB12B;PTPN12;EGFR;ERBB2
prerank,megakaryocyte differentiation (GO:0030219),0.38140034819985025,0.9295184782880178,0.5395033860045146,0.8452960381176703,1.0,2/11,7.58%,KIT;THPO
prerank,phasic smooth muscle contraction (GO:0014821),0.4014548108525674,0.9291853637082025,0.5442477876106194,0.845214953422611,1.0,3/10,14.14%,GDNF;EDNRB;DRD2
prerank,mitotic chromosome condensation (GO:0007076),-0.30323855440201564,-0.9288844907046203,0.58984375,0.7891275452846577,1.0,14/26,31.91%,SMC4;CSNK2B;RB1;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;KMT5A;NCAPH2;TTN;PLK1;CDK1;NCAPD2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.28618614413977145,-0.9286363625702369,0.5614366729678639,0.7891840454365668,1.0,16/36,31.99%,NLRC5;RIPK1;EDN1;CD74;MAVS;AGPAT1;HSPA1A;TXK;LAPTM5;CASP1;HSPA1B;PARP14;C1QTNF4;IRGM;PARP9;TRIM44
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3302546792463418,-0.9284406093263156,0.5663716814159292,0.7891567776628643,1.0,8/20,24.55%,LBP;TGFB1;PRKCE;TLR4;HCK;PTPN22;CCL2;BCL10
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3263658682442761,-0.9279908458931746,0.55637707948244,0.7896856127024546,1.0,8/20,17.16%,NOTCH1;SMAD9;CARF;VEGFA;ATF4;SMAD4;RELA;XBP1
prerank,regulation of platelet activation (GO:0010543),0.3328699182266296,0.9277493940419064,0.5450346420323325,0.8478836456505368,1.0,4/21,4.13%,PDGFRA;PLA2G4A;PRKCA;LYN
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2247946437125393,-0.9277486140608796,0.6181434599156118,0.7897670332963025,1.0,30/124,16.47%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;NFATC1;WNT11;PSMC4;PSMC5;PSMD14;PPP3CB;GNB1;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1
prerank,innate immune response in mucosa (GO:0002227),0.40205704725059344,0.9276070120851548,0.5414012738853503,0.8473260792538994,1.0,2/10,5.47%,IL4;BPIFB1
prerank,protein K11-linked ubiquitination (GO:0070979),0.310745869096088,0.9268558762054547,0.5562632696390658,0.8483000501141724,1.0,9/27,19.60%,PRKN;ANAPC1;UBE2E3;CDC23;CDC16;RNF26;UBE2E2;ANAPC5;CDC26
prerank,regulation of adenylate cyclase activity (GO:0045761),0.32852609679179584,0.9268289216884901,0.562363238512035,0.8475007291323279,1.0,1/22,0.22%,ADGRV1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.31458604384301136,0.9263778137856253,0.5567685589519651,0.8477917623604008,1.0,4/26,6.04%,PPARA;SLC5A3;SLC30A10;ABCD2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.29155827452039634,-0.9262622695815206,0.5862745098039216,0.7927000421923591,1.0,10/33,19.01%,ESR1;DDX5;UFM1;CBFB;DDRGK1;H3-3A;TRIM68;UFL1;KDM1A;UBA5
prerank,calcineurin-mediated signaling (GO:0097720),-0.3920078764111225,-0.9257441851166096,0.5724381625441696,0.7929609240822358,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3920078764111225,-0.9257441851166096,0.5724381625441696,0.7929609240822358,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3799612370821631,0.9254631018599531,0.5523385300668151,0.8491265113336752,1.0,2/12,3.27%,DOCK11;DOCK10
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.37116152926955054,-0.9254135827341295,0.5670289855072463,0.7932309326434024,1.0,6/14,36.29%,YBX3;TIRAP;BOLL;HNRNPC;ANGEL2;DAZL
prerank,regulation of calcium ion transport (GO:0051924),0.26904816128251574,0.9253833224622608,0.5847107438016529,0.8484483838081224,1.0,8/54,8.78%,ANK2;CACNA2D1;BCL2;P2RX4;MYLK;CAMK2B;CACNB2;SARAF
prerank,DNA replication checkpoint signaling (GO:0000076),-0.35558114761661974,-0.9248683756377253,0.5711645101663586,0.7940225957536249,1.0,8/16,34.13%,RAD9B;HUS1;RAD9A;RAD17;DNA2;CDC6;TICRR;CLSPN
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.28087258206442256,-0.9238509664433766,0.6,0.7958887409921569,1.0,8/38,13.71%,CAV1;APP;NEDD9;SHC1;LRP8;SRCIN1;CSF1R;ACE
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.30315688900576193,0.9237221257260881,0.5635964912280702,0.8514946871259185,1.0,3/29,4.95%,IL31RA;STAT5B;GHR
prerank,tRNA wobble base modification (GO:0002097),-0.35809338688698866,-0.9236849505884319,0.583793738489871,0.7957928092792756,1.0,5/14,28.07%,DPH3;TRMT9B;URM1;ADAT2;CTU2
prerank,peptide hormone secretion (GO:0030072),-0.30771667354997356,-0.922874915911067,0.5988700564971752,0.7971598765809341,1.0,16/26,45.49%,LTBP4;ANXA1;EDN1;RAB1A;PARK7;CAMK2G;ADCYAP1;SNX19;EXOC3L1;VIP;EDN3;SLC30A8;FAM3B;NEUROD1;IL6;GAL
prerank,regulation of interleukin-1 beta production (GO:0032651),0.256441738612872,0.9224010420296882,0.5840163934426229,0.8537992351361358,1.0,6/66,8.44%,IGF1;ORM2;GSTP1;NLRP12;GSDMD;NLRP2B
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3581771978476974,-0.922386696441516,0.5661375661375662,0.7977926094886936,1.0,7/14,30.93%,CAV1;NOTCH4;SPRY1;SPRED3;XDH;SPRED1;DLL1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21167252945315543,-0.9222478055092536,0.659877800407332,0.7976092087898013,1.0,48/172,21.69%,PLCG2;DGKH;PIP5K1B;BMX;TAMM41;PI4K2A;LPCAT3;INPP5D;PIK3R6;MFSD2A;CDS2;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;CHKA;PIK3C2A;CSNK2B;PITPNM2;MBOAT7;RUFY1;CEPT1;PITPNM3;RAB4A;FGF2;AGPAT1;PIK3R3;PITPNM1;FAR1;PIK3CA;MTM1;CSNK2A1;CSNK2A2;PCYT2;SYNJ1;PIK3R2;FIG4;PIK3C2B;DGKZ;LCAT;GPD1;ABHD8;AGPAT5;CPNE3;PCYT1A;CHAT;LPCAT2
prerank,response to light stimulus (GO:0009416),0.26356383762157193,0.921280684150463,0.5490196078431373,0.8556424854099264,1.0,7/55,7.61%,GPR88;DDB2;TRPM1;GTF2H2;COPS3;MEN1;CRY1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3547132986273039,-0.9210238658652348,0.587037037037037,0.7998516646868304,1.0,3/15,12.70%,ARPC1B;ARPC5;ACTR3
prerank,peptide catabolic process (GO:0043171),-0.3115722489912983,-0.9207562020225085,0.573076923076923,0.7999815988166308,1.0,7/23,13.71%,TPP1;LTA4H;ERAP1;IDE;GGT5;LNPEP;ACE
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.40060603714545034,-0.9203927766426429,0.6007604562737643,0.7998713156795639,1.0,3/10,13.26%,RACK1;SPHK2;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.40060603714545034,-0.9203927766426429,0.6007604562737643,0.7998713156795639,1.0,3/10,13.26%,RACK1;SPHK2;TNFRSF1A
prerank,establishment of spindle localization (GO:0051293),-0.36246085989447296,-0.9202404405180739,0.5831842576028623,0.7997442791988786,1.0,5/14,36.28%,MAP4;CFL1;TLE6;ESPL1;NLRP5
prerank,regulation of phagocytosis (GO:0050764),0.2735209477627244,0.9201557328082657,0.583804143126177,0.857563086399754,1.0,4/53,2.10%,CAMK1D;PRTN3;PLA2G5;AHSG
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3672496534718983,0.920087326204993,0.5331858407079646,0.8568452427950969,1.0,3/13,5.08%,PID1;PPARA;IL4
prerank,histone acetylation (GO:0016573),-0.2501729890487875,-0.9198109789025584,0.6127049180327869,0.8002622291049665,1.0,21/69,28.86%,LEF1;PHF20;TRRAP;JADE2;ING5;TRIM16;EPC1;NAA60;MRGBP;BRCA2;EP400;TADA3;BRPF1;TAF9;POLE3;RUVBL1;KAT6B;SPI1;TAF10;TAF5;NAA50
prerank,calcium import into the mitochondrion (GO:0036444),-0.3913581846701134,-0.9197833065250102,0.5604203152364273,0.799859013474627,1.0,5/10,24.61%,MCUB;MCUR1;MICU2;SMDT1;MCU
prerank,protein targeting to mitochondrion (GO:0006626),-0.2609112242415813,-0.9196973462457052,0.6,0.7995803428849391,1.0,19/52,28.18%,NDUFA13;IMMP2L;HSPD1;TIMM17A;TIMM21;TIMM29;TOMM22;CHCHD4;HSPA4;BCAP31;HSP90AA1;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,regulation of endocytosis (GO:0030100),-0.2564678024007031,-0.9196205997213784,0.5912698412698413,0.7992918373001686,1.0,23/61,26.21%,GPC3;NEDD4L;OPHN1;CD151;HIP1R;FLOT1;HIP1;RAB4B;ABL2;RUFY1;RAB4A;APOE;PACSIN1;TSC2;PACSIN3;PACSIN2;PTPN1;RUBCN;ZFYVE16;CBLL1;MTMR2;RAB5C;SMPD1
prerank,negative regulation of transposition (GO:0010529),0.35291964368821865,0.9194650187014486,0.5786026200873362,0.8574355204705243,1.0,3/16,13.84%,TUT4;PIWIL2;TEX15
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.31864963407168256,-0.9189863597280209,0.580896686159844,0.800278792496567,1.0,7/23,22.39%,FAR2;ELOVL7;ELOVL5;ACSL5;FAR1;ELOVL1;ACSF3
prerank,actin nucleation (GO:0045010),-0.3219946336648677,-0.9187439379768464,0.5940409683426443,0.8003455229606461,1.0,4/21,12.70%,ARPC1B;LMOD1;ARPC5;ACTR3
prerank,substrate-dependent cell migration (GO:0006929),0.37041077930202326,0.9184542143494823,0.5440528634361234,0.8590520354183897,1.0,2/14,1.80%,NRP1;ITGA11
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.38504700765201944,0.9176127714901453,0.5747126436781609,0.8602648197265957,1.0,3/11,9.10%,NOVA1;IGF2BP2;PCBP3
prerank,negative regulation of hemostasis (GO:1900047),0.3728450338868456,0.9174461934898444,0.5429864253393665,0.8598337430357401,1.0,3/12,5.80%,SERPINE2;APOH;SERPINE1
prerank,cellular response to interleukin-6 (GO:0071354),0.31216555114297667,0.917383215463333,0.5711252653927813,0.8591298240887397,1.0,3/26,3.92%,PID1;PTGIS;PTPRT
prerank,eye photoreceptor cell development (GO:0042462),-0.35038475368142835,-0.9171327099015711,0.5727611940298507,0.8034984875982983,1.0,4/15,18.65%,RP1;VEGFA;CEP290;RPGRIP1
prerank,negative regulation of developmental growth (GO:0048640),0.29984643512060966,0.9168421505532078,0.5770833333333333,0.8595143595185442,1.0,9/30,15.83%,WWC1;RTN4;CDKL3;DCC;BBS2;PTEN;ULK2;TRIM46;NKD1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3097867769256603,0.916783111540226,0.5862831858407079,0.8587836907892845,1.0,3/26,4.80%,ROCK2;LYN;EFNA3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.34605665224917836,0.9165814216070468,0.5578512396694215,0.8583834623270726,1.0,5/17,15.85%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.29526614021167835,-0.916465505902366,0.5746268656716418,0.8044663550464307,1.0,6/29,6.37%,LEF1;TLE4;RBBP5;TRRAP;PYGO2;TLE3
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.2693180150743296,-0.9160557586500714,0.6063432835820896,0.804933153291161,1.0,21/45,37.12%,RPL10;FOXO3;APP;RC3H1;TDRD7;RBM4B;PCIF1;PUM2;ZC3H7A;MEX3D;EIF4E;RBM3;METTL18;ZC3H10;PARP9;ATG14;NANOS1;LARP4;CYFIP1;TRIM71;EIF2A
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3077730580877257,-0.9159839550153174,0.5979591836734693,0.8046209138080617,1.0,4/25,4.89%,PLCG2;TMBIM4;HTT;CMKLR1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.30571583336491653,-0.9157415728459255,0.6074950690335306,0.804689622187404,1.0,8/26,19.90%,SHANK3;ACTG1;RAC1;PFN1;SYNPO;LIMK1;PTGER4;SHANK1
prerank,barbed-end actin filament capping (GO:0051016),0.3466113155472425,0.9156717465951582,0.5598194130925508,0.8587892180131503,1.0,1/18,0.16%,SVIL
prerank,actin filament capping (GO:0051693),0.3466113155472425,0.9156717465951582,0.5598194130925508,0.8587892180131503,1.0,1/18,0.16%,SVIL
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3479418331041025,-0.915517515175449,0.5652173913043478,0.8046901361994463,1.0,4/15,5.68%,KDR;F3;VEGFC;VEGFA
prerank,triglyceride metabolic process (GO:0006641),0.27638092012812077,0.9149488742384221,0.5946502057613169,0.8596027971406369,1.0,9/48,16.49%,AGMO;APOH;APOBR;MOGAT3;LPIN3;MOGAT2;DGAT2;FABP4;LPIN1
prerank,negative regulation of neuron differentiation (GO:0045665),0.32863406531718137,0.9147169886082543,0.5825688073394495,0.8592742181728985,1.0,5/22,8.54%,CNTN4;HES3;DTX1;SOX2;HES5
prerank,regulation of mitochondrial fission (GO:0090140),-0.31374590248068857,-0.9144852370878779,0.5852272727272727,0.8065326855002656,1.0,11/24,31.11%,KDR;CYRIB;MIEF1;MIEF2;INF2;FIS1;MCU;MYO19;MFF;MUL1;AURKA
prerank,negative regulation of cellular senescence (GO:2000773),-0.37469129264573064,-0.9142707943405529,0.620253164556962,0.8065442434162181,1.0,3/13,8.99%,CDK6;MAP3K3;TWIST1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3925718352867235,0.9139623106521891,0.5518763796909493,0.8601972895517543,1.0,1/10,1.32%,BMP5
prerank,positive regulation of leukocyte migration (GO:0002687),0.3051421647496547,0.9137568061603711,0.565922920892495,0.8598604527333065,1.0,2/27,5.08%,PTN;IL4
prerank,positive regulation of calcium ion transport (GO:0051928),-0.28825606645275703,-0.9134215917019811,0.5968688845401174,0.8080166493198533,1.0,8/36,16.26%,CAV1;TRPC3;STIM2;TRPC6;ORAI1;SPHK2;CACNA1D;ATP2B1
prerank,mRNA modification (GO:0016556),0.32670682110325977,0.9133798689450578,0.5683760683760684,0.8598858697907887,1.0,7/22,18.64%,VIRMA;RPUSD2;METTL16;PUS7;METTL3;METTL8;PUS1
prerank,cytosolic calcium ion transport (GO:0060401),-0.3054362129820852,-0.9133023705992847,0.5876685934489403,0.8078167341111534,1.0,15/28,24.61%,MCUB;ITPR3;SLC35G1;ATP2A3;MCUR1;JPH2;JPH4;CACNB3;ATP2B3;ATP2B1;MICU2;CACNA1C;JPH3;SMDT1;MCU
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3882283807284086,0.9129396451100458,0.5558086560364465,0.8600955828824771,1.0,3/11,10.18%,VCPIP1;RTN4;STX18
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3190798128645962,-0.912847627254965,0.5981818181818181,0.8083432667168913,1.0,9/22,20.91%,RAP1A;RAPGEF1;NGF;STMN2;AKT1;CIB1;KIDINS220;EHD1;RAPGEF2
prerank,negative regulation of proteolysis (GO:0045861),0.2850798067820466,0.9125894770788331,0.578838174273859,0.8600726001808167,1.0,3/34,7.28%,TIMP3;SERPINE2;TIMP4
prerank,axonal transport (GO:0098930),-0.27491011538827115,-0.912113204953365,0.5801526717557252,0.8094834161833424,1.0,17/36,38.38%,AP3M1;AP3B1;NEFL;KIF1B;DCTN1;OPA1;DTNBP1;AP3M2;SOD1;DST;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.39467537448889245,-0.9120715315130249,0.5956284153005464,0.8091177722173027,1.0,6/10,25.76%,CAMK1;SPHK2;SMAD4;RAPGEF3;CHEK1;HDAC5
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2810017286424356,0.9111820024546922,0.6016096579476862,0.8625441606582075,1.0,18/40,22.71%,CRY1;RADX;RPA2;FXR2;ANKLE1;MAPT;IER3;CDK9;FBXO5;ETAA1;UBE2N;WRNIP1;ARMT1;WDR76;NEK4;NPAS2;UBE2V2;RFWD3
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.31572635165087726,-0.9111715956660997,0.5724770642201835,0.8106535125597113,1.0,1/21,0.35%,CAV1
prerank,regulation of protein import into nucleus (GO:0042306),0.288058770768095,0.9109185154014907,0.576271186440678,0.862302702249011,1.0,3/36,2.77%,PIK3R1;ZIC1;SMAD3
prerank,regulation of interferon-gamma production (GO:0032649),-0.24154526383187563,-0.9103321531874895,0.632295719844358,0.8120090137386395,1.0,32/71,40.25%,SLC7A5;PDE4D;CYRIB;IL1R1;RARA;TLR3;HSPD1;INHBA;TLR4;VSIR;TXK;LAPTM5;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;INHA;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;PDCD1LG2;IL12RB1;ISL1;NR1H4
prerank,protein palmitoylation (GO:0018345),-0.29122045228938903,-0.9101704529649027,0.6078066914498141,0.8119040151332618,1.0,13/30,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2580361453384481,-0.9099832516359053,0.6285714285714286,0.8118239314819456,1.0,27/56,33.49%,SPTBN1;USP8;KIF23;DCTN3;RHOB;RTKN;MITD1;SNX18;IST1;ECT2;RASA1;ANLN;CENPA;EFHC2;CIT;CEP55;VPS4A;STMN1;ARL3;RACGAP1;TRIM36;PLK1;RHOA;CHMP4B;ESPL1;UNC119;STAMBP
prerank,brain morphogenesis (GO:0048854),0.3683645891623898,0.9087279868869834,0.5562770562770563,0.8667016936648267,1.0,4/12,10.34%,CTNNA2;SPEF2;BBS2;PTEN
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3356066775425802,-0.9083327093737651,0.5883458646616542,0.8149269172158866,1.0,2/18,0.53%,MEF2C;FLT1
prerank,positive regulation of insulin secretion (GO:0032024),0.2786464225256941,0.908093939554388,0.5949895615866388,0.8673530866907601,1.0,6/36,10.91%,TCF7L2;IRS2;NLGN2;TM7SF3;ADCY8;BAIAP3
prerank,regulation of cell morphogenesis (GO:0022604),0.29926122460388743,0.9076610298304092,0.5949367088607594,0.8675871614585247,1.0,3/30,5.13%,SH3D19;PHIP;ZMYM6
prerank,transferrin transport (GO:0033572),-0.2842089738628276,-0.9074923955786233,0.6026615969581749,0.816378503340303,1.0,8/33,11.50%,TFRC;ATP6V0B;ARHGAP1;ATP6V0A2;ATP6V0C;LMTK2;REP15;RAB11B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3768361581920904,0.9070064516066058,0.5835140997830802,0.8683460615330838,1.0,11/11,62.34%,PKD1L3;LPO;RTP2;PKD2L1;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;RTP4
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3887551218737,-0.9069802816105467,0.5890909090909091,0.8170290668986682,1.0,5/10,32.73%,HDAC4;SAE1;UBA2;MUL1;RASD2
prerank,O-glycan processing (GO:0016266),-0.2611856496341142,-0.9062054241418601,0.6411764705882353,0.8182504483539179,1.0,20/54,36.09%,ST3GAL4;ST6GAL1;C1GALT1C1;GALNT10;GXYLT1;ST6GALNAC2;B3GNT3;B3GNT8;GALNT5;GCNT4;GALNT6;GALNT9;GALNT1;B4GALT5;ST3GAL2;MUC1;ST6GALNAC4;MUC13;B3GNT2;MUC6
prerank,regulation of cell cycle phase transition (GO:1901987),-0.23066251002367838,-0.9060873664527339,0.644,0.8180493186187164,1.0,39/91,34.73%,CDKN1B;ANAPC15;PSMA6;ANAPC11;PSMB5;TCIM;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;CDKN1A;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;CUL1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;TRIM39;NEK10;XPC;BUB3;PSMC6;PLK1;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;PSMD2;UBE2C
prerank,sensory organ development (GO:0007423),-0.2567954713544626,-0.9055685830432887,0.6413255360623782,0.8187084609993218,1.0,9/51,11.80%,SMOC1;HIPK1;TGFB2;STRA6;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.31758774589141997,0.905466406412047,0.5833333333333334,0.8711283923899311,1.0,9/20,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,establishment of spindle orientation (GO:0051294),-0.28991823836417757,-0.9053892260954398,0.6110056925996205,0.8186174106300095,1.0,10/28,24.31%,MAP4;ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3326102618249388,-0.9050534274557797,0.5869947275922671,0.818878619023724,1.0,3/18,6.47%,CD34;HDAC7;EZR
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.31816447623328503,-0.904841171437658,0.5888689407540395,0.8188742296447393,1.0,7/21,20.67%,RPL11;RPL23;RPS7;CDC14B;RAB1A;FZR1;RPL5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.36812729374431535,-0.9045048967033111,0.5906542056074766,0.8191276582912743,1.0,7/12,39.24%,REST;PSMC3;POU2F3;CCL5;JUN;CCL4;INPP5K
prerank,protein-containing complex subunit organization (GO:0043933),0.23070402300241039,0.9042814078240428,0.6646464646464646,0.873171104344933,1.0,27/109,15.16%,TEAD1;MITF;RIMS1;MDM2;IL1RAP;JCHAIN;MAGI1;MNAT1;SLC7A9;GPAA1;FANCC;PPIH;TUBGCP4;KMT2A;HES5;KNTC1;NUP205;LPXN;NUP35;SNX9;LAMC1;LLGL1;DLG4;YAP1;TUBGCP2;TRAF2;GEMIN5
prerank,homologous chromosome segregation (GO:0045143),0.32131789941854616,0.9042343876932321,0.5584415584415584,0.8724118824083722,1.0,3/20,10.92%,MEIKIN;PRDM9;FMN2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.34196595845668215,-0.9040882414466058,0.6206293706293706,0.8195505715965471,1.0,3/16,4.12%,NOTCH1;BMPR2;TGFB2
prerank,bile acid biosynthetic process (GO:0006699),0.3141885522118449,0.9039718928317588,0.5490605427974948,0.8721790172647147,1.0,5/24,12.39%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP
prerank,epiboly involved in wound healing (GO:0090505),-0.33535365129393013,-0.9037914131493163,0.5946428571428571,0.8197354431205838,1.0,9/16,40.93%,CD44;CD151;MRTFA;PDCD10;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,ATP transport (GO:0015867),0.39017433971419535,0.9036006052413224,0.5600858369098712,0.8722100123788394,1.0,3/10,15.51%,SLC25A42;SLC25A24;CD47
prerank,mRNA destabilization (GO:0061157),0.28872032330869213,0.903366904386029,0.5906040268456376,0.8718745158024442,1.0,9/38,15.76%,TUT4;ROCK2;CPEB3;FTO;RIDA;KHSRP;METTL16;RBM24;METTL3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.30314469928178106,0.9025876983228157,0.5947136563876652,0.8728540919117506,1.0,5/27,8.31%,ABCA1;PPARA;PLA2G5;ABCA5;IL18
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2668505406159589,-0.902578973740098,0.6340508806262231,0.8219045404350476,1.0,12/41,18.30%,MGLL;EPHX1;CYP1B1;GPX1;ELOVL5;GSTM2;PTGS1;FAAH;GPX4;ACOT8;ELOVL1;DAGLB
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.31432320194851454,-0.902506885920484,0.600739371534196,0.8215720743796787,1.0,6/22,22.08%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22
prerank,histone deacetylation (GO:0016575),0.26840044584914613,0.9018699031593765,0.6066252587991718,0.8737032931369969,1.0,8/43,9.64%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1;BRMS1L;HDAC8
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.27175601756018936,0.901593112517641,0.6175869120654397,0.8734686684763874,1.0,11/46,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G12A
prerank,positive regulation of neuron death (GO:1901216),-0.2637484449240478,-0.9015445318021791,0.615819209039548,0.8231656763676191,1.0,11/46,17.03%,MAP3K5;FOXO3;REST;TGFB2;BACE1;ATF4;BAX;NF1;TLR4;C1QA;DDIT4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.36223384602856756,-0.9014325927167112,0.5933682373472949,0.8229271360170798,1.0,3/13,4.55%,STX3;HSP90AB1;RIC3
prerank,mRNA splice site selection (GO:0006376),0.2994153785280226,0.9010338866013252,0.588477366255144,0.8739734706739498,1.0,4/30,9.28%,CELF2;SRSF12;CELF4;SLU7
prerank,protein-DNA complex assembly (GO:0065004),0.22690379769939764,0.9009846523708241,0.6938775510204082,0.8732267584175596,1.0,26/116,19.03%,TCF4;DMC1;MCM3;ORC4;DDB2;GTF2H2;MNAT1;PSMA3;PSMF1;RPA2;MCM2;CCNH;MCM8;PSME3;ORC1;DAXX;SPTY2D1;RPA1;PSMD1;PSMB9;SART3;ORC3;PARP1;PSMD13;NAP1L2;ORC5
prerank,synaptic vesicle exocytosis (GO:0016079),0.27625187814729923,0.9009167673222861,0.6,0.8725320350202899,1.0,9/40,13.07%,RIMS1;UNC13C;SYT1;CPLX2;SNAP25;OTOF;STX1B;SNAPIN;SNAP47
prerank,primary neural tube formation (GO:0014020),0.29423802059949694,0.9008058674028391,0.562363238512035,0.8719176427915741,1.0,8/30,12.31%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,proteasomal protein catabolic process (GO:0010498),-0.20631280648565628,-0.899803230841311,0.7658227848101266,0.8259764683852131,1.0,56/201,24.41%,WWP1;NEDD4L;SEL1L;RNF41;ZNRF1;WWP2;RHBDD1;PSMA6;CUL4A;DNAJB12;PSMB5;NHLRC3;KCTD5;PLAA;RNF185;UCHL1;VCP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;UBXN1;PSMD14;FBXW5;ITCH;RNF5;SMURF1;RBX1;UBE2G1;PSMD8;PSMD11;KCTD10;PSMB4;PSMD12;PSMC1;PELI1;ZSWIM8;TBL1X;ERLEC1;KCTD2;UBE2B;PSMA1;ZFAND2B;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;PCNP;FBXL19;PSMA2;BRSK2;RAD23A;RNF187;COP1
prerank,positive regulation of viral life cycle (GO:1903902),-0.305846300121363,-0.8996625335008316,0.6243093922651933,0.8257909562609905,1.0,9/22,27.98%,CHMP2B;CD74;FMR1;TSG101;LGALS1;CHMP2A;LGALS9;VPS4A;P4HB
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2612707043145382,-0.8991856810349901,0.634862385321101,0.8263711061741982,1.0,16/46,28.18%,HK1;AKT1;HSPD1;TIMM17A;TIMM21;TOMM22;CHCHD4;BCAP31;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,lipid biosynthetic process (GO:0008610),0.24209871576369837,0.8987330460369186,0.6533066132264529,0.8757802875793784,1.0,15/77,17.27%,PAM;ACSM5;ACSL1;SCD5;NDUFAB1;PRLR;GNPAT;MCAT;ACSL6;ACACA;FADS1;SCD;OLAH;ACSS2;CYP51A1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3062784996642515,0.8986723434778655,0.6022471910112359,0.8750599167609224,1.0,4/26,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,cellular amide metabolic process (GO:0043603),0.23310186365443805,0.8984967565238996,0.6481481481481481,0.8746112668519508,1.0,22/102,16.99%,PCCA;ACSM5;CPZ;AEBP1;BAAT;CPXM1;DNPEP;PLPP3;ACOT11;PDZD11;ALDH1L1;NSMAF;FPGS;SLC46A1;THOP1;MTHFD1;PLAAT5;ACSL6;MTHFD1L;ST3GAL1;ACBD6;MCCC2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33916778910255996,0.8984600558614894,0.5862068965517241,0.873855324236288,1.0,3/16,7.62%,DAZAP1;TRA2A;CELF4
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.33310157900092213,-0.8979187813753958,0.6228893058161351,0.8286269790414815,1.0,4/17,7.32%,KCNB1;RAB27A;STX1A;SLC4A8
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38644341103515306,0.8978977934563774,0.5637149028077754,0.8743574380501177,1.0,2/10,11.78%,SEMA5A;ACTN2
prerank,epidermis development (GO:0008544),0.2551592915670756,0.8978634263842766,0.6425619834710744,0.8735991661114161,1.0,3/56,3.83%,SVEP1;FGFR2;ATP2A2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2934601730858318,0.8976157279245564,0.587737843551797,0.8733372324986466,1.0,6/33,11.17%,ALDH4A1;ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.35416832678151716,0.8975899206006642,0.5672268907563025,0.8725418403850747,1.0,3/14,14.05%,ANK2;ACTN2;ATP1B3
prerank,regulation of catabolic process (GO:0009894),-0.330749197338071,-0.8975592594863994,0.6103896103896104,0.828924154999116,1.0,2/18,2.94%,NEDD4L;FAP
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3126363014668782,0.8974384458605144,0.5831663326653307,0.8720796820265317,1.0,6/24,9.12%,SEMA5A;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,nuclear membrane disassembly (GO:0051081),0.34908111125871555,0.8973405381047386,0.584070796460177,0.8714539440028224,1.0,3/14,9.15%,PRKCA;AKAP8L;PRKCB
prerank,cilium movement (GO:0003341),-0.2597954735272625,-0.8970284608225964,0.6551724137931034,0.8296040441816761,1.0,28/48,44.25%,SPEF1;ODAD1;GAS8;DNAH5;CABYR;CFAP251;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;ZBBX;SPA17;DNAH17;CFAP70;CFAP206;DNAAF4;CCDC63;CFAP91;TEKT5;CFAP54;DNAH1;RSPH6A;DNHD1;DNAAF1;DNAI3;RSPH4A
prerank,tube closure (GO:0060606),0.28935439375033656,0.8964714330544141,0.5865800865800865,0.8725402380450372,1.0,8/31,12.31%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3323789572816699,0.8963515234716929,0.5934291581108829,0.871982054377971,1.0,2/16,5.08%,LRP1;IL4
prerank,positive regulation of ATPase activity (GO:0032781),-0.26764764452620715,-0.8960651591556317,0.6305970149253731,0.8312240390656317,1.0,12/41,22.06%,ATP1B1;DHX9;PFN1;VMP1;TOR1AIP1;DNAJC9;CHTOP;TOR1AIP2;DYNLL2;FGF10;ATP1B2;DNAJB1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3511536001006483,-0.8960090163997948,0.5928571428571429,0.8308583888144054,1.0,5/13,20.48%,ATG7;SAE1;UBA2;UBA5;UBA1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.34604502257510583,-0.8957237722969826,0.5929203539823009,0.8310102836360144,1.0,3/15,11.72%,DCTN2;CEP192;PCM1
prerank,negative regulation of blood coagulation (GO:0030195),-0.2739574459776126,-0.8954545984343183,0.6321626617375231,0.8311243804895395,1.0,6/38,8.93%,NOS3;CD34;F3;THBD;EDN1;PDGFA
prerank,transition metal ion transport (GO:0000041),0.2841642714434041,0.895439057714918,0.5987124463519313,0.8731710518638602,1.0,4/35,6.74%,CP;HEPH;SLC30A10;SLC31A2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.35800342052980727,-0.895202964024117,0.6190476190476191,0.8312119590644885,1.0,3/13,6.47%,OPHN1;MSN;EZR
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.25339885882972824,-0.8951383138304763,0.6407766990291263,0.8308860537852504,1.0,14/54,16.48%,GPC3;AGRN;HS3ST3A1;HEXA;NDST1;HS3ST1;IDUA;HAS1;SDC3;SGSH;HS3ST3B1;SLC35D2;GUSB;XYLT2
prerank,regulation of mRNA stability (GO:0043488),-0.21282414174417572,-0.8949800582555768,0.7068273092369478,0.8307865337201708,1.0,46/145,24.02%,VIM;UBB;HSPA8;UBC;RPS27A;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;FUS;PCBP4;PSMC4;PSMC5;YTHDF2;CIRBP;PSMD14;YWHAZ;E2F1;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;FASTKD3;HSPA1A;EXOSC8;GIGYF2;TENT5D;PUM2;SERBP1;PSMA1;YTHDF1;TBRG4;MEX3D;PSMB1;PSMC3;PAIP1;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB
prerank,positive regulation of nervous system process (GO:0031646),-0.3253374316456893,-0.8948877296502064,0.6119402985074627,0.8305251249201681,1.0,3/18,7.20%,PARD3;UNC13B;TNFRSF1B
prerank,mRNA 3'-end processing (GO:0031124),-0.2315210769833534,-0.8942600386955891,0.6535433070866141,0.8314026510142716,1.0,24/78,26.91%,RPRD1B;APP;SRSF2;SRSF5;SRSF6;U2AF1;LSM11;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;PAPOLG;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;PABPC1;THOC7;RPRD1A
prerank,negative regulation of cell cycle (GO:0045786),0.240679265677753,0.8940967451521658,0.6577319587628866,0.8754138812896807,1.0,11/73,10.48%,BMP2;NR2F2;SMAD3;BRINP1;BRINP3;MEN1;NLRP2B;GATA3;CHMP1A;PTEN;HPGD
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.34117240728103604,-0.8940633693554915,0.6096654275092936,0.8313161620234635,1.0,4/16,7.53%,ST6GALNAC3;ST8SIA4;ST8SIA6;A4GALT
prerank,determination of left/right symmetry (GO:0007368),-0.2765567708638144,-0.893475080670117,0.6390977443609023,0.8321560735696817,1.0,10/37,24.80%,NOTCH1;TBX1;SMO;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,protein deacetylation (GO:0006476),0.27354657644388725,0.893155615952326,0.6187624750499002,0.8766967694018138,1.0,7/41,9.09%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1;BRMS1L
prerank,regulation of chromosome segregation (GO:0051983),-0.33305943612028377,-0.8929725585636166,0.5912408759124088,0.8327368072225367,1.0,11/16,42.40%,RAD18;CSNK2A1;CSNK2A2;PUM2;MKI67;CDC6;BUB1;KIF2C;IHO1;AURKB;RMI2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.28445528257988395,-0.8927831367001815,0.6226053639846744,0.8326536441219572,1.0,20/29,45.89%,CYRIB;PVR;LAMP1;NECTIN2;SPI1;RASGRP1;AP1G1;NOS2;TYROBP;CADM1;SLAMF6;CD226;IL12A;CRTAM;IL12RB1;IL23A;KLRD1;CD160;KLRK1;IL23R
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2530941035301488,0.8926850481816079,0.6477732793522267,0.8769335139784359,1.0,9/60,11.38%,TCF7L2;CDK8;CEBPB;AGO4;TNRC6A;PPM1D;PAXIP1;PTEN;TNRC6B
prerank,histone methylation (GO:0016571),0.30323962972372726,0.8922274660491929,0.6244343891402715,0.8771025339876689,1.0,6/26,14.58%,NSD1;SMYD1;SMYD3;EHMT2;NSD3;EZH2
prerank,bile acid metabolic process (GO:0008206),0.3005467154586422,0.8921731344727344,0.5822784810126582,0.876403175101342,1.0,6/27,13.33%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP;GBA2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.22731239583764076,-0.8919612604383166,0.6765873015873016,0.8339796335825732,1.0,28/85,23.09%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.36995224879780764,-0.8919174831734978,0.5951940850277264,0.833601349409414,1.0,5/11,25.89%,MSN;EZR;VPS11;RDX;MTMR2
prerank,regulation of cellular metabolic process (GO:0031323),0.2720420912403523,0.8917486710322746,0.6118143459915611,0.8765332150618848,1.0,5/45,5.80%,PID1;PPARA;PDK4;PRKN;PDK3
prerank,negative regulation of ion transport (GO:0043271),-0.3054257011542069,-0.891372532267456,0.6477064220183486,0.8343044865793928,1.0,13/24,39.24%,PTK2B;WNK1;CASQ2;PACSIN3;LILRB1;NOS1;CD33;WNK4;HRH3;ADRA2A;VIP;GPM6B;INPP5K
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23838413219507382,-0.891126360574253,0.6626984126984127,0.8343844115748072,1.0,8/75,8.48%,PLCE1;RGS3;RGS5;MGLL;CALM1;GIT2;EDN1;RGS6
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24955194332438013,-0.8908182829910323,0.6392156862745098,0.834565738797773,1.0,13/55,19.26%,THBS1;TGFBR2;RNF41;RAC1;CYP1B1;RIPK1;ACE2;SPHK2;CDKN1A;COQ7;CBR1;SLC25A33;GADD45A
prerank,regulation of vasoconstriction (GO:0019229),-0.2916542685968099,-0.890753904507329,0.6161048689138576,0.8342272479064109,1.0,5/27,16.26%,CAV1;BMPR2;ACE2;ACE;ATP2B1
prerank,response to muscle stretch (GO:0035994),0.34813714327448086,0.8906654005501249,0.5878661087866108,0.8781857716883185,1.0,2/15,3.68%,SLC8A1;CSRP3
prerank,embryonic limb morphogenesis (GO:0030326),0.2822540852371193,0.890643643747402,0.6346555323590815,0.8773908582406587,1.0,4/34,7.77%,SALL1;TBX3;GLI3;RARG
prerank,error-free translesion synthesis (GO:0070987),-0.30830367947633325,-0.8900365498547275,0.6142857142857143,0.8352868475832571,1.0,6/22,15.51%,UBB;UBC;RPS27A;VCP;SPRTN;RPA3
prerank,negative regulation of protein depolymerization (GO:1901880),0.3031377584443562,0.8899074411883365,0.618510158013544,0.878214548787948,1.0,4/24,13.49%,PLEKHH2;ATXN7;CAMSAP1;NAV3
prerank,acute-phase response (GO:0006953),0.36056294929283084,0.8895170119015889,0.5812917594654788,0.8782619392293617,1.0,3/12,11.19%,AHSG;CEBPB;IL6R
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3011336073001507,0.8891478349213838,0.6140724946695096,0.8782877616261155,1.0,10/26,23.41%,PRDM9;KMT2A;KMT5C;SETD5;WDR82;KMT5B;VCPKMT;SETD4;SUV39H2;CTR9
prerank,regulation of T cell proliferation (GO:0042129),-0.24542256131852058,-0.8891293920872079,0.6780952380952381,0.8367459465062322,1.0,6/61,7.20%,IL15;SLC7A1;TFRC;ANXA1;TNFRSF21;TNFRSF1B
prerank,cellular response to osmotic stress (GO:0071470),-0.3164092149207152,-0.8887491446556045,0.6398537477148081,0.8370581400695088,1.0,10/21,33.54%,LRRC8D;YBX3;TRPV4;CAB39;ARHGEF2;PKD2;CAPN3;LRRC8E;AQP1;SLC4A11
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.32073299676668354,0.8885026363157,0.6025369978858351,0.8789532687525972,1.0,6/19,16.90%,CHRNB4;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;ACHE
prerank,positive regulation of isotype switching (GO:0045830),0.34455717698460725,0.8879515319413116,0.6071428571428571,0.8793856746498048,1.0,6/15,15.91%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B
prerank,protein transport (GO:0015031),0.19876200165287425,0.8878047730905672,0.7777777777777778,0.878891608615387,1.0,74/332,18.12%,WLS;VAMP5;STEAP3;ATP6V0A4;TBC1D4;TANGO2;RABGAP1L;TXNIP;LRP1;ABCA1;ARCN1;LRP1B;SNX33;RAB3C;SCFD1;MON1A;VPS26B;SYNDIG1;RAB5B;RAB29;SCG2;TBC1D2B;STX1B;RAB10;PRKCB;TMED10;SLU7;CHMP1A;ATP6V1H;STX7;LTBP2;BBS2;SEC31A;SNX9;TBC1D10C;EIF2D;KIF3A;HSP90B1;NGFR;DNAJC27;OPTN;STXBP3;TBC1D8B;STX12;SCAMP2;SYS1;SCAMP5;RPGR;RUNDC1;RAB38;SAR1B;ATP6V1B2;SCFD2;COPG2;TBC1D10A;ARRDC2;RAB20;ARL1;SCG5;TMED9;AFM;LRSAM1;SVBP;SNX8;TBC1D9;RAB19;RABL3;SGSM3;TRIM23;COPZ1;EVI5;MIA3;VLDLR;SNX6
prerank,regulation of neurotransmitter transport (GO:0051588),0.33735705202338523,0.8876504761484953,0.5960698689956332,0.8783937290784252,1.0,4/16,10.24%,RIMS1;CHRNB4;CPLX2;MCTP2
prerank,superoxide metabolic process (GO:0006801),-0.286547036183961,-0.8874112694255012,0.6155339805825243,0.8394992009942736,1.0,5/29,12.83%,SH3PXD2A;NOS3;NCF2;PREX1;NRROS
prerank,regulation of mRNA processing (GO:0050684),-0.2789206909333338,-0.8867225277785791,0.6452830188679245,0.8405011949658726,1.0,8/32,20.74%,QKI;SAFB;SRPK1;DHX9;JMJD6;HNRNPK;PTCD2;CPSF4
prerank,keratan sulfate metabolic process (GO:0042339),0.29155095901288225,0.8864725514456646,0.5886075949367089,0.8802187831003955,1.0,13/31,19.34%,FMOD;B3GNT7;OMD;GNS;LUM;GALNS;OGN;CHST1;GLB1;ST3GAL1;B4GAT1;CHST2;B4GALT6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.26600803164447573,-0.8864672147186021,0.6635160680529301,0.8405583265856686,1.0,18/37,30.24%,PARD3;SMAD7;CALM1;TGFB1;APP;CALM3;CAB39;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2;RPTOR;TNKS1BP1;IRGM;SPRED1;PLK1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3090005923507892,-0.8864039298889285,0.6313868613138686,0.840226906128284,1.0,6/23,10.91%,MINDY2;MINDY1;OTUD5;USP8;OTUB1;USP5
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2510658753556716,0.8856423000016423,0.6624472573839663,0.8812478619943551,1.0,8/63,8.56%,NELL1;TIMP3;LEPR;BCL2;DAP;SIRT2;TIMP4;GOLGA2
prerank,fatty acid catabolic process (GO:0009062),-0.2394130615989573,-0.8855940416264674,0.6941391941391941,0.841504303223238,1.0,15/67,18.04%,ABHD2;PPARD;ACAD11;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;FAAH;ECI1;ACOT8;MECR;HSD17B10
prerank,protein localization to chromosome (GO:0034502),-0.27599674788506084,-0.885451057176233,0.6353383458646616,0.8413237742220557,1.0,13/34,30.24%,ESR1;TPP1;RB1;SLF1;WAPL;BOD1;RAD21;CENPA;MRNIP;SLF2;CHMP7;TERF2IP;PLK1
prerank,lipoprotein biosynthetic process (GO:0042158),0.3697328192617767,0.8849719212537481,0.5891647855530474,0.881907556118459,1.0,4/11,15.78%,WDR45B;WIPI1;ATG10;PORCN
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.36126796427369845,-0.8846240250706727,0.6320582877959927,0.8426485580486656,1.0,6/12,29.22%,PLCG2;RAB27A;TLR4;GRIN1;CD36;TLR6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2998237359183887,-0.8843337517375373,0.6227897838899804,0.8427452847158553,1.0,9/25,21.17%,NOTCH1;BMPR2;FOXD1;ZNF423;ENG;SMAD4;SMAD2;BMPR1B;CDH5
prerank,vesicle transport along microtubule (GO:0047496),-0.29927995124628476,-0.8841943809991658,0.6079854809437386,0.8425799596705863,1.0,8/23,22.36%,TRAK1;HTT;TRAK2;NDE1;NDEL1;RAB1A;KIF1C;KIF13A
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.35675562638526354,-0.8837773225486024,0.6133093525179856,0.8429916782806025,1.0,4/12,17.77%,PTK2B;DIAPH1;CASQ2;UBASH3B
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3773932267227461,-0.8837221994762348,0.6201834862385321,0.8426394178647143,1.0,4/10,22.03%,DBI;APOE;TMEM30A;TRIAP1
prerank,organonitrogen compound catabolic process (GO:1901565),0.2549475388551489,0.8834774620630351,0.6434599156118144,0.8843785131828141,1.0,10/57,10.88%,PLA2G5;PLA2G4A;IL4I1;CPQ;CLPX;ANPEP;ENPEP;RIDA;NAALADL1;TRHDE
prerank,cell-cell junction maintenance (GO:0045217),0.37271952662683705,0.8830856905769553,0.6039823008849557,0.8843927968716175,1.0,2/11,6.25%,PRTN3;NLGN2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.2666224161948484,-0.8830776183245502,0.6758349705304518,0.8435515731787024,1.0,10/40,16.40%,B2M;ANXA2;VEGFA;INSR;HIP1;SGIP1;FMR1;WASL;HNRNPK;GREM1
prerank,negative regulation of response to external stimulus (GO:0032102),0.22733113865235616,0.8829703250834472,0.708502024291498,0.8838231991018036,1.0,14/105,10.34%,RORA;GRID2;PPARA;PTGIS;CTNNA2;IL4;SERPINE1;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6;PTEN
prerank,detection of calcium ion (GO:0005513),-0.3537973278456242,-0.8829503800145589,0.6123595505617978,0.8433401218423934,1.0,4/13,21.60%,CALM1;CALM3;CASQ2;KCNIP2
prerank,gluconeogenesis (GO:0006094),-0.26592584285988735,-0.882855187370315,0.6788461538461539,0.8430627979462214,1.0,8/39,16.12%,GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.31964656898095267,-0.8827472249738205,0.6408839779005525,0.8428265970025404,1.0,3/18,4.11%,CCN3;KCNB1;REST
prerank,replication fork processing (GO:0031297),0.27835623261011827,0.8826537342292681,0.6469194312796208,0.8837529654503786,1.0,15/38,22.71%,ZGRF1;GEN1;SETMAR;BLM;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;RTEL1;PCNA;ZRANB3;FBH1;RFWD3
prerank,regulation of actin filament-based process (GO:0032970),0.24121351659930526,0.8824585401822634,0.6833667334669339,0.8833557062715228,1.0,16/70,15.55%,LRP1;ARHGEF19;EPHA3;ROCK2;RHOH;RHOBTB1;DLC1;PDGFRB;RHOBTB3;EPHA5;GRHL3;RHOF;FZD10;RND1;PAK1;RHOQ
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.307641137283294,-0.8824395236275819,0.6454033771106942,0.8425426384713508,1.0,9/22,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.307641137283294,-0.8824395236275819,0.6454033771106942,0.8425426384713508,1.0,9/22,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3177540069332348,0.8823108607116853,0.6157024793388429,0.8828649138760026,1.0,2/21,3.32%,ANK2;CACNA2D1
prerank,dendritic spine organization (GO:0097061),-0.29266171565854954,-0.8820273086113584,0.649155722326454,0.8429421775165329,1.0,2/26,0.55%,SHANK3;IGF1R
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.20720219219812366,-0.8818481640805294,0.760914760914761,0.84285781589372,1.0,58/173,27.34%,SPTBN1;CD55;DCTN2;VAMP7;ZW10;KDELR1;CTSZ;DYNC1LI2;NAPA;NRBP1;CTSC;ATL3;TRIP11;SPTAN1;ATL2;ERGIC1;GOSR1;DCTN3;COPG1;TRAPPC11;DCTN1;TMEM115;COPB2;COG8;PEF1;BCAP31;RAB1A;MCFD2;COG3;LMAN2;DYNC1LI1;COG5;TRAPPC5;F5;VTI1B;NSF;TMED1;DYNLL2;TMED5;SEC24B;COG2;TRAPPC2L;TRAPPC2;USE1;TEX261;STX5;YIF1A;LMAN2L;COPZ2;HYOU1;CNIH2;SEC13;PDCD6;TMED3;DCTN4;GOLGB1;F8;SEC16B
prerank,icosanoid metabolic process (GO:0006690),-0.2621715454542187,-0.8815330681801382,0.651252408477842,0.8430416232938467,1.0,12/40,20.24%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;PON3;GGT5;PTGS1;FAAH;GPX4;DAGLB;GGT1
prerank,triglyceride catabolic process (GO:0019433),-0.3224009234961125,-0.8810531481419651,0.6466165413533834,0.8435874051981329,1.0,2/19,10.36%,PNPLA2;FABP5
prerank,chromosome organization (GO:0051276),-0.22472690261245912,-0.8810270746661735,0.7394636015325671,0.8431692361285554,1.0,42/99,30.77%,ZBTB7A;UBB;UBC;RPS27A;SAFB;CUL4A;HHEX;H3-3A;COPS6;HMGN1;GATAD1;COPS5;CDAN1;SMARCA4;NUP155;RBX1;CETN2;LDB1;TOP2A;HMGN2;PWWP3A;L3MBTL1;COPS7A;NDC80;POLE3;COPS4;COPS7B;EZH1;CDCA8;PHF19;HDAC5;FAM50A;XPC;GPS1;LIG4;CENPV;RAD23B;TOP2B;HMGB2;HDAC3;MYC;NUF2
prerank,DNA recombination (GO:0006310),0.278627190890462,0.8808684594782721,0.6358024691358025,0.8853170564514328,1.0,7/37,14.56%,DMC1;HDAC10;GEN1;BLM;RAD51C;RAD51B;RPA1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.355034392371644,0.8807804192648474,0.6059322033898306,0.8846724187854627,1.0,2/13,5.13%,GLI2;CAMK4
prerank,proteasome assembly (GO:0043248),-0.3672920261698026,-0.8806514388113811,0.6240458015267175,0.8434995906940739,1.0,3/11,24.04%,POMP;PSMD11;PSMG2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.33338830248287077,-0.8804372275117458,0.6162361623616236,0.8434654250094004,1.0,7/15,25.39%,APP;PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.31508221639134104,0.8802309339892331,0.625,0.8851109756272283,1.0,2/19,2.64%,PTGFR;PRKACA
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3771692375767425,0.8801706611175737,0.6081081081081081,0.8844239113057991,1.0,5/10,23.00%,CPEB3;CPEB1;PAF1;HSF1;NUDT21
prerank,negative regulation of cell cycle process (GO:0010948),0.2470108765481638,0.8800479491480786,0.6968421052631579,0.8838734250477978,1.0,18/61,20.86%,AURKAIP1;UXT;TFDP1;L3MBTL2;RNF2;APAF1;TOM1L2;PCGF6;EHMT2;TOM1L1;PPP1R10;EZH2;FBXO5;ZFYVE19;YAF2;CDC7;MGA;PCGF2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.36853903935720306,-0.8795548268392487,0.6407766990291263,0.8443834956546941,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.36853903935720306,-0.8795548268392487,0.6407766990291263,0.8443834956546941,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2315626320802684,0.8794494992851687,0.6885593220338984,0.8843841547761233,1.0,16/88,13.17%,SH3D19;DNAJC6;SORCS1;AP4B1;MYO5A;SCFD1;ACBD3;GBF1;ARFGEF2;TXNDC5;RAB10;CCDC93;SCAMP2;VPS35L;SYS1;LLGL1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.36126953555494584,0.8793863900978638,0.6328828828828829,0.8837043890696621,1.0,5/12,20.74%,NINL;BICD1;KIF3A;BBS4;CCDC68
prerank,negative regulation of axon extension (GO:0030517),-0.28101253839774337,-0.879209942799842,0.6492537313432836,0.844615272520115,1.0,5/30,9.74%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G
prerank,respiratory electron transport chain (GO:0022904),-0.3438253676409829,-0.8791809958543538,0.6392523364485981,0.8442152951876427,1.0,7/14,26.94%,PPARGC1A;SLC25A12;ETFB;ETFDH;SDHB;SLC25A22;ETFRF1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29368739501816554,-0.8791366030143944,0.6375227686703097,0.8438434018041667,1.0,10/24,29.92%,UBB;UBC;RPS27A;XRCC1;RPA3;POLK;RFC3;RFC2;LIG4;POLB
prerank,multivesicular body assembly (GO:0036258),-0.2840884536254041,-0.8787061634035918,0.6517509727626459,0.8442530231624291,1.0,14/30,32.17%,RAB11A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,maturation of 5.8S rRNA (GO:0000460),0.3331230177192035,0.8785821910536062,0.6177105831533477,0.8846478913182492,1.0,2/17,1.51%,MPHOSPH6;C1D
prerank,positive regulation of protein acetylation (GO:1901985),-0.36273419195146,-0.8784993512404405,0.6493055555555556,0.8442339779894138,1.0,3/12,16.94%,DIP2B;CAMK1;RAPGEF3
prerank,carboxylic acid metabolic process (GO:0019752),-0.2751800904163126,-0.8784857309189271,0.6439393939393939,0.8437876259533409,1.0,5/33,10.82%,SLC2A1;CSGALNACT1;ST6GAL1;PON3;CARNMT1
prerank,dendritic spine morphogenesis (GO:0060997),0.3361153996740691,0.8781238721409064,0.5957446808510638,0.8848448314353332,1.0,5/15,13.18%,DOCK10;CTNND2;EPHB1;PTEN;DLG4
prerank,negative regulation of lipid storage (GO:0010888),0.3206126793339479,0.8780892925809236,0.6192560175054704,0.8841159499804533,1.0,3/19,3.11%,ABCA1;PPARA;OSBPL8
prerank,polyamine metabolic process (GO:0006595),-0.34434371827960963,-0.8779885739026546,0.6264367816091954,0.8443575529060752,1.0,6/13,23.30%,AMD1;OAZ2;PAOX;SMS;SRM;DHPS
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.33652913512561883,-0.8774770911543253,0.6441947565543071,0.8448947982283737,1.0,9/15,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;CCT4;CCT6A;NOP10
prerank,glycerol metabolic process (GO:0006071),0.36921082975818514,0.8774654941068966,0.5685393258426966,0.8846987178230499,1.0,7/10,29.58%,GOT1;COQ3;GK;PDXP;ANGPTL3;COQ2;TKFC
prerank,regulation of urine volume (GO:0035809),-0.3718280404006241,-0.8774534846334083,0.6290322580645161,0.8444699627586981,1.0,6/10,39.24%,NPR1;NPR3;HAS2;HYAL2;TFAP2B;INPP5K
prerank,glucose metabolic process (GO:0006006),-0.24121769816053276,-0.8767080333019875,0.706766917293233,0.8455494398514919,1.0,11/58,16.93%,LRP5;PPARD;GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1;GALM
prerank,limb morphogenesis (GO:0035108),0.31476970581739017,0.876568236500332,0.6247191011235955,0.885925994875115,1.0,2/20,3.86%,TBX3;GLI3
prerank,body fluid secretion (GO:0007589),0.3409813490104598,0.8762209338919847,0.6090712742980562,0.8858819482720262,1.0,5/15,18.68%,SLC22A4;ERBB4;PRLR;GUCA1B;SLC22A2
prerank,ganglioside biosynthetic process (GO:0001574),-0.33869005682876685,-0.8760771345627867,0.6340508806262231,0.8463634578182437,1.0,3/15,6.49%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.21751855942640755,0.875969075144957,0.7206477732793523,0.8855797608512502,1.0,15/138,8.76%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;RARG;RBPJ;POLR2G
prerank,smooth muscle contraction (GO:0006939),0.3414950527383208,0.8752678672759769,0.6131868131868132,0.8863387308301429,1.0,3/14,6.27%,SLC8A1;ROCK2;MYLK
prerank,calcium ion transport into cytosol (GO:0060402),0.3077411138675256,0.8750640304953358,0.6200417536534447,0.8859592805535026,1.0,7/21,17.48%,SLC8A1;CACNA2D1;TRPM1;GRIN2A;JPH1;ADRA1A;GRIN2B
prerank,positive regulation of cellular respiration (GO:1901857),-0.36561783945510085,-0.8748722875380247,0.6331569664902998,0.848397998537167,1.0,5/11,26.99%,IFNAR1;VCP;IL10RB;PARK7;IFNLR1
prerank,DNA replication (GO:0006260),0.2235419655626167,0.8745202475238661,0.7242798353909465,0.8863398986734322,1.0,29/105,21.08%,RBMS1;MCM3;ORC4;TOP1;TOP3A;TOP1MT;BLM;RPA2;RFC5;MCM2;MCM9;MCM8;ORC1;NBN;ATM;RPA1;KAT5;BRIP1;ORC3;POLD4;WRNIP1;ORC5;POLD1;DONSON;SET;CDC7;DUT;RFC1;NT5M
prerank,modulation by host of symbiont process (GO:0051851),-0.2747813693065369,-0.8744968833319774,0.6712871287128713,0.8486937441405186,1.0,14/31,36.84%,LEF1;REST;SMARCA4;CX3CR1;SP1;NAPEPLD;CHD1;POU2F3;AQP1;CCL5;JUN;SAP30;HPN;CCL4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3550069077552704,-0.8741190809118313,0.6654804270462633,0.8490089631516867,1.0,5/12,39.15%,TMEM165;VPS33A;CCDC115;GRN;TMEM199
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.29940026672457787,-0.8740965120340668,0.6263736263736264,0.8485819813017423,1.0,2/23,0.97%,SLC12A7;SLC12A2
prerank,keratinocyte differentiation (GO:0030216),-0.284879037586432,-0.8739379925068905,0.6608527131782945,0.8484343107168891,1.0,10/29,27.46%,CLIC4;ANXA1;BCR;OPN3;EPHA2;DSP;EVPL;SCEL;CERS3;PIP5K1A
prerank,regulation of primary metabolic process (GO:0080090),-0.2130873679074051,-0.8734570045151535,0.7610993657505285,0.8489972208623704,1.0,43/126,28.05%,PPARD;NCOR1;TNFAIP8L3;NFYA;PLPP1;ADIPOR1;PSAP;PSMA6;PSMB5;LACTB;PSMC4;PSMC5;PSMD14;OAZ2;APOE;PSMD8;TM7SF2;PSMD11;SC5D;PSMB4;PSMD12;PSMC1;NQO1;SP1;TBL1X;TGS1;EDF1;HELZ2;PSMA1;RUBCNL;OPA3;PSMB1;PSMC3;FDPS;PSMA4;PSMA2;SREBF1;PSMB8;LSS;SIN3B;IDI1;NFYB;CERS2
prerank,DNA conformation change (GO:0071103),0.32868552225492037,0.8726843390745188,0.6150442477876106,0.8895404418079473,1.0,3/17,8.01%,TOP1;TOP3A;TOP1MT
prerank,neurotrophin signaling pathway (GO:0038179),-0.3079819833782353,-0.8725174817384044,0.638095238095238,0.8504033757190873,1.0,3/21,3.71%,RAP1A;RAPGEF1;NGF
prerank,microglial cell activation (GO:0001774),-0.29545877148450644,-0.8724604636380385,0.6504672897196262,0.8500377206257984,1.0,14/21,46.27%,APP;JAK2;CX3CR1;C1QA;IFNGR1;AIF1;TREM2;TYROBP;GRN;ITGB2;C5AR1;TNF;CX3CL1;CLU
prerank,polyol biosynthetic process (GO:0046173),-0.3355311640369715,-0.8723414275565851,0.6631578947368421,0.8498189018392841,1.0,6/16,14.12%,ITPKB;IPMK;ISYNA1;FGF2;ACER3;IP6K1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2812506709514543,0.8716122887116765,0.6450304259634888,0.8910709437678158,1.0,3/33,3.55%,AREG;DGKD;TGFA
prerank,regulation of axon extension (GO:0030516),-0.2717022021635795,-0.8713405444927236,0.68359375,0.8513717975093681,1.0,22/37,37.62%,SEMA7A;SHTN1;DIP2B;SEMA3G;DBNL;DBN1;APOE;NTN1;LIMK1;CTTN;DNM2;RTN4R;ZFYVE27;CDKL5;ISLR2;PTPRS;ABL1;MAP3K13;MAG;RNF6;L1CAM;TWF2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.30339810119225186,-0.8709746774505428,0.6380597014925373,0.8516771434527219,1.0,10/24,28.12%,MPHOSPH8;AEBP2;H3-3A;EPC1;BMI1;TASOR;RBBP4;CREBZF;PHF19;SPI1
prerank,regulation of axon regeneration (GO:0048679),0.348746655662245,0.8707367794893682,0.6244444444444445,0.8921814263280857,1.0,1/12,0.72%,PTN
prerank,cellular response to superoxide (GO:0071451),-0.3755287394213937,-0.8705699188721969,0.630188679245283,0.8520152028639725,1.0,1/10,1.10%,NOS3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3236424849558351,-0.8705102100915381,0.6429942418426103,0.8516706306521479,1.0,1/17,0.23%,ANO6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.35500048885374325,-0.8703213922852586,0.6344463971880492,0.8515861126479761,1.0,5/12,36.09%,TLR4;NOD2;SOX9;MUC13;MUC6
prerank,regulation of chemotaxis (GO:0050920),0.2929927610858533,0.8701965796922388,0.6516393442622951,0.8925440876508102,1.0,6/30,8.13%,MYCBP2;PDGFRA;P2RX4;PDGFRB;ZSWIM5;ADGRA2
prerank,protein localization to organelle (GO:0033365),-0.2093338499511232,-0.8695345799948273,0.7786407766990291,0.8527390563252877,1.0,33/133,22.42%,RAB11A;GBP5;ZBTB7A;IFT20;RPL11;SIX1;APP;STX1A;DHX9;DNAJA1;HHEX;LAMP1;DDRGK1;TOLLIP;TULP2;ZNF423;TOR1AIP1;SEC61B;TUB;ARL6;CEP68;COG3;SGTA;TSPAN17;GCC2;TMEM30A;EHD1;PACSIN2;MSX1;RIPOR1;CNEP1R1;STX5;CD68
prerank,methylguanosine-cap decapping (GO:0110156),-0.3785015567847598,-0.8695022163821209,0.6497277676950998,0.8523267959682742,1.0,5/10,19.91%,DCPS;PNRC2;EDC4;DCP1B;LSM1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.34918763632027905,-0.869368983589971,0.6389891696750902,0.8521362033006065,1.0,5/13,20.44%,PRPF8;DDX20;USP4;LSM2;CD2BP2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2913786602991073,0.8692569454305445,0.6200873362445415,0.8938520460341124,1.0,27/27,70.91%,NYNRIN;RNASE4;PARN;RNASEH1;NHP2;DICER1;ZC3H12B;TOE1;XRN1;LACTB2;POP1;CPSF3;ZC3H12A;POP7;RNASE1;ZC3H12C;SLFN14;RNASE6;TRIR;KHNYN;NUDT16;RPP30;CSTF3;PDE12;PCF11;ZC3H12D;ERN1
prerank,heterocycle biosynthetic process (GO:0018130),0.3353589193848066,0.868027797840076,0.6223175965665236,0.8957643230995568,1.0,1/14,2.11%,MOCS2
prerank,proteolysis (GO:0006508),-0.19489406214072477,-0.8678759990736543,0.8822314049586777,0.8546920365513516,1.0,43/252,13.71%,DPP4;SRGN;F3;FAP;TPP1;CAPN2;BACE2;CTSZ;ADAM10;CTSO;BACE1;CASP7;ADAM19;CTSC;CASP8;PSMA6;ERAP1;IDE;SPCS1;PRCP;CAPN15;PSMB5;LACTB;MMP14;CTSD;PSENEN;CPE;CTSF;HTRA3;CAPN5;FAM111A;HTRA4;LRP8;PSMC4;GGT5;CTSB;MMP15;DPP8;SPRTN;CAPN10;LNPEP;FBXL2;ACE
prerank,regulation of lipid storage (GO:0010883),-0.3006991748350206,-0.867695174706367,0.6428571428571429,0.8545991220491301,1.0,13/22,44.34%,NFKBIA;ITGB3;C3;HILPDA;ALKBH7;PTPN2;MEST;IKBKE;ITGAV;PLIN5;TNF;IL6;LPL
prerank,response to gamma radiation (GO:0010332),-0.29506233264936593,-0.8675009459724202,0.6477064220183486,0.854516434687896,1.0,11/24,30.31%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB;DCUN1D3;FANCD2;LIG4;TSPYL5;MYC
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.34663445696038886,-0.8668655394487716,0.6634429400386848,0.8553452023918908,1.0,4/13,12.89%,CD81;CD9;FCER1G;SYK
prerank,regulation of myelination (GO:0031641),-0.2951802788511281,-0.8667566079889378,0.6560747663551402,0.8550978484108319,1.0,4/25,7.20%,JAM2;PARD3;TNFRSF21;TNFRSF1B
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2838278227046813,-0.8663346627675388,0.6606170598911071,0.8554856822957546,1.0,8/28,14.84%,KCNB1;CHP1;MIEF1;GDI1;MIEF2;CIB1;HRAS;ERBB2
prerank,double-strand break repair (GO:0006302),-0.20394020192758822,-0.86587493577547,0.7947686116700201,0.8559438079089373,1.0,57/158,30.52%,PAXX;BRCC3;PRKDC;ZFYVE26;UIMC1;ERCC1;YY1;BABAM1;HERC2;VCP;MTA1;SFPQ;CIB1;UBXN1;HPF1;PPP5C;PSMD14;SLX4;DCLRE1C;REV3L;SAMHD1;XRCC1;PARP2;HUS1;MMS22L;EME2;RPA3;CYREN;BABAM2;BRCA2;AP5Z1;HELQ;POLQ;RAD21;ERCC4;SFR1;DTX3L;FAN1;POLL;NSMCE1;DNA2;RAD51AP1;LIG4;TNKS1BP1;BARD1;RNF8;HMGB2;MRE11;SWI5;EXD2;POLB;SMARCA5;MEIOB;RMI1;RAD52;PRPF19;RECQL
prerank,regulation of nervous system development (GO:0051960),0.2693353643234104,0.86578736157799,0.6511156186612576,0.8997382162402603,1.0,6/37,8.90%,PTN;HES3;SIRT2;DOCK7;HES5;NPHP3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.30159437503792486,0.8657476039726547,0.6617954070981211,0.8989849569654424,1.0,1/24,0.15%,EPHA7
prerank,lipid droplet formation (GO:0140042),-0.3704407045331284,-0.8655969497056735,0.6261510128913443,0.8560183749674035,1.0,2/10,7.82%,CDS2;CDS1
prerank,cellular response to retinoic acid (GO:0071300),0.2686671503070912,0.8654752446974211,0.6723404255319149,0.8987461207824115,1.0,11/42,14.79%,PTK7;EPHA3;LYN;ZNF35;BRINP1;BRINP3;FZD10;BRINP2;ATM;WNT6;WNT5B
prerank,neuron apoptotic process (GO:0051402),0.3146296098083499,0.865025991234897,0.6286307053941909,0.8988846760092031,1.0,6/19,12.55%,BCL2;SCN2A;ERBB3;ATN1;NGFR;DIABLO
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2877994024940641,-0.8646259632074192,0.6673114119922631,0.8575050353100366,1.0,6/26,15.59%,TRIB1;DHX58;MAPKBP1;ITCH;SIGIRR;TNFAIP3
prerank,negative regulation of cell aging (GO:0090344),-0.3363171688098755,-0.8642949932265136,0.6505576208178439,0.8577186065004333,1.0,3/16,8.99%,CDK6;MAP3K3;TWIST1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.31676445479571763,0.8641708775660567,0.6114790286975718,0.8999575991492326,1.0,3/19,7.43%,ASPA;ALDH7A1;DDO
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.31941813723753076,-0.8637801024308573,0.6496212121212122,0.8582948380979916,1.0,4/18,11.00%,PPIA;HSPB1;AKT1;BAG5
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.297285448002052,0.8635658134862559,0.6541666666666667,0.9004412194464004,1.0,4/23,10.29%,CASP3;SETMAR;EXOG;CECR2
prerank,nucleotide metabolic process (GO:0009117),-0.30491448161942863,-0.863347422749592,0.6608527131782945,0.8587016839410674,1.0,14/23,48.53%,ME1;CTPS2;NMNAT3;PARK7;NMNAT2;FHIT;CMPK2;DCK;ENPP3;DCTD;AK7;NUDT5;AK4;AK1
prerank,regulation of tissue remodeling (GO:0034103),0.3177976995334706,0.8622063179392362,0.6418219461697723,0.9025574927556759,1.0,3/18,8.31%,DDR2;LEPR;IL18
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.31390549116067157,0.8618098792965464,0.6422594142259415,0.902544716279539,1.0,4/19,9.12%,RHOH;IL4;AXL;GATA3
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.36149727747523075,-0.8615919798457896,0.65625,0.8617512922723266,1.0,4/11,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,organic cation transport (GO:0015695),0.30627687890590805,0.8612776657953845,0.6569037656903766,0.9028629535132993,1.0,4/20,9.41%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,myeloid dendritic cell activation (GO:0001773),0.3527524575858431,0.8611149072781579,0.6191489361702127,0.9023919875376615,1.0,3/12,12.82%,IL4;CAMK4;DOCK2
prerank,phagolysosome assembly (GO:0001845),0.3470690340299531,0.8608964740984166,0.6467991169977925,0.9020649992721301,1.0,4/12,19.23%,PLA2G5;RAB20;CLN3;RAB7B
prerank,motile cilium assembly (GO:0044458),0.3517348490787706,0.8608920206805569,0.6175115207373272,0.9012518509860958,1.0,4/12,22.14%,DNAAF3;BBOF1;RSPH9;CCDC39
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3441747578329447,0.8607012372703328,0.6347826086956522,0.9000475501098061,1.0,1/12,1.08%,FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3441747578329447,0.8607012372703328,0.6347826086956522,0.9000475501098061,1.0,1/12,1.08%,FBLN1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26303108294504896,0.8606929854642849,0.68,0.8992445324591477,1.0,4/39,4.69%,PIK3R1;PIP4K2A;ITPKC;EFR3A
prerank,negative regulation of coagulation (GO:0050819),0.3373822807768829,0.8596077341953976,0.6208425720620843,0.9007390762421261,1.0,3/14,5.80%,SERPINE2;APOH;SERPINE1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3691524237811728,-0.859445580198515,0.6347197106690777,0.865551722193253,1.0,8/10,43.57%,PPP2R1A;PTPN2;PARP14;NF2;PPP2CA;INPP5F;SOCS3;SH2B3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2218708984293599,-0.8593000141589643,0.7178988326848249,0.8653730609353724,1.0,22/88,19.99%,RACK1;RPS3;DAB2IP;IGFBP5;CNOT7;GAPDH;EDN1;AKT1;CST3;NCL;RPL13A;CAPRIN1;APOE;FMR1;PCIF1;LSM14A;GIGYF2;ATRAID;CDK5RAP3;TYMS;PAIP2B;SYNCRIP
prerank,prostanoid biosynthetic process (GO:0046457),-0.32706051668648944,-0.8590813267306817,0.671003717472119,0.8653453877627569,1.0,5/15,18.30%,PTGDS;EDN1;CD74;PTGS1;DAGLB
prerank,Golgi localization (GO:0051645),-0.3596874914909792,-0.8590452131713114,0.6594202898550725,0.8649547841469302,1.0,6/11,24.27%,STK25;COPG1;YWHAZ;RIPOR1;PDCD10;CDC42
prerank,receptor recycling (GO:0001881),-0.36552688833639313,-0.8589747759028741,0.6465201465201466,0.8646148165236631,1.0,5/10,25.16%,LMTK2;REP15;RAB11B;EHD3;PHETA2
prerank,cellular response to hypoxia (GO:0071456),-0.20689885264907654,-0.8587509043123593,0.7935222672064778,0.8645662752361423,1.0,41/126,25.45%,EGLN3;UBB;UBC;RPS27A;VEGFA;ACAA2;GATA6;PSMA6;RGCC;EGLN2;PSMB5;TWIST1;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;BNIP3L;PSMD8;PSMD11;PGK1;PSMB4;PSMD12;PSMC1;BAD;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;NPEPPS;PLK3;PSMA4;PSMA2;HILPDA;HYOU1;HIF1AN;CARD16;PSMB8;ANGPT4
prerank,response to tumor necrosis factor (GO:0034612),0.22622364895893537,0.8584322738327326,0.7405940594059406,0.902365663793435,1.0,11/91,10.33%,ADAMTS12;PID1;HYAL3;OCSTAMP;SFRP1;GGT7;CXCL16;CASP3;GATA3;CCL25;YTHDC2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3124264161599116,-0.8581973695496582,0.6817325800376648,0.8652143082633514,1.0,6/18,19.18%,ACTB;SPTBN1;MMP14;ABCA2;VTI1B;MISP
prerank,blood circulation (GO:0008015),0.2545101536796915,0.8577550264041711,0.6868250539956804,0.9029530114364447,1.0,6/49,5.85%,SGCZ;HTR7;SGCD;ROCK2;TNNI3;COL4A3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3100118348280325,-0.8567700690447154,0.6640926640926641,0.8675784913956095,1.0,6/18,22.92%,RAB11A;BRD4;CDK4;RCC2;CCND1;DTL
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20556341928298463,0.8565263086266142,0.7816091954022989,0.9047832131001559,1.0,18/166,9.27%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;POLR1A;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;POLR1G;RARG;RBPJ;POLR2G;POLR1B
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.29488485009528553,-0.8563306308470975,0.6588235294117647,0.8679467484532936,1.0,6/22,25.84%,ATF4;NCL;SMARCA4;ERBB2;PWP1;UTP15
prerank,regulation of cellular protein localization (GO:1903827),0.2581471397763627,0.8561128186705247,0.6872340425531915,0.9048342443269255,1.0,7/45,10.06%,GPC6;GPC4;GPC2;VCPIP1;GBF1;DVL3;GPC5
prerank,P-body assembly (GO:0033962),-0.34758107903987207,-0.855832192053925,0.6518650088809946,0.8684429153991549,1.0,4/12,21.05%,RC3H1;LIMD1;LSM14A;LSM3
prerank,negative regulation of bone remodeling (GO:0046851),-0.35606289549214815,-0.8553022362526644,0.6768953068592057,0.8690417606723675,1.0,4/11,17.77%,GPR137B;TNFAIP3;GREM1;UBASH3B
prerank,positive regulation of tissue remodeling (GO:0034105),0.35945342059026286,0.8552162078360851,0.6280623608017817,0.9058862097710726,1.0,2/10,8.31%,ROCK2;IL18
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.34614996355384814,-0.8538100884938359,0.6537037037037037,0.8715006281919595,1.0,2/13,2.97%,NOP14;RPS21
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3071781863742745,-0.8532895531761278,0.6951456310679611,0.8720534174365746,1.0,5/20,16.01%,FAR2;ACLY;PPT2;FAR1;SLC25A1
prerank,intestinal lipid absorption (GO:0098856),-0.34739150129787577,-0.8525490890486113,0.6353790613718412,0.8730146840048363,1.0,7/11,52.95%,CD36;SOAT2;LIMA1;LDLR;AKR1C1;ABCG5;NPC1L1
prerank,steroid catabolic process (GO:0006706),0.3603884227072513,0.8521677563341511,0.6439909297052154,0.911342977670832,1.0,1/10,1.77%,CYP27B1
prerank,myelination (GO:0042552),-0.24851378602757365,-0.8516940640142923,0.7236084452975048,0.8742058630972204,1.0,11/46,16.05%,ADGRG6;PARD3;CMTM8;MYOC;TNFRSF21;MAL;NF1;PLLP;ACER3;MALL;MARVELD1
prerank,regulation of protein neddylation (GO:2000434),-0.3606719087311088,-0.8507653532062542,0.666083916083916,0.8755211464490326,1.0,6/10,25.12%,DCUN1D5;RPL11;DCUN1D1;COPS9;RPL5;DCUN1D3
prerank,ovarian follicle development (GO:0001541),0.34210577113721163,0.8503284913676217,0.6623655913978495,0.9144187101879552,1.0,5/13,15.90%,KIT;CEBPB;ANG;EIF2B5;EIF2B2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3253170915484112,0.8502820671040054,0.6263736263736264,0.9136791977811953,1.0,15/15,67.50%,NYNRIN;RNASEH1;DICER1;ZC3H12B;LACTB2;POP1;ZC3H12A;POP7;ZC3H12C;SLFN14;KHNYN;NUDT16;RPP30;ZC3H12D;RPP40
prerank,cellular response to light stimulus (GO:0071482),-0.23138453428304234,-0.850266872741401,0.748046875,0.8760225425998808,1.0,25/66,32.61%,RPL26;RHBDD1;ATF4;N4BP1;YY1;BAK1;FMR1;GNB1;OPN3;KDM1A;POLK;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;PRKCD;SMPD1;NPM1;MYC;AQP1;RRH;OPN1MW3;OPN1MW;CREBBP
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3386907118142411,-0.8502284230198893,0.6794871794871795,0.8756309838833772,1.0,2/12,4.91%,CTPS1;CTPS2
prerank,zinc ion transport (GO:0006829),-0.29468978334908613,-0.8500699104152195,0.6781818181818182,0.875458471481173,1.0,5/21,14.06%,SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2914466222399754,-0.8500284018505018,0.6788321167883211,0.8750576822822875,1.0,13/23,30.55%,BAX;NDUFA13;TIMM29;TOMM22;HSPA4;HSP90AA1;BAD;TIMM13;TIMM10;TIMM8B;TIMM10B;PMAIP1;ROMO1
prerank,DNA geometric change (GO:0032392),-0.28764238627205135,-0.8499587332040173,0.6974169741697417,0.8747183006984267,1.0,11/24,35.57%,HNRNPA2B1;ANXA1;DHX9;ASCC3;DNA2;HMGB2;MRE11;RECQL;PIF1;RAD50;HMGB3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.25071865721288833,0.8499570124458127,0.7157258064516129,0.9134964741499451,1.0,17/52,21.85%,ALDH18A1;ADHFE1;PHYH;D2HGDH;ALDH1L1;FPGS;MDH2;SLC46A1;SDHA;MTHFD1;ASS1;MTHFD1L;GPT2;ALDH5A1;GOT1;SLC19A1;GOT2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3264790521861603,-0.849694483712218,0.6703499079189686,0.874754257845801,1.0,5/15,18.42%,EHD2;FLOT1;CAMK1;RAPGEF3;EHD1
prerank,smooth muscle tissue development (GO:0048745),-0.35775389604379965,-0.8496140594835933,0.6691588785046729,0.874441510749531,1.0,4/10,13.24%,SMO;STRA6;NF1;ENG
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2233038064570816,-0.8486645799845712,0.7391304347826086,0.8758174443001483,1.0,26/76,30.05%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;HDAC4;FAM107A;PTTG1IP;SAE1;SPRTN;UBA2;WDR48;CDK5RAP3;LAPTM5;UBE3A;TRAF6;BCL10;DCUN1D3;XIAP;TSPYL5;NDFIP2;MUL1;DERL1;HDAC3
prerank,tRNA modification (GO:0006400),-0.2299155433806772,-0.8485592671673938,0.7605363984674329,0.8755510233907701,1.0,21/62,28.52%,DUS2;THUMPD1;TRMT9B;QTRT2;URM1;TYW1;TRDMT1;QTRT1;TRMT61B;TRMT6;AARS2;TRMT44;TYW3;ANKRD16;PUSL1;WDR6;METTL1;ADAT2;CTU2;METTL2A;METTL2B
prerank,negative regulation of protein processing (GO:0010955),-0.34342550643637276,-0.8484967498787576,0.6486988847583643,0.8752104301806903,1.0,2/12,4.45%,THBS1;CTSZ
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.256190127211657,0.8483825008855126,0.6910229645093946,0.9158770696864273,1.0,6/46,10.70%,FBLN1;TIMP3;LYN;GSTP1;PTEN;RPS6KA6
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.28112886945479915,0.8478755026107638,0.6798336798336798,0.9161143465851095,1.0,7/28,16.51%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.32015895315271015,-0.8477921638564535,0.6630630630630631,0.8761365820029878,1.0,11/16,38.50%,SLX4;TOP2A;EME2;ERCC4;TOP2B;MEIOB;RMI1;MSH4;CENPX;EME1;SHOC1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3357119491520998,-0.8476732111660668,0.6542056074766355,0.8758976926132184,1.0,2/12,12.38%,ANO1;PPP3CB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3676476384711907,0.847622340540557,0.6227272727272727,0.9158347242745087,1.0,4/10,17.95%,RPS6KA6;KAT5;SP100;TP53
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.30145257218203336,-0.8474928096895714,0.6928702010968921,0.8757730481601677,1.0,8/19,29.26%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;MPI;UAP1;GNPDA1
prerank,histone H2A acetylation (GO:0043968),-0.3158423465453532,-0.8473826536517972,0.6616541353383458,0.8755234671331216,1.0,4/16,18.10%,TRRAP;SPHK2;EPC1;EP400
prerank,fatty acid transport (GO:0015908),-0.3112450234685248,-0.847287341255092,0.6979362101313321,0.8752444510952879,1.0,4/17,12.33%,PPARD;MFSD2A;FABP5;APOE
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28763530859793884,0.8472464797632222,0.6673728813559322,0.9157840263471225,1.0,3/24,5.52%,TTLL11;AGBL4;TTLL9
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.32653634787302865,0.8472106378533311,0.6348195329087049,0.9150375490907021,1.0,3/16,18.25%,PRKCA;PDE6G;MRAP2
prerank,microtubule polymerization (GO:0046785),-0.27178935787100506,-0.8470337889305236,0.6877256317689531,0.8752490067188,1.0,10/29,29.62%,CENPJ;SLAIN2;TRPV4;NDE1;NDEL1;PIN1;TPX2;MAP7D3;TUBG2;TUBGCP6
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.21545595462083142,-0.8462418139614993,0.7864077669902912,0.8762827998861297,1.0,33/95,32.48%,MEF2C;LBP;VIM;CYRIB;DAB2IP;TNFRSF1B;PLAA;TIRAP;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;CASP1;FZD5;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.33412597995687643,-0.8460288900990985,0.6844036697247706,0.8762342766998947,1.0,4/13,14.89%,LAMP1;SPHK2;SYK;GAB2
prerank,regulation of TORC1 signaling (GO:1903432),-0.26989177418676247,-0.8459838193864867,0.7037735849056603,0.8758498860442278,1.0,11/33,27.35%,GPR137B;PIP4P1;RRAGD;RRAGA;RRAGC;SESN2;CASTOR2;SEH1L;SIK3;LAMTOR5;SESN1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.32550986641812285,-0.8456718826867909,0.6809701492537313,0.8759886492788177,1.0,3/15,5.68%,SIX1;SMO;VEGFA
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23669135707841066,0.8452360171177692,0.7464503042596349,0.9182627871319163,1.0,16/76,14.14%,LPAR1;GPR55;GPR174;GRM1;CHRM2;OPRK1;HRH1;LPAR4;NMBR;ADRA1D;C3AR1;ADRA1B;GNA15;ACTN2;P2RY1;DRD2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.35301719830167055,-0.8451552422099464,0.6684210526315789,0.8765047674148513,1.0,5/11,22.03%,CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,positive regulation of chromatin organization (GO:1905269),-0.35180608101837363,-0.8448042987030077,0.6755725190839694,0.8766750887148942,1.0,3/12,16.98%,TAL1;H3-3A;MIER1
prerank,protein alkylation (GO:0008213),-0.2937011131342461,-0.8447778694619547,0.690566037735849,0.876250002410929,1.0,6/22,19.45%,PRMT8;SNRPD3;FAM98A;EEF2KMT;PRMT3;LCMT1
prerank,DNA metabolic process (GO:0006259),0.19195342941848487,0.8445373941209148,0.863905325443787,0.9188531309268388,1.0,69/270,21.96%,TCF7L2;DMC1;MCM3;ORC4;DDB2;MPG;STN1;AXIN2;SUMO1;MNAT1;TOP1;TOP3A;GEN1;FANCC;SETMAR;MEN1;KMT5C;TOP1MT;DNMT1;BLM;RPA2;RFC5;CHRNA4;MCM2;RAD51C;MCM8;RAD51B;ORC1;NBN;POLE4;ATM;CENPS;RIF1;RPA1;SMARCB1;KAT5;ENDOV;KMT5B;PDS5A;PARP4;NUDT1;PARP3;BACH1;POLI;INIP;ORC3;PARP1;SP100;UBE2N;POLD4;RNASEH1;ORC5;SMARCAL1;PDS5B;POLD1;RTEL1;CDC7;PCNA;POLD3;DOT1L;RFC1;PRIM1;ZRANB3;GLRX2;TOP3B;POLD2;PRIM2;DCLRE1B;UBE2V2
prerank,negative regulation of locomotion (GO:0040013),-0.3436424431207719,-0.8445318884270497,0.6743772241992882,0.8762379876607939,1.0,4/12,11.89%,FRMD5;CRK;CCDC125;DUSP3
prerank,regulation of actomyosin structure organization (GO:0110020),0.33591308341168946,0.8443500085960259,0.6373165618448637,0.918442461391793,1.0,3/13,9.17%,ROCK2;ASAP3;ALMS1
prerank,cholesterol homeostasis (GO:0042632),0.23548324610550206,0.8441135025229353,0.737603305785124,0.9180973920631127,1.0,8/64,11.14%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.23047372756231185,-0.8438880888670618,0.7560483870967742,0.8769522932817823,1.0,18/61,23.09%,CAV1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,negative regulation of hormone secretion (GO:0046888),0.36293985966517284,0.843590920615158,0.6175213675213675,0.9183212981393507,1.0,1/10,1.53%,GJA1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.280239187054686,-0.8422313248955285,0.694949494949495,0.8796264297561405,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.30159574220536933,-0.8417174003141341,0.6673151750972762,0.8801438634835175,1.0,9/18,42.85%,ATF4;MAF1;ERBB2;UTP15;POLR2L;LYAR;SIRT7;FLNA;RASL11A
prerank,regulation of muscle contraction (GO:0006937),-0.27693458368615576,-0.8416432645080323,0.6961325966850829,0.8798225284677523,1.0,2/26,0.35%,PLCE1;CAV1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.30431964187495103,0.8415780858259284,0.6724890829694323,0.9216571828173861,1.0,9/20,20.54%,AGO4;HELZ;TNRC6A;AJUBA;TNRC6B;AGO3;CNOT8;AGO1;AGO2
prerank,mRNA processing (GO:0006397),-0.1844155311234079,-0.8415187610816551,0.9445628997867804,0.8796004229690961,1.0,111/287,34.99%,DDX5;NOVA2;HNRNPA2B1;RPRD1B;CTNNBL1;HSPA8;PPARGC1A;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;GTF2H3;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;ZC3H11A;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;CHTOP;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;GTF2H4;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;THOC6;RBM19;CPSF4;LSM3;TBRG4;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;THOC7;RPRD1A;KIN;GTF2F2;SNRPB2;HNRNPR;WBP11;ERN1;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,sterol biosynthetic process (GO:0016126),-0.261625094925592,-0.8410723068731876,0.7135036496350365,0.880007158490126,1.0,15/33,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;CH25H;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2211862626723759,-0.840502668910373,0.781190019193858,0.880594454905339,1.0,22/83,22.68%,CDK6;CDK17;CDKN1B;BRD4;CUL4A;PLK2;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;TYMS;RCC1;EIF4EBP1;PLK3;CDK15
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.22620792681868945,-0.839823866749562,0.752,0.8813791932022582,1.0,8/69,7.54%,MEF2C;PTK2B;NGF;SIX1;PPARGC1A;TGFB3;TOX3;FOXQ1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.29227466231983606,0.8392365109435729,0.6886993603411514,0.9256042659565892,1.0,7/26,13.76%,ADCY5;STXBP4;FOXA2;EPHA5;ADCY8;BAIAP3;CDK16
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3175538759019353,-0.8390533677545564,0.6802973977695167,0.8823671863602156,1.0,4/15,11.98%,SMAD7;FKBP1A;CSNK2B;ACVR1
prerank,regulation of neuron projection arborization (GO:0150011),0.31881242660040293,0.8390514693612923,0.6462585034013606,0.9251433419679683,1.0,4/15,16.76%,GRIP1;DVL3;DLG4;MYO9A
prerank,metanephros development (GO:0001656),0.28793060081077987,0.8386249670207047,0.6926315789473684,0.9251723768266115,1.0,2/26,1.69%,ROBO2;GDNF
prerank,regulation of hormone secretion (GO:0046883),-0.31695033120816585,-0.838480366044878,0.6771217712177122,0.8829761755069145,1.0,2/15,7.67%,ANXA1;EDN1
prerank,synaptic vesicle recycling (GO:0036465),0.2763028861856759,0.8383721631743928,0.6476377952755905,0.9248832225443043,1.0,6/31,7.71%,STON1;NLGN2;TBC1D24;NLGN3;SYT1;NLGN1
prerank,regulation of viral transcription (GO:0046782),-0.2554840655865922,-0.8383202775036748,0.725417439703154,0.882793507384096,1.0,6/39,12.16%,MID2;IFITM3;DHX9;TRIM14;NELFE;TRIM62
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.24629588570562055,-0.8383082871828763,0.7431693989071039,0.8823430174004293,1.0,16/42,30.43%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,sterol homeostasis (GO:0055092),0.23313313621374177,0.8382486413100796,0.7520661157024794,0.9243159978240406,1.0,8/65,11.14%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.3664555776259222,0.838240347225268,0.6751054852320675,0.9235114188570809,1.0,2/10,1.77%,VDR;CYP27B1
prerank,ESCRT complex disassembly (GO:1904896),-0.3594336710775406,-0.8382382841169813,0.7027522935779816,0.8815369977346205,1.0,5/10,28.54%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.3594336710775406,-0.8382382841169813,0.7027522935779816,0.8815369977346205,1.0,5/10,28.54%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,positive regulation of cell death (GO:0010942),-0.23298206871958305,-0.8379833483778405,0.7602339181286549,0.8815387632678664,1.0,4/59,3.91%,SLC6A6;MAP3K5;ACER2;CDKN1B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.28968629612729724,-0.8377385272035625,0.6785046728971963,0.8815441905790451,1.0,7/21,22.00%,SMO;GAS8;ULK3;STK36;TUBD1;GLI1;DCDC2
prerank,regulation of chromatin organization (GO:1902275),-0.32086475704028133,-0.8376977779909109,0.6826923076923077,0.8811608607382246,1.0,4/14,21.07%,MLLT3;HPF1;SETD1A;MKI67
prerank,endochondral bone morphogenesis (GO:0060350),-0.3509775012760531,-0.8376169600052659,0.692167577413479,0.8808468634022205,1.0,2/11,2.11%,MEF2C;BMPR2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.26656067975921727,-0.8375659124405203,0.7137404580152672,0.880456994565425,1.0,2/30,2.11%,DACH1;BMPR2
prerank,neuron differentiation (GO:0030182),0.20347291431841194,0.8374210075860401,0.8303393213572854,0.9243169033912574,1.0,20/165,10.84%,WNT4;TENM3;GLI2;PTPRD;TENM2;PBX4;PHOX2A;FOXA2;CASP3;IL1RAPL1;LHX4;TGFBR1;RYK;ATOH8;CDK5R1;EPHA5;ALK;FUT9;ATP8A2;BRSK1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.26480301307414844,-0.8368761930142928,0.731610337972167,0.8813087117653746,1.0,13/32,28.35%,LPCAT3;MFSD2A;CHKA;CSNK2B;CEPT1;CSNK2A1;CSNK2A2;LCAT;PCYT1A;CHAT;PEMT;LPIN2;SLC27A1
prerank,sensory perception of light stimulus (GO:0050953),0.22428966876855483,0.8368230568795482,0.7648261758691206,0.9247270997510747,1.0,19/87,18.98%,ADGRV1;DHRS3;TRPM1;PCDH15;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;CLRN1;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.32157739100088417,-0.8366137665000752,0.7065217391304348,0.8813745367276864,1.0,4/14,12.36%,SEMA7A;PLCG2;CD74;MAVS
prerank,regulation of cholesterol storage (GO:0010885),-0.31664506477615867,-0.8364633875065455,0.7041984732824428,0.8811743038114739,1.0,6/15,19.05%,SCARB1;PPARD;ABCG1;NR1H2;EHD1;MSR1
prerank,positive regulation of lipid transport (GO:0032370),0.33238777120829416,0.8360444184022581,0.6518847006651884,0.9254496026730858,1.0,2/12,8.08%,LRP1;ABCB4
prerank,pyroptosis (GO:0070269),-0.3180856514953447,-0.8356604530866685,0.6835205992509363,0.8822487684243459,1.0,5/15,25.39%,CASP8;DHX9;AIM2;CASP1;TREM2
prerank,regulation of RNA export from nucleus (GO:0046831),0.35270109084300033,0.8355659604494249,0.6604651162790698,0.9255829299304911,1.0,2/11,7.13%,AKAP8L;KHDRBS1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3012522363487717,-0.8354536885916849,0.6941391941391941,0.8822057631680102,1.0,4/18,12.01%,NUP93;ENY2;HHEX;ZC3H11A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3262263825036488,0.8350380134382243,0.6740088105726872,0.9258221462749215,1.0,7/15,23.93%,CASP3;NGFR;BCAR1;FRS2;SORT1;NTRK2;BDNF
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.33068706651941226,-0.8346325446270911,0.7038461538461539,0.8832736843022484,1.0,6/13,32.78%,JAK2;OAS2;STAT1;IL6ST;IL27RA;CANX
prerank,quinone biosynthetic process (GO:1901663),-0.3325062985065044,-0.8346279512712279,0.687984496124031,0.8828165558533724,1.0,5/14,22.19%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,microtubule depolymerization (GO:0007019),-0.3067111929884126,-0.8338949866141625,0.7,0.8837142631283487,1.0,7/17,25.21%,STMN2;KATNB1;KIF24;KIF18A;KIF18B;NCKAP5L;STMN1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.2627926775712729,0.8338309601772612,0.6923076923076923,0.927431983583988,1.0,3/39,3.55%,ERRFI1;AREG;TGFA
prerank,negative regulation of transport (GO:0051051),0.24468310815834424,0.8338159569339328,0.7264770240700219,0.9266443428128515,1.0,12/51,16.73%,NRG1;PRTN3;EPHA3;SNX33;PRKN;ERBB3;YRDC;PTEN;SCAMP5;SYT11;LRSAM1;TRAT1
prerank,regulation of proteolysis (GO:0030162),-0.23757317886968476,-0.8335691601538164,0.7504798464491362,0.8838131589178471,1.0,10/48,17.09%,CAV1;LTBP4;CASP8;AKT1;PERP;CST3;ITCH;BAK1;IST1;BAD
prerank,photoperiodism (GO:0009648),-0.2700999382913713,-0.8333205314907748,0.7343453510436433,0.8838446376948957,1.0,9/28,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;CLOCK;SIK1;FBXL8
prerank,regulation of multicellular organismal development (GO:2000026),0.28513635704749557,0.8331408733880972,0.711864406779661,0.9271127863196712,1.0,3/25,9.12%,PTN;TRIP12;GATA3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2785449727744588,0.8326519930197535,0.7206477732793523,0.9273050107216544,1.0,6/28,11.46%,PRKAG2;MITF;PDK4;MFSD12;FGFR4;CTNS
prerank,protein trimerization (GO:0070206),0.32603572132333536,0.8323804212019649,0.6907216494845361,0.9262252054404468,1.0,6/14,23.64%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,protein homotrimerization (GO:0070207),0.32603572132333536,0.8323804212019649,0.6907216494845361,0.9262252054404468,1.0,6/14,23.64%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2889754279313349,-0.8322439025438192,0.718,0.8852519309720411,1.0,10/22,38.62%,GATA2;NES;KDM1A;DLL4;SHCBP1;TOX;FZD9;RASSF10;TRIM71;PROX1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3315180600200339,0.8321810834838106,0.6731601731601732,0.9258346814405509,1.0,2/13,3.63%,PARP16;PTGIS
prerank,negative regulation of defense response (GO:0031348),0.22746796742983355,0.8318907796882564,0.7693877551020408,0.9255809583640918,1.0,10/77,10.15%,RORA;PPARA;PTGIS;IL4;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6
prerank,peptidyl-lysine methylation (GO:0018022),0.2776334553327919,0.8318114014739192,0.6762749445676275,0.9249233538275498,1.0,5/26,11.56%,METTL21A;SMYD1;SETD7;SMYD3;EHMT2
prerank,histone ubiquitination (GO:0016574),-0.29079109778308726,-0.8317359337705809,0.7121771217712177,0.8856654715846388,1.0,8/21,29.67%,PHC1;RNF20;USP22;UBE2B;DTX3L;RNF40;RNF8;UHRF1
prerank,Golgi ribbon formation (GO:0090161),-0.32490833177490186,-0.831634954649508,0.707105719237435,0.8853889556267143,1.0,7/13,30.46%,TRIP11;FHDC1;GCC2;TMED5;GOLPH3;STX16;VAMP4
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2982848487937731,-0.8313924110327735,0.7155797101449275,0.8853699165842049,1.0,6/18,18.30%,PTGDS;EDN1;CD74;PTGS1;CBR1;DAGLB
prerank,transcription by RNA polymerase III (GO:0006383),0.27443093620376585,0.8311452861237568,0.716,0.9254130751963205,1.0,11/27,20.36%,SNAPC3;GTF3C3;GTF3C2;SNAPC1;GTF3C6;ICE1;GTF3C4;ICE2;POLR3H;POLR2K;POLR3GL
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.32219724964898633,0.8310169941049946,0.6713995943204868,0.9248633326152643,1.0,2/15,1.77%,VDR;CYP27B1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32087835774588297,-0.830997080852818,0.6887298747763864,0.8856472614947732,1.0,3/15,4.12%,STOX2;RICTOR;TGFB2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.27510598381368345,-0.8308309958438959,0.6963946869070209,0.8854963242633881,1.0,2/26,0.35%,ST3GAL6;ST3GAL4
prerank,response to interleukin-1 (GO:0070555),0.22776025053695384,0.8308056586824039,0.7777777777777778,0.9244538366119708,1.0,5/73,4.24%,ADAMTS12;HYAL3;PRKCA;PTGIS;SFRP1
prerank,cholesterol efflux (GO:0033344),-0.2927148869472421,-0.8306701318510186,0.6947565543071161,0.8853153363301084,1.0,5/20,13.92%,SCARB1;ABCG1;APOE;TSKU;NPC1
prerank,peripheral nervous system development (GO:0007422),0.29680601880302265,0.8305630847068194,0.6630669546436285,0.9241106310098247,1.0,5/23,10.55%,GDNF;ARTN;ASIC2;ERBB3;NFASC
prerank,muscle filament sliding (GO:0030049),-0.24582568629717455,-0.8304563768529539,0.7418772563176895,0.8847408763578628,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.24582568629717455,-0.8304563768529539,0.7418772563176895,0.8847408763578628,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,pre-replicative complex assembly (GO:0036388),-0.2257027636536688,-0.8303160738054268,0.7946257197696737,0.8845098981105693,1.0,20/64,25.24%,UBB;UBC;RPS27A;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;MCM5;PSMB8
prerank,peptidyl-lysine modification (GO:0018205),-0.21110119045792955,-0.8298181934736013,0.8384458077709611,0.8849465950616298,1.0,31/99,26.55%,NNAT;IFIH1;PLOD2;HDAC9;STX1A;NUP93;HDAC4;NDC1;TRIM28;NUP54;SAE1;PLOD3;NUP188;LOX;SUMO3;NUP155;RANBP2;NUP37;UBA2;CTH;USPL1;RANGAP1;NUP160;SENP5;ATPSCKMT;NUP43;SEH1L;PARK7;NUP107;NUP42;EEF1AKMT3
prerank,protein ubiquitination (GO:0016567),0.17821073528221143,0.8293627896407939,0.9765765765765766,0.9256592508921381,1.0,90/471,18.12%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;EPAS1;PELI2;TRIM38;FBXO24;DTX4;SPSB1;BCL2;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;TRIP12;RNF43;PRKN;KLHL41;HECW1;UBE2O;RNF138;VCPIP1;CUL9;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;PSMA3;RNF181;KLHL25;TRIM27;CDC23;PSMF1;CUL2;CDC16;MGRN1;AKTIP;RNF26;TOPORS;UBR3;SPOP;MIB1;PPIL2;SIAH2;UNKL;FBXO7;THOP1;BTRC;RNF146;RNF217;PSME3;RNF122;TRIM63;SASH1;BIRC2;ARIH2;FBXO44;ASB1;RNF34;UBA6;UBE3C;PSMD1;TRAF2;UBE2E2;FBXO28;PSMB9;LRSAM1;HECTD2;SKP1;NEDD4;SKP2;KLHL22;FBXO31;HLTF;TRIM35;RNFT1;SPSB2;NFE2L2;CUL7;FBXO21;TRIM23;RNF13;PSMD13;PEX10;UBE2N
prerank,histone exchange (GO:0043486),-0.257471657525006,-0.828932543425591,0.7333333333333333,0.8860553402944782,1.0,17/37,34.41%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;RNF8;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,placenta development (GO:0001890),-0.34267737946776977,-0.8288952308089568,0.7113594040968343,0.8856596115760751,1.0,2/12,6.61%,PTK2;ADAM19
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.3198132016707164,0.8288748791611682,0.6776859504132231,0.9257759838166717,1.0,2/16,6.06%,ANK2;GBF1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.28051204651536354,-0.8287801375883134,0.7452107279693486,0.885408168963844,1.0,6/24,12.16%,TGFB1;ABI3;PPP2R5A;AP2M1;GDI1;BCL2L1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.26272164381619134,0.8285937224958841,0.7142857142857143,0.9255502453172233,1.0,6/35,9.57%,TNK2;AAK1;IL4;SERPINE1;SNAP91;BICD1
prerank,serine family amino acid metabolic process (GO:0009069),-0.30780528638691995,-0.8284916130230389,0.7197106690777577,0.8854734615876352,1.0,9/16,36.01%,SARS1;CDO1;SEPHS2;CTH;GCLC;THNSL2;SRR;SHMT2;DAO
prerank,androgen metabolic process (GO:0008209),-0.30033057166691934,-0.8282805364659613,0.6830985915492958,0.8854015797078102,1.0,12/18,53.03%,SPP1;HSD17B10;HSD17B7;SRD5A2;SRD5A3;HSD3B2;CYP19A1;DHRS9;SRD5A1;HSD17B6;HSD17B3;AKR1D1
prerank,negative regulation of neurogenesis (GO:0050768),-0.25726590051088094,-0.8275302328972017,0.7200772200772201,0.8862866101382069,1.0,7/34,11.72%,B2M;NOTCH1;REST;ARHGDIA;GDI1;NF1;PCM1
prerank,regulation of B cell differentiation (GO:0045577),-0.30564875714606937,-0.8273960475355591,0.7019748653500898,0.8860696062320278,1.0,7/17,26.69%,MMP14;PPP2R3C;INHBA;SYK;XBP1;BTK;INHA
prerank,regulation of humoral immune response (GO:0002920),-0.2454282869524911,-0.8272750828614595,0.7364485981308411,0.8858144034604863,1.0,8/44,16.97%,CD55;CD81;GATA6;C1QB;C1QC;PHB2;CFP;C1QA
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3223831568485839,0.8261461284527963,0.6741071428571429,0.9295330780970863,1.0,3/15,5.39%,BCL2;MDM2;PRKN
prerank,protein tetramerization (GO:0051262),-0.22435815655521246,-0.8258738364371477,0.7912713472485768,0.8878908043709393,1.0,16/67,22.31%,B2M;KCNJ2;GBP5;PKD1;KCNC3;GLS;HOMER1;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;FARSB;PKD2;ACOT13;UPB1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2951763310344434,0.8257972674007649,0.6756756756756757,0.9293936837409629,1.0,2/20,5.49%,HECW2;HECW1
prerank,mitochondrion disassembly (GO:0061726),0.2652450383381847,0.8257665151692917,0.7259100642398287,0.9286507874566509,1.0,12/34,21.67%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A;ATG5;USP30;WDR45
prerank,negative regulation of protein metabolic process (GO:0051248),-0.23991617028249643,-0.8254939429990751,0.7758620689655172,0.888136927960493,1.0,16/48,25.39%,HSP90AB1;PFDN5;EDN1;APOE;INHBB;EGFR;FLOT2;CD84;AGAP2;CRYAB;PIN1;ITGB3;SNX3;PFDN6;PFDN4;TREM2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2634840043274399,0.8251918318920864,0.7354166666666667,0.9289621025326158,1.0,6/32,10.74%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH
prerank,phospholipid dephosphorylation (GO:0046839),0.2588433751948684,0.8246575543218473,0.7354838709677419,0.9291419185007697,1.0,9/37,17.91%,MTMR7;PLPP3;PLPPR1;PTEN;PLPP4;MTMR10;PLPPR5;OCRL;MTMR9
prerank,RNA modification (GO:0009451),-0.23314365200290058,-0.8242681619668825,0.791497975708502,0.8898364870022645,1.0,19/54,28.07%,ADAR;THUMPD1;NOP2;TRMT9B;JMJD6;QTRT2;URM1;TRDMT1;QTRT1;MEPCE;TRMT6;AARS2;ANKRD16;MRM2;METTL1;NSUN5;FTSJ3;ADAT2;CTU2
prerank,microtubule-based transport (GO:0099111),-0.32659624078261995,-0.8240744495560633,0.726148409893993,0.8897278420925979,1.0,6/13,27.29%,HTT;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,regulation of protein export from nucleus (GO:0046825),0.28993515540485587,0.823835609071671,0.6967032967032967,0.9299069666001126,1.0,1/23,0.18%,TCF7L2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21228657649325453,-0.8235818939948306,0.8265524625267666,0.8901205361043871,1.0,23/91,19.94%,RAB11A;OPHN1;SCARB1;MAPK3;RAB8B;HIP1R;USP7;CPLANE2;RAB8A;HIP1;RAB4B;ABL2;RAB11B;RUFY1;RAB4A;SYK;PACSIN1;LGI3;NSF;HCK;TSC2;PACSIN3;PACSIN2
prerank,DNA repair (GO:0006281),-0.1823434699303498,-0.823464383926586,0.9410569105691057,0.8898538460732304,1.0,105/284,34.25%,TRRAP;UBB;USP1;ASCC2;UBC;RPS27A;BRCC3;SMUG1;PRKDC;UIMC1;ERCC1;RAD1;USP3;GTF2H3;BABAM1;TRIM28;CHD1L;FAM111A;HERC2;VCP;MTA1;CIB1;UBXN1;HPF1;PPP5C;PNKP;SPRTN;SLX4;DCLRE1C;RAD9B;RAD18;XRCC1;CETN2;PARP2;HUS1;EME2;RPA3;NSMCE4A;RAD9A;RPAIN;ASCC3;RAD17;PWWP3A;BABAM2;WDR48;BRCA2;GTF2H4;NEIL1;POLQ;POLK;TRAIP;CHEK1;RAD21;ERCC4;GADD45A;UBE2B;APEX2;RHNO1;EID3;RFC3;DTX3L;RAD23A;RFC2;FAN1;POLL;EXO1;FBXO6;NSMCE1;PARK7;DNA2;SETD2;TDG;XPC;FANCD2;RAD51AP1;LIG4;TNKS1BP1;NPM1;RAD23B;BARD1;ATRIP;RNF8;MRE11;EXD2;POLB;SMARCA5;RAD52;FAAP24;RECQL;UPF1;INTS3;PARP9;CDK1;NSD2;TICRR;UBE2T;ABL1;RAD50;NEIL3;POLE;SLC30A9;CENPX;MAD2L2;POLA1;FANCF
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.33801171141486885,-0.8233287103715073,0.6850828729281768,0.8896281121487554,1.0,8/12,40.56%,UPP2;TK2;CAD;UMPS;UPP1;DCK;UCK2;TK1
prerank,protein insertion into ER membrane (GO:0045048),-0.2528709517080497,-0.8232554227867931,0.7369439071566731,0.8892985783027969,1.0,13/37,29.07%,APP;STX1A;CAMLG;EMC10;SEC61B;SGTA;EMC6;EMC9;STX5;UBE2J2;EMC1;TRAM1;VAMP2
prerank,regulation of trophoblast cell migration (GO:1901163),0.3374647870632078,0.8226404660489571,0.6526548672566371,0.9313503397701143,1.0,5/14,21.65%,GJA1;SMURF2;SYDE1;AGO2;TIMP1
prerank,neuron fate commitment (GO:0048663),0.32659875707048563,0.8223824230149503,0.6765375854214123,0.9310361792936352,1.0,5/14,19.69%,TGFBR1;MYT1L;PAX6;SHH;POU3F2
prerank,regulation of defense response to virus (GO:0050688),-0.3150832680477038,-0.8222808601405819,0.6894075403949731,0.8905565870811253,1.0,3/14,15.59%,DHX9;ITCH;TNFAIP3
prerank,regulation of macroautophagy (GO:0016241),-0.20722694747414697,-0.8222258115952381,0.8458049886621315,0.8901946601055082,1.0,37/105,32.31%,EXOC4;KDR;ATP6V0B;ATP6V0A2;GAPDH;QSOX1;AKT1;SCOC;ATP6V0C;UCHL1;EXOC1;EPM2A;LAMTOR2;BNIP3L;PIK3CA;PRKAG1;ATP6V1G1;RRAGD;TBC1D25;TSC2;RRAGA;RRAGC;SESN2;SMG1;RPTOR;ATP6V0D1;ATG13;LAMTOR5;SESN1;UBQLN2;ERN1;ATG101;ATP13A2;ATP6V0E2;ATP6V1C1;LAMTOR1;LAMTOR3
prerank,positive regulation of secretion (GO:0051047),-0.3376239166470314,-0.8221185960667232,0.7076648841354723,0.8899268333614094,1.0,2/11,17.16%,NPR1;XBP1
prerank,mitochondrial transcription (GO:0006390),-0.34682226639029423,-0.8215917414601795,0.6939890710382514,0.890403319125909,1.0,2/10,18.63%,FOXO3;SLC25A33
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3340164046573295,-0.8215646193873211,0.7080979284369114,0.8899907490556376,1.0,3/12,12.63%,LPCAT3;MBTPS2;ABCA2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.22186538846607,0.820722754658639,0.7745901639344263,0.9334790046725484,1.0,4/72,3.04%,FLRT2;FGFR2;KL;FLRT1
prerank,transcription by RNA polymerase II (GO:0006366),0.18421838909469926,0.8206548314855325,0.9406130268199234,0.9328047904710552,1.0,61/305,18.88%,RORA;MAF;AR;GLIS3;TBL1XR1;VDR;RARB;TEAD1;PRRX1;PPARA;TFCP2;TFDP1;PMF1;GTF2H2;MNAT1;HNF4G;MAML3;HSF2BP;HDAC10;DTX1;RPAP1;NFIX;FIP1L1;RARG;RBPJ;SNAPC3;POLR2G;SYMPK;SOX5;PHAX;PABPN1;CCNH;SNAPC1;MAML1;INTS7;ICE1;SCAF8;PGR;TAF5L;YAP1;INTS9;CPSF7;CCNT1;NRBF2;ICE2;PAX5;CDK9;HDAC1;PARP1;ESRRG;GTF2E2;MED4;POLR2D;GTF2B;TAF15;PAPOLA;ELOA;E2F2;PPARG;ELL2;TAF1C
prerank,negative regulation of T cell activation (GO:0050868),0.2584565637794455,0.8202997497471612,0.7510822510822511,0.9326830848957817,1.0,4/35,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2776395901572483,-0.81978784267544,0.7467652495378928,0.8926571564272412,1.0,7/26,15.16%,FNBP1L;ITSN2;AP2M1;ITSN1;FCHO2;SGIP1;AP2A1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3432004178989523,0.8195369354484849,0.6623655913978495,0.9332922417755654,1.0,2/10,12.94%,KLF15;SETD5
prerank,carbohydrate homeostasis (GO:0033500),-0.22169189090166558,-0.8191202428684589,0.8144329896907216,0.8933352259431069,1.0,6/67,5.35%,ADIPOR2;IGF1R;KCNB1;BACE2;KLF7;ADIPOR1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2752108058453393,-0.8189496103166664,0.7425925925925926,0.8931682831297104,1.0,15/26,30.83%,CDK6;RARA;GPR137B;TLR3;C1QC;INHBA;TLR4;TCTA;ZFPM1;INHA;PTPN2;LILRB3;CARTPT;MYC;LRRC17
prerank,regulation of B cell activation (GO:0050864),0.2767871518244512,0.8189175172377618,0.7345679012345679,0.9337056263723658,1.0,3/25,11.52%,IL4I1;IL4;AHR
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3356013510947013,-0.8188214994971272,0.7032136105860114,0.892898558407912,1.0,6/12,25.39%,PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,regulation of B cell apoptotic process (GO:0002902),0.32532751901278745,0.8183192502260657,0.6642857142857143,0.9340048686691772,1.0,3/12,5.54%,LYN;FNIP1;IRS2
prerank,macrophage chemotaxis (GO:0048246),0.3475641935421294,0.817894978928015,0.695067264573991,0.9340217016792812,1.0,3/10,19.87%,EDNRB;CKLF;TAFA4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.32749697022880897,-0.8178287955886983,0.7097378277153558,0.89417560984639,1.0,7/13,35.12%,ALG9;ALG12;ALG1;ALG2;ALG3;MPDU1;ALG6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.29530233545847845,-0.8170755781983587,0.710820895522388,0.8950601597559265,1.0,10/18,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;DCP2;CCT4;CCT6A;NOP10
prerank,metal ion transport (GO:0030001),-0.21334196428555285,-0.8166423253708733,0.7973231357552581,0.8953484151352098,1.0,12/86,11.23%,CAV1;TPT1;TRPC3;TRPM7;RAMP2;ATP2C1;SLC39A8;ATP2A3;TRPV4;TRPC4;CACNB3;NIPAL3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.33749321598459914,-0.8165379856819923,0.7085514834205934,0.895065649729642,1.0,3/12,11.05%,STX3;STX1A;STX2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.31124939202775087,-0.8161417881942877,0.7089678510998308,0.8948219544894155,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.31124939202775087,-0.8161417881942877,0.7089678510998308,0.8948219544894155,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3475778525796869,-0.8161157900188002,0.6996466431095406,0.894399958710362,1.0,5/10,29.11%,HOMER1;CD84;CASQ1;SLC8B1;GRAMD2A
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27388515218949844,-0.8160909097004104,0.7523629489603024,0.8939772128844697,1.0,9/23,24.31%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.31488763621328797,-0.8156585014740011,0.707089552238806,0.8942272243351345,1.0,6/15,32.29%,GBP5;TLR4;TREM2;CD36;TLR6;NLRC3
prerank,regulation of ion transport (GO:0043269),0.22132350625366126,0.8155613608864029,0.7830578512396694,0.9376777461256361,1.0,23/76,18.76%,GDNF;NKAIN2;P2RX4;PRKN;KCNJ16;SYT1;KCNJ3;NKAIN3;KCNJ5;CHRNA4;KCNJ14;SYT13;DRD2;KCNJ6;SYT11;SYT12;NEDD4;KCNJ9;VAMP3;PER1;SYT6;SNX6;HTR1A
prerank,inner dynein arm assembly (GO:0036159),0.348587570621469,0.8154799843245583,0.691764705882353,0.9370261776713738,1.0,11/11,65.17%,CCDC39;CFAP73;CCDC40;DNAAF5;CCDC103;CFAP100;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2986138549246557,-0.815305766638767,0.716390423572744,0.8943621207607462,1.0,8/18,26.50%,COA8;TIMM21;COA3;SURF1;FASTKD3;SCO1;PET100;BCS1L
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2799279143935424,0.8148665355182348,0.7256235827664399,0.9373630308655795,1.0,1/24,0.26%,CEMIP
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2811911178722552,0.8143198975699688,0.724669603524229,0.9376028044416201,1.0,9/22,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,glycoprotein catabolic process (GO:0006516),0.30401181663878957,0.8140717816877678,0.7006507592190889,0.9372479458307067,1.0,1/17,0.44%,ADAMTS12
prerank,Golgi to endosome transport (GO:0006895),-0.31100785984854074,-0.8138019348057642,0.7355679702048417,0.8964431231615356,1.0,5/16,15.16%,VPS13A;KIF16B;DOP1B;AP4M1;AP2A1
prerank,response to organonitrogen compound (GO:0010243),-0.25396694351296717,-0.8135217502082639,0.7642436149312377,0.8964235575517849,1.0,10/38,23.86%,SEL1L;RHBDD1;DNAJB12;RNF185;VCP;RNF5;ERLEC1;RRAGC;BRSK2;MEAK7
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.33730958347635875,0.8134093901306766,0.6967741935483871,0.9376722279044638,1.0,1/10,3.70%,SH3RF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.31714125307735785,-0.8133685018656212,0.7248201438848921,0.8962237159355936,1.0,5/13,29.65%,GLRX5;ISCA2;NFU1;ISCA1;CISD3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3319058537237411,0.8131237508221792,0.6814159292035398,0.9374163096686874,1.0,4/14,12.51%,CREB3L1;PRKN;CREB3;TXNDC12
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.33546167197692317,-0.8127709030238793,0.7122040072859745,0.8967655726488718,1.0,3/12,5.68%,SIX1;SMO;VEGFA
prerank,respiratory tube development (GO:0030323),0.26716090839531353,0.812466058760058,0.7454954954954955,0.9378546809171923,1.0,4/28,8.90%,FGFR2;GLI2;LOXL3;NPHP3
prerank,autophagosome assembly (GO:0000045),0.23848129317473019,0.8121814270029674,0.7888198757763976,0.9375456621781699,1.0,11/52,12.90%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,neural tube development (GO:0021915),0.31318909001919715,0.812127734308119,0.6919540229885057,0.936835368969293,1.0,1/15,0.56%,ALDH1A2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.27313801929713355,-0.8118113447607146,0.7542213883677298,0.8979233830046038,1.0,1/27,0.10%,GPCPD1
prerank,long-chain fatty acid transport (GO:0015909),0.26628369035744726,0.8117301757606595,0.7505330490405118,0.9367544132680874,1.0,9/30,18.81%,PRKAG2;ACSL1;ABCD2;CPT2;ACACA;FABP4;PRKAB2;SLC27A4;PPARG
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23493187330707976,-0.8113026236317943,0.7918367346938775,0.898336911977154,1.0,20/51,35.15%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8;CCT7;CTNNB1;SRC;PKIB;SMG6;PIF1;HNRNPC;DCP2;CCT4;MAP2K7;CCT6A
prerank,positive regulation of dephosphorylation (GO:0035306),-0.26615280792501966,-0.8102083681592741,0.7552581261950286,0.8997098179168835,1.0,13/27,26.21%,PPP1R16B;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2745608813566664,-0.8098452579276809,0.7434456928838952,0.8998613946326184,1.0,12/24,40.93%,CD44;CD151;MRTFA;PDCD10;ACVRL1;ITGA5;WNT7A;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,reverse cholesterol transport (GO:0043691),-0.3245211238719462,-0.8097880652320263,0.7211538461538461,0.8994930391778895,1.0,4/13,18.25%,SCARB1;ABCG1;APOE;LCAT
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.33524376217454166,-0.8086312043314623,0.7069271758436945,0.9005118228262582,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.33524376217454166,-0.8086312043314623,0.7069271758436945,0.9005118228262582,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,positive regulation of viral process (GO:0048524),-0.22405296365193686,-0.8085643495712456,0.822265625,0.9001748859307735,1.0,21/60,32.29%,ADAR;PPIA;CNOT7;SRPK1;DHX9;IFIT1;RAB7A;NELFE;STAU1;NR5A2;GTF2F1;RAD23A;VPS4A;PPID;PABPC1;GTF2F2;POLR2F;POLR2L;KPNA6;POLR2I;POLR2C
prerank,regulation of sister chromatid cohesion (GO:0007063),0.33061526197944957,0.8085340418768929,0.6921348314606741,0.9418916669041015,1.0,3/12,9.64%,AXIN2;CTCF;HDAC8
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.3233211831143249,-0.8081985066185237,0.7410881801125704,0.9003340703103048,1.0,3/13,9.35%,CSPG4;HEXA;IDUA
prerank,positive regulation of potassium ion transport (GO:0043268),-0.24787838916784782,-0.807586707691436,0.7838899803536346,0.9008975042905965,1.0,7/38,13.50%,KCNJ2;FHL1;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.30536891679748834,0.8073285781886305,0.7120535714285714,0.9433145878992016,1.0,16/16,69.49%,BLM;MCM2;RPA1;MCMDC2;MCM7;MCM6;MCM4;RECQL5;SSBP1;WRN;RECQL4;HMGA1;PURA;RAD51;TWNK;RECQL
prerank,spliceosomal snRNP assembly (GO:0000387),-0.24853047115888,-0.8068849146128958,0.7855750487329435,0.9016342646124405,1.0,19/38,40.09%,PRPF8;SNRPC;SNRPD3;SMN1;DDX20;SNRPG;USP4;LSM2;TGS1;CD2BP2;SNRPB;CLNS1A;PRPF19;SNUPN;SRSF10;SNRPE;SNRPF;GEMIN2;PRPF6
prerank,positive regulation of telomere capping (GO:1904355),-0.30241911196278926,-0.8062817425794153,0.7208029197080292,0.9021553538326329,1.0,2/17,3.11%,MAPK3;NEK7
prerank,cholesterol metabolic process (GO:0008203),-0.21691423920293532,-0.8058981125452116,0.835820895522388,0.9023343302333056,1.0,14/68,18.25%,PPARD;SCARF1;LBR;OSBPL1A;ACAA2;ACLY;ABCG1;PIP4P1;APOE;TSKU;DHCR24;TM7SF2;CH25H;LCAT
prerank,protein processing (GO:0016485),-0.2021782211221028,-0.8055403386299163,0.9022869022869023,0.9024644354004335,1.0,25/102,24.33%,SRGN;F3;ADAM10;BACE1;ADAM19;SPCS1;MMP14;PSENEN;CPE;FAM111A;SEC11A;SPRTN;FXN;APH1A;PHEX;VSIR;RCE1;TMEM208;PRSS12;CASP1;GGT1;SEC11C;CTSS;PTCH1;MYRF
prerank,stem cell development (GO:0048864),0.30261491938093876,0.8051085642818774,0.7208791208791209,0.9466564578798079,1.0,1/16,1.40%,NRG1
prerank,organophosphate biosynthetic process (GO:0090407),-0.24926482607864128,-0.8047635430506777,0.776386404293381,0.9032909432321369,1.0,7/37,16.18%,ITPKB;TPK1;IPMK;FGF2;IP6K1;MBOAT1;PCYT2
prerank,regulation of Golgi organization (GO:1903358),-0.2957073900205335,-0.8034474981749093,0.76007326007326,0.9049698391087024,1.0,6/17,22.33%,MAPK3;ARMH3;EHD3;PDCD10;STX5;CAMSAP3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.253184074092381,0.8027325017330215,0.7756410256410257,0.9500308785393088,1.0,12/36,20.86%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2;EZH2;YAF2;CDC7;MGA;PCGF2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.259111087748116,-0.80259578394908,0.768642447418738,0.9059441696341328,1.0,5/32,10.03%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3462250703341234,-0.8023175280573834,0.7247706422018348,0.9059369402878625,1.0,6/10,29.22%,AKT1;TLR4;CD68;TREM2;CD36;TLR6
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.32383068846106045,-0.8023124026593288,0.7295825771324864,0.9054867861215231,1.0,5/12,26.02%,PRKDC;RPS27L;CCND1;PLK3;PLK5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33891540774920575,-0.8020241637577448,0.7224264705882353,0.9054938325160918,1.0,5/10,27.12%,RCC2;ECT2;KNSTRN;CDC42;RACGAP1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2902901645521918,0.8009579524030638,0.7263157894736842,0.9516924464795379,1.0,19/19,71.01%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2902901645521918,0.8009579524030638,0.7263157894736842,0.9516924464795379,1.0,19/19,71.01%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.30910952310560924,-0.8006064140402076,0.7360594795539034,0.9073391869333445,1.0,3/13,21.30%,ENTPD7;OPA1;RAB23
prerank,mucosal immune response (GO:0002385),0.3104924864035535,0.8001626976604301,0.7205240174672489,0.9522901462113207,1.0,2/15,5.47%,IL4;BPIFB1
prerank,transcription by RNA polymerase I (GO:0006360),0.2545687588143192,0.7996924597110994,0.7808510638297872,0.9523215450526978,1.0,10/34,20.07%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1;TAF1C;TAF1;POLR2K
prerank,protein O-linked glycosylation (GO:0006493),0.20936125817879925,0.7995318481768297,0.8408163265306122,0.9518099417350218,1.0,9/96,7.80%,TMTC1;GALNTL6;GXYLT2;B3GNT7;B3GLCT;TMTC3;TMTC4;POGLUT2;CRPPA
prerank,glycogen catabolic process (GO:0005980),0.3081782365765594,0.7994894957032128,0.7119047619047619,0.9510702320913828,1.0,3/15,11.57%,PHKA1;STBD1;PYGM
prerank,regulation of protein localization to cell surface (GO:2000008),0.2545516434880767,0.7990484679874502,0.7674418604651163,0.9510596432581151,1.0,5/33,6.06%,LEPROT;SNX33;GPD1L;TAX1BP3;GBF1
prerank,transport along microtubule (GO:0010970),-0.3197314036796593,-0.798800319547663,0.7264325323475046,0.9098790585792829,1.0,3/13,9.41%,APP;BORCS5;COPG1
prerank,histone mRNA catabolic process (GO:0071044),0.31216268216177306,0.7987866792007293,0.7158351409978309,0.9507170956855684,1.0,7/15,26.89%,TUT4;ATM;TENT2;MTPAP;SSB;TENT4B;XRN1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.2975148538981707,-0.7966562353756439,0.7536231884057971,0.9128945843744868,1.0,6/17,17.87%,NOTCH1;TGFB1;HEYL;ACVR1;HEY1;DLL4
prerank,apoptotic DNA fragmentation (GO:0006309),0.29989652201053996,0.7962044116380548,0.7181628392484343,0.9545121942295454,1.0,3/16,10.29%,CASP3;EXOG;CECR2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.26389069351389227,-0.7961530641457621,0.7777777777777778,0.9132176831245212,1.0,10/28,23.65%,ESAM;WDR1;PFN1;DBNL;DBN1;RASA1;CTTN;HCLS1;PLEKHG2;ARHGAP18
prerank,hexose biosynthetic process (GO:0019319),0.24572014191468153,0.7959711282838142,0.7840172786177105,0.9540914786982213,1.0,7/42,11.74%,AKR1B1;SLC25A13;SLC25A10;CRY1;ALDOB;MDH2;ENO2
prerank,cellular response to alkaloid (GO:0071312),0.3033714675210965,0.7956156604267756,0.7466367713004485,0.9538945691089684,1.0,3/17,8.95%,SLC8A1;CASP3;BLM
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2742090611768526,-0.7955507257893902,0.7275862068965517,0.9137119537842802,1.0,6/23,12.83%,NOTCH1;CYP1B1;CENPJ;CRLF3;OCIAD1;HES1
prerank,GPI anchor biosynthetic process (GO:0006506),0.26033554447044643,0.7951733338253211,0.7796610169491526,0.9538669251139973,1.0,11/30,22.22%,GPAA1;PIGU;PIGH;PIGP;PIGX;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.1912740981810932,-0.7949661879337229,0.9078156312625251,0.9142074720124047,1.0,11/124,6.57%,FRY;FRYL;RAB11A;OPHN1;STX3;MAP4;APP;RAC1;PTPRM;TTC17;MYOC
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20095666378572116,-0.7948229477750933,0.8954635108481263,0.9139723126179816,1.0,34/101,32.48%,MEF2C;LBP;VIM;DAB2IP;TGFB1;TNFRSF1B;PLAA;PRKCE;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;HCK;CASP1;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,autophagosome organization (GO:1905037),0.23624844890311775,0.7946556197296646,0.8076152304609219,0.953960493424442,1.0,11/50,12.90%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,activin receptor signaling pathway (GO:0032924),0.3088587155117362,0.7943609790981235,0.732484076433121,0.9536844146417295,1.0,2/15,7.95%,SMAD3;TGFBR1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.31231065470296193,-0.7942433506567362,0.7435424354243543,0.9144549652174871,1.0,6/14,38.17%,FUS;WDR48;MRNIP;RAD51AP1;WRAP53;FANCB
prerank,presynaptic endocytosis (GO:0140238),0.278002754304535,0.7941395998960513,0.7223382045929019,0.953284341714987,1.0,5/24,7.71%,STON1;NLGN2;NLGN3;SYT1;NLGN1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.26177636365110685,0.7941200329956271,0.7822410147991543,0.9525118796857849,1.0,7/26,18.37%,HECW2;CDC23;CDC16;DLGAP5;FBXO5;ANAPC5;NSMCE2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3164380133003547,-0.793661541591021,0.7364620938628159,0.914906856952229,1.0,2/13,5.85%,TNRC6C;CNOT7
prerank,AMP metabolic process (GO:0046033),-0.30954147125134157,-0.7934465788227327,0.726148409893993,0.9147694525011212,1.0,7/13,30.09%,NT5E;ADSS2;NT5C1A;ADSS1;NUDT2;AK9;XDH
prerank,rRNA methylation (GO:0031167),-0.27559964716380103,-0.7931225575047341,0.7835820895522388,0.9148025847414968,1.0,8/22,28.38%,NOP2;EMG1;MRM3;ZCCHC4;MRM2;NSUN5;FTSJ3;MRM1
prerank,endodermal cell fate commitment (GO:0001711),-0.33909418314211326,-0.7930782928095929,0.7303370786516854,0.91441426440133,1.0,1/10,3.46%,SOX17
prerank,ubiquinone metabolic process (GO:0006743),-0.30862061411908415,-0.7930170107574799,0.7562380038387716,0.9140402800718932,1.0,5/15,22.19%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3469020838195107,-0.7929166026563265,0.7602862254025045,0.9137392587249338,1.0,1/10,0.70%,CSGALNACT1
prerank,regulation of TOR signaling (GO:0032006),-0.21242832176221732,-0.7928685816289699,0.841897233201581,0.9133456795256534,1.0,26/67,35.32%,SH3BP4;RICTOR;TNFAIP8L1;EPM2A;TBCK;LAMTOR2;PIK3CA;RRAGD;DDIT4;TSC2;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SEC13;PDCD6;LAMTOR5;FAM83D;HDAC3;LAMTOR1;LAMTOR3;PKHD1;DYRK3;TTI1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.2978583960590877,-0.7925243593302602,0.7578125,0.9134328155021167,1.0,6/15,17.33%,VEGFA;FZD3;DISC1;NF1;CX3CR1;KDM1A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.33789799986720886,0.7924516058522996,0.7229166666666667,0.9545935618753739,1.0,4/10,13.69%,IL4;IL18;GATA3;TSLP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.24109751372380755,0.7921236829430428,0.8161157024793388,0.9543611196788554,1.0,4/48,8.44%,ROBO1;STAP1;GSTP1;NLRP2B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2961395782377425,0.7917849182748308,0.7168141592920354,0.9541353385786547,1.0,7/15,21.86%,TNRC6A;CPEB3;POLR2G;TNRC6B;TOB1;AGO2;TENT4A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3132348096551325,-0.7914647678521005,0.7464028776978417,0.9146939611967451,1.0,8/13,41.21%,ANAPC15;DYNC1LI1;LCMT1;NDC80;DUSP1;CCNB1;CDK5RAP2;PCID2
prerank,cobalamin metabolic process (GO:0009235),-0.28963890548241095,-0.7912811197340923,0.7434094903339191,0.9145166528112514,1.0,4/17,17.77%,MTR;CUBN;MMADHC;CD320
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3081819143408795,0.7905778673001063,0.7662921348314606,0.9554201612720141,1.0,5/15,15.50%,FGFR2;PDGFRA;TGFBR1;MTHFD1;MTHFD1L
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.33578545847531854,-0.7898746379418197,0.7467889908256881,0.9163111772509533,1.0,2/10,4.54%,PDE4D;PDE2A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.32347098642441025,0.7897866015428262,0.7565011820330969,0.9560175755252293,1.0,4/12,17.06%,SETMAR;STK33;ORC1;NAE1
prerank,bone morphogenesis (GO:0060349),-0.3120453266291846,-0.7894745476313361,0.7382297551789078,0.9164829035148607,1.0,2/14,2.11%,LRP5;BMPR2
prerank,epithelial cell development (GO:0002064),-0.27789499854445743,-0.788672575501506,0.74,0.9172984759601255,1.0,11/20,40.75%,ACTA2;SIPA1L3;WNT7A;RILPL1;PKHD1;POF1B;GRHL2;RILPL2;WNT7B;RAB25;ROS1
prerank,positive regulation of cell division (GO:0051781),0.24490470910642373,0.7885186435782086,0.8174097664543525,0.9574328360473096,1.0,2/38,1.11%,SVIL;FGFR2
prerank,regulation of telomere capping (GO:1904353),-0.2716649266931647,-0.7880255330885605,0.7849462365591398,0.9178107544638199,1.0,4/23,12.51%,MAPK3;NEK7;USP7;PNKP
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.30322870384895567,-0.7879065575818347,0.7513711151736746,0.9175300091231714,1.0,10/15,35.80%,PLCG2;DDRGK1;PHB2;GLI1;NPM1;FAM83D;CUL3;KLHL18;DYRK3;CDC73
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3091796406551328,-0.7871732909027146,0.7664783427495292,0.9182294283615847,1.0,1/13,0.21%,SLC4A10
prerank,"transcription, DNA-templated (GO:0006351)",-0.17899849461538286,-0.7869315045598312,0.9527896995708155,0.9181531793263633,1.0,35/207,17.82%,RREB1;MLLT3;DDX5;MEF2A;FOXO3;AFF4;IVNS1ABP;NFYA;NR4A2;PTMA;GTF3C5;GTF2E1;ATF4;CBFB;TRIP11;PIR;GTF2H3;XAB2;NELFE;PPP5C;E2F1;RNPS1;BTF3;EPC1;POLR3A;IRF9;SMN1;DRAP1;GMEB2;CCNK;XBP1;GTF2F1;TCEA1;MED20;GTF2H4
prerank,lipid catabolic process (GO:0016042),-0.28807218271893575,-0.7864074015608008,0.7802197802197802,0.9185358653080044,1.0,6/18,33.37%,PLAAT3;ACADL;PLA1A;LIPH;HSD11B1;LIPE
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3256483122797239,-0.7858106791540324,0.7595419847328244,0.9190277762916564,1.0,5/11,35.22%,NR4A2;LMX1A;WNT2;CTNNB1;LRP6
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2846465170648237,-0.7852351361400407,0.7655417406749556,0.9194321268555625,1.0,4/17,10.73%,CD44;TWIST1;PTTG1IP;CD74
prerank,positive regulation of DNA repair (GO:0045739),-0.2289821953241046,-0.7851290639878215,0.8133595284872298,0.9191249028062601,1.0,10/46,17.16%,RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;SLF1;XRCC1;EGFR;BABAM2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.30168275506318043,0.7850944408771963,0.7264770240700219,0.9624809243454413,1.0,4/15,13.45%,UST;DCN;DSE;VCAN
prerank,response to axon injury (GO:0048678),0.29065342758830826,0.7850924064531694,0.7238493723849372,0.9616823516893904,1.0,5/18,17.41%,P2RX4;NREP;DPYSL3;SARM1;FLRT3
prerank,regulation of gastrulation (GO:0010470),0.31302901235795144,0.7846248235248056,0.7086092715231788,0.9616963603205585,1.0,2/14,6.59%,PHLDB2;FOXA2
prerank,camera-type eye morphogenesis (GO:0048593),0.3365030792456226,0.7843957370234786,0.7268993839835729,0.961269032647519,1.0,2/10,6.38%,TENM3;IFT122
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.29606325346166423,0.7843787744809981,0.7592190889370932,0.960493535787428,1.0,3/17,9.58%,NKX6-1;ATOH8;AHI1
prerank,sulfation (GO:0051923),0.3261450596170594,0.7841758991547149,0.684931506849315,0.960013278273684,1.0,2/11,7.11%,UST;SULT6B1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2088045659780421,-0.7841661375117209,0.8902439024390244,0.9201100066821328,1.0,22/70,28.84%,LPCAT3;MFSD2A;CHKA;DBI;CSNK2B;PLAAT3;MBOAT7;CEPT1;MBOAT1;CSNK2A1;CSNK2A2;NR1H2;LCAT;PCYT1A;CHAT;LPCAT2;PLA2G4F;ENPP2;PEMT;LPIN2;SLC27A1;PLA2G4B
prerank,secretory granule organization (GO:0033363),-0.33462919927147783,-0.783740791928259,0.7240773286467487,0.9203186090225574,1.0,2/10,5.21%,SRGN;LYST
prerank,cellular response to UV-A (GO:0071492),-0.32059018441610737,-0.7835569053615206,0.7223230490018149,0.9201287936325439,1.0,8/11,50.00%,OPN3;PPID;MMP3;MMP1;CERS1;OPN5;MMP9;OPN1SW
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2515014907404483,-0.7835160246668449,0.7935606060606061,0.9197338367516376,1.0,14/31,34.73%,DCUN1D5;DCUN1D1;CDC14B;RAB1A;BMI1;FZR1;PIN1;TRIB3;DCUN1D3;MAGEC2;RPS2;PLK1;CDC20;UBE2C
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21269208771195286,0.7831514271982033,0.8568464730290456,0.960929785539216,1.0,8/72,10.63%,ENPP1;DCP1A;DDB2;GTF2H2;SETMAR;RPA2;RFC5;RNASE4
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.26660591489058216,-0.7823752047507168,0.7963302752293578,0.9209868539639423,1.0,5/25,9.05%,DMD;WNK1;ATP1B1;COA8;TRPC6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3342762855186245,0.7822878998934435,0.7276887871853547,0.9615948108942144,1.0,5/11,17.95%,CREB3L1;CEBPB;ATF6;DDIT3;TP53
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.33448978166955856,0.7822633785673676,0.7159090909090909,0.9608464533936883,1.0,4/10,23.59%,DNMT1;RIF1;DNMT3B;SIRT1
prerank,chromatin disassembly (GO:0031498),-0.30150148550735206,-0.7820928163889319,0.7771639042357275,0.9204964750373389,1.0,7/14,37.58%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.30150148550735206,-0.7820928163889319,0.7771639042357275,0.9204964750373389,1.0,7/14,37.58%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3371287586406687,-0.7817555073096615,0.7636054421768708,0.9205492767016835,1.0,4/10,19.37%,ZBTB16;SOX6;BMPR1B;SOX9
prerank,negative regulation of macroautophagy (GO:0016242),0.2648795717884582,0.7811941560142758,0.7611940298507462,0.9618309959701493,1.0,3/26,4.38%,PHF23;UBQLN4;SCFD1
prerank,regulation of feeding behavior (GO:0060259),0.3260128359134829,0.7811932665726676,0.7417218543046358,0.9610354670427101,1.0,1/11,2.85%,LEPR
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.33215465725120824,-0.781006753831675,0.7831775700934579,0.9212044342798816,1.0,3/10,16.40%,MAPK3;FAS;GREM1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23086478259564153,0.7809289283414819,0.8283261802575107,0.9606810233470263,1.0,8/47,14.50%,WNT4;ROCK2;PTGIS;CRY1;KHSRP;ERLIN1;EP300;GLA
prerank,alcohol catabolic process (GO:0046164),0.3267857622914613,0.7801313034780245,0.7122969837587007,0.9611750329893716,1.0,2/10,9.73%,CYP27A1;CYP46A1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2641925326097453,-0.7800352516684611,0.78,0.9222259371904169,1.0,8/23,28.50%,RARA;INHBA;TLR4;VSIR;LAPTM5;LGALS9;INHA;LILRB1
prerank,regulation of cellular catabolic process (GO:0031329),0.22458605139258336,0.7800083237739476,0.8412698412698413,0.9605840174616316,1.0,11/62,13.80%,DAPK2;ITPR1;PIP4K2A;PRKN;DAPK1;KAT8;RAB39B;PIP4K2B;ATM;EP300;MAPT
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.33027246803949556,-0.779922501095635,0.7544169611307421,0.9219339071436725,1.0,6/10,52.90%,USP7;GNMT;SIRT7;DGKQ;PDK2;FBP1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3129631513608083,-0.7794380972613444,0.7490636704119851,0.9222012840066302,1.0,3/12,28.44%,NELFE;EAPP;RNF8
prerank,positive regulation of calcium ion import (GO:0090280),0.3142789054127092,0.778621552128165,0.7377049180327869,0.9620638085968753,1.0,2/12,6.91%,PDGFRB;CALCR
prerank,regulation of exosomal secretion (GO:1903541),-0.27858065396957754,-0.7784125191964987,0.7923497267759563,0.9232259165321356,1.0,8/19,30.79%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23424910569304647,0.7783490468727648,0.8082788671023965,0.961698710826381,1.0,13/45,19.15%,AURKAIP1;SMAD3;BRINP1;BRINP3;TOM1L2;WEE2;TOM1L1;PRCC;BRINP2;ZWINT;TRIM35;FOXC1;ZWILCH
prerank,microtubule anchoring at centrosome (GO:0034454),0.3288750508309264,0.7782676037309306,0.7402597402597403,0.9610422425484587,1.0,4/10,20.74%,NINL;KIF3A;BBS4;CCDC68
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.29751054025599133,-0.778110448634568,0.7598499061913696,0.923159880885579,1.0,10/16,33.39%,SNRPC;DCPS;RBM22;SFSWAP;DDX23;NCBP2;PSIP1;WBP11;SRSF1;WBP4
prerank,regulation of DNA replication (GO:0006275),0.2238607384851422,0.7779475066621899,0.8254310344827587,0.9607792545312364,1.0,12/49,20.32%,GLI2;STN1;USP37;ATAD5;BRPF3;BLM;EHMT2;PDS5A;FBXO5;ORC3;ORC5;PCNA
prerank,regulation of exocytosis (GO:0017157),-0.22859727910879074,-0.7778842864851139,0.8568773234200744,0.9230235538652083,1.0,6/46,9.84%,STXBP6;ANXA1;RAB8B;RAB27A;CPLANE2;RAB8A
prerank,cochlea morphogenesis (GO:0090103),0.3304979270169449,0.7777208608612645,0.7186813186813187,0.9603812169701047,1.0,1/10,2.25%,TBX18
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.26332114058887324,-0.7776917848510874,0.7977941176470589,0.9228656369636671,1.0,3/23,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.320205853286915,0.777595563930545,0.7515400410677618,0.9597971859676748,1.0,2/12,8.31%,STAP1;IL18
prerank,inositol phosphate catabolic process (GO:0071545),-0.3151068614845579,-0.777026662489314,0.7540687160940326,0.9233701762765542,1.0,4/12,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,protein heterooligomerization (GO:0051291),-0.2844418309313457,-0.7767177199829711,0.753199268738574,0.9233715966405246,1.0,8/17,36.06%,PKD1;MAT2A;FARSB;PKD2;GRIN1;KRT10;TMEM120B;TMEM120A
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3192168266170355,-0.7763359991516793,0.7639405204460966,0.9234489416256827,1.0,5/11,28.99%,REST;STK26;PARK7;P4HB;MMP3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.29296336656946165,0.7755736850399944,0.7638297872340426,0.9623011757764475,1.0,2/16,5.09%,LEPROT;VPS25
prerank,cellular response to leucine (GO:0071233),-0.33170388038598775,-0.7747787855690135,0.7626168224299066,0.9247348879978269,1.0,4/10,27.35%,RRAGD;SESN2;RPTOR;SESN1
prerank,response to leucine (GO:0043201),-0.33170388038598775,-0.7747787855690135,0.7626168224299066,0.9247348879978269,1.0,4/10,27.35%,RRAGD;SESN2;RPTOR;SESN1
prerank,positive regulation of DNA recombination (GO:0045911),0.264477660056786,0.7744836397585106,0.7697228144989339,0.9632454825423217,1.0,7/27,17.73%,SHLD2;PRDM9;KMT5C;PAXIP1;RIF1;KMT5B;PARP1
prerank,regulation of actin filament-based movement (GO:1903115),0.32670319462179515,0.7744616111672015,0.7521367521367521,0.9624934475888327,1.0,2/10,10.21%,ANK2;PDE4B
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3052757311863749,-0.7737596761591701,0.7787934186471663,0.925754259545886,1.0,2/13,8.14%,RPS15;NMD3
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3139567080722782,-0.773331423144162,0.7630161579892281,0.9259322533684465,1.0,7/12,34.80%,SEPHS2;CTH;GGT1;SERINC3;SERINC5;SRR;PSAT1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.27832501213035243,-0.7732147316302995,0.781651376146789,0.9256351428354417,1.0,8/20,23.71%,TGFB1;ABI3;PPP2R5A;AP2M1;BCL2L1;TMEM59;CSK;NUMB
prerank,nucleus organization (GO:0006997),-0.22493695853182216,-0.7729243237100647,0.8536585365853658,0.9255938866065809,1.0,14/47,28.54%,SYNE1;RPS19;CHMP2B;NUP93;NDC1;NUP54;NUP155;REEP4;CHMP2A;CEP55;VPS4A;SEH1L;NUP98;CHMP7
prerank,modification-dependent protein catabolic process (GO:0019941),-0.17805322445890664,-0.772914993980854,0.9672131147540983,0.9251527386358247,1.0,45/193,21.56%,NEDD4L;RNF144B;TRIM25;UBB;RLIM;UBC;RPS27A;RNF125;ANAPC15;RNF114;ANAPC11;RC3H1;UBE2L6;ARRDC1;RNF185;UBE2G2;TOLLIP;FBXL14;PCYOX1;PSMD14;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;UBL7;PSMD11;ANAPC7;KCTD10;CDC27;FZR1;XBP1;RNF19A;AMFR;PCYOX1L;KEAP1;UBE2B;UBA1;ANAPC2;BFAR
prerank,establishment of mitotic spindle localization (GO:0040001),-0.24772783135444237,-0.7725796334460177,0.8114602587800369,0.9251743093230856,1.0,9/28,24.31%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,C-terminal protein amino acid modification (GO:0018410),0.32978844426690973,0.771608937657396,0.7527352297592997,0.9662436280672116,1.0,3/11,10.81%,AGBL4;ATG12;FOLH1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2515352704096995,-0.77124698669685,0.7984790874524715,0.926650787183078,1.0,8/27,28.35%,CHKA;PLAAT3;CEPT1;PCYT2;NAPEPLD;SELENOI;LPIN2;SLC27A1
prerank,plasma membrane invagination (GO:0099024),-0.24945021471323692,-0.7710864364572662,0.8072519083969466,0.9264403994773721,1.0,8/29,24.27%,DOCK1;VAMP7;ARHGAP25;SNX18;MSR1;MYH9;AIF1;CDC42
prerank,prostaglandin metabolic process (GO:0006693),-0.2581184375987313,-0.7709027066341877,0.8195777351247601,0.9262381684426451,1.0,7/26,18.30%,PTGDS;EDN1;PLAA;CD74;PTGS1;GSTM1;DAGLB
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.25682185673554064,-0.770654874135501,0.793233082706767,0.9261314753742758,1.0,11/26,35.12%,ST3GAL4;ST8SIA6;RRM1;SCCPDH;LARGE1;GOLPH3;ALG2;B4GALT5;ST3GAL2;TPI1;ALG6
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3008812154904559,-0.7705520997600558,0.7777777777777778,0.9258246627211629,1.0,4/14,17.22%,HSP90AB1;JAK2;STAT1;IFNGR1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.2110022655076323,-0.7704301730609001,0.878968253968254,0.9255379953280066,1.0,9/61,9.33%,RPS3;BRCC3;USP7;RGCC;UIMC1;DHX9;BABAM1;TRIM28;USP9X
prerank,nucleosome assembly (GO:0006334),-0.24270887209388647,-0.7703337180148769,0.8155893536121673,0.9252249780945588,1.0,10/31,30.02%,H3-3A;NAA60;RBBP4;SOX9;NPM1;KAT6B;HMGB2;ANP32B;ASF1B;SMARCA5
prerank,Golgi inheritance (GO:0048313),-0.3207270723923019,-0.7693389751802839,0.7562277580071174,0.9261713115133077,1.0,7/11,26.02%,STK25;VRK1;YWHAZ;PDCD10;STX5;PLK3;PLK5
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2972697026934641,0.7690371566320929,0.7414529914529915,0.9695260251072876,1.0,4/14,23.29%,MOXD1;ACHE;SLC22A2;DAGLA
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25341686323986035,0.7686568869688866,0.8101545253863135,0.9693238131563341,1.0,5/30,13.15%,VAMP5;RAB10;BBS2;OPTN;SYS1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.24793931622269705,-0.7685968242167164,0.7980952380952381,0.9267730949105049,1.0,10/30,25.82%,ABLIM3;SAE1;VPS11;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;UBE2J2;ATG13
prerank,visual perception (GO:0007601),0.20898712186149634,0.768502998009001,0.879746835443038,0.9687602882644207,1.0,17/84,18.98%,ADGRV1;DHRS3;TRPM1;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,positive regulation of mRNA processing (GO:0050685),0.2699454476241,0.7681130422651997,0.7970085470085471,0.9685413716755383,1.0,3/21,7.62%,DAZAP1;TRA2A;CELF4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3072656980892979,0.7675249010752712,0.7483296213808464,0.968660790764975,1.0,4/12,20.13%,PRKCA;PRKCB;LPIN1;CCNB2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2754908122371338,-0.7674989180565285,0.7978339350180506,0.9278614506967728,1.0,8/19,33.91%,HTT;CSNK2A2;FZD5;SREBF1;PARK7;CAMKK2;ATP13A2;HTRA2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3214255758084007,0.7672662700933078,0.7320261437908496,0.9682734605464725,1.0,3/12,10.16%,GPAA1;INSIG2;KDELR3
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.331857026340732,-0.7671130246970651,0.7641681901279708,0.9279562221455337,1.0,4/10,17.06%,MLLT3;ACE;UFL1;HOXB4
prerank,regulation of DNA repair (GO:0006282),-0.2281151469895163,-0.7667589939224291,0.8203125,0.9280480740793688,1.0,7/44,9.21%,RPS3;USP1;BRCC3;UIMC1;DHX9;BABAM1;TRIM28
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.29367242911702846,-0.7667071744669576,0.7913043478260869,0.9276573440911097,1.0,7/15,29.10%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2;ERN1
prerank,antibacterial humoral response (GO:0019731),0.28460282757834476,0.7665420866381343,0.7363834422657952,0.9686137899796967,1.0,5/16,22.39%,JCHAIN;ANG;PLA2G6;RNASE3;SLPI
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19831919683233104,0.7654639283933047,0.8830897703549061,0.9694416935069715,1.0,23/95,18.39%,MCM3;RNF138;GEN1;POLN;GINS2;SWSAP1;BLM;RPA2;MCM2;MCM9;RAD51C;MCM8;RAD51B;FANCM;NBN;RPA1;SMC6;PARP1;SEM1;SMC5;UBE2N;NSMCE2;PALB2
prerank,neural crest cell differentiation (GO:0014033),-0.2831341738321903,-0.7653885117713336,0.8087954110898662,0.9289949826528605,1.0,1/18,0.31%,MEF2C
prerank,early endosome to Golgi transport (GO:0034498),-0.32138586130899244,-0.7650907193676997,0.7981651376146789,0.9289439543332499,1.0,5/11,29.68%,SURF4;EHD3;STX5;SNX2;RAB6A
prerank,Rac protein signal transduction (GO:0016601),-0.2790874777482558,-0.7640472009369621,0.7916666666666666,0.9299569562000316,1.0,4/18,16.41%,EPS8;RAC1;DBNL;NCKAP1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2303932368414004,-0.7633970140947929,0.867704280155642,0.9303690067276764,1.0,15/38,30.65%,PTPRJ;RACK1;AKT1;CIB1;EPHA2;PHLPP2;PHLDA3;TSC2;TRIB3;BANK1;PDCD6;PPP2R5B;MUL1;XDH;HYAL2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.30113802606587914,-0.7631634663463055,0.7978533094812165,0.9302052246018917,1.0,4/13,17.09%,CASP8;PERP;BAK1;BAD
prerank,pseudouridine synthesis (GO:0001522),0.3073960128777264,0.7628644886616386,0.7723404255319148,0.9727035238936789,1.0,5/13,22.80%,RPUSD2;PUS7;PUS1;NHP2;PUS10
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.25055798569188764,0.7626246191262405,0.8245967741935484,0.9722486043821444,1.0,2/29,2.58%,PLA2G5;PLA2G4A
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24684484242370197,-0.762380444472318,0.8172888015717092,0.9308285565597935,1.0,10/29,27.61%,ELOVL7;ACLY;ELOVL5;ACSL5;PPT2;SLC25A1;ELOVL1;ACSF3;HACD2;GCDH
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.32061988993756274,0.7622146839661086,0.7315436241610739,0.9720949615032608,1.0,4/11,17.95%,RPS6KA6;KAT5;SP100;TP53
prerank,regulation of lipase activity (GO:0060191),0.31133852335509804,0.7612918018901446,0.7350427350427351,0.9726737462781662,1.0,13/13,68.89%,PCSK6;SNCA;ANGPTL3;LIPC;LMF1;RHOC;APOA2;ANGPTL8;PCSK5;LPL;PLIN5;FURIN;RHOA
prerank,C4-dicarboxylate transport (GO:0015740),-0.29214337222178444,-0.7610852419487828,0.7958412098298677,0.9321708437974718,1.0,3/14,10.97%,LRRC8D;SLC1A1;SLC25A12
prerank,regulation of T cell migration (GO:2000404),-0.2773133761000557,-0.7609569718706434,0.7992351816443595,0.931888802012403,1.0,2/18,4.12%,LRCH1;APP
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2668005650814871,-0.7609186153540025,0.8169811320754717,0.9314855385859628,1.0,7/20,24.83%,MCUB;MCUR1;PHB2;MICU2;SMDT1;MCU;SLC8B1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.22521414095324765,-0.7602649311063953,0.8543689320388349,0.9319164336651989,1.0,14/42,30.55%,HSPD1;SEC63;HSPA5;TIMM17A;TIMM21;CHCHD4;SEC61B;TIMM50;ZFAND2B;RTN2;SEC61A1;PEX14;PEX6;ROMO1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2924095446960736,-0.7599879495590894,0.7942238267148014,0.9318524006091037,1.0,6/14,28.35%,CHKA;CEPT1;PCYT2;SELENOI;LPIN2;SLC27A1
prerank,protein homotetramerization (GO:0051289),-0.21879168224417272,-0.7594799712180824,0.8685714285714285,0.9320675775540836,1.0,12/49,22.31%,B2M;KCNJ2;GBP5;GLS;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;PKD2;ACOT13;UPB1
prerank,regulation of cilium assembly (GO:1902017),-0.20915689558800363,-0.7590762734328025,0.8853754940711462,0.9321601611511593,1.0,19/62,27.41%,LIMK2;TBC1D8;IFT20;HTT;TBC1D1;TBC1D22A;ATG3;CDK10;TBC1D9B;TBC1D2;RABEP2;DCDC2;TBC1D15;ODAD3;CCDC88A;TBC1D30;TBC1D17;CDKL5;TBC1D5
prerank,regulation of centrosome duplication (GO:0010824),-0.24427442623545653,-0.7590248924297334,0.8264925373134329,0.9317858055701582,1.0,7/30,18.15%,CHMP2B;CENPJ;PLK2;FBXW5;CCNF;TMEM67;CHMP2A
prerank,positive regulation of cytokinesis (GO:0032467),-0.23809710170599804,-0.7585572945925095,0.8246628131021194,0.9319793879563341,1.0,6/32,13.19%,PKP4;CDC14A;GIPC1;KIF23;PRKCE;CDC14B
prerank,response to peptide (GO:1901652),0.24410551983105244,0.7584284283712117,0.7982261640798226,0.9761873731913475,1.0,5/33,11.49%,STAT5B;GNAI1;CALCR;CHRNA7;EIF2B5
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.32667244233931153,-0.7582881668971613,0.7924865831842576,0.9318981027339561,1.0,3/10,17.87%,NOTCH1;PHACTR4;DLL4
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22944512697732392,-0.7579720420776195,0.863905325443787,0.9318807704691726,1.0,6/42,7.53%,ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;A4GALT
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.22052145695159908,0.7579513494219606,0.8571428571428571,0.9761077190127816,1.0,3/52,2.63%,SAMD4A;TUT4;DCP1A
prerank,inflammatory response (GO:0006954),0.18081125560875663,0.7576967097808601,0.9762376237623762,0.9757010277948921,1.0,20/195,10.65%,ADCY1;BMP2;PTGFR;HYAL3;SCUBE1;KIT;TPST1;CEBPB;IL4;PTGDR;ADM;PPBP;HRH1;SCG2;LOXL3;IL18;CCL25;TNFAIP6;C3AR1;ADCY8
prerank,cell cycle checkpoint signaling (GO:0000075),-0.30895539978838926,-0.7576733309702068,0.8046594982078853,0.9318192133191914,1.0,2/12,8.12%,ZW10;PLK2
prerank,glucan catabolic process (GO:0009251),0.28969150744183425,0.757101167653548,0.7632183908045977,0.975837811954934,1.0,3/15,11.57%,PHKA1;STBD1;PYGM
prerank,positive regulation of protein deacetylation (GO:0090312),0.29719384031592416,0.7570454045733472,0.7995594713656388,0.9751369467684105,1.0,3/14,11.00%,AKAP8L;BRMS1;SAP30BP
prerank,microtubule nucleation (GO:0007020),-0.26992718953962247,-0.757012622131645,0.8216911764705882,0.9322491763974203,1.0,7/20,29.62%,CENPJ;SLAIN2;NDE1;NDEL1;TPX2;TUBG2;TUBGCP6
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2469948917229569,-0.7569551783154451,0.8157894736842105,0.9318775494516711,1.0,8/27,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;SIK1;FBXL8
prerank,regulation of lymphocyte activation (GO:0051249),0.31270010672358595,0.756699934077246,0.7466666666666667,0.9748824511998628,1.0,12/12,68.75%,PAG1;LCK;IKZF3;SIT1;CD4;CD19;THEMIS2;CRTAM;CCL5;DCAF15;KAT2A;LAT
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3192843075161063,-0.7565856364999858,0.7707581227436823,0.9319055565268758,1.0,5/10,30.37%,SMYD2;KMT5A;SETD2;METTL18;EEF1AKMT2
prerank,glycolipid biosynthetic process (GO:0009247),0.2370278805406894,0.7565156318868811,0.8364779874213837,0.9743753955741572,1.0,12/38,20.47%,ST6GALNAC5;ST3GAL5;ST8SIA1;PIGU;PIGH;PIGP;ST8SIA5;PGAP3;DPM1;PIGN;B4GALT6;MPPE1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31500038363747535,0.756439946088458,0.7461024498886414,0.973690141985365,1.0,4/12,15.76%,PCGF5;SMCHD1;LRIF1;METTL3
prerank,cyclooxygenase pathway (GO:0019371),-0.3204073597650604,-0.7564006165343351,0.7853403141361257,0.9316920773141755,1.0,3/10,16.72%,PTGDS;PTGS1;CBR1
prerank,dendrite self-avoidance (GO:0070593),-0.28250385744454776,-0.7556090224683647,0.7863894139886578,0.9322547861400649,1.0,2/16,4.96%,BSG;ROBO4
prerank,negative regulation of gluconeogenesis (GO:0045721),0.31674019437915557,0.7553203163797512,0.7562076749435666,0.974599752582717,1.0,2/11,13.44%,CRY1;EP300
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.30495243459350874,-0.7543187005314798,0.7799642218246869,0.9333987902777185,1.0,3/12,11.39%,PRPS2;PRPS1;PRPS1L1
prerank,secondary alcohol metabolic process (GO:1902652),0.22740021391451898,0.7541040811181088,0.834061135371179,0.9756089774792929,1.0,5/42,9.34%,ABCA1;CYP27A1;IL4;ABCA5;SCAP
prerank,intracellular pH reduction (GO:0051452),-0.235917614168415,-0.7537522284110162,0.8434959349593496,0.9336548327431569,1.0,8/33,17.11%,ATP6V0B;ATP6V0A2;CLCN3;ATP6V0C;RAB7A;ATP6V1G1;GPR89B;GPR89A
prerank,regulation of mitotic spindle organization (GO:0060236),0.23394828399239753,0.7530069322129219,0.8481012658227848,0.9764099046255338,1.0,9/35,19.01%,GNAI1;MAP9;BORA;CHMP1A;FSD1;PARP3;NUMA1;DRG1;NUP62
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2441105541074714,-0.7529906453521598,0.8119001919385797,0.9341934553896875,1.0,13/28,44.21%,CYRIB;PRKDC;HSPD1;NOD2;FGF10;CCL2;TYROBP;TNIP2;IL12A;CCDC88B;TNFSF11;IL23A;IL6
prerank,protein lipidation (GO:0006497),0.21386303814319457,0.752272232891316,0.8755458515283843,0.9767083092241241,1.0,19/59,22.22%,WDR45B;ATG12;WIPI1;PIGU;GLUL;PIGH;PIGP;ATG10;ZDHHC2;PGAP3;PORCN;ZDHHC15;DPM1;PIGN;ZDHHC6;MPPE1;ATG5;WDR45;PIGB
prerank,regulation of histone deacetylation (GO:0031063),-0.3019356413143557,-0.75226757305653,0.778584392014519,0.9346696643087524,1.0,5/13,25.66%,CAMK2D;CTBP1;SPHK2;NIPBL;APLNR
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.20090574703763744,0.7517154196082018,0.8934426229508197,0.9767558180217806,1.0,23/80,19.23%,RAB9B;VPS26B;UBE2O;GBF1;RAB29;TRIM27;RHOBTB3;BAIAP3;TBC1D10C;PHETA1;VPS50;TBC1D10A;ARL1;TMED9;DENND5A;SNX8;SNX32;GOSR2;EVI5;VAMP3;SNX6;DENND2A;RAB7B
prerank,DNA dealkylation (GO:0035510),0.31605076087172135,0.751266033547155,0.7649667405764967,0.9758252102568857,1.0,2/10,9.31%,MPG;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31605076087172135,0.751266033547155,0.7649667405764967,0.9758252102568857,1.0,2/10,9.31%,MPG;FTO
prerank,autophagy of peroxisome (GO:0030242),-0.30740460130399905,-0.7510659986500363,0.7781818181818182,0.9358164084722854,1.0,1/12,3.68%,MAP1LC3B
prerank,muscle cell migration (GO:0014812),-0.31751604648817255,-0.750638996568558,0.7938931297709924,0.9359153694278478,1.0,2/10,3.90%,CCN3;SIX1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2435447775477101,0.7501163274195728,0.8461538461538461,0.9766280873987057,1.0,10/31,18.84%,CACNA1I;SYT1;CACNA1G;SYT13;STXBP3;SCAMP5;SYT11;SYT12;SYT6;RAB3GAP1
prerank,retinol metabolic process (GO:0042572),0.28798464858493433,0.7499066123382153,0.7746478873239436,0.9761370045350205,1.0,1/14,2.06%,DHRS3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2732006394644009,-0.7493691485193343,0.8127413127413128,0.9371121781563807,1.0,6/18,26.94%,ELOVL7;ELOVL5;ACSL5;ELOVL1;ACSF3;HACD2
prerank,phospholipid metabolic process (GO:0006644),0.20323510901019187,0.749182767677554,0.9163265306122449,0.9764202287886133,1.0,11/71,14.64%,PLA2G5;PIP4K2A;PLA2G4A;PLPP3;PLPPR1;PLBD2;LGALS13;PIP4K2B;GNPAT;FADS1;PLPPR5
prerank,regulation of myoblast fusion (GO:1901739),0.32215350346096083,0.7489768775559792,0.7742663656884876,0.9759214569099389,1.0,2/11,5.08%,CFLAR;IL4
prerank,regulation of chromosome organization (GO:0033044),-0.2585744735847592,-0.748469782232525,0.843351548269581,0.937846491781574,1.0,12/22,33.64%,RB1;SHCBP1L;WAPL;SMG1;LIG4;CENPV;TERF2IP;MYC;UPF1;SMG6;PIF1;BUB1
prerank,cellular response to misfolded protein (GO:0071218),-0.26709673240461645,-0.7479302598382412,0.8461538461538461,0.9380655840358264,1.0,4/20,12.80%,DNAJB12;RNF185;VCP;RNF5
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.25887945158665127,0.7477766027630788,0.7958333333333333,0.9768246215588643,1.0,1/22,0.54%,BMP2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24341882260163183,-0.7470401451654295,0.8515037593984962,0.9387192238350877,1.0,13/29,35.68%,HSP90AB1;PPIA;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.31625316265366943,-0.7468148035345619,0.8097826086956522,0.9385264718453108,1.0,2/10,11.03%,ATF4;HSPA5
prerank,tRNA wobble uridine modification (GO:0002098),-0.2853158923372454,-0.746552270917957,0.8196428571428571,0.9383966687600154,1.0,3/14,13.54%,DPH3;TRMT9B;URM1
prerank,base conversion or substitution editing (GO:0016553),0.3090318630499283,0.7453276266676955,0.7705263157894737,0.9794349047093028,1.0,1/11,3.36%,ADARB2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.1611055761903939,-0.7447751663799025,1.0,0.9401367455451412,1.0,80/341,23.09%,WWP1;NEDD4L;RNF144B;TRIM25;ZNRF1;WWP2;MVB12B;RLIM;RNF125;ANAPC15;PSMA6;RNF114;ANAPC11;RC3H1;CUL4A;PSMB5;NHLRC3;UBE2L6;KCTD5;PLAA;USP9X;ARRDC1;RNF185;UCHL1;UBE2G2;VCP;TOLLIP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;TSG101;UBL7;PSMD8;PSMD11;TNFAIP3;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;FZR1;XBP1;PELI1;RNF19A;ZSWIM8;TBL1X;AMFR;KCTD2;KEAP1;UBE2B;UBA1;PSMA1;ZFAND2B;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;DTL;PCNP;FBXL19;PSMA2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2695987654859806,-0.7446518183896181,0.798951048951049,0.9398442639495567,1.0,2/18,4.06%,MTR;CUBN
prerank,lymphocyte migration (GO:0072676),0.24306923602809843,0.7444493067305596,0.8155136268343816,0.9798684119743973,1.0,5/32,10.72%,TBX21;CCR6;GATA3;CCL25;MYO1G
prerank,regulation of mitochondrion organization (GO:0010821),0.22416194753579158,0.7439657219800788,0.8731182795698925,0.9797858339070735,1.0,8/47,14.30%,PID1;OMA1;PRKN;IAPP;PARL;EP300;MAPT;STOX1
prerank,mitochondrial membrane organization (GO:0007006),-0.23338241668182266,-0.7435811201805502,0.8605947955390335,0.9407688941216078,1.0,12/32,28.77%,CHCHD3;BCL2L1;BAK1;OPA1;BAD;HSPA9;CHCHD6;TIMM50;SLC25A4;APOO;MICOS13;PMAIP1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.25626822110387637,0.7433935390896252,0.8285714285714286,0.9798092967433895,1.0,5/25,12.48%,OMA1;ATXN3;UFD1;UGGT2;POMT2
prerank,atrial septum development (GO:0003283),-0.29623669993125623,-0.7428857397757519,0.8191681735985533,0.9411643372995644,1.0,2/13,4.12%,BMPR2;TGFB2
prerank,regulation of G0 to G1 transition (GO:0070316),0.23219808502700887,0.7425719214782387,0.8668076109936576,0.9801647492373066,1.0,7/38,11.56%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20241394135850405,-0.7422214199950593,0.9219330855018587,0.9415666022104549,1.0,25/68,29.80%,SLC2A1;MTR;SLC5A6;RFK;CUBN;TPK1;SLC19A3;SLC52A3;MMADHC;SLC2A3;SLC52A2;GSTO2;CD320;NNMT;MTHFS;MCCC1;CYB5R3;MTRR;AOX1;SLC25A19;GSTO1;PANK2;VNN1;SLC23A1;SLC23A2
prerank,negative regulation of translation (GO:0017148),0.19624123592307002,0.7419439679408782,0.9371196754563894,0.980273788618528,1.0,16/87,16.66%,SAMD4A;ROCK2;DAPK1;IGF2BP2;NANOS3;CPEB3;FTO;DDX6;RIDA;FXR2;METTL16;PUS7;RBM24;METTL3;TOB1;CPEB1
prerank,mesenchymal cell development (GO:0014031),-0.2701133705775611,-0.7413048505755924,0.8312611012433393,0.9421916668536205,1.0,7/18,30.11%,NOTCH1;HEYL;PEF1;SNAI2;SOX8;PDCD6;TBX20
prerank,protein homooligomerization (GO:0051260),-0.18557651383341214,-0.7410142033413888,0.9695121951219512,0.942084338514341,1.0,27/114,22.31%,B2M;KCNJ2;EHD4;GBP5;AQP11;ATL3;FUS;ATL2;PRMT8;JMJD6;GLS;SAMHD1;ALDH1A3;MLKL;CTH;NINJ1;HSD17B10;CHMP2A;POLQ;EHD1;AQP4;TRMT61B;ECT2;EHD3;PKD2;ACOT13;UPB1
prerank,snRNA transcription (GO:0009301),-0.20006841222293448,-0.7398445695975714,0.9227799227799228,0.9430571194953382,1.0,25/70,33.24%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;USPL1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,response to UV-B (GO:0010224),0.3081484804365226,0.7398280640735189,0.7933333333333333,0.9824284453413835,1.0,1/12,1.32%,HYAL3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3079108913078556,-0.7397123090858041,0.8086642599277978,0.9427542635040902,1.0,3/11,20.78%,NCL;SMARCA4;PWP1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.3006616091237806,0.7389145756548507,0.7886363636363637,0.9828944667275615,1.0,2/11,11.52%,IL4I1;AHR
prerank,peptidyl-lysine acetylation (GO:0018394),0.319565626765426,0.738085973690136,0.7770961145194274,0.9832133823267651,1.0,10/10,68.06%,EP300;KAT5;KAT2B;SIRT1;ESCO1;KAT7;BAG6;BLOC1S1;CREBBP;KAT2A
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2688394028132283,0.7373323700726471,0.8164556962025317,0.9834336332204409,1.0,2/18,3.41%,GDNF;POR
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.2691061337648757,0.736398277826736,0.8008752735229759,0.9839319832714749,1.0,4/18,11.72%,CHRM2;CHRM3;CDK5R1;GNA15
prerank,regulation of complement activation (GO:0030449),-0.2231210142713171,-0.7361010203950046,0.8861480075901328,0.9467598283841641,1.0,7/40,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,melanosome organization (GO:0032438),-0.24429030814514463,-0.7357783509287474,0.861271676300578,0.9466919464948964,1.0,15/26,38.38%,AP3B1;LYST;HPS1;RAB32;DTNBP1;KIF13A;ABCB6;AP1G1;BLOC1S2;BLOC1S6;AP3D1;SHROOM2;BLOC1S1;GPR143;BLOC1S4
prerank,carboxylic acid catabolic process (GO:0046395),-0.29512003304040857,-0.7352703679388057,0.7836363636363637,0.9468527482030115,1.0,6/12,29.26%,PON3;ACOT8;AMDHD2;RENBP;BCKDK;GNPDA1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27001973105408017,0.7352031596969797,0.7941176470588235,0.9847255321607838,1.0,2/18,2.69%,PPARA;IL4I1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2959779489661908,-0.7350442106038433,0.8032200357781754,0.9466739443348332,1.0,2/12,7.90%,KLF2;TRIM16
prerank,regulation of phosphatase activity (GO:0010921),0.2500355395825676,0.7349793448117028,0.8385744234800838,0.9842322879433759,1.0,1/24,0.54%,BMP2
prerank,central nervous system neuron development (GO:0021954),-0.27943571960180436,-0.7347462762125088,0.7946257197696737,0.9465620663987928,1.0,2/15,4.08%,HSP90AB1;LHX6
prerank,rRNA transcription (GO:0009303),0.278391999591011,0.7346374434849695,0.7913978494623656,0.983895462607716,1.0,6/17,14.65%,POLR1G;GTF3C3;ANG;GTF3C2;GTF3C6;GTF3C4
prerank,regulation of secretion by cell (GO:1903530),0.21260696624818504,0.7336454301517186,0.8907216494845361,0.9844292793093347,1.0,14/54,19.63%,RIMS1;RAB3C;CHRNB4;SYT1;CPLX2;RAB10;MCTP2;LLGL1;SCG5;HCRT;VAMP3;HTR1A;RIMS2;STXBP5
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.30572747469803696,-0.733594013285764,0.8299445471349353,0.9474632604616188,1.0,3/11,16.10%,TGFB2;SOX4;ZFPM2
prerank,cellular senescence (GO:0090398),0.2492222128301018,0.7333888195399396,0.8433476394849786,0.9839852988854728,1.0,2/27,4.65%,TBX3;MAPKAPK5
prerank,negative regulation of transferase activity (GO:0051348),-0.23909045304347287,-0.7332462279375109,0.8650190114068441,0.9473974086165363,1.0,12/28,32.96%,SMAD7;CDKN1B;BAG5;LIMK1;ERCC4;EIF4A2;DTX3L;CDKN1C;PARK7;SRC;PIF1;ABL1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2859603511752063,-0.7332320597549224,0.8206106870229007,0.9469603169306553,1.0,1/14,2.58%,ME1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.20089387076375181,0.7315552330844267,0.9249492900608519,0.9856182157492714,1.0,16/73,15.81%,KDM1B;POLR1A;GLMN;BAZ1B;POLR1G;TRIM27;IGF2;PPM1D;DNMT1;POLR1B;CTCF;EP300;MYBBP1A;EZH2;MYO1C;MTF2
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21830367683273097,-0.7302566127859047,0.9056974459724951,0.9500911801675928,1.0,11/40,18.63%,ARL6IP5;UBB;BAX;AKT1;VCP;BCL2L1;BAK1;ATP5IF1;TUSC2;BAD;SLC25A33
prerank,response to X-ray (GO:0010165),-0.28509848910205016,-0.7301432896345257,0.8333333333333334,0.9497709955584999,1.0,5/14,26.70%,ANXA1;BRCC3;IKBIP;NIPBL;LIG4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2454129162861107,-0.7295436855002695,0.8558558558558559,0.9500248754322551,1.0,4/25,12.35%,LIMK2;SLIT2;ABI3;CDK10
prerank,kinetochore organization (GO:0051383),-0.285482963042741,-0.7294088211985209,0.8330341113105925,0.9497308714379233,1.0,6/13,34.33%,POGZ;NDC80;CENPF;CENPA;NUF2;CENPW
prerank,negative regulation of translational initiation (GO:0045947),-0.2843212848786347,-0.728802843904113,0.8300884955752212,0.9500125561132226,1.0,4/13,26.81%,FMR1;PAIP2B;EIF4EBP1;PAIP2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.25815991057549437,0.728202558441037,0.8061002178649237,0.9892177301342266,1.0,6/22,13.80%,EFEMP2;AEBP1;CAMSAP1;CHRNA7;GBA2;MAPT
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.2670501199317161,-0.728056086245404,0.8608534322820037,0.9504269056300432,1.0,8/18,31.11%,KDR;MIEF1;MIEF2;FIS1;MCU;MFF;MUL1;AURKA
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.19173296816795213,0.7279546909105592,0.9429735234215886,0.9887592580132154,1.0,5/87,4.24%,FLRT2;FGFR2;KL;FLRT1;SFRP1
prerank,mRNA methylation (GO:0080009),0.28151852942061173,0.727940820610507,0.8367768595041323,0.9879969217034753,1.0,4/15,16.81%,VIRMA;METTL16;METTL3;METTL8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.23818421973880113,-0.7275192601049892,0.8609022556390977,0.9505932366803499,1.0,11/27,27.04%,AKT1;DISC1;ULK4;HOMER1;NDEL1;MBOAT1;BRSK2;EFHC2;CCDC88A;TREM2;CAMK2G
prerank,fatty acid transmembrane transport (GO:1902001),0.25927415190963854,0.7271609849740328,0.8369098712446352,0.9882363340276702,1.0,3/19,6.83%,PRKAG2;ABCD2;CPT2
prerank,nuclear pore complex assembly (GO:0051292),0.31002268923947807,0.7266078166288258,0.8165548098434005,0.9881549493544324,1.0,4/10,17.18%,RTN4;NUP205;AHCTF1;TMEM170A
prerank,tRNA 5'-end processing (GO:0099116),-0.27326649872543896,-0.7263598210085696,0.8358490566037736,0.9514541769634973,1.0,5/15,25.51%,RPP38;TRMT10C;HSD17B10;RPP21;RPP25L
prerank,regulation of nuclear division (GO:0051783),-0.25943094916818177,-0.7261854581863652,0.8579545454545454,0.9512227245987703,1.0,6/20,21.07%,CAV2;CDK13;L3MBTL1;PIN1;RCC1;MKI67
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.23617960173325658,0.7259933427004666,0.8669724770642202,0.9881506374561985,1.0,7/32,16.62%,CDK14;TFDP1;NPAT;ORC1;CDK16;BACH1;FBXO5
prerank,neuron projection organization (GO:0106027),-0.28359463590336487,-0.7258208931357506,0.8518518518518519,0.9511669383052788,1.0,3/15,10.22%,APP;INSR;DCTN1
prerank,nuclear membrane organization (GO:0071763),0.2637565368298689,0.7255318434097288,0.8109243697478992,0.9880016843390194,1.0,5/19,16.29%,AKAP8L;UBXN2B;UBXN2A;SPAST;EMD
prerank,histone H3-K4 trimethylation (GO:0080182),0.29631176160327427,0.7250296557049148,0.7808510638297872,0.9878516622100932,1.0,3/11,15.52%,PRDM9;KMT2A;WDR82
prerank,RNA 3'-end processing (GO:0031123),-0.19257926220068738,-0.724619853587535,0.9402390438247012,0.9520685697062622,1.0,20/69,26.91%,RPRD1B;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;THOC7;RPRD1A
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2502006335234799,0.7242735902227926,0.8385542168674699,0.9880317027999397,1.0,3/25,6.90%,AMPD3;PRPSAP2;GMPR
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2949900773218332,0.7241007990653148,0.8175675675675675,0.9874652157766485,1.0,4/13,16.35%,PTPRT;PIGU;TSLP;CRLF2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3000252755365236,-0.723935029240653,0.7935368043087971,0.9523706577765882,1.0,5/12,25.66%,CTBP1;VEGFA;NIPBL;PRKD2;APLNR
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.30376926099927165,-0.723776361582127,0.8241965973534972,0.9520910313785056,1.0,3/11,12.80%,RNF185;VCP;RNF5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.2906750017155237,0.7236771507254622,0.7897091722595079,0.9872412674949205,1.0,3/12,11.11%,ROCK2;TMED10;CHRNA7
prerank,glycogen metabolic process (GO:0005977),0.2421089454882366,0.7236150371293852,0.8388520971302428,0.9865575089913434,1.0,4/27,11.57%,PRKAG2;PHKA1;STBD1;PYGM
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.21567165989418835,-0.7226708838018538,0.8951310861423221,0.9529159652770072,1.0,7/41,13.50%,KCNJ2;KCNQ1;KCNJ10;ACE2;AKAP6;KCNJ15;GNB1
prerank,lipid homeostasis (GO:0055088),0.2047635344216468,0.7221192277192651,0.9008097165991903,0.9876777029663282,1.0,11/57,20.42%,ZBTB20;ABCA1;IRS2;ABCB4;TLCD2;DGAT2;ABHD5;MLXIPL;PPARG;POLD1;NR1D2
prerank,fatty acid metabolic process (GO:0006631),0.1827208324882356,0.7218876380870111,0.980276134122288,0.9871949063265821,1.0,19/115,15.11%,PPARA;ALOX12;ACSM5;ACADSB;ACSL1;BAAT;CPT1C;MSMO1;ABCD2;CPT2;ACOT11;HPGD;LPIN3;NDUFAB1;GNPAT;MCAT;ACSL6;ACACA;NUDT19
prerank,dendritic cell chemotaxis (GO:0002407),0.27886787385532974,0.7216425126422721,0.8322147651006712,0.9867445891598519,1.0,2/14,13.92%,CCR6;CXCR4
prerank,regulation of leukocyte activation (GO:0002694),-0.2766183996480537,-0.7212547346820197,0.8314606741573034,0.9540278156665993,1.0,8/14,36.97%,MFHAS1;GPR137B;CD74;CD200;SHPK;PJA2;CD33;GPER1
prerank,recombinational repair (GO:0000725),-0.1904215119078751,-0.7210091645696008,0.9621928166351607,0.9538472996242537,1.0,29/77,30.52%,ZFYVE26;YY1;SFPQ;PSMD14;SLX4;REV3L;SAMHD1;XRCC1;HUS1;MMS22L;RPA3;BRCA2;AP5Z1;HELQ;POLQ;ERCC4;SFR1;RHNO1;FAN1;POLL;NSMCE1;RAD51AP1;MRE11;SWI5;EXD2;MEIOB;RMI1;RAD52;RECQL
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.29786327384722966,-0.720953517505325,0.809433962264151,0.9534560288900441,1.0,1/11,1.59%,PLCG2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.25693094451635334,-0.7207162629434325,0.8542435424354243,0.9532486471202248,1.0,7/19,32.16%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.2810302509130695,0.7203051481339926,0.7948717948717948,0.987645923955753,1.0,2/13,10.20%,NFAT5;FUT9
prerank,protein import (GO:0017038),-0.18866875424397545,-0.7200227321823319,0.9623015873015873,0.9535469863265776,1.0,23/84,26.54%,RAB8B;NUP93;AKT1;PTTG1IP;E2F3;APOE;SYK;NUP188;TOMM22;HSPA4;PHB2;NUP155;TNPO3;RPAIN;HSP90AA1;TSC2;FIS1;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20623529126868614,-0.7191153164921191,0.9219047619047619,0.954061124741171,1.0,8/49,11.49%,JAM3;PRKCZ;SMAD6;AIDA;SVIP;RPL13A;HSPA5;IMPACT
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.265513980411351,-0.7190716875837931,0.8743362831858407,0.9536563148218157,1.0,6/17,26.39%,CAMLG;EMC10;SGTA;EMC6;EMC9;EMC1
prerank,negative regulation of endocytosis (GO:0045806),-0.2442774204627501,-0.7188587551502268,0.8637931034482759,0.9534334223412078,1.0,2/24,4.56%,CAV1;RAC1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2553578534102358,0.7176638168463988,0.8501070663811563,0.9900703162950346,1.0,3/20,7.95%,EPAS1;PRKN;TGFBR1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2712594034413264,0.7163944674930766,0.8066037735849056,0.9908093987272292,1.0,3/16,11.57%,PHKA1;STBD1;PYGM
prerank,nuclear envelope organization (GO:0006998),-0.2552276862312364,-0.7151014081161337,0.866913123844732,0.9570963287609995,1.0,5/20,17.35%,NUP93;TOR1AIP1;TMEM43;NUP155;REEP4
prerank,neuron remodeling (GO:0016322),-0.3068631751043739,-0.71348586341386,0.8275229357798165,0.9583719241744135,1.0,3/10,8.12%,SCARF1;APP;ANKS1A
prerank,fatty acid biosynthetic process (GO:0006633),-0.19468377642080698,-0.7130568349326517,0.9554655870445344,0.9583757502478559,1.0,10/63,17.96%,ABHD2;ELOVL7;LTA4H;ACLY;ASAH2;ELOVL5;TECRL;GPX4;XBP1;ELOVL1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2021845838040876,-0.7125001985572171,0.9372623574144486,0.9584987333967301,1.0,9/54,11.72%,RAB11A;LIMK2;CHP1;EZR;SLAIN2;DCTN1;TRPV4;CIB1;PCM1
prerank,regulation of gluconeogenesis (GO:0006111),-0.231786003063902,-0.710849297500922,0.85451197053407,0.9597544506705635,1.0,12/27,43.01%,PPARGC1A;USP7;NNMT;ARPP19;SIK1;PTPN2;GNMT;SIRT7;DDB1;CLK2;C1QTNF3;ERFE
prerank,regulation of DNA recombination (GO:0000018),0.2313548745942875,0.7107373920163144,0.8577680525164114,0.9966306598787625,1.0,6/32,14.72%,SHLD2;IL4;BLM;RPA2;THOC1;SIRT6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.25645179469028034,-0.7099707414748736,0.8851851851851852,0.9602637070739646,1.0,10/18,39.61%,BCL2L1;BAK1;BAD;SLC25A4;ALKBH7;MUL1;PMAIP1;HEBP2;SLC25A31;PPIF
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.2736259403376411,-0.7098781864083622,0.8450450450450451,0.9598982462615693,1.0,7/15,29.26%,AMDHD2;OGA;RENBP;LARGE1;CHST5;CHST3;GNPDA1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.26482927207764695,0.7097322124513886,0.8525,0.9962803099846775,1.0,5/17,16.35%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,cellular response to interleukin-7 (GO:0098761),0.26482927207764695,0.7097322124513886,0.8525,0.9962803099846775,1.0,5/17,16.35%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2460082402681032,-0.709622094700759,0.8745387453874539,0.9597259257699822,1.0,8/23,26.02%,ZW10;PLK2;PABIR1;CHEK1;CDK5RAP3;PLK3;VPS4A;PLK5
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.253710026899271,0.7095678528638827,0.8606741573033708,0.9957023960350092,1.0,6/20,18.25%,PID1;LZTFL1;SAPCD2;RHOQ;DAB2;MRAP2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.27066376396087993,0.7089162701954348,0.8362068965517241,0.995689086145648,1.0,6/17,22.16%,CTNNA2;GMFB;BRK1;FCHSD2;WASF1;ABI2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.25133553890870786,-0.7084304492758502,0.8461538461538461,0.9605314007190817,1.0,3/20,8.26%,PAICS;ADSS2;IMPDH1
prerank,embryonic axis specification (GO:0000578),0.27142920133823983,0.7082915598978823,0.8227571115973742,0.995635930366897,1.0,2/15,7.50%,TBX3;CXXC4
prerank,regulation of nervous system process (GO:0031644),-0.25672680843803686,-0.7081734158547185,0.8742857142857143,0.9603638271501717,1.0,2/18,4.12%,NOS3;APP
prerank,regulation of immune effector process (GO:0002697),-0.21376506115281124,-0.7076930490466872,0.9118198874296435,0.9603976107324518,1.0,7/41,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.29184602104483937,-0.7065868304843869,0.8685714285714285,0.96108346004991,1.0,3/11,20.27%,CBFB;VSIR;LGALS9
prerank,protein autoprocessing (GO:0016540),-0.26691166579392356,-0.7063015279165137,0.8503649635036497,0.9609212812585901,1.0,7/17,33.91%,FAM111A;SPRTN;FXN;CASP1;MYRF;PIDD1;HTRA2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.2344842975117056,-0.7059574961843684,0.8870370370370371,0.9608220749628136,1.0,7/24,20.91%,PDE4D;PDE2A;PRKAR2B;PRKAR2A;CGAS;UBE2B;RAPGEF2
prerank,peptidyl-asparagine modification (GO:0018196),-0.2234011448164407,-0.705043146183881,0.9024390243902439,0.9613194676087292,1.0,14/31,35.82%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2;MGAT5;HIF1AN;RPN2;STT3B;OSTC;NUDT14;RPN1;UGGT1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.28789834515769597,0.7050140449134549,0.8169642857142857,0.9985608947317051,1.0,3/11,18.41%,AXL;MERTK;CXCL12
prerank,regulation of regulated secretory pathway (GO:1903305),0.22246361445373466,0.7045839500799339,0.8977505112474438,0.9982860359033987,1.0,9/34,20.29%,RIMS1;SYT1;SYT13;SNAPIN;SYT11;SYT12;SYT6;RIMS2;UNC13D
prerank,protein acetylation (GO:0006473),-0.2295596432311819,-0.70453431004177,0.8875739644970414,0.9613716580922598,1.0,11/30,36.55%,FOXO1;ING5;NAA60;CLOCK;DSCC1;NAT9;NAA50;NAA80;CREBBP;ESCO2;BLOC1S1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.24652865623890077,-0.704397234421256,0.8728323699421965,0.9610549847065775,1.0,9/22,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,RNA catabolic process (GO:0006401),-0.20369901057873468,-0.7043900109819649,0.9297597042513863,0.9606094226226477,1.0,18/46,33.10%,MTREX;PPP1R8;DIS3L2;YTHDF2;RNH1;HSPA1A;LSM2;ZPR1;RNASEH2C;HSPA1B;DNA2;ERN1;XRN2;LSM6;ISG20;SIDT2;ZC3H12D;DCP2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.22237054317214405,-0.7042364052488128,0.9025735294117647,0.9603090733562558,1.0,3/32,4.12%,RPL10;FOXO3;APP
prerank,autophagy of mitochondrion (GO:0000422),0.2205925597692845,0.7039519371530986,0.904862579281184,0.9982470388048041,1.0,9/38,16.54%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A
prerank,nuclear pore organization (GO:0006999),0.2736654182749738,0.7037457920400216,0.8406113537117904,0.997714511848118,1.0,5/14,17.18%,RTN4;NUP205;NUP35;AHCTF1;TMEM170A
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24197332965268098,-0.7035870159160652,0.8714555765595463,0.9604917857777293,1.0,4/21,12.21%,RAB11A;BRD4;CDK4;RCC2
prerank,regulation of autophagosome assembly (GO:2000785),0.22578947202449565,0.7030834033443357,0.8637274549098196,0.9977343032144808,1.0,3/33,4.38%,PIP4K2A;PHF23;SCFD1
prerank,negative regulation of ATPase activity (GO:0032780),0.2694933464013898,0.7030664382407018,0.8344370860927153,0.9969872965596606,1.0,6/16,23.59%,TNNI3;TP53;PAM16;VCPKMT;PXK;SIRT1
prerank,oligodendrocyte differentiation (GO:0048709),-0.2543349329501518,-0.7028781723356404,0.8840304182509505,0.960748814549265,1.0,7/19,25.37%,SOX13;EIF2B3;SOX6;SOX9;MYRF;SOX8;NSUN5
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.21713058656224934,0.702772592799044,0.898406374501992,0.9965221997249569,1.0,5/41,8.94%,SLC8A1;ITPR1;CACNA2D1;IBTK;SLC24A2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2611887780301816,-0.7023122369522118,0.8740875912408759,0.9608744999210138,1.0,3/17,11.05%,STX3;STX1A;STX2
prerank,regulation of cell projection organization (GO:0031344),-0.2777002754105037,-0.702301923341779,0.8691588785046729,0.9604333035303458,1.0,10/13,57.33%,MFSD2A;TREM2;ERMN;NTNG1;MOV10;SEMA4D;NTNG2;FAM110C;MACF1;CCL19
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2749210851298424,0.7022841461163283,0.8148148148148148,0.9963204695652744,1.0,5/13,23.00%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,"DNA-templated transcription, termination (GO:0006353)",0.19679736738288348,0.7018769318404559,0.9446808510638298,0.996041143981392,1.0,12/68,14.52%,POLR1A;GTF2H2;MNAT1;FIP1L1;POLR1G;SYMPK;POLR1B;PABPN1;CCNH;SCAF8;TTF1;CPSF7
prerank,histone H3-K9 demethylation (GO:0033169),-0.29243012572581956,-0.7013067262387301,0.8543689320388349,0.9609702824962412,1.0,2/11,6.71%,JMJD1C;KDM3A
prerank,central nervous system myelination (GO:0022010),0.2932138883518626,0.7001988011444711,0.8097345132743363,0.9971353872201127,1.0,4/11,19.34%,HES5;PTEN;TENM4;B4GALT6
prerank,stress granule assembly (GO:0034063),-0.24833299093094854,-0.6999074020420152,0.8678899082568807,0.9619016659904223,1.0,6/20,20.98%,RPS23;ATXN2L;YTHDF2;CIRBP;LSM14A;YTHDF1
prerank,chromatin assembly or disassembly (GO:0006333),-0.2942881744336875,-0.6997634594898724,0.8605504587155963,0.9616006193805995,1.0,3/11,16.42%,MTA2;CDAN1;RBBP4
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.18965665450353617,-0.6985849349975444,0.9593810444874274,0.9622563270619365,1.0,24/69,33.24%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,positive regulation of double-strand break repair (GO:2000781),0.21568827893340844,0.698310932522745,0.9102296450939458,0.9984032900066888,1.0,9/39,17.73%,SHLD2;SETMAR;KMT5C;FMN2;SMCHD1;RIF1;KMT5B;PARP3;PARP1
prerank,covalent chromatin modification (GO:0016569),0.2712804710219332,0.6982522244529066,0.8102678571428571,0.9976993402472816,1.0,4/14,16.99%,MBD2;AURKC;SETD5;HDAC1
prerank,cellular lipid catabolic process (GO:0044242),-0.22972430666759355,-0.6982291658675334,0.9068901303538175,0.9621297080164795,1.0,9/27,29.73%,PPARD;CYP1B1;ACADL;FAAH;ACOT8;ENPP2;ACOX1;LPIN2;MGST2
prerank,integrated stress response signaling (GO:0140467),-0.2680414787375489,-0.6979522486600188,0.8678899082568807,0.9619445930063317,1.0,3/14,11.49%,ATF4;HSPA5;IMPACT
prerank,arachidonic acid secretion (GO:0050482),0.3048115834260762,0.6966998914531305,0.8041666666666667,0.99781500883124,1.0,1/10,2.09%,PLA2G5
prerank,arachidonate transport (GO:1903963),0.3048115834260762,0.6966998914531305,0.8041666666666667,0.99781500883124,1.0,1/10,2.09%,PLA2G5
prerank,nuclear body organization (GO:0030575),-0.2764643535426747,-0.6958645546418942,0.8563636363636363,0.9634129884865222,1.0,4/12,19.88%,ETS1;USPL1;ZPR1;SERBP1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.23822760922602712,0.6956339254990601,0.86,0.9981701896907245,1.0,5/23,17.91%,MTMR7;PTEN;MTMR10;OCRL;MTMR9
prerank,negative regulation of phagocytosis (GO:0050765),0.26336428810382956,0.6955055078491688,0.869098712446352,0.9975720974228928,1.0,4/17,15.93%,PRTN3;CD300LF;CD47;SYT11
prerank,regulation of mast cell degranulation (GO:0043304),-0.2707220546368252,-0.6953339661310869,0.8652094717668488,0.9634616852613628,1.0,6/14,24.01%,SPHK2;SYK;GAB2;CD84;LGALS9;STXBP2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2729058856310392,-0.6946820601618817,0.8623063683304647,0.9636316970666869,1.0,6/14,28.13%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2217409296634349,-0.6936734125327172,0.9097744360902256,0.9641160812976655,1.0,6/30,14.58%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2
prerank,long-term synaptic potentiation (GO:0060291),-0.24244973718634122,-0.6936387985465441,0.8851224105461394,0.9636970969641838,1.0,3/21,8.12%,PTK2B;PRKCZ;PLK2
prerank,GPI anchor metabolic process (GO:0006505),0.23422758818226286,0.6933987316530119,0.8898305084745762,0.9990629800028454,1.0,9/26,22.22%,PIGU;PIGH;PIGP;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,regulation of centriole replication (GO:0046599),0.2594306050596009,0.6918472504044342,0.8556034482758621,0.9999224776928975,1.0,8/18,23.01%,MDM1;CEP295NL;ALMS1;NUP62;TRIM37;CEP295;CEP76;KAT2B
prerank,intracellular lipid transport (GO:0032365),0.24331662943271815,0.6915688471517204,0.8705357142857143,0.9994562275625096,1.0,3/21,6.83%,PRKAG2;ABCD2;CPT2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2403374557819842,-0.6909885136641929,0.8949416342412452,0.9656578085479411,1.0,10/22,37.76%,FKBP1A;IKBKB;BOD1;MGAT5;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA;ROCK1
prerank,protein kinase A signaling (GO:0010737),-0.28485703983160493,-0.6897968211676628,0.8633879781420765,0.9663019034873193,1.0,2/12,6.47%,MYOM1;EZR
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.27071356722958767,-0.689740102399375,0.8520599250936329,0.9659001655944242,1.0,3/13,28.44%,NELFE;EAPP;RNF8
prerank,histone mRNA metabolic process (GO:0008334),-0.23054617405099273,-0.6891776634189584,0.9080459770114943,0.9659534349571262,1.0,8/27,24.84%,ERI1;SNRPD3;LSM11;SNRPG;LSM1;NCBP2;LSM10;SNRPB
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.1879474566900491,-0.6890508914262131,0.9614643545279383,0.9656030816624148,1.0,18/62,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,microtubule bundle formation (GO:0001578),-0.20749122233286013,-0.6887690686424727,0.9168356997971603,0.9654082027166281,1.0,13/42,32.27%,NAV1;RP1;CHP1;SPEF1;GAS8;GAS2L1;SPAG16;CLIP1;NCKAP5L;CAPN6;PLK1;PSRC1;CFAP206
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24304767846419803,0.6887573735769941,0.8822269807280514,1.0,1.0,4/20,11.11%,CHRM2;CHRM3;CDK5R1;CHRNA7
prerank,negative regulation of TOR signaling (GO:0032007),0.2162296742582624,0.6886364378693444,0.9017467248908297,1.0,1.0,3/36,4.65%,DEPTOR;FNIP1;MAPKAPK5
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23191605051928443,0.6860110644823599,0.8854166666666666,1.0,1.0,8/29,16.39%,SHISA9;GRIK2;CAMK2B;SYP;ZDHHC2;DLG4;DRD2;CLN3
prerank,DNA biosynthetic process (GO:0071897),-0.25839675396010653,-0.6853162846646749,0.8619469026548673,0.9680439084138931,1.0,9/16,42.41%,PPIA;TYMS;RFC3;POLL;TERT;POLE;POLA1;POLH;WRN
prerank,ether lipid metabolic process (GO:0046485),0.26874776718265697,0.6849683346423435,0.8757894736842106,1.0,1.0,1/14,1.30%,AGMO
prerank,regulation of hippo signaling (GO:0035330),-0.255207654151464,-0.6846096494272069,0.9019607843137255,0.9682024462656197,1.0,7/17,30.86%,MOB3B;WTIP;LIMD1;CIT;WWC2;MARK3;NF2
prerank,regulation of embryonic development (GO:0045995),0.21690556732427035,0.6845783886133003,0.9176954732510288,1.0,1.0,5/34,10.70%,PHLDB2;TRIP12;FOXA2;NPHP3;RPS6KA6
prerank,cellular defense response (GO:0006968),-0.2046708527659005,-0.6843339528906026,0.9245647969052224,0.9679975484667487,1.0,3/40,5.78%,LBP;PTK2B;NCF2
prerank,protein methylation (GO:0006479),-0.20843427426268973,-0.6842634338398665,0.9281663516068053,0.9676123493777339,1.0,13/40,30.37%,PRMT8;SNRPD3;FAM98A;EEF2KMT;ICMT;PRMT3;LCMT1;NTMT1;SNRPB;ATPSCKMT;EEF1AKMT3;RAB6A;EEF1AKMT2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.24599077979366407,-0.6839271218276758,0.8705035971223022,0.9674559535990781,1.0,7/19,27.29%,CABYR;AQP4;ROPN1L;ADCY10;SPAG17;NEK10;SPA17
prerank,mitochondrial transport (GO:0006839),0.20054799049974628,0.6837811377912968,0.9319148936170213,1.0,1.0,10/53,15.82%,AIP;BCL2;SLC25A13;MTX2;TOMM70;FBXO7;COX18;TIMM22;SLC25A24;MAIP1
prerank,cell differentiation in hindbrain (GO:0021533),0.27637787792912777,0.6834623603488664,0.8281573498964804,1.0,1.0,1/11,1.54%,GRID2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.28530228506236394,0.6834156172025166,0.8468085106382979,1.0,1.0,6/11,28.42%,ZC3H3;PAPOLA;PAF1;ZFP36L1;LEO1;AHCYL1
prerank,protein import into peroxisome matrix (GO:0016558),0.27955301651076664,0.6834080020260677,0.8422174840085288,1.0,1.0,12/12,72.07%,PEX5L;PEX10;PEX2;PEX16;PEX5;PEX12;PEX1;PEX26;PEX13;PEX7;PEX6;PEX14
prerank,B cell activation involved in immune response (GO:0002312),0.2671396283274736,0.6828566655924906,0.8589473684210527,1.0,1.0,13/13,73.31%,CD180;EXOSC3;RNF168;GPR183;CD40LG;GAPT;CD19;MSH2;BATF;MSH6;FCGR2B;RNF8;LIG4
prerank,primary miRNA processing (GO:0031053),0.2947735950735738,0.6827331566249094,0.8587443946188341,1.0,1.0,5/10,22.80%,SMAD3;METTL3;DROSHA;MRPL44;PUS10
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.28914786166773876,-0.6826120186915899,0.8601769911504424,0.9681757155151333,1.0,5/10,33.66%,EMC10;EMC6;EMC9;EMC1;EMC4
prerank,chromatin assembly (GO:0031497),-0.2053453050983439,-0.6822561247078596,0.9430255402750491,0.9680559981088592,1.0,13/38,30.02%,H3-3A;CDAN1;NAA60;LIN54;RBBP4;SOX9;POLE3;EZH1;NPM1;KAT6B;HMGB2;ANP32B;SMARCA5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23858647266169972,0.682109734894346,0.8840262582056893,0.9999527333758638,1.0,6/22,16.08%,VPS25;VPS37D;UBAP1;TOM1L1;VPS37A;NEDD4
prerank,dorsal/ventral pattern formation (GO:0009953),0.245885656691671,0.6819446844068623,0.8953229398663697,0.9993617685860464,1.0,3/20,9.35%,GLI2;SFRP1;BMPR1A
prerank,mRNA stabilization (GO:0048255),0.21227863818249382,0.6815720871676498,0.9337748344370861,0.9989717129126093,1.0,3/40,5.19%,GDNF;TENT5A;AXIN2
prerank,regulation of lipid catabolic process (GO:0050994),0.2518527823137795,0.6810590089831866,0.87117903930131,0.9987257234538564,1.0,19/19,74.84%,PDE3B;ALK;RARRES2;ANGPTL3;APOC3;SCT;LONP2;APOA2;IL1B;PRKAA1;HCAR2;ABCB11;TNF;ABCD1;CIDEA;ADRA2A;TYSND1;BSCL2;APOC1
prerank,positive regulation of vacuole organization (GO:0044090),0.2968630090230793,0.6808070101503056,0.8319502074688797,0.998213396890031,1.0,4/10,18.84%,PIP4K2A;PIP4K2B;LRSAM1;RAB3GAP1
prerank,phosphate ion transmembrane transport (GO:0035435),0.2716751766357164,0.680330208902127,0.8571428571428571,0.9978951519839131,1.0,3/12,15.22%,SLC20A2;SLC25A10;SLC25A30
prerank,monosaccharide transmembrane transport (GO:0015749),0.25262047761029416,0.6800690618652628,0.8627906976744186,0.9973710914910919,1.0,1/16,2.70%,SLC5A3
prerank,peroxisome organization (GO:0007031),-0.23323558746017564,-0.6798380979747298,0.9031657355679702,0.9697001166744058,1.0,11/25,33.99%,PLAAT3;ACOT8;FIS1;PEX11G;PEX11A;SEC16B;PEX14;MFF;PEX6;ABCD3;PEX7
prerank,positive regulation of translational initiation (GO:0045948),0.2507092253242479,0.679735578841336,0.8556034482758621,0.9969496380069767,1.0,6/18,18.32%,KHDRBS1;POLR2G;EIF2B5;HABP4;CDC123;POLR2D
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.29051445939213927,-0.6793373776536903,0.859375,0.969671971259047,1.0,4/10,29.30%,GRB10;ITGB3;PRKD2;ITGA5
prerank,sensory perception of taste (GO:0050909),0.289184608624694,0.6787665123445712,0.8449781659388647,0.9971149357466565,1.0,10/10,71.10%,ASIC2;TAS1R1;PKD1L3;PKD2L1;TAS1R3;GNAT3;ASIC1;TAS1R2;ASIC3;CD36
prerank,regulation of protein acetylation (GO:1901983),-0.2803368012140524,-0.6770006917334535,0.8808664259927798,0.9711950665296455,1.0,4/12,29.01%,CAMK1;RAPGEF3;PARK7;TERF2IP
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2312080987072752,-0.6758605471071621,0.9187620889748549,0.9716830867978427,1.0,9/24,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.25626328664151854,-0.6758208018976655,0.8998211091234347,0.9712694109710256,1.0,3/16,8.26%,PAICS;ADSS2;IMPDH1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.2672601251365615,-0.6753613186790649,0.8853046594982079,0.9711863503941929,1.0,3/14,16.02%,ACOX3;CROT;ACOT8
prerank,glial cell differentiation (GO:0010001),-0.22149246936688088,-0.6750613046403381,0.9273422562141491,0.9709720789350262,1.0,7/28,24.58%,ADGRG6;SOX4;SOX9;FGF10;METRN;MYRF;SOX8
prerank,mitochondrial genome maintenance (GO:0000002),0.2825115474192298,0.6748117210225232,0.8280542986425339,1.0,1.0,4/11,17.73%,AKT3;TOP3A;SLC25A36;PARP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.2805611016809418,-0.6746675244856151,0.8907721280602636,0.970835572989756,1.0,5/11,33.91%,FAS;LGALS9;PLAUR;PARK7;HTRA2
prerank,tRNA methylation (GO:0030488),0.2071038775028558,0.674159184661424,0.9444444444444444,0.9999552781567457,1.0,11/34,23.45%,DALRD3;FTSJ1;NSUN6;METTL6;BCDIN3D;TARBP1;TRMT1L;TRMT12;PRORP;TRMT5;THUMPD2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.2771724127549843,-0.6737456009476774,0.8597785977859779,0.9702538528887684,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.2771724127549843,-0.6737456009476774,0.8597785977859779,0.9702538528887684,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.2771724127549843,-0.6737456009476774,0.8597785977859779,0.9702538528887684,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.2945598191818023,-0.6727529924591465,0.8594594594594595,0.9705941422770603,1.0,2/10,17.36%,TLR4;VSIR
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.21999875246234316,-0.6726177782595363,0.9267326732673268,0.9702604137661862,1.0,12/30,31.28%,ELOVL7;ELOVL5;TECRL;ELOVL1;ACOT2;HACD4;SLC27A2;ACOX1;HACD2;SLC27A6;ACOT1;ABCD3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.21017864327577485,0.6725170289185703,0.9324894514767933,1.0,1.0,2/37,2.58%,PHLDB2;EPHA3
prerank,epithelial cell morphogenesis (GO:0003382),0.25044254744555855,0.672230074814406,0.8832271762208068,1.0,1.0,2/17,9.01%,COL22A1;CNMD
prerank,histone H3 deacetylation (GO:0070932),-0.26005770150500795,-0.6720787114798605,0.8945386064030132,0.970245411090627,1.0,3/15,11.34%,HDAC9;HDAC4;SFPQ
prerank,regulation of synapse maturation (GO:0090128),-0.2907601357608657,-0.6718598223794777,0.8776595744680851,0.9699661669758441,1.0,3/10,12.13%,ARHGEF15;DAB2IP;YWHAZ
prerank,coenzyme A metabolic process (GO:0015936),-0.2590262820918543,-0.6708795843459419,0.8844765342960289,0.9703101965105544,1.0,4/14,29.03%,ACLY;CROT;SLC25A16;PANK2
prerank,regulation of calcium ion import (GO:0090279),0.23765507424090096,0.6706973480787021,0.8852459016393442,1.0,1.0,5/21,18.41%,PDGFRB;TRIM27;PLPP4;WNK3;CXCL12
prerank,histone H2B ubiquitination (GO:0033523),-0.2887546215771877,-0.6703584989226905,0.8662900188323918,0.9702835518318264,1.0,5/10,35.80%,RNF20;DTX3L;RNF40;RNF8;CDC73
prerank,positive regulation of actin nucleation (GO:0051127),-0.2748014029151661,-0.6687275170499736,0.8825622775800712,0.9711861010251547,1.0,1/11,1.61%,WASF2
prerank,protein N-linked glycosylation (GO:0006487),-0.1799614470323198,-0.6686192980531168,0.9652509652509652,0.9708302916799552,1.0,20/66,27.54%,TMEM165;ST6GAL1;SLC39A8;MGAT1;FUT8;KRTCAP2;DAD1;GFPT1;OST4;MCFD2;TMEM258;ALG9;ALG12;MGAT5;ALG1;PGM3;RPN2;ALG2;ALG3;STT3B
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.25881236835839927,0.6679331517680436,0.8650963597430407,1.0,1.0,2/13,10.66%,CBLB;NUP35
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.26905785151994377,0.6678683731874419,0.8818181818181818,1.0,1.0,4/12,16.03%,GOLGA2;PTEN;BTRC;SKP1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.25840130710095677,-0.667729391312621,0.8814531548757171,0.9710501851388251,1.0,10/14,52.61%,PAEP;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,regulation of keratinocyte migration (GO:0051547),-0.27155265331948886,-0.6671955519226919,0.8880994671403197,0.9710206088236727,1.0,4/12,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2240124252801649,-0.6670996612826186,0.9260628465804066,0.9706500576781733,1.0,9/25,28.77%,TNFSF10;BAX;BBC3;BAD;BIK;PLAUR;HRK;MFF;PMAIP1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24574057721544357,0.6665403697314655,0.8801742919389978,1.0,1.0,2/19,8.91%,STN1;PINX1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.20930516577493877,0.6663099029737292,0.9371069182389937,1.0,1.0,6/36,13.15%,VAMP5;RAB10;BBS2;AFDN;OPTN;SYS1
prerank,axoneme assembly (GO:0035082),0.21945950519107035,0.6662189757016712,0.9147609147609148,1.0,1.0,3/31,6.91%,CFAP74;DNAAF3;CCDC65
prerank,L-serine metabolic process (GO:0006563),0.28114995919904606,0.6659117954460173,0.8688524590163934,1.0,1.0,10/10,71.90%,PSPH;PHGDH;CBS;SHMT1;SDS;SHMT2;PSAT1;SRR;SERINC5;SERINC3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.21822459922241946,0.6652304591108897,0.9154013015184381,0.9997811145932427,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,7-methylguanosine RNA capping (GO:0009452),0.21822459922241946,0.6652304591108897,0.9154013015184381,0.9997811145932427,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,interstrand cross-link repair (GO:0036297),-0.19059947351587575,-0.6648490156242938,0.9689320388349515,0.971885935817594,1.0,27/53,39.24%,UBB;USP1;UBC;RPS27A;ERCC1;VCP;SLX4;DCLRE1C;RPA3;WDR48;ERCC4;FAN1;FANCD2;RAD51AP1;ATRIP;RNF8;FAAP24;UBE2T;NEIL3;CENPX;FANCF;MSH6;RAD51;UBA52;EME1;FANCB;XPA
prerank,negative regulation of centrosome duplication (GO:0010826),-0.27528309990773314,-0.6643431351394048,0.894927536231884,0.9718343939973955,1.0,7/11,38.29%,CCNF;TMEM67;RBM14;NPM1;KAT2A;CDK5RAP2;BRCA1
prerank,neuron maturation (GO:0042551),-0.24357308839821643,-0.6641653522763665,0.9191321499013807,0.9715214377981796,1.0,3/18,8.12%,SCARF1;APP;ANKS1A
prerank,modulation by host of viral genome replication (GO:0044827),0.2680266389769956,0.664106805676656,0.8799171842650103,1.0,1.0,4/13,18.25%,PRKN;YTHDC2;TBC1D20;IFI27
prerank,long-term memory (GO:0007616),0.24543564784930647,0.6639592223779522,0.8824786324786325,0.9994217702141497,1.0,3/19,12.40%,CAMK4;CPEB3;RASGRF1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21820201572172032,0.6636599162235204,0.9204081632653062,0.9989282423644537,1.0,8/31,18.33%,SHLD2;KMT5C;PAXIP1;TNFRSF4;RIF1;KMT5B;VAMP3;RBP4
prerank,NAD biosynthetic process (GO:0009435),0.24598292858216214,0.6633467279610965,0.891832229580574,0.9984409926779498,1.0,3/20,10.06%,PARP16;PTGIS;KYNU
prerank,regulation of T cell mediated immunity (GO:0002709),-0.29274558557505626,-0.6633463767823656,0.8994515539305301,0.9716840312620343,1.0,1/10,7.20%,TNFRSF1B
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.27899153086063033,0.6632208404975785,0.8389261744966443,0.9978140440493611,1.0,4/11,26.29%,PARN;EXOSC3;EXOSC2;TENT4B
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2508370316560747,-0.6625595811994496,0.9055258467023173,0.9718233027738923,1.0,4/16,17.68%,PIGL;PIGF;PIGC;PIGW
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.2802796770097174,0.6616815684469433,0.862144420131291,0.9983413251836906,1.0,1/10,1.51%,LRP1
prerank,dopaminergic neuron differentiation (GO:0071542),0.2420919260112579,0.6615039180651916,0.8881278538812786,0.9977535049848141,1.0,3/19,8.57%,PHOX2A;FOXA2;RYK
prerank,lymphocyte chemotaxis (GO:0048247),0.21294705513026774,0.6608760618096219,0.9190371991247265,0.9975555402645163,1.0,3/34,9.84%,CYP7B1;CXCL16;CCL25
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.22991857038528712,0.6607153137943336,0.9045643153526971,0.9969544301662716,1.0,6/23,19.07%,ALOX12;GSTP1;HPGD;FADS1;ELOVL6;PTGS2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.24311814127394973,0.6604139292357852,0.8893905191873589,0.9964615879546694,1.0,4/17,16.46%,SULF1;FSTL3;PCSK6;TWSG1
prerank,retrograde axonal transport (GO:0008090),0.24647092146784716,0.6597851236601812,0.8671171171171171,0.9962693050122307,1.0,5/16,20.67%,DLG2;KIF1A;ACTR10;FBXW11;TMEM108
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24597128654215739,-0.6594824632414185,0.9022140221402214,0.9736654025401706,1.0,12/16,50.34%,CYRIB;LILRB1;IL12A;CEACAM1;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.21889220530618864,0.6590449283870387,0.9394572025052192,0.9961704362175371,1.0,8/27,18.77%,RIMS1;SYT1;SCIN;SYT13;SYT11;SYT12;SYT6;RIMS2
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2765282501837622,-0.6588674781786298,0.8998178506375227,0.9736589411690785,1.0,2/11,16.42%,H3-3A;RBBP4
prerank,ncRNA transcription (GO:0098781),-0.25909069704410337,-0.6584003887234616,0.9044117647058824,0.9735578175593899,1.0,4/13,20.05%,CAVIN1;SPIN1;USPL1;GTF3C1
prerank,magnesium ion transport (GO:0015693),0.2676090341489582,0.6583947258734958,0.8764568764568764,0.9959639564234872,1.0,4/12,20.75%,MAGT1;SLC41A1;TUSC3;NIPAL1
prerank,histone lysine demethylation (GO:0070076),0.22420196597719452,0.6575678020141871,0.8980891719745223,0.9959303086275115,1.0,7/25,18.71%,KDM1B;KDM7A;KDM2A;PHF8;HR;KDM4C;KDM5B
prerank,RNA methylation (GO:0001510),0.18414165219573553,0.6573113024766694,0.9711934156378601,0.9953795055208929,1.0,20/60,25.21%,VIRMA;FTSJ1;HENMT1;DIMT1;METTL16;NSUN6;MTERF4;METTL6;METTL3;BCDIN3D;METTL8;TFB1M;TARBP1;TRMT12;TRMT5;THUMPD2;RBM15;WTAP;BUD23;THUMPD3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2614233661116673,-0.6572761532871934,0.8938053097345132,0.9739493613635183,1.0,4/14,32.33%,TPP1;BRCA2;TERF2IP;TERT
prerank,regulation of microtubule nucleation (GO:0010968),-0.28227934608922206,-0.6539668834718014,0.8920863309352518,0.9759363485281093,1.0,3/10,21.43%,DCTN1;HSPA1A;HSPA1B
prerank,phagosome maturation (GO:0090382),-0.20371725518002357,-0.6536099649491446,0.9487704918032787,0.9757508138303809,1.0,12/35,31.20%,ATP6V0B;ATP6V0A2;MREG;ATP6V0C;RAB7A;ATP6V1G1;RAB32;RAB43;ATP6V0D1;CORO1A;ATP6V0E2;ATP6V1C1
prerank,regulation of DNA metabolic process (GO:0051052),0.1989937884646794,0.653604464290862,0.9358974358974359,0.9976140129176257,1.0,12/44,19.43%,KDM1B;RADX;HDAC8;HNRNPD;TOM1L1;THOC1;NBN;STOX1;CDK9;UBE2N;WRNIP1;SMG5
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.28613664244482484,-0.6533936419049178,0.8942652329749103,0.9754578291557621,1.0,5/10,24.30%,IMPACT;HSPA1A;NCK1;DNAJB1;HIF1AN
prerank,dendritic cell migration (GO:0036336),-0.2481897620688536,-0.6531222324214627,0.9041353383458647,0.9751950218519835,1.0,1/16,1.78%,EPS8
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2275960696966036,-0.6522002156518031,0.9253731343283582,0.975371455860419,1.0,4/22,17.36%,CBFB;BCL6;SOX12;VSIR
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2589302559222101,0.6521610763914976,0.8848758465011287,0.998041343819955,1.0,2/14,8.44%,GSTP1;NLRP2B
prerank,insulin secretion (GO:0030073),-0.23433977339149148,-0.6516288595963636,0.9236499068901304,0.9753359300109627,1.0,7/19,30.97%,ANXA1;RAB11B;PARK7;RAB11FIP5;CAMK2G;ADCYAP1;SNX19
prerank,phagosome acidification (GO:0090383),0.22510716246714146,0.651355254171888,0.9329388560157791,0.9979208704935648,1.0,5/26,15.44%,ATP6V0A4;ATP6V1H;RAB38;ATP6V1B2;RAB20
prerank,mRNA catabolic process (GO:0006402),0.19682932553744098,0.65128816344646,0.9628099173553719,0.9972470917258752,1.0,9/44,15.76%,TUT4;AGO4;DHX34;RIDA;PNPT1;METTL16;NBAS;NBDY;METTL3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.24701541804558869,-0.6505409623743639,0.9252873563218391,0.9756530990530277,1.0,2/15,12.89%,CD55;SYK
prerank,spliceosomal complex assembly (GO:0000245),0.19698194760780502,0.6500160477962217,0.9433198380566802,0.9975415746971739,1.0,4/46,10.05%,CELF2;CELF4;RBM5;GCFC2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.1907290757167961,-0.6491174066044968,0.9640151515151515,0.9761800134477953,1.0,16/48,31.95%,ACTB;SERTAD2;ARID1A;WBP2;SPHK2;ZMIZ2;CDCA4;CHEK1;POLR1F;TAF1B;POLR1C;POLR2F;SMARCA5;POLR1H;POLR2L;KAT2A
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.17570773773685633,-0.6489649305442775,0.9784313725490196,0.9758295213751886,1.0,18/64,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,negative regulation of histone acetylation (GO:0035067),0.27041201532600945,0.6489087365083618,0.8642241379310345,0.9976475478531354,1.0,6/11,25.80%,NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2394785495111761,-0.648441812937817,0.9347014925373134,0.9757336721769674,1.0,7/18,33.75%,JAK2;SMAD4;STAT1;IL6ST;SPI1;SRC;CBL
prerank,protein localization to cilium (GO:0061512),-0.20301582147148517,-0.648142808865883,0.9512195121951219,0.9754904068808905,1.0,7/32,18.42%,IFT20;TULP2;ZNF423;TUB;ARL6;RABEP1;EHD1
prerank,zymogen activation (GO:0031638),-0.19886388814223666,-0.6467221589303614,0.9664804469273743,0.9759625855691494,1.0,10/39,20.24%,CASP8;MMP14;PERP;BAK1;PGK1;BAD;VSIR;PLAU;PRSS12;GGT1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.19874991573008433,-0.6458524089121679,0.9534412955465587,0.9761118993660115,1.0,12/38,25.82%,ABLIM3;SAE1;VPS11;ATP5IF1;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;SREBF1;UBE2J2;ATG13
prerank,protein export from nucleus (GO:0006611),-0.2197919356449266,-0.6458287985365396,0.9482142857142857,0.9756823155422594,1.0,5/27,13.59%,TGFB1;PKD1;CHP1;STYX;SMURF1
prerank,lipid phosphorylation (GO:0046834),-0.2761242730607417,-0.6450439834942351,0.9078947368421053,0.9757559149115808,1.0,1/10,1.69%,DGKH
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.20278839355122272,0.6441706605266468,0.9471458773784355,1.0,1.0,14/42,26.08%,SHLD2;UBQLN4;RADX;RPA2;SMCHD1;RIF1;SIRT6;PARP1;RTEL1;FBH1;WAS;TIMELESS;ARID2;PPP4C
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.26089350611986967,-0.6441403909617252,0.8862385321100917,0.9759312128313913,1.0,6/13,28.59%,OGA;RENBP;PGM3;LARGE1;CHST5;CHST3
prerank,regulation of double-strand break repair (GO:2000779),0.19983370425646857,0.6432074221872993,0.958963282937365,1.0,1.0,5/39,10.92%,SHLD2;TRIP12;OTUB2;RPA2;FMN2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.2490111518051254,0.6421117794693545,0.8731182795698925,1.0,1.0,2/14,5.54%,ACTN3;IRS2
prerank,negative regulation of catabolic process (GO:0009895),0.1925261179344214,0.6420086555824251,0.9626556016597511,0.9999124246239193,1.0,12/47,20.26%,PPARA;ACTN3;SIRT2;PDE3B;ALK;FMN2;PRKCG;SF3B3;CYP51A1;NUPR1;IRAK3;AZIN2
prerank,nucleocytoplasmic transport (GO:0006913),-0.19066401130446506,-0.6410863671676044,0.9661654135338346,0.9774380907264506,1.0,22/40,40.17%,ANP32A;SNRPD3;HTATIP2;SMN1;RITA1;DDX20;HNRNPA1;SNRPG;NXT2;NCBP2;SNRPB;NPM1;NUP98;XPO1;RBM15B;RSRC1;SNUPN;SNRPE;SNRPF;GEMIN2;NXT1;NCBP1
prerank,urogenital system development (GO:0001655),-0.2636222230800981,-0.639664234693542,0.8906810035842294,0.9778700380681601,1.0,1/11,3.46%,ANXA1
prerank,protein heterotetramerization (GO:0051290),-0.25946686382238804,-0.6392820468772106,0.9007352941176471,0.9776652526153877,1.0,5/13,31.75%,PKD1;FARSB;PKD2;GRIN1;KRT10
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.2760885408238961,-0.6391646756715921,0.889090909090909,0.9772965606446062,1.0,2/10,12.33%,AKT1;PRKCE
prerank,regulation of microglial cell activation (GO:1903978),0.25611125249935135,0.6386450524222688,0.8906560636182903,1.0,1.0,14/15,63.93%,STAP1;SYT11;TTBK1;SPHK1;MMP8;PTPRC;NR1D1;CCL3;CX3CL1;IL6;TAFA3;CST7;GRN;LDLR
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.27465405630710216,-0.6384053828881239,0.9127134724857685,0.9773306973318581,1.0,4/10,27.86%,AIDA;DNAJA1;PTPN22;PDCD4
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2665841231326513,-0.6381127010844061,0.9169675090252708,0.9770827161078866,1.0,2/11,7.75%,TNFRSF21;RC3H1
prerank,regulation of catecholamine secretion (GO:0050433),0.20997507125116993,0.6375187101299659,0.9216494845360824,1.0,1.0,8/29,18.07%,PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,regulation of immunoglobulin production (GO:0002637),-0.21424128275594462,-0.6349814549736054,0.9402985074626866,0.97857873716052,1.0,4/23,17.16%,GPI;PHB2;CLCF1;XBP1
prerank,lysosome organization (GO:0007040),-0.19362371253556948,-0.6347905090702072,0.9515828677839852,0.9782534578942866,1.0,12/36,33.32%,TPP1;TMEM165;HPS1;VPS33A;TFEB;TPCN2;GNPTAB;MYO7A;ATP10B;CORO1A;LAMTOR1;MBTPS1
prerank,DNA-dependent DNA replication (GO:0006261),-0.1548471085709774,-0.6345605728901161,1.0,0.9779549800908243,1.0,49/128,37.58%,UBB;UBC;RPS27A;PSMA6;PSMB5;BAZ1A;PSMC4;PSMC5;PSMD14;PNKP;REV3L;DDX23;PSMD8;RPA3;PSMD11;RPAIN;PSMB4;PSMD12;PSMC1;GINS3;PSMA1;PSMB1;PSMC3;PSMA4;RFC3;PSMA2;POLE3;MCM5;RFC2;PSMB8;DNA2;POLB;PSMC6;RECQL;TWNK;CDC6;PSMD6;PSMA8;HELB;POLE;POLA1;PSMD2;GINS4;PSMB2;RAD51;SIRT7;UBA52;PURA;HMGA1
prerank,regulation of centrosome cycle (GO:0046605),0.22847942623552142,0.6339876373321032,0.9077568134171907,1.0,1.0,3/21,9.48%,ATF5;GEN1;CHMP1A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.27305253907475996,0.6329478252171339,0.8980477223427332,1.0,1.0,10/10,72.71%,RYK;WNT3;WNT5A;FZD1;WNT3A;WNT1;WNT9B;LRP6;CTNNB1;WNT2
prerank,regulation of histone methylation (GO:0031060),-0.24904524354154223,-0.632698130579599,0.9131205673758865,0.978616315536578,1.0,4/13,22.13%,CHTOP;AASS;TTLL12;NNMT
prerank,RNA biosynthetic process (GO:0032774),0.2067378198640912,0.6320110011732387,0.9509594882729211,1.0,1.0,30/31,71.58%,TTF1;GTF2B;TCEA2;TAF7;PRIM1;PRIM2;SETX;BRF1;BRF2;TBPL1;RSF1;TAF13;TBPL2;ELL3;TAF6;PRMT5;POLA2;TTF2;POLR2A;TAF12;NAT14;NCOA6;TBP;POLA1;HELB;TERT;SMARCA5;TAF5;TAF10;TAF4
prerank,hexose metabolic process (GO:0019318),-0.19177253723470924,-0.6313211641016766,0.9712746858168761,0.9789514648677408,1.0,15/39,36.94%,PPARD;HK1;PGM1;FUCA2;GALM;GALT;BRAT1;DCXR;FUCA1;ALDOA;HECTD4;ADPGK;GDPGP1;APOD;TFAP2B
prerank,regulation of telomere maintenance (GO:0032204),-0.2103992671276591,-0.6291725613953801,0.951310861423221,0.9797316522710657,1.0,11/26,33.30%,USP7;ERCC1;ERCC4;SMG1;MRE11;TERF2IP;MYC;UPF1;SMG6;PIF1;RAD50
prerank,detection of visible light (GO:0009584),0.23776800213137156,0.6281406374631445,0.9038461538461539,1.0,1.0,1/16,3.53%,ABCA4
prerank,superoxide anion generation (GO:0042554),0.2547129098331191,0.6272668896055753,0.896551724137931,1.0,1.0,1/13,2.55%,ALOX12
prerank,negative regulation of hippo signaling (GO:0035331),0.26139627338435073,0.6269784801712778,0.9071925754060325,1.0,1.0,2/12,8.58%,WWC1;AJUBA
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.20975474162449093,0.6264658474639058,0.9455337690631809,1.0,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.20975474162449093,0.6264658474639058,0.9455337690631809,1.0,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,positive regulation of cell development (GO:0010720),-0.19490063605681368,-0.6260439064208276,0.965183752417795,0.9810854589054341,1.0,8/31,26.70%,TGM2;FAIM;CX3CR1;BAD;NUMB;ATP6AP1;LRP2;LIG4
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.20595655138086122,-0.6248390938669367,0.9446564885496184,0.981323103572163,1.0,9/26,26.08%,APP;TAL1;DUSP3;HES1;USP22;ASNS;EIF4EBP1;EIF4E;TTL
prerank,protein K63-linked ubiquitination (GO:0070534),-0.18793399492435292,-0.6241610829440781,0.9770992366412213,0.9812718168646115,1.0,11/41,21.56%,WWP2;TRIM56;ITCH;RNF5;TRAF1;UBE2G1;TRIM5;HECTD1;PELI1;UBE2B;BFAR
prerank,adrenergic receptor signaling pathway (GO:0071875),0.22799989851633914,0.6240372834713509,0.9166666666666666,1.0,1.0,8/20,25.54%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3;LMBRD2;ADCY9;DRD3
prerank,somite development (GO:0061053),0.26461771691779196,0.622978393399261,0.8964757709251101,1.0,1.0,4/11,18.67%,LOXL3;MTHFD1;PPP2R3A;SHH
prerank,"base-excision repair, gap-filling (GO:0006287)",0.20024630247181716,0.6221385413753572,0.9561586638830898,1.0,1.0,11/35,21.92%,MPG;RPA2;RFC5;RPA1;PARP1;POLD4;POLD1;PCNA;POLD3;RFC1;POLD2
prerank,telomere maintenance via recombination (GO:0000722),0.2562472500770261,0.6217975190183851,0.9028077753779697,1.0,1.0,4/11,18.37%,TEP1;SMC6;SMC5;NSMCE2
prerank,eosinophil migration (GO:0072677),0.24367426382871837,0.6207634556722125,0.915948275862069,1.0,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.24367426382871837,0.6207634556722125,0.915948275862069,1.0,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,central nervous system neuron differentiation (GO:0021953),-0.19410157546162465,-0.6197901186268763,0.9625984251968503,0.9832764336794243,1.0,18/33,39.97%,OPHN1;NR4A2;AGTPBP1;SOX4;FAIM2;TOX;CEND1;LMX1A;WNT2;CTNNB1;DRAXIN;LRP6;SPOCK1;NPY;PROX1;KNDC1;MAP2;ISL1
prerank,male meiosis I (GO:0007141),0.2351367585531302,0.6195264017915526,0.9325842696629213,1.0,1.0,3/16,15.05%,HSF2BP;ZSCAN21;BRDT
prerank,axonemal dynein complex assembly (GO:0070286),0.2039945229158978,0.6192370102251104,0.9356223175965666,1.0,1.0,3/28,8.18%,DNAAF3;CCDC65;DNAL1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.26448053931645904,-0.618301654611014,0.9051878354203936,0.9827497471086029,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.26448053931645904,-0.618301654611014,0.9051878354203936,0.9827497471086029,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,t-circle formation (GO:0090656),-0.26448053931645904,-0.618301654611014,0.9051878354203936,0.9827497471086029,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,protein insertion into membrane (GO:0051205),-0.19697801903831608,-0.6174584327984037,0.9406130268199234,0.98278585375937,1.0,13/32,38.30%,APP;STX1A;SEC61B;EGFR;SGTA;STX5;UBE2J2;TRAM1;VAMP2;CCDC47;RTP4;RTP3;VAPA
prerank,protein oxidation (GO:0018158),0.25840124117485647,0.6168885079334797,0.8990825688073395,1.0,1.0,2/11,7.66%,LOXL2;LOXL3
prerank,intracellular sterol transport (GO:0032366),0.24863529685072666,0.6166502272291466,0.9149425287356322,1.0,1.0,3/13,14.37%,ABCA1;OSBP;RELCH
prerank,ncRNA catabolic process (GO:0034661),0.202152730553691,0.6156867468270407,0.9386503067484663,1.0,1.0,2/28,6.12%,TUT4;LIN28B
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2301949615552325,-0.6154069741641595,0.9323843416370107,0.9833962525482495,1.0,12/16,51.84%,TNFRSF1B;FGF10;PTPN22;LST1;TNFSF8;IL12A;CD22;TNFSF9;IL12B;LGALS3;TNFSF18;SOX11
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.2333515782630764,0.6152750262098535,0.9198218262806236,1.0,1.0,1/17,1.91%,APOH
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.18466466930141223,-0.6148275659988915,0.9812734082397003,0.9832594544211519,1.0,3/42,5.67%,LBP;RPL30;RPS19
prerank,protein import into peroxisome membrane (GO:0045046),0.2168643704812456,0.6144188614249539,0.9334811529933481,1.0,1.0,6/22,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX19;PEX2
prerank,UV-damage excision repair (GO:0070914),0.2504607641703507,0.6136662051032498,0.8886255924170616,1.0,1.0,1/12,3.73%,DDB2
prerank,telomere maintenance via telomerase (GO:0007004),-0.20270130835358163,-0.6133301915181666,0.9716981132075472,0.9835819292552015,1.0,12/28,35.68%,HSP90AB1;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.21554543401199389,-0.6131849816920107,0.9528301886792453,0.9832200868608114,1.0,6/21,28.22%,PPARD;FAAH;ACOT8;LDHD;ACOX1;LPIN2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.23595254681870104,0.6126111154701231,0.9300225733634312,1.0,1.0,5/14,23.00%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,lipid modification (GO:0030258),0.19646301690468473,0.6125525242442227,0.9631147540983607,1.0,1.0,8/37,17.58%,ALOX12;DGKD;PLPP3;PLPPR1;PLPP4;PLPPR5;PORCN;DGKI
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.20939243236573438,0.6122986217024604,0.9345372460496614,0.9997868027829528,1.0,5/23,14.57%,KIF5C;DYNC1I1;CCDC186;KIF1A;MAP6
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.2532448881811229,-0.6120974905624144,0.933572710951526,0.9833198871507653,1.0,5/12,39.71%,STMN2;CDH5;STMN1;DYRK1A;MAP2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.21404985591371545,-0.6118048154534926,0.9449715370018975,0.9830332758265475,1.0,11/22,42.86%,NCOR1;PPP2R5A;CCDC3;APOC1;BSCL2;APOD;GPER1;ADRA2A;CEACAM1;CIDEA;TNF
prerank,cell proliferation in forebrain (GO:0021846),-0.26542495074498157,-0.6114948449773263,0.9431818181818182,0.9827397039352586,1.0,4/10,31.10%,PCM1;NUMB;AKNA;WNT7A
prerank,regulation of intracellular transport (GO:0032386),0.18773622362229203,0.6088909828938895,0.9660297239915074,1.0,1.0,5/38,13.04%,WWC1;SCFD1;ATP9A;DYNLT2B;RINT1
prerank,heterochromatin assembly (GO:0031507),0.21941312807885693,0.6084695716837603,0.9403341288782816,1.0,1.0,4/20,16.99%,SIRT2;MBD2;SMCHD1;HDAC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.23916008048087792,0.6066774502366398,0.9026548672566371,1.0,1.0,2/14,10.46%,EARS2;PNPT1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.20683273730524648,0.6046001114346167,0.9588477366255144,1.0,1.0,5/27,15.00%,NAT8;TAF6L;KAT8;EP300;KAT5
prerank,receptor catabolic process (GO:0032801),-0.2043080219867279,-0.6025153256382841,0.9491833030852994,0.9866663603256088,1.0,5/24,15.16%,TGFB1;AP2M1;KIF16B;SMURF1;AP2A1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.24451518958245783,-0.602341150488294,0.9354838709677419,0.9862993105287975,1.0,10/12,53.99%,IL1R1;SLC11A1;IL12RB1;IL23A;IL23R;IL12B;XCL1;CCR2;IL1B;IL18R1
prerank,retinal metabolic process (GO:0042574),-0.2405179677799725,-0.6021195728579024,0.9445438282647585,0.9859763526789778,1.0,3/12,17.17%,CYP1B1;ALDH1A3;DHRS13
prerank,gas transport (GO:0015669),-0.2554811488868743,-0.6007703449466999,0.9320214669051878,0.986209483230482,1.0,5/10,41.43%,CYGB;MYC;AQP1;MB;NGB
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.22750237916742927,0.5971266591797161,0.9347319347319347,1.0,1.0,5/16,22.28%,CPEB3;KHSRP;RBM24;TARDBP;ZFP36L2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2542483667715309,-0.596606740468899,0.9384615384615385,0.987647640693559,1.0,2/10,25.17%,ABCA2;APOC1
prerank,positive regulation of rRNA processing (GO:2000234),0.25472349507250025,0.5956658500127184,0.9011235955056179,1.0,1.0,10/10,74.54%,DIMT1;HEATR1;BUD23;WDR75;WDR43;TRMT112;SIRT7;RIOK1;UTP15;RIOK2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.1916646111529211,-0.594474913357693,0.9685185185185186,0.988146154035643,1.0,5/27,22.08%,TLR4;PTPN6;TNFAIP3;CD200;PTPN22
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.21914476394975743,-0.5932736066510801,0.9487179487179487,0.9882428356154117,1.0,2/17,8.42%,MFSD2A;AKT1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2490731415046954,0.5932502936865854,0.9116279069767442,1.0,1.0,4/10,24.32%,MTHFD1;MTHFD1L;MTHFR;MTHFD2L
prerank,"phototransduction, visible light (GO:0007603)",-0.2335368661799067,-0.5919599068124828,0.9497098646034816,0.9883964524137117,1.0,3/14,21.19%,RP1;GNB1;GNA11
prerank,microtubule anchoring (GO:0034453),0.24458369038529681,0.5903432577890337,0.9399538106235565,1.0,1.0,3/12,15.97%,SAXO2;BICD1;DAG1
prerank,lipoxygenase pathway (GO:0019372),0.23571543525677646,0.590172221925743,0.9471264367816092,1.0,1.0,2/14,10.48%,ALOX12;HPGD
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.25066600041069387,-0.590013162575003,0.9377289377289377,0.9883537512735043,1.0,4/10,37.24%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.25066600041069387,-0.590013162575003,0.9377289377289377,0.9883537512735043,1.0,4/10,37.24%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,ncRNA 3'-end processing (GO:0043628),0.2312225066203698,0.5884748988538929,0.9309576837416481,1.0,1.0,7/14,26.40%,INTS6L;PTCD1;INTS7;TRNT1;SSB;INTS5;TOE1
prerank,snRNA 3'-end processing (GO:0034472),-0.21396623458032488,-0.5881541592952493,0.9603448275862069,0.9886369070360197,1.0,8/19,36.70%,INTS8;INTS1;EXOSC8;INTS12;EXOSC9;INTS2;INTS14;USB1
prerank,mismatch repair (GO:0006298),0.19669152580942303,0.5875203347312552,0.9573033707865168,1.0,1.0,11/27,23.98%,RPA2;MCM9;PMS2;RPA1;POLD4;POLD1;PCNA;POLD3;POLD2;PMS1;MUTYH
prerank,negative regulation of immune system process (GO:0002683),-0.2212946496952769,-0.5860849845232904,0.9310344827586207,0.9890341626417711,1.0,3/16,19.37%,COL3A1;CD200;SOX9
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.20030430187192091,-0.585447790267912,0.9591836734693877,0.9888344405688558,1.0,8/22,29.76%,CDKN1B;INHBA;CDKN1A;CDKN2C;CDKN1C;CDKN2B;INHA;PLEK
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.20413777613394252,-0.5849041464334882,0.9608938547486033,0.9886174772091413,1.0,8/21,27.85%,DUSP3;TNFAIP3;JAK3;LAPTM5;PTPN22;BANK1;LST1;LAX1
prerank,peroxisomal membrane transport (GO:0015919),0.19591028410888023,0.583303769492326,0.9663865546218487,1.0,1.0,7/27,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1894796380090497,0.5826788306365837,0.9609053497942387,1.0,1.0,29/29,81.09%,PRDM9;SYCE2;P3H4;TEX11;MEI4;SYCE3;RNF212;KASH5;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;TERB2;HORMAD1;ANKRD31;RNF212B;TERB1;RAD21L1;IHO1;SIRT7;STAG3;TEX12;ZCWPW1;MEIOB;MAJIN;FANCD2;REC8;RAD21
prerank,negative regulation of signaling (GO:0023057),0.1990501166786908,0.5825519877834692,0.9830148619957537,1.0,1.0,7/25,19.85%,NLRP12;ERBB3;OPTN;LIF;HHIP;TRAT1;SOCS5
prerank,cilium-dependent cell motility (GO:0060285),0.20574631435828983,0.5825317873934814,0.9675456389452333,1.0,1.0,2/22,6.91%,TEKT3;CCDC65
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2236911477548247,-0.5823792710202976,0.9575971731448764,0.9891391642824513,1.0,6/15,31.67%,SPCS1;RAB3GAP2;ZFAND2B;SEC61A1;EDEM1;SRPRA
prerank,intracellular cholesterol transport (GO:0032367),0.22522077825503123,0.581959162076856,0.9362186788154897,1.0,1.0,4/15,18.16%,ABCA1;OSBP;RELCH;LDLRAP1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.22815168257157192,0.5812269803094462,0.9370932754880694,1.0,1.0,13/13,77.20%,ITFG2;ATM;CASTOR1;DEPDC5;KPTN;SZT2;STK11;SPAAR;SESN3;RNF152;SESN1;CASTOR2;SESN2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.19349865746373318,-0.5810479607468638,0.972972972972973,0.9891966251011229,1.0,6/25,19.91%,PRPF8;SRSF4;DDX23;SF3A3;SCAF11;LSM1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.22908227998543126,-0.5796576389682953,0.949317738791423,0.9892673376558964,1.0,5/13,31.22%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.24915477008526937,-0.5796559420631666,0.9447415329768271,0.9888280991132719,1.0,3/10,18.00%,DKC1;RPUSD4;RPUSD1
prerank,protein prenylation (GO:0018342),-0.2557746300745646,-0.5793294207614422,0.935251798561151,0.9885216508376033,1.0,6/10,48.15%,RCE1;RABGGTB;CHM;RABGGTA;FNTB;AIPL1
prerank,negative regulation of organelle assembly (GO:1902116),0.18888353788897416,0.5781747693140169,0.9653679653679653,1.0,1.0,11/35,23.78%,PHF23;SCFD1;MDM1;YAP1;TCHP;NBDY;NUPR1;TRIM37;FEZ1;KAT2B;TESK1
prerank,rRNA modification (GO:0000154),-0.19924465636775243,-0.5776908022450651,0.9644194756554307,0.9886942517464329,1.0,5/21,25.96%,THUMPD1;DKC1;ZCCHC4;MRM2;FTSJ3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.21624400224879342,-0.5768580175345798,0.9585687382297552,0.9885704697256543,1.0,9/16,41.34%,UQCC2;VCP;SLC25A33;COX7A2L;SHMT2;PDE12;PPIF;COX7A2;ABCD1
prerank,regulation of spindle assembly (GO:0090169),-0.19403520146467315,-0.5762738684114556,0.969811320754717,0.9883457159849992,1.0,7/25,32.16%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,negative regulation by host of viral process (GO:0044793),0.2532878292194559,0.576026872127216,0.9105882352941177,1.0,1.0,1/10,5.39%,PRKN
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2155565689144769,-0.5758835041135527,0.9538461538461539,0.9880390056506505,1.0,3/16,16.01%,ACLY;PPT2;SLC25A1
prerank,piRNA metabolic process (GO:0034587),0.20777676815487028,0.5757320241061052,0.9575892857142857,1.0,1.0,3/19,13.84%,HENMT1;PIWIL2;TEX15
prerank,mitotic spindle assembly (GO:0090307),0.1747965592435396,0.5753595326241285,0.9794238683127572,1.0,1.0,6/42,12.31%,STAG1;MAP9;GOLGA2;MAP10;PIBF1;AURKC
prerank,positive regulation of receptor internalization (GO:0002092),0.20363815150722092,0.574524876023471,0.9508547008547008,1.0,1.0,2/22,9.58%,MAGI2;AHI1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24512098489076856,-0.5735922194836796,0.9377224199288257,0.9884053373155787,1.0,9/10,59.88%,E2F7;E2F8;STOML2;DBF4;SSBP1;CDT1;INO80;WIZ;ATRX
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.19888952636821955,0.5717385493132054,0.9630434782608696,1.0,1.0,10/24,28.22%,STN1;PINX1;PARP1;GNL3L;TNKS;TINF2;TENT4B;TNKS2;XRN1;NAT10
prerank,negative regulation of B cell activation (GO:0050869),-0.19561525342340996,-0.570083844173188,0.9696969696969697,0.9892031734609936,1.0,7/21,26.69%,TNFRSF21;RC3H1;INHBA;TNFAIP3;LAPTM5;BANK1;INHA
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.22709085495220777,-0.5697293914838514,0.9443413729128015,0.9888919044471874,1.0,4/12,24.94%,ELOVL5;ACOT8;ELOVL1;ACOX1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.2479933683948188,0.5697243431573554,0.9295774647887324,1.0,1.0,1/10,3.69%,DNAJB8
prerank,homocysteine metabolic process (GO:0050667),-0.23504672295115814,-0.568660954235971,0.9358974358974359,0.9888249054434468,1.0,6/11,42.66%,CTH;BLMH;MTRR;MPST;TST;DPEP1
prerank,regulation of microtubule-based movement (GO:0060632),0.23915716002583465,0.568616792340889,0.9523809523809523,1.0,1.0,2/11,11.65%,CCDC65;DYNLT2B
prerank,protein destabilization (GO:0031648),0.18142760066942934,0.5672504522527841,0.9874213836477987,1.0,1.0,8/32,20.06%,MDM2;PRKN;SENP2;BTRC;EP300;CTSH;FBXW11;PEX2
prerank,nucleosome organization (GO:0034728),0.16524609346434554,0.5671661494171049,0.9880478087649402,1.0,1.0,16/55,23.18%,PRDM9;CTCF;ANP32E;MCM3AP;DAXX;SPTY2D1;SMARCB1;BRDT;SART3;SRCAP;NAP1L2;SET;PAF1;SMARCD1;BPTF;NASP
prerank,positive regulation of transporter activity (GO:0032411),0.217562029194803,0.5671229484821687,0.9474885844748858,1.0,1.0,6/13,25.86%,KMT2A;WNK3;PDZK1;RXRA;NR1H3;SGK1
prerank,nucleic acid metabolic process (GO:0090304),0.15874626538914482,0.566853171347373,1.0,1.0,1.0,1/69,0.21%,ENPP1
prerank,serine family amino acid catabolic process (GO:0009071),-0.24664980449943863,-0.565251778315365,0.9547101449275363,0.9895522499281126,1.0,5/10,36.01%,DLD;AMT;THNSL2;SHMT2;DAO
prerank,rRNA catabolic process (GO:0016075),-0.20888660259296343,-0.5649623335758661,0.957089552238806,0.9892086682900629,1.0,9/16,50.32%,EXOSC8;DIS3;EXOSC9;PELO;ERN2;TRIR;DIS3L;SLFN14;EXOSC7
prerank,organophosphate catabolic process (GO:0046434),0.23515379786566218,0.5639236007394993,0.9408163265306122,1.0,1.0,11/11,76.50%,PLBD2;PLBD1;PDXP;ANGPTL3;PNLIPRP2;ABHD12;APOA2;LIPG;PON1;NUDT15;ENPP2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.19004583444603268,-0.5609634589901991,0.967984934086629,0.990069497246691,1.0,5/25,18.15%,LYST;CHMP2B;VCP;LAPTM4B;CHMP2A
prerank,glycerolipid metabolic process (GO:0046486),-0.2323289391086001,-0.5584653608462427,0.9437386569872959,0.9903732866152571,1.0,11/11,76.79%,DGKZ;PIP5K1A;DGKB;DGKG;PGP;DGKQ;GAL3ST1;PDXP;PLA2G15;PNPLA3;DGKA
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22849968612680474,0.557265685961949,0.9586956521739131,1.0,1.0,11/11,77.17%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22849968612680474,0.557265685961949,0.9586956521739131,1.0,1.0,11/11,77.17%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.22849968612680474,0.557265685961949,0.9586956521739131,1.0,1.0,11/11,77.17%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.23567557759694674,-0.5543207578287095,0.9607476635514018,0.9911499933405288,1.0,8/10,45.20%,TAF9;PIH1D2;ZNHIT6;RUVBL1;ZNHIT3;NUFIP1;NAF1;RUVBL2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.23626890967296474,0.5519916112287209,0.9510022271714922,1.0,1.0,10/10,76.39%,DLGAP1;DLGAP2;DLGAP3;CACNG5;NPTX2;NPTX1;AKAP9;NPTXR;DLGAP4;BEGAIN
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.23363050049364423,-0.5482262610171551,0.9640933572710951,0.9924736707725326,1.0,5/10,38.35%,RC3H1;LGALS9;SCRIB;CRTAM;PDCD1LG2
prerank,positive regulation of chromosome organization (GO:2001252),0.20529731378145544,0.5477283665726672,0.9671052631578947,1.0,1.0,4/15,19.74%,PPP1R10;NBN;SIRT6;RTEL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.204166389190425,0.5469925996244301,0.9688888888888889,1.0,1.0,3/18,12.95%,LYN;C3AR1;BCAR1
prerank,isotype switching (GO:0045190),0.23504042455955992,0.5438842596082117,0.9556541019955654,1.0,1.0,1/10,4.41%,CCR6
prerank,negative regulation of cell communication (GO:0010648),-0.18623581819076496,-0.5437777016789038,0.9829867674858223,0.9932330209138555,1.0,5/21,22.97%,IGFBP3;KIF26A;ACVR1;UBASH3B;PTPN1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.1733920532948148,0.5428914016336982,0.9776785714285714,1.0,1.0,1/31,2.11%,MOCS2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2310849748426169,0.5398094882765928,0.9535864978902954,1.0,1.0,2/10,14.21%,POGLUT2;MGAT5B
prerank,apoptotic nuclear changes (GO:0030262),-0.1854581130083051,-0.5396325516069689,0.9845261121856866,0.9938739411716966,1.0,8/24,31.16%,KPNA1;TOP2A;FOXL2;CDK5RAP3;DFFB;ACIN1;HMGB2;ENDOG
prerank,synaptic vesicle transport (GO:0048489),0.22291020117950533,0.5396058121522359,0.9598214285714286,1.0,1.0,3/11,16.28%,KIF5C;SNAPIN;TMEM230
prerank,positive regulation of acute inflammatory response (GO:0002675),0.21378790732718028,0.5386476475655932,0.9733333333333334,1.0,1.0,14/14,78.64%,OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;CREB3L3;TNF;ADAM8;PTGER3;PARK7;IL6ST
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2179746257923458,-0.5374493400350094,0.9541108986615678,0.9939937460428933,1.0,7/12,47.78%,PAEP;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,N-terminal protein amino acid modification (GO:0031365),-0.2090394110302262,-0.536924115822197,0.9846938775510204,0.9936996236324391,1.0,7/14,43.61%,NAA60;METAP1D;NTMT1;NAA50;METAP2;PDF;NAA11
prerank,negative regulation of telomere maintenance (GO:0032205),0.20513007887177573,0.5330987457710161,0.9891540130151844,1.0,1.0,6/15,22.87%,PINX1;NBN;ATM;PARP1;RTEL1;TNKS
prerank,regulation of inclusion body assembly (GO:0090083),-0.22237353651867275,-0.5318521601400188,0.9770723104056437,0.9944733142963174,1.0,5/11,29.23%,BAG5;HSPA1A;HSPA1B;DNAJB1;DNAJB6
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.1867967198831264,-0.5297409104677939,0.989010989010989,0.9936516044986571,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.1867967198831264,-0.5297409104677939,0.989010989010989,0.9936516044986571,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.1867967198831264,-0.5297409104677939,0.989010989010989,0.9936516044986571,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2223462691656046,0.5291232088776625,0.9563318777292577,1.0,1.0,4/11,24.09%,IL4;TAF7;SIRT1;CIITA
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.16981965889207576,-0.5280109064325226,0.9903100775193798,0.9935940845531154,1.0,11/31,37.21%,HSPD1;TIMM17A;TIMM21;CHCHD4;TIMM50;PEX14;PEX6;ROMO1;PEX7;DNLZ;GRPEL1
prerank,signal peptide processing (GO:0006465),0.21533276903261284,0.5255105184262168,0.9660297239915074,1.0,1.0,3/11,15.84%,HM13;PARL;SPCS3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.1880072999518021,0.5204047635217207,0.9873150105708245,1.0,1.0,4/21,18.07%,MITF;PAXIP1;MED12;MED4
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.19673042387304085,0.5195136413156418,0.9935760171306209,1.0,1.0,6/18,20.06%,SFRP1;GSTP1;EMD;TP53;B4GALT7;PEX2
prerank,oligodendrocyte development (GO:0014003),0.20482103251021105,0.5188482445272397,0.9617117117117117,1.0,1.0,4/15,19.34%,HES5;EIF2B5;EIF2B2;B4GALT6
prerank,base-excision repair (GO:0006284),-0.15131098439818008,-0.5181417382391057,0.9961315280464217,0.9952411443161435,1.0,12/48,26.42%,SMUG1;PNKP;XRCC1;RPA3;NEIL1;POLQ;APEX2;RFC3;RFC2;POLL;DNA2;TDG
prerank,regulation of superoxide anion generation (GO:0032928),-0.1977927169265591,-0.5177682762318987,0.9809160305343512,0.9948740708987162,1.0,5/14,31.22%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,prostanoid metabolic process (GO:0006692),-0.20414492472373152,-0.5134996945241489,0.9774859287054409,0.9952527117627618,1.0,3/13,15.05%,PLAA;PTGS1;GSTM1
prerank,regulation of actin nucleation (GO:0051125),0.21201481378619597,0.5117584402962775,0.9661399548532731,1.0,1.0,2/12,14.26%,SCIN;ARPIN
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17868821505374394,0.5115470038939017,0.9852941176470589,1.0,1.0,4/23,15.25%,GUCY2F;METAP1;GUCA1B;PDE6G
prerank,negative regulation of defense response to virus (GO:0050687),-0.21465058547521929,-0.5094320673559555,0.9740740740740741,0.9955885890041127,1.0,3/10,28.21%,ITCH;TSPAN6;MUL1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.1587368284129324,-0.5082608507705154,0.9981785063752276,0.9953687744340728,1.0,14/33,36.31%,HSP90AB1;DKC1;HSP90AA1;ZBTB48;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10;RAD51
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.18580257010973522,-0.5019711235302003,0.9744525547445255,0.9959869289037332,1.0,6/17,37.49%,SMUG1;NEIL1;TDG;TERF2IP;NEIL3;UNG
prerank,regulation of biosynthetic process (GO:0009889),0.20559091321894513,0.4981002889556635,0.9707724425887265,1.0,1.0,1/11,6.08%,GSTP1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.2147073583349191,-0.4976894811149958,0.9826589595375722,0.9962115641589893,1.0,7/10,56.72%,GNB1;PDE6B;RHO;GNAT1;PDE6A;CNGB1;SAG
prerank,lytic vacuole organization (GO:0080171),0.161089537192915,0.4968510678592911,0.9978858350951374,1.0,1.0,4/32,16.39%,ABCA1;AKTIP;SNAPIN;CLN3
prerank,DNA catabolic process (GO:0006308),0.20847457627118654,0.49679815751082834,0.9748858447488584,1.0,1.0,11/11,79.17%,SETMAR;FBH1;MUS81;DNASE1L3;REXO4;DNASE1;DNASE1L1;ISG20;XRN2;DFFB;DNASE1L2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.18972414256501446,0.49673178057679895,0.975929978118162,1.0,1.0,6/16,24.01%,EP300;NAA20;AANAT;NAA40;KAT2B;NAA15
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.19187336751201672,0.4965359592148139,0.9891540130151844,1.0,1.0,8/16,26.63%,PINX1;ATM;PARP1;SMG5;RTEL1;TNKS;TINF2;TNKS2
prerank,acyl-CoA metabolic process (GO:0006637),0.16111017220082666,0.4963672879197517,0.9978213507625272,1.0,1.0,8/35,20.77%,ACSM5;BAAT;ACOT11;ACSL6;ACACA;ACBD6;MCEE;HMGCS1
prerank,neuropeptide signaling pathway (GO:0007218),0.14322733918101066,0.49458541144702994,1.0,1.0,1.0,9/58,18.99%,SORCS1;GLRB;OPRK1;GLRA3;PNOC;HCRTR1;LTB4R2;SORT1;PDYN
prerank,synaptonemal complex assembly (GO:0007130),0.1893130729624511,0.49348036376303944,0.9768421052631578,1.0,1.0,15/15,81.09%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.1893130729624511,0.49348036376303944,0.9768421052631578,1.0,1.0,15/15,81.09%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,positive regulation of viral transcription (GO:0050434),-0.16422498890897558,-0.4914339285803918,0.992619926199262,0.9966765254352156,1.0,8/25,32.29%,DHX9;NELFE;GTF2F1;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.18217462719829178,0.4880609461412495,0.9810924369747899,1.0,1.0,4/17,23.28%,SUMO1;KCNS1;KCNS2;KCNE4
prerank,protein monoubiquitination (GO:0006513),0.1532283549450752,0.4877170692741615,0.9959758551307847,1.0,1.0,4/36,9.94%,PRKN;UBE2O;MGRN1;TOPORS
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.2078349722230037,-0.4820382275224737,0.9872262773722628,0.9974954050923776,1.0,2/10,16.28%,ELOVL5;NR1H2
prerank,protein targeting to peroxisome (GO:0006625),0.16083585856532762,0.4815274482847313,0.9957446808510638,1.0,1.0,7/29,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,regulation of T cell activation (GO:0050863),0.14646874130588516,0.477808726921593,0.997867803837953,1.0,1.0,6/42,15.76%,IL4I1;TBX21;IL27;PAG1;CD47;METTL3
prerank,snRNA processing (GO:0016180),-0.1817190869452917,-0.477023223413721,0.9947916666666666,0.9976248731142466,1.0,7/16,36.12%,INTS8;INTS1;INTS12;INTS2;INTS3;INTS14;INTS4
prerank,response to hydroxyurea (GO:0072710),0.1984804055093179,0.4766129010026416,0.9847826086956522,1.0,1.0,1/11,8.95%,BLM
prerank,regulation of cell aging (GO:0090342),0.19782570907854735,0.4759279420431746,0.9887640449438202,0.9995984782107753,1.0,3/11,20.43%,PNPT1;MIF;NEK4
prerank,cellular response to hydroxyurea (GO:0072711),0.19867915940481734,0.4667830928104683,0.991578947368421,1.0,1.0,1/10,8.95%,BLM
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2000608225561597,0.4621615972287604,0.9891067538126361,0.9999572539409008,1.0,3/10,21.96%,RIF1;RTEL1;DCLRE1B
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.16430636338910676,0.4583963659980844,0.9978308026030369,0.9996796399842637,1.0,6/21,20.12%,KNTC1;ATM;ZWINT;KLHL22;FBXO5;APC
prerank,telomere capping (GO:0016233),0.1724800468030539,0.4575935133221772,0.9846827133479212,0.9990885408162937,1.0,2/16,12.62%,STN1;NBN
prerank,transcription preinitiation complex assembly (GO:0070897),-0.1848201393684475,-0.4567347191116046,0.9909747292418772,0.9992493523017698,1.0,12/12,81.54%,BDP1;TAF1B;TBP;TAF7L;TAF12;DR1;GTF2A2;POLR1E;TAF11;TAF7;TAF1;GTF2B
prerank,regulation of receptor recycling (GO:0001919),-0.17049424266987068,-0.4545666037802768,0.9943609022556391,0.9989933731699432,1.0,3/16,17.44%,ANXA2;KIF16B;NSF
prerank,positive regulation of cilium assembly (GO:0045724),-0.16684860139054464,-0.453493436554352,0.9965156794425087,0.9986309530250383,1.0,1/18,4.88%,HTT
prerank,DNA modification (GO:0006304),0.15629508706872536,0.4460355623553435,0.9955947136563876,0.9995622753523394,1.0,4/22,17.73%,MPG;PARP3;EXOSC3;PARP1
prerank,peptidyl-amino acid modification (GO:0018193),0.1905718410645911,0.4458961480144355,0.9885321100917431,0.998894410850967,1.0,10/10,80.95%,METAP1;TTLL4;FKBP7;ATP7A;APOA2;APOA1;FKBP10;PDF;METAP2;METAP1D
prerank,DNA packaging (GO:0006323),-0.1668104085439668,-0.4458141669450478,0.9942196531791907,0.9987466215979173,1.0,4/16,31.43%,CDAN1;RBBP4;BANF2;BANF1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.1409178427761723,-0.4453409668693185,0.9981343283582089,0.9983474268658966,1.0,15/33,40.17%,SNRPD3;LSM11;SNRPG;CPSF4;NCBP2;LSM10;CSTF2T;SNRPB;MAZ;PCF11;CPSF1;CSTF3;SNRPE;SNRPF;NCBP1
prerank,regulation of transposition (GO:0010528),0.17558116279532904,0.4382508602981871,0.9914893617021276,0.998839174996463,1.0,3/13,20.49%,PIWIL2;TEX15;UBR2
prerank,regulation of response to stress (GO:0080134),-0.17932840314095788,-0.4263222233632793,0.994328922495274,0.9989887097907798,1.0,5/10,37.66%,MLC1;EIF4G1;DYRK3;SLC38A2;CRHBP
prerank,regulation of rRNA processing (GO:2000232),0.15450837669455172,0.40437147246984234,0.9978260869565218,1.0,1.0,5/16,24.92%,SHQ1;DIMT1;HEATR1;KAT2B;BUD23
prerank,peptidyl-methionine modification (GO:0018206),-0.15774320452661206,-0.387845516298055,1.0,0.9998338511392643,1.0,2/12,19.06%,NAA60;METAP1D
prerank,tRNA 5'-leader removal (GO:0001682),-0.1498308091948669,-0.38289468586351105,1.0,0.9995019777807789,1.0,6/13,43.91%,RPP38;RPP21;RPP25L;RPP40;RPP30;RPP25
prerank,protein import into mitochondrial matrix (GO:0030150),0.13978793350784105,0.3750965240635969,0.9978494623655914,1.0,1.0,5/18,20.39%,TOMM70;PAM16;GRPEL2;TOMM40;TOMM40L
prerank,natural killer cell activation (GO:0030101),0.12345226273611941,0.35346910149153815,1.0,0.9998185539598479,1.0,3/23,17.11%,AXL;NFIL3;RABL3
